<SEC-DOCUMENT>0001425450-20-000107.txt : 20200806
<SEC-HEADER>0001425450-20-000107.hdr.sgml : 20200806
<ACCEPTANCE-DATETIME>20200806134337
ACCESSION NUMBER:		0001425450-20-000107
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20200630
FILED AS OF DATE:		20200806
DATE AS OF CHANGE:		20200806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOPEDIATRICS CORP
		CENTRAL INDEX KEY:			0001425450
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				261761833
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38242
		FILM NUMBER:		201080894

	BUSINESS ADDRESS:	
		STREET 1:		2850 FRONTIER DRIVE
		CITY:			WARSAW
		STATE:			IN
		ZIP:			46582
		BUSINESS PHONE:		574-268-6379

	MAIL ADDRESS:	
		STREET 1:		2850 FRONTIER DRIVE
		CITY:			WARSAW
		STATE:			IN
		ZIP:			46582
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>kids-20200630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:6cad6b03-419c-4f54-8eef-33f01636649a,g:8b88b676-dabc-417a-b49f-ad3a7a6b9677,d:38c4d288f2604685a8c81d4642167bbd--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:kids="http://www.orthopediatrics.com/20200630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>kids-20200630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGFibGU6ZGRiYWUyOWYxZmZmNGU0NThjY2E1Y2E4NjlmNGE3YTYvdGFibGVyYW5nZTpkZGJhZTI5ZjFmZmY0ZTQ1OGNjYTVjYTg2OWY0YTdhNl8zLTEtMS0xLTA_680ccb9f-3d48-4b27-b135-bc092a4e36db">2020</ix:nonNumeric><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGFibGU6ZGRiYWUyOWYxZmZmNGU0NThjY2E1Y2E4NjlmNGE3YTYvdGFibGVyYW5nZTpkZGJhZTI5ZjFmZmY0ZTQ1OGNjYTVjYTg2OWY0YTdhNl80LTEtMS0xLTA_409d467f-47da-494b-bb24-96936a0178f7">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGFibGU6ZGRiYWUyOWYxZmZmNGU0NThjY2E1Y2E4NjlmNGE3YTYvdGFibGVyYW5nZTpkZGJhZTI5ZjFmZmY0ZTQ1OGNjYTVjYTg2OWY0YTdhNl81LTEtMS0xLTA_247cf476-978a-4c5f-8459-2e8e0f499358">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGV4dHJlZ2lvbjozYmY3OTE3YjlhMTE0NjYzYTRhYWMxYTRmYWY5NGYwN182MQ_86f3fb8f-e51f-498c-8b4a-b9bb39ede328">0001425450</ix:nonNumeric><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGV4dHJlZ2lvbjozYmY3OTE3YjlhMTE0NjYzYTRhYWMxYTRmYWY5NGYwN182Mw_fbc6db9f-ea86-4dde-9159-1fec82ad23db">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201" name="kids:ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfODQ_bf262227-ff5c-44d1-a84e-6eebb551fe29">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="kids:ClassOfWarrantOrRightTerm" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTU5Ng_22c0bf25-8204-4c32-a466-8f4c334e3f8a">P10Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="kids-20200630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i64001efefd914b23a423885f1db0f016_I20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-08-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i4daa9a471c454c999687c99d7d5c379c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4e2a354b98945b7ac75843c10a25a44_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5b873289d394f8698109e34413ebc6c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if33c7e6e77b34aadafae7225d988f633_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c138c5223b945249abec4b41802cfe9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ee305abb72e4348bdb25affaa6c5bb0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i581093052fd24f5683c783d8150a5768_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f552ff6bd064623b1279ee353b79be5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c69752a2cd84ef3bf96562629d01f6d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i688ab3c7a7c14968861796de50cec944_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8efc4342789a4574a5010b2cd5a5e4d4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i003a46bd442946f49063fccbb2f71fd2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic378826a602e45ea8c6a8ded2624b481_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96caa6529642403084788194234fac2d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84610b8d7d3b44b680b451fe979cb9a8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fd36dae3b2b4256bc00944063093da2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c7b4f7e5904e5e9d5168eb8819cc11_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i582149af38174a49b5d43f5c23400d89_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3d201608e0848fc80fcef2eecd22d46_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia54ab828e6394dc29714827ff395896a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8f67a7223747f88624ef41a564ed11_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied22f6706c404fd681c4a5fc164e16db_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i956afb27a29242589884eb0e1ccf86c9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f59b1fe6bf14e1d934932e9f19a662a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21ce4cf60f7042b380ec1757dc4f8a08_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i557ae529b0534b7e83bdfd35a6d1216a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id101b89cfc2f41c28814b80debdc3cb8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i296365e2b77b4e8183cf0fe4076355f8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d138a5d3c994ce39162445d9d354401_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55478baf239442988af0a3137120ff79_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22bef0eaffe04104b79fd06b8e9b6aa1_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a8b5cca80f46518592a4750ba5850a_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77602246977e4ab48559ae10f9ef671c_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i368ef1c3bb964a91992f82e0a63d6ec9_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264938c435d846aa93d88d47ad3d77af_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1922e3a342ea477b82afbb406801bb66_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib89641723e5a4a5189fce4a3e9a9f517_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2e6fb5fc5ad4a8883252831c70d9b8e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514e1984bf624bcab1ca800517fe8409_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0edebf080f80402f883427d33eb82646_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d824c1eb834a1196d7d2349e2b3500_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5c58d0d3a06407fae45526ac0b7f3a6_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2de6637c368451a83b9fbebce1b02cc_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7da59944142842809e0da6afc8bff8e2_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5be348dea4b94b1290c68f97c0b18392_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i437c34bd707949e2b3624b784bd27f1b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i606ed33122784ef28a374862e04b8938_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5b1d0fd10514bb7ae0a9c0147334def_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a285bb683e44422bf5d4ef530eb8f9a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:BandLokMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7586dec2cc8146b0a84c69f0ed6a9b88_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:BandLokMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae79c794ca74ecaab7e1f4be1666580_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1722f284f22149b0b62e23f146f1da73_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iade7dd3801514191b80df2d859180efe_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:SecondAnniversaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>kids:facility</xbrli:measure></xbrli:unit><xbrli:context id="ia07305a71eeb47d99be5750a3a47cb18_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:ThirdAnniversaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974a053f052c4233bccf37c504b97db0_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:FourthAnniversaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1832772ced4e4d7694796baf90a940a1_D20200610-20200610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:BandLokMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-10</xbrli:startDate><xbrli:endDate>2020-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kids:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-22</xbrli:startDate><xbrli:endDate>2020-06-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7c30dda4914c6593234714105f5846_I20200622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kids:FollowOnOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a679238a7a43869b57724937813e35_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa4a9026c5c340bca4066b1c0efd2063_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic55ec3187d414b9abaf5fb65b6c8a434_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6897b493df42eeb47e27f00c5abf4b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96d7db72a7864d59befbe7a971698da9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53ba86c7840345919cc20c4229f816e0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1287bce70e774c27965e7c70d082232c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i940588eb8f6a40e3a2e23b5b87a7a8b9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47943924a14342328b889ec2d330cf79_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd8747608254c9ab234730b9575a4fb_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad4e18322904bda9fe3bf97682b7114_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kids:SampleInventoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ce4805a31e8410d81b81251b9b1f57c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6bbf783a9584fe0a1bd64259cbff166_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kids:A2007EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa05c196b8e04e13accf63a52bae4361_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kids:New2017EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e55361217974608a2b11df6efaf5506_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i292238a1b0524036b2e519416ce7ebbc_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd7fadd1c8141f4bce22e9933efeca0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44bb1450f6e841a0b1500229ed099770_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66ddcda9efb2401e914b895725e8449a_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad1fff330924b20990fd0c7cf170c10_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib40f513d923c4826b58162f6f5582202_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cf98eb1a09e4ccb8140a7acdb7780b3_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia313240909774cbe8dc30507a797ccc1_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ad06b13cdff4f36ab42c19c49f5ec90_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i938290d2cdad418ea88e9197cb42d54e_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea2114642e614c76862ec79220c8b6de_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4871de21cf3c497a9d2222f88b61d7ab_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:SecondAnniversaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefda4158f9254c1eb3becf702fc558a8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:SecondAnniversaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36be2612ceac48918982f7de2682e1c5_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:ThirdAnniversaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de47578e860485f8740cf50e09ee68f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:ThirdAnniversaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i136967d17bba4ed28cf1f18b639b6b83_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:FourthAnniversaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i190a872146ee4e9187065e968ab399b3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:FourthAnniversaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0891c5d60bc5463e814034e47be08954_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a8bd33230e4f23a9d792dc0bb5a7ee_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9d0f0383c646788001508a2c5597bd_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95b3a7b0f9324955af777d48822570a9_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c8ff79382af4dbeb5b7c523481aa645_I20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9512287e4134097a7d49339bfdae2a8_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if66e4ed42c0340ae95515133232879f3_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697f880d24684012827b17b5de98d360_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51c7929e645642919dea6b4923e42798_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b0fbb66fe2467f9e999a25aaa3b1cc_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2036398d56b74a198f2a687eeb8fde44_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce021843bf7476ab44bfacfc23770c3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i779524b02e4741949cdceb2816836fca_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:OrthexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43216f47eeee41f6bb129feaeb6cdc7e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae923d4563d427bacf487bd51f6a91d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6894ee1ed534a779143dc099648c47f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id145432eb8c441e5b1dbddc0c0a863d0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee46e00cdee24529b067135f7e8c5115_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i217400e5358b4111bcda2d87a7c82ea6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b0498ea6ef04efdafac30fa191f07f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26700fd1a63342dd8c4212993b04610d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44183e3bfe624d5d8cb321bdf8e45312_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba47742d675456f97dcddba2466e3f9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12a267c66f9e460cbcdd61aca29f6e43_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb96a082b67d4e369fad244fcf9ecea7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58298dbcea9a43738bf180f55aa6c005_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4212d5ada3e1486386101c68b4a3ff9b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97ee1b03f3f34cb8a5a900dbd94f9e8a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55c4e72e21c0402b9665b56e75791946_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522cee87c6934a54b91779a2e4a36983_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32ecfc1db0094cdf9b81fbbdb546dc71_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91313831b49b4497a30f40930e592148_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia750dea5d4f84490a3ed6d2032d6b369_D20190604-20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-04</xbrli:startDate><xbrli:endDate>2019-06-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifea33470bf02413c92995e85b05b1ad0_D20171231-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-31</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaabfc50f270c4500963cf0c8d1d79fe8_I20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a7811335a9947b3b93354b5f0367da1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d597c299e87430aaf3c619817196928_I20190604"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eba4623b24a447fbe2ee28df0cdd245_D20191231-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:TermNoteBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-31</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5755d80d80843eaa4f3d75bcc7bbba4_D20191231-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-31</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e31cbfbaa6540549a2b910c978401be_D20200104-20200104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-04</xbrli:startDate><xbrli:endDate>2020-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3be7e495a9b44feba44e00526454ab10_D20130801-20130831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-08-01</xbrli:startDate><xbrli:endDate>2013-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901f004c0d1149749e65dd0a69e57ff2_I20130831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce9195684154b7296d03f48c3f26321_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2f23483cdc3453791280df0471e41a9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2007-12-01</xbrli:startDate><xbrli:endDate>2007-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e4452d90eff4a999d49f7af62efccde_D20170802-20170802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-08-02</xbrli:startDate><xbrli:endDate>2017-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib62efb33448d425f8bb4b13674e7e6c7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e2ab5c81fda421daa443c34171cffb0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b009d063c2e467993e163ef9a164f0e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720e0f76ea12446a83bf8ab6c5736641_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae1c5b976b9426ea7c2afb46f2de085_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cf3572a27664de18b2b944dc137f71d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86c42bd634d6439e9ab4f9d4586e1807_I20140530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-05-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fc9092f14204444ba24d4c873eb6e82_I20181211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff3b8a415a248e1b649428771d5dd22_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8a3c8fd6994c91bfa372ef62e86e22_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20d35bb680f64b0ba2acd454d8e86d83_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad46059f454f4bbea038030b853e05e6_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c7c78b58af646cd96f6b8bd5e1d1d13_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i432d3aa78750469da80bdc567e4824f6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie158e3539d5e4934824bb0f77b22ef76_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bb3e606a2bd424d964faaf220d28e88_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbb6455ee34645b9b482fe979192967c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f161809f3474a4cabfb3f9e420c96d1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7204f2c032b942a68028138eeece4cee_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46623ac889f4451080c334614620617b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife2d42f413d047f09f78455b81ba82e0_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00909a9da62143989aea8f861f283df1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d4b7eb4460144da819f7cf668aa8bdd_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>kids:segment</xbrli:measure></xbrli:unit><xbrli:context id="ice73e8c1b57f4796918a790a968b7015_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2622759db9c144acb87d793c9cf03743_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c269ea2edf4cf5aef8ed02d7e1f45c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fb48cad575945baac6067e33a96cadc_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia756c05cec28403f884770d9344bdac2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i721aca0cd1734c8aaf8b8d90702bc1d1_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id10512dde3404dfcb6e3c0cce3a1f040_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i266ee2942a4a4657a71d21bdf2710068_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id78469ce723d4142ae3b8ab43ffa60a0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i225cd71c1ec1426d8041c44a2184d1ae_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c889130704d4f80946a9c6286e05061_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed7c2942fcb4d46a5ca89a0294a7bf5_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fff3612ea874d5180f15f4a42bc8604_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9200b24feefc4b159ffafee02cb55e00_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7ea47b72ee450b8582bd233a4fac65_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id56952e6da1c40bb95f3ecf288efc864_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83e4b27552214a3a879d0adf2748bebb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c76b6d6fbcd4e0e87b78db6dea4ab41_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba3dd237ec5246bbba457e8a049a8981_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ce3387f4cd14200af133e93202fc096_D20190101-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="supplier"><xbrli:measure>kids:supplier</xbrli:measure></xbrli:unit><xbrli:context id="ie0deb0d220a848e5ab3218335eba7b86_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fb8f7b19c8b43a0ab7aa696389aad13_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:FMIHansaMedicalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82095520751c4542b0194bd4a6b61005_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:FMIHansaMedicalProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icef3ad5351134de9bd2e9409f0f579f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaad49ffb99f40309f22c27c5a29b41a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7249b3def0b34e65b3e605e288e1cc43_D20200101-20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70d54ac0693a4a3780155e252a95c82c_I20200803"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:FirstAmendedLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfc293021e554021ac712a08de896501_I20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:FirstAmendedLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9d46247c02e4dad89dcf4bf7fdb0780_D20200804-20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-04</xbrli:startDate><xbrli:endDate>2020-08-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc09a7c192ec43ffbf6d23af854df8b2_D20200804-20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:SecondAmendedLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-04</xbrli:startDate><xbrli:endDate>2020-08-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab10817a561491dad2e85b5bebc393f_I20200804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:SecondAmendedLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1955253c07c4f0f85875d92dbf6bbb7_D20200715-20200715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001425450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:TermNoteAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-15</xbrli:startDate><xbrli:endDate>2020-07-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i38c4d288f2604685a8c81d4642167bbd_1"></div><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:144%;">UNITED STATES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:144%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:144%;">Washington, D.C. 20549</span></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:144%;">FORM <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY184Mg_6a6bf04c-3b7c-4428-a8ad-dd0dcae2c50e">10-Q</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">(Mark One)</span></div><div style="text-align:center;"><span><br/></span></div><div style="padding-right:2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY185Nw_0b58b2e4-d628-4c4f-8083-00bbb9ac2a67"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY185Nw_ddf27337-bdbe-4007-9c13-b73b61c0662a">&#9746;</ix:nonNumeric></ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">For the quarterly period ended <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMjA_36e2a63b-e6ce-4965-8d15-19e27cebfa93">June&#160;30, 2020</ix:nonNumeric> </span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">OR</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMjk_649c0d45-39cf-4257-a0a5-63fd43fc7993"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMjk_86330223-e2f0-4e2c-84fc-c55a3099a20f">&#9744;</ix:nonNumeric></ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">For the transition period from _______ to _______</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:144%;">Commission file number: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:144%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18zOTc_eeb6321e-d283-4a90-9298-54b925eabc53">001-38242</ix:nonNumeric></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:144%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY180MDA_3089d0ab-98a8-4dd7-9ae4-d64ff7484bc5">OrthoPediatrics Corp</ix:nonNumeric>.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:144%;">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:48.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:48.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjUzYjYyZjg1OTA2NGZhOThkZDYxNTFmYTIyN2NiNzkvdGFibGVyYW5nZTpiNTNiNjJmODU5MDY0ZmE5OGRkNjE1MWZhMjI3Y2I3OV8wLTAtMS0xLTA_c9dd5444-23eb-413a-a0fb-9c89f0d57065">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2pt;padding-right:-2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjUzYjYyZjg1OTA2NGZhOThkZDYxNTFmYTIyN2NiNzkvdGFibGVyYW5nZTpiNTNiNjJmODU5MDY0ZmE5OGRkNjE1MWZhMjI3Y2I3OV8wLTEtMS0xLTA_f8041d4a-8c17-4f30-aa01-08292476928f">26-1761833</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2pt;padding-right:-2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">(I.R.S. Employer Identification Number)</span></div></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:48.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:48.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;text-align:center;margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV81_0ff520cb-9174-4a92-b44c-b9d82a207a81">2850 Frontier Drive</ix:nonNumeric></span></div><div style="padding-right:2pt;text-align:center;margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV84_4e7bfeb8-19e8-4401-8c77-ccd55ebdab3f">Warsaw</ix:nonNumeric>, <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV8xMg_138b97bd-0ab4-45fe-b38f-b09b83c6f6cd">IN</ix:nonNumeric> <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV8xNQ_26bd43c5-3368-471b-bd8b-4b8621bcb51a">46582</ix:nonNumeric></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2pt;padding-right:-2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">(<ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTEtMS0xLTAvdGV4dHJlZ2lvbjo5Y2RjNDQ1ZTk5Y2M0OGJlOGMzMGY3ZDQ2ZjUyNjk0Yl82_6afc3984-812a-40f5-95cb-d72ff7230835">574</ix:nonNumeric>) <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTEtMS0xLTAvdGV4dHJlZ2lvbjo5Y2RjNDQ1ZTk5Y2M0OGJlOGMzMGY3ZDQ2ZjUyNjk0Yl8xMA_08d90c9a-d906-4a78-8a28-dd880ec48014">268-6379</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2pt;padding-right:-2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">(Address of principal executive offices, including zip code)</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;text-align:center;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.070%;"><tr><td style="width:1.0%;"></td><td style="width:37.352%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.651%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.865%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.651%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:40.081%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of Each Class</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol(s)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6ZjdiNWYzMjhkZTNjNGMzZGFlNDUxMTE0NTczZmE1ZTYvdGFibGVyYW5nZTpmN2I1ZjMyOGRlM2M0YzNkYWU0NTExMTQ1NzNmYTVlNl8xLTAtMS0xLTA_a1147f3e-ce27-4257-9047-0e660836664a">Common Stock, $0.00025 par value per share</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6ZjdiNWYzMjhkZTNjNGMzZGFlNDUxMTE0NTczZmE1ZTYvdGFibGVyYW5nZTpmN2I1ZjMyOGRlM2M0YzNkYWU0NTExMTQ1NzNmYTVlNl8xLTItMS0xLTA_97d8db6f-8547-4aa0-b44e-653efad493ba">KIDS</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6ZjdiNWYzMjhkZTNjNGMzZGFlNDUxMTE0NTczZmE1ZTYvdGFibGVyYW5nZTpmN2I1ZjMyOGRlM2M0YzNkYWU0NTExMTQ1NzNmYTVlNl8xLTQtMS0xLTA_87eb18a5-b3ee-4d5e-82c5-cc8574c97846">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%;">________________________________________________________________________________________</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY185MDU_f58f4f0d-0826-47c9-9683-9df7cd36bfdc">Yes</ix:nonNumeric>&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">&#9746; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">No </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">&#168;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xMjI3_e991f960-5b60-41d0-8972-2e4d98dcfde9">Yes</ix:nonNumeric> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">&#9746; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">No </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">&#168;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.166%;"><tr><td style="width:1.0%;"></td><td style="width:44.153%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.348%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:27.149%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.350%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Large accelerated filer</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;margin-top:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjY5Y2Q0ODZkNTI1NGU4NDlhZmIyZTJmZWViZDU2MTUvdGFibGVyYW5nZTpiNjljZDQ4NmQ1MjU0ZTg0OWFmYjJlMmZlZWJkNTYxNV8wLTItMS0xLTA_9d24c090-dc1f-43f1-8622-a9ffec475c68">Accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9746;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Non-accelerated filer</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Smaller reporting company</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjY5Y2Q0ODZkNTI1NGU4NDlhZmIyZTJmZWViZDU2MTUvdGFibGVyYW5nZTpiNjljZDQ4NmQ1MjU0ZTg0OWFmYjJlMmZlZWJkNTYxNV8xLTMtMS0xLTA_7273b154-53ea-4e03-95cd-3549d5e3517d">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="padding-right:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Emerging growth company</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjY5Y2Q0ODZkNTI1NGU4NDlhZmIyZTJmZWViZDU2MTUvdGFibGVyYW5nZTpiNjljZDQ4NmQ1MjU0ZTg0OWFmYjJlMmZlZWJkNTYxNV8yLTEtMS0xLTA_f8df9ea7-04ad-4119-863d-d7be09bb3804">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="padding-right:2pt;margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160; </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xODMy_0b58b2e4-d628-4c4f-8083-00bbb9ac2a67"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xODMy_ddf27337-bdbe-4007-9c13-b73b61c0662a">&#9746;</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160; Yes </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:144%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xOTUz_649c0d45-39cf-4257-a0a5-63fd43fc7993"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xOTUz_86330223-e2f0-4e2c-84fc-c55a3099a20f">&#9744;</ix:nonNumeric></ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">&#160;&#160;&#160;&#160;No </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">&#9746;</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:144%;">As of August 4, 2020, the registrant had <ix:nonFraction unitRef="shares" contextRef="i64001efefd914b23a423885f1db0f016_I20200804" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMDAz_20462fbb-79f8-45ed-9f0c-b52d27aab8ae">19,549,201</ix:nonFraction> outstanding shares of common stock, $0.00025 par value per share. </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span><br/></span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">OrthoPediatrics Corp.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">Form 10-Q</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">For the Quarterly Period Ended</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:144%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">June&#160;30, 2020</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:144%;"> </span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">TABLE OF CONTENTS</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:7.134%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:79.570%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.296%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Page&#160;No.</span></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_10">Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_10">3</a></span></div></td></tr><tr><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PART I. FINANCIAL INFORMATION</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item&#160;1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_16">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_19">Condensed Consolidated Balance Sheets - </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_19">June 30, </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_19">2020 and December 31, 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25">Condensed Consolidated Statements of Operations - </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25">Three and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25">Six</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25"> Months Ended</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25"> June </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25">30,</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25"> 2020 and 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_25">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_28">Condensed Consolidated Statements of Comprehensive Loss - </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_28">Three and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_28">Six </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_28">Months Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_28">June 30, 2020</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_28"> and 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_28">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31">Condensed Consolidated Statements of Stockholders' Equity -</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31"> </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31">Three and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31">Six M</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31">onths Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31">June 30, 2020</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31"> and 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_31">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_34">Condensed Consolidated Statements of Cash Flows - </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_34">Six</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_34"> Months Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_34">June 30</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_34">, 2020 and 2019</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_34">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_37">10</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item&#160;2</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_79">31</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 3</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_109">39</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 4</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_112">Controls and Procedures</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_112">39</a></span></div></td></tr><tr><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PART II. OTHER INFORMATION</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item&#160;1</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_118">Legal Proceedings</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_118">41</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 1A</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_121">Risk Factors</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_121">41</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 2</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_124">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_124">42</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 3</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_127">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_127">43</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 4</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_130">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_130">43</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item 5</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_133">Other Information</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_133">43</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Item&#160;6</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_136">Exhibits</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_136">43</a></span></div></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_139">Exhibit Index</a></span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_139">44</a></span></div></td></tr><tr><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_142">Signatures</a></span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#i38c4d288f2604685a8c81d4642167bbd_142">46</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:1pt;padding-right:1pt;margin-top:6pt;margin-bottom:6pt;"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span><br/></span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_10"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All statements, other than statements of historical facts, contained in this quarterly report, including statements regarding our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our business, operations and financial performance and condition, are forward-looking statements. You can often identify forward-looking statements by words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "target," "ongoing," "plan," "potential," "predict," "project," "should," "will" or "would," or the negative of these terms or other terms. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as the impact of the COVID-19 pandemic, that may cause our results, activity levels, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements. Forward-looking statements may include, among other things, statements relating to:</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to achieve or sustain profitability in the future; </span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to raise additional capital to fund our existing commercial operations, develop and commercialize new products and expand our operations; </span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to commercialize our products in development and to develop and commercialize additional products through our research and development efforts, and if we fail to do so we may be unable to compete effectively; </span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to generate sufficient revenue from the commercialization of our products to achieve and sustain profitability;</span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to comply with extensive government regulation and oversight both in the United States and abroad;</span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to maintain and expand our network of third-party independent sales agencies and distributors to market and distribute our products; and</span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">our ability to protect our intellectual property rights or if we are accused of infringing on the intellectual property rights of others;</span></div><div style="padding-left:36pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We cannot assure you that forward-looking statements will prove to be accurate, and you are encouraged not to place undue reliance on forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations expressed or implied by the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this quarterly report, in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on March 5, 2020 and in other reports filed with the SEC that discuss the risks and factors that may affect our business. Other than as required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information, events or circumstances occurring after the date of this quarterly report. </span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_13"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">PART I.  FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_16"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 1.&#160;&#160;FINANCIAL STATEMENTS</span></div><div id="i38c4d288f2604685a8c81d4642167bbd_19"></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS CORP.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(In Thousands, Except Share Data)</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:66.005%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.626%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ASSETS</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMy0xLTEtMS0w_c17fbafb-552e-4e24-b0bc-db04d54f1a56">113,054</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMy0zLTEtMS0w_69f137a3-ea90-42b6-87b3-d48362c027e6">70,777</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted Cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNC0xLTEtMS0w_53c1bfbc-5f9e-4c19-9e74-eac471fb4f6f">1,361</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNC0zLTEtMS0w_31d1d38c-6b55-4253-a12d-4267b1a4f054">1,250</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Accounts receivable - trade, less allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0wLTEtMS0wL3RleHRyZWdpb246MWFjOTg0MWJjODI0NGFkNzkyMWU1MzMxZWIzNTUyNjlfNzM_dd8995ea-09a7-4069-952f-98bfddabc3c7">185</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0wLTEtMS0wL3RleHRyZWdpb246MWFjOTg0MWJjODI0NGFkNzkyMWU1MzMxZWIzNTUyNjlfODA_550dfb2d-19a5-4516-8c66-d6d412aa55c4">506</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0xLTEtMS0w_e16a2631-8082-4057-9834-451d0fd27268">14,897</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0zLTEtMS0w_03dffe8c-b5d9-4ccf-b88e-2031fa972d7d">16,003</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNi0xLTEtMS0w_89b8633f-fbe2-4e84-abdb-e8690fe674ac">48,875</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNi0zLTEtMS0w_4e24d857-452d-4264-a58c-e398a9550599">38,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notes receivable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOC0xLTEtMS0w_827aa140-6634-4f84-8f4c-2fae22d6afd1">656</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOC0zLTEtMS0w_2c5d19e5-e6ca-4969-9052-dbffbfada6f8">564</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOS0xLTEtMS0w_ce3c753e-26a7-41bb-9cac-2e0746308425">1,534</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOS0zLTEtMS0w_4df20434-a314-4101-ab8c-b5773de89e2c">1,464</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTEtMS0xLTEtMA_ebe5662d-1703-4bc1-b942-53941faf11a2">180,377</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTEtMy0xLTEtMA_652e3cc1-2ad4-4423-a3a9-7bf7b7b806d3">128,058</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTMtMS0xLTEtMA_3e0c90d8-4307-46cc-9b72-3d0cd3ad86dc">24,131</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTMtMy0xLTEtMA_a093b2bd-fb01-4669-bba1-2aae3d865b42">21,349</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:10pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortizable intangible assets, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTYtMS0xLTEtMA_05a6e098-d1b4-4152-954d-166733d5d620">42,206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTYtMy0xLTEtMA_d6845ba8-b85b-421e-a330-2776a1d60f88">14,484</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTctMS0xLTEtMA_84dbf1ea-27fb-4617-890b-b371e6e97c22">68,420</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTctMy0xLTEtMA_1ed81ec4-725d-4f4f-ba32-40938f754fa4">13,773</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other intangible assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTktMS0xLTEtMA_db156739-795c-446e-88b7-e2fd2d290c42">13,357</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTktMy0xLTEtMA_40631726-4384-4fbc-a09b-9765a5dfb6a8">4,490</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:AssetsNoncurrentExcludingPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjAtMS0xLTEtMA_0758ac44-2f7d-42e9-bcbe-edd536460888">123,983</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="kids:AssetsNoncurrentExcludingPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjAtMy0xLTEtMA_de4f562f-146d-4912-86ff-48ac283afedf">32,747</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjItMS0xLTEtMA_2fb39804-b2c2-4dc8-a44d-9223fcfe1c4b">328,491</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjItMy0xLTEtMA_0dfb3e71-ecd0-4887-a9ba-4ad1e4395de6">182,154</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable - trade</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjYtMS0xLTEtMA_a79fa506-e5c5-4c67-8442-d37300c7a276">6,003</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjYtMy0xLTEtMA_dd9066b4-3a82-4324-9704-70d75c44c03f">6,467</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued compensation and benefits</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjctMS0xLTEtMA_956e11ef-0b32-41e6-944c-44cdc86f61e7">4,501</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjctMy0xLTEtMA_c58f25a5-b08f-4a93-a493-82aebebdf68d">4,349</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current portion of long-term debt with affiliate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="kids:LongTermDebtCurrentMaturitiesRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjgtMS0xLTEtMA_dd7f2afa-6550-4afa-9d52-3bb447af56d8">128</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" name="kids:LongTermDebtCurrentMaturitiesRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjgtMy0xLTEtMA_af4d0bda-03af-4916-a7ef-61b7b3966d43">124</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current portion of acquisition installment payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjktMS0xLTEtNTE2_a11cf308-0af9-485a-8ece-c776cd812134">11,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:zerodash" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjktMy0xLTEtNTE2_d6ed23ce-121c-45d4-9a9f-51d3a4670da4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzItMS0xLTEtMA_c9014898-5005-47ae-b2f3-fc958c80299d">2,654</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzItMy0xLTEtMA_06d53f66-8d17-460c-9a53-f4351d5b6bd0">2,723</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzMtMS0xLTEtMA_84ad94a1-f6c2-4473-89a1-e176a348e550">24,771</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzMtMy0xLTEtMA_394cde90-c23d-41ee-860c-6e25a5976a38">13,663</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt with affiliate, net of current portion</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesAndLoans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzUtMS0xLTEtMA_97db733a-6025-4872-bb8a-c2b2db655f6a">21,017</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesAndLoans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzUtMy0xLTEtMA_cfee6033-803c-4835-88af-21d33699d760">26,067</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition installment payable, net of current portion</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMS0xLTEtMjUyNg_1bbe2216-537f-42ad-9e6d-47f0af01b9db">12,021</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:zerodash" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMy0xLTEtMjUyNg_79745a6b-a0f5-4ff9-ae3b-c5d736d84dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzYtMS0xLTEtMA_c360ff53-01ed-45f3-b9bc-9d7470e8743f">28,100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzYtMy0xLTEtMA_f015367f-f51c-4aff-8772-d7f18d141294">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMS0xLTEtMA_b0130cb2-5564-48d0-a59a-e86e947e1b82">120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMy0xLTEtMA_710a3615-8abd-4e6f-8bea-d028c3052677">63</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total long-term liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzgtMS0xLTEtMA_e794e32b-4c43-4c49-9aa1-00cf86583ced">61,258</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzgtMy0xLTEtMA_d8085234-18c3-49a1-9df3-b32a92922fb0">26,130</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNDAtMS0xLTEtMA_c3d34772-c67a-4dd6-9631-ba6d05fb8df8">86,029</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNDAtMy0xLTEtMA_046b81bc-5e3c-4d1e-97ef-4a80949f18d2">39,793</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzE4_2d3c9c47-cabe-4d00-ba24-1c013c923d90"><ix:nonFraction unitRef="usdPerShare" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzE4_fecce4a5-2c03-425f-9d7d-200a8fe562c9">0.00025</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzMy_62446702-cbdd-4493-9e07-179302fa91ac"><ix:nonFraction unitRef="shares" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzMy_89c00f66-6c86-4dac-94f8-4261ca3dc46f">50,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzU0_5317c855-0ce4-4b8b-b980-2cde6ff052d6"><ix:nonFraction unitRef="shares" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzU0_5358b0da-33e6-4451-a049-1ea75675a227">19,544,008</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzY4_b9da3925-ef5f-4613-b885-015442aa190f"><ix:nonFraction unitRef="shares" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzY4_d0af5785-8be4-446f-b8cb-0b576fb099b3">16,723,128</ix:nonFraction></ix:nonFraction> shares issued as of June 30, 2020 (unaudited) and December 31, 2019, respectively</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMS0xLTEtMA_e6ca2cb8-ed07-4613-8745-44beff94dfb6">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMy0xLTEtMA_a471a48f-d7c7-45f8-b20b-554a8383fe0f">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional paid-in capital</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTEtMS0xLTEtMA_f12c1aaa-22f5-4bb6-8a9b-74d54e115eb3">385,510</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTEtMy0xLTEtMA_1c174389-7c52-489f-ae51-2c28ed7d6420">271,182</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated deficit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTMtMS0xLTEtMA_f7af988b-c5ca-434c-bfee-68976588f740">143,214</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTMtMy0xLTEtMA_b2e2bc8f-d080-43f6-b3c9-9b7f2662c5d2">128,822</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTQtMS0xLTEtMA_4ca11bc6-933f-49f5-b35e-fb6a0d650622">161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTQtMy0xLTEtMA_dbd10c6f-5477-4639-9275-c123744d51ba">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total stockholders' equity</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTUtMS0xLTEtMA_a52abb7a-03ca-4b9b-926b-c695e0393672">242,462</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTUtMy0xLTEtMA_70a1d0a1-0440-45d5-8676-6ee6953ecf7b">142,361</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities and stockholders' equity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTctMS0xLTEtMA_d4837e72-13ed-4741-9137-853a180fe74c">328,491</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTctMy0xLTEtMA_1014c4b0-67bb-4655-a1b7-3f92338a7ddf">182,154</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%;">See notes to condensed consolidated financial statements.</span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_25"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ORTHOPEDIATRICS CORP.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(In Thousands, Except Share and Per Share Data)</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.303%;"><tr><td style="width:1.0%;"></td><td style="width:40.583%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.875%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.192%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.875%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.394%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.642%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.192%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.647%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi0xLTEtMS0w_25e93eb3-69c8-4218-a7a9-50086c6f8819">13,593</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi0zLTEtMS0w_326db432-6c03-495b-9623-8e25ea644660">18,200</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi01LTEtMS0w_86e0eb15-ce9f-4640-83aa-89c24c1a24fe">29,949</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi03LTEtMS0w_7bc49f2a-01ed-4667-9ba9-595adadd5f1d">32,856</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy0xLTEtMS0w_27281beb-29f0-48e6-b4bb-a9fd6047a745">3,532</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy0zLTEtMS0w_09e0af53-eb34-44cc-816a-9aa970733bdb">4,581</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy01LTEtMS0w_2a75e144-6d0d-4546-8e64-9ae9b2151da9">7,675</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy03LTEtMS0w_65652d61-efe4-4ce3-983a-697d220538c9">8,582</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC0xLTEtMS0w_50a37991-6d80-47f7-b2b9-c952660c11ee">10,061</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC0zLTEtMS0w_222a131c-eaec-4300-9e3c-c7fc1fd9f544">13,619</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC01LTEtMS0w_bfcb3287-05c2-447b-9bb5-71a17fd51af4">22,274</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC03LTEtMS0w_08727af2-d19a-49fe-ab5c-6614b0bb1efb">24,274</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales and marketing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi0xLTEtMS0w_6fb4b26e-10d4-4197-bc8f-87d6cb14ef45">5,620</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi0zLTEtMS0w_fde0bfa6-6be6-41fc-9bd7-060c5b242110">7,606</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi01LTEtMS0w_269f9e5a-32b9-4cf9-b796-2148d244a248">13,184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi03LTEtMS0w_e74cb87c-0ed9-4a49-a7a2-643a59fc588f">14,153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy0xLTEtMS0w_64325c4c-71cc-4ab7-a83a-68e229508651">10,577</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy0zLTEtMS0w_8c7982b5-822a-4d02-b749-44753f50f714">6,569</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy01LTEtMS0w_88d2055f-bde4-469c-8ac3-a0b0b8388371">18,458</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy03LTEtMS0w_a01cdfe3-f54d-46ff-84e5-352d393925a0">12,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC0xLTEtMS0w_98ef8ba7-332e-42c3-ae4c-8a99eba39558">881</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC0zLTEtMS0w_0342f6d5-acd2-42b9-9c80-312b8748515a">1,234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC01LTEtMS0w_85932ce1-6538-491b-be47-3bd2a22b252b">2,146</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC03LTEtMS0w_c4729a1e-e50f-478d-abc4-0a29a8ec8dae">2,447</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS0xLTEtMS0w_6c4dd153-4f32-4f2f-ae73-959b09546fc3">17,078</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS0zLTEtMS0w_5374f058-6d2f-433c-a0c7-7f77a195bc46">15,409</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS01LTEtMS0w_7652adcb-de02-4b15-ab3a-611036c007bb">33,788</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS03LTEtMS0w_65f05c45-9dcf-4b21-b8bf-4e2fb45f9ec9">28,781</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtMS0xLTEtMA_c47e1efb-ab92-4108-a9df-08ecf547104d">7,017</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtMy0xLTEtMA_6e8bc409-225f-4357-8727-67f4c4dfac03">1,790</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtNS0xLTEtMA_e063e2e1-82cb-4a01-9487-99270c3dcbda">11,514</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtNy0xLTEtMA_33360542-8c89-4b24-8c22-918c537b48dd">4,507</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other expenses:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItMS0xLTEtMA_8fdcdc11-28a7-4490-bf1e-31c217ab3925">1,399</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItMy0xLTEtMA_ac9a40d7-50f5-4b07-b468-013bb7fd756e">632</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItNS0xLTEtMA_a976e199-bcae-4c50-a9d3-d009f3f62ed5">1,778</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItNy0xLTEtMA_26a3865e-5818-443b-8518-6367c190cad0">935</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value adjustment of contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMS0xLTEtNTQw_0108e1d5-12e7-4fb1-b525-1abb593664fd">910</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMy0xLTEtNTUw_d5343433-d2e5-43b4-a855-74a0ebfac24e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNS0xLTEtNTQw_1c2a2e52-8071-4503-b29a-19bab49f44ca">910</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNy0xLTEtNTUw_3089ff6e-5c86-474d-81bf-f79cdeb3a4de">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMS0xLTEtMA_553e7294-59ab-4efd-bc17-96ff6cd6d00a">121</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMy0xLTEtMA_e75d5a3a-290e-4d78-88d0-09884cf6b376">37</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNS0xLTEtMA_dc030c15-c176-4dc4-af07-2b5ffbbc1fbf">190</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNy0xLTEtMA_bad10fb7-4b9d-42c4-b109-ec1a2db471eb">37</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtMS0xLTEtMA_c96e00e0-b5d8-427d-a4a4-20584d58c969">2,430</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtMy0xLTEtMA_4ba71f1a-c857-4e8a-a5c7-461c0cfc4aea">669</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtNS0xLTEtMA_8a9f1216-0e3b-497b-9053-836afcbf5d2c">2,878</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtNy0xLTEtMA_51130a36-7db5-49b6-ab44-34503a0c6743">972</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss from continuing operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtMS0xLTEtMA_3e7b9623-fc7f-46de-b074-2e8c8f031603">9,447</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtMy0xLTEtMA_49e1d90d-d5b3-4c6e-a2b8-c5f5ad3cf051">2,459</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtNS0xLTEtMA_3c474fa6-542e-490d-b2b2-bd110be701a7">14,392</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtNy0xLTEtMA_c135aa54-f251-4d77-81d1-2ce6e2a6e1df">5,479</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss from discontinued operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtMS0xLTEtMA_0b5d6440-4fe2-488e-aa07-8cca0b24e4f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtMy0xLTEtMA_98b43ff9-2d0a-4b6a-9dfc-8eb3e511e812">159</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtNS0xLTEtMA_5dbd8075-0ec1-47cc-9def-f927b6bb4f7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtNy0xLTEtMA_39b69175-589c-425b-8876-fbe8f2573179">159</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctMS0xLTEtMA_a5754da6-ec59-4fda-b504-6bd19879375e">9,447</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctMy0xLTEtMA_3b402a0f-6cc3-499a-82dc-87e1332764df"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctMy0xLTEtMA_d5a0baf5-9ffb-42ee-85b3-dffa3d94b999">2,618</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctNS0xLTEtMA_52ea228c-54cb-435d-9c0f-212c3ebc1c9b">14,392</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctNy0xLTEtMA_64e0c2ed-8d6e-43b8-bc52-021358e3db26">5,638</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average common stock - basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktMS0xLTEtMA_e3a584f5-98be-421b-aaaa-622b96733bed">17,549,118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktMy0xLTEtMA_2ca6c1c7-5ca8-43cf-a629-6617bad985e8">14,451,979</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktNS0xLTEtMA_69e6483f-ed8e-4ef1-8b0a-ef961f10b121">16,986,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktNy0xLTEtMA_85be0bc7-7e5f-428d-a3ad-8b1d038d75f1">14,409,752</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share - basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtMS0xLTEtMA_1c01a9ec-7c5b-44d6-b3bb-8f81dff0bf32">0.54</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtMy0xLTEtMA_4c596636-68ad-47fb-94dd-8031a9c85b64">0.18</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtNS0xLTEtMA_c529dda4-4bf7-4722-9f79-efa425697803">0.85</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtNy0xLTEtMA_d219c374-9313-4cd8-9f66-29d2deb8f980">0.39</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;margin-top:9pt;"><span><br/></span></div><div style="text-align:center;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See notes to condensed consolidated financial statements. </span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_28"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ORTHOPEDIATRICS CORP.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(In Thousands)</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:33.863%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.476%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.476%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.476%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.477%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi0xLTEtMS0w_fcccabc7-f9f9-448c-a2ff-8e14f8646602">9,447</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi0zLTEtMS0w_51094bd9-f83c-4b39-a73c-16c743783b14">2,618</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi01LTEtMS0w_0c7f76e7-78bc-40ec-8094-fcc0f015429b">14,392</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi03LTEtMS0w_3adfb7eb-c537-405d-87e0-b6b7c7f22a00">5,638</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC0xLTEtMS0w_7dc06b78-8c47-4929-8518-85392b9fa371">1,522</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC0zLTEtMS0w_0af670a5-b92a-4076-bf99-a26589cc217b">133</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC01LTEtMS0w_03d0b2eb-699c-4ed1-a5f5-03756d1ace8d">164</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC03LTEtMS0w_e4d580d0-da98-43a0-9379-65d7571c610e">168</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive (loss) income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS0xLTEtMS0w_c6f4c85b-be8a-4813-b986-9f51e11d9828">1,522</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS0zLTEtMS0w_c61bbdcc-a584-40b8-81bc-cb6090473697">133</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS01LTEtMS0w_e2cc41ad-8d39-4307-aa30-98312341777a">164</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS03LTEtMS0w_43c54e23-32ed-40d1-841c-c44529c82945">168</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi0xLTEtMS0w_89c061e7-756b-4ec5-b98a-13dbea6a2108">7,925</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi0zLTEtMS0w_7c4865fe-5b71-44ad-8e8a-9c7a2b29418d">2,751</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi01LTEtMS0w_2a7b41a2-7d1a-4b70-9231-c7e3eb25781b">14,228</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi03LTEtMS0w_9eb88dc6-06a4-4ef2-9831-5f823f9ad6b4">5,470</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;margin-top:9pt;"><span><br/></span></div><div style="text-align:center;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See notes to condensed consolidated financial statements. </span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">6</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_31"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ORTHOPEDIATRICS CORP.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(In Thousands, Except Share Data)</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:15.708%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td style="width:1.0%;"></td><td style="width:6.482%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.482%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.482%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.395%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.482%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.395%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.482%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.565%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.648%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.759%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="45" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three and Six Months Ended June 30, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Paid-in</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stockholders'</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deficit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if5b873289d394f8698109e34413ebc6c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xMC0xLTEtMA_f871e620-252d-4ba0-85be-1a6782a490e9">16,723,128</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5b873289d394f8698109e34413ebc6c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xMi0xLTEtMA_586201a3-6f69-4243-8e2b-e9157cc7e519">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="if33c7e6e77b34aadafae7225d988f633_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xNC0xLTEtMA_7b9940b4-1dc4-48d0-82f8-fd78b0252328">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if33c7e6e77b34aadafae7225d988f633_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xNi0xLTEtMA_48882db8-3bb2-4a7d-ba0b-1ce0780651e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3c138c5223b945249abec4b41802cfe9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xOC0xLTEtMA_3ebdef14-5831-4949-a06c-b0ac6fd678a3">271,182</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6ee305abb72e4348bdb25affaa6c5bb0_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0yMC0xLTEtMA_3ecda4e3-1347-4a4a-a468-03fd447c2104">128,822</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i581093052fd24f5683c783d8150a5768_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0yMi0xLTEtMA_f25ca132-55d9-414a-a4f7-3d9f2a30a7c7">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0yNC0xLTEtMA_1074414c-4555-40de-bbf1-204cd342ec81">142,361</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1f552ff6bd064623b1279ee353b79be5_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNi0yMC0xLTEtMA_f650e203-c937-46a7-bc39-bb4b845e44bd">4,945</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNi0yNC0xLTEtMA_7eb0fe94-b03e-4471-8857-6da5b2c4ae93">4,945</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3c69752a2cd84ef3bf96562629d01f6d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNy0yMi0xLTEtMA_967e2a10-9761-41c1-829c-a6773795a7f5">1,358</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNy0yNC0xLTEtMA_94513df0-ee3e-457f-b51c-6cfa0bc5077f">1,358</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock option exercise</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOC0xMC0xLTEtMA_ded7559a-d68c-4675-9895-74b9d22785c9">22,208</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i688ab3c7a7c14968861796de50cec944_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOC0xOC0xLTEtMA_376c4771-beaf-4919-a72a-ff75957c6203">688</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOC0yNC0xLTEtMA_cfd67353-fbb3-4501-885f-e9c37c552df4">688</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOS0xMC0xLTEtMA_4a3705df-9367-4174-94c7-ffe0f67f0372">105,710</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i688ab3c7a7c14968861796de50cec944_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOS0xOC0xLTEtMA_0e0451d1-7b20-4cca-8d50-3fed3069e3a8">958</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOS0yNC0xLTEtMA_d8240a75-9c53-4e5f-9bd9-86c6b60435de">958</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consideration for Telos Acquisition</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTAtMTAtMS0xLTA_c109254a-8dad-4bbd-9a96-2bb7b38469c0">36,628</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i688ab3c7a7c14968861796de50cec944_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTAtMTgtMS0xLTA_780b24e8-b17d-45cd-ab9d-b9da03d210f4">1,750</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTAtMjQtMS0xLTA_5db4260d-896c-4184-baf0-203b9d765ea7">1,750</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i8efc4342789a4574a5010b2cd5a5e4d4_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTEtMTQtMS0xLTA_406767dc-072d-4ae0-9a98-9749e5c3c170">4,014</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i8efc4342789a4574a5010b2cd5a5e4d4_D20200101-20200331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTEtMTYtMS0xLTA_9f32e138-d318-41ce-be34-4173aa1cec82">187</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTEtMjQtMS0xLTA_73b888df-6607-4831-a0f3-3e202a3f6d0d">187</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at March 31, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i003a46bd442946f49063fccbb2f71fd2_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTAtMS0xLTA_eaa7d75e-3843-4333-97fe-5cafdf20c44d">16,887,674</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i003a46bd442946f49063fccbb2f71fd2_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTItMS0xLTA_a562c856-6d1d-49d1-980a-e49cf863bb35">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ic378826a602e45ea8c6a8ded2624b481_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTQtMS0xLTA_8679065a-0fad-4d8b-8a34-8d78804b5ca3">4,014</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic378826a602e45ea8c6a8ded2624b481_I20200331" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTYtMS0xLTA_a02dca51-f2bb-4e4c-852e-e2ef3b3a1ea1">187</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i96caa6529642403084788194234fac2d_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTgtMS0xLTA_016fa2f0-b564-428a-8404-c921cdab5219">274,578</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i84610b8d7d3b44b680b451fe979cb9a8_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMjAtMS0xLTA_8605d9c4-8a85-4781-8261-e78078fbeedb">133,767</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9fd36dae3b2b4256bc00944063093da2_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMjItMS0xLTA_83951947-700f-43ec-a680-77b41f667946">1,361</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i78c7b4f7e5904e5e9d5168eb8819cc11_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMjQtMS0xLTA_df4a69c5-2acc-4b02-867c-3eb0d90f13d2">139,267</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Loss</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i582149af38174a49b5d43f5c23400d89_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTMtMjAtMS0xLTA_3bc0286a-6200-4144-bb17-be8b656b830a">9,447</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTMtMjQtMS0xLTA_ecb92bbf-21bc-48ed-9f76-3205d0fd09ee">9,447</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive loss</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie3d201608e0848fc80fcef2eecd22d46_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTQtMjItMS0xLTA_134b33e7-fb77-4402-a4fe-9c310c4fb6eb">1,522</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTQtMjQtMS0xLTA_56ccd95d-6704-49ab-9cad-48767a1c81f2">1,522</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock option exercise</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTYtMTAtMS0xLTA_ee4df976-d862-4f85-a1d0-8eda907dfe37">19,162</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTYtMTgtMS0xLTA_ea5225a2-5a76-4d37-85fe-f531acdb1a73">593</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTYtMjQtMS0xLTA_c5d6348d-95bd-45c1-b83a-ad5bc1068169">593</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTctMTAtMS0xLTA_98e1a974-ccc6-4114-92fc-98bb6b47a728">52,032</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTctMTgtMS0xLTA_a9e20ae9-d7b2-4538-8ac4-293fbd8872c9">2,495</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTctMjQtMS0xLTA_70151236-1dd4-4246-bd67-17a92bd2862c">2,495</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consideration for ApiFix acquisition and Band-Lok intellectual property purchase</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTAtMS0xLTU2OQ_0249fdcf-c8c2-40f8-b777-c48ebd8deb76">989,154</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTgtMS0xLTU2OQ_f409d08d-318a-4010-b9b9-8ed7e15892d9">37,638</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjQtMS0xLTU2OQ_46364969-86f2-429f-892a-c71811eca5b1">37,638</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common stock, net of issuance cost</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTAtMS0xLTU3OA_332cb720-5082-4474-b14d-7439a091267d">1,595,986</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTItMS0xLTU3OA_4e4222f8-6d27-45b4-a229-72283be49d08">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4e8f67a7223747f88624ef41a564ed11_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTQtMS0xLTU3OA_c249e90a-362e-493f-825e-4d7363dbe079">4,014</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e8f67a7223747f88624ef41a564ed11_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTYtMS0xLTU3OA_c0bc29a6-cbb2-4e0f-982e-5a9ff38d0549">187</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTgtMS0xLTU3OA_94296496-eae8-4750-b368-7636d47d0acd">70,206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMjQtMS0xLTU3OA_d28d07e8-7c6f-4d02-9d93-0d0525bc8066">70,394</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ied22f6706c404fd681c4a5fc164e16db_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTAtMS0xLTA_d61b881f-5d68-4437-822b-d361482101b8">19,544,008</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ied22f6706c404fd681c4a5fc164e16db_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTItMS0xLTA_88b3bd26-2bab-4085-8c77-81cff2a40123">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i956afb27a29242589884eb0e1ccf86c9_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTgtMS0xLTA_f0127c84-b0db-4cc8-9649-31e8171167ab">385,510</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6f59b1fe6bf14e1d934932e9f19a662a_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjAtMS0xLTA_63f0c7c8-cf24-4df7-b08e-a5527379ee27">143,214</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i21ce4cf60f7042b380ec1757dc4f8a08_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjItMS0xLTA_b65a3a37-5c50-45a1-a00c-50143f2a7792">161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjQtMS0xLTA_feae6997-ad55-426c-b9a9-7c518ef22f7f">242,462</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;margin-top:9pt;"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:16.601%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td style="width:1.0%;"></td><td style="width:10.946%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.946%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.946%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.946%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.946%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.949%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="33" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three and Six Months Ended June 30, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additional</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Paid-in</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stockholders'</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Capital</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deficit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 1, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i557ae529b0534b7e83bdfd35a6d1216a_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS01LTEtMS0w_a5cabab0-ac60-4d30-a269-8143ae3bf620">14,538,202</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i557ae529b0534b7e83bdfd35a6d1216a_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS03LTEtMS0w_179527d9-a6c7-43c6-b5e6-e7f33ab04006">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id101b89cfc2f41c28814b80debdc3cb8_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS05LTEtMS0w_c5248f35-a837-4bfc-b326-fcad544c812e">197,442</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i296365e2b77b4e8183cf0fe4076355f8_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS0xMS0xLTEtMA_490acb1d-9d49-456d-bbdd-b91bb768dd84">115,091</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1d138a5d3c994ce39162445d9d354401_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS0xMy0xLTEtMA_2e0fd352-3af0-4665-96f8-4a686248bdb7">623</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i55478baf239442988af0a3137120ff79_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS0xNS0xLTEtMA_057d456d-b844-476c-a083-ae75934c6b83">81,732</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i22bef0eaffe04104b79fd06b8e9b6aa1_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNi0xMS0xLTEtMA_b020f552-31ca-4309-981b-75c432d04282">3,020</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNi0xNS0xLTEtMA_3b5be776-ef74-46a2-be2a-6e68fb0f9258">3,020</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75a8b5cca80f46518592a4750ba5850a_D20190101-20190331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNy0xMy0xLTEtMA_aec6baa2-c6e6-4479-a93f-53800038e9d6">301</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNy0xNS0xLTEtMA_071ab351-a4fe-4ff4-b876-5c6e0fb23a0f">301</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock option exercise</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i77602246977e4ab48559ae10f9ef671c_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOC01LTEtMS0w_90e77767-5cd6-4335-b2e8-83ae16aa3b35">18,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i368ef1c3bb964a91992f82e0a63d6ec9_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOC05LTEtMS0w_4929d3ee-8ecb-4748-8f59-10ec2bff4586">565</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOC0xNS0xLTEtMA_4102a42b-822c-48a6-8f17-93b7607b0383">565</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i77602246977e4ab48559ae10f9ef671c_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOS01LTEtMS0w_67b82f1c-2c6e-4cd4-8c06-3d8d10afb643">125,769</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i368ef1c3bb964a91992f82e0a63d6ec9_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOS05LTEtMS0w_7cec00eb-142f-4890-a0e4-01890e94dc20">471</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOS0xNS0xLTEtMA_b7172c06-ea43-423b-995b-b68df06146be">471</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at March 31, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i264938c435d846aa93d88d47ad3d77af_I20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtNS0xLTEtMA_6446d337-fe9f-4296-8793-26f47fb9a5dc">14,682,398</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i264938c435d846aa93d88d47ad3d77af_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtNy0xLTEtMA_fbbd12ff-02ef-4282-adfd-6906cc1bd485">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1922e3a342ea477b82afbb406801bb66_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtOS0xLTEtMA_3da01e57-5230-461e-9bcd-3c14fb751afb">198,478</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib89641723e5a4a5189fce4a3e9a9f517_I20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtMTEtMS0xLTA_7e918970-5b58-40be-9789-37f87cdbec3f">118,111</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic2e6fb5fc5ad4a8883252831c70d9b8e_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtMTMtMS0xLTA_0424a3f6-cba9-45cd-9b76-ddf21b171e87">322</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i514e1984bf624bcab1ca800517fe8409_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtMTUtMS0xLTA_05c525ad-23df-480d-9f1c-c4858aac328c">80,049</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Loss</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0edebf080f80402f883427d33eb82646_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTEtMTEtMS0xLTA_2a02ec58-4fbb-49fa-bc7d-886655285115">2,618</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTEtMTUtMS0xLTA_1d186c11-b426-481d-a757-cf121b30e285">2,618</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive loss</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i17d824c1eb834a1196d7d2349e2b3500_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTItMTMtMS0xLTA_2c57f049-214e-46ee-aa29-41dbb8add3d6">133</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTItMTUtMS0xLTA_e9179ad2-bceb-41fa-95b5-492625db1b4a">133</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition consideration</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtNS0xLTEtNjY3_e07fae5a-e364-4f42-ae1c-0d006fbd2bba">245,352</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtOS0xLTEtNjcx_3423f0c3-e2d4-414b-b6f4-0aa3fa18d586">10,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtMTUtMS0xLTY3MQ_478ab99b-e965-402a-888f-719d4f064f20">10,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock option exercise</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtNS0xLTEtNjc1_3bb34d9c-44e5-4f6a-a008-cc6733022ff4">2,983</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtOS0xLTEtNjc5_4669166e-e586-4aff-8506-7c40fdeb1cf9">92</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTUtMS0xLTY3OQ_7f1b432b-47bd-448a-8a84-65250679b4a6">92</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtNS0xLTEtMA_821fdfc8-3cc6-41d9-be97-2c6f924a6817">8,729</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtOS0xLTEtMA_9539da38-412b-4428-a021-8efd9228dd94">692</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtMTUtMS0xLTA_9fcc3040-0f00-482f-bd30-e7ee8bc743e8">692</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at June 30, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5c58d0d3a06407fae45526ac0b7f3a6_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtNS0xLTEtMA_19918c8b-ce02-4f9c-bf76-698f2396ecfd">14,939,462</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5c58d0d3a06407fae45526ac0b7f3a6_I20190630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtNy0xLTEtMA_270f97d7-6f06-4e0e-898a-91861b44c3e1">4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id2de6637c368451a83b9fbebce1b02cc_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtOS0xLTEtMA_d8e4ca13-3684-4173-a8f9-90de63ff9c90">209,262</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7da59944142842809e0da6afc8bff8e2_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTEtMS0xLTA_842ced0b-4a0e-4444-a968-12057b6cdc67">120,729</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5be348dea4b94b1290c68f97c0b18392_I20190630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTMtMS0xLTA_8fc6950c-9331-4f43-987b-e8182a6d4289">455</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTUtMS0xLTA_fc6a4d04-ff15-4719-afee-8546142bd60f">88,082</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;margin-top:9pt;"><span><br/></span></div><div style="text-align:center;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See notes to condensed consolidated financial statements. </span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">7</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_34"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ORTHOPEDIATRICS CORP.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(In Thousands)</span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:65.857%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.774%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OPERATING ACTIVITIES</span></td><td colspan="9" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMy0xLTEtMS0w_add1eadd-4caf-4bbf-90ec-32608156264c">14,392</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMy0zLTEtMS0w_0a08ce54-1a30-4dc1-b006-508cf496becf">5,638</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNi0xLTEtMS0w_e3b49542-a399-452b-b453-53fb983c76cb">3,285</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNi0zLTEtMS0w_9ccf1dc7-9a83-4ab0-a5fd-7427fbbf384c">1,912</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock-based compensation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNy0xLTEtMS0w_48ee25fd-7270-4682-b04c-21eff46ae760">3,453</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNy0zLTEtMS0w_7c336d2d-85da-4592-81f2-78f0d56e34e3">1,163</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value adjustment of contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOC0xLTEtMS0zODI3_655baed8-f6ef-4aaa-b4bc-1bc0d0ada0e9">910</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOC0zLTEtMS0zODI3_f1c5582d-cd85-4afa-9eef-8619ce6935f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition installment payable</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="kids:BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOS0xLTEtMS0zODI3_834f39b2-ada1-4ad6-9976-3ced4fe317d8">886</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="kids:BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOS0zLTEtMS0zODI3_7dd02586-13c3-4efd-95d7-9242cfad115d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes in certain current assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable - trade</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTAtMS0xLTEtMA_b9e474d1-4081-4ed6-8a0f-230bcdc2b6db">1,609</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTAtMy0xLTEtMA_e33ee84f-f7ea-40e7-8ef6-d2bde89bf849">5,499</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTEtMS0xLTEtMA_8c6b787a-b45c-47f8-b562-3eafbfc61859">9,599</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTEtMy0xLTEtMA_716ed9c0-b6f0-4986-a6ff-56a0a2f29f1c">5,139</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTMtMS0xLTEtMA_a1945601-926d-4ea8-9f6e-68262843abd6">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTMtMy0xLTEtMA_2990a406-5db6-43a6-9dbb-59eb82eb7b88">14</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable - trade</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTQtMS0xLTEtMA_1893d29a-4417-499a-a097-233a4be51aff">746</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTQtMy0xLTEtMA_bbcd0215-4fe2-48d9-87b0-604b9ba18e84">1,934</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued expenses and other liabilities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTUtMS0xLTEtMA_9172dff9-14c2-4c38-bfb3-24dffc8ef4d4">129</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTUtMy0xLTEtMA_3a320345-c64a-4a46-a015-03b80f2de8cb">357</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTctMS0xLTEtMA_d4669f84-86f1-4aaf-98e0-4e8086af167e">50</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTctMy0xLTEtMA_0d9f8271-56c0-458f-9e44-4150a500add1">139</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in operating activities - continuing operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTgtMS0xLTEtMA_482c82fa-9378-42a1-9180-d3ced1d478f6">14,707</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTgtMy0xLTEtMA_d2d34fb1-2536-4527-b579-388702336aa5">10,785</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by operating activities - discontinued operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTktMS0xLTEtMA_98608106-cec9-4fbc-a675-6420849ca1c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTktMy0xLTEtMA_7c5a6d75-b131-43a9-801d-a01ade7c09bc">371</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in operating activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjAtMS0xLTEtMA_4b42ddae-62c5-4908-a883-295579473347">14,707</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjAtMy0xLTEtMA_19ab3adf-df4b-4755-9c3b-f5fa94941747">10,414</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition of Telos, net of cash acquired</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjMtMS0xLTEtMA_de76ba97-6c21-4c77-be70-a6c2e7961e67">1,670</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i606ed33122784ef28a374862e04b8938_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjMtMy0xLTEtMA_6fb64ed8-3ee7-4e29-b41c-42bfe1395095">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition of ApiFix, net of cash acquired</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMS0xLTEtNzIy_04891040-7d9d-419f-9104-8af12181c88d">1,723</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5b1d0fd10514bb7ae0a9c0147334def_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMy0xLTEtNzIy_0c5641da-d1cf-4980-a6c8-cb0595fc9cca">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition of Band-Lok intangible assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2a285bb683e44422bf5d4ef530eb8f9a_D20200101-20200630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjUtMS0xLTEtNzIy_2f9391e3-8387-4e85-a2dd-6d56ce6b73a4">796</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7586dec2cc8146b0a84c69f0ed6a9b88_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjUtMy0xLTEtNzIy_2549425b-c7e0-4bc9-ba91-f2a198d9be97">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition of Vilex and Orthex, net of cash acquired</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieae79c794ca74ecaab7e1f4be1666580_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjYtMS0xLTEtNzIy_e9cce4d0-450b-4092-9907-3bd83bc70049">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjYtMy0xLTEtNzIy_a891ff71-6e50-4ae7-9daf-0a519e992227">49,926</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchases of licenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMS0xLTEtMA_eaac19bb-7581-4fc6-a843-d305246429be">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMy0xLTEtMA_893d038c-8d4f-41df-aee8-759125aacd7e">170</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchases of property and equipment</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjctMS0xLTEtMA_7103a408-b327-4664-a623-55a1d44f7c16">5,160</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjctMy0xLTEtMA_de15c76b-0433-4148-8753-f7f58297b240">8,514</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities - continuing operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMS0xLTEtNzMx_a3837c02-1b17-442f-a4f2-a02b0e71a61d">9,349</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMy0xLTEtNzMx_6978a849-6fcc-49fc-b259-0f91153be019">58,610</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities - discontinued operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMS0xLTEtNzMx_f2f833d3-9f4d-4f6a-b3ac-244ddab1c909">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMy0xLTEtNzMx_fe451c6b-a46e-4da5-884a-4af7a60f4dc6">47</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjgtMS0xLTEtMA_a3e14e51-e4b1-4535-b7da-d71fda644896">9,349</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjgtMy0xLTEtMA_2502c8aa-2092-4870-9f00-189f8b88ed6b">58,657</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from issuance of debt with affiliate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMS0xLTEtMA_ff67c3a5-a606-42da-969c-637b4b75566e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMy0xLTEtMA_d88daccd-b0c5-46c0-994d-361245df87ea">30,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments on note with affiliate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMS0xLTEtMA_ccd9b482-a38f-4c32-9111-47921f7d77ea">5,000</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMy0xLTEtMA_7e451278-272c-4f8f-b83f-26f9f0f2262a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzMtMS0xLTEtMA_f84feff9-793f-491f-9ad6-85961d756814">70,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzMtMy0xLTEtMA_a7e3edd6-e5ab-4101-82a7-d3fcf5923067">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from exercise of stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzQtMS0xLTEtMA_78ed134a-3cfd-4a7d-ac3e-c827a34e2175">1,281</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzQtMy0xLTEtMA_3c9adbf2-4580-46f6-b52e-cc61ea2884f7">657</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments on mortgage notes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzYtMS0xLTEtMA_3fb14db9-4e52-447e-b636-109caaf6b4fc">61</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzYtMy0xLTEtMA_606077ad-44d7-4740-8362-1ab20429826c">59</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by financing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzgtMS0xLTEtMA_96d062c3-3811-4bd3-9c8c-32bf53791056">66,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzgtMy0xLTEtMA_a9dff8ae-79bc-418f-855b-6b5b9c3796a9">30,598</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of exchange rate changes on cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDAtMS0xLTEtMA_6ccd527e-514f-4fbd-9c8f-77aeebfdf447">17</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDAtMy0xLTEtMA_0cda2d29-b3fc-49dd-852b-f5dff1de7b81">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET INCREASE (DECREASE) IN CASH</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDItMS0xLTEtMA_61fb9312-c5b8-4ee9-99b9-46f7a8edc38b">42,388</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDItMy0xLTEtMA_a90ef318-e7b9-406d-ab71-e1ef26098b5a">38,473</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and restricted cash, beginning of year</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDQtMS0xLTEtMA_4aceceb2-9636-476b-b566-b6bf04c3341a">72,027</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i55478baf239442988af0a3137120ff79_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDQtMy0xLTEtMA_d2429a1a-dc18-4a8e-9391-86dd8348d2b6">60,691</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and restricted cash, end of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDUtMS0xLTEtMA_c6c9259f-7d13-4081-968e-fcf1733a9e55">114,415</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDUtMy0xLTEtMA_920d53d5-4157-4b0f-9e21-5574cb2a75ed">22,218</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less cash of discontinued operations, end of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDYtMS0xLTEtMA_f8ab9947-8609-4a5f-bf07-e9349ec3995e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDYtMy0xLTEtMA_cf52adaf-a513-43e8-bb06-dcb5f579e4fa">360</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash of continuing operations, end of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDctMS0xLTEtMA_258dac73-9dca-43ba-a660-73ee26450327">114,415</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDctMy0xLTEtMA_7371eecc-dd55-4fba-9576-72aa89ab1d63">21,858</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:65.857%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.774%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">SUPPLEMENTAL DISCLOSURES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for interest</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTAtMS0xLTEtMA_e8e360d3-99a2-4546-994b-13a8aa4edcd5">513</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTAtMy0xLTEtMA_872cb3aa-0722-41ee-baad-1edc95a4f00e">935</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transfer of instruments from property and equipment to inventory</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="kids:TransferOfPropertyAndEquipmentToInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTItMS0xLTEtMA_d8ab182c-d0cf-4a43-b041-c3c64ff221a3">229</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" name="kids:TransferOfPropertyAndEquipmentToInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTItMy0xLTEtMA_e5f86578-505e-4e89-af6c-f694d91ea4d4">267</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common shares to acquire Vilex and Orthex</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieae79c794ca74ecaab7e1f4be1666580_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTgtMS0xLTEtNzY0_de7a78ce-2858-476a-8d69-185572ff8fbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTgtMy0xLTEtNzY0_028fc031-3e10-4c29-bfd7-f9352489f688">10,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common shares to acquire Telos</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTMtMS0xLTEtMA_72a4f414-fefa-478e-94f4-f0f415d51602">1,568</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i606ed33122784ef28a374862e04b8938_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTMtMy0xLTEtMA_b0bca902-4443-42b8-b423-37efcadc38e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common shares to acquire ApiFix</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMS0xLTEtMzg1_c57a1cf1-d12c-43f0-8f3a-80a41b0c0979">35,176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5b1d0fd10514bb7ae0a9c0147334def_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMy0xLTEtMzg1_826ee932-686f-481d-82b0-c5df15167b6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Issuance of common shares to acquire Band-Lok</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a285bb683e44422bf5d4ef530eb8f9a_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMS0xLTEtMA_2fc3c6b4-7dcd-4fa4-9cfd-7cfba378a39f">2,644</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7586dec2cc8146b0a84c69f0ed6a9b88_D20190101-20190630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMy0xLTEtMA_52dc13e4-e0b0-4833-8443-4b98039817ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See notes to condensed consolidated financial statements. </span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">9</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ORTHOPEDIATRICS CORP.</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(Unaudited)</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">(Dollars In Thousands, Except Share and Per Share data)</span></div><div id="i38c4d288f2604685a8c81d4642167bbd_40"></div><div><span><br/></span></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 1 &#8211; <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMjgxMg_772ae6c9-791a-43d4-8fa0-4a3f624f29c0" continuedAt="i71c896caa9194d0093b0a3e260f20c02" escape="true">BUSINESS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i71c896caa9194d0093b0a3e260f20c02" continuedAt="i538732873c964fb2bd629b915da17515"><div style="padding-right:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">OrthoPediatrics Corp., a Delaware corporation, is a medical device company committed to designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers the ability to treat children with technologies specifically designed to meet their needs. We sell our specialized products, including PediLoc</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">, PediPlates</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">, Cannulated Screws, PediFlex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:400;line-height:121%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">nail, PediNail</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:400;line-height:121%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">, PediLoc</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"> Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, Bandloc, Pediguard, Pediatric Nailing Platform | Femur, Orthex, QuickPack</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">TM </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">and ApiFix to various hospitals and medical facilities throughout the United States and various international markets.  We currently use a contract manufacturing model for the manufacturing of implants and related surgical instrumentation. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2017, we expanded operations and established legal entities in the United Kingdom, Australia and New Zealand, permitting us to sell under an agency model direct to local hospitals in these countries. In September 2018, we further expanded operations in Canada selling direct to local hospitals, and in January 2019 we expanded to Belgium and the Netherlands. Additionally, in March 2019 we established a holding company and an operating company in the Netherlands and began selling direct to Italy in March 2020 enhancing our operations in Europe. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 4, 2019, we purchased all the issued and outstanding shares of stock of Vilex in Tennessee, Inc. ("Vilex") and all the issued and outstanding units of membership interests in Orthex, LLC ("Orthex") for $<ix:nonFraction unitRef="usd" contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTY5Mw_c21da05d-9fd7-4be6-8a0a-a0df592d3c2c">60,000</ix:nonFraction> in total consideration. Vilex and Orthex (the "Vilex Companies") are primarily manufacturers of foot and ankle surgical implants, including cannulated screws, fusion devices, surgical staples and bone plates, as well as Orthex Hexapod technology which is used to treat pediatrics congenital deformities and limb length discrepancies.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 31, 2019, we divested substantially all of the assets relating to Vilex's adult product offerings to a wholly-owned subsidiary of Squadron Capital LLC ("Squadron") in exchange for a $<ix:nonFraction unitRef="usd" contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMjIyNQ_ce1a7afd-74fb-4ed5-b0eb-6e64cf0315f3">25,000</ix:nonFraction> reduction in a Term Note owed to Squadron in connection with the initial acquisition.  As part of the sale, we also executed an exclusive license arrangement with Squadron providing for perpetual access to certain intellectual property and a mutual distribution agreement.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 9, 2020, we purchased all the issued and outstanding membership interest of Telos Partners, LLC ("Telos") for $<ix:nonFraction unitRef="usd" contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTgyNg_9e4d3d61-916e-421a-a5bc-b102e694526b">3,300</ix:nonFraction> in total consideration. Telos is a boutique regulatory consulting firm formed in Colorado. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2020, we purchased all the issued and outstanding membership interest of ApiFix, Ltd. ("ApiFix") for (a) $<ix:nonFraction unitRef="usd" contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTgzNw_9ebf1f89-c37d-43b1-9c1f-ebb8a3127604">2,000</ix:nonFraction> in cash, and (b) <ix:nonFraction unitRef="shares" contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg0OA_e28d075a-b0b4-42df-8ca1-b906d1511add">934,783</ix:nonFraction> shares of the Company's common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg3Nw_8c038528-068e-4c85-b96c-2612a597276a">0.00025</ix:nonFraction> par value per share, representing approximately $<ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg1Nw_13bb0413-13f6-4ff3-8f52-7479b7a32df1">35,000</ix:nonFraction> (based on a closing share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg2OQ_6d71aef0-a40c-4327-973e-a48dc84b27b6">37.63</ix:nonFraction> on April 1, 2020. ApiFix, a corporation organized under the laws of Israel, has developed a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis ("ApiFix System"). In addition, we have also agreed to pay as part of the purchase price the following anniversary payments: (i) $<ix:nonFraction unitRef="usd" contextRef="iade7dd3801514191b80df2d859180efe_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkxNQ_a17e3a07-1290-41f5-8e7e-edde17e816e4">13,000</ix:nonFraction> on the second anniversary of the closing date, provided that such payment will be paid earlier if <ix:nonFraction unitRef="facility" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="INF" name="kids:BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkzOA_688541d3-9161-4cab-85e8-d1138c9fa993">150</ix:nonFraction> clinical procedures using the ApiFix System are completed in the United States before such anniversary date, (ii) $<ix:nonFraction unitRef="usd" contextRef="ia07305a71eeb47d99be5750a3a47cb18_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkwNA_9a4f2d8f-3428-47ee-a80e-3f0f519a3284">8,000</ix:nonFraction> on the third anniversary of the closing date; and (iii) $<ix:nonFraction unitRef="usd" contextRef="i974a053f052c4233bccf37c504b97db0_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg4Nw_ff9d3dba-6b9e-4183-ab86-44a71e092917">9,000</ix:nonFraction> on the fourth anniversary of the closing date. In addition, to the extent that the product of our revenues from the ApiFix System for the twelve months ended June 30, 2024 multiplied by <ix:nonFraction unitRef="number" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="INF" name="kids:BusinessCombinationContingentConsiderationRevenueMultiplier" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg5OA_e1ffc5a5-41ea-4fe9-bd15-9eda8873429c">2.25</ix:nonFraction> exceeds the anniversary payments </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i538732873c964fb2bd629b915da17515" continuedAt="i7b120fc4b7194b19a840039871e4b38b"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">actually made for the third and fourth years, we have agreed to pay the selling shareholders a system sales payment in the amount of such excess. The anniversary payments and system sales payment may each be made in cash or cash and common stock. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 10, 2020, we purchased certain intellectual property assets from Band-Lok, LLC, a North Carolina limited liability company ("Band-Lok"), related to its Tether Clamp and Implantation System ("Tether Clamp System") for approximately $<ix:nonFraction unitRef="usd" contextRef="i1832772ced4e4d7694796baf90a940a1_D20200610-20200610" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkyNw_e29be7f5-597e-4397-8814-0afc966345c5">3,400</ix:nonFraction> in total consideration. We use the Tether Clamp System in connection with our Bandloc 5.5/6.0 System. We were previously the sole licensee of the purchased assets under a license agreement with Band-Lok. </span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i7b120fc4b7194b19a840039871e4b38b">Our largest investor is Squadron, a private investment firm based in Granby, Connecticut.</ix:continuation>   </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_43"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 2 &#8211; <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTc_40bf1b35-d490-4394-8339-f87d8df18b19" continuedAt="i68eacfc673c84e6fb67115fb2fed62f8" escape="true">SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i68eacfc673c84e6fb67115fb2fed62f8" continuedAt="i294822a8a881461d8aab2df5cd752d5d"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTU_0efd3d4c-4113-4e34-a5c3-76b94cfc7809" continuedAt="if3947dfea2c642e9907a72b5f0537b81" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying condensed consolidated financial statements include the accounts of OrthoPediatrics Corp. and its wholly-owned subsidiaries, OrthoPediatrics US Distribution Corp., OrthoPediatrics EU Limited, OrthoPediatrics AUS PTY LTD, OrthoPediatrics NZ Limited, OP EU B.V., OP Netherlands B.V., Vilex in Tennessee, Inc., Orthex, LLC, Telos Partners, LLC, ApiFix Ltd. and ApiFix Inc. (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;).  All intercompany balances and transactions have been eliminated.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Unaudited Interim Condensed Consolidated Financial Statements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have prepared the accompanying condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The accompanying condensed consolidated balance sheets as of June&#160;30, 2020 and December 31, 2019, the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of comprehensive loss for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of stockholders&#8217; equity for the three and six months ended June&#160;30, 2020 and 2019 and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2020 and 2019 are unaudited and should be read in conjunction with the annual consolidated financial statements as of and for the year ended December&#160;31, 2019 and related notes thereto contained in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 5, 2020. The financial data and other financial information disclosed in the notes to the accompanying condensed consolidated financial statements are also unaudited. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to applicable rules and regulations thereunder. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended December 31, 2019 and, in management&#8217;s opinion, include all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the financial statements for the interim periods. The results of operations for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results to be expected for the full fiscal year or for any other period. </span></div></ix:nonNumeric><div style="padding-left:1pt;padding-right:1pt;"><span><br/></span></div><div style="padding-left:1pt;padding-right:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="if3947dfea2c642e9907a72b5f0537b81">The accompanying condensed consolidated financial statements have been prepared assuming our Company will continue as a going concern.</ix:continuation>  We have experienced recurring losses from operations since our inception and had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjcwNg_f7af988b-c5ca-434c-bfee-68976588f740">143,214</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjcxMw_440b0555-67ce-4b5f-b11d-9793b26e05b5">128,822</ix:nonFraction> as of June&#160;30, 2020 and December 31, 2019, respectively. Management continues to monitor cash flows and liquidity on a regular basis. We believe that our cash balance at June&#160;30, 2020 and expected cash flows from operations for the next twelve months subsequent to the issuance of the accompanying condensed consolidated </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i294822a8a881461d8aab2df5cd752d5d" continuedAt="i2e9b8101b0104e19b025b2f586216b49"><div style="padding-left:1pt;padding-right:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements, are sufficient to enable us to maintain current and essential planned operations for more than the next twelve months. </span></div><div style="padding-left:1pt;padding-right:1pt;"><span><br/></span></div><div style="padding-left:1pt;padding-right:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 22, 2020, we completed a follow-on offering of our common stock, in which we issued and sold <ix:nonFraction unitRef="shares" contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzY3MQ_bc41ed9e-db7b-4b5b-a32c-161ed47f0328">1.6</ix:nonFraction>&#160;million shares of common stock at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iee7c30dda4914c6593234714105f5846_I20200622" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzcwOA_aeee88ae-bf49-4b9e-8181-0582900906e8">47.00</ix:nonFraction> per share for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzY4NA_7964aa6f-ba5b-47b9-8165-b5df76bb1279">75,200</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzY5Mw_4f56dc19-6844-4c17-b026-cb554a5d8967">70,207</ix:nonFraction> in net proceeds after deducting $<ix:nonFraction unitRef="usd" contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfNTQ5NzU1ODE2NDg2NQ_1e559a1a-f923-4397-8498-b01dd16102da">4,512</ix:nonFraction> of underwriting discounts and commissions and paying $<ix:nonFraction unitRef="usd" contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzcwMg_5d49046e-94b4-4a94-9392-93325630f3d8">481</ix:nonFraction> in offering costs. </span></div><div style="padding-left:1pt;padding-right:1pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTQ_d805542e-8c53-4dbb-a52d-0085f30a01af" continuedAt="i5000bf453788477b848e5670e90ff922" escape="true">Use of Estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i5000bf453788477b848e5670e90ff922">Preparation of the condensed consolidated financial statements requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as of the date of the condensed consolidated financial statements.  By their nature, these judgments are subject to an inherent degree of uncertainty. The impact of the coronavirus disease ("COVID-19") has significantly increased economic and demand uncertainty.  We use historical experience and other assumptions as the basis for our judgments and estimates.  Because future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.  Any changes in these estimates will be reflected in the condensed consolidated financial statements.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDM_6cfb1793-5d14-4ee9-8422-2041f9b23365" continuedAt="idf5c4928f2d342abb7cc153ad18ef3c0" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Foreign Currency Transactions</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently bill our international distributors in United States ("U.S.") dollars, resulting in minimal foreign exchange transaction expense. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="idf5c4928f2d342abb7cc153ad18ef3c0">Beginning in the second quarter of 2017, we began selling direct within the United Kingdom, Ireland, Australia and New Zealand and billing using the local currency for each country. In September 2018, we began selling direct in Canada, in January 2019 in Belgium and the Netherlands, in March 2020 in Italy and in April 2020 in Israel. The financial statements of our foreign subsidiaries are accounted for and have been translated into U.S. dollars using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. Foreign currency translation adjustments have been recorded as a separate component of the condensed consolidated statements of comprehensive loss.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTk_0deafc92-e2c5-4ed1-856c-88097f2ff7f6" continuedAt="ie9c9a1ea123449ac8649224de95d9d78" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue from Contracts with Customers</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In accordance with ASC 606, "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue From Contracts With Customers </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ASC 606)", revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services, and excludes any sales incentives or taxes collected from a customer which are subsequently remitted to government authorities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue Recognition &#8211; United States</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue in the United States is generated primarily from the sale of our implants and, to a much lesser extent, from the sale of our instruments.  Sales in the United States are primarily to hospital accounts through independent sales agencies.  We recognize revenue when our performance obligations under the terms of a contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customers, generally upon implantation or when title passes upon shipment. The products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.   </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i2e9b8101b0104e19b025b2f586216b49" continuedAt="ie7c48a6abb63424f8f690d9d627dc186"><ix:continuation id="ie9c9a1ea123449ac8649224de95d9d78" continuedAt="i44f4b9eef78e4cb188023587a22cfa63"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue Recognition &#8211; International</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Outside of the United States, we primarily sell our products through independent stocking distributors. Generally, the distributors are allowed to return products, and some are thinly capitalized. Based on our history of collections and returns from international customers, prior to 2019, we concluded that collectability was not reasonably assured at the time of delivery for certain customers who had not evidenced a consistent pattern of timely payment. Accordingly, in the past we did not recognize international revenue and associated cost of revenue at the time title transfers for these customers for whom collectability had not been deemed probable based on the customer&#8217;s history and ability to pay, but rather when cash had been received. </span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a review of our collection history, we deemed collectability was probable for all international stocking distributors effective January 1, 2019. Based on a history of reliable collections, we have concluded that a contract exists and revenue should be recognized when our performance obligations under the terms of the contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customer, generally upon implantation or when title passes upon shipment.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#226600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div></ix:continuation><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i44f4b9eef78e4cb188023587a22cfa63">In the countries where we sell under an agency model direct to local hospitals, the products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.</ix:continuation>     </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDQ_87c35ded-e010-48e6-93f0-db5c534d63dd" continuedAt="ifb424856198e4373be7b2e0a585dc729" escape="true">Cash and Cash Equivalents</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ifb424856198e4373be7b2e0a585dc729">We maintain cash in bank deposit accounts which, at times, may exceed federally insured limits.  To date, we have not experienced any loss in such accounts.  We consider all highly liquid investments with original maturity of three months or less at inception to be cash equivalents.  The carrying amounts reported in the balance sheet for cash are valued at cost, which approximates fair value.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDA_41506e55-6abe-41d8-905f-47aa2ee4d259" continuedAt="iae76676c9b6c44e9a3da9ae7a2d79097" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accounts receivable are uncollateralized customer obligations due under normal trade terms, generally requiring payment within 30 days from the invoice date. Account balances with invoices over 30 days past due are considered delinquent.  No interest is charged on past due accounts. Payments of accounts receivable are applied to the specific invoices identified on the customer's remittance advice or, if unspecified, to the customer's account as an unapplied credit.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="iae76676c9b6c44e9a3da9ae7a2d79097">The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected, determined principally on the basis of historical experience, management's assessment of the collectability of specific customer accounts and the aging of the accounts receivable. All accounts or portions thereof deemed to be uncollectible or to require an excessive collection cost are written off to the allowance for doubtful accounts.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4ODk_70f9948e-7e94-47bd-99c7-221400d38377" continuedAt="ic16c944eff1746648c7aa47368d82d41" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Inventories, net </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories are stated at the lower of cost or net realizable value, with cost determined using the first-in-first-out method. Inventories, which consist of implants and instruments held in our warehouse or with third-party independent sales agencies or distributors, are considered finished goods and are purchased from third parties. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate the carrying value of our inventories in relation to the estimated forecast of product demand, which takes into consideration the life cycle of the product.  A significant decrease in demand could result </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ie7c48a6abb63424f8f690d9d627dc186" continuedAt="i1e7c03232f7746a1a7e7b9b2f77d4a3b"><ix:continuation id="ic16c944eff1746648c7aa47368d82d41" continuedAt="i3000d28351e5414088fe36181d651aba"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in an increase in the amount of excess inventory on hand, which could lead to additional charges for excess and obsolete inventory.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The need to maintain substantial levels of inventory impacts our estimates for excess and obsolete inventory.  Each of our implant systems are designed to include implantable products that come in different sizes and shapes to accommodate the surgeon&#8217;s needs.  Typically, a small number of the set components are used in each surgical procedure.  Certain components within each set may become obsolete before other components based on the usage patterns.  We adjust inventory values, as needed, to reflect these usage patterns and life cycle.     </span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i3000d28351e5414088fe36181d651aba">In addition, we continue to introduce new products, which may require us to take additional charges for excess and obsolete inventory in the future.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTE_92559c84-34b4-47d2-8860-8099e7eac7fb" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Property and Equipment, net </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful life of the assets. When assets are retired or otherwise disposed of, costs and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in operations for the period. Maintenance and repairs that prolong or extend the useful life are capitalized, whereas standard maintenance, replacements, and repair costs are expensed as incurred. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Instruments are hand-held devices, specifically designed for use with our implants and are used by surgeons during surgery. Instruments deployed within the United States, United Kingdom, Australia, New Zealand, Canada, Belgium, the Netherlands and Italy are carried at cost less accumulated depreciation and are recorded in property and equipment, net on the condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sample inventory consists of our implants and instruments, and is maintained to market and promote our products. <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTA_ee8c9493-f08b-4c90-8ee2-d7a418f8bb3a" continuedAt="ie72cb766abc3427b8d017bce4d671083" escape="true">Sample inventory is carried at cost less accumulated depreciation. </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie72cb766abc3427b8d017bce4d671083"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciable lives are generally as follows:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:48.000%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:48.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Building and building improvements</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i06a679238a7a43869b57724937813e35_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMC0xLTEtMS0wL3RleHRyZWdpb246Njg3N2Y2YzhkZDhlNGRhNWI3OGU3ZjAxYmNlNjAyNGVfNA_a56cd397-6c73-4731-80ad-1d55044d41ef">25</ix:nonNumeric> to <ix:nonNumeric contextRef="ifa4a9026c5c340bca4066b1c0efd2063_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMC0xLTEtMS0wL3RleHRyZWdpb246Njg3N2Y2YzhkZDhlNGRhNWI3OGU3ZjAxYmNlNjAyNGVfMTA_7eeebe39-66c4-47d8-8968-7341faeb4e08">30</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and fixtures</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="ic55ec3187d414b9abaf5fb65b6c8a434_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMS0xLTEtMS0wL3RleHRyZWdpb246OWU4NGYyNzAzYWUzNDI1MWI1NDAyNTc3ZjNhNTRhYmZfNA_58aed653-cd1c-4d8a-96ca-ae87d614bc6c">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i6f6897b493df42eeb47e27f00c5abf4b_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMS0xLTEtMS0wL3RleHRyZWdpb246OWU4NGYyNzAzYWUzNDI1MWI1NDAyNTc3ZjNhNTRhYmZfMTA_97cab574-a798-4696-964a-c69c8ae16800">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i96d7db72a7864d59befbe7a971698da9_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMi0xLTEtMS0wL3RleHRyZWdpb246ODY3MzJiMDI1MTU2NGM1MmExNWNjZGVmOTc4MzQ3NTZfNA_49670fa8-5abf-463d-b562-66a6ccb325ee">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i53ba86c7840345919cc20c4229f816e0_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMi0xLTEtMS0wL3RleHRyZWdpb246ODY3MzJiMDI1MTU2NGM1MmExNWNjZGVmOTc4MzQ3NTZfMTA_279e673d-addf-4e7f-800d-e93007bb046a">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Business software</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i1287bce70e774c27965e7c70d082232c_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMy0xLTEtMS0wL3RleHRyZWdpb246OWM5ZDM3NzYzODZmNDAyNzgyMGVkYzA0NTYxY2YwOTFfNA_cd4ba9d7-a451-4228-b2cf-d706f1ff3d47">3</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office and other equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i940588eb8f6a40e3a2e23b5b87a7a8b9_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNC0xLTEtMS0wL3RleHRyZWdpb246ZTBjMTJiYzkwNzJlNDgzMzg3ZGM3MDUxNGRiYTQ5MDZfNA_2907580b-e4da-4d4b-89a2-83e0fbd4ae90">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i47943924a14342328b889ec2d330cf79_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNC0xLTEtMS0wL3RleHRyZWdpb246ZTBjMTJiYzkwNzJlNDgzMzg3ZGM3MDUxNGRiYTQ5MDZfMTA_0d5770ff-4a51-43eb-98a7-0366700003aa">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instruments</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i3fd8747608254c9ab234730b9575a4fb_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNS0xLTEtMS0wL3RleHRyZWdpb246ZWIzZmQ4NDU2ZTc4NGM5ZDhlNDMyNjJlYTk5YTM5MDNfNA_51f08fab-f9ad-458f-a867-52d5dec74704">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sample inventory</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonNumeric contextRef="i2ad4e18322904bda9fe3bf97682b7114_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNi0xLTEtMS0wL3RleHRyZWdpb246ZDJlZWJlYWY4ZTU0NDliNThmYTllZTk5ZmU4ODI3MjBfNA_c3347463-dae2-432c-a97d-8635c3485840">2</ix:nonNumeric> years</span></div></td></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4ODU_8a05127d-48d4-46ba-95e4-7886dab71a67" continuedAt="i8d827cc9cea04affa8a8ad81e1010102" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Amortizable Intangible Assets, net</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amortizable intangible assets</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">include fees necessary to secure various patents and licenses, including Band-Lok, the value of internally developed software, customer relationships, and non-competition agreements related to the acquisition of Orthex, and customer relationships and non-competition agreements related to the acquisitions of Telos and ApiFix. Amortization is calculated on a straight-line basis over the estimated useful life of the asset.  Amortization for patents and licenses commences at the time of patent approval and market launch, respectively. Amortization for assets acquired commences upon acquisition. Intangible assets are amortized over a <ix:nonNumeric contextRef="i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTMwMDA_d17b778d-afd1-4638-ac62-6fcabe8ea3b5">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i7ce4805a31e8410d81b81251b9b1f57c_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTMwMDY_8566c0d5-1c63-49f7-822b-3faa03458da9">20</ix:nonNumeric> year period. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amortizable intangible assets are assessed for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i1e7c03232f7746a1a7e7b9b2f77d4a3b" continuedAt="i2ce6e64b2b5a44acae0f8d7ac8bc239d"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i8d827cc9cea04affa8a8ad81e1010102">measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_4f4f859b-cbdc-495d-8221-b494e9067572"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_9b62658a-3f91-459a-bfc6-5f98cf22f8c1"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_ae42fa20-5e6b-4dc9-86a1-ef14b08be36c"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_c9f2111d-6be9-4e24-a1cd-3fc5c0e2bf70">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment charges were recorded in any of the periods presented.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4Nzk_0d936fd3-09c3-4087-bf06-44aab478d0bb" continuedAt="i477e87cc09af40d98c34ddd99530bfd4" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Goodwill and Other Intangible Assets</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our goodwill represents the excess of the cost over the fair value of net assets acquired. The determination of the value of goodwill and intangible assets arising from acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of net tangible and intangible assets acquired. Goodwill is not amortized and is assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstances warrant such a review. The goodwill is considered to be impaired if we determine that the carrying value of the reporting unit exceeds its respective fair value. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i477e87cc09af40d98c34ddd99530bfd4">We have indefinite lived tradename assets that are reviewed for impairment by performing a quantitative analysis, which occurs annually in the fourth quarter or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.</ix:continuation>  <ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_05c512af-f6ac-4d15-84ca-45148d6aa291"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_904541cb-e062-4eee-ab29-cb78b5395ff4"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_a21d772a-5a0e-4ee6-a811-5b1949e2f06f"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_ca6ec78e-441d-442e-b2c4-0f9034d5659c">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment charges were recorded in any of the periods presented. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="kids:CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTE_535b8486-bdc1-4d2f-bf40-92e6e1c9a586" continuedAt="ia6b4a73b1932465d91a15579b8f232ab" escape="true">Cost of Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ia6b4a73b1932465d91a15579b8f232ab">Cost of revenue consists primarily of products purchased from third-party suppliers, excess and obsolete inventory adjustments, inbound freight, and royalties.  Our implants and instruments are manufactured to our specifications by third-party suppliers who meet our manufacturer qualifications standards.  Our third-party manufacturers are required to meet the standards of the Food and Drug Administration (the &#8220;FDA&#8221;), and the International Organization for Standardization, as well as other country-specific quality standards.  The majority of our implants and instruments are produced in the United States.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="kids:SalesAndMarketingExpensePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4NzM_3b034b09-a519-4e23-9291-654d7489c81e" continuedAt="i0946e8be64634056b00cc0547858fa80" escape="true">Sales and Marketing Expenses</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i0946e8be64634056b00cc0547858fa80">Sales and marketing expenses primarily consist of commissions to our domestic and select international independent sales agencies and consignment distributors, as well as compensation, commissions, benefits and other related costs for personnel we employ. Commissions and bonuses are generally based on a percentage of sales.  Our international independent stocking distributors purchase instrument sets and replenishment stock for resale, and we do not pay commissions or any other sales related costs for international sales to distributors.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDY_e8d2ba6e-3e22-40f0-905c-e9801a07b1cd" continuedAt="i55d87f067bbe45d7b603f6f58ad7feaa" escape="true">Advertising Costs </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i55d87f067bbe45d7b603f6f58ad7feaa">Advertising costs consist primarily of print advertising, trade shows, and other related expenses. Advertising costs are expensed as incurred and are recorded as a component of sales and marketing expense.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDc_430d94af-a777-4240-87a9-8d16c6bdc137" continuedAt="i9749f56efe5a4c6caab08615ac458163" escape="true">Research and Development Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i9749f56efe5a4c6caab08615ac458163">Research and development costs are expensed as incurred. Our research and development expenses primarily consist of costs associated with engineering, product development, consulting services, outside prototyping services, outside research activities, materials, development and protection of our intellectual property portfolio, as well as other costs associated with development of our products. Research and development costs also include related personnel and consultants&#8217; compensation expense.</ix:continuation>  </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i2ce6e64b2b5a44acae0f8d7ac8bc239d" continuedAt="iafae16b182404e28a50ef140f19f901c"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTI_e977ed9b-aa6f-4697-b6ee-424afe16f538" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to our Initial Public Offering ("IPO") in October 2017, we maintained an Amended and Restated 2007 Equity Incentive Plan (the &#8220;2007 Plan&#8221;) that provided for grants of options and restricted stock to employees, directors and associated third-party representatives of the Company as determined by the Board of Directors. The 2007 Plan had authorized <ix:nonFraction unitRef="shares" contextRef="ie6bbf783a9584fe0a1bd64259cbff166_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTczNDE_0302f09c-5213-4384-960e-4c8d149ea12d">1,585,000</ix:nonFraction> shares for award. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Immediately prior to our IPO, we adopted our 2017 Incentive Award Plan (the "2017 Plan") which replaced the 2007 Plan. The 2017 Plan provides for grants of options and restricted stock to officers, employees, consultants or directors of our Company. The 2017 Plan has authorized <ix:nonFraction unitRef="shares" contextRef="iaa05c196b8e04e13accf63a52bae4361_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc2NDM_bf1970e4-dee5-4f61-9a39-e09cb75c633e">1,789,647</ix:nonFraction> shares for award. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Options holders, upon vesting, may purchase common stock at the exercise price, which is the estimated fair value of our common stock on the date of grant. Option grants generally vest immediately or over <ix:nonNumeric contextRef="i9e55361217974608a2b11df6efaf5506_D20200101-20200630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzE_d2bc94c5-59c1-4e7e-bd1c-92195d1d9aea">three years</ix:nonNumeric>. <ix:nonFraction unitRef="shares" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_51dbc7ad-3b7a-4389-8a79-a97b55bcf91f"><ix:nonFraction unitRef="shares" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_6511da61-6ad5-43bd-b9ee-d7427979dc3e"><ix:nonFraction unitRef="shares" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_ef30983d-30d2-4dfa-84ae-bb51afc1e5f9"><ix:nonFraction unitRef="shares" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_f3284a52-772c-4e62-b1b7-df029c58dadc">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> stock options were granted in any of the periods presented.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Restricted stock may not be transferred prior to the expiration of the restricted period, which is typically three years. The restricted stock that had been granted under the 2007 Plan had restriction periods that generally lasted until the earlier of <ix:nonNumeric contextRef="i292238a1b0524036b2e519416ce7ebbc_D20200101-20200630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTgxOTE_b6aa7160-672a-4a97-888e-fa5ff26345d1">six years</ix:nonNumeric> from the date of grant, or an IPO or change in control, as defined in the 2007 Plan. All restricted stock granted prior to May 2014 vested upon our IPO and the remaining grants under the 2007 Plan vested <ix:nonNumeric contextRef="i6dd7fadd1c8141f4bce22e9933efeca0_D20200101-20200630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTgzOTg_f8ec7369-5564-4aea-a682-cb8f3809a3a6">six months</ix:nonNumeric> after the IPO. We recognize the reversal of stock compensation expense when a restricted stock forfeiture occurs as opposed to estimating future forfeitures.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We record the fair value of restricted stock at the grant date.  Stock-based compensation is recognized ratably over the requisite service period, which is generally the restriction period for restricted stock.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTM_196c33ad-af44-4a4f-8122-2b4168268280" continuedAt="i9d4f8bf8596e43c1a15938c9fd62b66e" escape="true">Comprehensive Income (Loss)</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i9d4f8bf8596e43c1a15938c9fd62b66e">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income (loss) includes foreign currency translation adjustments.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4ODM_7c5c6be4-134e-447e-996d-634afabbe284" continuedAt="i68674f1cedf04d539df694a499af2b98" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Income Taxes</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements. Under this method, we determine deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i68674f1cedf04d539df694a499af2b98">We record uncertain tax positions on the bases of a two-step process in which (i) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the positions and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="iafae16b182404e28a50ef140f19f901c" continuedAt="i48f0b61a18b44a3399888685297b102d"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="kids:EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTQ_b0c772f0-5858-4983-9a26-5c08f40e7217" continuedAt="i8b994ac2fd374342804f58c71d5bb69f" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">&#8220;Emerging Growth Company&#8221; Reporting Requirements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We qualify as an &#8220;emerging growth company&#8221; as defined in the JOBS Act. For as long as a company is deemed to be an emerging growth company, it may take advantage of specified reduced reporting and other regulatory requirements that are generally unavailable to other public companies. Among other things, we are not required to provide an auditor attestation report on the assessment of the internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act of 2002. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Section 107 of the JOBS Act also provides that an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i8b994ac2fd374342804f58c71d5bb69f">In April 2017, the SEC adopted new rules that included an inflation-adjusted threshold in the definition of an emerging growth company. Under the new inflation-adjusted threshold, we would cease to be an emerging growth company on the last day of the fiscal year in which our annual gross revenues exceed $1.07 billion. This is an increase of $70 million from the previous $1 billion threshold.</ix:continuation>    </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDI_5b39a649-5069-4570-836c-b3aa94a9c3a2" continuedAt="id321cb97514f478dad86a5310937a121" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU No. 2016-13 "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments"</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financials assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Based on ASU 2019-10 and our status as a Smaller Reporting Company, the Company will adopt ASU 2016-13 effective January 1, 2023. The adoption of this guidance is not expected to have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2017, the FASB issued ASU 2017-04, "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment"</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. This pronouncement eliminates Step 2 from the goodwill impairment test and requires an entity to perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. Under this guidance, an entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. It is effective for reporting periods beginning after December 15, 2020, although earlier adoption is permitted. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><ix:continuation id="i48f0b61a18b44a3399888685297b102d" continuedAt="icb16469e00854aee947901dda34bee39"><ix:continuation id="id321cb97514f478dad86a5310937a121" continuedAt="i3fc5e8fc270d46aa952de28ce637e0cc"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU No. 2019-12 "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes: Simplifying the Accounting for Income Taxes"</span></ix:continuation></ix:continuation><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="icb16469e00854aee947901dda34bee39"><ix:continuation id="i3fc5e8fc270d46aa952de28ce637e0cc"> intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside cost basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">17</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_46"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 3 &#8211; <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfNDcxNQ_58f28862-3c37-41ad-b40e-d9a3d209cc22" continuedAt="i31283b3f80964835b5ba1ebbac9608a8" escape="true">BUSINESS COMBINATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i31283b3f80964835b5ba1ebbac9608a8" continuedAt="i71ff9c1d7f6a440e9e654afd7db7b0a8"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">ApiFix</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On April 1, 2020, the Company purchased all the issued and outstanding membership interest of ApiFix for $<ix:nonFraction unitRef="usd" contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ4MQ_9ebf1f89-c37d-43b1-9c1f-ebb8a3127604">2,000</ix:nonFraction> in cash, including $<ix:nonFraction unitRef="usd" contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU0NQ_3e8d6d32-511a-4d09-9738-11899fea7f97">343</ix:nonFraction> of cash acquired, <ix:nonFraction unitRef="shares" contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ5MA_e28d075a-b0b4-42df-8ca1-b906d1511add">934,783</ix:nonFraction> shares of the Company's common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUwMA_8c038528-068e-4c85-b96c-2612a597276a">0.00025</ix:nonFraction> par value per share, representing approximately $<ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU2Ng_5a3d314e-5f03-4d47-a8d9-c81777681121">35,176</ix:nonFraction> (based on a closing share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUwNw_6d71aef0-a40c-4327-973e-a48dc84b27b6">37.63</ix:nonFraction> on April 1, 2020), $<ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAnniversaryPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU1NA_1554941b-ae67-4ba8-b47d-747b54765902">30,000</ix:nonFraction> in anniversary payments, and approximately $<ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationSystemSalesPayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU3OA_53626521-df28-4f17-8f0c-c91012dc8d73">41,741</ix:nonFraction> in a system sales payment. The total consideration transferred of $<ix:nonFraction unitRef="usd" contextRef="i44bb1450f6e841a0b1500229ed099770_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NTI3MA_a70902c7-5030-4897-9041-f653fcd97d6e">87,379</ix:nonFraction> is preliminary and subject to certain limitations and adjustments. ApiFix, a corporation organized under the laws of Israel, has developed a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis ("ApiFix System").  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company incurred $<ix:nonFraction unitRef="usd" contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU5MA_69192033-8bbf-403c-a6e5-8153012b8b7a">310</ix:nonFraction> of acquisition-related costs that are included in general and administrative expenses on the consolidated statements of operations. The purchase price allocation set forth herein is preliminary. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyMw_28974099-8aeb-4c19-9170-6f99a6b7ad78" continuedAt="i7dcdb5c5110d4af18037fa0c0d6bfe35" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for ApiFix and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands):  </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"></td><td style="width:62.677%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.574%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:31.549%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preliminary fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMS0yLTEtMS0zMzc3_236efd67-5f83-4cf7-8282-f8a8a8931cdc">87,379</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMy0yLTEtMS0zMzc3_eba6009e-dd48-45d6-86af-2fa0d7f0ee4d">344</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNC0yLTEtMS0zMzc3_aa78f1fe-24ce-4e2c-9fa5-7319303ceec5">245</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNS0yLTEtMS0zMzc3_cd26d313-6420-4e0f-865a-d814e202c881">685</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNi0yLTEtMS0zMzc3_e456661a-2644-42f5-8079-8b2deef6b840">77</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNy0yLTEtMS0zMzc3_7e8529a9-c4fb-4ecd-a14f-d41c0047643a">153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfOC0yLTEtMS0zMzc3_1761d490-12a2-486f-bdd4-172a3d7c63fb">24,330</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfOS0yLTEtMS0zMzc3_b6e75cdb-38a7-46b2-b9eb-47c0fe9b223a">8,620</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTAtMi0xLTEtMzM3Nw_1a609785-478d-4edf-a4d2-2eed56f07ec6">104</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTEtMi0xLTEtMzM3Nw_bf943b1c-b638-4400-8993-7ebd15592ad2">34,558</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTMtMi0xLTEtMzM3Nw_13d47dca-2611-4935-b99e-28a4cc04daa9">226</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTQtMi0xLTEtMzM3Nw_e8d2c13a-fc40-4324-ac65-35d5abbb5e0c">106</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTYtMi0xLTEtMzM3Nw_fa737e07-2582-4c6b-bc47-92440628f033">270</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTctMi0xLTEtMzM3Nw_9b4b39bc-5696-4cf4-8140-bebf7e82d667">602</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTgtMi0xLTEtMzM3Nw_d322ce15-e7de-4ff9-96cd-b771c10688ee">33,956</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTktMi0xLTEtMzM3Nw_f31b1755-6f8c-4912-9424-0e7446600207">53,423</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyNA_1cbfa600-aac9-4372-8f63-9a20340b3051" continuedAt="i4b12a876578d4842874a7854e293a1c6" escape="true"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyNA_f0a7be16-50e1-4738-a6f6-c1c8b46da087" continuedAt="ia818bf6ee18f41e991717f3995665e3b" escape="true">The estimated fair value and useful life of identifiable intangible assets are as follows: </ix:nonNumeric></ix:nonNumeric></span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i71ff9c1d7f6a440e9e654afd7db7b0a8" continuedAt="ib2cc1dd6837947f8bf6062254fda9ed5"><div style="margin-bottom:6pt;"><ix:continuation id="i4b12a876578d4842874a7854e293a1c6" continuedAt="i8ceb729800d5430b9d5361331745e603"><ix:continuation id="ia818bf6ee18f41e991717f3995665e3b" continuedAt="i936e4d0719c644f6b4c9d2c094501a19"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:33.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.883%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.883%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:38.226%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i66ddcda9efb2401e914b895725e8449a_D20200309-20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMS0yLTEtMS0zMjQ1_ef2c16c3-7a51-44a7-b490-4b5a639a8e65">8,620</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icad1fff330924b20990fd0c7cf170c10_D20200309-20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMi0yLTEtMS0zMjQ1_31464e1f-dce9-4332-90c8-a1a0725bd9eb">23,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ib40f513d923c4826b58162f6f5582202_D20190604-20190604" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMi00LTEtMS0zMjQ3_28a04012-4652-481a-a8e9-622de6d7c82c">15</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5cf98eb1a09e4ccb8140a7acdb7780b3_D20200309-20200309" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMy0yLTEtMS0zMjQ1_a28e884f-62a0-4919-925a-9a03d9765b44">340</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia313240909774cbe8dc30507a797ccc1_D20190604-20190604" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMy00LTEtMS0zMjQ3_b1008aac-e35a-4179-af3a-5ee539c35145">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ad06b13cdff4f36ab42c19c49f5ec90_D20200309-20200309" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfNC0yLTEtMS0zMjQ1_002eb94d-8715-429e-94d7-38f99f057c8e">200</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i938290d2cdad418ea88e9197cb42d54e_D20190604-20190604" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfNC00LTEtMS0zMjQ3_6cb417d0-33fb-4b70-bba7-13385f63e0f7">4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea2114642e614c76862ec79220c8b6de_D20200309-20200309" decimals="-3" format="ixt:numdotdecimal" name="kids:IntangibleAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfNS0yLTEtMS0zMjQ1_43863b9f-038d-4b4a-91e1-368053dc2ba0">32,950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company is obligated to make anniversary payments of: (i) $<ix:nonFraction unitRef="usd" contextRef="iade7dd3801514191b80df2d859180efe_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUxNg_a17e3a07-1290-41f5-8e7e-edde17e816e4">13,000</ix:nonFraction> on the second anniversary of the closing date, provided that such payment will be paid earlier if <ix:nonFraction unitRef="facility" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="INF" name="kids:BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUyMQ_688541d3-9161-4cab-85e8-d1138c9fa993">150</ix:nonFraction> clinical procedures using the ApiFix System are completed in the United States before such anniversary date, (ii) $<ix:nonFraction unitRef="usd" contextRef="ia07305a71eeb47d99be5750a3a47cb18_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUyOQ_9a4f2d8f-3428-47ee-a80e-3f0f519a3284">8,000</ix:nonFraction> on the third anniversary of the closing date; and (iii) $<ix:nonFraction unitRef="usd" contextRef="i974a053f052c4233bccf37c504b97db0_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUzNw_ff9d3dba-6b9e-4183-ab86-44a71e092917">9,000</ix:nonFraction> on the fourth anniversary of the closing date, subject to adjustments. The Company anticipates making the second anniversary payment of $<ix:nonFraction unitRef="usd" contextRef="iade7dd3801514191b80df2d859180efe_D20200401-20200401" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYwMQ_5f37d783-17aa-41a3-ab1d-1b340a400ef9">13,000</ix:nonFraction> during the first half of 2021. In addition, to the extent that the product of our revenues from the ApiFix System for the twelve months ended June 30, 2024 multiplied by <ix:nonFraction unitRef="number" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="INF" name="kids:BusinessCombinationContingentConsiderationRevenueMultiplier" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU0Mw_e1ffc5a5-41ea-4fe9-bd15-9eda8873429c">2.25</ix:nonFraction> exceeds the anniversary payments actually made for the third and fourth years, we have agreed to pay the selling shareholders a system sales payment in the amount of such excess. The anniversary payments and system sales payment may each be made in cash or cash and common stock, subject to certain limitations; provided that the Company makes the determination with respect to anniversary payments and a representative of the former ApiFix shareholders may make the determination with respect to the system sales payment, if any. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of the contingent consideration payments is considered a Level 3 investment and were determined by an independent valuation specialist at the original issuance date using an option pricing model and a Monte Carlo simulation based on forecast annual revenue, expected volatility and an implied probability of achieving revenue forecasts. The fair value of the payments will continue to be adjusted as additional information becomes available regarding the progress toward achievement of the revenue forecast. The adjustment in the fair value of the contingent consideration payments of $<ix:nonFraction unitRef="usd" contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NTI4Mg_87d929a8-c757-4fc3-9d27-f9ac89c00980">910</ix:nonFraction> was recognized as an expense for the six month period ended June 30, 2020 in other expenses on the condensed consolidated statements of operations. An additional $<ix:nonFraction unitRef="usd" contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NTI4OA_e5429f0c-d828-43ff-9ce3-c32abc3e444b">886</ix:nonFraction> was recognized as interest expense for the six month period ended June 30, 2020 on the condensed consolidated statements of operations for the adjustment in the fair value of the acquisition installment payable. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyNQ_3724080d-0fcf-4400-8e76-98c8ca9606ac" continuedAt="i0f6fe318066f4ae08ecabde73088aef9" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Presented below is a summary of the present value of the anniversary payments and system sales payment related to the ApiFix acquisition: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:56.974%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.873%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">April 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anniversary Payments: </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Second Year Payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4871de21cf3c497a9d2222f88b61d7ab_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMi0yLTEtMS0zMjQx_d38a6be4-5421-4376-93a9-51ac5694d60e">10,980</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iefda4158f9254c1eb3becf702fc558a8_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMi00LTEtMS0zMjQz_703bed0c-b100-4607-bfed-c78e53763ace">11,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Third Year Payment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i36be2612ceac48918982f7de2682e1c5_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMy0yLTEtMS0zMjQx_fab43373-5900-4d92-ad31-8963b95c16fe">5,780</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3de47578e860485f8740cf50e09ee68f_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMy00LTEtMS0zMjQz_838a3602-b75a-4564-b049-dffd85114cd9">5,965</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fourth Year Payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i136967d17bba4ed28cf1f18b639b6b83_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNC0yLTEtMS0zMjQx_730e94e0-df8b-4193-a3ed-bcc090ddbba4">5,860</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i190a872146ee4e9187065e968ab399b3_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNC00LTEtMS0zMjQz_42dc5d97-263f-4ac9-8750-fdecdf631799">6,056</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total acquisition installment payable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNS0yLTEtMS0zMjQx_7b52d626-b454-47bb-b0c3-cd601f2e42bd">22,620</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0891c5d60bc5463e814034e47be08954_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNS00LTEtMS0zMjQz_99a1474a-02c3-4f39-9d22-1c3f5e9aa25a">23,506</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current portion of acquisition installment payable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNi0yLTEtMS0zMjQx_95d83f35-9c14-41dd-b643-d6084117b92e">10,980</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0891c5d60bc5463e814034e47be08954_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNi00LTEtMS0zMjQz_92521fd0-ef17-4136-b854-f65c419217f9">11,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition installment payable, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNy0yLTEtMS0zMjQx_7436086b-4867-4173-bca2-d6aa2fe9b0ad">11,640</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0891c5d60bc5463e814034e47be08954_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNy00LTEtMS0zMjQz_5c78c21c-17f4-4d30-ad85-43c5542617b7">12,021</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">System sales payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationRevenuePayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOC0yLTEtMS0zMjQx_3cd806d9-08b7-4d3f-924a-f879fad154b0">27,190</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0891c5d60bc5463e814034e47be08954_I20200630" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationContingentConsiderationRevenuePayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOC00LTEtMS0zMjQz_6a93f723-143b-4beb-b1c7-87548b275d15">28,100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ApiFix future consideration, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOS0yLTEtMS0zMjQx_4264f87a-71d7-407c-8238-48d7b7b4b465">38,830</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0891c5d60bc5463e814034e47be08954_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOS00LTEtMS0zMjQz_f6f3e0e6-5eef-450a-83c4-3b22b6db8fe3">40,121</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"><ix:continuation id="i0f6fe318066f4ae08ecabde73088aef9">Pre-acquisition revenues and earnings for ApiFix were not material to the condensed consolidated operations.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="ib2cc1dd6837947f8bf6062254fda9ed5" continuedAt="i38a77e75f89349079bf2a2429ada8b79"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Telos</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On March 9, 2020, the Company purchased the issued and outstanding membership interest of Telos for $<ix:nonFraction unitRef="usd" contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTQy_e47db6c9-dbe4-4d24-8536-cbbce35444a3">1,750</ix:nonFraction> in cash, including $<ix:nonFraction unitRef="usd" contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTY0_e790941d-4d08-4667-814c-76ec88a3fa70">81</ix:nonFraction> of cash acquired, and <ix:nonFraction unitRef="shares" contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTg5_d303ca3a-b47b-49bd-8445-b811c34a5332">36,628</ix:nonFraction> shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMjE2_2a2d2a38-7d5f-41f8-b2fd-66e0472ecf79">0.00025</ix:nonFraction> par value per share, of the Company. The shares of common stock were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ1OA_16387f4c-97a6-4018-96eb-6113c41cfd16">42.81</ix:nonFraction> per share, the Company's closing share price on March 9, 2020. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ2Nw_a8c9de6a-1dac-4901-a807-faa701eb3e67">25</ix:nonFraction> of acquisition-related costs, that are included in general and administrative expenses on the consolidated statements of operations.  The purchase price allocation set forth herein is preliminary.  </span></div><div><span><br/></span></div><ix:continuation id="i7dcdb5c5110d4af18037fa0c0d6bfe35" continuedAt="i5e38e6f9e3304689b578b84830190dca"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for Telos and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"></td><td style="width:62.677%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.574%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:31.549%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preliminary fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMS0yLTEtMS0w_2b9a35e3-db6e-4fa5-8216-2a313501e8e5">3,318</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMy0yLTEtMS0w_2bd6b049-5eb2-42f5-a45e-7591e71da866">81</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfNC0yLTEtMS0w_b4275d32-74ce-454c-aee7-4b94efb3cdbb">215</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfNy0yLTEtMS0w_20fb1498-313f-4e28-bdf1-6baa1bbacfc2">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfOC0yLTEtMS0w_2990850d-8f01-4ac7-9e73-72292d82d132">950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfOS0yLTEtMS0zMzcz_991695e3-8b24-4123-b602-11d07648da44">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTEtMi0xLTEtMA_c088393f-2659-4291-bc0b-9d5b5a249071">1,466</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTMtMi0xLTEtMA_5cf56e0b-6b8b-4815-accc-205475cfae33">60</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTctMi0xLTEtMA_55a98997-a15d-455f-a61f-e271effd24c5">60</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTgtMi0xLTEtMA_5b368dca-45bb-4ef1-ae66-6cf9b6247d5f">1,406</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTktMi0xLTEtMA_d0494b01-6d52-4ad2-b742-2663ae6280b8">1,912</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><ix:continuation id="i8ceb729800d5430b9d5361331745e603" continuedAt="i9cb5d3b193624365bedc0d3d009395b9"><ix:continuation id="i936e4d0719c644f6b4c9d2c094501a19" continuedAt="ieb755ba09906412b81dab2052e8d78d9"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:33.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.883%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.883%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:38.226%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80a8bd33230e4f23a9d792dc0bb5a7ee_D20200309-20200309" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMS0yLTEtMS0w_b4666fb5-3dcd-458f-b879-de20107b8d75">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a9d0f0383c646788001508a2c5597bd_D20200309-20200309" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMi0yLTEtMS0w_2c668cdb-ffd0-444a-b3b4-ef5b01546475">910</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i8a9d0f0383c646788001508a2c5597bd_D20200309-20200309" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMi00LTEtMS0w_19d15078-ebf6-4f58-be75-3426c5ae5044">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i95b3a7b0f9324955af777d48822570a9_D20200309-20200309" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMy0yLTEtMS0w_6dfb5fc9-04b1-4ccd-80f5-7047a0c60285">40</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i95b3a7b0f9324955af777d48822570a9_D20200309-20200309" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMy00LTEtMS0w_f7ed75ce-4d44-4d74-ae0d-ab39437bac60">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309" decimals="-3" format="ixt:numdotdecimal" name="kids:IntangibleAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfNC0yLTEtMS0w_f8d107a1-53c3-42be-b609-bb4921a9fd0d">1,160</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Vilex and Orthex</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 4, 2019, the Company purchased all the issued and outstanding shares of stock of Vilex and units of membership interests in Orthex for $<ix:nonFraction unitRef="usd" contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTE0MQ_a0fc8613-cb8a-41d3-a0bf-ba8303df22bf">50,000</ix:nonFraction> in cash, adjusted for working capital, and <ix:nonFraction unitRef="shares" contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTE4Nw_c0463524-273e-4ac5-bdc2-411160a7e8ca">245,352</ix:nonFraction> shares of common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTIxNA_1c074bf9-ea8c-4293-a941-5d608d8a3cd1">0.00025</ix:nonFraction> par value per share, of the Company. The shares of common stock were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c8ff79382af4dbeb5b7c523481aa645_I20190604" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTI5Ng_c2578d60-e793-404e-b82a-88595a0345db">40.76</ix:nonFraction> per share, the volume weighted average trading price during the thirty day trading period ending on May 30, 2019. In addition, $<ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="kids:BusinessCombinationEscrowDeposit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTQyNg_ca083ff7-298d-4afd-b9fa-06e9846a78ed">3,000</ix:nonFraction> was placed in an escrow account for a period of up to <ix:nonNumeric contextRef="id9512287e4134097a7d49339bfdae2a8_D20190604-20190604" format="ixt-sec:durwordsen" name="kids:BusinessCombinationEscrowDepositMaximumTerm" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTQ4Mw_5f562251-cb6b-4071-ab8f-2e444d61a520">twenty months</ix:nonNumeric> to cover certain indemnification obligations and to secure certain closing adjustments. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTU5NQ_7ce74f78-108a-4c9f-a5e7-2f26a1d19e6f">737</ix:nonFraction> of acquisition-related costs, that are included in general and administrative expenses on the consolidated statements of operations.  The purchase price allocation set forth herein is final as to working capital amounts, intangible values and tax accounting matters. </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i38a77e75f89349079bf2a2429ada8b79" continuedAt="i51b8d00db85d46bdbb8b06dc83353de9"><ix:continuation id="i5e38e6f9e3304689b578b84830190dca"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for Vilex and Orthex and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"></td><td style="width:62.677%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.574%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:31.549%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMS0yLTEtMS0w_81b35dba-6aaa-424f-ba8c-b018c0309631">60,184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMy0yLTEtMS0w_c5321d95-1064-4069-a057-f754ec2e44e7">348</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNC0yLTEtMS0w_91ec5a01-e14e-4d73-9e00-e7fee2baa416">2,088</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNS0yLTEtMS0w_efbba9d8-70c1-4176-9583-685f658be462">3,652</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNi0yLTEtMS0w_c36f0931-a419-4937-9928-0881a66284b8">12</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNy0yLTEtMS0w_9554b652-2aed-4ac5-a53d-18369f5ea3f3">7,540</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfOC0yLTEtMS0w_2af0a061-d428-4232-954c-d3285299082b">31,180</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" name="kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTAtMi0xLTEtMA_93eba735-d358-4f9f-8fe2-b01518e8ff27">323</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTEtMi0xLTEtMA_48d98cf6-5400-49fc-b0c3-21e65a6fbbe6">45,143</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTMtMi0xLTEtMA_da55c98c-73bd-4e3e-809f-076ddec3b525">563</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" name="kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTQtMi0xLTEtMA_0066ade4-76d3-4f26-807a-c3d59d949968">323</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Deferred tax liability</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTUtMi0xLTEtMA_7f18ef79-34e8-4c0b-8ef0-0b9b1ebb41bf">1,175</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTYtMi0xLTEtMA_d431a756-0c83-4832-a7fb-f3cc5f338349">68</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTctMi0xLTEtMA_fd8c84df-6538-4fd8-8905-3c308bb45b89">2,129</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTgtMi0xLTEtMA_e78907a9-891e-40cd-888e-28009b61a4d2">43,014</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTktMi0xLTEtMA_339415fe-8154-44fc-8424-bbcb8ea4da37">17,170</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><ix:continuation id="i9cb5d3b193624365bedc0d3d009395b9"><ix:continuation id="ieb755ba09906412b81dab2052e8d78d9"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:33.737%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.883%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.871%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.883%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:38.226%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if66e4ed42c0340ae95515133232879f3_D20190604-20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMS0yLTEtMS0w_390e4749-38aa-4119-b39a-c1ecd84b2024">4,610</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i697f880d24684012827b17b5de98d360_D20190604-20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMi0yLTEtMS0w_b4248c69-fe91-499d-a8bd-65189c3f5ce4">22,390</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i697f880d24684012827b17b5de98d360_D20190604-20190604" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMi00LTEtMS0w_2c207d16-dd3c-4e82-aba8-0fa22dcac311">15</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Internally Developed Software</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51c7929e645642919dea6b4923e42798_D20190604-20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMy0yLTEtMS0w_916b5959-788f-4145-8073-3c688c67e1c3">1,550</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i51c7929e645642919dea6b4923e42798_D20190604-20190604" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMy00LTEtMS0w_b20195bb-1f65-46b3-bb7c-1c339b5c6648">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32b0fbb66fe2467f9e999a25aaa3b1cc_D20190604-20190604" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNC0yLTEtMS0w_ccbd830e-c646-41a4-babe-50424ea39605">2,570</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i32b0fbb66fe2467f9e999a25aaa3b1cc_D20190604-20190604" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNC00LTEtMS0w_abd405f3-943e-4a95-8a89-ab7b45538172">12</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2036398d56b74a198f2a687eeb8fde44_D20190604-20190604" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNS0yLTEtMS0w_b769ba13-306a-41cf-ba50-02697ecc6da0">60</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i2036398d56b74a198f2a687eeb8fde44_D20190604-20190604" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNS00LTEtMS0w_4be2ad79-2257-43b3-93c8-740c8def2e71">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604" decimals="-3" format="ixt:numdotdecimal" name="kids:IntangibleAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNi0yLTEtMS0w_e41678bf-ead4-4889-900a-9b631e147a8d">31,180</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company recorded a measurement period adjustment during fiscal 2020 to increase inventory and decrease goodwill related to working capital adjustments to allocate inventory between Orthex and Vilex. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Since the Vilex products include adult offerings that are not core to the Company's pediatric business, the Company received Board approval to take the steps necessary to divest the non-core Vilex assets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On December 31, 2019, the Company divested substantially all of the assets relating to Vilex's adult product offering to a wholly-owned subsidiary of Squadron Capital, LLC in exchange for a $<ix:nonFraction unitRef="usd" contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMjkzMQ_9257f965-c33e-4ed6-8834-20fa9cec80ea">25,000</ix:nonFraction> reduction in a term note owed to Squadron in connection with the initial acquisition along with certain ongoing intellectual property rights. Of the $<ix:nonFraction unitRef="usd" contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzA4Mw_b6ad940b-c046-4e85-8efe-07afc56afa4b">25,000</ix:nonFraction> purchase price, $<ix:nonFraction unitRef="usd" contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="kids:DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzEwMg_a7635751-4520-4c36-85a3-3ee88c293722">12,410</ix:nonFraction> was attributable to the license of the Orthex intellectual property and the remaining $<ix:nonFraction unitRef="usd" contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="kids:DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzE5MQ_76df2bcc-a93a-49f6-894b-2f8a9d43ad66">12,590</ix:nonFraction> was applied to the Vilex assets and liabilities divested.</span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"><ix:continuation id="i51b8d00db85d46bdbb8b06dc83353de9" continuedAt="i089aca36c335427c83cda9161045a676">After the issuance of our December 31, 2019 annual consolidated financial statements, and in connection with the preparation of our condensed consolidated financial statements for the three months ended March 31, 2020, we identified and corrected an immaterial error related to the deferred revenue liability recognized from license of Orthex intellectual property as of December 31, 2019.  The immaterial correction of the error resulted in a reduction of the deferred revenue liability and goodwill on the consolidated balance sheet as of December 31, 2019 of $<ix:nonFraction unitRef="usd" contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="kids:DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzgxNA_2c95e232-3f16-4e5d-97a7-1439dc659b59">12,410</ix:nonFraction>, based on the conclusion that the consideration transferred was allocable to a portion of certain Orthex patent assets sold concurrently with the sale of Vilex. We have evaluated the adjustment and, based on an analysis of quantitative and qualitative factors, determined that the related impact was not material to our consolidated financial statements for any prior annual or interim period presented. In order to accurately present the historical period, we have revised our December 31, 2019 balance sheet and related footnotes to reflect the immaterial correction of this error.</ix:continuation></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i089aca36c335427c83cda9161045a676">Pro forma net revenue and net loss from continuing operations for the six months ended June 30, 2019 assuming the Orthex and Vilex acquisition occurred on January 1, 2019 would have been $<ix:nonFraction unitRef="usd" contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQzMw_3beb9169-515f-42b1-a66d-3b2c3d1e13fc">34,792</ix:nonFraction> and ($<ix:nonFraction unitRef="usd" contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ0NQ_46220301-2319-45b0-b4e8-ac6529c9a8b7">4,948</ix:nonFraction>), respectively.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_658"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 4 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90ZXh0cmVnaW9uOjQxNjJjZWQxMGE4NjRiYTdiYzU4NWI2YzQ4MzNhMmU5XzEwOTk1MTE2MzE1ODY_99d240a7-d0d3-44ec-a141-7a651df4779f" continuedAt="ic9a3b5a7aa5b4868aa8850773884cb28" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic9a3b5a7aa5b4868aa8850773884cb28" continuedAt="i478707dd4a214e8d9de20be5c073e62c"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Goodwill</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90ZXh0cmVnaW9uOjQxNjJjZWQxMGE4NjRiYTdiYzU4NWI2YzQ4MzNhMmU5XzEwOTk1MTE2MzE1ODc_4076d66f-bdc2-43b9-860b-55427a8499c7" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Changes in the carrying amount of goodwill for the six months ended June 30, 2020 were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:77.487%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.872%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i55478baf239442988af0a3137120ff79_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzEtMi0xLTEtMzQyMA_3d7ede13-2470-4265-b9c7-fa2c7c512622">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vilex Companies acquisition</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ce021843bf7476ab44bfacfc23770c3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzItMi0xLTEtMzQxOA_5ba86953-5778-4015-8067-2e4c09189c69">17,170</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Divestiture of Vilex in Tennessee, Inc. </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0ce021843bf7476ab44bfacfc23770c3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzMtMi0xLTEtMzQxOA_9acb0121-dd89-44ad-9ca1-4497d0953b75">3,397</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at January 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzQtMi0xLTEtMzQxOA_7237dfa9-71bc-413f-a381-103367ca7353">13,773</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Telos acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzUtMi0xLTEtMzQxOA_17f0a2ee-32fe-4e64-a5b4-699120b30c8d">1,912</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthex measurement period adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i779524b02e4741949cdceb2816836fca_D20200101-20200630" decimals="-3" sign="-" name="kids:GoodwillMeasurementPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzYtMi0xLTEtMzQxOA_0c0c6c0c-f9c8-444b-96c0-bfc61c869a87">688</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ApiFix acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzctMi0xLTEtMzQxOA_c46c279e-26e4-49bf-9fc2-fad6e5e008c8">53,423</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzgtMi0xLTEtMzQxOA_87a6cf57-5c0f-4d11-890d-46735a6223c2">68,420</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90ZXh0cmVnaW9uOjQxNjJjZWQxMGE4NjRiYTdiYzU4NWI2YzQ4MzNhMmU5XzEwOTk1MTE2MzE1ODk_8f3fb81e-95f0-4628-86cb-f8b64eec51dc" continuedAt="i68f4198b9e2b42f6a512719940a76d5a" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the balances of amortizable intangible assets were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.504%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Intangible Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Intangible Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i43216f47eeee41f6bb129feaeb6cdc7e_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtMi0xLTEtMzQzMA_db24b931-715a-42dc-bda3-6d3bf2347f32">15.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaae923d4563d427bacf487bd51f6a91d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtNC0xLTEtMjkzNQ_228e1e70-8464-4ba9-a138-b5c6695ba46f">33,182</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iaae923d4563d427bacf487bd51f6a91d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtNi0xLTEtMjkzNQ_f440ab2d-1019-4b19-8067-9e5cbf0d2c8b">1,019</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaae923d4563d427bacf487bd51f6a91d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtOC0xLTEtMjkzNQ_d7b50e27-a363-46dd-bdd1-760f54e5da87">32,163</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intellectual Property</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ic6894ee1ed534a779143dc099648c47f_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItMi0xLTEtMzQzMA_644a6118-6895-41b4-a583-2097a44d8cce">10.8</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItNC0xLTEtMjkzNQ_0c30e7cf-f539-4e01-b9cf-4421490b2f91">8,950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItNi0xLTEtMjkzNQ_4b166035-82d6-42b5-8e81-3b5ca4073594">473</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItOC0xLTEtMjkzNQ_bc4ff914-fc87-45b0-8e9c-0e6f1a4721c2">8,477</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">License Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="id145432eb8c441e5b1dbddc0c0a863d0_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtMi0xLTEtMzQzMA_1942f5fa-78ba-4b26-b56c-fe5c566d25bd">3.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee46e00cdee24529b067135f7e8c5115_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtNC0xLTEtMjkzNQ_aeb713d0-acfa-4f21-9d53-e03d4040c528">2,765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iee46e00cdee24529b067135f7e8c5115_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtNi0xLTEtMjkzNQ_4c54d5d9-01df-46c9-91fd-c0dd60d6e454">1,199</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee46e00cdee24529b067135f7e8c5115_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtOC0xLTEtMjkzNQ_ebcdcd78-bdde-4017-a5f4-5611d6cd8f23">1,566</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amortizable assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzQtNC0xLTEtMjkzNQ_ab30bbc2-c66f-401c-978d-233c2f9457d0">44,897</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzQtNi0xLTEtMjkzNQ_9066418f-41a8-4a39-b079-5ededab7c223">2,691</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzQtOC0xLTEtMjkzNQ_5b4c6d77-a8da-4d4d-8f6f-d4677641d5f5">42,206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i478707dd4a214e8d9de20be5c073e62c" continuedAt="i46683c97ecb84bd783ffd2ac2a2275fe"><ix:continuation id="i68f4198b9e2b42f6a512719940a76d5a"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, the balances of amortizable intangible assets were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.428%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.504%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Intangible Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Intangible Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i217400e5358b4111bcda2d87a7c82ea6_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtMi0xLTEtMzQzNw_c15b5f3a-02f5-40b0-9333-0c242b1c4cdb">17.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b0498ea6ef04efdafac30fa191f07f5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtNC0xLTEtMjg5OA_51958cb8-c06b-4c42-8e27-d23a0675efc0">9,287</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2b0498ea6ef04efdafac30fa191f07f5_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtNi0xLTEtMjg5OA_22608902-981d-429e-bd31-21afadad2ee4">363</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b0498ea6ef04efdafac30fa191f07f5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtOC0xLTEtMjg5OA_31413f46-c501-43f0-aa6b-c434b91c3183">8,924</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intellectual Property</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i26700fd1a63342dd8c4212993b04610d_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItMi0xLTEtMzQzNw_ac668a28-715e-4432-8ec9-0939b4f04f83">10.7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i44183e3bfe624d5d8cb321bdf8e45312_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItNC0xLTEtMjg5OA_7e142fee-8b45-4010-af2c-119293c05e43">4,020</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i44183e3bfe624d5d8cb321bdf8e45312_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItNi0xLTEtMjg5OA_63377c76-29ef-43ea-b528-e3eab2d7fedf">213</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i44183e3bfe624d5d8cb321bdf8e45312_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItOC0xLTEtMjg5OA_e85ac772-ef17-4fe5-a7a8-4cf24d7af3d9">3,807</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">License Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i6ba47742d675456f97dcddba2466e3f9_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtMi0xLTEtMzQzNw_ebda0699-305d-451d-9f7e-7b7a9534b729">3.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12a267c66f9e460cbcdd61aca29f6e43_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtNC0xLTEtMjg5OA_f883f11d-16eb-4011-b246-844bdb21f18c">2,765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i12a267c66f9e460cbcdd61aca29f6e43_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtNi0xLTEtMjg5OA_8ebbe9ad-a31f-452e-85d0-9a87c6b48d65">1,012</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12a267c66f9e460cbcdd61aca29f6e43_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtOC0xLTEtMjg5OA_3c001233-b6ed-43e2-b930-f41b8fd936ea">1,753</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amortizable assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzQtNC0xLTEtMjkwMw_5aeab268-b545-4d9a-bbe3-22ba8bd44af8">16,072</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzQtNi0xLTEtMjkwMw_7941d5df-5703-4ace-960e-fbe71c8ac7db">1,588</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzQtOC0xLTEtMjkwMw_c8d6790c-2629-4e9a-9eee-e183c3ab0e67">14,484</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 10, 2020, we purchased certain intellectual property assets from Band-Lok, LLC, a North Carolina limited liability company ("Band-Lok"), related to its Tether Clamp and Implantation System ("Tether Clamp System") for $3,394 in total consideration. We use the Tether Clamp System in connection with our Bandloc 5.5/6.0 System. We were previously the sole licensee of the purchased assets under a license agreement with Band-Lok.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Licenses are tied to product launches and do not begin amortizing until the product is launched to the market. </span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i46683c97ecb84bd783ffd2ac2a2275fe">Trademarks are non-amortizing intangible assets which were $13,357 and $4,490 as of June 30, 2020 and December 31, 2019, respectively. Concurrently with our acquisition of each company, we acquired the trademark of Orthex on June 4, 2019 valued at $4,230, the trademark of Telos on March 9, 2020 valued at $210 and the trademark of ApiFix on April 1, 2020 valued at $8,620. Trademarks are recorded in Other Intangible assets on the Condensed Consolidated Balance Sheets.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_649"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 5 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90ZXh0cmVnaW9uOmU4YjVmY2I0MjkyMTQyMTBiMDZlODAyMzZkOGIyOWI5XzEwOTk1MTE2MjkxMDY_bc984318-660c-4d5d-a141-ff4672b08a4e" continuedAt="i6d1c0ca8668b4c95bc79ed48f281cbb9" escape="true">DISCONTINUED OPERATIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6d1c0ca8668b4c95bc79ed48f281cbb9"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 4, 2019, the Company acquired Vilex, a manufacturer of foot and ankle surgical implants. Since the Vilex products included adult offerings that were not core to the Company's pediatric business, the Company received Board approval to take the steps necessary to divest the non-core Vilex assets and those Vilex assets were sold on December 31, 2019. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90ZXh0cmVnaW9uOmU4YjVmY2I0MjkyMTQyMTBiMDZlODAyMzZkOGIyOWI5XzEwOTk1MTE2MjkxMDc_131cabad-b0b6-4f73-953d-f4c2b4a2aacd" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following summarized financial information has been segregated from continuing operations and reported as discontinued operations for the three and six months ended June 30, 2019:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:75.403%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:20.597%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three and Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzItMS0xLTEtMzQ0Mw_a9e86ba5-5d21-4b99-b307-a6fd72903260"><ix:nonFraction unitRef="usd" contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzItMS0xLTEtMzQ0Mw_feefc105-7ab2-4582-9a65-e658e3cb927a">414</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzMtMS0xLTEtMzQ0Mw_0e9710e4-4d85-48d2-b8b0-bff0d6f89bc9"><ix:nonFraction unitRef="usd" contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzMtMS0xLTEtMzQ0Mw_a4f127cc-4516-400d-b236-2a487dbe12ad">507</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzQtMS0xLTEtMzQ0Mw_256b1a9d-b0aa-4121-a15a-702669592771"><ix:nonFraction unitRef="usd" contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzQtMS0xLTEtMzQ0Mw_d0abebed-aeab-4e92-a74b-664514e1895d">66</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzUtMS0xLTEtMzQ0Mw_0f4dd68f-6dbc-42fe-bd46-f08be29a579e"><ix:nonFraction unitRef="usd" contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzUtMS0xLTEtMzQ0Mw_d924158d-11da-4986-a2da-dbbddaa6ce65">159</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss from discontinued operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzctMS0xLTEtMzQ0Mw_2f8c4c70-2ff8-421f-8156-da2471a95bf9"><ix:nonFraction unitRef="usd" contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzctMS0xLTEtMzQ0Mw_588c3888-38ff-49c1-bd1d-613140d453af">159</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">23</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 6 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzY3MA_da987bad-2915-4894-95c7-5d6b1c21dfa4" continuedAt="i3f54755ee8d34e3cb74d41d1fa33a11e" escape="true">DEBT AND CREDIT ARRANGEMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3f54755ee8d34e3cb74d41d1fa33a11e" continuedAt="i07712676283d42dab025191756551c7f"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzY3Mg_11cf1b66-a197-4313-8d82-f7439c29eeb7" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Long-term debt consisted of the following: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%;"><tr><td style="width:1.0%;"></td><td style="width:57.069%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:18.064%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.602%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.065%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Note payable to Squadron</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb96a082b67d4e369fad244fcf9ecea7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMS0xLTEtMS0w_cf81f3d4-8bb4-4009-8a65-d29f7d7a6827">19,907</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58298dbcea9a43738bf180f55aa6c005_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMS0zLTEtMS0w_52cc6ffe-8e17-41a0-8231-6d14b3e83f3f">19,891</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revolving credit facility with Squadron</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4212d5ada3e1486386101c68b4a3ff9b_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMi0xLTEtMS0w_51386c07-99a6-4574-b356-aaf9d8a9d8ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97ee1b03f3f34cb8a5a900dbd94f9e8a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMi0zLTEtMS0w_14b5f50b-eae5-4c8d-a74f-8055cc0d072b">5,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mortgage payable to affiliate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i55c4e72e21c0402b9665b56e75791946_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNC0xLTEtMS0w_0a8e42e9-4f26-4e2d-85b8-22bc858c3859">1,238</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i522cee87c6934a54b91779a2e4a36983_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNC0zLTEtMS0w_f4e4d633-e1a7-4260-8e4d-0dcb8bf590ab">1,300</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNS0xLTEtMS0w_adb65dc7-77d7-43f5-a90c-55b2d463de17">21,145</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNS0zLTEtMS0w_277de826-481c-4ba6-a1af-a87d42283175">26,191</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current maturities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNi0xLTEtMS0w_28a475b6-fa96-4a7e-833e-b5f21c8eb0e5">128</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNi0zLTEtMS0w_dd611b7b-8dde-457a-9f93-56785017e4af">124</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt with affiliate, net of current maturities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNy0xLTEtMS0w_1ea815b8-48f4-416e-a93d-150dc48150fe">21,017</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNy0zLTEtMS0w_f2a81a49-5626-4869-a9a6-b162c8553c3b">26,067</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 31, 2017, we entered into a Fourth Amended and Restated Loan and Security Agreement, or the Loan Agreement, with Squadron Capital LLC, or Squadron. Pursuant to the Loan Agreement, a majority of the term loan amounts under the previous agreement with Squadron were consolidated into a $<ix:nonFraction unitRef="usd" contextRef="i32ecfc1db0094cdf9b81fbbdb546dc71_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzg3_d86f5052-aef8-4da3-bec9-943e628ca59b">20,000</ix:nonFraction> term note, or the Term Note A, and a $<ix:nonFraction unitRef="usd" contextRef="i91313831b49b4497a30f40930e592148_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNDI3_e9fce331-0912-444a-b012-e616ea6f753e">15,000</ix:nonFraction> revolving credit facility was established. Both facilities include interest only payments and provide for an interest rate equal to the greater of (a) three month LIBOR plus <ix:nonFraction unitRef="number" contextRef="ia750dea5d4f84490a3ed6d2032d6b369_D20190604-20190604" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjA0_3902f82c-8902-4f44-be28-384c6780f8e7"><ix:nonFraction unitRef="number" contextRef="ifea33470bf02413c92995e85b05b1ad0_D20171231-20171231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjA0_551fb194-4d98-4ce8-a13a-a12a52e3b032">8.61</ix:nonFraction></ix:nonFraction>% and (b) <ix:nonFraction unitRef="number" contextRef="iaabfc50f270c4500963cf0c8d1d79fe8_I20190604" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjE1_89c53362-42f0-4fdf-b2fb-5a0d0af71b70"><ix:nonFraction unitRef="number" contextRef="i2a7811335a9947b3b93354b5f0367da1_I20171231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjE1_b08fd373-0c4a-480a-9141-b500876920b6">10</ix:nonFraction></ix:nonFraction>%. The Loan Agreement also extended the maturity date to January 31, 2023. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In order to finance a portion of the cash consideration for the acquisition of the Vilex Companies, the Company entered into a First Amendment, or the First Amendment, to the Loan Agreement (as so amended, the "First Amended Loan Agreement"), with Squadron. The First Amended Loan Agreement provided for a new $<ix:nonFraction unitRef="usd" contextRef="i2d597c299e87430aaf3c619817196928_I20190604" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfOTg1_33b5cd1c-b415-44c4-a1c0-2428dd9e5153">30,000</ix:nonFraction> term loan facility, represented by a Term Note B,  in addition to the existing $<ix:nonFraction unitRef="usd" contextRef="i32ecfc1db0094cdf9b81fbbdb546dc71_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTA2Nw_d86f5052-aef8-4da3-bec9-943e628ca59b">20,000</ix:nonFraction> Term Note A and $<ix:nonFraction unitRef="usd" contextRef="i91313831b49b4497a30f40930e592148_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTA4Ng_e9fce331-0912-444a-b012-e616ea6f753e">15,000</ix:nonFraction> revolving credit facility. Similar to the other facilities under the First Amended Loan Agreement, the Term Note B was subject to interest only payments at an interest rate equal to the greater of (a) three month LIBOR plus <ix:nonFraction unitRef="number" contextRef="ia750dea5d4f84490a3ed6d2032d6b369_D20190604-20190604" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMwNw_3902f82c-8902-4f44-be28-384c6780f8e7"><ix:nonFraction unitRef="number" contextRef="ifea33470bf02413c92995e85b05b1ad0_D20171231-20171231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMwNw_551fb194-4d98-4ce8-a13a-a12a52e3b032">8.61</ix:nonFraction></ix:nonFraction>%, and (b) <ix:nonFraction unitRef="number" contextRef="iaabfc50f270c4500963cf0c8d1d79fe8_I20190604" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMxOQ_89c53362-42f0-4fdf-b2fb-5a0d0af71b70"><ix:nonFraction unitRef="number" contextRef="i2a7811335a9947b3b93354b5f0367da1_I20171231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMxOQ_b08fd373-0c4a-480a-9141-b500876920b6">10.00</ix:nonFraction></ix:nonFraction>%. The Term Note B, which would have matured no later than May 31, 2020, was paid in full on December 31, 2019 using $<ix:nonFraction unitRef="usd" contextRef="i7eba4623b24a447fbe2ee28df0cdd245_D20191231-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTQzNw_6b6e193c-5126-4028-bc40-851ca935a1a9">25,000</ix:nonFraction> received in exchange for the divestiture of the adult product offerings of Vilex and the related Orthex license agreement, and $<ix:nonFraction unitRef="usd" contextRef="if5755d80d80843eaa4f3d75bcc7bbba4_D20191231-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTU2Nw_4143b4ee-ae66-4202-aa7b-4c008b8a0239">5,000</ix:nonFraction> from the available Squadron revolving credit facility. On January 4, 2020, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i9e31cbfbaa6540549a2b910c978401be_D20200104-20200104" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTY2Mg_b96430e9-f75c-48b6-a33f-638ad76024f8">5,000</ix:nonFraction> on the revolving loan agreement with Squadron. </span></div><div><span><br/></span></div><div style="padding-right:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:123%;">Borrowings under the First Amended Loan Agreement are secured by substantially all of the Company's assets and are unconditionally guaranteed by each of its subsidiaries with the exception of Vilex. There are no traditional financial covenants associated with the First Amended Loan Agreement. However, there are negative covenants that prohibit us from, among other things, transferring any of our material assets, merging with or acquiring another entity, entering into a transaction that would result in a change of control, incurring additional indebtedness, creating any lien on our property, making investments in third parties and redeeming stock or paying dividends.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of our notes payable to Squadron were estimated based on prices for the same or similar issues and the current interest rates offered for the debt of the same remaining maturities, which are considered level 2 inputs in accordance with ASC Topic 820, &#8220;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements and Disclosures</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#8221; At June&#160;30, 2020, the fair value approximated the carrying value. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the purchase of our office and warehouse space in Warsaw, Indiana in August 2013, we entered into a mortgage note payable to Tawani Enterprises Inc., an affiliate of Squadron. Pursuant to the terms of the mortgage note, we pay Tawani Enterprises Inc. monthly principal and interest installments of $<ix:nonFraction unitRef="usd" contextRef="i3be7e495a9b44feba44e00526454ab10_D20130801-20130831" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzA2MQ_d6e94a63-4fe1-4662-bb28-71805cdf9d51">16</ix:nonFraction> with interest compounded at <ix:nonFraction unitRef="number" contextRef="i901f004c0d1149749e65dd0a69e57ff2_I20130831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzA5Mg_80d3b0ab-e0f9-44be-b7ae-824d5a49884e">5</ix:nonFraction>% until maturity in 2028, at which time a final payment of remaining principal and interest is due. The mortgage is secured by the related real estate and building.  At December 31, 2019, the mortgage balance was $<ix:nonFraction unitRef="usd" contextRef="i522cee87c6934a54b91779a2e4a36983_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzMwNw_ede04ab3-accf-47da-b98f-638b4241dbe2">1,300</ix:nonFraction> of which current principal due of $<ix:nonFraction unitRef="usd" contextRef="i522cee87c6934a54b91779a2e4a36983_I20191231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzM0NQ_2feba72b-6a3a-4b22-9a01-f28f5c1cb781">124</ix:nonFraction> was included in current portion of long-term debt.  At June 30, 2020 the mortgage balance was  $<ix:nonFraction unitRef="usd" contextRef="i55c4e72e21c0402b9665b56e75791946_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzQ0NQ_2f57f47f-b1ec-48a6-b62e-d9452d4508c4">1,238</ix:nonFraction> of which current principal of $<ix:nonFraction unitRef="usd" contextRef="i55c4e72e21c0402b9665b56e75791946_I20200630" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzQ4MA_3397a05d-8921-445c-ae6c-989394f30105">128</ix:nonFraction> was included in current portion of long-term debt.  </span></div></ix:continuation><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i07712676283d42dab025191756551c7f">Interest expense relating to notes payable to Squadron and Tawani was $<ix:nonFraction unitRef="usd" contextRef="i0ce9195684154b7296d03f48c3f26321_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzYwOA_606729de-a536-4bc4-8b3c-62d2090efbdd">513</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic2f23483cdc3453791280df0471e41a9_D20190401-20190630" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzYxNQ_b7095ce6-c8a2-4af4-a8ca-3910dd0d509d">632</ix:nonFraction> for the three months ended June&#160;30, 2020 and 2019, respectively, and $892 and $935 for the six months ended June&#160;30, 2020 and 2019, respectively.</ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_52"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 7 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTU2MQ_4169419b-d338-4852-927f-29a539aa4257" continuedAt="i3d7fce5f255a43509f6442f11f8db8b4" escape="true">STRATEGIC ARRANGEMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3d7fce5f255a43509f6442f11f8db8b4" continuedAt="ie398d383cafa4caa89db0d6ee79a5f39"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Effective December 1, 2007, we entered into a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfODQ_bf262227-ff5c-44d1-a84e-6eebb551fe29">ten</span>-year agreement with Case Western Reserve University (&#8220;CASE&#8221;) to assist in certain aspects of our research and development. Effective August 2, 2017, we entered into an Amended and Restated License Agreement to account for additional licensed product and extend the agreement for another <ix:nonNumeric contextRef="i9e4452d90eff4a999d49f7af62efccde_D20170802-20170802" format="ixt-sec:durwordsen" name="kids:ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMzc0_3f07be00-5474-48a1-bdcc-7c87e7957d67">ten years</ix:nonNumeric>. The main focus of this research and development involves leveraging our exclusive rights to the Hamann-Todd Collection of the Cleveland National History Museum, the world's largest pediatric osteological collection, to assist in the design of implants which match pediatric bone curvature and structure.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In exchange for services, CASE receives certain royalties and up-front fees. The royalties and certain fees are contingent upon our obtaining FDA approval and the launch of our products into the marketplace. CASE receives a minimum annual royalty of $<ix:nonFraction unitRef="usd" contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201" decimals="-3" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfOTMz_64b66a0a-51ca-41a0-adf5-f2bbdb9f5a39">10</ix:nonFraction> or a royalty of <ix:nonFraction unitRef="number" contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201" decimals="INF" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfOTUy_2c012d31-2cb8-42a5-b830-69d7116cd153">3</ix:nonFraction>% of net sales on products, whichever is greater. Additionally, for each new product developed, CASE will receive milestone payments of $<ix:nonFraction unitRef="usd" contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201" decimals="-3" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTA4OQ_d63ecf04-9a0d-4a83-9701-0507a22dca8d">5</ix:nonFraction> for FDA approval to sell our products within the United States and $<ix:nonFraction unitRef="usd" contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201" decimals="-3" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTE1OQ_5ec90c39-6d8b-4d3c-b588-33f78aab8538">10</ix:nonFraction> for general product launch. Additionally, CASE receives a royalty of <ix:nonFraction unitRef="number" contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201" decimals="INF" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTIzMQ_c3dc8411-ffd2-487c-82a3-9d30ca66357c">3</ix:nonFraction>% of net sales on products fully developed and being sold in the marketplace.</span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ie398d383cafa4caa89db0d6ee79a5f39">The royalty expense recognized related to the CASE agreement is recorded as a component of cost of revenue and was $<ix:nonFraction unitRef="usd" contextRef="ib62efb33448d425f8bb4b13674e7e6c7_D20200401-20200630" decimals="-3" name="us-gaap:RoyaltyExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTQyNg_e8450ffa-6316-456b-b740-4e07be44cc7d">24</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6e2ab5c81fda421daa443c34171cffb0_D20190401-20190630" decimals="-3" name="us-gaap:RoyaltyExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTQzMw_67e0e00d-3f3a-4846-a734-c02ff2dd25dc">37</ix:nonFraction> for the three months ended June&#160;30, 2020 and 2019, respectively, and $55 and $74 for the six months ended June&#160;30, 2020 and 2019, respectively. At June&#160;30, 2020 and December 31, 2019, $<ix:nonFraction unitRef="usd" contextRef="i6b009d063c2e467993e163ef9a164f0e_I20200630" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTUxNw_6969ab88-cf1b-47f2-a6b2-c1f5d87383df">24</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i720e0f76ea12446a83bf8ab6c5736641_I20191231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTUyNA_18405ff3-fcc0-49e2-974b-82f611a9e91d">39</ix:nonFraction>, respectively, was due to CASE.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_55"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 8 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMzMyMw_e53a4b0f-2d94-4b58-bd5b-a90371c933ba" continuedAt="i24ddefb4788f4ff197ded93ca74afcf7" escape="true">INCOME TAXES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i24ddefb4788f4ff197ded93ca74afcf7" continuedAt="i69212f1bc4f84367acfdb06a78017661"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 ("2017 Tax Act"). Corporate taxpayers may carryback net operating losses ("NOLs") originating during 2018 through 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for tax years beginning January 1, 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally eligible for 15-year cost-recovery and 100% bonus depreciation. The enactment of the CARES Act did not result in any material adjustments to our income tax provision for the three or six months ended June 30, 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the three and six months ended June&#160;30, 2020 and 2019, we calculated the provision of income taxes by applying an estimate of the annual effective tax rate for the full fiscal year to the ordinary loss for the reporting period resulting in a <ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_4cb09a7c-07a8-4c8c-bf50-3c8031b7b395"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_64cc34ab-8088-462a-836a-15436ba9a825"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_95978b75-23bc-40c3-a3f0-ad8dab986b19"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_f9472ef0-ec96-4857-8ab0-ee48d744365c">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> tax provision consistent with prior periods.  </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i69212f1bc4f84367acfdb06a78017661" continuedAt="i813772063f854de4b050e80219b29e72">The deferred tax assets were fully offset by a valuation allowance at June&#160;30, 2020 and December 31, 2019, and <ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTg0MA_39b7c3d6-25da-44e2-ad84-dcebc6108fbd"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTg0MA_5c81297d-196f-4c59-9696-a5594593dbca">no</ix:nonFraction></ix:nonFraction> income tax benefit has been recognized in our condensed consolidated statements of operations for any of the periods presented.  At December 31, 2019, we had available federal and state tax loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i8ae1c5b976b9426ea7c2afb46f2de085_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjA1Mw_2813e677-aa4c-4749-ba35-a55b2efd7d7e">86,807</ix:nonFraction>, state loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i9cf3572a27664de18b2b944dc137f71d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjA4NQ_15514056-2061-4e1c-a7df-7af228944345">64,026</ix:nonFraction> and tax credits for federal and state tax purposes of $<ix:nonFraction unitRef="usd" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="-3" name="us-gaap:TaxCreditCarryforwardAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjE0Mg_daecb844-580f-4887-86d9-9a7a848e85df">260</ix:nonFraction>. Federal net operating losses generated after January 1, 2018 will have an indefinite carryforward period. An ownership change under Section 382 of the Internal Revenue Code was deemed to occur on May 30, 2014.  Given the limitation calculation, we anticipate approximately $<ix:nonFraction unitRef="usd" contextRef="i86c42bd634d6439e9ab4f9d4586e1807_I20140530" decimals="-3" format="ixt:numdotdecimal" name="kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjQxOQ_6447a114-349b-42a8-b9b0-ed55b8db1ab9">16,200</ix:nonFraction> in losses generated prior to the ownership change date will be subject to potential limitation. The estimated annual limitation is $<ix:nonFraction unitRef="usd" contextRef="i86c42bd634d6439e9ab4f9d4586e1807_I20140530" decimals="-3" format="ixt:numdotdecimal" name="kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjU1Mw_970bde24-214a-4736-b7dd-6520c01bf773">1,062</ix:nonFraction>. A second ownership change under Section 382 was deemed to occur on December 11, 2018. The estimated annual limitation is $<ix:nonFraction unitRef="usd" contextRef="i5fc9092f14204444ba24d4c873eb6e82_I20181211" decimals="-3" format="ixt:numdotdecimal" name="kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjY3OA_1ade6bba-db0d-45f9-b1fb-fc848dc37b03">9,736</ix:nonFraction>, which is increased by $<ix:nonFraction unitRef="usd" contextRef="i5fc9092f14204444ba24d4c873eb6e82_I20181211" decimals="-3" format="ixt:numdotdecimal" name="kids:OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjcwNA_76a2cd77-d3d6-41dc-b670-f656e91a7848">22,430</ix:nonFraction> annually over the first five years as a result of an unrealized built in gain. NOLs sustained prior to May 30, 2014 will still be constrained by the lower limitation. </ix:continuation></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i813772063f854de4b050e80219b29e72">Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred over the three-year period ended  June&#160;30, 2020. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_58"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 9 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg1Nw_49ea64ca-0cd2-472d-8dd9-2872db9a9e08" continuedAt="i527d740878914d139476d51e5fcbedb6" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i527d740878914d139476d51e5fcbedb6" continuedAt="id169cbdf9fde44ab8c2903a612a96ee6"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value for options granted at the time of issuance were estimated at the date of grant using a Black-Scholes options pricing model. Significant assumptions included in the option value model include the fair value of our common stock at the grant date, weighted average volatility, risk-free interest rate, dividend yield and the forfeiture rate. There were <ix:nonFraction unitRef="shares" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNDE3_071249f6-43a6-48a8-9283-1088bf581eca"><ix:nonFraction unitRef="shares" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNDE3_bb3ccead-a930-4e03-a229-72b77b7c48fc">no</ix:nonFraction></ix:nonFraction> stock options granted in any of the periods presented.</span></div><div style="padding-left:36pt;"><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg1OQ_ede436df-88aa-4a49-b858-2cc926944e46" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our stock option activity and related information are summarized as follows: </span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.070%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.788%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.788%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.951%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contractual Terms</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in Years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMi0yLTEtMS0w_4dc08e6f-7413-4cc9-8fe5-36f0a9f831cd">70,628</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMi00LTEtMS0w_3fcafe0f-d71e-4888-8c8c-fe04c5b37b85">30.97</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iaff3b8a415a248e1b649428771d5dd22_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMi02LTEtMS0w_f294d825-84f2-4a21-b995-84c9bac65a80">1.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMy0yLTEtMS0w_0dfedc81-296a-430c-9242-1b81e4d2e28d">41,370</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMy00LTEtMS0w_e8aa0eee-a7f2-4bdc-be71-57788e7cdcc7">30.97</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfNS0yLTEtMS0w_6a7ec493-2b22-4526-9482-f0dfd9552e8f">29,258</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfNS00LTEtMS0w_a1097fbb-2ad6-4877-a1b3-69d50b10b757">30.97</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfNS02LTEtMS0w_9d04ed77-873a-465a-97ef-14cc8eb02ad4">1.2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Options generally include a time-based vesting schedule permitting the options to vest ratably over <ix:nonNumeric contextRef="i6b8a3c8fd6994c91bfa372ef62e86e22_D20200101-20200630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNjU3_e38cc4df-4f3f-4f57-9ba6-aac9b76af4d6">three years</ix:nonNumeric>. At June&#160;30, 2020 and December 31, 2019, all options were fully vested. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There was <ix:nonFraction unitRef="usd" contextRef="i20d35bb680f64b0ba2acd454d8e86d83_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_12d9ebfc-1611-470d-aaf5-986d095d93ed"><ix:nonFraction unitRef="usd" contextRef="iad46059f454f4bbea038030b853e05e6_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_8459f26f-1e50-486d-b004-21d6e4600478"><ix:nonFraction unitRef="usd" contextRef="i6b8a3c8fd6994c91bfa372ef62e86e22_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_9a51c7c4-a9a8-4edf-a8c7-4e4a11985039"><ix:nonFraction unitRef="usd" contextRef="i4c7c78b58af646cd96f6b8bd5e1d1d13_D20190401-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_9dbf093b-54c3-4fcf-927c-16dfddc0b76b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> stock-based compensation expense on stock options for the three and six months ended June&#160;30, 2020 and 2019, respectively.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="id169cbdf9fde44ab8c2903a612a96ee6"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg2NA_d68f2a0f-e428-484b-a6bb-fda83e423d84" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our restricted stock activity and related information are summarized as follows: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:56.333%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.032%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.033%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contractual Terms</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in Years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i432d3aa78750469da80bdc567e4824f6_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNC0yLTEtMS0w_090845d1-0ce4-493b-8150-fa53dbcb294e">318,002</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ie158e3539d5e4934824bb0f77b22ef76_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNC00LTEtMS0w_22cf397e-e2d8-4483-b94c-6aa87fee5688">1.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNS0yLTEtMS0w_e9044876-5115-40fb-bf86-0552501ac9a1">158,310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNi0yLTEtMS0w_17669840-62fa-442b-8f35-de40b35292f8">568</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNy0yLTEtMS0w_1a8bcc56-4d1c-4c2d-af20-d32f857fa45b">38,397</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3bb3e606a2bd424d964faaf220d28e88_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfOC0yLTEtMS0w_8800d1b9-caed-47cf-bc3a-6dc2c1cd5798">437,347</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfOC00LTEtMS0w_a28c8966-68e9-4cc5-a55c-96052a59312b">1.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock exercisable at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i3bb3e606a2bd424d964faaf220d28e88_I20200630" decimals="INF" format="ixt:zerodash" name="kids:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfOS0yLTEtMS0w_bf1554f2-ed5f-4b05-904b-0190706e20db">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At June&#160;30, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i3bb3e606a2bd424d964faaf220d28e88_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfOTU3_a5dee106-2074-4fb3-801c-52a217ee1f2b">9,865</ix:nonFraction> of unrecognized compensation expense remaining related to our service-based restricted stock awards. The unrecognized compensation cost was expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTE2MA_2d55f263-c086-48a5-981f-006097cc5a46">1.6</ix:nonNumeric> years or earlier upon an elimination of the restriction period as a result of a change in control event. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock-based compensation expense on restricted stock amounted to $<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMzg0ODI5MDY5OTI4Mw_4288501d-5d8c-4198-9b71-f304eeb4830f">2,495</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMzg0ODI5MDY5OTI4OQ_5b2b3254-4983-4fab-9441-a0095c4d9fac">692</ix:nonFraction> for the three months ended June&#160;30, 2020 and 2019, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTMzNQ_48ee25fd-7270-4682-b04c-21eff46ae760">3,453</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMzg0ODI5MDY5OTI2MQ_f1911a56-b290-44c2-9807-799ebe74d9e7">1,163</ix:nonFraction> for the six months ended June&#160;30, 2020 and 2019, respectively. The increase in the stock compensation expense for the three months ended June 30, 2020 was due to a one-time stock grant to the Company's Chief Executive Officer that vested immediately resulting in an additional $<ix:nonFraction unitRef="usd" contextRef="idbb6455ee34645b9b482fe979192967c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTA5OTUxMTYzMDQ1NA_9a870fc8-7526-4f59-96f4-bf73fda86b76">1,322</ix:nonFraction> of expense.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Warrants</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg2MQ_337c5597-4529-498a-90a4-866f78e596d8" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our warrant activity and related information are summarized as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%;"><tr><td style="width:1.0%;"></td><td style="width:54.058%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.607%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:19.163%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.607%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:19.165%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfMi0yLTEtMS0w_bcf99818-a615-4738-9ea6-62b3703241cb">404</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfMi00LTEtMS0w_5f3e8781-8a8f-4722-a20f-14900637e4d3">30.97</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfNC0yLTEtMS0w_f71a519e-6592-4f15-a965-be34b17250d3">404</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfNC00LTEtMS0w_13b3b5eb-552a-4c3a-b90b-685719d76013">30.97</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For all periods presented, the warrants were issued at an exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTU2Mg_ab74e385-98e0-4176-b86a-e5a2d9ca702d">30.97</ix:nonFraction> per share. The warrants have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTU5Ng_22c0bf25-8204-4c32-a466-8f4c334e3f8a">ten</span>-year term. At June&#160;30, 2020, <ix:nonFraction unitRef="shares" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="INF" format="ixt-sec:numwordsen" name="kids:ClassOfWarrantOrRightExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTYxNw_30b0a5fe-aec9-4c01-90a3-ceccebb917ec">no</ix:nonFraction> warrants had been exercised.  At inception, no fair value was assigned to the warrants.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_61"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 10 &#8211; <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RleHRyZWdpb246MTllYmQyYjBhMTQyNDYxN2JiNjA1YmE1YmZkNzE4NzhfOTQ3_b0b5d5b3-a157-4fc7-acf9-464f8b1fab9f" continuedAt="i32c67c1387ff4683b9a6da10dce94047" escape="true">NET LOSS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i32c67c1387ff4683b9a6da10dce94047" continuedAt="i333fb379828e461388d9751c6544ef4a"><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RleHRyZWdpb246MTllYmQyYjBhMTQyNDYxN2JiNjA1YmE1YmZkNzE4NzhfOTQ4_38b06b8e-ad5b-495e-b5a4-8163a2369915" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic and diluted net loss per share:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:49.762%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.538%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.538%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.538%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.541%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS0xLTEtMS0w_84be1d29-a645-4ba8-ab8e-f43bd854fb81">9,447</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS0zLTEtMS0w_14075e3b-032d-454b-9814-6e419bd2b558">2,618</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS01LTEtMS0w_feccc401-16e0-41ae-9ad8-6ee170a935d9">14,392</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS03LTEtMS0w_879eb903-509d-44af-ab28-ddd8afa2e1b8">5,638</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of shares - basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy0xLTEtMS0w_f26c6a55-96a4-48fc-a882-236f5ec94dfa">17,549,118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy0zLTEtMS0w_d9c49ce6-43bd-472d-8c02-3e3b678d7661">14,451,979</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy01LTEtMS0w_7a8ab222-7efd-4a55-99df-bb71b3b5e5fb">16,986,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy03LTEtMS0w_232c42cb-fe8e-4d4d-9b49-3ead5057524c">14,409,752</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share - basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC0xLTEtMS0w_5a9a0616-141a-4caf-af7e-1d4ef50a3508">0.54</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC0zLTEtMS0w_21d40350-c507-48b4-9ea5-1b0ef8bf8f72">0.18</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC01LTEtMS0w_00e554c0-c9b8-4c15-94f5-0974c56fbfaf">0.85</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usdPerShare" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC03LTEtMS0w_c613b5a4-9e3d-4d9d-b9b8-10fa9db21baf">0.39</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i333fb379828e461388d9751c6544ef4a"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our basic and diluted net loss per share is computed using the two-class method.&#160; The two-class method is an earnings allocation that determines net income per share for each class of common stock and participating securities according to their participation rights in dividends and undistributed earnings or losses.&#160; Non-vested restricted stock that includes non-forfeitable rights to dividends are considered participating securities.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because we have incurred a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share. <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RleHRyZWdpb246MTllYmQyYjBhMTQyNDYxN2JiNjA1YmE1YmZkNzE4NzhfOTUx_75dd4045-e3b5-40db-a7fe-f44b19e81c51" continuedAt="i05503d2b563b4543b1b162da315f4bd1" escape="true">The following contingently issuable and convertible equity shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for all periods presented:</ix:nonNumeric></span></div><div style="text-align:center;margin-bottom:6pt;"><ix:continuation id="i05503d2b563b4543b1b162da315f4bd1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.160%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:25.520%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.600%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:25.520%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7f161809f3474a4cabfb3f9e420c96d1_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNC0xLTEtMS0w_ba6aa2ea-83fd-4c4d-85d6-b8522bdbcd5a">437,347</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7204f2c032b942a68028138eeece4cee_D20190101-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNC0zLTEtMS0w_fef23cef-cf27-4b07-aba0-2261bcdff087">307,347</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i46623ac889f4451080c334614620617b_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNS0xLTEtMS0w_0f13a88a-4c95-4e7c-b5ec-7114136143c6">29,258</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ife2d42f413d047f09f78455b81ba82e0_D20190101-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNS0zLTEtMS0w_b287d5b9-0a75-4c06-a9e5-377430f87858">90,685</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i00909a9da62143989aea8f861f283df1_D20200101-20200630" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNi0xLTEtMS0w_afe463a4-1d64-4278-8b30-47f6d69d3387">404</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1d4b7eb4460144da819f7cf668aa8bdd_D20190101-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNi0zLTEtMS0w_9a57f7d0-b01d-41eb-a061-0e8862b8c769">4,979</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total shares</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNy0xLTEtMS0w_bd8c5f96-72d6-4408-8c73-49d1f2bba3ab">467,009</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNy0zLTEtMS0w_8c25d6c4-1ccb-43e7-8898-ab1487ef6ceb">403,011</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_64"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 11 &#8211; <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMTg3MQ_cbf3e21f-c59a-439f-9432-01709b56f5b4" continuedAt="i44152b685b8244d9a9c1fcba5e7a4c74" escape="true">BUSINESS SEGMENT  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i44152b685b8244d9a9c1fcba5e7a4c74" continuedAt="i2c093ec1612d4cc5934d73aac09abd78"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. We have <ix:nonFraction unitRef="segment" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMzE5_2450d501-5972-4a75-b1e5-5802773d560e"><ix:nonFraction unitRef="segment" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMzE5_c1661e31-e0e6-451d-a7f7-61a06d17a0a4">one</ix:nonFraction></ix:nonFraction> operating and reporting segment, OrthoPediatrics Corp., which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. Our chief operating decision-maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance, accompanied by disaggregated revenue information by product category. We determined that disaggregating revenue into these categories achieves the disclosure objective of illustrating the differences in the nature, timing and uncertainty of our revenue streams. We do not assess the performance of our individual product categories on measures of profit or loss, or other asset-based metrics. Therefore, the information below is presented only for revenue by category and geography. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Product sales attributed to a country or region includes product sales to hospitals, physicians and distributors and is based on the final destination where the products are sold. No customers accounted for more than 10% of total product sales for the three and six months ended June&#160;30, 2020 or 2019. No customer accounted for more than 10% of consolidated accounts receivable as of June&#160;30, 2020 and December 31, 2019. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMTg3Mw_7c9e869b-e64a-468c-af11-c98ae7fd3927" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Product sales by source were as follows: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:37.743%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.423%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.425%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by geographic location:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S.</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ice73e8c1b57f4796918a790a968b7015_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi0xLTEtMS0w_ba8d9d3c-118e-4dd1-ab12-6c312b42a185">12,146</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2622759db9c144acb87d793c9cf03743_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi0zLTEtMS0w_606915a1-aae1-490e-81ab-cae7e39604d1">13,848</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9c269ea2edf4cf5aef8ed02d7e1f45c_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi01LTEtMS0w_3c5f3cf2-6a3a-4f49-80c4-6c67aec09829">25,530</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fb48cad575945baac6067e33a96cadc_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi03LTEtMS0w_e33b0025-a1ae-43fc-b75f-481465c2757c">24,115</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia756c05cec28403f884770d9344bdac2_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy0xLTEtMS0w_75a15d30-e44f-417d-8875-2efadbd08ecf">1,447</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i721aca0cd1734c8aaf8b8d90702bc1d1_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy0zLTEtMS0w_67232c60-f74c-4439-b37e-63b7dae95911">4,352</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id10512dde3404dfcb6e3c0cce3a1f040_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy01LTEtMS0w_bbbd0f70-3d0c-49e5-8b9e-ac845c399cf2">4,419</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i266ee2942a4a4657a71d21bdf2710068_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy03LTEtMS0w_d36ad5ac-958e-4c64-ba0a-b28f6573dbba">8,741</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC0xLTEtMS0w_3a772023-5042-4fd3-a71f-8d7e2f01300d">13,593</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC0zLTEtMS0w_c6bf7ba2-fa4c-4e90-ae6f-348aba7126b1">18,200</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC01LTEtMS0w_ae72df90-d7fe-49af-b1ec-085b8a2d8d57">29,949</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC03LTEtMS0w_1b594549-ed27-4e6c-b369-d24d592ad80c">32,856</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center;"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:16.025%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMTg3MA_baaab50c-eda0-4f46-b9ff-8300045689d4" continuedAt="ic914fa3052da45fda2baa51cd388e19a" escape="true"></ix:nonNumeric><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;margin-bottom:6pt;"><ix:continuation id="i2c093ec1612d4cc5934d73aac09abd78" continuedAt="i089fdc6c7b7b41cdb838d9bcdb2ee61a"><ix:continuation id="ic914fa3052da45fda2baa51cd388e19a"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:37.743%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.423%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.583%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.585%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by category:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trauma and deformity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id78469ce723d4142ae3b8ab43ffa60a0_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi0xLTEtMS0w_68c53832-5995-42d1-becd-c251e93ff99c">9,220</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i225cd71c1ec1426d8041c44a2184d1ae_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi0zLTEtMS0w_241cb43a-7c62-4c21-afb0-3d4e8ca08dc4">11,887</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8c889130704d4f80946a9c6286e05061_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi01LTEtMS0w_e87fc33f-6266-4559-8db8-8612bbf2857c">21,430</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ed7c2942fcb4d46a5ca89a0294a7bf5_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi03LTEtMS0w_0a298dfe-b792-4ed9-a38f-46c046c8d652">21,904</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Scoliosis</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0fff3612ea874d5180f15f4a42bc8604_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy0xLTEtMS0w_23b20b09-c81e-4e57-9073-acadb01ac394">3,836</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9200b24feefc4b159ffafee02cb55e00_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy0zLTEtMS0w_7ca79d2c-0dd0-40c0-beed-eded9d6e8af3">5,866</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1e7ea47b72ee450b8582bd233a4fac65_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy01LTEtMS0w_0a1512df-d2f5-46f3-b680-3582acfab64b">7,547</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id56952e6da1c40bb95f3ecf288efc864_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy03LTEtMS0w_8b47acb2-808c-415c-a210-60a892fff912">10,124</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sports medicine/other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83e4b27552214a3a879d0adf2748bebb_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC0xLTEtMS0w_759c86a1-6036-407a-bc40-cacd707ec910">537</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1c76b6d6fbcd4e0e87b78db6dea4ab41_D20190401-20190630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC0zLTEtMS0w_da2e20db-fe0e-4532-af52-91fa92b76569">447</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iba3dd237ec5246bbba457e8a049a8981_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC01LTEtMS0w_4c138db4-2a8a-46a9-9d31-623bc8dca48e">972</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ce3387f4cd14200af133e93202fc096_D20190101-20190630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC03LTEtMS0w_00066db4-430b-4eb0-88a5-c90d6f575f02">828</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS0xLTEtMS0w_834faec7-5c35-4369-997d-79ff3ef04cf3">13,593</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS0zLTEtMS0w_8fb8d27d-0ec1-49dc-834d-2db43cc26de5">18,200</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS01LTEtMS0w_2998ae45-b652-4b98-af84-df54460586fe">29,949</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS03LTEtMS0w_a0f51277-6eeb-4e7d-94c9-5a487931d3f7">32,856</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i089fdc6c7b7b41cdb838d9bcdb2ee61a">No individual country with sales originating outside of the United States accounted for more than 10% of consolidated revenue for the three and six months ended June&#160;30, 2020 and 2019.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_67"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 12 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMTA2Mg_d63d3659-3fdd-422c-bb1b-0aa4a421d9e0" continuedAt="i5da7c2355c3743b38520c5f5ebc1cc71" escape="true">RELATED PARTY TRANSACTIONS</ix:nonNumeric></span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i5da7c2355c3743b38520c5f5ebc1cc71" continuedAt="ib1e9d35befc646688ce0a9eb4ee5e98f">In addition to the debt and credit agreements and mortgage with Squadron and its affiliate (see Note 6), we currently use Structure Medical, LLC (&#8220;Structure Medical&#8221;) as <ix:nonFraction unitRef="supplier" contextRef="ie0deb0d220a848e5ab3218335eba7b86_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="kids:NumberOfRelatedPartyEntitiesSuppliers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMjEy_371f2132-f994-4a5c-b863-2c28c2199eee">one</ix:nonFraction> of our suppliers. Structure Medical is affiliated with Squadron and we do not have a long-term contract with them. We made aggregate payments to Structure Medical of $<ix:nonFraction unitRef="usd" contextRef="i4fb8f7b19c8b43a0ab7aa696389aad13_D20200401-20200630" decimals="-3" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMzgx_75ffd39e-8cc4-4a09-86f7-d32e5cc141a8">934</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i82095520751c4542b0194bd4a6b61005_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMzg4_28d5dd19-4a92-447c-8cfe-805174c2f883">1,729</ix:nonFraction> for the three months ended June&#160;30, 2020 and 2019, respectively, and $2,135 and $2,493 for the six months ended June&#160;30, 2020 and 2019 . </ix:continuation></span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ib1e9d35befc646688ce0a9eb4ee5e98f">On December 31, 2019, the Company divested Vilex for $<ix:nonFraction unitRef="usd" contextRef="icef3ad5351134de9bd2e9409f0f579f0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfNDk3_24079efa-9d36-4a26-8e16-dfbeda893f49">25,000</ix:nonFraction> to an affiliate of Squadron. In conjunction with the divestiture, the Company also entered into an exclusive perpetual license agreement to permit the purchasers of Vilex the ability to access intellectual property and sell products using the external fixation technology of Orthex, LLC to non-pediatric accounts. The Orthex license agreement was determined to have a value of $<ix:nonFraction unitRef="usd" contextRef="ibaad49ffb99f40309f22c27c5a29b41a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfODc3_441176a9-6a10-4e5e-88d4-1efadf80444c">12,410</ix:nonFraction> and is determined to be a sale of functional intellectual property, resulting in the derecognition or sale of certain patent intangibles acquired in the Vilex and Orthex acquisition.</ix:continuation> </span></div><div style="margin-top:12pt;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_70"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 13 - <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83MC9mcmFnOmFlMWU3MWE1NWFiZjRjOTlhMDZiYzY1OGZjNWUwZGFkL3RleHRyZWdpb246YWUxZTcxYTU1YWJmNGM5OWEwNmJjNjU4ZmM1ZTBkYWRfNzgz_4e963da0-6120-4c08-b8db-23f87b5b6d36" continuedAt="ic9ff7fe2572645c8ab3098aa9737f875" escape="true">EMPLOYEE BENEFIT PLAN</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ic9ff7fe2572645c8ab3098aa9737f875">We have a defined-contribution plan, OrthoPediatrics 401(k) Retirement Plan (the &#8220;401(k) Plan&#8221;), which includes a cash or deferral (Section 401(k)) arrangement.  The 401(k) Plan covers those employees who meet certain eligibility requirements and elect to participate. Employee contributions are limited to the annual amounts permitted under the Internal Revenue Code. The 401(k) Plan allows us to make a discretionary matching contribution. Discretionary matching contributions are determined annually by management. Effective January 1, 2020, we have elected to match our employees' 401(k) contributions up to <ix:nonFraction unitRef="number" contextRef="i7249b3def0b34e65b3e605e288e1cc43_D20200101-20200101" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83MC9mcmFnOmFlMWU3MWE1NWFiZjRjOTlhMDZiYzY1OGZjNWUwZGFkL3RleHRyZWdpb246YWUxZTcxYTU1YWJmNGM5OWEwNmJjNjU4ZmM1ZTBkYWRfNjUy_7b3dceb3-d123-4ab9-a60a-1ff29acdb73e">4</ix:nonFraction>% of employees' salary. Prior to January 1, 2020, we matched our employees' 401(k) contributions up to <ix:nonFraction unitRef="number" contextRef="iaff3b8a415a248e1b649428771d5dd22_D20190101-20191231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83MC9mcmFnOmFlMWU3MWE1NWFiZjRjOTlhMDZiYzY1OGZjNWUwZGFkL3RleHRyZWdpb246YWUxZTcxYTU1YWJmNGM5OWEwNmJjNjU4ZmM1ZTBkYWRfNzU2_9dbdbd3b-dccc-4039-bfbd-3d1490d9a237">3</ix:nonFraction>% of employees' salary.</ix:continuation>  </span></div><div><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_73"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 14 &#8211; <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzk2OQ_fcf5927c-8bf1-43dc-ab69-20217760dbf7" continuedAt="i87dd4d3dc39b4495a7118b6903b1590a" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i87dd4d3dc39b4495a7118b6903b1590a" continuedAt="i10d8987d2c43475fbf50c7a9403f3e70"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Leases</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company calculates the associated lease liability and corresponding right-of-use asset upon lease commencement using a discount rate based on a borrowing rate commensurate with the term of the lease. </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><ix:continuation id="i10d8987d2c43475fbf50c7a9403f3e70" continuedAt="i7d77c0ae3f454441a8dcece718097060"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company records lease liabilities within current liabilities or long-term liabilities based upon the length of time associated with the lease payments. The Company records its operating lease right-of-use assets as long-term assets. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">As of June 30, 2020, the Company has recorded a lease liability of $<ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfODkw_5f78eac7-8c91-4c4c-8c5f-6b0909b115de">120</ix:nonFraction> and corresponding right-of-use-asset of $<ix:nonFraction unitRef="usd" contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfOTMz_932c5b3e-30b5-4a38-9b38-76685f3b719b">123</ix:nonFraction> on its condensed consolidated balance sheet. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">From time to time, we are involved in various legal proceedings arising in the ordinary course of our business. On January 20, 2017, K2M, Inc. filed suit against us in the United States District Court for the District of Delaware (K2M, Inc. v. OrthoPediatrics Corp. et al., Case No. 1:17-cv-0061) seeking unspecified damages for alleged infringement of U.S. Patent No. 9,532,816. The complaint was amended on August 21, 2017 to add, among other things, a claim of patent infringement regarding U.S. Patent No. 9,655,664. These patents relate to certain instruments used in our RESPONSE&#8482; spine systems, which represent a portion of our total scoliosis portfolio. We have denied these claims and responded with counterclaims seeking declaratory relief that the patents in question are both invalid and not infringed. The parties attended a court-ordered mediation on October 24, 2017, which did not resolve the dispute, but as we move forward with this matter we welcome constructive discussions on a negotiated settlement. Nevertheless, we view our case as particularly strong and will continue to vigorously defend this matter. On June 28, 2018, the United States Patent and Trademark Office's Patent Trial and Appeal Board ("PTAB") instituted limited review concerning whether certain third parties had described the invention of certain of K2M's patent claims before allegedly invented by K2M. On July 10, 2018, the Court stayed the litigation pending the outcome of PTAB's review. On June 4, 2019, PTAB completed its review, finding, among other things, insufficient evidence of such description by the third parties. In early October 2019, the Court orally lifted the stay in federal district court. Thereafter, on November 19, 2019, K2M amended its complaint to add two (2) additional issued patents, to add claims of patent infringement regarding U.S. Patent Nos. 10,285,735 and 10,292,736 (both issued in May 2019). Like before, these newly issued patents relate to certain instruments used in our RESPONSE&#8482; spine systems. Additionally, we have denied these most recent claims and responded with counterclaims seeking declaratory relief that the subject patents are both invalid and not infringed. Moreover, on November 20, 2019, the Court issued a Scheduling Order, which in part, set a trial date for April 12, 2021. Subsequently, the parties attended a second court-ordered mediation on February 25, 2020, which did not resolve the dispute, but we continue to welcome constructive discussions on a negotiated settlement. Although we believe that the K2M lawsuit is without merit and will vigorously defend the claims asserted against us, intellectual property litigation can involve complex factual and legal questions, and an adverse resolution of this proceeding could have a material adverse effect on our business, operating results and financial condition. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">We are not presently a party to any other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate materially affect our financial position, results of operations or cash flows.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Royalties</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;30, 2020, we are contracted to pay royalties to individuals and entities that provide research and development services, which range from <ix:nonFraction unitRef="number" contextRef="i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630" decimals="INF" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzQ3Ng_1590763b-584b-4a0b-8711-fada6af56fee">0.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7ce4805a31e8410d81b81251b9b1f57c_D20200101-20200630" decimals="INF" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzQ4Mg_46455420-f32f-46b7-8693-bf8672dd249b">20</ix:nonFraction>% of sales.  Additionally, we had minimum royalty commitments of $<ix:nonFraction unitRef="usd" contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" decimals="INF" name="kids:ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzU0OQ_342162ae-a321-4e5f-8db9-b030390645da">500</ix:nonFraction> annually through 2026 which ceased upon the purchase of the Band-Lok assets in June 2020.  </span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i7d77c0ae3f454441a8dcece718097060">We have products in development that have milestone payments and royalty commitments.  In any development project, there are significant variables that will affect the amount and timing of these payments and as of June&#160;30, 2020, we have not been able to determine the amount and timing of payments.  We do not anticipate these future payments will have a material impact on our financial results.</ix:continuation>     </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">30</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">NOTE 15 &#8211; <ix:nonNumeric contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NDcxOA_43e455ea-9fad-40a8-a57c-2b0d8c0c43a1" continuedAt="ice5753731fe14141b8b0a3f7902fd27a" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ice5753731fe14141b8b0a3f7902fd27a" continuedAt="ie03ffeae6a734b70a46550760c1b9ace"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On August 4, 2020, the Company entered into a Second Amendment (the &#8220;Second Amendment&#8221;) to its First Amended Loan Agreement with Squadron (as so further amended, the &#8220;Second Amended Loan Agreement&#8221;).  Pursuant to the Second Amendment, the First Amended Loan Agreement&#8217;s revolving credit commitment was increased from the previously established $<ix:nonFraction unitRef="usd" contextRef="i70d54ac0693a4a3780155e252a95c82c_I20200803" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQzNw_4b9715df-b256-4758-94dc-c055c7c41b41">15,000</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="idfc293021e554021ac712a08de896501_I20200804" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQ0Ng_a07fe8ee-fe1c-43b8-868b-331a895f3a1c">25,000</ix:nonFraction>. The Company has agreed to pay Squadron an unused commitment fee in an amount equal to the per annum rate of <ix:nonFraction unitRef="number" contextRef="ie9d46247c02e4dad89dcf4bf7fdb0780_D20200804-20200804" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQ1NQ_355681ce-a1b3-44ff-aaa9-a61988658c95">0.50</ix:nonFraction>% (computed on the basis of a year of 360 days and the actual number of days elapsed) times the daily unused portion of the revolving credit commitment.  The unused commitment fee is payable quarterly in arrears.  </span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Borrowings under the revolving credit facility will be made under a First Amended and Restated Revolving Note, dated August 4, 2020 (the &#8220;Amended Revolving Note&#8221;), payable, jointly and severally, by the Company and each of its subsidiaries party thereto. The Amended Revolving Note will mature at the earlier of: (i) the date on which any person or persons acquire (x) capital stock of the Company possessing the voting power to elect a majority of the Company&#8217;s Board of Directors (whether by merger, consolidation, reorganization, combination, sale or transfer), or (y) all or substantially all of the Company&#8217;s assets, determined on a consolidated basis; and (ii) January 1, 2024.  Prior to the Second Amendment, the revolving credit facility was to have matured on January 31, 2023. The Second Amended Loan Agreement continues to provide for interest only payments, which are payable monthly, with interest rates equal to the greater of (a) three month LIBOR plus <ix:nonFraction unitRef="number" contextRef="icc09a7c192ec43ffbf6d23af854df8b2_D20200804-20200804" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQyMg_07532a0d-154a-41c5-9c86-37bfee1b5fbb">8.61</ix:nonFraction>%, and (b) <ix:nonFraction unitRef="number" contextRef="i5ab10817a561491dad2e85b5bebc393f_I20200804" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQyOQ_e238b900-5862-4546-adb9-5d77e4b96808">10.00</ix:nonFraction>%</span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ie03ffeae6a734b70a46550760c1b9ace">On July 15, 2020, the Company repaid the $<ix:nonFraction unitRef="usd" contextRef="ic1955253c07c4f0f85875d92dbf6bbb7_D20200715-20200715" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NDcyMA_cd08c48d-7136-4072-b77d-73cdebfe6646">20,000</ix:nonFraction> principal amount outstanding under the Loan Agreement&#8217;s Term Note A, together with all unpaid interest and other related amounts payable. Following such repayment, there are no outstanding term loan obligations under the Second Amended Loan Agreement.</ix:continuation>  </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_79"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">ITEM 2.&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_82"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">This Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the condensed consolidated financial statements and related notes thereto contained elsewhere in this quarterly report, as well as the information under "Note Regarding Forward-Looking Statements."</span></div><div style="text-align:justify;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_85"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Overview</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We are the only medical device company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market in order to improve the lives of children with orthopedic conditions. We design, develop and commercialize innovative orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients, who we believe have been largely neglected by the orthopedic industry. We currently serve three of the largest categories in this market. We estimate that the portion of this market that we currently serve represents a $3.2 billion opportunity globally, including over $1.4 billion in the United States.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We sell implants and instruments to our customers for use by pediatric orthopedic surgeons to treat orthopedic conditions in children. We provide our implants in sets that consist of a range of implant sizes and include the instruments necessary to perform the surgical procedure. In the United States, our customers typically expect us to have full sets of implants and instruments on site at each hospital but do not purchase the implants until they are used in surgery. Accordingly, we must make an up-front investment in inventory of consigned implants and instruments before we can generate revenue from a particular hospital and we maintain substantial levels of inventory and instruments at any given time.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently market 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market: (i) trauma and deformity, (ii) scoliosis and (iii) sports medicine/other. We rely on a broad network of third parties to manufacture the components of our products, which we then inspect and package. We believe our innovative products promote improved surgical accuracy, increase consistency of outcomes and enhance surgeon confidence in achieving high standards of care. In the future, we expect to expand our product offering within these categories, as well as to address additional categories of the pediatric orthopedic market.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The majority of our revenue has been generated in the United States, where we sell our products through a network of 37 independent sales agencies employing more than 164 sales representatives specifically focused on pediatrics. These independent sales agents are trained by us, distribute our products and are compensated through sales-based commissions and performance bonuses. We do not sell our products through or participate in physician-owned distributorships, or PODs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We market and sell our products internationally in 43 countries, primarily through independent stocking distributors. Our independent distributors manage the billing relationship with each hospital in their respective territories and are responsible for servicing the product needs of their surgeon customers. In April 2017, we began to supplement our use of independent distributors with direct sales programs in the United Kingdom, Ireland, Australia and New Zealand and further expanded to Canada in September 2018 and Belgium and the Netherlands in January 2019, and in Italy on March 1, 2020. In these markets, we work through sales agencies that are paid a commission, similar to our U.S. sales model. We expect these arrangements to generate an increase in revenue and gross margin. </span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On June 4, 2019, we purchased all of the issued and outstanding shares of stock of Vilex in Tennessee, Inc. ("Vilex") and all of the issued and outstanding units of membership interests in Orthex, LLC ("Orthex") for $60.2 million in total consideration, net of working capital adjustments. Vilex and Orthex (the &#8220;Vilex Companies&#8221;) are primarily manufacturers of foot and ankle surgical implants, including cannulated screws, fusion devices, surgical staples and bone plates, as well as Orthex Hexapod technology which is used to treat pediatrics congenital deformities and limb length discrepancies.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On December 31, 2019, we divested substantially all of the assets relating to Vilex's adult product offerings to a wholly-owned subsidiary of Squadron Capital LLC ("Squadron") in exchange for a $25.0 million reduction in a term note owed to Squadron in connection with the initial acquisition. As part of the sale, we also executed an exclusive license arrangement with Squadron providing for perpetual access to certain intellectual property.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On March 9, 2020, we purchased all the issued and outstanding membership interest of Telos Partners, LLC ("Telos") for $3.3 million in total consideration. Telos is a boutique regulatory consulting firm formed in Colorado. </span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On April 1, 2020, we purchased all of the issued and outstanding shares of stock of Apifix Ltd. ("Apifix") for (a) $2.0 million in cash, and (b) 934,783 shares of the Company&#8217;s common stock, $0.00025 par value per share, representing approximately $35.2 million (based on a closing share price of $37.63 on April 1, 2020). ApiFix, a corporation organized under the laws of Israel, has developed and manufactures a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis (AIS) (the &#8220;ApiFix System&#8221;). The purchase price is subject to a post-closing working capital adjustment. In addition, the Company has also agreed to pay as part of the purchase price the following anniversary payments: (i) $13.0 million on the second anniversary of the closing date, provided that such payment will be paid earlier if 150 clinical procedures using the ApiFix System are completed in the United States before such anniversary date; (ii) $8.0 million on the third anniversary of the closing date; and (iii) $9.0 million on the fourth anniversary of the closing date. In addition, to the extent that the product of the Company&#8217;s revenues from the ApiFix System for the twelve months ended June 30, 2024 multiplied by 2.25 exceeds the anniversary payments actually made for the third and fourth years (subject to certain limitations), the Company has agreed to pay the selling shareholders a system sales payment in the amount of such </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">excess. The anniversary payments and the system sales payment may each be made in cash or cash and common stock, subject to certain limitations; provided that the Company may make the determination with respect to anniversary payments and a representative of the former ApiFix shareholders may make the determination with respect to the system sales payment, if any.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On June 10, 2020, we purchased certain intellectual property assets from Band-Lok, LLC, a North Carolina limited liability company ("Band-Lok"), related to its Tether Clamp and Implantation System ("Tether Clamp System") for approximately $3,400 in total consideration. We use the Tether Clamp System in connection with our Bandloc 5.5/6.0 System. We were previously the sole licensee of the purchased assets under a license agreement with Band-Lok. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe there are significant opportunities for us to strengthen our position in U.S. and international markets by increasing investments in consigned implant and instrument sets, strengthening our global sales and distribution infrastructure and expanding our product offering.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Impact of COVID-19 on our Business</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A novel strain of the coronavirus disease ("COVID-19") was first identified in Wuhan, China in December 2019, and the related outbreak was subsequently declared a pandemic by the World Health Organization and a national emergency by the President of the United States.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Health and Safety</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From the earliest signs of the outbreak, we have taken proactive, aggressive action to protect the health and safety of our employees, customers, partners and suppliers. We enacted rigorous safety measures in all applicable locations, including implementing social distancing protocols, requiring working from home for those employees that do not need to be physically present on the warehouse floor, suspending travel, extensively and frequently disinfecting our workspaces and providing masks to those employees who must be physically present. We expect to continue to implement these measures until we determine that the COVID-19 pandemic is adequately contained for purposes of our business, and we may take further actions as government authorities require or recommend or as we determine to be in the best interests of our employees, customers, partners and suppliers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Supply</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have not yet experienced any significant impacts or interruptions to our supply chain as a result of the COVID-19 pandemic. To mitigate the risk of any potential supply interruptions from the COVID-19 pandemic, we chose to increase certain inventory levels during the quarter. We may decide to take similar actions going forward. Additionally, restrictions or disruptions of transportation, such as reduced availability of air transport, port closures and increased border controls or closures, have started to result in higher costs and delays.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Demand</span></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The outbreak has significantly increased economic and demand uncertainty. We anticipate that the current outbreak or continued spread of COVID-19, and the actions taken by governmental authorities and other third parties to contain the virus, will cause a global economic slowdown, and it is possible that it could cause a global recession. In the event of a recession, demand for our products would decline and our business would be adversely effected. We have experienced a reduction in revenue as a result of global delays in elective surgeries. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;">Liquidity</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Although there is uncertainty related to the anticipated impact of the recent COVID-19 outbreak on our future results, we believe our business model, our current cash reserves and the recent steps we have </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">taken to strengthen our balance sheet, including our June 2020 and December 2019 equity offerings, leave us well-positioned to manage our business through this crisis as it continues to unfold. We believe our existing balances of  cash and our currently anticipated operating cash flows will be sufficient to meet our cash needs arising in the ordinary course of business for the next twelve months.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We continue to monitor the rapidly evolving situation and guidance from international and domestic authorities, including federal, state and local public health authorities and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our operating plan. As such, given the dynamic nature of this situation, we cannot reasonably estimate the impacts of COVID-19 on our financial condition, results of operations or cash flows in the future. </span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_88"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Emerging Growth Company and Smaller Reporting Company Status</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and reflect the financial position, results of operations, and cash flows of OrthoPediatrics Corp (the "Company," &#8220;we,&#8221; "our" or "us"). We qualify as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act (the &#8220;JOBS Act&#8221;). For as long as a company is deemed to be an emerging growth company, it may take advantage of specified reduced reporting and other regulatory requirements that are generally unavailable to other public companies. We also qualify as a "smaller reporting company," as such term is defined in Rule 12b-2 under the Exchange Act. To the extent that we continue to qualify as a smaller reporting company, after we cease to qualify as an emerging growth company, certain of the exemptions available to us as an emerging growth company may continue to be available to us as a smaller reporting company. The JOBS Act also provides that an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we are subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. </span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_91"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Summary of Statements of Operations for the Three and Six Months Ended June&#160;30, 2020 and 2019</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth our results of operations for the three and six months ended June 30, 2020 and 2019:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:29.570%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.775%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.134%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.775%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:4.410%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.775%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:4.254%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase<br/>(Decrease)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase (Decrease)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4,607)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,907)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of revenue</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,581&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,049)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,675&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(907)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales and marketing expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,606&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,986)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(26)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(969)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">General and administrative expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,577&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,569&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,008&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,458&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,277&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">881&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(353)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(301)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">669&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1761&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">263&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,878&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,906&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss from continuing operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,447)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,459)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,988&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">284&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,392)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,479)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,913&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss from discontinued operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(159)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(159)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,447)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,618)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,829&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">261&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,392)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,638)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,754&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">155&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Net Revenue  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following tables set forth our net revenue by geography and product category for the three and six months ended June&#160;30, 2020 and 2019:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:36.141%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.441%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.903%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.601%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.907%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by geographic location:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S.</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,848&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,530&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,115&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by category:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trauma and deformity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,887&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,904&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Scoliosis</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,836&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,866&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,547&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sports medicine/other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">537&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net revenue decreased $4.6 million, or 25%, from $18.2 million for the three months ended June&#160;30, 2019 to $13.6 million for the three months ended June&#160;30, 2020 and decreased $2.9 million, or 9%, from $32.9 million for the six months ended June&#160;30, 2019 to $29.9 million for the six months ended June&#160;30, 2020.  The decrease was due to the global suspension of elective surgeries related to the COVID-19 pandemic. International revenue decreased at a higher rate than U.S revenue, and international markets continue to be impacted by COVID-19, as there are fewer stand-alone pediatric hospitals internationally and elective procedures have been slower to return. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trauma and deformity sales declined $2.7 million, or 22%, and $0.5 million, or 2%, during the three and six months ended June&#160;30, 2020, respectively, primarily driven by lower sales of our deformity correction product portfolio, specifically our PNP Femur and two new cannulated screw systems. Scoliosis sales declined $2.0 million, or 35%, and $2.6 million, or 25%, during the three and six months ended June&#160;30, 2020, respectively, primarily driven by lower sales of our RESPONSE 5.5/6.0 system and FIREFLY</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Pedicle Screw Navigation Guides. These sales declines were offset by sports medicine / other growth of $0.1 million, or 20%, and $0.1 million, or 17%, during the three and six months ended June&#160;30, 2020, respectively. Nearly all the change in each category was due to a decrease in the unit volume sold and not a result of price changes.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Cost of Revenue and Gross Margin</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cost of revenue decreased $1.0 million, or 23%, from $4.6 million for the three months ended June&#160;30, 2019 to $3.5 million for the three months ended June&#160;30, 2020. Cost of revenue decreased $0.9 million, or 11%, from $8.6 million for the six months ended June&#160;30, 2019 to $7.7 million for the six months ended June&#160;30, 2020. The decrease was due primarily to decreased sales volume in both the U.S. and international markets resulting from the suspension of elective surgeries related to the COVID-19 pandemic. Gross margin was 75% for the three months ended June&#160;30, 2019, 74% for the three months ended June&#160;30, 2020 and 74% for the six months ended June&#160;30, 2019 and June&#160;30, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Sales and Marketing Expenses</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales and marketing expenses decreased $2.0 million, or 26%, to $5.6 million for the three months ended June&#160;30, 2020 from $7.6 million for the three months ended June&#160;30, 2019. Sales and marketing expenses decreased $1.0 million, or 7%, to $13.2 million for the six months ended June&#160;30, 2020 from $14.2 million for the six months ended June&#160;30, 2019. The decrease for the three and six month periods </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ended June&#160;30, 2020 were due primarily to decreased sales commission expenses, driven by the decrease in unit volume sold, related to the suspension of elective surgeries due to the COVID-19 pandemic. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">General and Administrative Expenses</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">General and administrative expenses increased $4.0 million, or 61%, from $6.6 million for the three months ended June&#160;30, 2019 to $10.6 million for the three months ended June&#160;30, 2020. General and administrative expenses increased $6.3 million, or 52%, from $12.2 million for the six months ended June&#160;30, 2019 to $18.5 million for the six months ended June&#160;30, 2020. The increase for the three and six month periods ended June&#160;30, 2020 were due primarily to increased stock compensation of $2.3 million related to a one-time stock grant of $1.3 million to our Chief Executive Officer and the increase of our stock price on new stock grants, increased legal expenses of $0.8 million related to our ongoing litigation and acquisitions, and increased general and administrative expenses associated with the acquisitions of ApiFix and Telos. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciation and amortization expenses increased $0.9 million, or 80%, from $1.1 million for the three months ended June&#160;30, 2019 to $1.9 million for the three months ended June&#160;30, 2020. Depreciation and amortization expenses increased $1.4 million, or 74%, from $1.9 million for the six months ended June&#160;30, 2019 to $3.3 million for the six months ended June&#160;30, 2020. The increase for the three and six month periods ended June&#160;30, 2020 were primarily due to increased investments in consigned surgical instrument sets and amortization of intangible assets acquired through the Vilex, Telos and ApiFix acquisitions and the purchase of the Band-Lok intellectual property.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Research and Development Expenses</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Research and development expenses decreased $0.4 million, or 29%, from $1.2 million for the three months ended June&#160;30, 2019 to $0.9 million for the three months ended June&#160;30, 2020. Research and development expenses decreased $0.3 million, or 12%, from $2.4 million for the six months ended June&#160;30, 2019 to $2.1 million for the six months ended June&#160;30, 2020.The decrease for the three and six month periods ended June&#160;30, 2020 were driven by a reduced investment in research and development project expenses as a result of the sales decline related to the COVID-19 pandemic and the reversal of the Bandloc minimum royalty. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other Expenses</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other expenses were $2.4 million and $0.7 million for the three months ended June&#160;30, 2020 and 2019, respectively. Other expenses were $2.9 million and $1.0 million for the six months ended June&#160;30, 2020 and 2019, respectively. The increase in other expenses is due to fair value adjustment of $1.8 million related to the ApiFix contingent consideration payment. </span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_94"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have incurred operating losses since inception which resulted in negative cash flows for continuing operations from operating activities of $14.7 million and $10.8 million for the six months ended June&#160;30, 2020 and 2019, respectively. As of June&#160;30, 2020, we had an accumulated deficit of $143.2 million. We anticipate that our losses will continue in the near term as we continue to expand our product portfolio and invest in additional consigned implant and instrument sets to support our expansion into existing and new markets. Since inception, we have funded our operations primarily with proceeds from the sales of our common and preferred stock, convertible securities and debt, as well as through sales of our products. At June&#160;30, 2020, we had cash and restricted cash of $114.4 million.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">36</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cash Flows</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth our cash flows from operating, investing and financing activities for the periods indicated:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.038%;"><tr><td style="width:1.0%;"></td><td style="width:66.608%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.372%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.609%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.211%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in operating activities - continuing operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,707)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10,785)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by operating activities - discontinued operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities - continuing operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,349)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(58,610)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used in investing activities - discontinued operations</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(47)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash provided by financing activities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,598&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of exchange rate changes on cash</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net increase (decrease) in cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,388&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38,473)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash Used in Operating Activities</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in operating activities from continuing operations was $14.7 million and $10.8 million for the six months ended June&#160;30, 2020 and 2019, respectively. The primary use of this cash was to fund our operations related to the development and commercialization of our products in each of these years. Net cash used for working capital was $8.8 million and $8.2 million for the six months ended June&#160;30, 2020 and 2019, respectively. During the six months ended June&#160;30, 2020, the primary driver of working capital cash usage was the increase in inventory of $9.6 million related to future sales growth and our acquisitions and new agencies.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash Used in Investing Activities</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash used in investing activities from continuing operations was $9.3 million and $58.6 million for the six months ended June&#160;30, 2020 and 2019, respectively. Net cash used in investing activities consisted primarily of the acquisition of Telos of $1.7 million, net of cash received, the acquisition of ApiFix for $1.7 million, net of cash received, the acquisition of the Band-Lok intellectual propoerty of $0.8 million, the acquisition of Vilex and Orthex of $49.9 million, net of cash received, and the purchases of instrument sets, which were consigned in the United States, United Kingdom, Australia, New Zealand, Belgium and the Netherlands of $5.2 million and $8.5 million for the six months ended June&#160;30, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash Provided By Financing Activities</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net cash provided by financing activities was $66.4 million and $30.6 million for the six months ended June&#160;30, 2020 and 2019, respectively. Net cash provided by financing activities for the six  months ended June&#160;30, 2020 consisted primarily of the proceeds from the issuance of common stock of $70.2 million, net of issuance costs and $1.3 million from the exercise of stock options, offset by the payment of $5.0 million of the revolving credit facility with Squadron.</span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_100"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Indebtedness</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Loan Agreement</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 31, 2017, we entered into a Fourth Amended and Restated Loan and Security Agreement, or the Loan Agreement, with Squadron Capital LLC, or Squadron, the Company's largest investor. Under the terms of the Loan Agreement, Squadron provided us a term loan in the principal amount of $20.0 million, represented by a Term Note A, and a revolving loan in an aggregate principal amount to not </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">exceed $15.0 million, represented by a Revolving Note. Interest on the Term Note A and Revolving Note accrued at the greater of (a) three month LIBOR plus 8.61% and (b) 10.0%.</span></div><div><span><br/></span></div><div style="padding-right:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In order to finance a portion of the cash consideration for the acquisition of the Vilex Companies, the Company entered into a First Amendment, or the First Amendment, to the Loan Agreement (as so amended, the "First Amended Loan Agreement"), with Squadron. The First Amended Loan Agreement provided for a new $30.0 million term loan facility, represented by a Term Note B,  in addition to the existing $20.0 million Term Note A and $15.0 million revolving credit facility. Similar to the other facilities under the First Amended Loan Agreement, the Term Note B was subject to interest only payments at an interest rate equal to the greater of (a) three month LIBOR plus 8.61%, and (b) 10.00%. The Term Note B, which would have matured no later than May 31, 2020, was paid in full on December 31, 2019 using $25.0 million received in exchange for the divestiture of the adult product offerings of Vilex and the related Orthex license agreement, and $5.0 million from the available Squadron revolving credit facility. On January 4, 2020, the Company repaid $5.0 million on the revolving credit facility with Squadron. </span></div><div><span><br/></span></div><div style="padding-right:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:123%;">At June&#160;30, 2020, we had approximately $19.9 million in outstanding indebtedness under the First Amended Loan Agreement. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On August 4, 2020, the Company entered into a Second Amendment (the &#8220;Second Amendment&#8221;) to its First Amended Loan Agreement with Squadron (as so further amended, the &#8220;Second Amended Loan Agreement&#8221;).  Pursuant to the Second Amendment, the First Amended Loan Agreement&#8217;s revolving credit commitment was increased from the previously established $15,000 to $25,000. The Company has agreed to pay Squadron an unused commitment fee in an amount equal to the per annum rate of 0.50% (computed on the basis of a year of 360 days and the actual number of days elapsed) times the daily unused portion of the revolving credit commitment.  The unused commitment fee is payable quarterly in arrears.  </span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Borrowings under the revolving credit facility will be made under a First Amended and Restated Revolving Note, dated August 4, 2020 (the &#8220;Amended Revolving Note&#8221;), payable, jointly and severally, by the Company and each of its subsidiaries party thereto. The Amended Revolving Note will mature at the earlier of: (i) the date on which any person or persons acquire (x) capital stock of the Company possessing the voting power to elect a majority of the Company&#8217;s Board of Directors (whether by merger, consolidation, reorganization, combination, sale or transfer), or (y) all or substantially all of the Company&#8217;s assets, determined on a consolidated basis; and (ii) January 1, 2024.  Prior to the Second Amendment, the revolving credit facility was to have matured on January 31, 2023. The Second Amended Loan Agreement continues to provide for interest only payments, which are payable monthly, with interest rates equal to the greater of (a) three month LIBOR plus 8.61%, and (b) 10.00%</span></div><div><span><br/></span></div><div style="padding-right:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:123%;">Borrowings under the Second Amended Loan Agreement are secured by substantially all of the Company's assets and are unconditionally guaranteed by each of its subsidiaries with the exception of Vilex. There are no traditional financial covenants associated with the Second Amended Loan Agreement. However, there are negative covenants that prohibit us from, among other things, transferring any of our material assets, merging with or acquiring another entity, entering into a transaction that would result in a change of control, incurring additional indebtedness, creating any lien on our property, making investments in third parties and redeeming stock or paying dividends, in each case subject to certain exceptions as further detailed in the Second Amended Loan Agreement.</span></div><div><span><br/></span></div><div style="padding-right:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Second Amended Loan Agreement includes events of default, the occurrence and continuation of any of which provides Squadron with the right to exercise remedies against us and the collateral securing the loans, including cash. These events of default include, among other things, the failure to pay amounts due under the credit facilities, insolvency, the occurrence of a material adverse event, which includes a material adverse change in our business, operations or properties (financial or otherwise) or a material impairment of the prospect of repayment of any portion of the obligations, the occurrence of any default under certain other indebtedness and a final judgment against us in an amount greater than $250 </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="padding-right:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">thousand. The occurrence of a material adverse change could result in the acceleration of payment of the debt.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Mortgage Note</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2013, pursuant to the purchase of our office and warehouse space, we entered into a mortgage note payable to Tawani Enterprises Inc., the owner of which is a member of Squadron&#8217;s Managing Committee. Pursuant to the terms of the mortgage note, we pay Tawani Enterprises Inc. monthly principal and interest installments of $16 thousand, with interest compounded at 5% until maturity in August 2028, at which time a final payment of remaining principal and interest will become due. The mortgage is secured by the related real estate and building. The mortgage balance was $1.2 million and $1.3 million at June&#160;30, 2020 and December&#160;31, 2019, respectively.                      </span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_103"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Pediatric Orthopedic Business Seasonality</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our revenue is typically higher in the summer months and holiday periods, driven by higher sales of our trauma and deformity and scoliosis products, which is influenced by the higher incidence of pediatric surgeries during these periods due to recovery time provided by breaks in the school year. Additionally, our scoliosis patients tend to have additional health challenges that make scheduling their procedures variable in nature.</span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_106"></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This management&#8217;s discussion and analysis of financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue and expenses during the reporting periods. We monitor and analyze these items for changes in facts and circumstances, and material changes in these estimates could occur in the future. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ materially from these estimates under different assumptions or conditions.</span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_109"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 3.&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%;">As a "smaller reporting company," we are not required to provide the information required by this item. </span></div><div style="text-align:justify;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_112"></div><div style="text-align:justify;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 4.&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">a.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt;">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) at the end of the period covered by this quarterly report. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Based on this evaluation, we concluded that, as of such date, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize that any controls system, no matter how well designed and operated, can provide only reasonable assurance of achieving its objectives, and our management necessarily applies its judgment in evaluating the benefits of possible controls and procedures relative to their costs. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">b. Changes in Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no changes in our internal control over financial reporting during the period covered by this quarterly report that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act).</span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">40</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">PART II.  OTHER INFORMATION</span></div><div style="text-align:justify;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_118"></div><div style="text-align:justify;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 1.&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">From time to time, we are involved in various legal proceedings arising in the ordinary course of our business. On January 20, 2017, K2M, Inc. filed suit against us in the United States District Court for the District of Delaware (K2M, Inc. v. OrthoPediatrics Corp. et al., Case No. 1:17-cv-0061) seeking unspecified damages for alleged infringement of U.S. Patent No. 9,532,816. The complaint was amended on August 21, 2017 to add, among other things, a claim of patent infringement regarding U.S. Patent No. 9,655,664. These patents relate to certain instruments used in our RESPONSE&#8482; spine systems, which represent a portion of our total scoliosis portfolio. We have denied these claims and responded with counterclaims seeking declaratory relief that the patents in question are both invalid and not infringed. The parties attended a court-ordered mediation on October 24, 2017, which did not resolve the dispute, but as we move forward with this matter we welcome constructive discussions on a negotiated settlement. Nevertheless, we view our case as particularly strong and will continue to vigorously defend this matter. On June 28, 2018, the United States Patent and Trademark Office's Patent Trial and Appeal Board ("PTAB") instituted limited review concerning whether certain third parties had described the invention of certain of K2M's patent claims before allegedly invented by K2M. On July 10, 2018, the Court stayed the litigation pending the outcome of PTAB's review. On June 4, 2019, PTAB completed its review, finding, among other things, insufficient evidence of such description by the third parties. In early October 2019, the Court orally lifted the stay in federal district court. Thereafter, on November 19, 2019, K2M amended its complaint to add two (2) additional issued patents, to add claims of patent infringement regarding U.S. Patent Nos. 10,285,735 and 10,292,736 (both issued in May 2019). Like before, these newly issued patents relate to certain instruments used in our RESPONSE&#8482; spine systems. Additionally, we have denied these most recent claims and responded with counterclaims seeking declaratory relief that the subject patents are both invalid and not infringed. Moreover, on November 20, 2019, the Court issued a Scheduling Order, which in part, set a trial date for April 12, 2021. Subsequently, the parties attended a second court-ordered mediation on February 25, 2020, which did not resolve the dispute, but we continue to welcome constructive discussions on a negotiated settlement. Although we believe that the K2M lawsuit is without merit and will vigorously defend the claims asserted against us, intellectual property litigation can involve complex factual and legal questions, and an adverse resolution of this proceeding could have a material adverse effect on our business, operating results and financial condition. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">We are not presently a party to any other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate materially affect our financial position, results of operations or cash flows.</span></div><div style="padding-right:3pt;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_121"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 1A.&#160;&#160;RISK FACTORS</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Except for the additional risk factor set forth below, there have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, as filed with the SEC on March 5, 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">The ongoing COVID-19 pandemic and measures intended to prevent its spread have adversely impacted our business and financial results, and the ultimate impact will depend on future developments, which are highly uncertain and cannot be predicted, including the severity and duration of the pandemic and further actions taken by governmental authorities and other third parties to contain and treat the virus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The recent outbreak of COVID-19 was first identified in Wuhan, China in December 2019, and subsequently declared a pandemic by the World Health Organization.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On March 12, 2020, the President of the United States declared the COVID-19 outbreak in the United States a national emergency. As a result of the pandemic, we have experienced significant business disruption. For example, in preparation for COVID-19-related hospitalizations, various governments, governmental agencies and hospital administrators have instructed hospitals to postpone some elective procedures. As a majority of our </span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">products are utilized in elective surgeries or procedures, the deferrals of such surgeries and procedures have had, and will continue to have, a significant negative impact on our business and results of operations. The COVID-19 outbreak has also resulted in governmental authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter in place or total lock-down orders, social distancing requirements, and business limitations and shutdowns.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">While these measures have negatively impacted the ability of our sales professionals to reach physicians, such measures have not yet had any significant impacts on our product supply chain.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">However, we anticipate these measures having a negative impact on the production and delivery of our products in the future, resulting in a further decline in sales, an increase in accounts receivable reserves, lower gross margins, and greater challenges in forecasting business results and making business decisions.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The COVID-19 pandemic has adversely impacted, and may continue to adversely impact, the economies and financial markets of many countries, which may result in a period of regional, national or global economic slowdown or regional, national or global recessions. The extent to which the outbreak impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and are difficult to predict, including, but not limited to, the duration and spread of the outbreak, its severity, actions taken by governmental authorities and other third parties to contain and treat the virus, and how quickly and to what extent normal economic and operating conditions can resume. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Moreover, the effects of the COVID-19 pandemic may heighten many of the other risks described in the section entitled &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019, and any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">While we do not yet know the full extent of the COVID-19 impact, the negative effects on our business, results of operations and financial condition could be material.</span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_124"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 2.&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">a. Sale of Unregistered Securities. </span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On April 1, 2020, the Company issued 934,783 shares of its common stock, $0.00025 par value per share, in connection with the purchase of all of the issued and outstanding shares of ApiFix Ltd. The purchase price also included $2.0 million in cash and additional anniversary and system sales payments. The shares were valued at $37.63 per share on the date of issuance. The issuance of the common stock was made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended. </span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On June 10, 2020, the Company issued 54,371 shares of its common stock, $0.00025 par value per share, in connection with the purchase of certain intellectual property assets from Band-Lok, LLC.The purchase price also included $0.75 million in cash. The shares were valued at $48.63 per share on the date of issuance. The issuance of the common stock was made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">b. Use of Proceeds.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None.</span></div><div style="text-indent:36pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">c. Issuer Purchases of Equity Securities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None. </span></div><div><span><br/></span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="padding-left:36pt;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">42</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_127"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 3.&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None. </span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_130"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 4.&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">None. </span></div><div><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_133"></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 5.&#160;&#160;OTHER INFORMATION</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:144%;">a. Failure to file under Form 8-K.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%;">None. </span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">b. Modifications to nomination process. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%;">None. </span></div><div style="text-indent:36pt;text-align:justify;"><span><br/></span></div><div id="i38c4d288f2604685a8c81d4642167bbd_136"></div><div style="text-align:justify;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:144%;">ITEM 6.&#160;&#160;EXHIBITS</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%;">The following exhibits are included within this Report or incorporated herein by reference. </span></div><div style="text-align:justify;"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span><br/></span></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">43</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_139"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:7.821%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.654%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.544%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:81.037%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Exhibit</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Number</span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td></tr><tr><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:13pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000110465920041900/tm2014274d1_ex2-1.htm">2.1*</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000110465920041900/tm2014274d1_ex2-1.htm">Share Purchase Agreement, dated April 1, 2020, by and among OrthoPediatrics Corp., ApiFix Ltd. (&#8220;ApiFix&#8221;), certain controlling shareholders of ApiFix, and the sellers&#8217; representative named therein (Incorporated by reference to Exhibit 2.1 of registrant's Form 8-K filed on April 1, 2020) (SEC File No. 001-38242)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex3-1.htm">3.1</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex3-1.htm">Amended and Restated Certificate of Incorporation of OrthoPediatrics Corp. (Incorporated by reference to Exhibit 3.1 of registrant's Form 8-K filed on October 16, 2017) (SEC File No. 001-38242)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex3-2.htm">3.2</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex3-2.htm">Amended and Restated Bylaws of OrthoPediatrics Corp. (Incorporated by reference to Exhibit 3.2 of registrant's Form 8-K filed on October 16, 2017) (SEC File No. 001-38242)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000157104917008060/t1702546_ex4-1.htm">4.1</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000157104917008060/t1702546_ex4-1.htm">Specimen stock certificate evidencing the shares of common stock (Incorporated by reference to Exhibit 4.1 of registrant's Amendment No. 3 to Form S-1 filed on October 2, 2017) (SEC File No. 333-212076)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420416108591/v441750_ex4-2.htm">4.2</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420416108591/v441750_ex4-2.htm">Registration Rights Agreement, by and between the registrant and Squadron, dated as of May 30, 2014 (Incorporated by reference to Exhibit 4.2 of registrant's Form S-1 filed on June 16, 2016) (SEC File No. 333-212076)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex10-2.htm">4.3</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex10-2.htm">First Amendment to Registration Rights Agreement, by and between the registrant and Squadron, dated October 16, 2017 (Incorporated by reference to Exhibit 10.2 of registrant's Form 8-K filed on October 16, 2017) (SEC File No. 001-38242)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex10-1.htm">4.4</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420417052654/tv477015_ex10-1.htm">Stockholders Agreement, by and between the registrant and Squadron, dated October 16, 2017 (Incorporated by reference to Exhibit 10.1 of registrant's Form 8-K filed on October 16, 2017) (SEC File No. 001-38242)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000142545018000008/fourthamendedandrestatedlo.htm">10.1</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000142545018000008/fourthamendedandrestatedlo.htm">Fourth Amended and Restated Loan Agreement, by and among the registrant, its subsidiaries and Squadron, dated as of December 31, 2017 (Incorporated by reference to Exhibit 10.1 of registrant's Form 8-K filed on January 8, 2018) (SEC File No. 001-38242)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420419029810/tv523066_ex10-2.htm">10</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420419029810/tv523066_ex10-2.htm">.2</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1425450/000114420419029810/tv523066_ex10-2.htm">First Amendment to the Fourth Amended and Restated Loan Agreement, dated as of June 4, 2019, by and among OrthoPediatrics Corp., its subsidiaries named therein and Squadron Capital LLC (Incorporated by reference to Exhibit 10.2 of registrant's Form 8-K filed on June 5, 2019) (SEC File No. 001-38242)</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="kids10-qex103xsecondam.htm">10.3</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="kids10-qex103xsecondam.htm">Second Amendment to the Fourth Amended and Restated Loan Agreement, dated as of August 4, 2020, by and among OrthoPediatrics Corp., its subsidiaries named therein and Squadron Capital LLC</a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="kids10-qex104xfirstame.htm">10.4</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="kids10-qex104xfirstame.htm">First Amended and Restated Revolving Note, dated August 4, 2020, made payable, jointly and severally, by OrthoPediatrics Corp. and each of its subsidiaries party thereto</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit311-ceocertific.htm">31.1</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit311-ceocertific.htm">Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit312-cfocertific.htm">31.2</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit312-cfocertific.htm">Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit321-ceocertific.htm">32.1</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">++</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit321-ceocertific.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit322-cfocertific.htm">32.2</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">++</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="exhibit322-cfocertific.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.INS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Instance Document (The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.SCH</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.CAL</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.DEF</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.LAB</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.PRE</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">+</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101)</span></td></tr></table></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%;">*</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:144%;">     </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:144%;">The schedules to the Share Purchase Agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish a copy of any schedule omitted from the Purchase Agreement to the SEC upon request.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">+ Filed herewith.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">++ Furnished herewith. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">45</span></div></div></div><div id="i38c4d288f2604685a8c81d4642167bbd_142"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:22pt;text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:174%;">SIGNATURES</span></div><div style="text-indent:24pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%;"><tr><td style="width:1.0%;"></td><td style="width:45.690%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.470%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:45.840%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:39pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:39pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:39pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">ORTHOPEDIATRICS CORP.</span></div></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">August 6, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">By:</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Mark C. Throdahl</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Mark C. Throdahl</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Chief Executive Officer</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:45.767%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.613%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:45.620%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:39pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="height:39pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">August 6, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ David S. Bailey</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">David S. Bailey<br/>President</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:45.767%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.464%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:45.769%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:39pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="6" style="height:39pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">August 6, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">By:</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">/s/ Fred L. Hite</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Fred L. Hite</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Chief Financial Officer and Chief Operating Officer</span></div></td></tr></table></div><div><span><br/></span></div><div style="position:relative;width:100%;height:54pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">46</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>kids10-qex103xsecondam.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ide7b2926ae854298b8ddd63ec208d732_1"></div><div style="min-height:72pt;width:100%;"><div style="text-align:right;"><font><br></font></div></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">SECOND AMENDMENT TO </font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">FOURTH AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This SECOND AMENDMENT TO FOURTH AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Amendment</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;) is entered into as of August 4, 2020, by and among Squadron Capital LLC, a Delaware limited liability company (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Lender</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics Corp., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics US Distribution Corp., a Delaware corporation, (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics US Distribution</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics EU Limited, a company incorporated and registered in England and Wales (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics EU</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics Aus Pty Ltd., a company organized under the laws of Australia (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics Aus</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics NZ Ltd., a company organized under the laws of New Zealand (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics NZ</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;) and Orthex, LLC, a Florida limited liability company (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Orthex</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and together with OrthoPediatics, OrthoPediatrics US Distribution, OrthoPediatrics EU, OrthoPediatrics Aus and OrthoPediatrics NZ, &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and individually a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Borrower</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;).</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">RECITALS&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">A.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.31pt;">Lender made loans and certain other financial accommodations to Borrowers as evidenced by that certain Fourth Amended and Restated Loan and Security Agreement dated as of December 31, 2017, among Borrowers and Lender (as amended, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Existing</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Loan and Security Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;).</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">B.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.92pt;">Borrowers and Lender hereby agree to amend the Existing Loan and Security Agreement as described in this Amendment.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">NOW, THEREFORE, in consideration of the foregoing Recitals, which are hereby incorporated into this Amendment and made a part hereof, and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">a.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:28.37pt;">Incorporation of Recitals</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  Borrowers and Lender hereby agree that all of the Recitals in this Amendment are hereby incorporated into and made a part hereof.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">b.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:27.75pt;">Capitalized Terms</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  Except as otherwise defined in this Amendment, each capitalized term used herein shall have the same meaning as that assigned to it in the Existing Loan and Security Agreement, and such definitions shall be incorporated herein by reference, as if fully set forth herein.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">c.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:28.37pt;">Amendments to Existing Loan and Security Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  </font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:30.2pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">i.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Section 1.1</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> of the Existing Loan and Security Agreement is hereby amended by amending and restating the following definition&#58;</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Maturity Date</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;&#58;  The earlier to occur (unless sooner terminated by acceleration or otherwise) of&#58;</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(a) &#160;there occurs any transaction or series of transactions pursuant to which any Person(s) in the aggregate acquire(s) (x) capital stock of OrthoPediatrics possessing the voting power to elect a majority of OrthoPediatrics&#8217; Board of Directors (whether by merger, consolidation, reorganization, combination, sale or transfer of OrthoPediatrics&#8217; </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:justify;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">capital stock) or (y) all or substantially all of OrthoPediatrics&#8217; assets determined on a consolidated basis&#59; and </font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(b) &#160;January 1, 2024.</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Revolving Loan Commitment</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;&#58;  $25,000,000.</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:27.15pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">ii.A new </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Section 3.7</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> is hereby added to the Existing Loan and Security Agreement in its entirety as follows&#58;</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">3.7.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Unused Commitment Fee</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  For the period from and including the date hereof to but not including the Maturity Date, the Borrowers shall pay to the Lender an unused fee equal to the rate per annum of 0.50% (computed on the basis of a year of 360&#160;days and the actual number of days elapsed) times the daily unused portion of the Revolving Loan Commitment.&#160; Such unused fee shall be payable quarterly</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;"> </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">in arrears on March 31, June 30, September 30 and December 31 of each year (commencing on the first such date occurring after the date hereof) and on the Maturity Date.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:24.1pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">iii.A new </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Section 3.8</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> is hereby added to the Existing Loan and Security Agreement in its entirety as follows&#58;</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">3.8.&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">LIBOR Replacement Terms</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  Notwithstanding anything herein to the contrary, in the event Lender determines (i) LIBOR is permanently or indefinitely unavailable or unascertainable, or ceases to be published by the LIBOR administrator or its successor, (ii) LIBOR is determined to be no longer representative by the regulatory supervisor of the administrator of LIBOR, (iii) LIBOR can no longer be lawfully relied upon in contracts of this nature, or (iv) LIBOR does not reflect Lender&#8217;s cost of making or maintaining the type of loans or advances under this Agreement, then, at the election of Lender, all references to the Applicable Rate herein will instead be to a replacement rate determined by Lender in its sole judgment, including any adjustment to the replacement rate to reflect a different credit spread, term or other mathematical adjustment deemed necessary by Lender in its sole judgment (including the implementation of any rate floor).  Lender will provide reasonable notice to Borrowers of such replacement rate and the date on which it will become effective. </font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">In deciding upon a replacement rate, Lender shall give due consideration to (a) any selection or recommendation of a replacement rate or the mechanism for determining such a rate by the Relevant Governmental Body or (b) any evolving or then-prevailing market convention for determining a rate of interest as a replacement to LIBOR for U.S. dollar-denominated credit facilities.  &#8220;Relevant Governmental Body&#8221; means the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York.</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:24.7pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">iv.The Existing Loan and Security Agreement is hereby amended by amending and restating </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit C</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> in its entirety with </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit C</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> attached hereto.</font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">d.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:27.75pt;">Representations, Warranties and Covenants</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  Each Borrower hereby represents, warrants and covenants to Lender as follows&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A.&#160;no Unmatured Default or Event of Default has occurred and is continuing under the Existing Loan and Security Agreement or any other Loan Document&#59;</font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">B.&#160;the representations and warranties of such Borrower in the Existing Loan and Security Agreement and each other Loan Document are true and correct in all material respects as of the date hereof as though each of said representations and warranties was made on the date hereof (except, in each case for representations and warranties which by their terms are expressly applicable to an earlier date, in which case, such representations and warranties shall be true and correct in all material respects as of such earlier date)&#59; and</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">C.&#160;this Amendment has been duly authorized, executed and delivered on behalf of such Borrower and this Amendment constitutes the legal, valid and binding obligation of such Borrower, enforceable in accordance with its terms except as enforceability may be limited by applicable bankruptcy, insolvency or laws affecting creditor's rights generally and by general principles of equity.</font></div><div style="text-indent:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">e.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:28.37pt;">Joinder to Existing Loan and Security Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:66.2pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">i.Effective as of the date of this Amendment, each of OP EU B.V., a company organized under the laws of the Netherlands (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP EU Netherlands</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OP Netherlands B.V., a company organized under the laws of the Netherlands (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP Netherlands</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), Telos Partners, LLC, a Colorado limited liability company (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Telos</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), ApiFix Ltd., a company organized under the laws of Israel (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ApiFix Israel</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;) and ApiFix, Inc., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ApiFix</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and together with OP EU Netherlands, OP Netherlands, Telos and ApiFix Israel, each a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Joining Party</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and collectively, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Joining Parties</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;) hereby acknowledges that it has received and reviewed a copy of the Existing Loan and Security Agreement, and acknowledges and hereby&#58;</font></div><div style="text-indent:36pt;padding-left:108pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(1)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;">joins in the execution of, and becomes a party to, the Existing Loan and Security Agreement as a Borrower thereunder, as indicated by its signature below&#59;</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(2)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;">agrees to be bound by all representations, warranties, covenants, agreements, liabilities and acknowledgements of a Borrower under the Existing Loan and Security Agreement with the same force and effect as if it was an original signatory to the Existing Loan and Security Agreement&#59;</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(3)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;">assumes all rights and interests and agrees to perform all applicable duties and Obligations of a Borrower under the Existing Loan and Security Agreement&#59;</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(4)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;">as collateral security for the prompt and complete payment and performance when due (whether at stated maturity, by acceleration or otherwise) of the Obligations of Borrowers and the Joining Parties, each Joining Party (other than OP Netherlands, OP EU Netherlands and ApiFix Israel) grants to Lender a lien on and security interest in, all of such Joining Party&#8217;s right, title and interest in, to and under the personal Property of such Joining Party and expressly assumes all obligations and liability of a debtor thereunder&#59; and</font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(5)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;">adds the information in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit A</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> attached hereto to the Schedules to the Existing Loan and Security Agreement. </font></div><div style="text-indent:36pt;padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:27.15pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">ii.Each Joining Party hereby makes the representations and warranties set forth in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Section 5</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> of the Existing Loan and Security Agreement as of the date hereof and confirms that such representations and warranties are true and correct.</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:24.1pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">iii.Each Joining Party covenants and agrees to be bound by and to comply with the affirmative and negative covenants set forth in </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Sections 6</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> and </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">7</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> of the Existing Loan and Security Agreement as if such Joining Party was an original party to the Existing Loan and Security Agreement.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">f.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:29.59pt;">Post-Closing Obligations</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  </font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:25.7pt;padding-left:40.5pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">i.Within sixty (60) days following the date hereof, as collateral security for the prompt and complete payment and performance when due (whether at stated maturity, by acceleration or otherwise) of the Obligations of Borrowers and the Joining Parties, each of OP Netherlands and OP EU Netherlands agree to grant to Lender a security interest in, all of OP Netherlands&#8217; and OP EU Netherlands&#8217; right, title and interest in, to and under the personal Property of such party and expressly assumes all obligations and liability of a debtor thereunder.</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:22.65pt;padding-left:40.5pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">ii.Within sixty (60) days following the date hereof, each Joining Party shall enter into, execute and deliver to Lender a Grant of Patent Security Agreement covering United States patents filed by such Joining Party and a Grant of Trademark Security Agreement covering United States trademarks filed by such Joining Party, as applicable. </font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:19.6pt;padding-left:40.5pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">iii.Within sixty (60) days following the date hereof, each of OrthoPediatrics and the Joining Parties agree to file with the United States Patent and Trademark Office, Intellectual Property filings for the Intellectual Property listed on </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit B</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> attached hereto. </font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">g.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:27.75pt;">Conditions Precedent</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  The obligation of Lender to enter into this Amendment is subject to the following conditions precedent&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:66.2pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">i.Borrowers shall have entered into, executed and delivered to Lender&#58;</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(1)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;">this Amendment&#59; and</font></div><div style="padding-left:108pt;text-align:justify;"><font><br></font></div><div style="text-indent:108pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(2)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt;">the First Amended and Restated Revolving Note (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">A&#38;R Note</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:63.15pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">ii.For filing by Lender immediately following the date hereof, Telos, ApiFix and Lender shall have an agreed upon form of (i) a Uniform Commercial Code financing statement naming Telos as debtor and Lender as secured party, for filing with the Secretary of State of the State of Colorado and (ii) a Uniform Commercial Code financing statement naming ApiFix as debtor and Lender as secured party, for filing with the Secretary of State of the State of Delaware, each which creates in favor of Lender a legal, valid and enforceable first priority (except for Permitted Liens entitled to priority under Law) security interest in and Lien upon such party&#8217;s Collateral.</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-indent:60.1pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">iii.Lender shall have received a certificate from the Secretary of Borrowers and the Joining Parties, or any equivalent in the respective jurisdictions, (i) attesting to the resolutions of the Board of Directors authorizing its execution, delivery and performance of this Amendment and the A&#38;R Note (ii) authorizing specific officers of Borrowers and Joining Parties, or any equivalent in the respective jurisdictions, to execute this Amendment and the A&#38;R Note and (iii) attesting to the incumbency, where this is appropriate, and signature of specific officers of Borrowers and Joining Parties.</font></div><div style="padding-left:72pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">g.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:27.75pt;">Waiver of Claims</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  Each Borrower hereby acknowledges, agrees and affirms that it currently possesses no claims, defenses, offsets, recoupment or counterclaims of any kind or nature against or with respect to the enforcement of the Existing Loan and Security Agreement or any other Loan Document or any amendments thereto (collectively, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Claims</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), nor does any Borrower now have knowledge of any facts that would or might give rise to any Claims.  If facts now exist which would or could give rise to any Claim against or with respect to the enforcement of the Existing Loan and Security Agreement or any other Loan Document, as amended hereby, each Borrower hereby unconditionally, irrevocably and unequivocally waives to the extent permitted by applicable law and fully releases any and all such Claims as if such Claims were the subject of a lawsuit (other than the defense of payment in full), adjudicated to final judgment from which no appeal could be taken and therein dismissed with prejudice.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">h.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:27.75pt;">Ratification of Existing Loan and Security Documents</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  From and after the date hereof, the Existing Loan and Security Agreement and the other Loan Documents shall be deemed to be amended and modified as provided herein, and, except as so amended and modified, the Existing Loan and Security Agreement and the other Loan Documents shall continue in full force and effect and the Existing Loan and Security Agreement and the applicable provisions of this Amendment shall be read, taken and construed as one and the same instrument.  Each Borrower hereby remakes, ratifies and reaffirms all of its Obligations under the terms of the Existing Loan and Security Agreement and the other Loan Documents and any other document to which it is a party evidencing, creating or securing the Loans, as of the date hereof after giving effect to the amendments contained herein including, without limitation, the granting of a security interest thereunder.  On and after the date hereof, the term &#8220;Loan and Security Agreement&#8221; used in any document evidencing the Loan shall mean the Existing Loan and Security Agreement as amended hereby.  Except as expressly set forth in this Amendment, nothing in this Amendment shall constitute a waiver or relinquishment of (a) any Unmatured Default or Event of Default under any of the Loan Documents, (b) any of the agreements, terms or conditions contained in any of the Loan Documents, (c) any rights or remedies of Lender with respect to the Loan Documents, or (d) the rights of Lender to collect the full amounts owing to them under the Loan Documents.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">i.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:30.2pt;">Consents</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  Each Borrower hereby represents that this Amendment does not violate any provision of any instrument, document, contract or agreement to which such party is a party, or each Borrower hereby represents that it has obtained all requisite consents under those third party instruments prior to entering into this Amendment.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">j.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:30.2pt;">Further Assurances</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  The parties hereto, shall, at any time and from time to time, following the execution of this Amendment, execute and deliver all such further instruments and take all such further action as may be reasonably necessary or appropriate in order to carry out the provisions of this Amendment.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">k.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:27.75pt;">Counterparts</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  This Amendment may be executed in any number of counterparts, and by the different parties hereto and thereto on the same or separate counterparts, each of which, when so </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">executed and delivered, shall be deemed to be an original&#59; all the counterparts for this Amendment shall together constitute one and the same agreement.  Delivery of a counterpart to this Amendment by facsimile or electronic transmission shall constitute delivery of an original counterpart hereto.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">l.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:30.2pt;">Representation by Counsel</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  Each Borrower hereby represents that it has been represented by competent counsel of its choice in the negotiation and execution of this Amendment&#59; that it has read and fully understands the terms hereof, that such party and its counsel have been afforded an opportunity to review, negotiate and modify the terms of this Amendment, and that it intends to be bound hereby.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">m.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:24.7pt;">No Third Party Beneficiaries</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  The terms and provisions of this Amendment shall be for the sole benefit of the parties hereto and their respective successors and assigns&#59; no other person, firm, entity or corporation shall have any right, benefit or interest under this Amendment.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">n.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:27.75pt;">Governing Law</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  The provision of </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Section 11.15</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> of the Existing Loan and Security Agreement is hereby incorporated herein by reference.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:40.5pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">o.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;padding-left:23.25pt;">WAIVER OF TRIAL BY JURY</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">.  TO THE EXTENT PERMITTED BY LAW, BORROWERS AND LENDER HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE THE RIGHT TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AMENDMENT OR THE OTHER LOAN DOCUMENTS OR ANY COURSE OF CONDUCT, COURSE OF DEALINGS, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF EITHER PARTY IN CONNECTION HEREWITH.  EACH BORROWER HEREBY EXPRESSLY ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR LENDER TO ENTER INTO THIS AMENDMENT.&#160;</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;">THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK.</font></div><div style="text-align:center;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">6</font></div><div><font><br></font></div></div></div><div id="ide7b2926ae854298b8ddd63ec208d732_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">IN WITNESS WHEREOF, the parties hereto have executed this Second Amendment to Fourth Amended and Restated Loan and Security Agreement dated as of the date first written above.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%;"><tr><td style="width:1.0%;"></td><td style="width:42.771%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:53.229%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">BORROWERS&#58;</font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS CORP.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Mark Throdahl&#160;</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark Throdahl</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Executive Officer</font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS US DISTRIBUTION CORP.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Mark Throdahl&#160;</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark Throdahl</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">President &#38; Chief Executive Officer</font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS EU LIMITED</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS AUS PTY LTD</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS NZ LTD</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHEX, LLC</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Manager</font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Second Amendment to Fourth Amended and Restated</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Loan and Security Agreement</font></div></div></div><div id="ide7b2926ae854298b8ddd63ec208d732_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:right;"><font><br></font></div></div><div style="text-align:justify;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%;"><tr><td style="width:1.0%;"></td><td style="width:42.934%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:53.066%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP EU B.V.</font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP NETHERLANDS B.V.</font></div><div><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">TELOS PARTNERS, LLC</font></div><div style="padding-left:3.75pt;"><font><br></font></div><div><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">APIFIX LTD.</font></div><div><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">APIFIX, INC.</font></div><div><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;"><font><br></font></div><div style="padding-left:3.75pt;"><font><br></font></div></td></tr></table></div><div style="text-indent:-18pt;padding-left:234pt;margin-bottom:12pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:justify;"><font><br></font></div></div></div><div id="ide7b2926ae854298b8ddd63ec208d732_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:right;"><font><br></font></div></div><div style="text-indent:-18pt;padding-left:234pt;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">LENDER&#58;</font></div><div style="text-indent:-18pt;padding-left:234pt;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">SQUADRON CAPITAL LLC</font></div><div style="text-indent:-18pt;padding-left:234pt;margin-bottom:12pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:234pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; David Pelizzon&#160;</font></div><div style="padding-left:216pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;David Pelizzon</font></div><div style="padding-left:216pt;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;President</font></div><div style="margin-bottom:12pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:justify;"><font><br></font></div></div></div><div id="ide7b2926ae854298b8ddd63ec208d732_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit A</font></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">ADDENDUM TO SCHEDULES</font></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#91;Omitted&#93;</font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div><div id="ide7b2926ae854298b8ddd63ec208d732_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:right;"><font><br></font></div></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit B</font></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">INTELLECTUAL PROPERTY FILINGS</font></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#91;Omitted&#93;</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:justify;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit C</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Notice of Borrowing</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Reference is made to that certain Fourth Amended and Restated Loan and Security Agreement, dated as of December 31, 2017 (as amended, supplemented, modified or restated from time to time, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Fourth Amended and Restated Loan and Security Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), by and among Squadron Capital LLC (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Lender</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), and OrthoPediatrics Corp., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics US Distribution Corp., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics US</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics EU Limited, a company incorporated and registered in England and Wales (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics EU</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics Aus Pty Ltd., a company organized under the laws of Australia (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics Aus</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics NZ Ltd., a company organized under the laws of New Zealand (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics NZ</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), Orthex, LLC, a Florida limited liability company (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Orthex</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OP EU B.V., a company organized under the laws of the Netherlands (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OP EU Netherlands</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OP Netherlands B.V., a company organized under the laws of the Netherlands (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OP Netherlands</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), Telos Partners, LLC, a Colorado limited liability company (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Telos</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), ApiFix Ltd., a company organized under the laws of Israel (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">ApiFix Israel</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;) and ApiFix, Inc., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">ApiFix</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and together with OrthoPediatrics, OrthoPediatrics US, OrthoPediatrics EU, OrthoPediatrics AZ, OrthoPediatrics NZ, Orthex, OP EU Netherlands, OP Netherlands, Telos and ApiFix Israel, &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and individually a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Borrower</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;).  All capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Fourth Amended and Restated Loan and Security Agreement.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Pursuant to Section 2.2(b) of the Fourth Amended and Restated Loan and Security Agreement, Borrowers request that Lender make a $___________ Revolving Loan to Borrowers in accordance with the applicable terms and conditions of the Fourth Amended and Restated Loan and Security Agreement on _______________ (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Borrowing Date</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;)&#58;</font></div><div style="text-align:justify;"><font><br></font></div><div style="margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Each Borrower hereby certifies to Lender that as of the Borrowing Date&#58;</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(i)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt;">after making the Revolving Loan requested on the Borrowing Date, the amount of the Revolving Loan outstanding will not exceed $25,000,000&#59; </font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(ii)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt;">each of the representations and warranties contained in the Fourth Amended and Restated Loan and Security Agreement, the Loan Documents or in any document or instrument delivered pursuant to or in connection with the Fourth Amended and Restated Loan and Security Agreement are true in all material respects as of the date as of which they were made and will be true and deemed remade as such at and as of the time of the making of the Revolving Loan  requested hereby, except to the extent such representations and warranties relate expressly to an earlier date, in which case such representations and warranties are true, correct and complete on and as of such earlier date&#59; </font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(iii)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt;">no Event of Default will have occurred and be continuing&#59; and</font></div><div style="text-indent:36pt;padding-left:36pt;text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">(iv)</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt;">there has been no event or condition which has had or would reasonably be expected to have a Material Adverse Effect.</font></div><div style="text-align:center;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#91;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;">Signature pages follow</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#93;</font></div><div style="text-align:center;margin-bottom:12pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div><div style="text-align:right;"><font><br></font></div></div></div><div id="ide7b2926ae854298b8ddd63ec208d732_19"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="text-align:justify;margin-bottom:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">DATED&#58;  __________________</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics Corp.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics US Distribution Corp.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics EU Limited</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics AUS Pty Ltd</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OrthoPediatrics NZ Ltd</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="margin-bottom:12pt;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Orthex, LLC</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div style="text-align:justify;"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="margin-bottom:12pt;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP EU B.V.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP Netherlands B.V.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">Telos Partners, LLC</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ApiFix Ltd.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ApiFix, Inc.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font><br></font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Name&#58;&#160;</font></div><div style="padding-left:216pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Title&#58;&#160;</font></div><div style="text-align:center;margin-bottom:12pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div><div style="text-align:right;"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>kids10-qex104xfirstame.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i73835f79332f4235a2f5cb6ff0bcc734_1"></div><div style="min-height:72pt;width:100%;"><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">EXECUTION VERSION</font></div></div><div style="text-align:center;margin-bottom:24pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">FIRST AMENDED AND RESTATED REVOLVING NOTE</font></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">$25,000,000&#160;August 4, 2020</font></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">FOR VALUE RECEIVED, the undersigned, OrthoPediatrics Corp., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics US Distribution Corp., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics US</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics EU Limited, a company incorporated and registered in England and Wales (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics EU</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics Aus Pty Ltd., a company organized under the laws of Australia (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics Aus</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OrthoPediatrics NZ Ltd., a company organized under the laws of New Zealand (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OrthoPediatrics NZ</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), Orthex, LLC, a Florida limited liability company (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Orthex</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OP EU B.V., a company organized under the laws of the Netherlands (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OP EU Netherlands</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), OP Netherlands B.V., a company organized under the laws of the Netherlands (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">OP Netherlands</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), Telos Partners, LLC, a Colorado limited liability company (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Telos</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), ApiFix Ltd., a company organized under the laws of Israel (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">ApiFix Israel</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;) and ApiFix, Inc., a Delaware corporation (&#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">ApiFix</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and together with OrthoPediatrics, OrthoPediatrics US, OrthoPediatrics EU, OrthoPediatrics Aus, OrthoPediatrics NZ, Orthex, OP EU Netherlands, OP Netherlands, Telos and ApiFix Israel, &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Borrowers</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221; and individually a &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Borrower</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), jointly and severally promise to pay to the order of Squadron Capital LLC, a Delaware limited liability company (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Lender</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;), at the place and times provided in the Fourth Amended and Restated Loan and Security Agreement referred to below, the lesser of (i) the principal amount of $25,000,000 or (ii) the principal amount of the Revolving Loan outstanding and owing to the Lender, together with all the accrued and unpaid interest under this First Amended and Restated Revolving Note pursuant to that certain Fourth Amended and Restated Loan and Security Agreement, dated as of December 31, 2017 (as amended, supplemented, modified or restated from time to time, the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Fourth Amended and Restated Loan Agreement</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;) by and among Borrowers and Lender.  Capitalized terms used herein and not defined herein shall have the meanings assigned thereto in the Fourth Amended and Restated Loan Agreement.  </font></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">The unpaid principal amount of this First Amended and Restated Revolving Note from time to time outstanding is subject to mandatory repayment as provided in the Fourth Amended and Restated Loan Agreement and shall bear interest as provided in Section 3.1(b) of the Fourth Amended and Restated Loan Agreement.  This First Amended and Restated Revolving Note may be voluntarily prepaid from time to time as provided in the Fourth Amended and Restated Loan Agreement and any principal amounts repaid may be borrowed, repaid (without premium or penalty) and reborrowed again, from time to time in whole or in part.  All payments of principal and interest on this First Amended and Restated Revolving Note shall be payable in lawful currency of the United States of America in immediately available funds to such account as the Lender shall specify from time to time by notice to the Borrowers.  The principal and all accrued and unpaid interest under this First Amended and Restated Revolving Note shall be due and payable on the Maturity Date.</font></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">This First Amended and Restated Revolving Note is entitled to the benefits of, and evidences Obligations incurred under, the Fourth Amended and Restated Loan Agreement, to which reference is made for a description of the security for this First Amended and Restated Revolving Note and for a statement of the terms and conditions on which Borrowers are permitted and required to make prepayments and repayments of principal of the Obligations evidenced by this First Amended and Restated Revolving Note and on which such Obligations may be declared to be immediately due and payable.</font></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">THIS FIRST AMENDED AND RESTATED REVOLVING NOTE SHALL BE GOVERNED, CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE </font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%;"> US_ACTIVE-154260557.4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">STATE OF ILLINOIS, WITHOUT REFERENCE TO THE CONFLICTS OR CHOICE OF LAW PRINCIPLES THEREOF.</font></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Each Borrower hereby waives all requirements as to diligence, presentment, demand of payment, protest and (except as required by the Fourth Amended and Restated Loan Agreement) notice of any kind with respect to this First Amended and Restated Revolving Note.</font></div><div style="text-align:justify;margin-bottom:12pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">This First Amended and Restated Revolving Note constitutes a renewal and restatement of, and replacement and substitution for, that certain Revolving Note dated as of December 31, 2017 in the principal amount of $15,000,000 executed by the Borrowers and made payable to the order of Lender (the &#8220;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">Prior Note</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#8221;). The indebtedness evidenced by the Prior Note is continuing indebtedness evidenced hereby, and nothing herein shall be deemed to constitute a payment, settlement or novation of the Prior Note, or to release or otherwise adversely affect any lien, or any equivalent in the respective jurisdictions, mortgage or security interest securing such indebtedness or any rights of Lender against any guarantor, surety or other party primarily or secondarily liable for such indebtedness.</font></div><div style="text-align:center;margin-bottom:24pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;">* * Signature Page to Follow * *</font></div><div style="text-align:center;margin-bottom:24pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font><br></font></div><div><font><br></font></div></div></div><div id="i73835f79332f4235a2f5cb6ff0bcc734_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:36pt;text-align:justify;margin-bottom:24pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">IN WITNESS WHEREOF, each of the undersigned has executed this First Amended and Restated Revolving Note as of the day and year first written above.</font></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%;"><tr><td style="width:1.0%;"></td><td style="width:42.771%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:53.229%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">BORROWERS&#58;</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS CORP.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Mark Throdahl&#160;</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark Throdahl</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Executive Officer</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS US DISTRIBUTION CORP.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Mark Throdahl&#160;</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark Throdahl</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">President &#38; Chief Executive Officer</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS EU LIMITED</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS AUS PTY LTD</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHOPEDIATRICS NZ LTD</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">ORTHEX, LLC</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> </font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Fred Hite&#160;</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fred Hite</font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Manager</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Signature Page &#8211; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">First </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amended and Restated Revolving Note</font></div><div><font><br></font></div></div></div><div id="i73835f79332f4235a2f5cb6ff0bcc734_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%;"><div><font><br></font></div></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%;"><tr><td style="width:1.0%;"></td><td style="width:42.771%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:53.229%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP EU B.V.</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">OP NETHERLANDS B.V.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">TELOS PARTNERS, LLC</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">APIFIX LTD.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;">APIFIX, INC.</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">By&#58;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration: underline;">  &#47;s&#47; Daniel Gerritzen&#160;</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Daniel Gerritzen</font></div><div style="text-indent:27.15pt;padding-left:3.75pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">Authorized Representative</font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div><div style="padding-left:3.75pt;text-align:justify;"><font><br></font></div></td></tr></table></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Signature Page &#8211; </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;">First </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amended and Restated Revolving Note</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit311-ceocertific.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i796686e9e11f40608b18d56d3850cb23_1"></div><div style="min-height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:center;-sec-extract:summary;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">CERTIFICATION PURSUANT TO RULE 13a-14(a)&#47;15d-14(a) </font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">OF THE SECURITIES EXCHANGE ACT OF 1934, </font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">I, Mark C. Throdahl, certify that&#58; </font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">I have reviewed this Quarterly Report on Form 10-Q of OrthoPediatrics Corp.&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">3.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">4.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">a.&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">b.&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">c.&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">d.&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">5.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">a.&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="padding-left:72pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">b.&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  </font></div><div style="padding-left:36pt;"><font><br></font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-align:right;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:44.230%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;">&#47;s&#47; Mark C. Throdahl</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Mark C. Throdahl</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">(Principal Executive Officer)</font></div></td></tr></table></div><div style="padding-left:36pt;"><font><br></font></div><div style="margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">Date&#58; &#160;August 6, 2020</font></div><div style="margin-bottom:8pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>exhibit312-cfocertific.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="id98858a72e76432fa5d19fad02c3376b_1"></div><div style="min-height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:center;-sec-extract:summary;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">CERTIFICATION PURSUANT TO RULE 13a-14(a)&#47;15d-14(a) </font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">OF THE SECURITIES EXCHANGE ACT OF 1934, </font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">I, Fred L. Hite, certify that&#58; </font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">I have reviewed this Quarterly Report on Form 10-Q of OrthoPediatrics Corp.&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">3.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">4.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">a.&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">b.&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles&#59;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">c.&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">d.&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">5.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">a.&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="padding-left:72pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:72pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">b.&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  </font></div><div style="padding-left:36pt;"><font><br></font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-align:right;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:44.230%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;">&#47;s&#47; Fred L. Hite</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Fred L. Hite</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer and Chief Operating Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">(Principal Financial Officer)</font></div></td></tr></table></div><div style="padding-left:36pt;"><font><br></font></div><div style="margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">Date&#58; &#160;August 6, 2020</font></div><div style="margin-bottom:8pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>exhibit321-ceocertific.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i74ae9897c16a42419febfe9af5482fd3_1"></div><div style="min-height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:center;-sec-extract:summary;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">In connection with the Quarterly Report on Form 10-Q of OrthoPediatrics Corp. (the &#8220;Company&#8221;) for the quarterly period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, Mark C. Throdahl, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge&#58;</font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">the information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">This certificate is being furnished solely for purposes of Section 906 and is not being filed as part of the Report. </font></div><div><font><br></font></div><div style="text-align:right;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:44.230%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;">&#47;s&#47; Mark C. Throdahl</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Mark C. Throdahl</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">(Principal Executive Officer)</font></div></td></tr></table></div><div style="padding-left:36pt;"><font><br></font></div><div style="margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">Date&#58; &#160;August 6, 2020</font></div><div style="margin-bottom:8pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>exhibit322-cfocertific.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i93991b099660458e99844dd54f342e1a_1"></div><div style="min-height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-align:center;-sec-extract:summary;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">In connection with the Quarterly Report on Form 10-Q of OrthoPediatrics Corp. (the &#8220;Company&#8221;) for the period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, Fred L. Hite, Chief Financial Officer and Chief Operating Officer of the Company, hereby certifies, pursuant to 18 Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge&#58;</font></div><div><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">1.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;"><font><br></font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">2.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;padding-left:11.34pt;">the information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">This certificate is being furnished solely for purposes of Section 906 and is not being filed as part of the Report. </font></div><div style="padding-left:36pt;text-align:right;"><font><br></font></div><div style="text-align:right;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:44.230%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%;">&#47;s&#47; Fred L. Hite</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Fred L. Hite</font></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer and Chief Operating Officer</font></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">(Principal Financial Officer)</font></div></td></tr></table></div><div style="padding-left:36pt;"><font><br></font></div><div style="margin-bottom:8pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:130%;">Date&#58; &#160;August 6, 2020</font></div><div style="margin-bottom:8pt;"><font><br></font></div><div style="position:relative;width:100%;height:72pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>kids-20200630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:6cad6b03-419c-4f54-8eef-33f01636649a,g:8b88b676-dabc-417a-b49f-ad3a7a6b9677-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:kids="http://www.orthopediatrics.com/20200630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.orthopediatrics.com/20200630">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kids-20200630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kids-20200630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kids-20200630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kids-20200630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.orthopediatrics.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESS" roleURI="http://www.orthopediatrics.com/role/BUSINESS">
        <link:definition>2101101 - Disclosure - BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSDetails">
        <link:definition>2402401 - Disclosure - BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails" roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails">
        <link:definition>2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Assets Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails" roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails">
        <link:definition>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Amortization Intangible Assets, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails" roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails">
        <link:definition>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATION" roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATION">
        <link:definition>2110103 - Disclosure - BUSINESS COMBINATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONTables" roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables">
        <link:definition>2311302 - Disclosure - BUSINESS COMBINATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONApiFixDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails">
        <link:definition>2412406 - Disclosure - BUSINESS COMBINATION - ApiFix (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails">
        <link:definition>2413407 - Disclosure - BUSINESS COMBINATION - Summary of the Present Value of Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONTelosDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails">
        <link:definition>2414408 - Disclosure - BUSINESS COMBINATION - Telos (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONVilexandOrthexDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails">
        <link:definition>2415409 - Disclosure - BUSINESS COMBINATION - Vilex and Orthex (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2116104 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2317303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>2418410 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails" roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails">
        <link:definition>2419411 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Changes in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails" roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails">
        <link:definition>2420412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Amortizable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISCONTINUEDOPERATIONS" roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS">
        <link:definition>2121105 - Disclosure - DISCONTINUED OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISCONTINUEDOPERATIONSTables" roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables">
        <link:definition>2322304 - Disclosure - DISCONTINUED OPERATIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISCONTINUEDOPERATIONSDetails" roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails">
        <link:definition>2423413 - Disclosure - DISCONTINUED OPERATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDCREDITARRANGEMENTS" roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS">
        <link:definition>2124106 - Disclosure - DEBT AND CREDIT ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDCREDITARRANGEMENTSTables" roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables">
        <link:definition>2325305 - Disclosure - DEBT AND CREDIT ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails" roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails">
        <link:definition>2426414 - Disclosure - DEBT AND CREDIT ARRANGEMENTS - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1" roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1">
        <link:definition>2426414 - Disclosure - DEBT AND CREDIT ARRANGEMENTS - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTANDCREDITARRANGEMENTSNarrativeDetails" roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails">
        <link:definition>2427415 - Disclosure - DEBT AND CREDIT ARRANGEMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STRATEGICARRANGEMENTS" roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS">
        <link:definition>2128107 - Disclosure - STRATEGIC ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STRATEGICARRANGEMENTSDetails" roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails">
        <link:definition>2429416 - Disclosure - STRATEGIC ARRANGEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.orthopediatrics.com/role/INCOMETAXES">
        <link:definition>2130108 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.orthopediatrics.com/role/INCOMETAXESDetails">
        <link:definition>2431417 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2132109 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2333306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYStockOptionsDetails" roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails">
        <link:definition>2434418 - Disclosure - STOCKHOLDERS' EQUITY - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYRestrictedStockDetails" roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails">
        <link:definition>2435419 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYWarrantsDetails" roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails">
        <link:definition>2436420 - Disclosure - STOCKHOLDERS' EQUITY - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARE" roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARE">
        <link:definition>2137110 - Disclosure - NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARETables" roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARETables">
        <link:definition>2338307 - Disclosure - NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>2439421 - Disclosure - NET LOSS PER SHARE - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREAntidilutiveSecuritiesDetails" roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails">
        <link:definition>2440422 - Disclosure - NET LOSS PER SHARE - Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENT" roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENT">
        <link:definition>2141111 - Disclosure - BUSINESS SEGMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTTables" roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables">
        <link:definition>2342308 - Disclosure - BUSINESS SEGMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTNarrativeDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails">
        <link:definition>2443423 - Disclosure - BUSINESS SEGMENT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails">
        <link:definition>2444424 - Disclosure - BUSINESS SEGMENT - Schedule of Revenue by Geographical Location (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails" roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails">
        <link:definition>2445425 - Disclosure - BUSINESS SEGMENT - Schedule of Revenue by Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONS" roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS">
        <link:definition>2146112 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSDetails" roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails">
        <link:definition>2447426 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLAN" roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN">
        <link:definition>2148113 - Disclosure - EMPLOYEE BENEFIT PLAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANNarrativeDetails" roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails">
        <link:definition>2449427 - Disclosure - EMPLOYEE BENEFIT PLAN - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2150114 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2451428 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS">
        <link:definition>2152115 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>2453429 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" abstract="false" name="BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationAnniversaryPayments" abstract="false" name="BusinessCombinationContingentConsiderationAnniversaryPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_ClassOfWarrantOrRightOutstandingRollForward" abstract="true" name="ClassOfWarrantOrRightOutstandingRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationRevenuePayment" abstract="false" name="BusinessCombinationContingentConsiderationRevenuePayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_OrthexMember" abstract="true" name="OrthexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" abstract="false" name="OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_SalesAndMarketingExpensePolicyPolicyTextBlock" abstract="false" name="SalesAndMarketingExpensePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" abstract="false" name="EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="kids_FirstAmendedLoanAgreementMember" abstract="true" name="FirstAmendedLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_TransferOfPropertyAndEquipmentToInventory" abstract="false" name="TransferOfPropertyAndEquipmentToInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_VilexAndOrthexMember" abstract="true" name="VilexAndOrthexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_BandLokMember" abstract="true" name="BandLokMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_ClassOfWarrantOrRightExercised" abstract="false" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="kids_SampleInventoryMember" abstract="true" name="SampleInventoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_ClassOfWarrantOrRightTerm" abstract="false" name="ClassOfWarrantOrRightTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kids_TermNoteAMember" abstract="true" name="TermNoteAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_VilexMember" abstract="true" name="VilexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationRevenueMultiplier" abstract="false" name="BusinessCombinationContingentConsiderationRevenueMultiplier" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="kids_SecondAnniversaryMember" abstract="true" name="SecondAnniversaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_LoanAgreementMember" abstract="true" name="LoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_SecondAmendedLoanAgreementMember" abstract="true" name="SecondAmendedLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_CaseWesternReserveUniversityMember" abstract="true" name="CaseWesternReserveUniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" abstract="false" name="OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_A2007EquityIncentivePlanMember" abstract="true" name="A2007EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_SpineMember" abstract="true" name="SpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_FourthAnniversaryMember" abstract="true" name="FourthAnniversaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_RevolvingLoanMember" abstract="true" name="RevolvingLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationSystemSalesPayment" abstract="false" name="BusinessCombinationContingentConsiderationSystemSalesPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_GoodwillMeasurementPeriodAdjustment" abstract="false" name="GoodwillMeasurementPeriodAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_BusinessCombinationEscrowDeposit" abstract="false" name="BusinessCombinationEscrowDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_ThirdAnniversaryMember" abstract="true" name="ThirdAnniversaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_TermNoteBMember" abstract="true" name="TermNoteBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_IntangibleAssetsAcquired" abstract="false" name="IntangibleAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" abstract="false" name="BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" abstract="false" name="CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="kids_NumberOfRelatedPartyEntitiesSuppliers" abstract="false" name="NumberOfRelatedPartyEntitiesSuppliers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="kids_BusinessAcquisitionAnniversaryAxis" abstract="true" name="BusinessAcquisitionAnniversaryAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="kids_BusinessAcquisitionAnniversaryDomain" abstract="true" name="BusinessAcquisitionAnniversaryDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_BusinessCombinationEscrowDepositMaximumTerm" abstract="false" name="BusinessCombinationEscrowDepositMaximumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kids_FollowOnOfferingMember" abstract="true" name="FollowOnOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_FMIHansaMedicalProductsMember" abstract="true" name="FMIHansaMedicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_TraumaAndDeformityMember" abstract="true" name="TraumaAndDeformityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_TelosPartnersLLCMember" abstract="true" name="TelosPartnersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_SquadronMember" abstract="true" name="SquadronMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" abstract="false" name="OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" abstract="false" name="ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_LongTermDebtCurrentMaturitiesRelatedParty" abstract="false" name="LongTermDebtCurrentMaturitiesRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment" abstract="false" name="AssetsNoncurrentExcludingPropertyPlantAndEquipment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kids_New2017EquityIncentivePlanMember" abstract="true" name="New2017EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_SportsMedicineandOtherMember" abstract="true" name="SportsMedicineandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_ApiFixLtdMember" abstract="true" name="ApiFixLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>kids-20200630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:6cad6b03-419c-4f54-8eef-33f01636649a,g:8b88b676-dabc-417a-b49f-ad3a7a6b9677-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/Cover" xlink:type="simple" xlink:href="kids-20200630.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_49adae00-7300-45e7-8f41-885f54452672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4c7c2b93-0208-4125-8abc-aeabf6315abf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49adae00-7300-45e7-8f41-885f54452672" xlink:to="loc_us-gaap_AssetsCurrent_4c7c2b93-0208-4125-8abc-aeabf6315abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_eb3e0cbf-7f94-4635-a5c9-223976c875d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49adae00-7300-45e7-8f41-885f54452672" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_eb3e0cbf-7f94-4635-a5c9-223976c875d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_ac082ee4-0b3f-4ec4-bf00-c571815cd83c" xlink:href="kids-20200630.xsd#kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49adae00-7300-45e7-8f41-885f54452672" xlink:to="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_ac082ee4-0b3f-4ec4-bf00-c571815cd83c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_63051b62-b028-47ff-9321-a68efb506ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fc1b443f-7ae2-4a70-b504-8ead35789fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_63051b62-b028-47ff-9321-a68efb506ec5" xlink:to="loc_us-gaap_CommonStockValue_fc1b443f-7ae2-4a70-b504-8ead35789fd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_73b2fdcc-f2e6-4a72-b37c-e48232630788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_63051b62-b028-47ff-9321-a68efb506ec5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_73b2fdcc-f2e6-4a72-b37c-e48232630788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aef75079-c882-4662-a19a-aec7c5dbd255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_63051b62-b028-47ff-9321-a68efb506ec5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aef75079-c882-4662-a19a-aec7c5dbd255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_46af0935-38a2-44d0-845b-9c0d50f43384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_63051b62-b028-47ff-9321-a68efb506ec5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_46af0935-38a2-44d0-845b-9c0d50f43384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2831b0ca-7e8b-4298-b2db-2a4138a8d54b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_63051b62-b028-47ff-9321-a68efb506ec5" xlink:to="loc_us-gaap_TreasuryStockValue_2831b0ca-7e8b-4298-b2db-2a4138a8d54b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_8c8e22fd-d56d-4b9b-a1e6-7bbbdf19f52c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesAndLoans_c5bb9568-58de-452c-8472-efa5c9087217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesAndLoans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_8c8e22fd-d56d-4b9b-a1e6-7bbbdf19f52c" xlink:to="loc_us-gaap_LongTermNotesAndLoans_c5bb9568-58de-452c-8472-efa5c9087217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_88b3a353-412b-4643-be91-185a8fc05c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_8c8e22fd-d56d-4b9b-a1e6-7bbbdf19f52c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_88b3a353-412b-4643-be91-185a8fc05c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8c255ef9-2db8-43db-9c30-c2307ac6cf89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_8c8e22fd-d56d-4b9b-a1e6-7bbbdf19f52c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8c255ef9-2db8-43db-9c30-c2307ac6cf89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_ce3fc42b-8855-4802-aeb5-500fb6b78820" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_8c8e22fd-d56d-4b9b-a1e6-7bbbdf19f52c" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_ce3fc42b-8855-4802-aeb5-500fb6b78820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_562768ce-1069-48d8-b136-07eae6e9ae36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2f3f5b64-363f-4f4f-9b93-752bcf61585a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_562768ce-1069-48d8-b136-07eae6e9ae36" xlink:to="loc_us-gaap_AccountsPayableCurrent_2f3f5b64-363f-4f4f-9b93-752bcf61585a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_87cca334-200f-4a3e-a698-52adb8cdce4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_562768ce-1069-48d8-b136-07eae6e9ae36" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_87cca334-200f-4a3e-a698-52adb8cdce4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_LongTermDebtCurrentMaturitiesRelatedParty_4c63cebe-42ad-4f87-a422-0cf8f97b4fb5" xlink:href="kids-20200630.xsd#kids_LongTermDebtCurrentMaturitiesRelatedParty"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_562768ce-1069-48d8-b136-07eae6e9ae36" xlink:to="loc_kids_LongTermDebtCurrentMaturitiesRelatedParty_4c63cebe-42ad-4f87-a422-0cf8f97b4fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_745f30a1-1653-47e9-859f-1d6dd9e14ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_562768ce-1069-48d8-b136-07eae6e9ae36" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_745f30a1-1653-47e9-859f-1d6dd9e14ec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_677aafd5-6e8d-4bdf-8b16-21f24c192f0d" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_562768ce-1069-48d8-b136-07eae6e9ae36" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_677aafd5-6e8d-4bdf-8b16-21f24c192f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_27cd5a29-0366-4c4d-a9f3-d63e90ae55f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0e7880b9-a9d4-482c-b8ec-41789828deab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_27cd5a29-0366-4c4d-a9f3-d63e90ae55f5" xlink:to="loc_us-gaap_Liabilities_0e7880b9-a9d4-482c-b8ec-41789828deab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e0e20b6c-1de7-4e0a-a5f4-7df71e74fc0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_27cd5a29-0366-4c4d-a9f3-d63e90ae55f5" xlink:to="loc_us-gaap_StockholdersEquity_e0e20b6c-1de7-4e0a-a5f4-7df71e74fc0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_837e2fb5-97cf-44ad-97d9-afa818c388fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_a27e96d7-eb8b-4922-940b-392eaf658f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_837e2fb5-97cf-44ad-97d9-afa818c388fe" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_a27e96d7-eb8b-4922-940b-392eaf658f2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f655f1dc-634a-479f-bb29-487654acd64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_837e2fb5-97cf-44ad-97d9-afa818c388fe" xlink:to="loc_us-gaap_InventoryNet_f655f1dc-634a-479f-bb29-487654acd64c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_81d07556-4ec1-4822-ac9e-f61fe1680e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_837e2fb5-97cf-44ad-97d9-afa818c388fe" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_81d07556-4ec1-4822-ac9e-f61fe1680e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c1154016-57c6-4211-afbd-c3c38a2d6ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_837e2fb5-97cf-44ad-97d9-afa818c388fe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c1154016-57c6-4211-afbd-c3c38a2d6ab2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_800b3df1-7407-4793-9c0a-f23bab041958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_837e2fb5-97cf-44ad-97d9-afa818c388fe" xlink:to="loc_us-gaap_RestrictedCashCurrent_800b3df1-7407-4793-9c0a-f23bab041958" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3528639f-b703-422b-a5ba-75c0fdde15f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_837e2fb5-97cf-44ad-97d9-afa818c388fe" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3528639f-b703-422b-a5ba-75c0fdde15f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_92675ce8-1a6b-4432-afcf-a5cf61cc81fd" xlink:href="kids-20200630.xsd#kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b8b50b62-5940-41e2-b1e9-0a8ba57f22c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_92675ce8-1a6b-4432-afcf-a5cf61cc81fd" xlink:to="loc_us-gaap_Goodwill_b8b50b62-5940-41e2-b1e9-0a8ba57f22c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b81947d9-59ba-42a4-bd89-91483fe14fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_92675ce8-1a6b-4432-afcf-a5cf61cc81fd" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b81947d9-59ba-42a4-bd89-91483fe14fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_66346b85-67ef-4a9f-b7f5-fd75da838c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_92675ce8-1a6b-4432-afcf-a5cf61cc81fd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_66346b85-67ef-4a9f-b7f5-fd75da838c38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8af72673-85bd-4043-8653-6bf43df9fe5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_cbf67bc6-50f4-4103-a5cc-961d5592bee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8af72673-85bd-4043-8653-6bf43df9fe5e" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_cbf67bc6-50f4-4103-a5cc-961d5592bee3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cef9c7ab-86bb-471c-99be-21ff6ea4cf08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8af72673-85bd-4043-8653-6bf43df9fe5e" xlink:to="loc_us-gaap_LiabilitiesCurrent_cef9c7ab-86bb-471c-99be-21ff6ea4cf08" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d18ec183-2b1d-42b4-aad9-b55e5aa8df4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_d51aa9f1-2bed-4702-828c-2e55933d7373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d18ec183-2b1d-42b4-aad9-b55e5aa8df4a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_d51aa9f1-2bed-4702-828c-2e55933d7373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_3ea1f832-1d1c-4843-a7ad-570216b87a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d18ec183-2b1d-42b4-aad9-b55e5aa8df4a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_3ea1f832-1d1c-4843-a7ad-570216b87a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_24917e6e-675d-43e9-9951-9b0fcb76558e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4cd95d68-ee69-4445-a457-331410ca6638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_24917e6e-675d-43e9-9951-9b0fcb76558e" xlink:to="loc_us-gaap_GrossProfit_4cd95d68-ee69-4445-a457-331410ca6638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_36ee21bf-5cad-44ed-91a5-8a802271657d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_24917e6e-675d-43e9-9951-9b0fcb76558e" xlink:to="loc_us-gaap_OperatingExpenses_36ee21bf-5cad-44ed-91a5-8a802271657d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7beb4af6-5370-4654-b89f-73010383cf69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_f456b257-a30c-4ff4-ae39-7190028f002e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7beb4af6-5370-4654-b89f-73010383cf69" xlink:to="loc_us-gaap_SellingAndMarketingExpense_f456b257-a30c-4ff4-ae39-7190028f002e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ae1ee481-7ccf-484a-b83b-229fdedcd42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7beb4af6-5370-4654-b89f-73010383cf69" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ae1ee481-7ccf-484a-b83b-229fdedcd42c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_48cf65bd-cb39-4e25-9301-a401572ecee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7beb4af6-5370-4654-b89f-73010383cf69" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_48cf65bd-cb39-4e25-9301-a401572ecee2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8ade5012-9072-47fd-baff-788839804fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95025446-1b76-4d77-9505-f17c7d8eb36c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_8ade5012-9072-47fd-baff-788839804fc6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95025446-1b76-4d77-9505-f17c7d8eb36c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_203c9930-912d-4daa-9e26-c854694b9a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_8ade5012-9072-47fd-baff-788839804fc6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_203c9930-912d-4daa-9e26-c854694b9a90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_39aedf0a-5d0d-44fa-81ef-ae8df07ba1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_de9f58ec-0316-4182-a148-95c8c63f2f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_39aedf0a-5d0d-44fa-81ef-ae8df07ba1f0" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_de9f58ec-0316-4182-a148-95c8c63f2f48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b7b8a287-d70d-4cde-8c35-37589d7e5c5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_39aedf0a-5d0d-44fa-81ef-ae8df07ba1f0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b7b8a287-d70d-4cde-8c35-37589d7e5c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_225fa5bd-53cd-4d39-9efb-ad0c8747d14e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_39aedf0a-5d0d-44fa-81ef-ae8df07ba1f0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_225fa5bd-53cd-4d39-9efb-ad0c8747d14e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_5d0a0485-56cd-4a21-8365-141e65498e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ce9390b2-74a5-4e66-90b7-de10d64edbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_5d0a0485-56cd-4a21-8365-141e65498e2b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ce9390b2-74a5-4e66-90b7-de10d64edbc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d3f103f3-4208-4520-b1b3-84cbb27e0339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_5d0a0485-56cd-4a21-8365-141e65498e2b" xlink:to="loc_us-gaap_OperatingIncomeLoss_d3f103f3-4208-4520-b1b3-84cbb27e0339" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f0b597b-84c5-41b4-b705-7805e9f7b24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0c10fdea-b5b3-4bb9-84b3-03a692923e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f0b597b-84c5-41b4-b705-7805e9f7b24c" xlink:to="loc_us-gaap_NetIncomeLoss_0c10fdea-b5b3-4bb9-84b3-03a692923e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_63647824-6bb5-4466-a64d-12be75379257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f0b597b-84c5-41b4-b705-7805e9f7b24c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_63647824-6bb5-4466-a64d-12be75379257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_391016ea-1365-44dd-89c0-3e10a77561fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8071f14f-987c-46bc-8dbe-cc12b2b2c80d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_391016ea-1365-44dd-89c0-3e10a77561fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8071f14f-987c-46bc-8dbe-cc12b2b2c80d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1f653af3-db18-4403-8fa1-601ae2b3052d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9fc3ea7f-a316-4b2b-9f93-17582f166b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1f653af3-db18-4403-8fa1-601ae2b3052d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9fc3ea7f-a316-4b2b-9f93-17582f166b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a7df7065-111a-461e-bfbe-09f46a73169b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1f653af3-db18-4403-8fa1-601ae2b3052d" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_a7df7065-111a-461e-bfbe-09f46a73169b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_585e2d63-1da5-4001-86f6-4653367d1a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_1f653af3-db18-4403-8fa1-601ae2b3052d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_585e2d63-1da5-4001-86f6-4653367d1a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7328a775-5be9-4ad8-955f-785993be6a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_64139b9e-5203-4e83-9a1d-acd5fdac80e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7328a775-5be9-4ad8-955f-785993be6a7e" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_64139b9e-5203-4e83-9a1d-acd5fdac80e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_31f27896-f687-4331-91d9-cecfab95a9bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7328a775-5be9-4ad8-955f-785993be6a7e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_31f27896-f687-4331-91d9-cecfab95a9bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_658a1ede-a46a-473c-90e6-5052cb8ac69f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_658a1ede-a46a-473c-90e6-5052cb8ac69f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_411314d3-866c-4964-a5a2-0c4dd802c3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_411314d3-866c-4964-a5a2-0c4dd802c3f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_108143ec-f22c-4c6f-8e3b-884cd70146ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_108143ec-f22c-4c6f-8e3b-884cd70146ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a37d474f-5bd7-4b08-9f8e-7e727e7da939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a37d474f-5bd7-4b08-9f8e-7e727e7da939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f2d92491-f844-4441-8c7b-251d9ebb46d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f2d92491-f844-4441-8c7b-251d9ebb46d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cd4f41b9-e7d4-4bdf-8855-29b1960967ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_ShareBasedCompensation_cd4f41b9-e7d4-4bdf-8855-29b1960967ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b9fbff50-1dce-472a-96e7-9f9aceabc6e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_NetIncomeLoss_b9fbff50-1dce-472a-96e7-9f9aceabc6e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_38f69632-6762-4b19-9d49-3a49b349598f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_38f69632-6762-4b19-9d49-3a49b349598f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_268f216a-5745-4dc6-b30e-7455f03cc734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_268f216a-5745-4dc6-b30e-7455f03cc734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bec96862-11f5-4003-b612-4ace404b733d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bec96862-11f5-4003-b612-4ace404b733d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_e53a8b23-852e-4f43-9df0-5f63266e448a" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_1669ea73-d435-412b-8161-c9e3aff179a9" xlink:to="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_e53a8b23-852e-4f43-9df0-5f63266e448a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64637c48-30ee-45fc-b228-bebbe4ddee00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_7a174bc9-744f-4871-a0a0-4c5d208628e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64637c48-30ee-45fc-b228-bebbe4ddee00" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_7a174bc9-744f-4871-a0a0-4c5d208628e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_4980ff86-2fb0-43a5-ba1d-660fb948e7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64637c48-30ee-45fc-b228-bebbe4ddee00" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_4980ff86-2fb0-43a5-ba1d-660fb948e7fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6a9347d-0088-46aa-99c6-5478e48685a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a419c355-a3c0-4b91-b9b5-317264f5047e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6a9347d-0088-46aa-99c6-5478e48685a2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a419c355-a3c0-4b91-b9b5-317264f5047e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e62ad40f-5011-4f93-80f6-3d036a2bb599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6a9347d-0088-46aa-99c6-5478e48685a2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e62ad40f-5011-4f93-80f6-3d036a2bb599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_efabac15-a322-4685-8d6c-207185211bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6a9347d-0088-46aa-99c6-5478e48685a2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_efabac15-a322-4685-8d6c-207185211bb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7e62df85-b825-47d9-b114-063d31a0cfe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e6a9347d-0088-46aa-99c6-5478e48685a2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7e62df85-b825-47d9-b114-063d31a0cfe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_36bc4d20-38e0-4f7f-a7b9-5b60160355cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_57c331b0-005d-43a0-8fa3-4461c3ea6b8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_36bc4d20-38e0-4f7f-a7b9-5b60160355cb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_57c331b0-005d-43a0-8fa3-4461c3ea6b8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4da74584-f3c2-460e-a53e-91218d95d091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_36bc4d20-38e0-4f7f-a7b9-5b60160355cb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4da74584-f3c2-460e-a53e-91218d95d091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_acc1856c-f33a-4016-b156-ba932eb76836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1840e735-5163-4e48-a50b-118462238cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_acc1856c-f33a-4016-b156-ba932eb76836" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1840e735-5163-4e48-a50b-118462238cec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_8ad2eda3-ed21-489c-8542-327d1151ddd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_acc1856c-f33a-4016-b156-ba932eb76836" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_8ad2eda3-ed21-489c-8542-327d1151ddd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_9309d213-ed76-4b51-b7d3-831dbcda3744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_acc1856c-f33a-4016-b156-ba932eb76836" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_9309d213-ed76-4b51-b7d3-831dbcda3744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_de2830bf-60de-4504-8776-478cf51ea617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_acc1856c-f33a-4016-b156-ba932eb76836" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_de2830bf-60de-4504-8776-478cf51ea617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_db7b50d8-993e-450d-958b-3789e1e2b29a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_acc1856c-f33a-4016-b156-ba932eb76836" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_db7b50d8-993e-450d-958b-3789e1e2b29a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESS" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATION" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATION"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONTables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONApiFixDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eb21c0f0-5d24-4921-a0af-3f5ef556b155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0a483730-52b2-481d-bfdc-cbd20ef1c13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eb21c0f0-5d24-4921-a0af-3f5ef556b155" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0a483730-52b2-481d-bfdc-cbd20ef1c13f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_df960c34-ed73-4048-a683-df5a73d42ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_eb21c0f0-5d24-4921-a0af-3f5ef556b155" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_df960c34-ed73-4048-a683-df5a73d42ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ccd350b8-6848-45f6-a4dd-66935af0652d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_494bae8e-1c59-4b88-ae2d-44cf246051cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ccd350b8-6848-45f6-a4dd-66935af0652d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_494bae8e-1c59-4b88-ae2d-44cf246051cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_bde45195-fb6b-4d8c-8610-ff840355f93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ccd350b8-6848-45f6-a4dd-66935af0652d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_bde45195-fb6b-4d8c-8610-ff840355f93f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_af1e219b-8f1a-45ae-9c2c-959da871b754" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ccd350b8-6848-45f6-a4dd-66935af0652d" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_af1e219b-8f1a-45ae-9c2c-959da871b754" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3078a9b6-2d99-4fc1-aad0-c559da684c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ccd350b8-6848-45f6-a4dd-66935af0652d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3078a9b6-2d99-4fc1-aad0-c559da684c1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b2d43314-a014-4e37-90e5-b3d2a5987fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b2d43314-a014-4e37-90e5-b3d2a5987fae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9be8fd43-b95d-4862-bbe2-3031dc82fde9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9be8fd43-b95d-4862-bbe2-3031dc82fde9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_960d6b1a-a142-45e7-961c-775d899f3799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_960d6b1a-a142-45e7-961c-775d899f3799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_995475ec-a0d9-4d86-9538-560f832b2002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_995475ec-a0d9-4d86-9538-560f832b2002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0ae62458-ac1c-47d3-8f2c-55dff5be1672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0ae62458-ac1c-47d3-8f2c-55dff5be1672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_94a0e036-188b-468c-9e79-db37cf67098f" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_94a0e036-188b-468c-9e79-db37cf67098f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_613355d6-93b1-4fed-bbd8-6aec5401a709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_613355d6-93b1-4fed-bbd8-6aec5401a709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_8e45635d-0d36-4db3-96e8-3bd24e9c9a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_8e6ca7fb-e2ba-4bda-bc90-1a1549e60436" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_8e45635d-0d36-4db3-96e8-3bd24e9c9a67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired_c29feb3e-5677-4d8b-addd-52537ab716e2" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2cc206f0-d7d1-4005-bb3b-9b8841c92970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kids_IntangibleAssetsAcquired_c29feb3e-5677-4d8b-addd-52537ab716e2" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2cc206f0-d7d1-4005-bb3b-9b8841c92970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_8e5ee25a-632e-4ffe-8d04-0a9d69d17dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kids_IntangibleAssetsAcquired_c29feb3e-5677-4d8b-addd-52537ab716e2" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_8e5ee25a-632e-4ffe-8d04-0a9d69d17dbe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_77db5c29-51a1-475a-ba18-ee2fc48350d5" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_64e9b645-8539-468c-b076-5423bbc098cc" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_77db5c29-51a1-475a-ba18-ee2fc48350d5" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_64e9b645-8539-468c-b076-5423bbc098cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_15e9c678-7c7d-4ff2-84b9-afa8e8c0dacd" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_77db5c29-51a1-475a-ba18-ee2fc48350d5" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_15e9c678-7c7d-4ff2-84b9-afa8e8c0dacd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_619f693a-22a8-434b-bc28-3f7fb1b5d367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_398a81b4-e61a-4529-b5fd-dea45fc04b1d" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenuePayment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_619f693a-22a8-434b-bc28-3f7fb1b5d367" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_398a81b4-e61a-4529-b5fd-dea45fc04b1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_72a2b1e4-3ba4-4ac0-8281-bbd6fd5e324e" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_619f693a-22a8-434b-bc28-3f7fb1b5d367" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_72a2b1e4-3ba4-4ac0-8281-bbd6fd5e324e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONTelosDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONVilexandOrthexDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONSTables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_58a7e607-338b-401f-9093-9cb66490cd8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_429c1821-f9df-4bd6-9b1b-1a76aa63716e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_58a7e607-338b-401f-9093-9cb66490cd8c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_429c1821-f9df-4bd6-9b1b-1a76aa63716e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f7686c74-184d-4638-9627-7b48193bad97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_58a7e607-338b-401f-9093-9cb66490cd8c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f7686c74-184d-4638-9627-7b48193bad97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_848646c3-72be-4f1b-9e97-6d179a02076d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_58a7e607-338b-401f-9093-9cb66490cd8c" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_848646c3-72be-4f1b-9e97-6d179a02076d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_cd9159c7-3d19-435d-b5d5-b12dbdd4aa73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_356f3d30-e387-49bc-9349-b4ba2b38e61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_cd9159c7-3d19-435d-b5d5-b12dbdd4aa73" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_356f3d30-e387-49bc-9349-b4ba2b38e61b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSTables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_a2a614f6-477b-4d30-9263-b577123cb057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bc05cdeb-6b71-4ef1-b8d7-19dd24fbd81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_a2a614f6-477b-4d30-9263-b577123cb057" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bc05cdeb-6b71-4ef1-b8d7-19dd24fbd81b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_da8dcbad-dea4-4d5a-bfeb-9f787e505da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_a2a614f6-477b-4d30-9263-b577123cb057" xlink:to="loc_us-gaap_LongTermDebtCurrent_da8dcbad-dea4-4d5a-bfeb-9f787e505da9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_d90ff87f-ea57-45c6-8cfe-5ba40f59b98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a4bbe8b4-a487-445b-975c-97444f1a56b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_d90ff87f-ea57-45c6-8cfe-5ba40f59b98d" xlink:to="loc_us-gaap_LongTermDebt_a4bbe8b4-a487-445b-975c-97444f1a56b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_9b501a15-db45-418e-9682-87ed13284785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_d90ff87f-ea57-45c6-8cfe-5ba40f59b98d" xlink:to="loc_us-gaap_NotesPayable_9b501a15-db45-418e-9682-87ed13284785" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#STRATEGICARRANGEMENTS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STRATEGICARRANGEMENTSDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="kids-20200630.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#INCOMETAXESDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/INCOMETAXESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYStockOptionsDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYRestrictedStockDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYWarrantsDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARE" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHARE"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHARE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARETables" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHARETables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHARETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHAREAntidilutiveSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENT" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENT"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTTables"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN" xlink:type="simple" xlink:href="kids-20200630.xsd#EMPLOYEEBENEFITPLAN"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#EMPLOYEEBENEFITPLANNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="kids-20200630.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#SUBSEQUENTEVENTS"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:calculationLink xlink:role="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>kids-20200630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:6cad6b03-419c-4f54-8eef-33f01636649a,g:8b88b676-dabc-417a-b49f-ad3a7a6b9677-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/Cover" xlink:type="simple" xlink:href="kids-20200630.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/Cover" xlink:type="extended" id="i421f75e224c54aa5a4ece22cddbfb1ca_Cover"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i16620d618e9b4594baa63d3956c5f595_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i7b63ec2a7753463698628b3b549313ac_CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i6ff609dcad244df6b755fb4ab7b307a4_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended" id="if8f6e96d507b4f64b16ff852a43d7c23_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i2a64a0a997d84e1d910a17a8bb627808_CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_20fa1e0a-8f36-427c-a7d4-3e642c1e6bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_20fa1e0a-8f36-427c-a7d4-3e642c1e6bc7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_139c61d8-31cf-44a4-8905-5891253ff903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_139c61d8-31cf-44a4-8905-5891253ff903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0f6bf859-eec4-4bcc-b0f1-e5ee3cc14938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockholdersEquity_0f6bf859-eec4-4bcc-b0f1-e5ee3cc14938" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_27981797-2799-41ef-ac83-27508345f4e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockShares_27981797-2799-41ef-ac83-27508345f4e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_88404a5e-107f-4914-a202-d21a2a10ae0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockValue_88404a5e-107f-4914-a202-d21a2a10ae0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f348f13b-45c9-4393-a0ce-cf4c096c45e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_NetIncomeLoss_f348f13b-45c9-4393-a0ce-cf4c096c45e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb5fe456-729c-44b0-a86d-1c33aa1f0440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb5fe456-729c-44b0-a86d-1c33aa1f0440" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1f743722-e8e0-4556-a07d-fb90516dc606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1f743722-e8e0-4556-a07d-fb90516dc606" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_527d9fb3-9d27-4f6e-96b4-e65ba871fae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_527d9fb3-9d27-4f6e-96b4-e65ba871fae5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_aa4df5ec-c33c-47b9-8a52-d3355742d498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_aa4df5ec-c33c-47b9-8a52-d3355742d498" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fb6aa451-15d7-460e-b365-76bea0b4a901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fb6aa451-15d7-460e-b365-76bea0b4a901" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9fc4110e-5b72-44b2-9e01-db757bec4779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9fc4110e-5b72-44b2-9e01-db757bec4779" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2d66c532-0d3b-45ce-9ed9-073030fda1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2d66c532-0d3b-45ce-9ed9-073030fda1c3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83a2e6ac-a063-4d79-ab82-565f0d5f0fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83a2e6ac-a063-4d79-ab82-565f0d5f0fe3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ef7f65f3-fae2-4ede-9a50-c1fdbe68e55c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ef7f65f3-fae2-4ede-9a50-c1fdbe68e55c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_844a81e6-ece0-47c6-8a00-90c714d2c1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_844a81e6-ece0-47c6-8a00-90c714d2c1e8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_6d53b6ae-4400-4053-8abc-849d64c5cd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_6d53b6ae-4400-4053-8abc-849d64c5cd20" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc99058c-54b7-40f2-985e-5d3e053eab15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b0b2305-7c0b-4df0-aa48-dea6ecabbff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b261cfb6-b6ef-487d-9de0-ca150eaf1776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_20fa1e0a-8f36-427c-a7d4-3e642c1e6bc7" xlink:to="loc_us-gaap_StatementTable_b261cfb6-b6ef-487d-9de0-ca150eaf1776" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be60acc4-c150-45c2-9d32-b69e3795e0b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b261cfb6-b6ef-487d-9de0-ca150eaf1776" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be60acc4-c150-45c2-9d32-b69e3795e0b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be60acc4-c150-45c2-9d32-b69e3795e0b5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be60acc4-c150-45c2-9d32-b69e3795e0b5" xlink:to="loc_us-gaap_EquityComponentDomain_be60acc4-c150-45c2-9d32-b69e3795e0b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be60acc4-c150-45c2-9d32-b69e3795e0b5" xlink:to="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_559fcc9e-24ec-4dc0-93fd-a51ce6746283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_CommonStockMember_559fcc9e-24ec-4dc0-93fd-a51ce6746283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ca2469a6-69b3-40ae-96b2-5490d1f7587c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_TreasuryStockMember_ca2469a6-69b3-40ae-96b2-5490d1f7587c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f0f4f411-d847-400e-a411-a93d6e3057f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f0f4f411-d847-400e-a411-a93d6e3057f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0d7b5155-0ac5-447a-89f5-66cfae1281fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_RetainedEarningsMember_0d7b5155-0ac5-447a-89f5-66cfae1281fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_51b83933-eb22-4bb0-880c-a77c85db52c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_51b83933-eb22-4bb0-880c-a77c85db52c0" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="ic9ef79fa94164cf7b1d7239dee62a542_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8f86fd06-06b5-4875-a0b0-e7aa0561dfdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_NetIncomeLoss_8f86fd06-06b5-4875-a0b0-e7aa0561dfdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3557400b-62b9-4e58-8e92-3ab93635d5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3557400b-62b9-4e58-8e92-3ab93635d5ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_445c8561-df64-4d25-a7c8-2caeb01ac26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_ShareBasedCompensation_445c8561-df64-4d25-a7c8-2caeb01ac26b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_98b22964-e14e-4765-a8eb-76b10dd6521f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_98b22964-e14e-4765-a8eb-76b10dd6521f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_5e977d0e-cbb0-4d19-bdea-391d3e4d0d65" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_5e977d0e-cbb0-4d19-bdea-391d3e4d0d65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_fe6079ba-9e67-4da3-914d-7031bdac460b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_fe6079ba-9e67-4da3-914d-7031bdac460b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_53e86528-1927-4d0a-bdb7-e17372fcc702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_53e86528-1927-4d0a-bdb7-e17372fcc702" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d85fda5c-8627-495a-9378-a8ffa35d463c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d85fda5c-8627-495a-9378-a8ffa35d463c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_599eb6af-2f58-479f-83c4-c589f6ce7c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_599eb6af-2f58-479f-83c4-c589f6ce7c41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b06e6705-a410-4262-929f-3b75ef31fbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b06e6705-a410-4262-929f-3b75ef31fbfa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0cda0bc7-b52d-4e41-ae10-21939d3d5554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0cda0bc7-b52d-4e41-ae10-21939d3d5554" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ba3980ad-5996-4dac-bbbc-b37ca7b73977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ba3980ad-5996-4dac-bbbc-b37ca7b73977" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_d6a1ea08-2fce-40ec-98ea-11aca845b018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_d6a1ea08-2fce-40ec-98ea-11aca845b018" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814fd0b3-9d39-46d3-aab8-91b4a0e5d827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814fd0b3-9d39-46d3-aab8-91b4a0e5d827" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4581add2-9c35-42d4-a9cc-aa9b905e0cad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4581add2-9c35-42d4-a9cc-aa9b905e0cad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f029f6c7-e8fe-49fa-9646-8b3701b55b11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f029f6c7-e8fe-49fa-9646-8b3701b55b11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f5f10181-739d-4141-9d65-f67144bf6289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f5f10181-739d-4141-9d65-f67144bf6289" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_dd6c03a9-54b9-40f6-b40c-a81e9fa24b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_dd6c03a9-54b9-40f6-b40c-a81e9fa24b5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_ac81991f-49ba-4971-9c85-cefbd4c55672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_ac81991f-49ba-4971-9c85-cefbd4c55672" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a48181f3-c307-4726-acc6-2f8ecf77c37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a48181f3-c307-4726-acc6-2f8ecf77c37a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_775c1364-bd8c-4c4e-86fe-edc11f5616b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_775c1364-bd8c-4c4e-86fe-edc11f5616b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_162951ec-8cb0-4dae-ac9b-78225c84850c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_162951ec-8cb0-4dae-ac9b-78225c84850c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_81c36932-0795-46b3-97dc-c79f0e3a44d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_81c36932-0795-46b3-97dc-c79f0e3a44d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_fe40ed19-9f97-4fbc-bbe3-d236d74a773d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_fe40ed19-9f97-4fbc-bbe3-d236d74a773d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_2f305225-be6a-487a-b7f1-a564cb2e03b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_2f305225-be6a-487a-b7f1-a564cb2e03b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c8a2b2a-9b78-4eb3-9283-120e6fb36b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c8a2b2a-9b78-4eb3-9283-120e6fb36b13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8c277bad-6d88-4987-b3a1-5508a601fc9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8c277bad-6d88-4987-b3a1-5508a601fc9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_60dc440f-b2ff-47ac-8311-95b062847385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_60dc440f-b2ff-47ac-8311-95b062847385" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_93e99402-31dd-4548-8a2f-e8c4c726730e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_93e99402-31dd-4548-8a2f-e8c4c726730e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_06cf01c6-31d9-4c53-9a2d-3c0f6157ef39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_f24102e8-5baa-422c-afc3-14c6523d3449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_f24102e8-5baa-422c-afc3-14c6523d3449" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f535e545-6884-4aba-873b-f61413b60ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f535e545-6884-4aba-873b-f61413b60ad8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2cc1ffcb-3e56-4072-a8b8-705530f2f404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:to="loc_us-gaap_InterestPaidNet_2cc1ffcb-3e56-4072-a8b8-705530f2f404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TransferOfPropertyAndEquipmentToInventory_b98a32a3-7017-4024-a076-f093105ac16e" xlink:href="kids-20200630.xsd#kids_TransferOfPropertyAndEquipmentToInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:to="loc_kids_TransferOfPropertyAndEquipmentToInventory_b98a32a3-7017-4024-a076-f093105ac16e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_e545ea85-9224-4cb8-b52f-6425e0c275e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:to="loc_us-gaap_StockIssued1_e545ea85-9224-4cb8-b52f-6425e0c275e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59b3b4c7-df07-47db-a62f-8f0d5de7bcec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_StatementTable_59b3b4c7-df07-47db-a62f-8f0d5de7bcec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_56daa77c-a153-41f9-b598-ba4a661aaf59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_59b3b4c7-df07-47db-a62f-8f0d5de7bcec" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_56daa77c-a153-41f9-b598-ba4a661aaf59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56daa77c-a153-41f9-b598-ba4a661aaf59_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_56daa77c-a153-41f9-b598-ba4a661aaf59" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_56daa77c-a153-41f9-b598-ba4a661aaf59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_56daa77c-a153-41f9-b598-ba4a661aaf59" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_a614469b-e8bc-4883-9e72-e65a2994e4cb" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_TelosPartnersLLCMember_a614469b-e8bc-4883-9e72-e65a2994e4cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_6da42f73-ec42-41e7-b0e9-bfe87366e827" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_ApiFixLtdMember_6da42f73-ec42-41e7-b0e9-bfe87366e827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BandLokMember_ee1d3f40-382c-4c74-810c-c1d04b8e20d8" xlink:href="kids-20200630.xsd#kids_BandLokMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_BandLokMember_ee1d3f40-382c-4c74-810c-c1d04b8e20d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexAndOrthexMember_d43d4833-62e3-4c78-a478-6fd1db45d674" xlink:href="kids-20200630.xsd#kids_VilexAndOrthexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_VilexAndOrthexMember_d43d4833-62e3-4c78-a478-6fd1db45d674" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESS" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESS" xlink:type="extended" id="i987baf7f9f414ee7819ee0204cc73386_BUSINESS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSDetails" xlink:type="extended" id="i8ac18249b79a46119bb8eec6d6221b11_BUSINESSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7d19a6a3-d4aa-4760-982a-cac7d060f080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7d19a6a3-d4aa-4760-982a-cac7d060f080" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_e4bc14b9-380f-481d-a58d-017ad30813a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_e4bc14b9-380f-481d-a58d-017ad30813a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_5b929520-eda7-424f-88c1-80aa03524888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_5b929520-eda7-424f-88c1-80aa03524888" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_824157b2-9409-429d-839d-c47db9404319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_824157b2-9409-429d-839d-c47db9404319" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_27b48d20-db8d-4fbc-8376-dfb4e830bfad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_27b48d20-db8d-4fbc-8376-dfb4e830bfad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned_28c79d96-042d-418a-8102-7cbe47ec3c1a" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned_28c79d96-042d-418a-8102-7cbe47ec3c1a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_7be042d9-f205-4a7b-b98c-112094106acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_7be042d9-f205-4a7b-b98c-112094106acb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_80e801c1-0fc7-4835-a1a7-0326208388b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_80e801c1-0fc7-4835-a1a7-0326208388b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_321d4641-5526-48ef-82e9-1052d3f32d89" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_321d4641-5526-48ef-82e9-1052d3f32d89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_2d77a787-4246-4f10-898f-d3d968a9a7ec" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenueMultiplier"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_2d77a787-4246-4f10-898f-d3d968a9a7ec" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0ba76bca-b717-4e90-8546-b68cefcd8013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0ba76bca-b717-4e90-8546-b68cefcd8013" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ba76bca-b717-4e90-8546-b68cefcd8013_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0ba76bca-b717-4e90-8546-b68cefcd8013" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ba76bca-b717-4e90-8546-b68cefcd8013_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0ba76bca-b717-4e90-8546-b68cefcd8013" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexAndOrthexMember_7af31a86-4f0c-46ac-aef6-caad550f138e" xlink:href="kids-20200630.xsd#kids_VilexAndOrthexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_VilexAndOrthexMember_7af31a86-4f0c-46ac-aef6-caad550f138e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_1dea4de4-a7f6-45bd-b2f8-d158072e95c1" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_TelosPartnersLLCMember_1dea4de4-a7f6-45bd-b2f8-d158072e95c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_7e278d5b-17d0-4c27-a3ff-a5b16850c1d0" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_ApiFixLtdMember_7e278d5b-17d0-4c27-a3ff-a5b16850c1d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BandLokMember_f91e50b8-6e0b-4efe-81b9-9e3010468067" xlink:href="kids-20200630.xsd#kids_BandLokMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_BandLokMember_f91e50b8-6e0b-4efe-81b9-9e3010468067" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b750d33e-e724-465d-aa49-95e543e35e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b750d33e-e724-465d-aa49-95e543e35e10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_5ee31368-4b82-4e93-b25a-6011acaeb2b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b750d33e-e724-465d-aa49-95e543e35e10" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_5ee31368-4b82-4e93-b25a-6011acaeb2b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryAxis_51de1e4a-3c99-450d-80c2-8fde8a1d9b10" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:to="loc_kids_BusinessAcquisitionAnniversaryAxis_51de1e4a-3c99-450d-80c2-8fde8a1d9b10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_51de1e4a-3c99-450d-80c2-8fde8a1d9b10_default" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_51de1e4a-3c99-450d-80c2-8fde8a1d9b10" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_51de1e4a-3c99-450d-80c2-8fde8a1d9b10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_51de1e4a-3c99-450d-80c2-8fde8a1d9b10" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAnniversaryMember_184a3e17-e75f-4fb3-8b1f-f2433d9c60c3" xlink:href="kids-20200630.xsd#kids_SecondAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:to="loc_kids_SecondAnniversaryMember_184a3e17-e75f-4fb3-8b1f-f2433d9c60c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ThirdAnniversaryMember_4b512775-f44d-4003-a547-d82d8cf45168" xlink:href="kids-20200630.xsd#kids_ThirdAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:to="loc_kids_ThirdAnniversaryMember_4b512775-f44d-4003-a547-d82d8cf45168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FourthAnniversaryMember_cb6a5eca-216b-4339-8658-416105b531ab" xlink:href="kids-20200630.xsd#kids_FourthAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:to="loc_kids_FourthAnniversaryMember_cb6a5eca-216b-4339-8658-416105b531ab" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="icbd4284cfc7948ac8046b2fac23307be_SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="i26bce7946a8d4de3a3dfacf905506d55_SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended" id="id74783276a4b4e08bf8ca4af8c7859dc_SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="i334d9f34203a4d4ab62ee61afb1b2486_SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d4dd6a0b-774c-4d50-9ff6-e7d9613be0b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d4dd6a0b-774c-4d50-9ff6-e7d9613be0b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8cc56dc3-49a1-495e-b7fe-ba9fdf568c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8cc56dc3-49a1-495e-b7fe-ba9fdf568c1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_19df36c8-dc73-4c40-94c9-854ff809ae12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_19df36c8-dc73-4c40-94c9-854ff809ae12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_ae86ec8e-e1ee-42ed-90b0-9751a65cd4d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_ae86ec8e-e1ee-42ed-90b0-9751a65cd4d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6f58bddd-2b01-4ce4-acb1-cd88b9c42fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6f58bddd-2b01-4ce4-acb1-cd88b9c42fa7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_87736d68-7d08-4ac4-8acf-9277155d0fe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_87736d68-7d08-4ac4-8acf-9277155d0fe7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_e1b5dec2-9271-407d-a29c-ad1d573d1e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_e1b5dec2-9271-407d-a29c-ad1d573d1e18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_43a03b47-cc51-4771-bf83-2d078082daa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_43a03b47-cc51-4771-bf83-2d078082daa0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_624e0c9b-b3f7-4ec8-aca9-e40d492be207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_624e0c9b-b3f7-4ec8-aca9-e40d492be207" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3deb0934-672b-4ca7-995f-fa9a80c0292a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_SubsequentEventTable_3deb0934-672b-4ca7-995f-fa9a80c0292a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e9330ac-d379-4d76-933a-056abc0f8912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3deb0934-672b-4ca7-995f-fa9a80c0292a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e9330ac-d379-4d76-933a-056abc0f8912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e9330ac-d379-4d76-933a-056abc0f8912_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e9330ac-d379-4d76-933a-056abc0f8912" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6e9330ac-d379-4d76-933a-056abc0f8912_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b70b4f47-5fe9-426e-bd84-a793b473fad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e9330ac-d379-4d76-933a-056abc0f8912" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b70b4f47-5fe9-426e-bd84-a793b473fad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FollowOnOfferingMember_c4366953-9d03-4490-9442-b9d7a519b832" xlink:href="kids-20200630.xsd#kids_FollowOnOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b70b4f47-5fe9-426e-bd84-a793b473fad6" xlink:to="loc_kids_FollowOnOfferingMember_c4366953-9d03-4490-9442-b9d7a519b832" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails" xlink:type="extended" id="i29e9af0d844e4bc28782ab47a54f4420_SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_92b28820-3eec-49cd-900d-661d29669a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c151d979-b81a-43e2-b744-1a7c925ed262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_92b28820-3eec-49cd-900d-661d29669a41" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c151d979-b81a-43e2-b744-1a7c925ed262" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_92b28820-3eec-49cd-900d-661d29669a41" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a0112e7-b09b-4f6f-aac8-39ba52f92da5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a0112e7-b09b-4f6f-aac8-39ba52f92da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7a0112e7-b09b-4f6f-aac8-39ba52f92da5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a0112e7-b09b-4f6f-aac8-39ba52f92da5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7a0112e7-b09b-4f6f-aac8-39ba52f92da5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a0112e7-b09b-4f6f-aac8-39ba52f92da5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_803ec676-0a6a-4bab-b9b5-c2e075c335e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_803ec676-0a6a-4bab-b9b5-c2e075c335e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c470c915-0e80-42a0-813b-f594b53fd9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c470c915-0e80-42a0-813b-f594b53fd9d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_ef3912ec-d57f-47a4-bb1e-6293086be6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_ComputerEquipmentMember_ef3912ec-d57f-47a4-bb1e-6293086be6ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_91672796-e7b2-4c5f-b199-14721a81918f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_91672796-e7b2-4c5f-b199-14721a81918f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_3dd4c903-6301-4387-ac3a-5a5675f8d49b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_OfficeEquipmentMember_3dd4c903-6301-4387-ac3a-5a5675f8d49b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyEquipmentMember_e653f372-cf06-4347-b7e5-957091abe3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_TechnologyEquipmentMember_e653f372-cf06-4347-b7e5-957091abe3dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SampleInventoryMember_9756cdde-a46d-4169-859e-fc9c540351b4" xlink:href="kids-20200630.xsd#kids_SampleInventoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_kids_SampleInventoryMember_9756cdde-a46d-4169-859e-fc9c540351b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:to="loc_srt_RangeAxis_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff" xlink:to="loc_srt_RangeMember_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff" xlink:to="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_95e55aec-6a1c-419e-a4b4-1743f60d1b73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:to="loc_srt_MinimumMember_95e55aec-6a1c-419e-a4b4-1743f60d1b73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a946dcb5-8fac-4e94-8a46-487c566c85ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:to="loc_srt_MaximumMember_a946dcb5-8fac-4e94-8a46-487c566c85ac" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails" xlink:type="extended" id="ia7d2efd6c32349a582d73490fcf80eab_SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_31fa76e4-27bc-4701-ab9a-eadf370704de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7d38d6b3-2616-41d3-9fff-3f6a3247bf0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_31fa76e4-27bc-4701-ab9a-eadf370704de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7d38d6b3-2616-41d3-9fff-3f6a3247bf0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f4a9a416-f6e8-47ad-b423-a3c129834cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_31fa76e4-27bc-4701-ab9a-eadf370704de" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f4a9a416-f6e8-47ad-b423-a3c129834cc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b5bfef3-0474-44be-ae3c-913e91e948b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f4a9a416-f6e8-47ad-b423-a3c129834cc7" xlink:to="loc_srt_RangeAxis_0b5bfef3-0474-44be-ae3c-913e91e948b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0b5bfef3-0474-44be-ae3c-913e91e948b1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0b5bfef3-0474-44be-ae3c-913e91e948b1" xlink:to="loc_srt_RangeMember_0b5bfef3-0474-44be-ae3c-913e91e948b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0b5bfef3-0474-44be-ae3c-913e91e948b1" xlink:to="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6a13f284-19c8-41f2-a21f-14c662270c96" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:to="loc_srt_MinimumMember_6a13f284-19c8-41f2-a21f-14c662270c96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6fd146da-1020-46bc-ab31-b3b2c1a08ca9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:to="loc_srt_MaximumMember_6fd146da-1020-46bc-ab31-b3b2c1a08ca9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails" xlink:type="extended" id="icc02935e61014f32aec2bd18923a18ef_SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_00f92b26-8e85-425c-8631-bbf0ed071cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_00f92b26-8e85-425c-8631-bbf0ed071cb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3efabc85-69c6-4a8c-aff8-d8ef3e84f438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3efabc85-69c6-4a8c-aff8-d8ef3e84f438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a1f4f902-a73d-45a3-baad-a29ebcfd4b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a1f4f902-a73d-45a3-baad-a29ebcfd4b34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_eff660b2-2a9f-4567-a3d0-37974cc1a402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_us-gaap_PlanNameAxis_eff660b2-2a9f-4567-a3d0-37974cc1a402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_eff660b2-2a9f-4567-a3d0-37974cc1a402_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_eff660b2-2a9f-4567-a3d0-37974cc1a402" xlink:to="loc_us-gaap_PlanNameDomain_eff660b2-2a9f-4567-a3d0-37974cc1a402_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_eff660b2-2a9f-4567-a3d0-37974cc1a402" xlink:to="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_A2007EquityIncentivePlanMember_acd7235b-7be8-4b56-84c1-885a3807dc57" xlink:href="kids-20200630.xsd#kids_A2007EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:to="loc_kids_A2007EquityIncentivePlanMember_acd7235b-7be8-4b56-84c1-885a3807dc57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_New2017EquityIncentivePlanMember_762fa704-08a4-489d-a56c-36d10679a969" xlink:href="kids-20200630.xsd#kids_New2017EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:to="loc_kids_New2017EquityIncentivePlanMember_762fa704-08a4-489d-a56c-36d10679a969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_36a20350-d212-4811-9237-9a705b1fc5ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_us-gaap_AwardTypeAxis_36a20350-d212-4811-9237-9a705b1fc5ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_36a20350-d212-4811-9237-9a705b1fc5ab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_36a20350-d212-4811-9237-9a705b1fc5ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_36a20350-d212-4811-9237-9a705b1fc5ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_36a20350-d212-4811-9237-9a705b1fc5ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_59b96dfc-886e-4ab8-b282-16fa466e1018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:to="loc_us-gaap_EmployeeStockOptionMember_59b96dfc-886e-4ab8-b282-16fa466e1018" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_3d05339c-129a-4cb4-a12e-89d6f27e4500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:to="loc_us-gaap_RestrictedStockMember_3d05339c-129a-4cb4-a12e-89d6f27e4500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f29eb5c1-b284-4a3c-977e-40c50fa961e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_srt_RangeAxis_f29eb5c1-b284-4a3c-977e-40c50fa961e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f29eb5c1-b284-4a3c-977e-40c50fa961e5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f29eb5c1-b284-4a3c-977e-40c50fa961e5" xlink:to="loc_srt_RangeMember_f29eb5c1-b284-4a3c-977e-40c50fa961e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_83c65314-911c-4cf7-8832-501ec1a73bba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f29eb5c1-b284-4a3c-977e-40c50fa961e5" xlink:to="loc_srt_RangeMember_83c65314-911c-4cf7-8832-501ec1a73bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ffe4b6a-ce15-4144-90fd-51c99f7bc3c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_83c65314-911c-4cf7-8832-501ec1a73bba" xlink:to="loc_srt_MaximumMember_2ffe4b6a-ce15-4144-90fd-51c99f7bc3c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_d1df206c-6f1e-4e42-9fe4-65ec9eca8781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_us-gaap_VestingAxis_d1df206c-6f1e-4e42-9fe4-65ec9eca8781" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_d1df206c-6f1e-4e42-9fe4-65ec9eca8781_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_d1df206c-6f1e-4e42-9fe4-65ec9eca8781" xlink:to="loc_us-gaap_VestingDomain_d1df206c-6f1e-4e42-9fe4-65ec9eca8781_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_d1df206c-6f1e-4e42-9fe4-65ec9eca8781" xlink:to="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_18699e2c-2b5c-42a7-8ecd-e69f33454313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_18699e2c-2b5c-42a7-8ecd-e69f33454313" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_4ae64e47-2f47-4105-8de9-70096eaeb6c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_4ae64e47-2f47-4105-8de9-70096eaeb6c7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATION" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATION"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATION" xlink:type="extended" id="ia466271310d343c78311cebb13ec1428_BUSINESSCOMBINATION"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONTables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables" xlink:type="extended" id="i95a923b2d2ad45c9b728d5cfd0cc7dcf_BUSINESSCOMBINATIONTables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONApiFixDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails" xlink:type="extended" id="ib2eedf4167374259a2d5448d29b80d93_BUSINESSCOMBINATIONApiFixDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f2486215-9270-425b-84bb-22c539466a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f2486215-9270-425b-84bb-22c539466a52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_00905a5e-6e0a-428d-9673-24c32e2d6906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_00905a5e-6e0a-428d-9673-24c32e2d6906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3010d933-0654-4da0-b880-1e87fdacbecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3010d933-0654-4da0-b880-1e87fdacbecf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a3fadad3-348c-4256-ad8a-8ade915baa09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a3fadad3-348c-4256-ad8a-8ade915baa09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_939ad7dc-388e-485f-a07c-8a514bb09ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_939ad7dc-388e-485f-a07c-8a514bb09ab0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_b6550846-2348-4856-9f5d-bfb753c5e759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_b6550846-2348-4856-9f5d-bfb753c5e759" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAnniversaryPayments_588cf1b6-3c6f-48ef-ab68-b855530d5efa" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAnniversaryPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAnniversaryPayments_588cf1b6-3c6f-48ef-ab68-b855530d5efa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationSystemSalesPayment_5891716b-6164-4d74-9074-34500f1d8a32" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationSystemSalesPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationSystemSalesPayment_5891716b-6164-4d74-9074-34500f1d8a32" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5bff3703-1c5a-4318-88b2-3e25f4e8db5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5bff3703-1c5a-4318-88b2-3e25f4e8db5b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9133262f-f7ab-4393-b187-f72bfdf49344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9133262f-f7ab-4393-b187-f72bfdf49344" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4715d522-2845-4299-ab6b-a08ac2ba4e8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4715d522-2845-4299-ab6b-a08ac2ba4e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e3b41c6-5278-42ba-a68b-cf2c4d7d4c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e3b41c6-5278-42ba-a68b-cf2c4d7d4c2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b4c88a76-f646-4754-9159-16ce17b936a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b4c88a76-f646-4754-9159-16ce17b936a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fc922626-ed06-4602-b89d-b9987ad75035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fc922626-ed06-4602-b89d-b9987ad75035" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_78869f33-65d9-4e7c-9ef7-f36558dbd9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_78869f33-65d9-4e7c-9ef7-f36558dbd9c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5defd6c6-bdbd-4e81-81fe-6c40406dcd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5defd6c6-bdbd-4e81-81fe-6c40406dcd10" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_bdbe5f89-c903-4fb3-89b1-e34b70d7de1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_bdbe5f89-c903-4fb3-89b1-e34b70d7de1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_1e2cc403-6d0f-467b-a634-fec0a6b0c5e7" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_1e2cc403-6d0f-467b-a634-fec0a6b0c5e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02784a47-6234-4e6e-9930-b38f80b3738b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02784a47-6234-4e6e-9930-b38f80b3738b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_1b5341b4-94eb-4a15-92ec-5f7e857a4798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_1b5341b4-94eb-4a15-92ec-5f7e857a4798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_146c9d85-f440-4cf4-a222-b0ceb50ac464" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_146c9d85-f440-4cf4-a222-b0ceb50ac464" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a29056f4-8b12-486d-ba13-13fb8be307b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a29056f4-8b12-486d-ba13-13fb8be307b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_cd569da7-23e8-4edd-810d-29289960d3b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_cd569da7-23e8-4edd-810d-29289960d3b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5a2ecb2c-49cb-4a41-bc42-fc232b34507c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5a2ecb2c-49cb-4a41-bc42-fc232b34507c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2244780d-ee55-462b-a213-58acdc2d1cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2244780d-ee55-462b-a213-58acdc2d1cdd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fe1aa97f-82be-444c-821b-ffcdc8f52781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_Goodwill_fe1aa97f-82be-444c-821b-ffcdc8f52781" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_db1f4632-6b31-4ac8-87b6-a52945bcdbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_db1f4632-6b31-4ac8-87b6-a52945bcdbf3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b1867b4e-c2ac-4bcc-be29-208c483a0e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b1867b4e-c2ac-4bcc-be29-208c483a0e53" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired_3243b9a4-6005-4831-84ad-02fe08f1f531" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_IntangibleAssetsAcquired_3243b9a4-6005-4831-84ad-02fe08f1f531" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f14692b4-667d-46e2-9bc2-926ad216e1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f14692b4-667d-46e2-9bc2-926ad216e1a9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_74456195-e79f-4b2a-90c1-506bf12e6352" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenueMultiplier"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_74456195-e79f-4b2a-90c1-506bf12e6352" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_459c459a-837e-490b-94a8-f5840ac3fa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_459c459a-837e-490b-94a8-f5840ac3fa89" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8e40f9bb-8cff-4038-8c4f-a05895138f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8e40f9bb-8cff-4038-8c4f-a05895138f21" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_fa27cf39-6157-4119-b1d5-861f7fd2093e" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenuePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_fa27cf39-6157-4119-b1d5-861f7fd2093e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ca3bc4ef-6d4c-4f6a-a210-468cc357b76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_InterestExpense_ca3bc4ef-6d4c-4f6a-a210-468cc357b76e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f342d2a5-c46b-4ef6-a65c-006a8a4ec9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f342d2a5-c46b-4ef6-a65c-006a8a4ec9d2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_aca03cdc-6805-4021-a8b6-5eb608b986c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_aca03cdc-6805-4021-a8b6-5eb608b986c5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_8d749f8f-4c4c-400c-b5fa-2c2ffaaa93db" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_8d749f8f-4c4c-400c-b5fa-2c2ffaaa93db" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f6e20e94-2df5-4b85-92a2-cace357128fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f6e20e94-2df5-4b85-92a2-cace357128fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6e20e94-2df5-4b85-92a2-cace357128fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f6e20e94-2df5-4b85-92a2-cace357128fb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f6e20e94-2df5-4b85-92a2-cace357128fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59266ac3-ebd5-4bc8-ba89-5dc8ecc30860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f6e20e94-2df5-4b85-92a2-cace357128fb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59266ac3-ebd5-4bc8-ba89-5dc8ecc30860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_052dc406-53e4-4958-963d-995c89ac5d23" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59266ac3-ebd5-4bc8-ba89-5dc8ecc30860" xlink:to="loc_kids_ApiFixLtdMember_052dc406-53e4-4958-963d-995c89ac5d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d02f04b-0927-4f35-8116-076ef008b62e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d02f04b-0927-4f35-8116-076ef008b62e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d02f04b-0927-4f35-8116-076ef008b62e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d02f04b-0927-4f35-8116-076ef008b62e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d02f04b-0927-4f35-8116-076ef008b62e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d02f04b-0927-4f35-8116-076ef008b62e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_c8d2b9ad-c7e7-482f-b935-af5f9a9d8bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:to="loc_us-gaap_PatentsMember_c8d2b9ad-c7e7-482f-b935-af5f9a9d8bea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c5a3192f-be29-43c6-a376-c9054e57ade3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c5a3192f-be29-43c6-a376-c9054e57ade3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e7873965-f292-42e8-899b-0b8b0a5b6882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e7873965-f292-42e8-899b-0b8b0a5b6882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_10b94c0e-8997-4aab-a054-0757299f4140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_10b94c0e-8997-4aab-a054-0757299f4140" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_10b94c0e-8997-4aab-a054-0757299f4140_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_10b94c0e-8997-4aab-a054-0757299f4140" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_10b94c0e-8997-4aab-a054-0757299f4140_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f658a933-d649-4722-8144-ba34d73c4e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_10b94c0e-8997-4aab-a054-0757299f4140" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f658a933-d649-4722-8144-ba34d73c4e79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_2be2f951-68d3-4038-b44b-6aa1c478ecab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f658a933-d649-4722-8144-ba34d73c4e79" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_2be2f951-68d3-4038-b44b-6aa1c478ecab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryAxis_e63157c8-a4c3-4bab-a8c7-9d456bb49622" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_kids_BusinessAcquisitionAnniversaryAxis_e63157c8-a4c3-4bab-a8c7-9d456bb49622" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_e63157c8-a4c3-4bab-a8c7-9d456bb49622_default" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_e63157c8-a4c3-4bab-a8c7-9d456bb49622" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_e63157c8-a4c3-4bab-a8c7-9d456bb49622_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_e63157c8-a4c3-4bab-a8c7-9d456bb49622" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAnniversaryMember_8c379e15-66fc-4f34-9a50-047163f446d0" xlink:href="kids-20200630.xsd#kids_SecondAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:to="loc_kids_SecondAnniversaryMember_8c379e15-66fc-4f34-9a50-047163f446d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ThirdAnniversaryMember_e316b610-7da2-40a3-9a92-9ed1f89de631" xlink:href="kids-20200630.xsd#kids_ThirdAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:to="loc_kids_ThirdAnniversaryMember_e316b610-7da2-40a3-9a92-9ed1f89de631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FourthAnniversaryMember_838aa253-3c6e-4d50-88ad-b02c74fae1b3" xlink:href="kids-20200630.xsd#kids_FourthAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:to="loc_kids_FourthAnniversaryMember_838aa253-3c6e-4d50-88ad-b02c74fae1b3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails" xlink:type="extended" id="i50a6e7f2ce81432faeef14c184c9d83f_BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_3d699257-3319-42a2-b708-97ef26d13627" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_3d699257-3319-42a2-b708-97ef26d13627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_1665f5fd-2dd0-4e94-88e5-3cd70253b493" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_1665f5fd-2dd0-4e94-88e5-3cd70253b493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_3cc845c6-7859-4616-b11a-b4520b2b74dd" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_3cc845c6-7859-4616-b11a-b4520b2b74dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_526ed632-1f8a-4115-a402-85ed9aff35da" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenuePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_526ed632-1f8a-4115-a402-85ed9aff35da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77c2e8ba-f888-4632-a03a-9ce3cf32bd93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77c2e8ba-f888-4632-a03a-9ce3cf32bd93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_16aec9d7-56c7-4f74-847b-d29c4f1245f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_16aec9d7-56c7-4f74-847b-d29c4f1245f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16aec9d7-56c7-4f74-847b-d29c4f1245f6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16aec9d7-56c7-4f74-847b-d29c4f1245f6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16aec9d7-56c7-4f74-847b-d29c4f1245f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0002ea66-e47c-4503-8717-170d56942eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16aec9d7-56c7-4f74-847b-d29c4f1245f6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0002ea66-e47c-4503-8717-170d56942eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_d1b45118-e065-43bb-85bf-c2c071f3f92f" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0002ea66-e47c-4503-8717-170d56942eac" xlink:to="loc_kids_ApiFixLtdMember_d1b45118-e065-43bb-85bf-c2c071f3f92f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryAxis_0c40f70c-fe42-4d45-a09f-dd49352bf36d" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:to="loc_kids_BusinessAcquisitionAnniversaryAxis_0c40f70c-fe42-4d45-a09f-dd49352bf36d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_0c40f70c-fe42-4d45-a09f-dd49352bf36d_default" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_0c40f70c-fe42-4d45-a09f-dd49352bf36d" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_0c40f70c-fe42-4d45-a09f-dd49352bf36d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_0c40f70c-fe42-4d45-a09f-dd49352bf36d" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAnniversaryMember_7a0b0c89-f797-4092-b09c-b169d22ca2b4" xlink:href="kids-20200630.xsd#kids_SecondAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:to="loc_kids_SecondAnniversaryMember_7a0b0c89-f797-4092-b09c-b169d22ca2b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ThirdAnniversaryMember_c05abe50-ee93-428a-9c93-4602c04e7d9e" xlink:href="kids-20200630.xsd#kids_ThirdAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:to="loc_kids_ThirdAnniversaryMember_c05abe50-ee93-428a-9c93-4602c04e7d9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FourthAnniversaryMember_1a802150-700e-4005-b5dc-942f44d4f38e" xlink:href="kids-20200630.xsd#kids_FourthAnniversaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:to="loc_kids_FourthAnniversaryMember_1a802150-700e-4005-b5dc-942f44d4f38e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONTelosDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails" xlink:type="extended" id="i507aa39bd04741e3bc1dc55dfba7455d_BUSINESSCOMBINATIONTelosDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c535467-462a-4c8d-afae-962b738de1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c535467-462a-4c8d-afae-962b738de1d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_36e0c12d-7a3d-43fd-9979-712a6667dace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_36e0c12d-7a3d-43fd-9979-712a6667dace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_89ece70b-2d88-48c9-bf8f-507edd00605c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_89ece70b-2d88-48c9-bf8f-507edd00605c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_832929d7-dbd6-404c-83ab-3f8dc2aa42ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_832929d7-dbd6-404c-83ab-3f8dc2aa42ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_f5495c13-0047-4250-a26f-320432996aad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_f5495c13-0047-4250-a26f-320432996aad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1f87d4db-9705-44b5-9ca6-8724d6739302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1f87d4db-9705-44b5-9ca6-8724d6739302" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4415ba36-ec09-476f-8dd5-dab9343acfd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4415ba36-ec09-476f-8dd5-dab9343acfd8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f2682232-1241-4048-a506-b4993dba1f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f2682232-1241-4048-a506-b4993dba1f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707ef0a-56f8-4ffd-8709-5b9e324941cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707ef0a-56f8-4ffd-8709-5b9e324941cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f403d7d6-465b-4e1c-a7e2-c4f1a302f25a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f403d7d6-465b-4e1c-a7e2-c4f1a302f25a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f0f47096-1aed-4354-a66f-06a7d1dde65b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f0f47096-1aed-4354-a66f-06a7d1dde65b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_5d7c81e5-743f-4cdf-a656-81b30a7ed402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_5d7c81e5-743f-4cdf-a656-81b30a7ed402" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_16e31eff-d70a-4189-a2df-59842a78746c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_16e31eff-d70a-4189-a2df-59842a78746c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_757219a2-fb64-4418-aa66-1a63cb748c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_757219a2-fb64-4418-aa66-1a63cb748c6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3f4f8af-08a2-4166-af83-58b32bbdd4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3f4f8af-08a2-4166-af83-58b32bbdd4f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cbfe7c77-e98c-43a0-a84e-17a25d5e7168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cbfe7c77-e98c-43a0-a84e-17a25d5e7168" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2fc82b6d-dd8f-4e34-8c42-9a3c0d49f6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_Goodwill_2fc82b6d-dd8f-4e34-8c42-9a3c0d49f6bd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_240be40b-67ff-4c15-840c-d987de08a80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_240be40b-67ff-4c15-840c-d987de08a80e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_af06c85e-25a1-4796-846f-54815614f2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_af06c85e-25a1-4796-846f-54815614f2b1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired_4113bad3-36fd-44bb-91fd-4f5ed0bc7fa8" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_kids_IntangibleAssetsAcquired_4113bad3-36fd-44bb-91fd-4f5ed0bc7fa8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_959a3783-8b51-468f-83e2-5c117dff33ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_959a3783-8b51-468f-83e2-5c117dff33ae" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc226315-a805-4017-93f4-7918a7306838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc226315-a805-4017-93f4-7918a7306838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc226315-a805-4017-93f4-7918a7306838_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc226315-a805-4017-93f4-7918a7306838" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc226315-a805-4017-93f4-7918a7306838_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_937e613c-11ea-417f-8f3e-9853c16bb290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc226315-a805-4017-93f4-7918a7306838" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_937e613c-11ea-417f-8f3e-9853c16bb290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_0f6d115a-1a7d-4f01-be7a-41d6bf499c9c" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_937e613c-11ea-417f-8f3e-9853c16bb290" xlink:to="loc_kids_TelosPartnersLLCMember_0f6d115a-1a7d-4f01-be7a-41d6bf499c9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fbcb614b-57bd-45e3-8689-d414f00fa944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fbcb614b-57bd-45e3-8689-d414f00fa944" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbcb614b-57bd-45e3-8689-d414f00fa944_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fbcb614b-57bd-45e3-8689-d414f00fa944" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_fbcb614b-57bd-45e3-8689-d414f00fa944_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28061637-8be7-43dc-9091-fdd82b1301cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fbcb614b-57bd-45e3-8689-d414f00fa944" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28061637-8be7-43dc-9091-fdd82b1301cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_9edf0be1-0d61-4c58-9bc4-b9ac609542ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28061637-8be7-43dc-9091-fdd82b1301cc" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_9edf0be1-0d61-4c58-9bc4-b9ac609542ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_838c6036-b6ac-4a34-9c67-0e0af1701ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_838c6036-b6ac-4a34-9c67-0e0af1701ca5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_838c6036-b6ac-4a34-9c67-0e0af1701ca5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_838c6036-b6ac-4a34-9c67-0e0af1701ca5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_838c6036-b6ac-4a34-9c67-0e0af1701ca5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_838c6036-b6ac-4a34-9c67-0e0af1701ca5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1ba33100-cc16-409c-8543-8919a7bb62a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1ba33100-cc16-409c-8543-8919a7bb62a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d3a06fe1-202b-4da2-80a3-9181c56a6406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d3a06fe1-202b-4da2-80a3-9181c56a6406" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONVilexandOrthexDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails" xlink:type="extended" id="i2bd1d6109752424e8b43395691f3c156_BUSINESSCOMBINATIONVilexandOrthexDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_4699e054-baab-4fa7-956f-3cf273051625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_4699e054-baab-4fa7-956f-3cf273051625" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1bda992a-90cb-4d5c-959c-e6b9091fead5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1bda992a-90cb-4d5c-959c-e6b9091fead5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1040fb04-5dcb-49f7-93d4-cfe82baff2c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1040fb04-5dcb-49f7-93d4-cfe82baff2c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_0f37a69d-2317-492e-9558-1ab097a48bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_0f37a69d-2317-492e-9558-1ab097a48bec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationEscrowDeposit_aca42631-3996-4e3c-9c2d-6e4649e9e06f" xlink:href="kids-20200630.xsd#kids_BusinessCombinationEscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_BusinessCombinationEscrowDeposit_aca42631-3996-4e3c-9c2d-6e4649e9e06f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationEscrowDepositMaximumTerm_a811f13c-ba84-4547-bf05-20f54e10a271" xlink:href="kids-20200630.xsd#kids_BusinessCombinationEscrowDepositMaximumTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_BusinessCombinationEscrowDepositMaximumTerm_a811f13c-ba84-4547-bf05-20f54e10a271" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_89418c57-4788-43e0-9785-fddd151053e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_89418c57-4788-43e0-9785-fddd151053e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fc2c594a-c6b9-40ab-81b1-fe80354f1ded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fc2c594a-c6b9-40ab-81b1-fe80354f1ded" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d786eed2-d5f1-4604-8b5a-f653db2df6e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d786eed2-d5f1-4604-8b5a-f653db2df6e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_76f559d7-60b6-4f00-b3fb-737b65ad0c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_76f559d7-60b6-4f00-b3fb-737b65ad0c07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0e1ee917-6a2c-4ee9-b8fe-2f0eb76de1ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0e1ee917-6a2c-4ee9-b8fe-2f0eb76de1ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e9ed5c22-603c-4563-8a16-546f65a18961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e9ed5c22-603c-4563-8a16-546f65a18961" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94a9a5b7-a940-477b-a078-ca9c2e3c3c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94a9a5b7-a940-477b-a078-ca9c2e3c3c79" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d352e69c-ca99-4b4f-b953-a3005d141916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d352e69c-ca99-4b4f-b953-a3005d141916" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_987ce793-e62e-464f-bd57-d1f10d0440b5" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_987ce793-e62e-464f-bd57-d1f10d0440b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_63cd0266-f032-48ec-be06-64f4df5e763e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_63cd0266-f032-48ec-be06-64f4df5e763e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa900575-278c-4f26-9fae-d8235066307e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa900575-278c-4f26-9fae-d8235066307e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_8e1615cc-f1c4-4e79-8768-51ac03f3fe5c" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_8e1615cc-f1c4-4e79-8768-51ac03f3fe5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ddaa3c79-0722-43c7-b7cf-a1a01bea0c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ddaa3c79-0722-43c7-b7cf-a1a01bea0c60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6777daa4-f084-4ec0-83fc-3d5a0f5986cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6777daa4-f084-4ec0-83fc-3d5a0f5986cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_240f74a0-e0b0-4bb8-9ca2-d124c3b00400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_240f74a0-e0b0-4bb8-9ca2-d124c3b00400" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f067ab8b-2dd7-43f1-8c94-fe932dda1082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f067ab8b-2dd7-43f1-8c94-fe932dda1082" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9a4ce236-9556-4bdd-a901-714af159fe48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_Goodwill_9a4ce236-9556-4bdd-a901-714af159fe48" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d62ef547-97ca-4d2c-8de2-106bcb2eeb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d62ef547-97ca-4d2c-8de2-106bcb2eeb38" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2ec77da8-f1be-4e44-84e8-fb97840f0a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2ec77da8-f1be-4e44-84e8-fb97840f0a41" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f4213f1f-3610-4a29-b446-481d6f604307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f4213f1f-3610-4a29-b446-481d6f604307" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired_b0e05871-16e4-4542-bbfd-5b28f036d2af" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_IntangibleAssetsAcquired_b0e05871-16e4-4542-bbfd-5b28f036d2af" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f2270c8-a4e4-4209-acba-0066c550daef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f2270c8-a4e4-4209-acba-0066c550daef" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue_cce9e8cd-1445-4336-af03-ddef670cabdf" xlink:href="kids-20200630.xsd#kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue_cce9e8cd-1445-4336-af03-ddef670cabdf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities_51088278-9b73-4e29-97f7-a1d967c4c931" xlink:href="kids-20200630.xsd#kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities_51088278-9b73-4e29-97f7-a1d967c4c931" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a16d0296-ed27-42c1-8656-031f2eefc2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a16d0296-ed27-42c1-8656-031f2eefc2fb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_d2f75b56-f575-4dfd-a4ff-cda6decc8758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_d2f75b56-f575-4dfd-a4ff-cda6decc8758" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cf07a393-82e8-497b-9ca6-5894bf40a64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cf07a393-82e8-497b-9ca6-5894bf40a64c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf07a393-82e8-497b-9ca6-5894bf40a64c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cf07a393-82e8-497b-9ca6-5894bf40a64c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cf07a393-82e8-497b-9ca6-5894bf40a64c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cf07a393-82e8-497b-9ca6-5894bf40a64c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexAndOrthexMember_adc12377-dd0c-4f3e-88ba-56f05f4b523a" xlink:href="kids-20200630.xsd#kids_VilexAndOrthexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:to="loc_kids_VilexAndOrthexMember_adc12377-dd0c-4f3e-88ba-56f05f4b523a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OrthexMember_a7346bca-c67e-4483-a108-cbc2112b42ef" xlink:href="kids-20200630.xsd#kids_OrthexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:to="loc_kids_OrthexMember_a7346bca-c67e-4483-a108-cbc2112b42ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexMember_67912414-8fdc-4ab1-8618-5e82ef5b06ba" xlink:href="kids-20200630.xsd#kids_VilexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:to="loc_kids_VilexMember_67912414-8fdc-4ab1-8618-5e82ef5b06ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ed6addad-3e5b-4523-bc59-e3b841c2968f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ed6addad-3e5b-4523-bc59-e3b841c2968f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ed6addad-3e5b-4523-bc59-e3b841c2968f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ed6addad-3e5b-4523-bc59-e3b841c2968f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ed6addad-3e5b-4523-bc59-e3b841c2968f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ab710006-9821-455a-a607-82d7dc055257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ed6addad-3e5b-4523-bc59-e3b841c2968f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ab710006-9821-455a-a607-82d7dc055257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_90f8c8cb-fca5-4012-906c-cf434e91fb6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ab710006-9821-455a-a607-82d7dc055257" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_90f8c8cb-fca5-4012-906c-cf434e91fb6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd505ff5-8082-41da-a36b-01a7bc6b8d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd505ff5-8082-41da-a36b-01a7bc6b8d17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_bd505ff5-8082-41da-a36b-01a7bc6b8d17_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd505ff5-8082-41da-a36b-01a7bc6b8d17" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_bd505ff5-8082-41da-a36b-01a7bc6b8d17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_947430d0-2b7d-4a10-8a02-b74ca5b308f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd505ff5-8082-41da-a36b-01a7bc6b8d17" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_947430d0-2b7d-4a10-8a02-b74ca5b308f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_84fb3999-8846-4167-9aa6-ffdfb8dad48a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_947430d0-2b7d-4a10-8a02-b74ca5b308f3" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_84fb3999-8846-4167-9aa6-ffdfb8dad48a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2b301a2d-ae5a-427d-873a-d52c3e9dab38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2b301a2d-ae5a-427d-873a-d52c3e9dab38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2b301a2d-ae5a-427d-873a-d52c3e9dab38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2b301a2d-ae5a-427d-873a-d52c3e9dab38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2b301a2d-ae5a-427d-873a-d52c3e9dab38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2b301a2d-ae5a-427d-873a-d52c3e9dab38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_810a2954-85e8-49e0-bcc6-a4ecfa0278aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_PatentsMember_810a2954-85e8-49e0-bcc6-a4ecfa0278aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a87083dc-6f6c-4beb-a03c-da96aebafd95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a87083dc-6f6c-4beb-a03c-da96aebafd95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c07a00ab-e725-4c33-b165-577f57d069c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c07a00ab-e725-4c33-b165-577f57d069c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_13d44d91-4524-4f39-97b5-9f2c0a3ab5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_13d44d91-4524-4f39-97b5-9f2c0a3ab5ce" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended" id="icfdaa2859228493cb578f06281c4d96c_GOODWILLANDINTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended" id="i99aac8a308654a4680667525e9ee817f_GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended" id="ie44d06ba06134a23a810f39069f6961d_GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails" xlink:type="extended" id="id970b67183ac461ea000a7dd3958a6ca_GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e3801abb-ec1d-4fe2-b47e-84f544e9e175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e3801abb-ec1d-4fe2-b47e-84f544e9e175" xlink:to="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2dd7a57-5052-4b43-ae3b-9ffc26b68fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_us-gaap_Goodwill_e2dd7a57-5052-4b43-ae3b-9ffc26b68fb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6395e2b2-b50f-42b2-bf6d-f456070a1f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6395e2b2-b50f-42b2-bf6d-f456070a1f6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_d054c622-6a8b-4712-be79-9ac330ed3c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_d054c622-6a8b-4712-be79-9ac330ed3c60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_GoodwillMeasurementPeriodAdjustment_05bb5079-427e-4fb3-8ac0-6c22ed4b332c" xlink:href="kids-20200630.xsd#kids_GoodwillMeasurementPeriodAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_kids_GoodwillMeasurementPeriodAdjustment_05bb5079-427e-4fb3-8ac0-6c22ed4b332c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1c400139-c539-4a6d-8804-60fe3d45ae4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63c478ed-e442-4fed-8813-673beee7a46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e3801abb-ec1d-4fe2-b47e-84f544e9e175" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63c478ed-e442-4fed-8813-673beee7a46d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_766fa4fc-1d4a-4995-8ac8-93c1990593d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63c478ed-e442-4fed-8813-673beee7a46d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_766fa4fc-1d4a-4995-8ac8-93c1990593d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_766fa4fc-1d4a-4995-8ac8-93c1990593d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_766fa4fc-1d4a-4995-8ac8-93c1990593d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_766fa4fc-1d4a-4995-8ac8-93c1990593d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_766fa4fc-1d4a-4995-8ac8-93c1990593d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexMember_27e055fc-6a52-47d4-b69e-0cf8845e832a" xlink:href="kids-20200630.xsd#kids_VilexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_VilexMember_27e055fc-6a52-47d4-b69e-0cf8845e832a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_3a202233-9eb4-47f2-bfc3-fb63a5fd5ab9" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_TelosPartnersLLCMember_3a202233-9eb4-47f2-bfc3-fb63a5fd5ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OrthexMember_48babe62-e91c-4fca-89e7-ecfe4a4046ce" xlink:href="kids-20200630.xsd#kids_OrthexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_OrthexMember_48babe62-e91c-4fca-89e7-ecfe4a4046ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_62820095-07f4-44b3-9be9-2bcc47864e13" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_ApiFixLtdMember_62820095-07f4-44b3-9be9-2bcc47864e13" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails" xlink:type="extended" id="if9b27ec105424ba8bb4fdd9df48f8f86_GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aa15a382-d784-4841-9358-9b37d558449c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aa15a382-d784-4841-9358-9b37d558449c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_af0912f1-d59e-4f41-a25f-b93d194f6bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_af0912f1-d59e-4f41-a25f-b93d194f6bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3cabe443-c99f-4de3-a4c3-824994eee821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3cabe443-c99f-4de3-a4c3-824994eee821" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df0f9773-bfdf-4654-a717-fc9af38c7a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df0f9773-bfdf-4654-a717-fc9af38c7a02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_3d9585a7-5b0b-4cc3-9975-150435e89dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_3d9585a7-5b0b-4cc3-9975-150435e89dec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ec75eb6-7b76-468a-a232-bd99d89a3962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_3d9585a7-5b0b-4cc3-9975-150435e89dec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ec75eb6-7b76-468a-a232-bd99d89a3962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ec75eb6-7b76-468a-a232-bd99d89a3962_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ec75eb6-7b76-468a-a232-bd99d89a3962" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ec75eb6-7b76-468a-a232-bd99d89a3962_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ec75eb6-7b76-468a-a232-bd99d89a3962" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_e9607d83-4753-46dc-8a0a-cd1fc0f11fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:to="loc_us-gaap_PatentsMember_e9607d83-4753-46dc-8a0a-cd1fc0f11fe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_201025f9-7ff3-4653-9653-a62bbc444926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:to="loc_us-gaap_IntellectualPropertyMember_201025f9-7ff3-4653-9653-a62bbc444926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_e9eea0f6-46a5-4e9e-a55e-a7ab9e094ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:to="loc_us-gaap_LicensingAgreementsMember_e9eea0f6-46a5-4e9e-a55e-a7ab9e094ff5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS" xlink:type="extended" id="ifd47480ca97d41df902812bded8b02b1_DISCONTINUEDOPERATIONS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONSTables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables" xlink:type="extended" id="ib569fb3c559b4acfb5f030f3e4fd905a_DISCONTINUEDOPERATIONSTables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended" id="i877ce0af02764f22b7aa55a6cbe17791_DISCONTINUEDOPERATIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e1e3ae7b-f708-4c41-b3cf-1cf7c029e8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e1e3ae7b-f708-4c41-b3cf-1cf7c029e8b7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f2fe4822-d85d-4d9a-a9f5-c4ec9ec4e785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f2fe4822-d85d-4d9a-a9f5-c4ec9ec4e785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_b498f05e-99a4-49df-865c-89104bfa43d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_b498f05e-99a4-49df-865c-89104bfa43d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_eced75da-793d-401a-9e9b-47ba2b329692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_eced75da-793d-401a-9e9b-47ba2b329692" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_97b5df93-6757-4564-b64e-d64f108e347a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_97b5df93-6757-4564-b64e-d64f108e347a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_23719c96-5afa-4601-bc54-646d6be1d9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_23719c96-5afa-4601-bc54-646d6be1d9e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5d7b386f-b182-47cd-8d9f-bcd60aa48033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e1e3ae7b-f708-4c41-b3cf-1cf7c029e8b7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5d7b386f-b182-47cd-8d9f-bcd60aa48033" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a2270500-1fb8-4389-8abb-ae88669091e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5d7b386f-b182-47cd-8d9f-bcd60aa48033" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a2270500-1fb8-4389-8abb-ae88669091e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a2270500-1fb8-4389-8abb-ae88669091e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a2270500-1fb8-4389-8abb-ae88669091e2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a2270500-1fb8-4389-8abb-ae88669091e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bcf0f943-d33e-4482-9037-7f01b865c312" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a2270500-1fb8-4389-8abb-ae88669091e2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bcf0f943-d33e-4482-9037-7f01b865c312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_2a1cc346-0f4e-462e-8602-4c92ec541674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bcf0f943-d33e-4482-9037-7f01b865c312" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_2a1cc346-0f4e-462e-8602-4c92ec541674" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS" xlink:type="extended" id="i36b080742aa5470b996aeacfd9ec33ea_DEBTANDCREDITARRANGEMENTS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSTables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables" xlink:type="extended" id="i4500659b6ca44f2190d23335d6b043ee_DEBTANDCREDITARRANGEMENTSTables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="extended" id="i5d6710b833d44c92988591d337bdc6ac_DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_53592a18-e1ed-403a-9602-2e308ea4be52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_NotesPayable_53592a18-e1ed-403a-9602-2e308ea4be52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_23e42c28-e7e6-423c-bd7a-c0479cda91e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_LongTermDebt_23e42c28-e7e6-423c-bd7a-c0479cda91e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_404d39eb-c9cc-4fd0-9c8e-be537b1588c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_404d39eb-c9cc-4fd0-9c8e-be537b1588c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1683e2e6-a06f-43d8-bcfc-43f189928692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_LongTermDebtCurrent_1683e2e6-a06f-43d8-bcfc-43f189928692" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_17bc0fa5-fe10-4f0c-a98c-4aa4b80ee618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_17bc0fa5-fe10-4f0c-a98c-4aa4b80ee618" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5b91770e-dad0-4331-b357-5e981f13948b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5b91770e-dad0-4331-b357-5e981f13948b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5b91770e-dad0-4331-b357-5e981f13948b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5b91770e-dad0-4331-b357-5e981f13948b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5b91770e-dad0-4331-b357-5e981f13948b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5b91770e-dad0-4331-b357-5e981f13948b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_e30b8f24-525b-4158-a25f-9da1c5b04bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_e30b8f24-525b-4158-a25f-9da1c5b04bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_42d3ae37-c34b-44a8-9963-c4f499e0eec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:to="loc_us-gaap_LineOfCreditMember_42d3ae37-c34b-44a8-9963-c4f499e0eec4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_8761d0a0-29ac-46d1-9c60-7d681ae3b624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:to="loc_us-gaap_MortgagesMember_8761d0a0-29ac-46d1-9c60-7d681ae3b624" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_93daa73e-6891-4ece-bf50-aaf346442188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:to="loc_us-gaap_CreditFacilityAxis_93daa73e-6891-4ece-bf50-aaf346442188" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_93daa73e-6891-4ece-bf50-aaf346442188_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_93daa73e-6891-4ece-bf50-aaf346442188" xlink:to="loc_us-gaap_CreditFacilityDomain_93daa73e-6891-4ece-bf50-aaf346442188_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_67f1b225-2830-47a2-9f0c-654c4d25e9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_93daa73e-6891-4ece-bf50-aaf346442188" xlink:to="loc_us-gaap_CreditFacilityDomain_67f1b225-2830-47a2-9f0c-654c4d25e9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0393c13a-5d00-4158-be42-f86d58d91157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_67f1b225-2830-47a2-9f0c-654c4d25e9fc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0393c13a-5d00-4158-be42-f86d58d91157" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails" xlink:type="extended" id="i75856619d7a34e49b41a068c6e01924e_DEBTANDCREDITARRANGEMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0c40083e-dd64-4f70-9b81-280e2a313b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_LongTermDebt_0c40083e-dd64-4f70-9b81-280e2a313b97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d94e8b34-b8ec-4829-99ae-159d95b3f78c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d94e8b34-b8ec-4829-99ae-159d95b3f78c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2636027b-d70b-4073-89a1-61b0ea2a7297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2636027b-d70b-4073-89a1-61b0ea2a7297" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e18f8778-eda7-40f0-af26-a37978ab4a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e18f8778-eda7-40f0-af26-a37978ab4a0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b651a3f8-a538-4e5d-b539-9852bffbc874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b651a3f8-a538-4e5d-b539-9852bffbc874" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_65afefcb-607c-4617-8b4a-e24c07fdfddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_65afefcb-607c-4617-8b4a-e24c07fdfddd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_81861efb-7112-4227-b95f-79d0e8e44ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_81861efb-7112-4227-b95f-79d0e8e44ca9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92db80dd-4b3c-4341-ad3c-de659332b17a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92db80dd-4b3c-4341-ad3c-de659332b17a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f5f36593-e75d-4fee-8d21-a800d98c3425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_LongTermDebtCurrent_f5f36593-e75d-4fee-8d21-a800d98c3425" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_db511d3c-7395-4643-a8d6-ea91a1983e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_db511d3c-7395-4643-a8d6-ea91a1983e2a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_VariableRateAxis_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc" xlink:to="loc_us-gaap_VariableRateDomain_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_65edfbfa-a74a-4721-be2e-76cfa4a7c3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc" xlink:to="loc_us-gaap_VariableRateDomain_65edfbfa-a74a-4721-be2e-76cfa4a7c3d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d02607dd-cb78-4d24-bf77-557806102eb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_65edfbfa-a74a-4721-be2e-76cfa4a7c3d6" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d02607dd-cb78-4d24-bf77-557806102eb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_CreditFacilityAxis_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d" xlink:to="loc_us-gaap_CreditFacilityDomain_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7aaafaca-465c-4009-8e06-684c9686a7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d" xlink:to="loc_us-gaap_CreditFacilityDomain_7aaafaca-465c-4009-8e06-684c9686a7ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b81455f8-425c-4f13-b96f-4199be037ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7aaafaca-465c-4009-8e06-684c9686a7ac" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b81455f8-425c-4f13-b96f-4199be037ce3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d858668-ba95-4c7f-80a5-b6b43aa9cea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d858668-ba95-4c7f-80a5-b6b43aa9cea7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3d858668-ba95-4c7f-80a5-b6b43aa9cea7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d858668-ba95-4c7f-80a5-b6b43aa9cea7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3d858668-ba95-4c7f-80a5-b6b43aa9cea7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d858668-ba95-4c7f-80a5-b6b43aa9cea7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_9af5de8d-cac5-43b0-b226-1d867018ac2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_9af5de8d-cac5-43b0-b226-1d867018ac2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_2b6b765c-ac2b-4723-9bb7-4ff8b2ee9d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:to="loc_us-gaap_MortgagesMember_2b6b765c-ac2b-4723-9bb7-4ff8b2ee9d22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_c6d05ab4-4d14-4e57-8352-a3966d25fb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_c6d05ab4-4d14-4e57-8352-a3966d25fb38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_c6d05ab4-4d14-4e57-8352-a3966d25fb38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_c6d05ab4-4d14-4e57-8352-a3966d25fb38" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_c6d05ab4-4d14-4e57-8352-a3966d25fb38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_0f476ccf-a16c-4eb4-9828-0a2f8873541b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_c6d05ab4-4d14-4e57-8352-a3966d25fb38" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_0f476ccf-a16c-4eb4-9828-0a2f8873541b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_48e26f26-4555-40b7-9d84-7c9977010319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0f476ccf-a16c-4eb4-9828-0a2f8873541b" xlink:to="loc_us-gaap_LineOfCreditMember_48e26f26-4555-40b7-9d84-7c9977010319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f7741373-8d9a-44ce-85b1-880a25ff9a19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_DebtInstrumentAxis_f7741373-8d9a-44ce-85b1-880a25ff9a19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f7741373-8d9a-44ce-85b1-880a25ff9a19_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f7741373-8d9a-44ce-85b1-880a25ff9a19" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f7741373-8d9a-44ce-85b1-880a25ff9a19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f7741373-8d9a-44ce-85b1-880a25ff9a19" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TermNoteBMember_b28e49d1-9b7e-44ca-8de3-31406399ed40" xlink:href="kids-20200630.xsd#kids_TermNoteBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:to="loc_kids_TermNoteBMember_b28e49d1-9b7e-44ca-8de3-31406399ed40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_LoanAgreementMember_5f96aed3-421f-491c-8fe4-a7bea22c57d1" xlink:href="kids-20200630.xsd#kids_LoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:to="loc_kids_LoanAgreementMember_5f96aed3-421f-491c-8fe4-a7bea22c57d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_RevolvingLoanMember_461f15dd-3188-48df-8b95-d57e8fcdfabc" xlink:href="kids-20200630.xsd#kids_RevolvingLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:to="loc_kids_RevolvingLoanMember_461f15dd-3188-48df-8b95-d57e8fcdfabc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_24d3b506-250f-4924-9971-d7a2fafb453e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_srt_CounterpartyNameAxis_24d3b506-250f-4924-9971-d7a2fafb453e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24d3b506-250f-4924-9971-d7a2fafb453e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_24d3b506-250f-4924-9971-d7a2fafb453e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24d3b506-250f-4924-9971-d7a2fafb453e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fbe1da4e-fae7-4096-ad8b-ab7598c2e0bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_24d3b506-250f-4924-9971-d7a2fafb453e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fbe1da4e-fae7-4096-ad8b-ab7598c2e0bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SquadronMember_7ca89bd2-a369-464f-9525-d69a98672c85" xlink:href="kids-20200630.xsd#kids_SquadronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fbe1da4e-fae7-4096-ad8b-ab7598c2e0bc" xlink:to="loc_kids_SquadronMember_7ca89bd2-a369-464f-9525-d69a98672c85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bed668a3-32da-481e-bd8e-cc9649b1c946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bed668a3-32da-481e-bd8e-cc9649b1c946" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bed668a3-32da-481e-bd8e-cc9649b1c946_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bed668a3-32da-481e-bd8e-cc9649b1c946" xlink:to="loc_us-gaap_RelatedPartyDomain_bed668a3-32da-481e-bd8e-cc9649b1c946_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fc8c39b0-0c06-4ab6-bd69-0c277b32f267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bed668a3-32da-481e-bd8e-cc9649b1c946" xlink:to="loc_us-gaap_RelatedPartyDomain_fc8c39b0-0c06-4ab6-bd69-0c277b32f267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_3b407ffb-e9a0-4b16-9039-5e1da0954220" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fc8c39b0-0c06-4ab6-bd69-0c277b32f267" xlink:to="loc_srt_AffiliatedEntityMember_3b407ffb-e9a0-4b16-9039-5e1da0954220" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#STRATEGICARRANGEMENTS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS" xlink:type="extended" id="ie28fd52b884f46418e92b737a371f25d_STRATEGICARRANGEMENTS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STRATEGICARRANGEMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails" xlink:type="extended" id="idb0a6fca24c646d8bf0f96435fa0eae0_STRATEGICARRANGEMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm_aa43799d-921d-4aba-b3a5-c2e65d7fa7bb" xlink:href="kids-20200630.xsd#kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm_aa43799d-921d-4aba-b3a5-c2e65d7fa7bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_a489115c-3e31-46dd-a893-d5aaa43ae0a9" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_a489115c-3e31-46dd-a893-d5aaa43ae0a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_577277c8-db7e-4222-bf3a-2ac5cd27661b" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_577277c8-db7e-4222-bf3a-2ac5cd27661b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment_bb1ca4fc-fc61-4a1b-8363-ad3ea2554622" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment_bb1ca4fc-fc61-4a1b-8363-ad3ea2554622" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment_32467c4b-1c5e-4660-85bf-91efa27fe943" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment_32467c4b-1c5e-4660-85bf-91efa27fe943" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_9ff49a73-d338-4919-9491-5b6012fd9c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_us-gaap_RoyaltyExpense_9ff49a73-d338-4919-9491-5b6012fd9c06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_a40b8885-bc8b-4396-a037-e5bb33d8451a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_a40b8885-bc8b-4396-a037-e5bb33d8451a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ba9edaeb-8f48-489b-b592-1f3e44784914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ba9edaeb-8f48-489b-b592-1f3e44784914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ba9edaeb-8f48-489b-b592-1f3e44784914_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ba9edaeb-8f48-489b-b592-1f3e44784914" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ba9edaeb-8f48-489b-b592-1f3e44784914_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_65d073ed-0f16-4813-815b-fb23d8a4761e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ba9edaeb-8f48-489b-b592-1f3e44784914" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_65d073ed-0f16-4813-815b-fb23d8a4761e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementTermsMember_192a94cd-a3a3-462a-9608-a1b122f69336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementTermsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_65d073ed-0f16-4813-815b-fb23d8a4761e" xlink:to="loc_us-gaap_RoyaltyAgreementTermsMember_192a94cd-a3a3-462a-9608-a1b122f69336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_799fb955-f845-442a-9870-85496e9d1346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_799fb955-f845-442a-9870-85496e9d1346" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_799fb955-f845-442a-9870-85496e9d1346_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_799fb955-f845-442a-9870-85496e9d1346" xlink:to="loc_us-gaap_ProjectMember_799fb955-f845-442a-9870-85496e9d1346_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_4819a3ff-506b-4e93-8529-eca59ac2f009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_799fb955-f845-442a-9870-85496e9d1346" xlink:to="loc_us-gaap_ProjectMember_4819a3ff-506b-4e93-8529-eca59ac2f009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_CaseWesternReserveUniversityMember_e2beb9ad-d309-490a-8c7a-3fbff63bce51" xlink:href="kids-20200630.xsd#kids_CaseWesternReserveUniversityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_4819a3ff-506b-4e93-8529-eca59ac2f009" xlink:to="loc_kids_CaseWesternReserveUniversityMember_e2beb9ad-d309-490a-8c7a-3fbff63bce51" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="kids-20200630.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/INCOMETAXES" xlink:type="extended" id="i9ebc300a45e84b5d90b08ca8e519d8a4_INCOMETAXES"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/INCOMETAXESDetails" xlink:type="extended" id="i32871f02e9fb46e990c0a799cea0ad79_INCOMETAXESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_0f0214e1-951b-4918-8db0-620489b9e780" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4d25993a-b76c-4ef8-b7c1-55cdea530d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_0f0214e1-951b-4918-8db0-620489b9e780" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4d25993a-b76c-4ef8-b7c1-55cdea530d76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_dc45f44a-0cec-4d16-9d53-9acb38928521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_0f0214e1-951b-4918-8db0-620489b9e780" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_dc45f44a-0cec-4d16-9d53-9acb38928521" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ca5883c0-d5d7-4321-9822-3e71584cccbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_dc45f44a-0cec-4d16-9d53-9acb38928521" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ca5883c0-d5d7-4321-9822-3e71584cccbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ca5883c0-d5d7-4321-9822-3e71584cccbd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ca5883c0-d5d7-4321-9822-3e71584cccbd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ca5883c0-d5d7-4321-9822-3e71584cccbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ca5883c0-d5d7-4321-9822-3e71584cccbd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b82c8c95-e2e0-4caf-9099-79343572c3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:to="loc_us-gaap_DomesticCountryMember_b82c8c95-e2e0-4caf-9099-79343572c3f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_4e28011b-e006-49c0-8628-78de3af22906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_4e28011b-e006-49c0-8628-78de3af22906" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY" xlink:type="extended" id="ic53c49df390842aaa9fb0a14782b734f_STOCKHOLDERSEQUITY"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended" id="i6b0c65f713c940ffa54d5e61bfd5ab98_STOCKHOLDERSEQUITYTables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails" xlink:type="extended" id="i05f9f821153649869668f34922bb75e0_STOCKHOLDERSEQUITYStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_815922ed-e279-4212-883b-a037835274f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_815922ed-e279-4212-883b-a037835274f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d80d269d-63ec-47ef-af8d-7f51c1b97f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d80d269d-63ec-47ef-af8d-7f51c1b97f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ee082bd-3f44-4b12-b7fb-fe3ef6487861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ee082bd-3f44-4b12-b7fb-fe3ef6487861" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f39a1b54-d87b-4aeb-9990-5bb2b1f675cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c358d29d-f592-4ee6-b69b-b5c8027ee84d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c358d29d-f592-4ee6-b69b-b5c8027ee84d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18254792-9c2d-4820-84b8-c7da770d484d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18254792-9c2d-4820-84b8-c7da770d484d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_21b128ef-e269-452c-b324-0d9053f72b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9a247e9-db92-46af-a926-94c7b14674ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9a247e9-db92-46af-a926-94c7b14674ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87224850-b3b7-4c2a-a009-e15000b5fc48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87224850-b3b7-4c2a-a009-e15000b5fc48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a09739f7-41fd-4260-83ab-78b48478bf1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a09739f7-41fd-4260-83ab-78b48478bf1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bca2f932-04ac-4df1-bd21-45f2bd5c474e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bca2f932-04ac-4df1-bd21-45f2bd5c474e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ea418345-2aab-4c25-950a-09a30e4a8503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bca2f932-04ac-4df1-bd21-45f2bd5c474e" xlink:to="loc_us-gaap_AwardTypeAxis_ea418345-2aab-4c25-950a-09a30e4a8503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea418345-2aab-4c25-950a-09a30e4a8503_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ea418345-2aab-4c25-950a-09a30e4a8503" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ea418345-2aab-4c25-950a-09a30e4a8503_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213153a9-df0d-431d-b291-6340f121b8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ea418345-2aab-4c25-950a-09a30e4a8503" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213153a9-df0d-431d-b291-6340f121b8ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3161b4f4-afc0-4970-935d-8960e734fa4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213153a9-df0d-431d-b291-6340f121b8ac" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3161b4f4-afc0-4970-935d-8960e734fa4d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails" xlink:type="extended" id="ia0215784b111444b9be5dbf131e496a3_STOCKHOLDERSEQUITYRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d0669aa3-fd73-40b3-8adf-6dc26f93cfca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d0669aa3-fd73-40b3-8adf-6dc26f93cfca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a40c4842-f442-43be-a225-3f12ad3dab97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a40c4842-f442-43be-a225-3f12ad3dab97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1f5118a8-596d-48e3-afec-3f5e96cc0055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1f5118a8-596d-48e3-afec-3f5e96cc0055" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04fb44dc-c28e-4396-be64-f67f879012d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04fb44dc-c28e-4396-be64-f67f879012d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b2e35ef-edb9-4db7-b1d5-3174c04bb631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8f1c65bb-1949-4382-b711-453084929626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8f1c65bb-1949-4382-b711-453084929626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_9b952b9d-4ae9-442d-b526-4b715200f8a2" xlink:href="kids-20200630.xsd#kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_9b952b9d-4ae9-442d-b526-4b715200f8a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f023b6f1-ee09-4b1d-b434-e195511e2122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f023b6f1-ee09-4b1d-b434-e195511e2122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c4f52bc9-9b16-465b-9dd2-baeb1161bf82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c4f52bc9-9b16-465b-9dd2-baeb1161bf82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_27a7e099-f4e3-4e67-8141-120f1067c8d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_ShareBasedCompensation_27a7e099-f4e3-4e67-8141-120f1067c8d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6adcba14-77ae-4a98-ab7b-5971257fae42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:to="loc_us-gaap_AwardTypeAxis_6adcba14-77ae-4a98-ab7b-5971257fae42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6adcba14-77ae-4a98-ab7b-5971257fae42_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6adcba14-77ae-4a98-ab7b-5971257fae42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6adcba14-77ae-4a98-ab7b-5971257fae42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04fce695-1b65-46dd-83fd-fa60f4922f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6adcba14-77ae-4a98-ab7b-5971257fae42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04fce695-1b65-46dd-83fd-fa60f4922f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a931bddf-ea23-4369-b45e-96549dcb3cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04fce695-1b65-46dd-83fd-fa60f4922f8e" xlink:to="loc_us-gaap_RestrictedStockMember_a931bddf-ea23-4369-b45e-96549dcb3cf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_a294a803-5bbf-4e2a-80f7-6e958ce6a405" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:to="loc_srt_TitleOfIndividualAxis_a294a803-5bbf-4e2a-80f7-6e958ce6a405" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a294a803-5bbf-4e2a-80f7-6e958ce6a405_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_a294a803-5bbf-4e2a-80f7-6e958ce6a405" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a294a803-5bbf-4e2a-80f7-6e958ce6a405_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9d687e36-72e2-403b-90e8-38083419dd21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_a294a803-5bbf-4e2a-80f7-6e958ce6a405" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9d687e36-72e2-403b-90e8-38083419dd21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_20acf146-8e0a-4e49-90f1-c3fa1eff1340" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9d687e36-72e2-403b-90e8-38083419dd21" xlink:to="loc_srt_ChiefExecutiveOfficerMember_20acf146-8e0a-4e49-90f1-c3fa1eff1340" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails" xlink:type="extended" id="i9b3bf1cc5e22488f89c1eda3f00f2156_STOCKHOLDERSEQUITYWarrantsDetails"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARE" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHARE"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHARE" xlink:type="extended" id="i5a30ff5c609e45ab9b2fe451895aa6b4_NETLOSSPERSHARE"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARETables" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHARETables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHARETables" xlink:type="extended" id="i6f47b1c3c9ce4d43b9c2bf2ad0ec4035_NETLOSSPERSHARETables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended" id="if7bdcb43f1a0452993cb607ae83b0ce5_NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHAREAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="extended" id="ief3df21e20044f2880b1e514672c97b2_NETLOSSPERSHAREAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d320b8d5-cb9c-49d0-8363-035d488661c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f14e5527-10fa-4832-8b03-8e300f0d6615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d320b8d5-cb9c-49d0-8363-035d488661c5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f14e5527-10fa-4832-8b03-8e300f0d6615" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91ba4edf-f6cb-4578-b1cd-3d3e4db5350f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d320b8d5-cb9c-49d0-8363-035d488661c5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91ba4edf-f6cb-4578-b1cd-3d3e4db5350f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3998fdfe-0b4c-456d-a75f-993b6589b918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91ba4edf-f6cb-4578-b1cd-3d3e4db5350f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3998fdfe-0b4c-456d-a75f-993b6589b918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3998fdfe-0b4c-456d-a75f-993b6589b918_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3998fdfe-0b4c-456d-a75f-993b6589b918" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3998fdfe-0b4c-456d-a75f-993b6589b918_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3998fdfe-0b4c-456d-a75f-993b6589b918" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2072c7a6-21db-4be4-9e8e-ef880ac5df22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:to="loc_us-gaap_RestrictedStockMember_2072c7a6-21db-4be4-9e8e-ef880ac5df22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_780d2be7-baad-4d56-9975-0eff89adeeef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:to="loc_us-gaap_EmployeeStockOptionMember_780d2be7-baad-4d56-9975-0eff89adeeef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_5e4f63ed-9706-446a-978d-c07ad315ba25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:to="loc_us-gaap_WarrantMember_5e4f63ed-9706-446a-978d-c07ad315ba25" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENT" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENT"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENT" xlink:type="extended" id="ifb7f0272de8d4d86be82313df9d2266f_BUSINESSSEGMENT"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTTables"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables" xlink:type="extended" id="i7b946686727b4e249ec78febce4155fb_BUSINESSSEGMENTTables"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails" xlink:type="extended" id="iaed4e3405e6d43aaa1b343d845a42584_BUSINESSSEGMENTNarrativeDetails"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails" xlink:type="extended" id="i0ea1e1770cae490e900a6ace307b072f_BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_34352d6e-8bff-420d-9511-c35c9394dcb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ff21c30-91f6-401d-9938-bf237531b5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_34352d6e-8bff-420d-9511-c35c9394dcb6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ff21c30-91f6-401d-9938-bf237531b5a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2839ab5e-b1f3-4418-9edd-9ae55ebec577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_34352d6e-8bff-420d-9511-c35c9394dcb6" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2839ab5e-b1f3-4418-9edd-9ae55ebec577" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6ec37416-b7d2-4fc1-a3dc-982a86d16b30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2839ab5e-b1f3-4418-9edd-9ae55ebec577" xlink:to="loc_srt_StatementGeographicalAxis_6ec37416-b7d2-4fc1-a3dc-982a86d16b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6ec37416-b7d2-4fc1-a3dc-982a86d16b30_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6ec37416-b7d2-4fc1-a3dc-982a86d16b30" xlink:to="loc_srt_SegmentGeographicalDomain_6ec37416-b7d2-4fc1-a3dc-982a86d16b30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6ec37416-b7d2-4fc1-a3dc-982a86d16b30" xlink:to="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2de9eb6d-e05b-4107-bc02-9c279b07aad8" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:to="loc_country_US_2de9eb6d-e05b-4107-bc02-9c279b07aad8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_056dccc3-a6d8-47db-8ffc-206ad6bcc9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:to="loc_us-gaap_NonUsMember_056dccc3-a6d8-47db-8ffc-206ad6bcc9ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails" xlink:type="extended" id="i7ba00b04b4bf44f5af93901b0b29e6e6_BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b0e2739f-24c2-4b9c-a6b5-1e95fa275fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fb50359-5a1d-477f-a3fd-e18f0bd505b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e2739f-24c2-4b9c-a6b5-1e95fa275fba" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fb50359-5a1d-477f-a3fd-e18f0bd505b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccdc4fd7-38fc-4db5-bbe6-4ef94a6a3d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e2739f-24c2-4b9c-a6b5-1e95fa275fba" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccdc4fd7-38fc-4db5-bbe6-4ef94a6a3d2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_535de56e-e3a5-4b48-93b5-766106913ece" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccdc4fd7-38fc-4db5-bbe6-4ef94a6a3d2a" xlink:to="loc_srt_ProductOrServiceAxis_535de56e-e3a5-4b48-93b5-766106913ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_535de56e-e3a5-4b48-93b5-766106913ece_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_535de56e-e3a5-4b48-93b5-766106913ece" xlink:to="loc_srt_ProductsAndServicesDomain_535de56e-e3a5-4b48-93b5-766106913ece_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_535de56e-e3a5-4b48-93b5-766106913ece" xlink:to="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TraumaAndDeformityMember_eae17183-f765-4b49-b2cd-647bb3d826a3" xlink:href="kids-20200630.xsd#kids_TraumaAndDeformityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:to="loc_kids_TraumaAndDeformityMember_eae17183-f765-4b49-b2cd-647bb3d826a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SpineMember_896ca8bd-795f-49c7-b260-4c714c93cbaa" xlink:href="kids-20200630.xsd#kids_SpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:to="loc_kids_SpineMember_896ca8bd-795f-49c7-b260-4c714c93cbaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SportsMedicineandOtherMember_61b16568-ecf0-4137-a89c-7699a176546a" xlink:href="kids-20200630.xsd#kids_SportsMedicineandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:to="loc_kids_SportsMedicineandOtherMember_61b16568-ecf0-4137-a89c-7699a176546a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended" id="ia6f7bbb0490c48219e3e20dcdd4ced04_RELATEDPARTYTRANSACTIONS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended" id="ic12d0a028ffe480f8868b7aa2af088f4_RELATEDPARTYTRANSACTIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_NumberOfRelatedPartyEntitiesSuppliers_4391d9bb-583a-473d-85f4-d1ccd11a7222" xlink:href="kids-20200630.xsd#kids_NumberOfRelatedPartyEntitiesSuppliers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_kids_NumberOfRelatedPartyEntitiesSuppliers_4391d9bb-583a-473d-85f4-d1ccd11a7222" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_86a26d39-8d3f-4c84-aa7b-610be1da846e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_86a26d39-8d3f-4c84-aa7b-610be1da846e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_788a923c-403f-4a68-b3f6-a0abc387326d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_788a923c-403f-4a68-b3f6-a0abc387326d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0094b811-4683-4d30-96ed-dfe1f76869c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0094b811-4683-4d30-96ed-dfe1f76869c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_43c68be0-680a-4749-9de4-c634dbdcd44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_43c68be0-680a-4749-9de4-c634dbdcd44d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_43c68be0-680a-4749-9de4-c634dbdcd44d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_43c68be0-680a-4749-9de4-c634dbdcd44d" xlink:to="loc_us-gaap_RelatedPartyDomain_43c68be0-680a-4749-9de4-c634dbdcd44d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5573aa5e-ac2e-4afc-94b3-299756f84134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_43c68be0-680a-4749-9de4-c634dbdcd44d" xlink:to="loc_us-gaap_RelatedPartyDomain_5573aa5e-ac2e-4afc-94b3-299756f84134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_836e4453-0ce1-4bd4-b88f-7405eeedc566" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5573aa5e-ac2e-4afc-94b3-299756f84134" xlink:to="loc_srt_AffiliatedEntityMember_836e4453-0ce1-4bd4-b88f-7405eeedc566" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3ce67a30-edac-493a-b1bf-6371e2fa0e34" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:to="loc_srt_CounterpartyNameAxis_3ce67a30-edac-493a-b1bf-6371e2fa0e34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ce67a30-edac-493a-b1bf-6371e2fa0e34_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_3ce67a30-edac-493a-b1bf-6371e2fa0e34" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ce67a30-edac-493a-b1bf-6371e2fa0e34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cd1139e-7f30-473f-9b5d-45a40dfc11b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_3ce67a30-edac-493a-b1bf-6371e2fa0e34" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cd1139e-7f30-473f-9b5d-45a40dfc11b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FMIHansaMedicalProductsMember_2a267c41-fd31-4b05-a396-7d0feb6c669b" xlink:href="kids-20200630.xsd#kids_FMIHansaMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cd1139e-7f30-473f-9b5d-45a40dfc11b4" xlink:to="loc_kids_FMIHansaMedicalProductsMember_2a267c41-fd31-4b05-a396-7d0feb6c669b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_820cabdd-8e2d-4e17-afca-e22c8ab05ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_820cabdd-8e2d-4e17-afca-e22c8ab05ad8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_820cabdd-8e2d-4e17-afca-e22c8ab05ad8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_820cabdd-8e2d-4e17-afca-e22c8ab05ad8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_820cabdd-8e2d-4e17-afca-e22c8ab05ad8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_504859dc-13f5-4d05-865f-08da7279be6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_820cabdd-8e2d-4e17-afca-e22c8ab05ad8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_504859dc-13f5-4d05-865f-08da7279be6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6ba9db7e-6896-44b2-bc33-f1f769a6acd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_504859dc-13f5-4d05-865f-08da7279be6d" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6ba9db7e-6896-44b2-bc33-f1f769a6acd8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN" xlink:type="simple" xlink:href="kids-20200630.xsd#EMPLOYEEBENEFITPLAN"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN" xlink:type="extended" id="i0d5560e62c7041c2b734e35641b5fcbb_EMPLOYEEBENEFITPLAN"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#EMPLOYEEBENEFITPLANNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails" xlink:type="extended" id="i0e1f6f8d740845c3ab70efe51b3e724e_EMPLOYEEBENEFITPLANNarrativeDetails"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="kids-20200630.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i3adecf9f03944ff68ceebf7c81558a5c_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ifd3d09292aa543659a40b99295277a5b_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_72542621-acdd-4834-ba31-32a3ea399e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_us-gaap_OperatingLeaseLiability_72542621-acdd-4834-ba31-32a3ea399e0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_455d022a-9589-4250-88bc-8e3a44b0535a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_455d022a-9589-4250-88bc-8e3a44b0535a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_ad213de4-a22c-4ed7-ae53-4c3eb5de4e41" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_ad213de4-a22c-4ed7-ae53-4c3eb5de4e41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_ffbf45b3-0d38-48b9-8373-7803be445b45" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_ffbf45b3-0d38-48b9-8373-7803be445b45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_90c74214-b358-4ba1-bced-c6009550a05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_90c74214-b358-4ba1-bced-c6009550a05a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_90c74214-b358-4ba1-bced-c6009550a05a" xlink:to="loc_srt_RangeAxis_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f" xlink:to="loc_srt_RangeMember_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f" xlink:to="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7cb060ae-40e7-4e3f-8b20-4990471edc97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:to="loc_srt_MinimumMember_7cb060ae-40e7-4e3f-8b20-4990471edc97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6110e94-ab07-42d0-bfd5-8639166c7638" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:to="loc_srt_MaximumMember_a6110e94-ab07-42d0-bfd5-8639166c7638" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#SUBSEQUENTEVENTS"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS" xlink:type="extended" id="if634d136770f4ae890a66da921f999cd_SUBSEQUENTEVENTS"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="i612a71fbb1af43819baa57c15e2901db_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_68a08eda-740e-4d1b-a80f-9a218eb6eb9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_68a08eda-740e-4d1b-a80f-9a218eb6eb9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4f921b27-b961-4a56-a513-27b71c1a5481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4f921b27-b961-4a56-a513-27b71c1a5481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_03ca3af7-06d3-4597-b970-57c46e6e15a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_03ca3af7-06d3-4597-b970-57c46e6e15a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_375611a4-b75b-4903-b501-2e62f9567d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_375611a4-b75b-4903-b501-2e62f9567d06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_0b10cfaf-d128-453e-96b9-70289db0d7f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_0b10cfaf-d128-453e-96b9-70289db0d7f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_96f4cb82-6c7e-404d-8ac7-3108e98bd518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_96f4cb82-6c7e-404d-8ac7-3108e98bd518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_96f4cb82-6c7e-404d-8ac7-3108e98bd518_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96f4cb82-6c7e-404d-8ac7-3108e98bd518" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_96f4cb82-6c7e-404d-8ac7-3108e98bd518_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_35948416-fdc3-4513-b2f9-5271a15bde72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96f4cb82-6c7e-404d-8ac7-3108e98bd518" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_35948416-fdc3-4513-b2f9-5271a15bde72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e4e2dc99-a548-48fb-8595-ad42b43581c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_35948416-fdc3-4513-b2f9-5271a15bde72" xlink:to="loc_us-gaap_SubsequentEventMember_e4e2dc99-a548-48fb-8595-ad42b43581c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03784e66-86a3-4fcf-be24-3e279800914d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03784e66-86a3-4fcf-be24-3e279800914d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03784e66-86a3-4fcf-be24-3e279800914d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03784e66-86a3-4fcf-be24-3e279800914d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03784e66-86a3-4fcf-be24-3e279800914d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_83942a9a-68e3-49b8-92ef-4d577e537950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03784e66-86a3-4fcf-be24-3e279800914d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_83942a9a-68e3-49b8-92ef-4d577e537950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_2c98bb24-128d-45d3-8e0c-c3b5f6a6c2ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_83942a9a-68e3-49b8-92ef-4d577e537950" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_2c98bb24-128d-45d3-8e0c-c3b5f6a6c2ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9149c9f4-ff2f-431d-ad58-bb66011e4bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_DebtInstrumentAxis_9149c9f4-ff2f-431d-ad58-bb66011e4bfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9149c9f4-ff2f-431d-ad58-bb66011e4bfc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9149c9f4-ff2f-431d-ad58-bb66011e4bfc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9149c9f4-ff2f-431d-ad58-bb66011e4bfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9149c9f4-ff2f-431d-ad58-bb66011e4bfc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TermNoteAMember_858cbdf9-e8ec-4c68-842b-8f460cecb42e" xlink:href="kids-20200630.xsd#kids_TermNoteAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:to="loc_kids_TermNoteAMember_858cbdf9-e8ec-4c68-842b-8f460cecb42e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAmendedLoanAgreementMember_83419678-f5f3-4f99-bc09-324b2e035254" xlink:href="kids-20200630.xsd#kids_SecondAmendedLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:to="loc_kids_SecondAmendedLoanAgreementMember_83419678-f5f3-4f99-bc09-324b2e035254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FirstAmendedLoanAgreementMember_f43a707a-122e-4e64-96cd-ef9f9b0b8047" xlink:href="kids-20200630.xsd#kids_FirstAmendedLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:to="loc_kids_FirstAmendedLoanAgreementMember_f43a707a-122e-4e64-96cd-ef9f9b0b8047" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_dffbae6c-a58b-4643-9449-5affe5abbcac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_srt_CounterpartyNameAxis_dffbae6c-a58b-4643-9449-5affe5abbcac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dffbae6c-a58b-4643-9449-5affe5abbcac_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_dffbae6c-a58b-4643-9449-5affe5abbcac" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_dffbae6c-a58b-4643-9449-5affe5abbcac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c7b61c8-a263-4f8a-a2b3-1fa5d0711cbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_dffbae6c-a58b-4643-9449-5affe5abbcac" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c7b61c8-a263-4f8a-a2b3-1fa5d0711cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SquadronMember_2a74864d-1915-4f3c-af99-d11dee473e9d" xlink:href="kids-20200630.xsd#kids_SquadronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c7b61c8-a263-4f8a-a2b3-1fa5d0711cbb" xlink:to="loc_kids_SquadronMember_2a74864d-1915-4f3c-af99-d11dee473e9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_0e3c77ac-f45e-4f5a-87ec-b299e813606a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_VariableRateAxis_0e3c77ac-f45e-4f5a-87ec-b299e813606a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0e3c77ac-f45e-4f5a-87ec-b299e813606a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_0e3c77ac-f45e-4f5a-87ec-b299e813606a" xlink:to="loc_us-gaap_VariableRateDomain_0e3c77ac-f45e-4f5a-87ec-b299e813606a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_99357c2d-c629-4401-829a-ef6ecee4cb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_0e3c77ac-f45e-4f5a-87ec-b299e813606a" xlink:to="loc_us-gaap_VariableRateDomain_99357c2d-c629-4401-829a-ef6ecee4cb9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da7cb665-f229-4ccc-953b-6d22d827f347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_99357c2d-c629-4401-829a-ef6ecee4cb9d" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da7cb665-f229-4ccc-953b-6d22d827f347" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>kids-20200630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:6cad6b03-419c-4f54-8eef-33f01636649a,g:8b88b676-dabc-417a-b49f-ad3a7a6b9677-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_89746ddd-0870-43f9-9a9b-9e716fa38f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_8f4fce1d-6dd1-4ff5-8673-079ce16677d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_dd4b83b6-ea48-482c-8cd8-d6b3e4daddb1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e8720ed3-e5bb-4c38-98b3-01553d5c059c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3683e897-d8eb-4b3d-85b0-3f1329058e61_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4f822818-0fde-4337-8e14-6bc99fecfb92_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_1f62db7d-cf6d-42e2-99b1-806971b13c2f_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_409151c9-6c53-42a2-b76f-a36f2fb2a9a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_ef1e076e-5f65-4080-b7c5-9787d8039d7e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLAN</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationRevenuePayment_46b3a20d-5494-40c8-a70f-35a213eedced_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationRevenuePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">System sales payment</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationRevenuePayment_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationRevenuePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Revenue Payment</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationRevenuePayment_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationRevenuePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Revenue Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenuePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment" xlink:to="lab_kids_BusinessCombinationContingentConsiderationRevenuePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_e367d151-b011-4163-8586-4dba0f6e9523_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_8c49c399-e3f7-47bc-80fb-74d6a60a3d6c_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9f186bfe-3df0-4d98-8031-09fff641f153_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f362436e-d353-4995-a980-f93615c69635_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_bc3d9cb6-3512-4250-86a0-08888828cf3e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan facility with Squadron</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8970cda7-fdca-4b21-ba16-6f614cf08c18_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_SecondAmendedLoanAgreementMember_5d7f5c3a-b930-47e2-a764-c1063cf6fc7c_terseLabel_en-US" xlink:label="lab_kids_SecondAmendedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Amended Loan Agreement</link:label>
    <link:label id="lab_kids_SecondAmendedLoanAgreementMember_label_en-US" xlink:label="lab_kids_SecondAmendedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Amended Loan Agreement [Member]</link:label>
    <link:label id="lab_kids_SecondAmendedLoanAgreementMember_documentation_en-US" xlink:label="lab_kids_SecondAmendedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Amended Loan Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAmendedLoanAgreementMember" xlink:href="kids-20200630.xsd#kids_SecondAmendedLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_SecondAmendedLoanAgreementMember" xlink:to="lab_kids_SecondAmendedLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_e8de2ebe-40b4-4eb1-af1b-86bc0252fcaa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly interest and principal installments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_063df832-8d54-46d3-8b9b-f2e923ae5cf9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities - continuing operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_601ef4fe-cde4-4537-abce-51ce7e9ca22d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_dc87853f-98a2-4167-b86f-005c73a7d65b_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5b1bea41-14d8-4d6f-987c-b3147bc79087_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_799c8d09-661f-4690-8ea4-048f71d3c9d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e6279010-ed2f-42fe-aeef-6b4295096e07_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_02cf099a-3e2d-404e-8b9f-1e53a0b3b44b_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_SpineMember_f7da69a3-4e96-4190-abc9-5e803c46827b_terseLabel_en-US" xlink:label="lab_kids_SpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scoliosis</link:label>
    <link:label id="lab_kids_SpineMember_label_en-US" xlink:label="lab_kids_SpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SpineMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SpineMember" xlink:href="kids-20200630.xsd#kids_SpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_SpineMember" xlink:to="lab_kids_SpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0c820e78-536a-4ef2-bce2-2b5b99634639_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_41868427-60df-49fe-96f0-12163ca968b0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_d694f07d-e1db-45de-be36-1ecde4945266_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities - continuing operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_3da89695-b4e1-44db-874c-bb1dc0ca1077_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4a1c1844-f74f-46c0-832a-7fa135c1b3db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_ff9f6a32-5ee7-4d56-9ac8-cda8193f5092_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_fb02c539-41e1-48c8-b007-e8dce38ba936_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_827c8ded-af20-48b9-9fb9-61c1a1c666c8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c3142b8e-306f-448c-a11d-fe0d0bc9ebfa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesAndLoans_383dba03-4b9c-469d-8c01-d523cfb4f703_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesAndLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt with affiliate, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesAndLoans_label_en-US" xlink:label="lab_us-gaap_LongTermNotesAndLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Loans, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesAndLoans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesAndLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesAndLoans" xlink:to="lab_us-gaap_LongTermNotesAndLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_12df9fd8-e803-4be5-b807-eb0d3b338a54_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fee69750-f2e1-4ae0-83d4-79aa5781ea14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_b65043ac-0017-4b90-a537-c2f7fabae578_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_44520edf-f97c-43e3-ae7b-0b3bd997aab0_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_583c874d-f03e-4d73-ab78-cb5fae1033d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7745854e-b1a0-4588-a4e8-016503f7f5bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable - trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAnniversaryPayments_34c136ad-69c8-46bf-9f9a-88f12f46bd6a_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAnniversaryPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anniversary payments</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAnniversaryPayments_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAnniversaryPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Anniversary Payments</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAnniversaryPayments_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAnniversaryPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Anniversary Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAnniversaryPayments" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAnniversaryPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationAnniversaryPayments" xlink:to="lab_kids_BusinessCombinationContingentConsiderationAnniversaryPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2983e067-f081-4a0b-a233-1892c2a5fd3e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_FirstAmendedLoanAgreementMember_913f7133-9330-4305-93fb-c41201bfe5ef_terseLabel_en-US" xlink:label="lab_kids_FirstAmendedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Amended Loan Agreement</link:label>
    <link:label id="lab_kids_FirstAmendedLoanAgreementMember_label_en-US" xlink:label="lab_kids_FirstAmendedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Amended Loan Agreement [Member]</link:label>
    <link:label id="lab_kids_FirstAmendedLoanAgreementMember_documentation_en-US" xlink:label="lab_kids_FirstAmendedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Amended Loan Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FirstAmendedLoanAgreementMember" xlink:href="kids-20200630.xsd#kids_FirstAmendedLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_FirstAmendedLoanAgreementMember" xlink:to="lab_kids_FirstAmendedLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c86ba562-d0ce-4ea8-ba8b-a9975f318a27_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_48c0bf0a-eefb-4bb5-941c-6a2064b35a18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4bdf7119-1fe6-4b7a-a0f6-202f4d7d4a26_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f6d22cc5-6db2-446d-bf39-d970832d604a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Economic Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_5a953f9d-3692-4186-85b7-85f191e5cb97_netLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_de4b4560-b84f-4d9b-ab07-f0cc45c01c47_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c563f9cd-1d19-462f-99b2-d3853c5af921_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period start (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_430e0a12-7a57-4821-9bcd-7fbf6a642bc3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_be9c9216-b456-404c-99de-d5e669a6c914_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_41872bd2-2d51-4a6f-9c48-4872571e159a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_0949a4fc-01fc-4519-9638-977511ea94fc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt with affiliate</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_e0f1627f-d0f3-4e2d-b6a5-45605ced6d4c_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e26bfe2f-c7d1-4fc1-9a71-67a96fd4a947_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_77d0c7a3-a136-40b1-8939-c56cbc0a6e85_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_49962ad0-7be6-4d2a-94d9-4ae0b82fe4e3_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_886a8b47-7d28-4361-95a5-aba189bf88b0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyEquipmentMember_0fa24be5-224d-4967-9e5f-f62de2601462_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_us-gaap_TechnologyEquipmentMember_label_en-US" xlink:label="lab_us-gaap_TechnologyEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyEquipmentMember" xlink:to="lab_us-gaap_TechnologyEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_dd4e611d-1fe5-4610-9c1e-0e104d5910f1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounts and commissions</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7823791e-8c2a-408f-93a7-643c9e57f23a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9cea8063-0301-4648-8496-5127e52cac4e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_FourthAnniversaryMember_396c246e-8c07-4da3-be53-3cf613e240c2_terseLabel_en-US" xlink:label="lab_kids_FourthAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fourth Anniversary</link:label>
    <link:label id="lab_kids_FourthAnniversaryMember_label_en-US" xlink:label="lab_kids_FourthAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fourth Anniversary [Member]</link:label>
    <link:label id="lab_kids_FourthAnniversaryMember_documentation_en-US" xlink:label="lab_kids_FourthAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fourth Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FourthAnniversaryMember" xlink:href="kids-20200630.xsd#kids_FourthAnniversaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_FourthAnniversaryMember" xlink:to="lab_kids_FourthAnniversaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6c9ead38-3e15-43fe-8e37-730575175fa4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_ca047402-778e-4fcd-8ac3-9c95bb1e867f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_c41620ce-46d6-4ba3-a9d3-ac67c7494861_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86bb62b2-7115-47ed-a877-34c4401b50fb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bd4de30c-be88-4d1b-ae34-dcf38c7d5a09_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b3a9e807-1bac-4082-80c0-bc0334e08899_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_aecfdc0b-4eea-4f04-8719-e0d869d52bda_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_TermNoteBMember_e0e438d9-720b-43c8-a0a5-73784690fea8_terseLabel_en-US" xlink:label="lab_kids_TermNoteBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Note B</link:label>
    <link:label id="lab_kids_TermNoteBMember_label_en-US" xlink:label="lab_kids_TermNoteBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Note B [Member]</link:label>
    <link:label id="lab_kids_TermNoteBMember_documentation_en-US" xlink:label="lab_kids_TermNoteBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Note B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TermNoteBMember" xlink:href="kids-20200630.xsd#kids_TermNoteBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_TermNoteBMember" xlink:to="lab_kids_TermNoteBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f03f0d25-ecb1-4b78-9bfc-3e95aaf041ef_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_b21e927c-4be4-410b-a50e-f79a586c2e1e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c509e475-a660-401d-b6bf-e3ad27a52af2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of antidilutive securities excluded from computation of net loss per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_cca8cf97-ba95-4a0c-a5aa-62a4a4d94a12_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f38efd08-cf62-4ccc-80dd-a8f8d6973c4d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_14b6de3f-97fc-4c7e-a317-b4a64c5bb59f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_5ba01508-992b-4bc9-bc04-5201482073b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_7dd88f9f-bfc5-4e16-87ae-cdf3d7b49e43_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_dd66fb0b-0c52-4875-a6cc-2885618f1762_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApiFix future consideration, net of current portion</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f76e9899-b1e0-4deb-b85d-b8bee39f2ea8_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApiFix future consideration, net of current portion</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3060d556-7a92-46e9-a1a6-86250f1a94b9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f1d1f4f2-3dee-41d7-be96-50b6396505f9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_7b35722f-7647-4f83-9159-fa8329c2f690_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_4812deec-f05f-4d9a-b800-51675c25d2d6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_16abe2aa-3255-4665-a25b-1ff90e40792f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_5212491f-66c7-40a4-b6c0-267cb60659f7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ebbbbf9f-6b95-47c9-b7ce-5864df22299c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning weighted-average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9029cc9d-30db-436c-994c-66a7f37c6a5c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending weighted-average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_aa68f1d2-e2ac-4483-8a09-303e52c4c0d9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - basic and diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_e5c1c222-5754-4d51-9de6-17e283c4112a_totalLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anniversary payments</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Acquisition Installment Payable</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Acquisition Installment Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" xlink:to="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8280646d-7704-4336-b5c0-3d40c26780bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8d37b1be-c146-4bfe-b157-80491f3de215_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued and sold</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyAgreementTermsMember_7d037578-c558-49ec-ac5e-bead7da930e6_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreement Terms</link:label>
    <link:label id="lab_us-gaap_RoyaltyAgreementTermsMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreement Terms [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementTermsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementTermsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyAgreementTermsMember" xlink:to="lab_us-gaap_RoyaltyAgreementTermsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_a5947335-7c59-47bc-9590-2fa7fdb79b54_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT AND CREDIT ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_7f4e7a52-86df-473c-b9b1-70e03224201d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_56d53ee1-a885-4da4-bdf7-9f50df88b5c8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_a9068ebf-9782-4319-8dd4-8c4083130e60_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4ab3908a-b837-4d7a-a44d-fc65617b9f88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of basic and diluted net loss per share attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ThirdAnniversaryMember_3ee79a09-cafb-42f7-9252-a6a1100fd1c3_terseLabel_en-US" xlink:label="lab_kids_ThirdAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Anniversary</link:label>
    <link:label id="lab_kids_ThirdAnniversaryMember_label_en-US" xlink:label="lab_kids_ThirdAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Anniversary [Member]</link:label>
    <link:label id="lab_kids_ThirdAnniversaryMember_documentation_en-US" xlink:label="lab_kids_ThirdAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ThirdAnniversaryMember" xlink:href="kids-20200630.xsd#kids_ThirdAnniversaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ThirdAnniversaryMember" xlink:to="lab_kids_ThirdAnniversaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_aa67d20f-ded9-4668-a2a5-7330c87627a7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_5a4efd9e-88e1-4c5d-a835-10c6ff2e5803_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock value</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_bad69cfb-88b6-4a94-a031-bf7509a6e67a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for award (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_202c3be4-4e69-4897-9f19-6995b8da5734_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5cac125a-5dec-42bd-87f3-ddc4c12c06fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_822700e1-9f7b-4049-af3f-d809d1c03018_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ApiFixLtdMember_9e11c786-10b0-4080-bf5b-5c0a6f04a804_terseLabel_en-US" xlink:label="lab_kids_ApiFixLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApiFix Ltd</link:label>
    <link:label id="lab_kids_ApiFixLtdMember_label_en-US" xlink:label="lab_kids_ApiFixLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApiFix Ltd. [Member]</link:label>
    <link:label id="lab_kids_ApiFixLtdMember_documentation_en-US" xlink:label="lab_kids_ApiFixLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApiFix Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ApiFixLtdMember" xlink:to="lab_kids_ApiFixLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_de2f818c-426d-4682-93f4-8ee00ff82bde_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_6f402522-c90a-4d25-b9e8-5add29329022_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on note with affiliate</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_2caa365d-4922-486c-9ad4-004a9ef466b5_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on note with affiliate</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_570e7cef-1162-41b3-845f-4ea2a457351f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_783a34b9-6802-4a90-abdf-2ed34b82d3ed_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_d5434623-af08-4fce-8f9d-8d90a751064d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a3f0a3ba-4a92-4feb-a20a-5f199280ed2f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_940d4c00-6871-4dd5-8553-2569e2903154_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_012d7ea5-5850-479d-af46-209c87466c13_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_5d4d8157-4e13-4c9b-bede-06829fad78d0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a842d4ed-dc50-43d2-90b5-eca881bd5449_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee09980a-f0d1-4f04-837e-50bc60b8b3e9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_CaseWesternReserveUniversityMember_f0ce7224-ed85-4768-a0d2-37845930c00a_terseLabel_en-US" xlink:label="lab_kids_CaseWesternReserveUniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASE</link:label>
    <link:label id="lab_kids_CaseWesternReserveUniversityMember_label_en-US" xlink:label="lab_kids_CaseWesternReserveUniversityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Case Western Reserve University [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_CaseWesternReserveUniversityMember" xlink:href="kids-20200630.xsd#kids_CaseWesternReserveUniversityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_CaseWesternReserveUniversityMember" xlink:to="lab_kids_CaseWesternReserveUniversityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_11ffa91e-73b3-4c26-b55e-94f0ffaa0f6d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bee2bc78-c092-4adc-b928-4b62f31ef2cf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6c482b90-700b-49c4-a08e-da54febb0627_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0525d580-881d-46ef-a083-29487dfe19ca_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_c19bc89e-4005-4468-9606-40ce4f6e343a_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_25b66f7c-910d-4eae-aad7-609baad941f9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ClassOfWarrantOrRightOutstandingRollForward_f60e9d3d-cfda-4d94-b15c-6c1b3ed6c751_terseLabel_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right Outstanding [Roll Forward]</link:label>
    <link:label id="lab_kids_ClassOfWarrantOrRightOutstandingRollForward_label_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right Outstanding [Roll Forward]</link:label>
    <link:label id="lab_kids_ClassOfWarrantOrRightOutstandingRollForward_documentation_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ClassOfWarrantOrRightOutstandingRollForward" xlink:href="kids-20200630.xsd#kids_ClassOfWarrantOrRightOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ClassOfWarrantOrRightOutstandingRollForward" xlink:to="lab_kids_ClassOfWarrantOrRightOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5547bae9-9cc6-40ed-9c11-2bbf8b438c40_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_ed11484c-a569-4ae5-bb97-e895ef469065_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_15b16936-715d-4caf-9e4c-5a284b46e2c0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_b60cbcd0-5ea2-42d7-b334-bd731da4c3b6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance cost</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_8f14910a-0214-48dc-9bde-c07a7a5de59b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_a4f95abd-1a0b-48b8-8864-c9327d9c2166_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a139948d-5f11-4203-a992-0c08051d0f0b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_bb5a6d73-e49e-4e27-9581-4f27da647598_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_400e7af8-dda9-43af-9046-c725a83a3fd1_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges, finite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_313cb8bc-00e1-4880-af86-375f00c879cc_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cash of discontinued operations, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_267cc010-586d-44b4-ab3a-e6a054390b2a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period start (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e6ced1b5-597f-4516-88c1-1a0edcef30d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_f7f48644-b433-4af6-b716-f29b817e9b83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_b6baf1e6-3ec1-4b0f-bd2f-060d5a1ab61c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities_359d7d35-5f5f-435d-9eb7-9e69d5f26db7_terseLabel_en-US" xlink:label="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated purchase price</link:label>
    <link:label id="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities_label_en-US" xlink:label="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Assets And Liabilities</link:label>
    <link:label id="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities_documentation_en-US" xlink:label="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Assets And Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" xlink:href="kids-20200630.xsd#kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" xlink:to="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_8d1b11d3-be02-44cb-a0f5-4c4b0a4ccb40_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable - trade</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts and Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_17a46925-a3eb-4c1d-a104-cae74131490b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_42bc352a-451c-436b-8b09-2b40dd085200_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c5187cac-bd6e-4af0-b039-239d1ccad472_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_daee2bbb-b841-4148-bef2-d6fed60517f0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_NumberOfRelatedPartyEntitiesSuppliers_2d95ee74-6418-4c1c-b5e3-adc5d2f10aa6_terseLabel_en-US" xlink:label="lab_kids_NumberOfRelatedPartyEntitiesSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of related party suppliers</link:label>
    <link:label id="lab_kids_NumberOfRelatedPartyEntitiesSuppliers_label_en-US" xlink:label="lab_kids_NumberOfRelatedPartyEntitiesSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Related Party Entities Suppliers</link:label>
    <link:label id="lab_kids_NumberOfRelatedPartyEntitiesSuppliers_documentation_en-US" xlink:label="lab_kids_NumberOfRelatedPartyEntitiesSuppliers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Related Party Entities Suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_NumberOfRelatedPartyEntitiesSuppliers" xlink:href="kids-20200630.xsd#kids_NumberOfRelatedPartyEntitiesSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_NumberOfRelatedPartyEntitiesSuppliers" xlink:to="lab_kids_NumberOfRelatedPartyEntitiesSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_998e0f50-8299-4cc3-85de-01c24b445f33_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_6b602ff6-424a-40a9-b8ba-cb19a5b1d397_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_9841cf20-25ad-4b56-b420-32c8c89b115d_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_99bc5798-4706-4097-980f-cdd2a8854ade_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ae2e490c-a698-4e48-b448-56b7bd2f76e6_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9cec42ed-37da-4d4f-990e-7f20fd481f37_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e58d68cf-a6e9-4406-bf60-901fcd69a4c2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b5412293-f4d3-43d4-b351-40145d0154da_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_15e86552-79f1-4911-878f-1a6677e25f44_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_11dd2985-7f24-4bcc-96e7-41bb56a647b6_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a676a7d0-bcba-480c-b294-b247010f9ccd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5efe3a24-2ed4-4282-8251-f8b4629e5eb1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense, weighted average period of recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_bfbf8b33-78a8-40ef-bb5f-b4c83528cd09_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURES</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_914d89cb-ffde-4356-891a-deb348f55bac_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6866244f-84ac-4f5b-821b-da8e643e0bd3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0f87617d-eb93-471c-9042-8350b67a2aed_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_26f80d2b-18a4-47c4-be7c-54a344c8f433_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_28c77da4-d3c3-47df-a5bf-bc9a74122d7b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_fe0c4142-6f48-4ec3-97c1-f387f0ed0558_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STRATEGIC ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_92e6cdce-13f6-4846-b2bb-54a833ba2b03_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e347456a-e281-41dd-afb2-77f5e913b1e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable - trade</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a7c16951-1d32-4046-950b-481b49b139a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6b855697-6516-4020-96a8-65e2100aeaf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit_cd62761e-24a9-482e-98a5-982c2a58ab41_terseLabel_en-US" xlink:label="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual limitation of losses</link:label>
    <link:label id="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit_label_en-US" xlink:label="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Limitations on Use Estimated Amount Subject to Limitation Annual Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" xlink:href="kids-20200630.xsd#kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" xlink:to="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a7d01d68-7183-4b2a-8b3e-c125d7c48386_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b8ba8dc6-9c77-421e-84a6-d3f44bc62674_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_0a355cea-70c8-47cd-9b5e-51cbda53b416_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_bbfbc8e6-c330-4a02-b4fd-b665e574fecb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_5acda278-5374-425a-a05f-3fcb1920a3f7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_413bb66c-d08f-4cce-bbdf-a3fb83d1b4ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_e5b4d435-e605-46c8-9d7d-2ac431294182_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent payments</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_bbca17a7-fee6-436c-8465-dd7a4aecfdd2_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_2787a014-214a-4ddb-b0d9-f37212d26f99_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c725147d-8ad2-4963-8ce4-c889085523bf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cddeba1c-bc78-42e1-9910-1553dad01265_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a69c95d0-7da0-4b3c-98f4-b743ead9cd2c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_36bdce3c-a565-4259-8c5d-c9d7a12f6c85_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_b74e44f1-0646-4c62-9385-03e4dd8e3a46_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_94007f1d-0bc4-4020-aac9-5ac727ebb198_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_87eeb9e8-41a7-42ca-8541-41b04a83f437_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_a28a7dd0-749a-4814-9fa6-8280b624c81c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_76828ef8-057e-428e-a781-a233cf020010_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period start, Weighted-Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f1ac6a2c-723b-4c37-a655-aeb3298fee20_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at period end, Weighted-Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_b3ce3427-8b3c-4b32-9cf4-98d2aed8ef64_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_160e40b6-49b7-4e00-9928-748bad1394af_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_6dd1eb62-9b9a-4d25-81b7-ce1e19bbb45a_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and state</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_28adb5bd-eaf7-4fd8-acd9-c20e4881f880_terseLabel_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum annual royalty payment</link:label>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_8b76916e-7e6b-4caf-a7d1-bc24fcbfb542_verboseLabel_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum annual royalty commitments through 2026</link:label>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_label_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement Contract to Perform for Others Minimum Annual Royalty Payment</link:label>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_documentation_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement Contract to Perform for Others Minimum Annual Royalty Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" xlink:to="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_252545eb-9d16-4afb-bd57-9ce87994649a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of Telos, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3c9ba033-c00b-4174-b1a0-5f0d1253ee80_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_1d558c00-04a5-4bfd-a783-7aa5f15902b2_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_faf7d616-1cc9-44f4-b9c3-7e666e33960e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a8df2682-20b3-447d-b2d3-f64ae73cced1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of product sales by category</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock_46b8933f-23ac-4d5f-b233-b8eb9e1414c6_terseLabel_en-US" xlink:label="lab_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">"Emerging Growth Company" Reporting Requirements</link:label>
    <link:label id="lab_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company Reporting Requirements, Policy [Policy Text Block]</link:label>
    <link:label id="lab_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company Reporting Requirements, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" xlink:href="kids-20200630.xsd#kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" xlink:to="lab_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f943064e-94c7-4ad5-8b5e-854a8d5b2be9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3d5142c2-8f6d-472b-bb4a-272607af4571_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e64352d2-e019-463d-9cfb-8eba543b1f3d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_db7d1649-d1e4-44f5-b1f8-a964c072dec3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_77e79f18-b9c6-4cf1-a44a-c40f6e10a1b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_f535fe38-c230-4169-90c0-e48af26d1945_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty payable</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cecefe2d-dba1-44af-a468-63e0b2de7b84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_6aaa5a9a-f02a-4ba7-b816-3bf451ed7307_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities - discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_545ac46f-7584-42b6-9159-d0289e0121b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_1a24a931-7395-4014-8518-74fee419be79_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted stock activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d0bc5955-a19d-4080-82e6-75c5b5ef5e0f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3287697d-12c1-4ca9-9bdc-2fc8e6117da1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_0fa9ad09-2c48-493d-bc5a-3161add82944_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_6b6594e8-35f8-4cd6-a3b7-e39f021d0aca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_e7add3ad-67ef-4502-9118-f3836822bcda_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2f9e1c85-9440-4969-a195-99b9a3c0ff54_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_9335dc01-02cd-49d7-867b-f337847a2dba_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessAcquisitionAnniversaryAxis_002d3a78-6bf1-4ec0-9b41-3ed0db69eaec_terseLabel_en-US" xlink:label="lab_kids_BusinessAcquisitionAnniversaryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Anniversary [Axis]</link:label>
    <link:label id="lab_kids_BusinessAcquisitionAnniversaryAxis_label_en-US" xlink:label="lab_kids_BusinessAcquisitionAnniversaryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Anniversary [Axis]</link:label>
    <link:label id="lab_kids_BusinessAcquisitionAnniversaryAxis_documentation_en-US" xlink:label="lab_kids_BusinessAcquisitionAnniversaryAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryAxis" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis" xlink:to="lab_kids_BusinessAcquisitionAnniversaryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_ee799f4d-69a7-445d-b0ca-1ef0be1acadf_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3064decc-eb17-4168-8d7a-30454c5d583f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_New2017EquityIncentivePlanMember_d6320cc2-55c0-4481-bfcf-9a50c346b3a9_terseLabel_en-US" xlink:label="lab_kids_New2017EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Plan</link:label>
    <link:label id="lab_kids_New2017EquityIncentivePlanMember_label_en-US" xlink:label="lab_kids_New2017EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New 2017 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_New2017EquityIncentivePlanMember" xlink:href="kids-20200630.xsd#kids_New2017EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_New2017EquityIncentivePlanMember" xlink:to="lab_kids_New2017EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_3ee6c6fc-d334-4da5-9c92-1ad10e31e65c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_45e6c328-c140-49da-8b2c-b7632c620303_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f9b04a07-6b9c-4c7d-80c6-17d012c2a1d8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3ce941f7-5904-457e-a170-b63e6749256a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_1ae46dcb-34d9-4808-b704-e18227f7ecb8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_VilexAndOrthexMember_01c256c2-d51a-4ac5-ab17-c358458c1a24_terseLabel_en-US" xlink:label="lab_kids_VilexAndOrthexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vilex and Orthex</link:label>
    <link:label id="lab_kids_VilexAndOrthexMember_label_en-US" xlink:label="lab_kids_VilexAndOrthexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vilex and Orthex [Member]</link:label>
    <link:label id="lab_kids_VilexAndOrthexMember_documentation_en-US" xlink:label="lab_kids_VilexAndOrthexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vilex and Orthex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexAndOrthexMember" xlink:href="kids-20200630.xsd#kids_VilexAndOrthexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_VilexAndOrthexMember" xlink:to="lab_kids_VilexAndOrthexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_2c260030-2728-4cf7-ab51-885d0196b2d4_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable to Squadron</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f50688b5-17bd-48b8-8d08-716c722252ff_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6edb8795-39fd-41c1-9594-70f209294c32_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_d0771703-ef12-4307-b185-da56432de0cd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired during period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fab83d2d-3383-439c-9e3b-b1f47d217895_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contribution as a percentage of employees' salary</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationSystemSalesPayment_4919ccda-7029-4774-8a30-b724e4e23023_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationSystemSalesPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">System sales payment</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationSystemSalesPayment_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationSystemSalesPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, System Sales Payment</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationSystemSalesPayment_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationSystemSalesPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, System Sales Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationSystemSalesPayment" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationSystemSalesPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationSystemSalesPayment" xlink:to="lab_kids_BusinessCombinationContingentConsiderationSystemSalesPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_291a791b-69df-4a51-a004-cba6f14f2bde_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciable lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_ab1e703b-e6e5-4e8b-a15b-a531898c5c30_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_15cd1d93-76d1-46d5-be64-d50245267ec5_netLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage payable to affiliate</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_56991293-9c26-4653-ae5c-bc6e56d3991b_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage balance</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_A2007EquityIncentivePlanMember_847f560b-abdc-4b99-a736-30272435ee67_terseLabel_en-US" xlink:label="lab_kids_A2007EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 Plan</link:label>
    <link:label id="lab_kids_A2007EquityIncentivePlanMember_label_en-US" xlink:label="lab_kids_A2007EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_A2007EquityIncentivePlanMember" xlink:href="kids-20200630.xsd#kids_A2007EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_A2007EquityIncentivePlanMember" xlink:to="lab_kids_A2007EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_da40cfd1-613a-4b10-9720-95eac00e40fb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_4bce306d-d930-4547-ae86-1c0c6d5d0382_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5d51a49e-f178-45e8-a7dd-bfe6c6635e8f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_RevolvingLoanMember_8bbfe5f6-0a5e-47c3-9ac8-201e5743456f_terseLabel_en-US" xlink:label="lab_kids_RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Loan</link:label>
    <link:label id="lab_kids_RevolvingLoanMember_label_en-US" xlink:label="lab_kids_RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Loan [Member]</link:label>
    <link:label id="lab_kids_RevolvingLoanMember_documentation_en-US" xlink:label="lab_kids_RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_RevolvingLoanMember" xlink:href="kids-20200630.xsd#kids_RevolvingLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_RevolvingLoanMember" xlink:to="lab_kids_RevolvingLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_798942d6-af9b-404f-81c3-216a13c4427e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_82d37d62-9a29-4856-b5cf-7234b956ce83_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_14b46fdb-7d2d-4c17-a04d-5714bcd6d3f6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate gross proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_57e25c1f-0892-404d-b7d9-7d812acafe8e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5aaeb363-9cf8-47ec-b4b7-617677425c34_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_8b7ed9c5-08ba-4b8f-bbe0-cdbd8a6c60db_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_57189742-68e2-4617-af0b-7a34bc21a7aa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable-trade</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_f85529c2-1f1c-434f-a56b-a231c8df68d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_523a64ff-6dc6-43dd-b51f-f07bd1a1fcbb_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_165faceb-d2a9-402f-aff8-a2b2df135608_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_17f15390-c16f-4cb4-9581-fd401ee5bdaa_verboseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition installment payable, net of current portion</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_ed428761-5f40-4051-ad43-94125c778a9e_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition installment payable, net of current portion</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Acquisition Installment Payable, Noncurrent</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Acquisition Installment Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" xlink:to="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_72378bc2-0fe8-4db5-a862-e3a1f3a1434b_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_6cc27811-70cd-4e10-9acd-4a4c72b7d42c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_efb70413-a498-43e6-9daa-a22225e051ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_76fda44b-fcc9-434b-865b-9f41bcf5fb4f_terseLabel_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty agreement percentage</link:label>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_label_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement Contract to Perform for Others Royalty Agreement Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" xlink:to="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_aa6c5e83-1264-4f83-8278-83a563d68298_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_dabb9c84-1080-4bbd-94b7-50ecb73364ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, Weighted-Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_84a04b49-e642-42c0-bdc3-c76bf320a8e6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d7b04ff1-81f8-474f-9428-3011988e32a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_00c101a2-c44e-4897-bcb6-16c3fa765cc1_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_1a2592b3-944c-4058-b56e-3c735969eafb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused commitment fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0d4c254a-1e77-4da8-a771-f2dfcbcae2b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_e2b67210-d46b-4273-872e-b3901ef2136d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_2d099d6f-9a33-4c88-ad49-48ca8230a1cf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized [Abstract]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_617bd311-699e-4b56-924a-6a9d7e9c3099_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_54d41ed0-db7f-4372-ab4b-a7d075209688_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_2bcc24c0-fb40-40fc-aedc-1ff42a82a801_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e304c41e-04dc-4988-a693-e34ef557938d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_c5682d11-c83e-43d7-9870-b9a778a5eadd_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_612c466d-250e-4c6e-b6fd-1372c4f13c66_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e22d6a32-7f34-4adf-960c-714dd2834dda_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses:</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_TermNoteAMember_2cdaed3d-1aa9-44b1-8c55-9845edf34dd7_terseLabel_en-US" xlink:label="lab_kids_TermNoteAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Note A</link:label>
    <link:label id="lab_kids_TermNoteAMember_label_en-US" xlink:label="lab_kids_TermNoteAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Note A [Member]</link:label>
    <link:label id="lab_kids_TermNoteAMember_documentation_en-US" xlink:label="lab_kids_TermNoteAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Note A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TermNoteAMember" xlink:href="kids-20200630.xsd#kids_TermNoteAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_TermNoteAMember" xlink:to="lab_kids_TermNoteAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_8e78e660-14e1-465f-b6fd-8d99441a2afd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, effective percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e1693795-f039-44ee-8ffd-d361fd3e339a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable - trade, less allowance for doubtful accounts of $185 and $506, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_11c5cb33-2864-4576-91dd-c82369512de5_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationRevenueMultiplier" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue multiplier</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationRevenueMultiplier" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Revenue Multiplier</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationRevenueMultiplier" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Revenue Multiplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenueMultiplier"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier" xlink:to="lab_kids_BusinessCombinationContingentConsiderationRevenueMultiplier" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_532e7e74-180d-4ee9-b5a1-0488f175d66d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_c0c6fa4e-7e29-411a-baa5-3bf2e0430b1f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_fb0ed1d1-2f44-4aae-8280-91edcd06fb83_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock - basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b984a56c-916a-4bb5-9539-cc47dd7af17c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares - basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_07472ebc-21cd-4afe-8dc1-8642dd6025f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_TransferOfPropertyAndEquipmentToInventory_6121140b-6601-4bcf-b72e-ccfbbaa6dd92_terseLabel_en-US" xlink:label="lab_kids_TransferOfPropertyAndEquipmentToInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of instruments from property and equipment to inventory</link:label>
    <link:label id="lab_kids_TransferOfPropertyAndEquipmentToInventory_label_en-US" xlink:label="lab_kids_TransferOfPropertyAndEquipmentToInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Of Property And Equipment To Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TransferOfPropertyAndEquipmentToInventory" xlink:href="kids-20200630.xsd#kids_TransferOfPropertyAndEquipmentToInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_TransferOfPropertyAndEquipmentToInventory" xlink:to="lab_kids_TransferOfPropertyAndEquipmentToInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_23d44e16-d8e1-4647-ae9b-465d67754595_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_49f64677-01f8-40ff-a86f-6895f19f1b9e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_dfbcd761-179d-4aec-a7a5-79b51a35f177_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_19cd174d-5ed2-40cc-8d5f-49a0e9276c71_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_244a828a-d6ad-46d7-bd1a-e2150c1c5b97_verboseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of acquisition installment payable</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_6a94eabb-f3dc-4c54-86da-c4fc6599ad82_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion of acquisition installment payable</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Acquisition Installment Payable, Current</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Acquisition Installment Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" xlink:to="lab_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b68c0afb-8848-4eb8-b9d3-b8c542123dd4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6c87fa6e-41ae-4f50-b6f9-0f96ac57da07_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_OrthexMember_b4af3817-83b0-4993-9afc-ed9f8192c03e_terseLabel_en-US" xlink:label="lab_kids_OrthexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthex</link:label>
    <link:label id="lab_kids_OrthexMember_label_en-US" xlink:label="lab_kids_OrthexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthex [Member]</link:label>
    <link:label id="lab_kids_OrthexMember_documentation_en-US" xlink:label="lab_kids_OrthexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OrthexMember" xlink:href="kids-20200630.xsd#kids_OrthexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_OrthexMember" xlink:to="lab_kids_OrthexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_fba36f4b-f647-427b-be86-1819ac1297e2_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_6f1b4698-414d-4f8f-aa17-ceeb874cd86e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_1f2ff3f8-b4e1-4d02-a2c0-66687fa2d7e4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_72179a28-1d88-49ba-ba4b-ede0bc26eaad_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_a8a0caa2-5ba1-4f2e-8036-7eca9f791229_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at January 1, 2020</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_d38de991-f414-4e31-84bb-c658196a6596_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at June 30, 2020</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment_85931959-8603-4419-b889-911ca83b9f7f_terseLabel_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments for FDA approval to sell our products within the United States</link:label>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment_label_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement Contract to Perform for Others Royalty Agreement Ability to Sell Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" xlink:to="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_0b932c2f-ca9a-4ca2-be00-2f8ed842300e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_0f7f4bcb-f3cd-44f7-9604-62f76c7f3be5_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of clinical procedures</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number of Clinical Procedures</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number of Clinical Procedures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" xlink:to="lab_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ed023e1e-9012-4ddf-8c96-ddda3b2dbbd0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture purchase price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_0bf142d4-a160-40a7-942a-4a1c3dfa46be_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_df3b04e3-25b3-450b-8feb-19cd2fe350a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_95831987-f027-4bf6-b7cc-7f379e338021_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue_06af8569-7757-4aef-a831-b03676075da8_terseLabel_en-US" xlink:label="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Attributable to deferred revenue</link:label>
    <link:label id="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue_label_en-US" xlink:label="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Deferred Revenue</link:label>
    <link:label id="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue_documentation_en-US" xlink:label="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" xlink:href="kids-20200630.xsd#kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" xlink:to="lab_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_4b0087fd-86de-4f4c-8553-6a6041cf13ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d12e0f40-d0da-4394-b327-2e40b1a3be64_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISCONTINUED OPERATIONS</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d3674ef4-b17b-4dd7-a7e6-5db48c4fa8cd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_607a4797-1e7b-4a57-9bb1-cc06d37ac273_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_dec0478a-2554-4f0e-bf0d-9092511fa99e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_cf24e7ec-dcfb-40dd-93c6-d287b651b43e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_24a6105b-231c-4fc0-8403-f23c92cd5f0b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_e323167e-cf66-4d1f-a470-bb13f077853a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_042ecc3a-5f6b-4578-9d9f-9c0d6220a5d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_0b866d27-ec48-44cd-a19e-4be2b65ee5a0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_af42da91-6b8d-4486-80a3-ae318b9998af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_35abecde-faef-48c9-8f3e-5d1ec05b0049_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_ce276504-a6b3-45b8-bd95-9ce567ac58d1_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_1ab204ae-fd2d-4519-9971-42e81df42aff_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_eb8ea6d4-6f41-42de-8faa-f334ebde7b4b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_c7ab7f73-6709-4d2e-adb8-7594e0d044f0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_595f8c9c-1f6d-45d2-a1cf-ffa48cf04e7e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_TelosPartnersLLCMember_2fbdb06f-fa4a-470b-9a10-4aaa64287320_terseLabel_en-US" xlink:label="lab_kids_TelosPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Telos</link:label>
    <link:label id="lab_kids_TelosPartnersLLCMember_label_en-US" xlink:label="lab_kids_TelosPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Telos Partners LLC [Member]</link:label>
    <link:label id="lab_kids_TelosPartnersLLCMember_documentation_en-US" xlink:label="lab_kids_TelosPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Telos Partners LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_TelosPartnersLLCMember" xlink:to="lab_kids_TelosPartnersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_91af2720-5a46-4c66-853a-10ef7615cd7b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_117ef043-74cd-4d22-a6eb-7af726afc191_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_1a6d5249-3f31-4ac4-8c14-006cd9955e6b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_447d06ed-0033-4427-993a-837019820276_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_662eef5d-e490-4c7c-bba8-ff3e5941f8a8_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6f2a1eac-5150-4268-878f-ce2e85c90ff0_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_d34812d1-3481-415c-9eb1-85b3167d2c77_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_87f53399-1531-4796-a6df-6f8ff4521f3f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.00025 par value; 50,000,000 shares authorized; 19,544,008 shares and 16,723,128 shares issued as of June 30, 2020 (unaudited) and December 31, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_9c4a5708-96ab-48a0-8126-f91cd35a0a5d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_632705fe-0fba-4fea-aad2-fabd57f53a2a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_SampleInventoryMember_f1869e27-4d14-48ef-ac75-3d013816b64a_terseLabel_en-US" xlink:label="lab_kids_SampleInventoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sample inventory</link:label>
    <link:label id="lab_kids_SampleInventoryMember_label_en-US" xlink:label="lab_kids_SampleInventoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SampleInventoryMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SampleInventoryMember" xlink:href="kids-20200630.xsd#kids_SampleInventoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_SampleInventoryMember" xlink:to="lab_kids_SampleInventoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_87dc0e51-ced4-41e2-a54f-4461743457dd_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_ae3f16a6-35c4-4f3d-868d-64a376bcf84a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_c382c87d-98e7-4065-9fb1-9f701de5e072_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt with affiliate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_4811106e-6ab6-44e1-96a2-4b95098ec78a_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public offering price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_f75b170f-964d-4873-a4f1-fb53c2394ea1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_4e26bc8c-9635-425f-97ed-0898206f8ce2_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Asset</link:label>
    <link:label id="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:to="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2ca39f21-e320-4a03-ad6e-0f2758e14255_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6715f018-b74c-473a-b623-dc64cbfb3021_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c10c0005-be88-4dec-8db6-f34ff7435cf9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: total net assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_bbbadca3-e77c-44ab-8d86-f7bfcfdac987_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition installment payable</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_label_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Change in Fair Value, Acquisition Installment Payable</link:label>
    <link:label id="lab_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_documentation_en-US" xlink:label="lab_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Change in Fair Value, Acquisition Installment Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" xlink:to="lab_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_0f5cd627-8662-462f-8fda-c496638f953e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_26e8b4e3-cab4-4b45-b21f-cbff2370c563_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_54752d2a-051c-4510-87d5-44c35a62c897_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2496a787-cfa6-45d0-bd81-8e09402a62c8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationEscrowDeposit_c5edd5ea-fef3-4d7b-a784-f461c3301a5d_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow deposit</link:label>
    <link:label id="lab_kids_BusinessCombinationEscrowDeposit_label_en-US" xlink:label="lab_kids_BusinessCombinationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Escrow Deposit</link:label>
    <link:label id="lab_kids_BusinessCombinationEscrowDeposit_documentation_en-US" xlink:label="lab_kids_BusinessCombinationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationEscrowDeposit" xlink:href="kids-20200630.xsd#kids_BusinessCombinationEscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationEscrowDeposit" xlink:to="lab_kids_BusinessCombinationEscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c5ff88bf-b7dd-49a5-bb6e-33f90500a5f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_5f6d03f7-89a6-409d-96ff-715196c226ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_e102671a-b504-491a-85a8-d247cc3a4946_terseLabel_en-US" xlink:label="lab_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock exercisable (in shares)</link:label>
    <link:label id="lab_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_label_en-US" xlink:label="lab_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award Equity Instruments Other than Options Exercisable Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:href="kids-20200630.xsd#kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:to="lab_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_388efc35-ca20-4ed7-8f50-ec109918ee50_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net of current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProjectMember_62df950a-e48c-43d5-8b08-76c2b808133f_terseLabel_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Domain]</link:label>
    <link:label id="lab_us-gaap_ProjectMember_label_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProjectMember" xlink:to="lab_us-gaap_ProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_989c6061-097b-4a7a-8443-ebc8f16fbf53_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ee029679-a697-448e-ac6a-56790ce78786_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a1d2b5cf-815f-4768-932b-e89fd6e90dab_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6bd722e9-f801-4dc2-a42c-593899ebeffc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_03177dc1-90fb-4275-b20d-164068302f1d_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_277d0c5f-d6b9-4a7f-8dc1-9026cc7c7501_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a32935fe-958a-47f0-948d-4eca20fcfcdd_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_166d998d-67fb-4021-b7ab-eac8c8368008_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_52b86934-90d6-4b1c-b1ff-a676ebcd41d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of shares and membership interests in common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f288063-72c5-42bd-a955-4186c5e13e11_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4f6831cf-f12f-4db8-a813-683c76d8ac79_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_2d3599a5-88b9-4b37-8bdf-ccf41d22e9ef_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayable_8e747124-55d2-48a6-a713-7199cb033dae_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable to Squadron</link:label>
    <link:label id="lab_us-gaap_NotesPayable_label_en-US" xlink:label="lab_us-gaap_NotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable" xlink:to="lab_us-gaap_NotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_b6a635bf-be64-4d9c-be1e-98bc2fc6111e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_9aa0aaa9-31bb-4c7f-ae68-319680347fad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of licenses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_f431d759-af76-4622-b193-9c7dc210b63a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2f92fb6f-a0be-4af2-9b6c-65e27aab49ce_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8943f83f-e3c0-47c0-87e0-bd1dd0ebd3a4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of estimated total acquisition consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_7ef88acb-1b79-4ed7-afb3-f136411cd918_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_4e6863f8-97d5-4934-ac16-d3281ca767c1_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84b4a6d1-bbf0-4839-b9fb-4575de872073_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shares</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ClassOfWarrantOrRightTerm_ac5ab178-5e63-4719-a120-06ae4dd80ab9_terseLabel_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of warrants</link:label>
    <link:label id="lab_kids_ClassOfWarrantOrRightTerm_label_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right Term</link:label>
    <link:label id="lab_kids_ClassOfWarrantOrRightTerm_documentation_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ClassOfWarrantOrRightTerm" xlink:href="kids-20200630.xsd#kids_ClassOfWarrantOrRightTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ClassOfWarrantOrRightTerm" xlink:to="lab_kids_ClassOfWarrantOrRightTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_IntangibleAssetsAcquired_43093f30-9441-42c8-b102-befdd760d2ac_totalLabel_en-US" xlink:label="lab_kids_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of identifiable intangible assets</link:label>
    <link:label id="lab_kids_IntangibleAssetsAcquired_label_en-US" xlink:label="lab_kids_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Acquired</link:label>
    <link:label id="lab_kids_IntangibleAssetsAcquired_documentation_en-US" xlink:label="lab_kids_IntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_IntangibleAssetsAcquired" xlink:to="lab_kids_IntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_182bbe7f-0d9a-4180-b1a4-5a210ae9df6c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f7241f3f-01f6-46fa-a6f8-685d613d3b7d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b3df99aa-a817-4cac-bfa4-5f798e4e76dd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_fc3946fc-68c1-4c57-9232-2af24f4210c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_d48948e0-c5d2-4086-8e7f-29f2dd8ed883_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a82df3a3-6b67-41c0-9e72-46c9431267ae_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e12cba37-3c1d-4cd6-8ab4-056668626c14_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition - United States and International</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0499b980-cf98-44eb-b3c8-fae2069907f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_1b163741-4a0e-4d68-9405-6a35066ee466_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5e60e9fc-9049-4586-8ffd-4caeab049774_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5ed505bd-63bd-433d-8b60-c7d02109c6fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in certain current assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_a4108c06-7c96-4c27-9c9c-34bbedbfda4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_56a48930-d50c-48fe-8947-57b5fcf7ddca_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three month LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_29ee5551-8287-4de6-b865-81d053c27a44_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_41cc5d5f-daa8-4fc7-ba34-c8c0a9cc2ae9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b00f436a-538a-4c2d-9911-bc396adf504a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_cbab4788-313a-470d-95a9-f02497678e62_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_1f8684a9-75b2-46f0-8385-0929a04106a5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ed8be516-e1cb-4184-9e41-6f6eaea95ef7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_608ae1d2-53e9-470a-9fff-54afe2f86f64_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_d9467416-ce6c-445e-817f-b71fa0e16b1b_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a3cb1832-f827-4093-9460-8fa94a8de87a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_84f452bb-1892-4ce5-a702-e8a7457e3bdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_940ff292-5b64-4fa0-86eb-cec9b9310dbd_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_TraumaAndDeformityMember_ecc9f344-ea4e-4c6e-99d5-faf2797cb0b3_terseLabel_en-US" xlink:label="lab_kids_TraumaAndDeformityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and deformity</link:label>
    <link:label id="lab_kids_TraumaAndDeformityMember_label_en-US" xlink:label="lab_kids_TraumaAndDeformityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and Deformity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TraumaAndDeformityMember" xlink:href="kids-20200630.xsd#kids_TraumaAndDeformityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_TraumaAndDeformityMember" xlink:to="lab_kids_TraumaAndDeformityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_ad6f37a7-1e6d-4ae8-a6f2-b8294c26b95b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_09a4f774-4f69-46e9-992b-c3342ab5fffc_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesMember_569c2db3-3500-4543-907b-0862cb27eed2_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage payable to affiliate</link:label>
    <link:label id="lab_us-gaap_MortgagesMember_label_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesMember" xlink:to="lab_us-gaap_MortgagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_b7c9c10e-f991-4d52-a3aa-aefb99df5ef5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_3faa979a-adc7-4eac-8741-4ddfb3aacc1e_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e00fc598-768e-45c0-8ee6-8205c21f00ff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a0139f5c-85bb-4c6f-b1ef-4892865ad394_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e1bf15bc-a8a1-4584-a39f-ff2a04381b3a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_be2c07bb-9543-4f8d-9d1a-6fe2393c6a49_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_GoodwillMeasurementPeriodAdjustment_45d41005-6839-4062-bd65-e99b9b06ffef_terseLabel_en-US" xlink:label="lab_kids_GoodwillMeasurementPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, measurement period adjustment</link:label>
    <link:label id="lab_kids_GoodwillMeasurementPeriodAdjustment_label_en-US" xlink:label="lab_kids_GoodwillMeasurementPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Measurement Period Adjustment</link:label>
    <link:label id="lab_kids_GoodwillMeasurementPeriodAdjustment_documentation_en-US" xlink:label="lab_kids_GoodwillMeasurementPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Measurement Period Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_GoodwillMeasurementPeriodAdjustment" xlink:href="kids-20200630.xsd#kids_GoodwillMeasurementPeriodAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_GoodwillMeasurementPeriodAdjustment" xlink:to="lab_kids_GoodwillMeasurementPeriodAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_FMIHansaMedicalProductsMember_01ed87db-91a2-400f-9a2f-30c78ed863da_terseLabel_en-US" xlink:label="lab_kids_FMIHansaMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FMI</link:label>
    <link:label id="lab_kids_FMIHansaMedicalProductsMember_label_en-US" xlink:label="lab_kids_FMIHansaMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FMI Hansa Medical Products [Member]</link:label>
    <link:label id="lab_kids_FMIHansaMedicalProductsMember_documentation_en-US" xlink:label="lab_kids_FMIHansaMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FMI Hansa Medical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FMIHansaMedicalProductsMember" xlink:href="kids-20200630.xsd#kids_FMIHansaMedicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_FMIHansaMedicalProductsMember" xlink:to="lab_kids_FMIHansaMedicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_d70114eb-69f2-4839-ae0f-f07a9dc3a43b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, depreciable lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_e4b7f058-67ee-461e-bb9e-5ac5f33206ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_8e550510-cd77-47d3-b720-70a8e7da0603_totalLabel_en-US" xlink:label="lab_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other assets</link:label>
    <link:label id="lab_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_label_en-US" xlink:label="lab_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent, Excluding Property, Plant and Equipment</link:label>
    <link:label id="lab_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent, Excluding Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment" xlink:href="kids-20200630.xsd#kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment" xlink:to="lab_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_SportsMedicineandOtherMember_6347c136-a243-4431-aaef-bebfbc978222_terseLabel_en-US" xlink:label="lab_kids_SportsMedicineandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sports medicine/other</link:label>
    <link:label id="lab_kids_SportsMedicineandOtherMember_label_en-US" xlink:label="lab_kids_SportsMedicineandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SportsMedicineandOtherMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SportsMedicineandOtherMember" xlink:href="kids-20200630.xsd#kids_SportsMedicineandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_SportsMedicineandOtherMember" xlink:to="lab_kids_SportsMedicineandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0bb8101c-70d4-4976-96dd-804eb162d379_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance cost (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_b542ad8f-2bd1-4cbc-8c4c-5acf32565260_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Intangible Assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_b00fb733-767e-4040-b27e-ef50c781ecf0_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_bebb4b78-ecfe-4a06-9fd1-b2bb9b714914_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned_c52c05bb-c645-46f2-b427-d7d9f1bac98a_terseLabel_en-US" xlink:label="lab_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock approximate value</link:label>
    <link:label id="lab_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned_label_en-US" xlink:label="lab_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Approximate Value Assigned</link:label>
    <link:label id="lab_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned_documentation_en-US" xlink:label="lab_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Approximate Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" xlink:to="lab_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a47aa6ba-25f2-48fc-b864-706e43d83054_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercise (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2578fcd0-8929-4c0b-bee9-f187770f7e63_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationEscrowDepositMaximumTerm_41ffc6f9-5ec9-476c-a4c6-b74b931836f4_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationEscrowDepositMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow deposit period</link:label>
    <link:label id="lab_kids_BusinessCombinationEscrowDepositMaximumTerm_label_en-US" xlink:label="lab_kids_BusinessCombinationEscrowDepositMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Escrow Deposit, Maximum Term</link:label>
    <link:label id="lab_kids_BusinessCombinationEscrowDepositMaximumTerm_documentation_en-US" xlink:label="lab_kids_BusinessCombinationEscrowDepositMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Escrow Deposit, Maximum Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationEscrowDepositMaximumTerm" xlink:href="kids-20200630.xsd#kids_BusinessCombinationEscrowDepositMaximumTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationEscrowDepositMaximumTerm" xlink:to="lab_kids_BusinessCombinationEscrowDepositMaximumTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cf7621aa-3016-4a33-991d-9a6fdfa91dfe_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_6230e734-a001-41d2-9754-40fad3893126_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_a2b16785-6e8c-446d-9d3f-5458ff4ccfb4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease_b195b2ba-20d2-4036-9f4f-d66fb435d901_terseLabel_en-US" xlink:label="lab_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase of estimated annual limitation of first five years</link:label>
    <link:label id="lab_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease_label_en-US" xlink:label="lab_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Limitationson Use Estimated Amount Subject to Limitation Annual Limit Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" xlink:href="kids-20200630.xsd#kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" xlink:to="lab_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_812376fb-b735-4453-996c-d6d28c8ff661_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5c8e4c07-4ee0-46d0-be24-cc1d9fdbaaf0_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_444a99e8-a572-430f-84b6-f40576f9978d_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Unaudited Interim Consolidated Financial Statements</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_2cabd0b9-5896-4a3c-9c5d-004ec922b199_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common shares to acquire business</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ede653ff-d9eb-4289-bd1b-fd0ed053cbf7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessAcquisitionAnniversaryDomain_55e40f38-0997-448a-b88d-7ae06179e685_terseLabel_en-US" xlink:label="lab_kids_BusinessAcquisitionAnniversaryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Anniversary [Domain]</link:label>
    <link:label id="lab_kids_BusinessAcquisitionAnniversaryDomain_label_en-US" xlink:label="lab_kids_BusinessAcquisitionAnniversaryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Anniversary [Domain]</link:label>
    <link:label id="lab_kids_BusinessAcquisitionAnniversaryDomain_documentation_en-US" xlink:label="lab_kids_BusinessAcquisitionAnniversaryDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain" xlink:to="lab_kids_BusinessAcquisitionAnniversaryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_da1f16ce-447d-4b21-9f17-160574dd8833_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_b198959c-c593-4f67-a069-e3b3567f5754_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d5daa3a4-ba7a-4bf8-a774-5893e285dfd0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2cc3f209-a4fc-4407-9d98-debd14257340_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_3a86739f-08b4-46a4-99c6-8a1d9e3934be_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3d7329d3-fd82-4d43-9f34-cf06a3950eb4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0ebd55e2-f1ff-48a7-924c-f7144485ba1b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_LoanAgreementMember_a1d83fdf-72f1-4d08-8ccc-3a57ae60982a_terseLabel_en-US" xlink:label="lab_kids_LoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Agreement</link:label>
    <link:label id="lab_kids_LoanAgreementMember_label_en-US" xlink:label="lab_kids_LoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Agreement [Member]</link:label>
    <link:label id="lab_kids_LoanAgreementMember_documentation_en-US" xlink:label="lab_kids_LoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_LoanAgreementMember" xlink:href="kids-20200630.xsd#kids_LoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_LoanAgreementMember" xlink:to="lab_kids_LoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_0e28b979-29d1-414e-85b3-8d153d693ee0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_fd314025-9bb3-4842-923b-347a9396f29e_terseLabel_en-US" xlink:label="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_label_en-US" xlink:label="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability</link:label>
    <link:label id="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_documentation_en-US" xlink:label="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:to="lab_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8dd4d195-a90a-4e5c-aa74-e564cd7c3939_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash of continuing operations, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1b5f5a1f-bd82-4557-a3ca-ac385deb60cd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_8c3c1f4e-b641-4373-bbd8-5a4711908555_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a30e0a3c-d833-49b3-830a-27c91d16cf17_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_0385279c-78ac-4f04-8c24-8cd639996483_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of product sales by geographic location</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_bc875287-b388-4461-ba4c-ac5e9de3c21f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_cf4e48c2-1780-4bcc-9cc4-995284f6b884_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of shares and membership interests in cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_2f7efd71-e639-426c-a1e4-b0209afd399f_totalLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_2c6c5555-3a41-4b65-a4d2-af8e71c20943_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period one</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ClassOfWarrantOrRightExercised_04f98f44-2737-4481-822a-abb8ba823913_terseLabel_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants exercised (in shares)</link:label>
    <link:label id="lab_kids_ClassOfWarrantOrRightExercised_label_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right Exercised</link:label>
    <link:label id="lab_kids_ClassOfWarrantOrRightExercised_documentation_en-US" xlink:label="lab_kids_ClassOfWarrantOrRightExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ClassOfWarrantOrRightExercised" xlink:href="kids-20200630.xsd#kids_ClassOfWarrantOrRightExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ClassOfWarrantOrRightExercised" xlink:to="lab_kids_ClassOfWarrantOrRightExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_ce5102ed-ea3f-4ec4-8232-8af3518e2339_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_SecondAnniversaryMember_155a9a66-5db0-4204-b980-12ab74b16676_terseLabel_en-US" xlink:label="lab_kids_SecondAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Anniversary</link:label>
    <link:label id="lab_kids_SecondAnniversaryMember_label_en-US" xlink:label="lab_kids_SecondAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Anniversary [Member]</link:label>
    <link:label id="lab_kids_SecondAnniversaryMember_documentation_en-US" xlink:label="lab_kids_SecondAnniversaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAnniversaryMember" xlink:href="kids-20200630.xsd#kids_SecondAnniversaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_SecondAnniversaryMember" xlink:to="lab_kids_SecondAnniversaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_dbeee653-2429-45f6-b4f7-d236c0ea984d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long-term debt instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_VilexMember_88cae9d6-3bfc-470e-85e2-23bd231d9792_terseLabel_en-US" xlink:label="lab_kids_VilexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vilex</link:label>
    <link:label id="lab_kids_VilexMember_label_en-US" xlink:label="lab_kids_VilexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vilex [Member]</link:label>
    <link:label id="lab_kids_VilexMember_documentation_en-US" xlink:label="lab_kids_VilexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vilex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexMember" xlink:href="kids-20200630.xsd#kids_VilexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_VilexMember" xlink:to="lab_kids_VilexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_d9d368c6-8542-4bc2-b07a-166e01c3b848_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_6481c45f-d99f-40a7-986a-3d227ad8f617_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_f76bb642-eb43-4831-b55d-ad01b833dcff_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercise</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5f7c09ac-6a4d-446f-9440-a03ccf0ccbf0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_701e9842-a054-48f3-bbc9-013b5e51662b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_5f6635c6-4069-4f86-bbb7-3837c725392b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma net revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_FollowOnOfferingMember_fbb66207-0e95-4767-b24a-4ee0e39ee642_terseLabel_en-US" xlink:label="lab_kids_FollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-on Offering</link:label>
    <link:label id="lab_kids_FollowOnOfferingMember_label_en-US" xlink:label="lab_kids_FollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-on Offering [Member]</link:label>
    <link:label id="lab_kids_FollowOnOfferingMember_documentation_en-US" xlink:label="lab_kids_FollowOnOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow-on Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FollowOnOfferingMember" xlink:href="kids-20200630.xsd#kids_FollowOnOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_FollowOnOfferingMember" xlink:to="lab_kids_FollowOnOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a7010b26-a1bf-463a-86d0-659f9a412a0c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_BandLokMember_5d172ad5-e1ed-4e4e-96ee-3bd39c3f2302_terseLabel_en-US" xlink:label="lab_kids_BandLokMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Band-Lok</link:label>
    <link:label id="lab_kids_BandLokMember_label_en-US" xlink:label="lab_kids_BandLokMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Band-Lok [Member]</link:label>
    <link:label id="lab_kids_BandLokMember_documentation_en-US" xlink:label="lab_kids_BandLokMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Band-Lok</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BandLokMember" xlink:href="kids-20200630.xsd#kids_BandLokMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_BandLokMember" xlink:to="lab_kids_BandLokMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_693f7ff7-ba76-420d-b272-17484a24901b_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock_6405a207-c56b-4825-a3cc-86959a38def4_terseLabel_en-US" xlink:label="lab_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock_label_en-US" xlink:label="lab_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold, Policy [Policy Text Block]</link:label>
    <link:label id="lab_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" xlink:href="kids-20200630.xsd#kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" xlink:to="lab_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_799bddcb-d4af-4b07-93d5-af4f1ac0fd9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_54f157fc-db2b-4fb3-a7b3-92ace72352d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on mortgage notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_2a243b26-3a6a-4919-806f-ced164f8d223_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_77432540-f8b6-46df-8686-63053a0cf89d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_ec0590d7-1b5a-4ba7-8318-30146cc0ed26_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities - discontinued operations</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_SquadronMember_ee17642e-e64a-4c97-a1c8-3f296e13995b_terseLabel_en-US" xlink:label="lab_kids_SquadronMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Squadron</link:label>
    <link:label id="lab_kids_SquadronMember_label_en-US" xlink:label="lab_kids_SquadronMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Squadron [Member]</link:label>
    <link:label id="lab_kids_SquadronMember_documentation_en-US" xlink:label="lab_kids_SquadronMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Squadron</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SquadronMember" xlink:href="kids-20200630.xsd#kids_SquadronMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_SquadronMember" xlink:to="lab_kids_SquadronMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c3c87b0b-7778-4acc-9519-a7afb01301e4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_ab922832-b288-475a-837c-942b06802219_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, divestiture of business</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_aee79241-23db-4eee-af49-6c68bcd4c01a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_SalesAndMarketingExpensePolicyPolicyTextBlock_8d19542a-8e96-4f13-b8e2-6a2496de3980_terseLabel_en-US" xlink:label="lab_kids_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Marketing Expenses</link:label>
    <link:label id="lab_kids_SalesAndMarketingExpensePolicyPolicyTextBlock_label_en-US" xlink:label="lab_kids_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales And Marketing Expense Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:href="kids-20200630.xsd#kids_SalesAndMarketingExpensePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:to="lab_kids_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_529de4bd-dab7-42a0-9fda-bede438162bf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0345e20a-decc-4182-a139-6908e83b2fd4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Terms</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6d469f-a129-402a-90a5-be3ea31792e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_538936d5-6c18-4495-bdaa-1e9a2dd8a303_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_63797082-0d78-4b07-92e9-5cf2260cf895_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_89f6a512-60f7-4ea0-8599-215d18ee8d7f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation_e1d5f2b7-26dc-4741-84c8-15dbeb889744_terseLabel_en-US" xlink:label="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated limitation on losses generated prior to ownership change date</link:label>
    <link:label id="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation_label_en-US" xlink:label="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Limitations on Use Estimated Amount Subject to Limitation</link:label>
    <link:label id="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation_documentation_en-US" xlink:label="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Limitations on Use Estimated Amount Subject to Limitation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" xlink:href="kids-20200630.xsd#kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" xlink:to="lab_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_f0807743-f637-4f07-a4a6-784af7241ce0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_661a9525-f3fe-484e-a662-af4ddf6096d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_7c6ee72d-52bd-450d-b05e-f19c5c0ab2de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Terms</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_bc7fffb0-8a7c-4982-b8a0-f8d788ba410e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d8f12671-f5f9-4e88-b50a-ff4b832c72c7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET LOSS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_75b95873-6334-4845-b4fa-c1d29e2b999a_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and other equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_LongTermDebtCurrentMaturitiesRelatedParty_fc2f6e47-f56a-42e4-a0ff-a6ba001a611e_terseLabel_en-US" xlink:label="lab_kids_LongTermDebtCurrentMaturitiesRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt with affiliate</link:label>
    <link:label id="lab_kids_LongTermDebtCurrentMaturitiesRelatedParty_label_en-US" xlink:label="lab_kids_LongTermDebtCurrentMaturitiesRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Related Party</link:label>
    <link:label id="lab_kids_LongTermDebtCurrentMaturitiesRelatedParty_documentation_en-US" xlink:label="lab_kids_LongTermDebtCurrentMaturitiesRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities, Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_LongTermDebtCurrentMaturitiesRelatedParty" xlink:href="kids-20200630.xsd#kids_LongTermDebtCurrentMaturitiesRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_LongTermDebtCurrentMaturitiesRelatedParty" xlink:to="lab_kids_LongTermDebtCurrentMaturitiesRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm_010c2898-48ef-4d5c-8008-5ffc3381f534_terseLabel_en-US" xlink:label="lab_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty agreement period</link:label>
    <link:label id="lab_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm_label_en-US" xlink:label="lab_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ResearchandDevelopmentArrangementContracttoPerformforOthersTerm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" xlink:href="kids-20200630.xsd#kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" xlink:to="lab_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5f755f8e-adb5-42c2-81f0-b3034e15a6e3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment_47003a2a-0bd9-4d84-a8db-393027f249a8_terseLabel_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment for general product launch</link:label>
    <link:label id="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment_label_en-US" xlink:label="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement Contract to Perform for Others Royalty Agreement Product Launch Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" xlink:to="lab_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_6c0a5dcb-8f0d-4e95-9fe1-d1a60d24ac02_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_84dfdc55-e79b-411d-94d5-344428d06f9a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>kids-20200630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:6cad6b03-419c-4f54-8eef-33f01636649a,g:8b88b676-dabc-417a-b49f-ad3a7a6b9677-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/Cover" xlink:type="simple" xlink:href="kids-20200630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_268cb531-f072-4921-9b59-34bceabc6e83" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_DocumentType_268cb531-f072-4921-9b59-34bceabc6e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_41b343b2-9cf0-4bc0-aa01-53e05c8047bf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_DocumentPeriodEndDate_41b343b2-9cf0-4bc0-aa01-53e05c8047bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e71e89b1-4475-46ba-8e1a-5ca129974978" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityRegistrantName_e71e89b1-4475-46ba-8e1a-5ca129974978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_86d1eaa1-b1d2-4440-96b0-c2e0bcbefb51" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityCentralIndexKey_86d1eaa1-b1d2-4440-96b0-c2e0bcbefb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2fecae47-0b82-461f-b40b-8f9f620d54c7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_CurrentFiscalYearEndDate_2fecae47-0b82-461f-b40b-8f9f620d54c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_4d15feb6-409a-45b9-bb8a-e2ae6d70b821" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityFilerCategory_4d15feb6-409a-45b9-bb8a-e2ae6d70b821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f316adac-9cd1-4ce9-a59b-3330c9705865" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityEmergingGrowthCompany_f316adac-9cd1-4ce9-a59b-3330c9705865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_b3377e6d-f4f4-415a-8095-31f0c42f580d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityExTransitionPeriod_b3377e6d-f4f4-415a-8095-31f0c42f580d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1d2a4647-d4d2-4324-b506-201adb6b5490" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntitySmallBusiness_1d2a4647-d4d2-4324-b506-201adb6b5490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6aa8288c-07dd-448a-9590-01449e567d95" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_472534db-c60b-451f-8843-643100048cbb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_1681a211-63c0-40e5-962e-ba81f03184ad" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_DocumentFiscalYearFocus_1681a211-63c0-40e5-962e-ba81f03184ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f3e8c2a9-394e-4033-93fe-0b8c2f8485f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f3e8c2a9-394e-4033-93fe-0b8c2f8485f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bec60ca0-cde7-4408-8600-1f0ff3788b69" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_AmendmentFlag_bec60ca0-cde7-4408-8600-1f0ff3788b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3cc5e0f4-156f-45a1-9ed2-f915c0655a94" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3cc5e0f4-156f-45a1-9ed2-f915c0655a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3c911bb3-ab1c-42bb-b191-39e660174231" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityFileNumber_3c911bb3-ab1c-42bb-b191-39e660174231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6d952579-ff05-4e30-af3a-254b4726365d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6d952579-ff05-4e30-af3a-254b4726365d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ee66ebbf-78a2-4b39-89f6-7f09f59858a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityTaxIdentificationNumber_ee66ebbf-78a2-4b39-89f6-7f09f59858a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0c774a72-f786-45f1-bd6e-bef991697837" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityAddressAddressLine1_0c774a72-f786-45f1-bd6e-bef991697837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_13b8d738-af6f-43b6-a5f0-ffb3b241d6b1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityAddressCityOrTown_13b8d738-af6f-43b6-a5f0-ffb3b241d6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_96c01761-5136-41ba-802f-61b5f6a7d428" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityAddressStateOrProvince_96c01761-5136-41ba-802f-61b5f6a7d428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f9ff2f8a-d22e-469b-b071-b0695ad791f8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityAddressPostalZipCode_f9ff2f8a-d22e-469b-b071-b0695ad791f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_60bda6fa-58b4-41f8-9107-bc85ca6384dc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_CityAreaCode_60bda6fa-58b4-41f8-9107-bc85ca6384dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e9ebd71f-cee7-4ee3-b222-859c94c78aac" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_LocalPhoneNumber_e9ebd71f-cee7-4ee3-b222-859c94c78aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b83d177b-cce6-4635-b87f-9224d963ef99" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_Security12bTitle_b83d177b-cce6-4635-b87f-9224d963ef99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_280f273f-4fce-4e81-88e6-35004e1e4287" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_TradingSymbol_280f273f-4fce-4e81-88e6-35004e1e4287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_348eb8d8-40a2-4b9f-9766-9b6404c08c5d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_SecurityExchangeName_348eb8d8-40a2-4b9f-9766-9b6404c08c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7131019c-97f2-46af-8aa7-415f5a672494" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityCurrentReportingStatus_7131019c-97f2-46af-8aa7-415f5a672494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_cc86a2bd-c7b5-49a4-b153-16868872df67" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityInteractiveDataCurrent_cc86a2bd-c7b5-49a4-b153-16868872df67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a0070f46-63e2-4ae3-abed-fe5a35a94852" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_DocumentQuarterlyReport_a0070f46-63e2-4ae3-abed-fe5a35a94852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_bfe720f1-e1ed-45ca-a021-8d1f31fcad45" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_DocumentTransitionReport_bfe720f1-e1ed-45ca-a021-8d1f31fcad45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_77c709c4-6123-457b-b00d-07284fdfbad7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cc75de2f-c348-4e9e-84a9-1c09fb6c5715" xlink:to="loc_dei_EntityShellCompany_77c709c4-6123-457b-b00d-07284fdfbad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ca84567a-2a32-4bde-a592-f9492c4a8d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_68e98a8e-bbbb-48f5-8de1-c12b7c25ed03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ca84567a-2a32-4bde-a592-f9492c4a8d4b" xlink:to="loc_us-gaap_AssetsAbstract_68e98a8e-bbbb-48f5-8de1-c12b7c25ed03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68e98a8e-bbbb-48f5-8de1-c12b7c25ed03" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_638a5b91-87e2-4a99-8ca6-60e4d2c4d14b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_638a5b91-87e2-4a99-8ca6-60e4d2c4d14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_24417b9d-e4c2-439d-b717-8f7ca3af2821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:to="loc_us-gaap_RestrictedCashCurrent_24417b9d-e4c2-439d-b717-8f7ca3af2821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_69278dd0-0a90-4428-8166-ee3cbfe754e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_69278dd0-0a90-4428-8166-ee3cbfe754e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_083bd0af-3cd8-4b20-99f9-4489e23bd77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:to="loc_us-gaap_InventoryNet_083bd0af-3cd8-4b20-99f9-4489e23bd77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_196f3662-3d9a-4e8f-b20b-6075ff9b6c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_196f3662-3d9a-4e8f-b20b-6075ff9b6c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c0879828-a7e1-4bff-b834-606c85841567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c0879828-a7e1-4bff-b834-606c85841567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d91886e5-ed95-4365-a653-82826a5ebeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d33b8eb2-641d-4e36-af2a-c981b442d020" xlink:to="loc_us-gaap_AssetsCurrent_d91886e5-ed95-4365-a653-82826a5ebeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_186c692e-8982-4924-b822-122121dde776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68e98a8e-bbbb-48f5-8de1-c12b7c25ed03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_186c692e-8982-4924-b822-122121dde776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_91c382e0-6d24-4ce2-813f-c6d856775838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68e98a8e-bbbb-48f5-8de1-c12b7c25ed03" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_91c382e0-6d24-4ce2-813f-c6d856775838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4f7132bd-9b4c-4233-aab9-dbd3f29b37dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_91c382e0-6d24-4ce2-813f-c6d856775838" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4f7132bd-9b4c-4233-aab9-dbd3f29b37dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2bf95cb5-7e63-431c-88af-95ab907529bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_91c382e0-6d24-4ce2-813f-c6d856775838" xlink:to="loc_us-gaap_Goodwill_2bf95cb5-7e63-431c-88af-95ab907529bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4fa044a5-7b66-4247-b20e-4bb2ca730750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_91c382e0-6d24-4ce2-813f-c6d856775838" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4fa044a5-7b66-4247-b20e-4bb2ca730750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_feb4d9f8-ee86-4862-914d-a6388ae2a20d" xlink:href="kids-20200630.xsd#kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_91c382e0-6d24-4ce2-813f-c6d856775838" xlink:to="loc_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment_feb4d9f8-ee86-4862-914d-a6388ae2a20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_04bd5878-5f3c-4e9a-9c83-b2b2f45493eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_68e98a8e-bbbb-48f5-8de1-c12b7c25ed03" xlink:to="loc_us-gaap_Assets_04bd5878-5f3c-4e9a-9c83-b2b2f45493eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37229916-4742-44ec-bf8f-aa93cd77f2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ca84567a-2a32-4bde-a592-f9492c4a8d4b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37229916-4742-44ec-bf8f-aa93cd77f2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37229916-4742-44ec-bf8f-aa93cd77f2d3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7e7bd1ec-03a0-4f42-b087-e6a8b5abf623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:to="loc_us-gaap_AccountsPayableCurrent_7e7bd1ec-03a0-4f42-b087-e6a8b5abf623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e7fa2e15-244a-4ccf-b045-abad8b296fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e7fa2e15-244a-4ccf-b045-abad8b296fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_LongTermDebtCurrentMaturitiesRelatedParty_2900955b-c786-41fa-9ee0-a1b7efaae2fd" xlink:href="kids-20200630.xsd#kids_LongTermDebtCurrentMaturitiesRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:to="loc_kids_LongTermDebtCurrentMaturitiesRelatedParty_2900955b-c786-41fa-9ee0-a1b7efaae2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_6f06ae87-0c38-4e4b-b8b9-2dad1610845b" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_6f06ae87-0c38-4e4b-b8b9-2dad1610845b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c0b567eb-5557-44c4-bcdf-985a16bc5340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c0b567eb-5557-44c4-bcdf-985a16bc5340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_55025b47-442e-48f8-9d24-4258a5f8f9f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9dee9a4-807f-47db-a6b0-2dce44f3f662" xlink:to="loc_us-gaap_LiabilitiesCurrent_55025b47-442e-48f8-9d24-4258a5f8f9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_b9f92ae8-4382-40da-8793-a49f5a594141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37229916-4742-44ec-bf8f-aa93cd77f2d3" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_b9f92ae8-4382-40da-8793-a49f5a594141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesAndLoans_294f04f0-0ba8-497f-bad6-106002c93521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesAndLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_b9f92ae8-4382-40da-8793-a49f5a594141" xlink:to="loc_us-gaap_LongTermNotesAndLoans_294f04f0-0ba8-497f-bad6-106002c93521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_bed1b737-d390-4f47-a80f-c5dc1036dbbc" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_b9f92ae8-4382-40da-8793-a49f5a594141" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_bed1b737-d390-4f47-a80f-c5dc1036dbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3f7658ff-4183-4ab0-87b8-097599efc255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_b9f92ae8-4382-40da-8793-a49f5a594141" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3f7658ff-4183-4ab0-87b8-097599efc255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9f9fce90-286f-4a83-b6e7-faf7c7c980f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_b9f92ae8-4382-40da-8793-a49f5a594141" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9f9fce90-286f-4a83-b6e7-faf7c7c980f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_0e7a2f3b-2f54-4a70-b650-9755f726c4ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_b9f92ae8-4382-40da-8793-a49f5a594141" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_0e7a2f3b-2f54-4a70-b650-9755f726c4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_80150c7b-13e8-49f4-bb8a-969a2942ee80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37229916-4742-44ec-bf8f-aa93cd77f2d3" xlink:to="loc_us-gaap_Liabilities_80150c7b-13e8-49f4-bb8a-969a2942ee80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1f0d5d9d-6383-4b2d-91b5-be9beae9321a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37229916-4742-44ec-bf8f-aa93cd77f2d3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1f0d5d9d-6383-4b2d-91b5-be9beae9321a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_dbb23459-d4fc-455c-8726-158f053cd0e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f0d5d9d-6383-4b2d-91b5-be9beae9321a" xlink:to="loc_us-gaap_CommonStockValue_dbb23459-d4fc-455c-8726-158f053cd0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_9cdb2ed7-9539-4195-94ed-c0bc45ab914c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f0d5d9d-6383-4b2d-91b5-be9beae9321a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_9cdb2ed7-9539-4195-94ed-c0bc45ab914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a5bfbfdc-0242-44f0-94fa-adf222bc06e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f0d5d9d-6383-4b2d-91b5-be9beae9321a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a5bfbfdc-0242-44f0-94fa-adf222bc06e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d6f3c088-f21f-467d-b6b9-093000903be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f0d5d9d-6383-4b2d-91b5-be9beae9321a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d6f3c088-f21f-467d-b6b9-093000903be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_11e57997-e484-4779-8d1b-a498f5e4b6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f0d5d9d-6383-4b2d-91b5-be9beae9321a" xlink:to="loc_us-gaap_StockholdersEquity_11e57997-e484-4779-8d1b-a498f5e4b6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f10b0344-813d-45a4-b090-1f4f8adfc43d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_37229916-4742-44ec-bf8f-aa93cd77f2d3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f10b0344-813d-45a4-b090-1f4f8adfc43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bf6b3f6d-462c-469d-8a0c-3a4b51cefb84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d64e63b7-8944-4b2a-ae66-b4ee7336df26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf6b3f6d-462c-469d-8a0c-3a4b51cefb84" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d64e63b7-8944-4b2a-ae66-b4ee7336df26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_94299670-1e00-4954-ba83-24ad8d994747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf6b3f6d-462c-469d-8a0c-3a4b51cefb84" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_94299670-1e00-4954-ba83-24ad8d994747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3d78cda1-533c-445e-97b9-e82785ff4b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf6b3f6d-462c-469d-8a0c-3a4b51cefb84" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3d78cda1-533c-445e-97b9-e82785ff4b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_94feb8c7-05d5-4e2c-8c6a-27ab7fdf6292" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf6b3f6d-462c-469d-8a0c-3a4b51cefb84" xlink:to="loc_us-gaap_CommonStockSharesIssued_94feb8c7-05d5-4e2c-8c6a-27ab7fdf6292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_46f044ed-528f-4901-ba77-45f1b13dfb17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf6b3f6d-462c-469d-8a0c-3a4b51cefb84" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_46f044ed-528f-4901-ba77-45f1b13dfb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20ced5b8-48bf-44dc-a8dc-cc4f97d175d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20ced5b8-48bf-44dc-a8dc-cc4f97d175d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c068e406-72bb-4021-87c3-e037241272b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c068e406-72bb-4021-87c3-e037241272b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_952352f0-1328-4db9-846e-f3dbcde2890f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_GrossProfit_952352f0-1328-4db9-846e-f3dbcde2890f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0066c3a7-e287-4072-9a10-da3eedf09504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0066c3a7-e287-4072-9a10-da3eedf09504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_2eb28313-115f-4a9e-b7ff-c455abaa8d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0066c3a7-e287-4072-9a10-da3eedf09504" xlink:to="loc_us-gaap_SellingAndMarketingExpense_2eb28313-115f-4a9e-b7ff-c455abaa8d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_053725c5-086a-4008-a12f-101d97217478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0066c3a7-e287-4072-9a10-da3eedf09504" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_053725c5-086a-4008-a12f-101d97217478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c1720688-fa9f-404c-b949-96545c50f1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0066c3a7-e287-4072-9a10-da3eedf09504" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c1720688-fa9f-404c-b949-96545c50f1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_fb20452c-ae62-495a-9219-dac3adde36ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0066c3a7-e287-4072-9a10-da3eedf09504" xlink:to="loc_us-gaap_OperatingExpenses_fb20452c-ae62-495a-9219-dac3adde36ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_40adc790-d6c0-4622-879e-54e2dd583e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_OperatingIncomeLoss_40adc790-d6c0-4622-879e-54e2dd583e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f833885a-6222-412f-b7a7-e417fd5f7b75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f833885a-6222-412f-b7a7-e417fd5f7b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_1ef8dff5-639e-4e03-bb51-000d6fc2a023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f833885a-6222-412f-b7a7-e417fd5f7b75" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_1ef8dff5-639e-4e03-bb51-000d6fc2a023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f8ed7a58-dbaa-472a-9a16-425cf11b2f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f833885a-6222-412f-b7a7-e417fd5f7b75" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f8ed7a58-dbaa-472a-9a16-425cf11b2f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d23b89fc-feb4-461f-9886-b352b9e0ed3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f833885a-6222-412f-b7a7-e417fd5f7b75" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d23b89fc-feb4-461f-9886-b352b9e0ed3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cacd82e6-01ed-48fc-9274-b5f80a1620d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f833885a-6222-412f-b7a7-e417fd5f7b75" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cacd82e6-01ed-48fc-9274-b5f80a1620d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_3c176027-361b-429c-af28-d6e815e6e56a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_3c176027-361b-429c-af28-d6e815e6e56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_bce72c81-ee03-4cb4-a952-9c3d12c4e844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_bce72c81-ee03-4cb4-a952-9c3d12c4e844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_60a71afe-cece-4213-8b91-00ada6579c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_60a71afe-cece-4213-8b91-00ada6579c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_08574f59-0fd2-4f42-a861-be726178b8f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_08574f59-0fd2-4f42-a861-be726178b8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_c3713510-3602-4685-890a-552bdddbe591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_79a7eb40-9b48-4aba-8468-a51a8af832a7" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_c3713510-3602-4685-890a-552bdddbe591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5c7e3434-a335-4421-bc6f-9fe1a50d9601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_40e93259-f87a-45fb-a800-e348e02bc2ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5c7e3434-a335-4421-bc6f-9fe1a50d9601" xlink:to="loc_us-gaap_NetIncomeLoss_40e93259-f87a-45fb-a800-e348e02bc2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_1c41fb53-8e3c-4cbe-8f51-5f1f65fb2108" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5c7e3434-a335-4421-bc6f-9fe1a50d9601" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_1c41fb53-8e3c-4cbe-8f51-5f1f65fb2108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cc5453e8-66ae-46f9-8809-9dd192a3a5c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_1c41fb53-8e3c-4cbe-8f51-5f1f65fb2108" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cc5453e8-66ae-46f9-8809-9dd192a3a5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3f95ef35-aceb-4fd9-8012-88296da7c321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5c7e3434-a335-4421-bc6f-9fe1a50d9601" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3f95ef35-aceb-4fd9-8012-88296da7c321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b1310093-b9f1-4084-ad69-241515163046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5c7e3434-a335-4421-bc6f-9fe1a50d9601" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b1310093-b9f1-4084-ad69-241515163046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_02482deb-443a-44e8-b22f-1609b4aa0f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b261cfb6-b6ef-487d-9de0-ca150eaf1776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_02482deb-443a-44e8-b22f-1609b4aa0f0d" xlink:to="loc_us-gaap_StatementTable_b261cfb6-b6ef-487d-9de0-ca150eaf1776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be60acc4-c150-45c2-9d32-b69e3795e0b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b261cfb6-b6ef-487d-9de0-ca150eaf1776" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be60acc4-c150-45c2-9d32-b69e3795e0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be60acc4-c150-45c2-9d32-b69e3795e0b5" xlink:to="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_559fcc9e-24ec-4dc0-93fd-a51ce6746283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_CommonStockMember_559fcc9e-24ec-4dc0-93fd-a51ce6746283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ca2469a6-69b3-40ae-96b2-5490d1f7587c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_TreasuryStockMember_ca2469a6-69b3-40ae-96b2-5490d1f7587c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f0f4f411-d847-400e-a411-a93d6e3057f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f0f4f411-d847-400e-a411-a93d6e3057f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_0d7b5155-0ac5-447a-89f5-66cfae1281fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_RetainedEarningsMember_0d7b5155-0ac5-447a-89f5-66cfae1281fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_51b83933-eb22-4bb0-880c-a77c85db52c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b27d7c1f-5a54-4f7a-a1de-f6dc72d7f94e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_51b83933-eb22-4bb0-880c-a77c85db52c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_20fa1e0a-8f36-427c-a7d4-3e642c1e6bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b261cfb6-b6ef-487d-9de0-ca150eaf1776" xlink:to="loc_us-gaap_StatementLineItems_20fa1e0a-8f36-427c-a7d4-3e642c1e6bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20fa1e0a-8f36-427c-a7d4-3e642c1e6bc7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_139c61d8-31cf-44a4-8905-5891253ff903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_139c61d8-31cf-44a4-8905-5891253ff903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0f6bf859-eec4-4bcc-b0f1-e5ee3cc14938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockholdersEquity_0f6bf859-eec4-4bcc-b0f1-e5ee3cc14938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_27981797-2799-41ef-ac83-27508345f4e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockShares_27981797-2799-41ef-ac83-27508345f4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_88404a5e-107f-4914-a202-d21a2a10ae0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockValue_88404a5e-107f-4914-a202-d21a2a10ae0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f348f13b-45c9-4393-a0ce-cf4c096c45e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_NetIncomeLoss_f348f13b-45c9-4393-a0ce-cf4c096c45e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb5fe456-729c-44b0-a86d-1c33aa1f0440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bb5fe456-729c-44b0-a86d-1c33aa1f0440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1f743722-e8e0-4556-a07d-fb90516dc606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1f743722-e8e0-4556-a07d-fb90516dc606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_527d9fb3-9d27-4f6e-96b4-e65ba871fae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_527d9fb3-9d27-4f6e-96b4-e65ba871fae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_aa4df5ec-c33c-47b9-8a52-d3355742d498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_aa4df5ec-c33c-47b9-8a52-d3355742d498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fb6aa451-15d7-460e-b365-76bea0b4a901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fb6aa451-15d7-460e-b365-76bea0b4a901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9fc4110e-5b72-44b2-9e01-db757bec4779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9fc4110e-5b72-44b2-9e01-db757bec4779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2d66c532-0d3b-45ce-9ed9-073030fda1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_2d66c532-0d3b-45ce-9ed9-073030fda1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83a2e6ac-a063-4d79-ab82-565f0d5f0fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83a2e6ac-a063-4d79-ab82-565f0d5f0fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ef7f65f3-fae2-4ede-9a50-c1fdbe68e55c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ef7f65f3-fae2-4ede-9a50-c1fdbe68e55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_844a81e6-ece0-47c6-8a00-90c714d2c1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_844a81e6-ece0-47c6-8a00-90c714d2c1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_6d53b6ae-4400-4053-8abc-849d64c5cd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_6d53b6ae-4400-4053-8abc-849d64c5cd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dc99058c-54b7-40f2-985e-5d3e053eab15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dc99058c-54b7-40f2-985e-5d3e053eab15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b0b2305-7c0b-4df0-aa48-dea6ecabbff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0dfaa8e-f158-4eb2-a4b0-8a03623c907a" xlink:to="loc_us-gaap_StockholdersEquity_3b0b2305-7c0b-4df0-aa48-dea6ecabbff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="kids-20200630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_99fbd28b-bcc0-41aa-a03a-5503336337eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_59b3b4c7-df07-47db-a62f-8f0d5de7bcec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_99fbd28b-bcc0-41aa-a03a-5503336337eb" xlink:to="loc_us-gaap_StatementTable_59b3b4c7-df07-47db-a62f-8f0d5de7bcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_56daa77c-a153-41f9-b598-ba4a661aaf59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59b3b4c7-df07-47db-a62f-8f0d5de7bcec" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_56daa77c-a153-41f9-b598-ba4a661aaf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_56daa77c-a153-41f9-b598-ba4a661aaf59" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_a614469b-e8bc-4883-9e72-e65a2994e4cb" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_TelosPartnersLLCMember_a614469b-e8bc-4883-9e72-e65a2994e4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_6da42f73-ec42-41e7-b0e9-bfe87366e827" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_ApiFixLtdMember_6da42f73-ec42-41e7-b0e9-bfe87366e827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BandLokMember_ee1d3f40-382c-4c74-810c-c1d04b8e20d8" xlink:href="kids-20200630.xsd#kids_BandLokMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_BandLokMember_ee1d3f40-382c-4c74-810c-c1d04b8e20d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexAndOrthexMember_d43d4833-62e3-4c78-a478-6fd1db45d674" xlink:href="kids-20200630.xsd#kids_VilexAndOrthexMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7a36-3457-44a8-900e-03044ab56741" xlink:to="loc_kids_VilexAndOrthexMember_d43d4833-62e3-4c78-a478-6fd1db45d674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_59b3b4c7-df07-47db-a62f-8f0d5de7bcec" xlink:to="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8f86fd06-06b5-4875-a0b0-e7aa0561dfdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_NetIncomeLoss_8f86fd06-06b5-4875-a0b0-e7aa0561dfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3557400b-62b9-4e58-8e92-3ab93635d5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3557400b-62b9-4e58-8e92-3ab93635d5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_445c8561-df64-4d25-a7c8-2caeb01ac26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_ShareBasedCompensation_445c8561-df64-4d25-a7c8-2caeb01ac26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_98b22964-e14e-4765-a8eb-76b10dd6521f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_98b22964-e14e-4765-a8eb-76b10dd6521f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_5e977d0e-cbb0-4d19-bdea-391d3e4d0d65" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable_5e977d0e-cbb0-4d19-bdea-391d3e4d0d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1a80407f-6126-41d1-a111-d7dad3282b45" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_fe6079ba-9e67-4da3-914d-7031bdac460b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_fe6079ba-9e67-4da3-914d-7031bdac460b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_53e86528-1927-4d0a-bdb7-e17372fcc702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_53e86528-1927-4d0a-bdb7-e17372fcc702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d85fda5c-8627-495a-9378-a8ffa35d463c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d85fda5c-8627-495a-9378-a8ffa35d463c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_599eb6af-2f58-479f-83c4-c589f6ce7c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_599eb6af-2f58-479f-83c4-c589f6ce7c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b06e6705-a410-4262-929f-3b75ef31fbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_b06e6705-a410-4262-929f-3b75ef31fbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0cda0bc7-b52d-4e41-ae10-21939d3d5554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7029c4dc-a763-4fed-9914-b92edef2cb96" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0cda0bc7-b52d-4e41-ae10-21939d3d5554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ba3980ad-5996-4dac-bbbc-b37ca7b73977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_ba3980ad-5996-4dac-bbbc-b37ca7b73977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_d6a1ea08-2fce-40ec-98ea-11aca845b018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_d6a1ea08-2fce-40ec-98ea-11aca845b018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814fd0b3-9d39-46d3-aab8-91b4a0e5d827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_919ab3ed-c9c0-4512-ab34-c02833ec5711" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814fd0b3-9d39-46d3-aab8-91b4a0e5d827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4581add2-9c35-42d4-a9cc-aa9b905e0cad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4581add2-9c35-42d4-a9cc-aa9b905e0cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f029f6c7-e8fe-49fa-9646-8b3701b55b11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f029f6c7-e8fe-49fa-9646-8b3701b55b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f5f10181-739d-4141-9d65-f67144bf6289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f5f10181-739d-4141-9d65-f67144bf6289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_dd6c03a9-54b9-40f6-b40c-a81e9fa24b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_dd6c03a9-54b9-40f6-b40c-a81e9fa24b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_ac81991f-49ba-4971-9c85-cefbd4c55672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_ac81991f-49ba-4971-9c85-cefbd4c55672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a48181f3-c307-4726-acc6-2f8ecf77c37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd70922d-f7a4-446f-b521-0f44b6cdd066" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a48181f3-c307-4726-acc6-2f8ecf77c37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_775c1364-bd8c-4c4e-86fe-edc11f5616b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_775c1364-bd8c-4c4e-86fe-edc11f5616b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_162951ec-8cb0-4dae-ac9b-78225c84850c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_162951ec-8cb0-4dae-ac9b-78225c84850c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_81c36932-0795-46b3-97dc-c79f0e3a44d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_81c36932-0795-46b3-97dc-c79f0e3a44d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_fe40ed19-9f97-4fbc-bbe3-d236d74a773d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_fe40ed19-9f97-4fbc-bbe3-d236d74a773d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_2f305225-be6a-487a-b7f1-a564cb2e03b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_2f305225-be6a-487a-b7f1-a564cb2e03b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c8a2b2a-9b78-4eb3-9283-120e6fb36b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4745cd7-7f61-4f33-b4a6-00e0453ff168" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c8a2b2a-9b78-4eb3-9283-120e6fb36b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8c277bad-6d88-4987-b3a1-5508a601fc9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8c277bad-6d88-4987-b3a1-5508a601fc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_60dc440f-b2ff-47ac-8311-95b062847385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_60dc440f-b2ff-47ac-8311-95b062847385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_93e99402-31dd-4548-8a2f-e8c4c726730e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_93e99402-31dd-4548-8a2f-e8c4c726730e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_06cf01c6-31d9-4c53-9a2d-3c0f6157ef39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations_06cf01c6-31d9-4c53-9a2d-3c0f6157ef39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_f24102e8-5baa-422c-afc3-14c6523d3449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations_f24102e8-5baa-422c-afc3-14c6523d3449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f535e545-6884-4aba-873b-f61413b60ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f535e545-6884-4aba-873b-f61413b60ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a2c44733-9668-46bf-a62b-24926c288a20" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2cc1ffcb-3e56-4072-a8b8-705530f2f404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:to="loc_us-gaap_InterestPaidNet_2cc1ffcb-3e56-4072-a8b8-705530f2f404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TransferOfPropertyAndEquipmentToInventory_b98a32a3-7017-4024-a076-f093105ac16e" xlink:href="kids-20200630.xsd#kids_TransferOfPropertyAndEquipmentToInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:to="loc_kids_TransferOfPropertyAndEquipmentToInventory_b98a32a3-7017-4024-a076-f093105ac16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_e545ea85-9224-4cb8-b52f-6425e0c275e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_90ed539f-602d-4412-9baa-83521ba0e9ba" xlink:to="loc_us-gaap_StockIssued1_e545ea85-9224-4cb8-b52f-6425e0c275e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESS" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e82c3353-a8a5-46ed-9b16-a990d0171161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_b44dc829-e140-46ba-ba64-b44ad0634801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e82c3353-a8a5-46ed-9b16-a990d0171161" xlink:to="loc_us-gaap_NatureOfOperations_b44dc829-e140-46ba-ba64-b44ad0634801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2d77d848-db2f-49e6-b3a2-b5d503873d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2d77d848-db2f-49e6-b3a2-b5d503873d44" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0ba76bca-b717-4e90-8546-b68cefcd8013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0ba76bca-b717-4e90-8546-b68cefcd8013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0ba76bca-b717-4e90-8546-b68cefcd8013" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexAndOrthexMember_7af31a86-4f0c-46ac-aef6-caad550f138e" xlink:href="kids-20200630.xsd#kids_VilexAndOrthexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_VilexAndOrthexMember_7af31a86-4f0c-46ac-aef6-caad550f138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_1dea4de4-a7f6-45bd-b2f8-d158072e95c1" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_TelosPartnersLLCMember_1dea4de4-a7f6-45bd-b2f8-d158072e95c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_7e278d5b-17d0-4c27-a3ff-a5b16850c1d0" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_ApiFixLtdMember_7e278d5b-17d0-4c27-a3ff-a5b16850c1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BandLokMember_f91e50b8-6e0b-4efe-81b9-9e3010468067" xlink:href="kids-20200630.xsd#kids_BandLokMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7014ba41-405d-4803-a455-c4bbc2538210" xlink:to="loc_kids_BandLokMember_f91e50b8-6e0b-4efe-81b9-9e3010468067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b750d33e-e724-465d-aa49-95e543e35e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b0f79bfc-38c8-40c2-8b39-1d599b66c8d4" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b750d33e-e724-465d-aa49-95e543e35e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_5ee31368-4b82-4e93-b25a-6011acaeb2b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_b750d33e-e724-465d-aa49-95e543e35e10" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_5ee31368-4b82-4e93-b25a-6011acaeb2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryAxis_51de1e4a-3c99-450d-80c2-8fde8a1d9b10" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:to="loc_kids_BusinessAcquisitionAnniversaryAxis_51de1e4a-3c99-450d-80c2-8fde8a1d9b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_51de1e4a-3c99-450d-80c2-8fde8a1d9b10" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAnniversaryMember_184a3e17-e75f-4fb3-8b1f-f2433d9c60c3" xlink:href="kids-20200630.xsd#kids_SecondAnniversaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:to="loc_kids_SecondAnniversaryMember_184a3e17-e75f-4fb3-8b1f-f2433d9c60c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ThirdAnniversaryMember_4b512775-f44d-4003-a547-d82d8cf45168" xlink:href="kids-20200630.xsd#kids_ThirdAnniversaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:to="loc_kids_ThirdAnniversaryMember_4b512775-f44d-4003-a547-d82d8cf45168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FourthAnniversaryMember_cb6a5eca-216b-4339-8658-416105b531ab" xlink:href="kids-20200630.xsd#kids_FourthAnniversaryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_2f83a58e-b78f-4c7f-a960-80158d86e647" xlink:to="loc_kids_FourthAnniversaryMember_cb6a5eca-216b-4339-8658-416105b531ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fa36c586-83fa-4153-b8f5-9b9f23b5495e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7d19a6a3-d4aa-4760-982a-cac7d060f080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7d19a6a3-d4aa-4760-982a-cac7d060f080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_e4bc14b9-380f-481d-a58d-017ad30813a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_e4bc14b9-380f-481d-a58d-017ad30813a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_5b929520-eda7-424f-88c1-80aa03524888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_5b929520-eda7-424f-88c1-80aa03524888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_824157b2-9409-429d-839d-c47db9404319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_824157b2-9409-429d-839d-c47db9404319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_27b48d20-db8d-4fbc-8376-dfb4e830bfad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_27b48d20-db8d-4fbc-8376-dfb4e830bfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned_28c79d96-042d-418a-8102-7cbe47ec3c1a" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned_28c79d96-042d-418a-8102-7cbe47ec3c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_7be042d9-f205-4a7b-b98c-112094106acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_7be042d9-f205-4a7b-b98c-112094106acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_80e801c1-0fc7-4835-a1a7-0326208388b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_80e801c1-0fc7-4835-a1a7-0326208388b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_321d4641-5526-48ef-82e9-1052d3f32d89" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_321d4641-5526-48ef-82e9-1052d3f32d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_2d77a787-4246-4f10-898f-d3d968a9a7ec" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenueMultiplier"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a19feff0-6750-4231-b67f-1ea51eb95f92" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_2d77a787-4246-4f10-898f-d3d968a9a7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_94c3616a-7104-41d2-b9d7-6eca59ff8a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_87e67443-d1c0-4ddf-a4b0-00b6bbd13878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_94c3616a-7104-41d2-b9d7-6eca59ff8a86" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_87e67443-d1c0-4ddf-a4b0-00b6bbd13878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d0324c4f-d7fd-4aef-9c30-578d205b2224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d0324c4f-d7fd-4aef-9c30-578d205b2224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_af3e8e2f-3a57-4743-a872-0fad973fa0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_UseOfEstimates_af3e8e2f-3a57-4743-a872-0fad973fa0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e8690694-653a-4c4e-bd83-ec44dcaf9d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e8690694-653a-4c4e-bd83-ec44dcaf9d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_76499757-e46b-46be-b9ac-d627efb0b1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_76499757-e46b-46be-b9ac-d627efb0b1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a3b05020-6b51-425d-ab73-0c513d54cbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_a3b05020-6b51-425d-ab73-0c513d54cbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_a7d74ed1-45f4-4d9f-8a06-67527391a02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_a7d74ed1-45f4-4d9f-8a06-67527391a02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_2c71515f-046e-4f72-8e0a-ed7197340168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_2c71515f-046e-4f72-8e0a-ed7197340168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_59b81b31-91f9-45ce-a249-68bedf88e684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_59b81b31-91f9-45ce-a249-68bedf88e684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_e6a5bff0-db9e-4d21-8baf-f72406fb17eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_e6a5bff0-db9e-4d21-8baf-f72406fb17eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_035c564c-ea8f-4061-bcc5-3bef9318e6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_035c564c-ea8f-4061-bcc5-3bef9318e6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock_05cbe57f-e53b-4c0d-8fb8-e54ae7b887c7" xlink:href="kids-20200630.xsd#kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock_05cbe57f-e53b-4c0d-8fb8-e54ae7b887c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SalesAndMarketingExpensePolicyPolicyTextBlock_a0cc7354-1529-445b-a527-b110c67e7074" xlink:href="kids-20200630.xsd#kids_SalesAndMarketingExpensePolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_kids_SalesAndMarketingExpensePolicyPolicyTextBlock_a0cc7354-1529-445b-a527-b110c67e7074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_da19664d-f051-4aba-ab97-b5b8573f1e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_da19664d-f051-4aba-ab97-b5b8573f1e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_db9a266a-05cf-4201-adc2-27e511fe368b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_db9a266a-05cf-4201-adc2-27e511fe368b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_769d3a45-4b0b-4f0b-a7a1-9f36a2e3e6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_769d3a45-4b0b-4f0b-a7a1-9f36a2e3e6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d383d9bd-6b92-421f-8660-619facb16da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_d383d9bd-6b92-421f-8660-619facb16da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_3c6262a9-04a6-4f62-8b3f-a26c2199d0de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_3c6262a9-04a6-4f62-8b3f-a26c2199d0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock_6582c031-abc1-4371-a994-85cfce405904" xlink:href="kids-20200630.xsd#kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock_6582c031-abc1-4371-a994-85cfce405904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6000c2d0-a30b-45df-a251-11486c55d69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1286027e-603f-42c0-86ea-ad33bd305a6d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6000c2d0-a30b-45df-a251-11486c55d69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_14ed835d-0455-49b8-b7e2-69b58b166e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_daddefe8-9e63-481c-a911-d38d1ea1b48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_14ed835d-0455-49b8-b7e2-69b58b166e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_daddefe8-9e63-481c-a911-d38d1ea1b48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e4709eb7-5e76-46a5-8bb7-614dcc5742e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3deb0934-672b-4ca7-995f-fa9a80c0292a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e4709eb7-5e76-46a5-8bb7-614dcc5742e0" xlink:to="loc_us-gaap_SubsequentEventTable_3deb0934-672b-4ca7-995f-fa9a80c0292a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6e9330ac-d379-4d76-933a-056abc0f8912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3deb0934-672b-4ca7-995f-fa9a80c0292a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6e9330ac-d379-4d76-933a-056abc0f8912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b70b4f47-5fe9-426e-bd84-a793b473fad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6e9330ac-d379-4d76-933a-056abc0f8912" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b70b4f47-5fe9-426e-bd84-a793b473fad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FollowOnOfferingMember_c4366953-9d03-4490-9442-b9d7a519b832" xlink:href="kids-20200630.xsd#kids_FollowOnOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b70b4f47-5fe9-426e-bd84-a793b473fad6" xlink:to="loc_kids_FollowOnOfferingMember_c4366953-9d03-4490-9442-b9d7a519b832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3deb0934-672b-4ca7-995f-fa9a80c0292a" xlink:to="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d4dd6a0b-774c-4d50-9ff6-e7d9613be0b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d4dd6a0b-774c-4d50-9ff6-e7d9613be0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8cc56dc3-49a1-495e-b7fe-ba9fdf568c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8cc56dc3-49a1-495e-b7fe-ba9fdf568c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_19df36c8-dc73-4c40-94c9-854ff809ae12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_19df36c8-dc73-4c40-94c9-854ff809ae12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_ae86ec8e-e1ee-42ed-90b0-9751a65cd4d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_ae86ec8e-e1ee-42ed-90b0-9751a65cd4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6f58bddd-2b01-4ce4-acb1-cd88b9c42fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6f58bddd-2b01-4ce4-acb1-cd88b9c42fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_87736d68-7d08-4ac4-8acf-9277155d0fe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_87736d68-7d08-4ac4-8acf-9277155d0fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_e1b5dec2-9271-407d-a29c-ad1d573d1e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_e1b5dec2-9271-407d-a29c-ad1d573d1e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_43a03b47-cc51-4771-bf83-2d078082daa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_43a03b47-cc51-4771-bf83-2d078082daa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_624e0c9b-b3f7-4ec8-aca9-e40d492be207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c74dc1f1-7956-49e5-b845-16c7f152b223" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_624e0c9b-b3f7-4ec8-aca9-e40d492be207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4fb9a861-f5c1-4f5e-982c-c1005ce612c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4fb9a861-f5c1-4f5e-982c-c1005ce612c4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a0112e7-b09b-4f6f-aac8-39ba52f92da5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a0112e7-b09b-4f6f-aac8-39ba52f92da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7a0112e7-b09b-4f6f-aac8-39ba52f92da5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_803ec676-0a6a-4bab-b9b5-c2e075c335e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_803ec676-0a6a-4bab-b9b5-c2e075c335e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_c470c915-0e80-42a0-813b-f594b53fd9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_c470c915-0e80-42a0-813b-f594b53fd9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_ef3912ec-d57f-47a4-bb1e-6293086be6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_ComputerEquipmentMember_ef3912ec-d57f-47a4-bb1e-6293086be6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_91672796-e7b2-4c5f-b199-14721a81918f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_91672796-e7b2-4c5f-b199-14721a81918f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_3dd4c903-6301-4387-ac3a-5a5675f8d49b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_OfficeEquipmentMember_3dd4c903-6301-4387-ac3a-5a5675f8d49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyEquipmentMember_e653f372-cf06-4347-b7e5-957091abe3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_us-gaap_TechnologyEquipmentMember_e653f372-cf06-4347-b7e5-957091abe3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SampleInventoryMember_9756cdde-a46d-4169-859e-fc9c540351b4" xlink:href="kids-20200630.xsd#kids_SampleInventoryMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75597453-55cf-4f6f-9f27-ca91254513b5" xlink:to="loc_kids_SampleInventoryMember_9756cdde-a46d-4169-859e-fc9c540351b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:to="loc_srt_RangeAxis_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f42e82ac-6d17-43ac-bcdd-65d43e52d0ff" xlink:to="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_95e55aec-6a1c-419e-a4b4-1743f60d1b73" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:to="loc_srt_MinimumMember_95e55aec-6a1c-419e-a4b4-1743f60d1b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a946dcb5-8fac-4e94-8a46-487c566c85ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_87c17576-f161-47a4-bee6-8b696ef48bf3" xlink:to="loc_srt_MaximumMember_a946dcb5-8fac-4e94-8a46-487c566c85ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_92b28820-3eec-49cd-900d-661d29669a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e5ffcd1b-3471-49b3-8f9a-adcc441f51ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_92b28820-3eec-49cd-900d-661d29669a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c151d979-b81a-43e2-b744-1a7c925ed262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_92b28820-3eec-49cd-900d-661d29669a41" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c151d979-b81a-43e2-b744-1a7c925ed262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1ccccc06-cf96-4d15-aca6-be8c332c0119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f4a9a416-f6e8-47ad-b423-a3c129834cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1ccccc06-cf96-4d15-aca6-be8c332c0119" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f4a9a416-f6e8-47ad-b423-a3c129834cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0b5bfef3-0474-44be-ae3c-913e91e948b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f4a9a416-f6e8-47ad-b423-a3c129834cc7" xlink:to="loc_srt_RangeAxis_0b5bfef3-0474-44be-ae3c-913e91e948b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0b5bfef3-0474-44be-ae3c-913e91e948b1" xlink:to="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6a13f284-19c8-41f2-a21f-14c662270c96" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:to="loc_srt_MinimumMember_6a13f284-19c8-41f2-a21f-14c662270c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6fd146da-1020-46bc-ab31-b3b2c1a08ca9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8fc2a86f-4365-4dbb-994d-a4198d7f2ddd" xlink:to="loc_srt_MaximumMember_6fd146da-1020-46bc-ab31-b3b2c1a08ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_31fa76e4-27bc-4701-ab9a-eadf370704de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_f4a9a416-f6e8-47ad-b423-a3c129834cc7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_31fa76e4-27bc-4701-ab9a-eadf370704de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7d38d6b3-2616-41d3-9fff-3f6a3247bf0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_31fa76e4-27bc-4701-ab9a-eadf370704de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7d38d6b3-2616-41d3-9fff-3f6a3247bf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6df72d48-4e0a-4ed5-9c8b-768f3bff204d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6df72d48-4e0a-4ed5-9c8b-768f3bff204d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_eff660b2-2a9f-4567-a3d0-37974cc1a402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_us-gaap_PlanNameAxis_eff660b2-2a9f-4567-a3d0-37974cc1a402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_eff660b2-2a9f-4567-a3d0-37974cc1a402" xlink:to="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_A2007EquityIncentivePlanMember_acd7235b-7be8-4b56-84c1-885a3807dc57" xlink:href="kids-20200630.xsd#kids_A2007EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:to="loc_kids_A2007EquityIncentivePlanMember_acd7235b-7be8-4b56-84c1-885a3807dc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_New2017EquityIncentivePlanMember_762fa704-08a4-489d-a56c-36d10679a969" xlink:href="kids-20200630.xsd#kids_New2017EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7bc66960-f1f4-42a8-ba1a-c08c0c620d1e" xlink:to="loc_kids_New2017EquityIncentivePlanMember_762fa704-08a4-489d-a56c-36d10679a969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_36a20350-d212-4811-9237-9a705b1fc5ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_us-gaap_AwardTypeAxis_36a20350-d212-4811-9237-9a705b1fc5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_36a20350-d212-4811-9237-9a705b1fc5ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_59b96dfc-886e-4ab8-b282-16fa466e1018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:to="loc_us-gaap_EmployeeStockOptionMember_59b96dfc-886e-4ab8-b282-16fa466e1018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_3d05339c-129a-4cb4-a12e-89d6f27e4500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e13e947-2e13-43cf-8bc9-a841692b4708" xlink:to="loc_us-gaap_RestrictedStockMember_3d05339c-129a-4cb4-a12e-89d6f27e4500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f29eb5c1-b284-4a3c-977e-40c50fa961e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_srt_RangeAxis_f29eb5c1-b284-4a3c-977e-40c50fa961e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_83c65314-911c-4cf7-8832-501ec1a73bba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f29eb5c1-b284-4a3c-977e-40c50fa961e5" xlink:to="loc_srt_RangeMember_83c65314-911c-4cf7-8832-501ec1a73bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ffe4b6a-ce15-4144-90fd-51c99f7bc3c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_83c65314-911c-4cf7-8832-501ec1a73bba" xlink:to="loc_srt_MaximumMember_2ffe4b6a-ce15-4144-90fd-51c99f7bc3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_d1df206c-6f1e-4e42-9fe4-65ec9eca8781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_us-gaap_VestingAxis_d1df206c-6f1e-4e42-9fe4-65ec9eca8781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_d1df206c-6f1e-4e42-9fe4-65ec9eca8781" xlink:to="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_18699e2c-2b5c-42a7-8ecd-e69f33454313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_18699e2c-2b5c-42a7-8ecd-e69f33454313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_4ae64e47-2f47-4105-8de9-70096eaeb6c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_294ec9d4-03b1-46d2-b964-3ccb3818bf42" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_4ae64e47-2f47-4105-8de9-70096eaeb6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_067c7ead-d998-4cd4-b9cb-abff3725e814" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_00f92b26-8e85-425c-8631-bbf0ed071cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_00f92b26-8e85-425c-8631-bbf0ed071cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3efabc85-69c6-4a8c-aff8-d8ef3e84f438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3efabc85-69c6-4a8c-aff8-d8ef3e84f438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a1f4f902-a73d-45a3-baad-a29ebcfd4b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e30291b9-73de-410d-9c9c-aad46d7892fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a1f4f902-a73d-45a3-baad-a29ebcfd4b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATION" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATION"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_15fd62b2-4ca4-4c34-9d8d-4f496ce84f49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b3d3b2a7-d43f-4f68-9670-69f38f412848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_15fd62b2-4ca4-4c34-9d8d-4f496ce84f49" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b3d3b2a7-d43f-4f68-9670-69f38f412848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONTables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7306579f-0352-4514-8e6f-e940b8c6aaaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b0abc386-cbf9-4392-b318-b32b9b1c1583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7306579f-0352-4514-8e6f-e940b8c6aaaa" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b0abc386-cbf9-4392-b318-b32b9b1c1583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_44a0b8c4-c335-43bb-a804-f0b2607d0d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7306579f-0352-4514-8e6f-e940b8c6aaaa" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_44a0b8c4-c335-43bb-a804-f0b2607d0d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_ffbf60de-d8a3-4e6b-80c8-4f24737d14a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7306579f-0352-4514-8e6f-e940b8c6aaaa" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_ffbf60de-d8a3-4e6b-80c8-4f24737d14a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_db26edd3-ea2a-4ca0-b866-efa14305d3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7306579f-0352-4514-8e6f-e940b8c6aaaa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_db26edd3-ea2a-4ca0-b866-efa14305d3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONApiFixDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c6ccb5e5-274a-4f48-b948-6444453eb83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c6ccb5e5-274a-4f48-b948-6444453eb83d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f6e20e94-2df5-4b85-92a2-cace357128fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f6e20e94-2df5-4b85-92a2-cace357128fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59266ac3-ebd5-4bc8-ba89-5dc8ecc30860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f6e20e94-2df5-4b85-92a2-cace357128fb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59266ac3-ebd5-4bc8-ba89-5dc8ecc30860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_052dc406-53e4-4958-963d-995c89ac5d23" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_59266ac3-ebd5-4bc8-ba89-5dc8ecc30860" xlink:to="loc_kids_ApiFixLtdMember_052dc406-53e4-4958-963d-995c89ac5d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d02f04b-0927-4f35-8116-076ef008b62e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d02f04b-0927-4f35-8116-076ef008b62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d02f04b-0927-4f35-8116-076ef008b62e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_c8d2b9ad-c7e7-482f-b935-af5f9a9d8bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:to="loc_us-gaap_PatentsMember_c8d2b9ad-c7e7-482f-b935-af5f9a9d8bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c5a3192f-be29-43c6-a376-c9054e57ade3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c5a3192f-be29-43c6-a376-c9054e57ade3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e7873965-f292-42e8-899b-0b8b0a5b6882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a9c5da9-3e5b-4ae3-a580-393b29b8feed" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e7873965-f292-42e8-899b-0b8b0a5b6882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_10b94c0e-8997-4aab-a054-0757299f4140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_10b94c0e-8997-4aab-a054-0757299f4140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f658a933-d649-4722-8144-ba34d73c4e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_10b94c0e-8997-4aab-a054-0757299f4140" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f658a933-d649-4722-8144-ba34d73c4e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_2be2f951-68d3-4038-b44b-6aa1c478ecab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f658a933-d649-4722-8144-ba34d73c4e79" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_2be2f951-68d3-4038-b44b-6aa1c478ecab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryAxis_e63157c8-a4c3-4bab-a8c7-9d456bb49622" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_kids_BusinessAcquisitionAnniversaryAxis_e63157c8-a4c3-4bab-a8c7-9d456bb49622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_e63157c8-a4c3-4bab-a8c7-9d456bb49622" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAnniversaryMember_8c379e15-66fc-4f34-9a50-047163f446d0" xlink:href="kids-20200630.xsd#kids_SecondAnniversaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:to="loc_kids_SecondAnniversaryMember_8c379e15-66fc-4f34-9a50-047163f446d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ThirdAnniversaryMember_e316b610-7da2-40a3-9a92-9ed1f89de631" xlink:href="kids-20200630.xsd#kids_ThirdAnniversaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:to="loc_kids_ThirdAnniversaryMember_e316b610-7da2-40a3-9a92-9ed1f89de631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FourthAnniversaryMember_838aa253-3c6e-4d50-88ad-b02c74fae1b3" xlink:href="kids-20200630.xsd#kids_FourthAnniversaryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_9d651a8c-0037-4bdc-bc71-f1ab1e894c0d" xlink:to="loc_kids_FourthAnniversaryMember_838aa253-3c6e-4d50-88ad-b02c74fae1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0bfa1634-7653-4862-8ef2-74697163a21c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_f2486215-9270-425b-84bb-22c539466a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_f2486215-9270-425b-84bb-22c539466a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_00905a5e-6e0a-428d-9673-24c32e2d6906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_00905a5e-6e0a-428d-9673-24c32e2d6906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3010d933-0654-4da0-b880-1e87fdacbecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_3010d933-0654-4da0-b880-1e87fdacbecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a3fadad3-348c-4256-ad8a-8ade915baa09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a3fadad3-348c-4256-ad8a-8ade915baa09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_939ad7dc-388e-485f-a07c-8a514bb09ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_939ad7dc-388e-485f-a07c-8a514bb09ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_b6550846-2348-4856-9f5d-bfb753c5e759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_b6550846-2348-4856-9f5d-bfb753c5e759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAnniversaryPayments_588cf1b6-3c6f-48ef-ab68-b855530d5efa" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAnniversaryPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAnniversaryPayments_588cf1b6-3c6f-48ef-ab68-b855530d5efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationSystemSalesPayment_5891716b-6164-4d74-9074-34500f1d8a32" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationSystemSalesPayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationSystemSalesPayment_5891716b-6164-4d74-9074-34500f1d8a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5bff3703-1c5a-4318-88b2-3e25f4e8db5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5bff3703-1c5a-4318-88b2-3e25f4e8db5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9133262f-f7ab-4393-b187-f72bfdf49344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9133262f-f7ab-4393-b187-f72bfdf49344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4715d522-2845-4299-ab6b-a08ac2ba4e8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4715d522-2845-4299-ab6b-a08ac2ba4e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e3b41c6-5278-42ba-a68b-cf2c4d7d4c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e3b41c6-5278-42ba-a68b-cf2c4d7d4c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b4c88a76-f646-4754-9159-16ce17b936a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_b4c88a76-f646-4754-9159-16ce17b936a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fc922626-ed06-4602-b89d-b9987ad75035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fc922626-ed06-4602-b89d-b9987ad75035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_78869f33-65d9-4e7c-9ef7-f36558dbd9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_78869f33-65d9-4e7c-9ef7-f36558dbd9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5defd6c6-bdbd-4e81-81fe-6c40406dcd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5defd6c6-bdbd-4e81-81fe-6c40406dcd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_bdbe5f89-c903-4fb3-89b1-e34b70d7de1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_bdbe5f89-c903-4fb3-89b1-e34b70d7de1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_1e2cc403-6d0f-467b-a634-fec0a6b0c5e7" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_1e2cc403-6d0f-467b-a634-fec0a6b0c5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02784a47-6234-4e6e-9930-b38f80b3738b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13e96f7d-bbb8-4d54-bf78-633a3ba5ac70" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02784a47-6234-4e6e-9930-b38f80b3738b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_1b5341b4-94eb-4a15-92ec-5f7e857a4798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_1b5341b4-94eb-4a15-92ec-5f7e857a4798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_146c9d85-f440-4cf4-a222-b0ceb50ac464" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_146c9d85-f440-4cf4-a222-b0ceb50ac464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a29056f4-8b12-486d-ba13-13fb8be307b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_a29056f4-8b12-486d-ba13-13fb8be307b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_cd569da7-23e8-4edd-810d-29289960d3b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_cd569da7-23e8-4edd-810d-29289960d3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5a2ecb2c-49cb-4a41-bc42-fc232b34507c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a0b4eb06-dee0-4993-a65e-2b4c63699ee9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5a2ecb2c-49cb-4a41-bc42-fc232b34507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2244780d-ee55-462b-a213-58acdc2d1cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2244780d-ee55-462b-a213-58acdc2d1cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fe1aa97f-82be-444c-821b-ffcdc8f52781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_Goodwill_fe1aa97f-82be-444c-821b-ffcdc8f52781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_db1f4632-6b31-4ac8-87b6-a52945bcdbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_db1f4632-6b31-4ac8-87b6-a52945bcdbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b1867b4e-c2ac-4bcc-be29-208c483a0e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_b1867b4e-c2ac-4bcc-be29-208c483a0e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired_3243b9a4-6005-4831-84ad-02fe08f1f531" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_IntangibleAssetsAcquired_3243b9a4-6005-4831-84ad-02fe08f1f531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f14692b4-667d-46e2-9bc2-926ad216e1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f14692b4-667d-46e2-9bc2-926ad216e1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_74456195-e79f-4b2a-90c1-506bf12e6352" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenueMultiplier"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenueMultiplier_74456195-e79f-4b2a-90c1-506bf12e6352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_459c459a-837e-490b-94a8-f5840ac3fa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_459c459a-837e-490b-94a8-f5840ac3fa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8e40f9bb-8cff-4038-8c4f-a05895138f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_8e40f9bb-8cff-4038-8c4f-a05895138f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_fa27cf39-6157-4119-b1d5-861f7fd2093e" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenuePayment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_fa27cf39-6157-4119-b1d5-861f7fd2093e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ca3bc4ef-6d4c-4f6a-a210-468cc357b76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_InterestExpense_ca3bc4ef-6d4c-4f6a-a210-468cc357b76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f342d2a5-c46b-4ef6-a65c-006a8a4ec9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f342d2a5-c46b-4ef6-a65c-006a8a4ec9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_aca03cdc-6805-4021-a8b6-5eb608b986c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_aca03cdc-6805-4021-a8b6-5eb608b986c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_8d749f8f-4c4c-400c-b5fa-2c2ffaaa93db" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_aa55df64-224c-4043-9485-3b5627130cd1" xlink:to="loc_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures_8d749f8f-4c4c-400c-b5fa-2c2ffaaa93db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1463e347-f685-4b2c-bfa6-27ac419ffb68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1463e347-f685-4b2c-bfa6-27ac419ffb68" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_16aec9d7-56c7-4f74-847b-d29c4f1245f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_16aec9d7-56c7-4f74-847b-d29c4f1245f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0002ea66-e47c-4503-8717-170d56942eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_16aec9d7-56c7-4f74-847b-d29c4f1245f6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0002ea66-e47c-4503-8717-170d56942eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_d1b45118-e065-43bb-85bf-c2c071f3f92f" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0002ea66-e47c-4503-8717-170d56942eac" xlink:to="loc_kids_ApiFixLtdMember_d1b45118-e065-43bb-85bf-c2c071f3f92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryAxis_0c40f70c-fe42-4d45-a09f-dd49352bf36d" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:to="loc_kids_BusinessAcquisitionAnniversaryAxis_0c40f70c-fe42-4d45-a09f-dd49352bf36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:href="kids-20200630.xsd#kids_BusinessAcquisitionAnniversaryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryAxis_0c40f70c-fe42-4d45-a09f-dd49352bf36d" xlink:to="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAnniversaryMember_7a0b0c89-f797-4092-b09c-b169d22ca2b4" xlink:href="kids-20200630.xsd#kids_SecondAnniversaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:to="loc_kids_SecondAnniversaryMember_7a0b0c89-f797-4092-b09c-b169d22ca2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ThirdAnniversaryMember_c05abe50-ee93-428a-9c93-4602c04e7d9e" xlink:href="kids-20200630.xsd#kids_ThirdAnniversaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:to="loc_kids_ThirdAnniversaryMember_c05abe50-ee93-428a-9c93-4602c04e7d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FourthAnniversaryMember_1a802150-700e-4005-b5dc-942f44d4f38e" xlink:href="kids-20200630.xsd#kids_FourthAnniversaryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_BusinessAcquisitionAnniversaryDomain_842a82c3-ff28-4bbf-9f45-353c11c9946b" xlink:to="loc_kids_FourthAnniversaryMember_1a802150-700e-4005-b5dc-942f44d4f38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2f84a2c4-d5f3-4d1d-a7ed-0a10e39cd72d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_3d699257-3319-42a2-b708-97ef26d13627" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable_3d699257-3319-42a2-b708-97ef26d13627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_1665f5fd-2dd0-4e94-88e5-3cd70253b493" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent_1665f5fd-2dd0-4e94-88e5-3cd70253b493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_3cc845c6-7859-4616-b11a-b4520b2b74dd" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent_3cc845c6-7859-4616-b11a-b4520b2b74dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_526ed632-1f8a-4115-a402-85ed9aff35da" xlink:href="kids-20200630.xsd#kids_BusinessCombinationContingentConsiderationRevenuePayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_kids_BusinessCombinationContingentConsiderationRevenuePayment_526ed632-1f8a-4115-a402-85ed9aff35da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77c2e8ba-f888-4632-a03a-9ce3cf32bd93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0d4cd65f-1854-4bb8-b935-a037b9601a87" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_77c2e8ba-f888-4632-a03a-9ce3cf32bd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONTelosDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b39faf89-0cb5-4ede-9ba4-2e6ba1b396db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b39faf89-0cb5-4ede-9ba4-2e6ba1b396db" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc226315-a805-4017-93f4-7918a7306838" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc226315-a805-4017-93f4-7918a7306838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_937e613c-11ea-417f-8f3e-9853c16bb290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc226315-a805-4017-93f4-7918a7306838" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_937e613c-11ea-417f-8f3e-9853c16bb290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_0f6d115a-1a7d-4f01-be7a-41d6bf499c9c" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_937e613c-11ea-417f-8f3e-9853c16bb290" xlink:to="loc_kids_TelosPartnersLLCMember_0f6d115a-1a7d-4f01-be7a-41d6bf499c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fbcb614b-57bd-45e3-8689-d414f00fa944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fbcb614b-57bd-45e3-8689-d414f00fa944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28061637-8be7-43dc-9091-fdd82b1301cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_fbcb614b-57bd-45e3-8689-d414f00fa944" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28061637-8be7-43dc-9091-fdd82b1301cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_9edf0be1-0d61-4c58-9bc4-b9ac609542ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28061637-8be7-43dc-9091-fdd82b1301cc" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_9edf0be1-0d61-4c58-9bc4-b9ac609542ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_838c6036-b6ac-4a34-9c67-0e0af1701ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_838c6036-b6ac-4a34-9c67-0e0af1701ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_838c6036-b6ac-4a34-9c67-0e0af1701ca5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1ba33100-cc16-409c-8543-8919a7bb62a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1ba33100-cc16-409c-8543-8919a7bb62a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d3a06fe1-202b-4da2-80a3-9181c56a6406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8f459c2f-d8b2-4dd4-86ba-e3999cd409df" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d3a06fe1-202b-4da2-80a3-9181c56a6406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdf20373-8293-4825-b085-2acd16668b85" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c535467-462a-4c8d-afae-962b738de1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c535467-462a-4c8d-afae-962b738de1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_36e0c12d-7a3d-43fd-9979-712a6667dace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_36e0c12d-7a3d-43fd-9979-712a6667dace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_89ece70b-2d88-48c9-bf8f-507edd00605c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_89ece70b-2d88-48c9-bf8f-507edd00605c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_832929d7-dbd6-404c-83ab-3f8dc2aa42ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_832929d7-dbd6-404c-83ab-3f8dc2aa42ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_f5495c13-0047-4250-a26f-320432996aad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_f5495c13-0047-4250-a26f-320432996aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1f87d4db-9705-44b5-9ca6-8724d6739302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1f87d4db-9705-44b5-9ca6-8724d6739302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4415ba36-ec09-476f-8dd5-dab9343acfd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4415ba36-ec09-476f-8dd5-dab9343acfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f2682232-1241-4048-a506-b4993dba1f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f2682232-1241-4048-a506-b4993dba1f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707ef0a-56f8-4ffd-8709-5b9e324941cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_f707ef0a-56f8-4ffd-8709-5b9e324941cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f403d7d6-465b-4e1c-a7e2-c4f1a302f25a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_f403d7d6-465b-4e1c-a7e2-c4f1a302f25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f0f47096-1aed-4354-a66f-06a7d1dde65b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f0f47096-1aed-4354-a66f-06a7d1dde65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_5d7c81e5-743f-4cdf-a656-81b30a7ed402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_5d7c81e5-743f-4cdf-a656-81b30a7ed402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_16e31eff-d70a-4189-a2df-59842a78746c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_d9664fcc-8203-4b98-a9a3-2fb0f4a2a1f1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_16e31eff-d70a-4189-a2df-59842a78746c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_757219a2-fb64-4418-aa66-1a63cb748c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_757219a2-fb64-4418-aa66-1a63cb748c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3f4f8af-08a2-4166-af83-58b32bbdd4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_10d266c0-20f0-4589-b937-8df54b2a3e33" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c3f4f8af-08a2-4166-af83-58b32bbdd4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cbfe7c77-e98c-43a0-a84e-17a25d5e7168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cbfe7c77-e98c-43a0-a84e-17a25d5e7168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2fc82b6d-dd8f-4e34-8c42-9a3c0d49f6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_Goodwill_2fc82b6d-dd8f-4e34-8c42-9a3c0d49f6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_240be40b-67ff-4c15-840c-d987de08a80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_240be40b-67ff-4c15-840c-d987de08a80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_af06c85e-25a1-4796-846f-54815614f2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_af06c85e-25a1-4796-846f-54815614f2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired_4113bad3-36fd-44bb-91fd-4f5ed0bc7fa8" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_kids_IntangibleAssetsAcquired_4113bad3-36fd-44bb-91fd-4f5ed0bc7fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_959a3783-8b51-468f-83e2-5c117dff33ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3305c1e8-1b49-4ee9-9367-5a53f3cde676" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_959a3783-8b51-468f-83e2-5c117dff33ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSCOMBINATIONVilexandOrthexDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e7142608-ac37-4fa9-8270-82dd36e4d947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e7142608-ac37-4fa9-8270-82dd36e4d947" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cf07a393-82e8-497b-9ca6-5894bf40a64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cf07a393-82e8-497b-9ca6-5894bf40a64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cf07a393-82e8-497b-9ca6-5894bf40a64c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexAndOrthexMember_adc12377-dd0c-4f3e-88ba-56f05f4b523a" xlink:href="kids-20200630.xsd#kids_VilexAndOrthexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:to="loc_kids_VilexAndOrthexMember_adc12377-dd0c-4f3e-88ba-56f05f4b523a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OrthexMember_a7346bca-c67e-4483-a108-cbc2112b42ef" xlink:href="kids-20200630.xsd#kids_OrthexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:to="loc_kids_OrthexMember_a7346bca-c67e-4483-a108-cbc2112b42ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexMember_67912414-8fdc-4ab1-8618-5e82ef5b06ba" xlink:href="kids-20200630.xsd#kids_VilexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c982af3-3000-452c-8d25-172c2928eef7" xlink:to="loc_kids_VilexMember_67912414-8fdc-4ab1-8618-5e82ef5b06ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ed6addad-3e5b-4523-bc59-e3b841c2968f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ed6addad-3e5b-4523-bc59-e3b841c2968f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ab710006-9821-455a-a607-82d7dc055257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ed6addad-3e5b-4523-bc59-e3b841c2968f" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ab710006-9821-455a-a607-82d7dc055257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_90f8c8cb-fca5-4012-906c-cf434e91fb6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ab710006-9821-455a-a607-82d7dc055257" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_90f8c8cb-fca5-4012-906c-cf434e91fb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd505ff5-8082-41da-a36b-01a7bc6b8d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd505ff5-8082-41da-a36b-01a7bc6b8d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_947430d0-2b7d-4a10-8a02-b74ca5b308f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd505ff5-8082-41da-a36b-01a7bc6b8d17" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_947430d0-2b7d-4a10-8a02-b74ca5b308f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_84fb3999-8846-4167-9aa6-ffdfb8dad48a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_947430d0-2b7d-4a10-8a02-b74ca5b308f3" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_84fb3999-8846-4167-9aa6-ffdfb8dad48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2b301a2d-ae5a-427d-873a-d52c3e9dab38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2b301a2d-ae5a-427d-873a-d52c3e9dab38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2b301a2d-ae5a-427d-873a-d52c3e9dab38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_810a2954-85e8-49e0-bcc6-a4ecfa0278aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_PatentsMember_810a2954-85e8-49e0-bcc6-a4ecfa0278aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a87083dc-6f6c-4beb-a03c-da96aebafd95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a87083dc-6f6c-4beb-a03c-da96aebafd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c07a00ab-e725-4c33-b165-577f57d069c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c07a00ab-e725-4c33-b165-577f57d069c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_13d44d91-4524-4f39-97b5-9f2c0a3ab5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38da5000-0f66-47f5-80d1-438d60d9db6f" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_13d44d91-4524-4f39-97b5-9f2c0a3ab5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0fc985b3-b164-405b-bbca-17a59d740d5e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_4699e054-baab-4fa7-956f-3cf273051625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_4699e054-baab-4fa7-956f-3cf273051625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1bda992a-90cb-4d5c-959c-e6b9091fead5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1bda992a-90cb-4d5c-959c-e6b9091fead5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1040fb04-5dcb-49f7-93d4-cfe82baff2c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1040fb04-5dcb-49f7-93d4-cfe82baff2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_0f37a69d-2317-492e-9558-1ab097a48bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_0f37a69d-2317-492e-9558-1ab097a48bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationEscrowDeposit_aca42631-3996-4e3c-9c2d-6e4649e9e06f" xlink:href="kids-20200630.xsd#kids_BusinessCombinationEscrowDeposit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_BusinessCombinationEscrowDeposit_aca42631-3996-4e3c-9c2d-6e4649e9e06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationEscrowDepositMaximumTerm_a811f13c-ba84-4547-bf05-20f54e10a271" xlink:href="kids-20200630.xsd#kids_BusinessCombinationEscrowDepositMaximumTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_BusinessCombinationEscrowDepositMaximumTerm_a811f13c-ba84-4547-bf05-20f54e10a271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_89418c57-4788-43e0-9785-fddd151053e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_89418c57-4788-43e0-9785-fddd151053e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fc2c594a-c6b9-40ab-81b1-fe80354f1ded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_fc2c594a-c6b9-40ab-81b1-fe80354f1ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d786eed2-d5f1-4604-8b5a-f653db2df6e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d786eed2-d5f1-4604-8b5a-f653db2df6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_76f559d7-60b6-4f00-b3fb-737b65ad0c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_76f559d7-60b6-4f00-b3fb-737b65ad0c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0e1ee917-6a2c-4ee9-b8fe-2f0eb76de1ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0e1ee917-6a2c-4ee9-b8fe-2f0eb76de1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e9ed5c22-603c-4563-8a16-546f65a18961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_e9ed5c22-603c-4563-8a16-546f65a18961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94a9a5b7-a940-477b-a078-ca9c2e3c3c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94a9a5b7-a940-477b-a078-ca9c2e3c3c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d352e69c-ca99-4b4f-b953-a3005d141916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_d352e69c-ca99-4b4f-b953-a3005d141916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_987ce793-e62e-464f-bd57-d1f10d0440b5" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_987ce793-e62e-464f-bd57-d1f10d0440b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_63cd0266-f032-48ec-be06-64f4df5e763e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_cf48c963-b8d8-4894-9db0-aaeffe960774" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_63cd0266-f032-48ec-be06-64f4df5e763e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa900575-278c-4f26-9fae-d8235066307e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_fa900575-278c-4f26-9fae-d8235066307e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_8e1615cc-f1c4-4e79-8768-51ac03f3fe5c" xlink:href="kids-20200630.xsd#kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability_8e1615cc-f1c4-4e79-8768-51ac03f3fe5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ddaa3c79-0722-43c7-b7cf-a1a01bea0c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ddaa3c79-0722-43c7-b7cf-a1a01bea0c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6777daa4-f084-4ec0-83fc-3d5a0f5986cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6777daa4-f084-4ec0-83fc-3d5a0f5986cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_240f74a0-e0b0-4bb8-9ca2-d124c3b00400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_c5cae136-d84b-4cae-8a38-bc99c2a64d50" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_240f74a0-e0b0-4bb8-9ca2-d124c3b00400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f067ab8b-2dd7-43f1-8c94-fe932dda1082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f067ab8b-2dd7-43f1-8c94-fe932dda1082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9a4ce236-9556-4bdd-a901-714af159fe48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_Goodwill_9a4ce236-9556-4bdd-a901-714af159fe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d62ef547-97ca-4d2c-8de2-106bcb2eeb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d62ef547-97ca-4d2c-8de2-106bcb2eeb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2ec77da8-f1be-4e44-84e8-fb97840f0a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_2ec77da8-f1be-4e44-84e8-fb97840f0a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f4213f1f-3610-4a29-b446-481d6f604307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f4213f1f-3610-4a29-b446-481d6f604307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_IntangibleAssetsAcquired_b0e05871-16e4-4542-bbfd-5b28f036d2af" xlink:href="kids-20200630.xsd#kids_IntangibleAssetsAcquired"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_IntangibleAssetsAcquired_b0e05871-16e4-4542-bbfd-5b28f036d2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f2270c8-a4e4-4209-acba-0066c550daef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9f2270c8-a4e4-4209-acba-0066c550daef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue_cce9e8cd-1445-4336-af03-ddef670cabdf" xlink:href="kids-20200630.xsd#kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue_cce9e8cd-1445-4336-af03-ddef670cabdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities_51088278-9b73-4e29-97f7-a1d967c4c931" xlink:href="kids-20200630.xsd#kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities_51088278-9b73-4e29-97f7-a1d967c4c931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a16d0296-ed27-42c1-8656-031f2eefc2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_a16d0296-ed27-42c1-8656-031f2eefc2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_d2f75b56-f575-4dfd-a4ff-cda6decc8758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02d90950-b01e-424f-8269-4daa1bcef0fa" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_d2f75b56-f575-4dfd-a4ff-cda6decc8758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_61be1912-360c-4fd3-abfb-ea4add92d376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7a16e0d0-0a16-4ba1-bea9-78186dd10955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_61be1912-360c-4fd3-abfb-ea4add92d376" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7a16e0d0-0a16-4ba1-bea9-78186dd10955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c01d75a8-77e4-4652-bafc-9395d6a3d51d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_34f4c676-19e3-41c7-9bba-2c83390a3b3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c01d75a8-77e4-4652-bafc-9395d6a3d51d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_34f4c676-19e3-41c7-9bba-2c83390a3b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cb91a941-4899-4f38-a60c-9beba9d3dc48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c01d75a8-77e4-4652-bafc-9395d6a3d51d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_cb91a941-4899-4f38-a60c-9beba9d3dc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9ce5a8aa-95c3-4f8a-9969-c1e03ef3aae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5efef94c-bc99-467d-b628-d181b3722cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63c478ed-e442-4fed-8813-673beee7a46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5efef94c-bc99-467d-b628-d181b3722cfc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63c478ed-e442-4fed-8813-673beee7a46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_766fa4fc-1d4a-4995-8ac8-93c1990593d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63c478ed-e442-4fed-8813-673beee7a46d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_766fa4fc-1d4a-4995-8ac8-93c1990593d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_766fa4fc-1d4a-4995-8ac8-93c1990593d7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_VilexMember_27e055fc-6a52-47d4-b69e-0cf8845e832a" xlink:href="kids-20200630.xsd#kids_VilexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_VilexMember_27e055fc-6a52-47d4-b69e-0cf8845e832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TelosPartnersLLCMember_3a202233-9eb4-47f2-bfc3-fb63a5fd5ab9" xlink:href="kids-20200630.xsd#kids_TelosPartnersLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_TelosPartnersLLCMember_3a202233-9eb4-47f2-bfc3-fb63a5fd5ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OrthexMember_48babe62-e91c-4fca-89e7-ecfe4a4046ce" xlink:href="kids-20200630.xsd#kids_OrthexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_OrthexMember_48babe62-e91c-4fca-89e7-ecfe4a4046ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ApiFixLtdMember_62820095-07f4-44b3-9be9-2bcc47864e13" xlink:href="kids-20200630.xsd#kids_ApiFixLtdMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1abe25bf-3dfe-47c1-9a1d-139af0324c85" xlink:to="loc_kids_ApiFixLtdMember_62820095-07f4-44b3-9be9-2bcc47864e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e3801abb-ec1d-4fe2-b47e-84f544e9e175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63c478ed-e442-4fed-8813-673beee7a46d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e3801abb-ec1d-4fe2-b47e-84f544e9e175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e3801abb-ec1d-4fe2-b47e-84f544e9e175" xlink:to="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2dd7a57-5052-4b43-ae3b-9ffc26b68fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_us-gaap_Goodwill_e2dd7a57-5052-4b43-ae3b-9ffc26b68fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6395e2b2-b50f-42b2-bf6d-f456070a1f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6395e2b2-b50f-42b2-bf6d-f456070a1f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_d054c622-6a8b-4712-be79-9ac330ed3c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_d054c622-6a8b-4712-be79-9ac330ed3c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_GoodwillMeasurementPeriodAdjustment_05bb5079-427e-4fb3-8ac0-6c22ed4b332c" xlink:href="kids-20200630.xsd#kids_GoodwillMeasurementPeriodAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_kids_GoodwillMeasurementPeriodAdjustment_05bb5079-427e-4fb3-8ac0-6c22ed4b332c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1c400139-c539-4a6d-8804-60fe3d45ae4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9ed9f80d-9f69-451c-b2d7-79a1b9fb1dbc" xlink:to="loc_us-gaap_Goodwill_1c400139-c539-4a6d-8804-60fe3d45ae4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2e39ce0a-64a2-4c5e-9c95-9d7a8672dc48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_3d9585a7-5b0b-4cc3-9975-150435e89dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2e39ce0a-64a2-4c5e-9c95-9d7a8672dc48" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_3d9585a7-5b0b-4cc3-9975-150435e89dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ec75eb6-7b76-468a-a232-bd99d89a3962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_3d9585a7-5b0b-4cc3-9975-150435e89dec" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ec75eb6-7b76-468a-a232-bd99d89a3962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5ec75eb6-7b76-468a-a232-bd99d89a3962" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_e9607d83-4753-46dc-8a0a-cd1fc0f11fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:to="loc_us-gaap_PatentsMember_e9607d83-4753-46dc-8a0a-cd1fc0f11fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_201025f9-7ff3-4653-9653-a62bbc444926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:to="loc_us-gaap_IntellectualPropertyMember_201025f9-7ff3-4653-9653-a62bbc444926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_e9eea0f6-46a5-4e9e-a55e-a7ab9e094ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc59a31c-7b35-4690-b208-5e7dccc32e7e" xlink:to="loc_us-gaap_LicensingAgreementsMember_e9eea0f6-46a5-4e9e-a55e-a7ab9e094ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_3d9585a7-5b0b-4cc3-9975-150435e89dec" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aa15a382-d784-4841-9358-9b37d558449c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_aa15a382-d784-4841-9358-9b37d558449c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_af0912f1-d59e-4f41-a25f-b93d194f6bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_af0912f1-d59e-4f41-a25f-b93d194f6bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3cabe443-c99f-4de3-a4c3-824994eee821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3cabe443-c99f-4de3-a4c3-824994eee821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df0f9773-bfdf-4654-a717-fc9af38c7a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_423ccfd0-4741-4cd3-bb6e-16d1c8d23db4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_df0f9773-bfdf-4654-a717-fc9af38c7a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e426b4fd-a7c4-4d24-8163-d27818abbd91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_093f301c-72f7-41e3-abc3-f1e83d5345c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e426b4fd-a7c4-4d24-8163-d27818abbd91" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_093f301c-72f7-41e3-abc3-f1e83d5345c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONSTables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_deb6e427-b259-4263-9e90-117743933726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b01b6cee-c5d7-4e70-8dcc-baa181ff1efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_deb6e427-b259-4263-9e90-117743933726" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b01b6cee-c5d7-4e70-8dcc-baa181ff1efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ced249d9-5099-49ce-ad1f-900102312f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5d7b386f-b182-47cd-8d9f-bcd60aa48033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ced249d9-5099-49ce-ad1f-900102312f3e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5d7b386f-b182-47cd-8d9f-bcd60aa48033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a2270500-1fb8-4389-8abb-ae88669091e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5d7b386f-b182-47cd-8d9f-bcd60aa48033" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a2270500-1fb8-4389-8abb-ae88669091e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bcf0f943-d33e-4482-9037-7f01b865c312" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a2270500-1fb8-4389-8abb-ae88669091e2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bcf0f943-d33e-4482-9037-7f01b865c312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_2a1cc346-0f4e-462e-8602-4c92ec541674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bcf0f943-d33e-4482-9037-7f01b865c312" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_2a1cc346-0f4e-462e-8602-4c92ec541674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e1e3ae7b-f708-4c41-b3cf-1cf7c029e8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5d7b386f-b182-47cd-8d9f-bcd60aa48033" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e1e3ae7b-f708-4c41-b3cf-1cf7c029e8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e1e3ae7b-f708-4c41-b3cf-1cf7c029e8b7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f2fe4822-d85d-4d9a-a9f5-c4ec9ec4e785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_f2fe4822-d85d-4d9a-a9f5-c4ec9ec4e785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_b498f05e-99a4-49df-865c-89104bfa43d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_b498f05e-99a4-49df-865c-89104bfa43d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_eced75da-793d-401a-9e9b-47ba2b329692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_eced75da-793d-401a-9e9b-47ba2b329692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_97b5df93-6757-4564-b64e-d64f108e347a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_97b5df93-6757-4564-b64e-d64f108e347a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_23719c96-5afa-4601-bc54-646d6be1d9e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_4adad2cb-ba12-4c91-b824-f3051a007faf" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_23719c96-5afa-4601-bc54-646d6be1d9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_93668e48-79c9-43f3-bdda-a09ca6e8775d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ac42b6ae-bab5-4a82-b661-901f08603d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93668e48-79c9-43f3-bdda-a09ca6e8775d" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ac42b6ae-bab5-4a82-b661-901f08603d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_609026a0-e63e-4ea6-beee-904d1c964c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_85e5fb15-c229-456e-8947-ab9cdc972966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_609026a0-e63e-4ea6-beee-904d1c964c86" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_85e5fb15-c229-456e-8947-ab9cdc972966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2d86fabe-ef87-4193-a0b4-a23ba4f2b969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2d86fabe-ef87-4193-a0b4-a23ba4f2b969" xlink:to="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5b91770e-dad0-4331-b357-5e981f13948b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5b91770e-dad0-4331-b357-5e981f13948b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5b91770e-dad0-4331-b357-5e981f13948b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_e30b8f24-525b-4158-a25f-9da1c5b04bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_e30b8f24-525b-4158-a25f-9da1c5b04bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_42d3ae37-c34b-44a8-9963-c4f499e0eec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:to="loc_us-gaap_LineOfCreditMember_42d3ae37-c34b-44a8-9963-c4f499e0eec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_8761d0a0-29ac-46d1-9c60-7d681ae3b624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_11820c75-f1c5-4b4b-a6a9-7634a756994a" xlink:to="loc_us-gaap_MortgagesMember_8761d0a0-29ac-46d1-9c60-7d681ae3b624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_93daa73e-6891-4ece-bf50-aaf346442188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:to="loc_us-gaap_CreditFacilityAxis_93daa73e-6891-4ece-bf50-aaf346442188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_67f1b225-2830-47a2-9f0c-654c4d25e9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_93daa73e-6891-4ece-bf50-aaf346442188" xlink:to="loc_us-gaap_CreditFacilityDomain_67f1b225-2830-47a2-9f0c-654c4d25e9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0393c13a-5d00-4158-be42-f86d58d91157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_67f1b225-2830-47a2-9f0c-654c4d25e9fc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0393c13a-5d00-4158-be42-f86d58d91157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_12fd2aff-da7e-4108-aa5b-8b07673abd8f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayable_53592a18-e1ed-403a-9602-2e308ea4be52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_NotesPayable_53592a18-e1ed-403a-9602-2e308ea4be52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_23e42c28-e7e6-423c-bd7a-c0479cda91e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_LongTermDebt_23e42c28-e7e6-423c-bd7a-c0479cda91e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_404d39eb-c9cc-4fd0-9c8e-be537b1588c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_404d39eb-c9cc-4fd0-9c8e-be537b1588c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1683e2e6-a06f-43d8-bcfc-43f189928692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_LongTermDebtCurrent_1683e2e6-a06f-43d8-bcfc-43f189928692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_17bc0fa5-fe10-4f0c-a98c-4aa4b80ee618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36418a77-9c49-4253-a530-e8732fce9963" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_17bc0fa5-fe10-4f0c-a98c-4aa4b80ee618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#DEBTANDCREDITARRANGEMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4a325723-3552-4761-84b9-70307effb903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4a325723-3552-4761-84b9-70307effb903" xlink:to="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_VariableRateAxis_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_65edfbfa-a74a-4721-be2e-76cfa4a7c3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_6e7c520e-72a1-40a7-82dc-6a1ce490cfcc" xlink:to="loc_us-gaap_VariableRateDomain_65edfbfa-a74a-4721-be2e-76cfa4a7c3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d02607dd-cb78-4d24-bf77-557806102eb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_65edfbfa-a74a-4721-be2e-76cfa4a7c3d6" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d02607dd-cb78-4d24-bf77-557806102eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_CreditFacilityAxis_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7aaafaca-465c-4009-8e06-684c9686a7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ce7e6cd0-cfd3-4e8c-8f7c-e6498c125f3d" xlink:to="loc_us-gaap_CreditFacilityDomain_7aaafaca-465c-4009-8e06-684c9686a7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b81455f8-425c-4f13-b96f-4199be037ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7aaafaca-465c-4009-8e06-684c9686a7ac" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b81455f8-425c-4f13-b96f-4199be037ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d858668-ba95-4c7f-80a5-b6b43aa9cea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d858668-ba95-4c7f-80a5-b6b43aa9cea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d858668-ba95-4c7f-80a5-b6b43aa9cea7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_9af5de8d-cac5-43b0-b226-1d867018ac2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_9af5de8d-cac5-43b0-b226-1d867018ac2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_2b6b765c-ac2b-4723-9bb7-4ff8b2ee9d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c67acbb1-c60f-49d6-b20a-f4cfb3d310bd" xlink:to="loc_us-gaap_MortgagesMember_2b6b765c-ac2b-4723-9bb7-4ff8b2ee9d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_c6d05ab4-4d14-4e57-8352-a3966d25fb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_c6d05ab4-4d14-4e57-8352-a3966d25fb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_0f476ccf-a16c-4eb4-9828-0a2f8873541b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_c6d05ab4-4d14-4e57-8352-a3966d25fb38" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_0f476ccf-a16c-4eb4-9828-0a2f8873541b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_48e26f26-4555-40b7-9d84-7c9977010319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_0f476ccf-a16c-4eb4-9828-0a2f8873541b" xlink:to="loc_us-gaap_LineOfCreditMember_48e26f26-4555-40b7-9d84-7c9977010319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f7741373-8d9a-44ce-85b1-880a25ff9a19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_DebtInstrumentAxis_f7741373-8d9a-44ce-85b1-880a25ff9a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f7741373-8d9a-44ce-85b1-880a25ff9a19" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TermNoteBMember_b28e49d1-9b7e-44ca-8de3-31406399ed40" xlink:href="kids-20200630.xsd#kids_TermNoteBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:to="loc_kids_TermNoteBMember_b28e49d1-9b7e-44ca-8de3-31406399ed40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_LoanAgreementMember_5f96aed3-421f-491c-8fe4-a7bea22c57d1" xlink:href="kids-20200630.xsd#kids_LoanAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:to="loc_kids_LoanAgreementMember_5f96aed3-421f-491c-8fe4-a7bea22c57d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_RevolvingLoanMember_461f15dd-3188-48df-8b95-d57e8fcdfabc" xlink:href="kids-20200630.xsd#kids_RevolvingLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69e046e8-c2b6-4dd7-b89f-a5709479407b" xlink:to="loc_kids_RevolvingLoanMember_461f15dd-3188-48df-8b95-d57e8fcdfabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_24d3b506-250f-4924-9971-d7a2fafb453e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_srt_CounterpartyNameAxis_24d3b506-250f-4924-9971-d7a2fafb453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fbe1da4e-fae7-4096-ad8b-ab7598c2e0bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_24d3b506-250f-4924-9971-d7a2fafb453e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fbe1da4e-fae7-4096-ad8b-ab7598c2e0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SquadronMember_7ca89bd2-a369-464f-9525-d69a98672c85" xlink:href="kids-20200630.xsd#kids_SquadronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fbe1da4e-fae7-4096-ad8b-ab7598c2e0bc" xlink:to="loc_kids_SquadronMember_7ca89bd2-a369-464f-9525-d69a98672c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bed668a3-32da-481e-bd8e-cc9649b1c946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bed668a3-32da-481e-bd8e-cc9649b1c946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fc8c39b0-0c06-4ab6-bd69-0c277b32f267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bed668a3-32da-481e-bd8e-cc9649b1c946" xlink:to="loc_us-gaap_RelatedPartyDomain_fc8c39b0-0c06-4ab6-bd69-0c277b32f267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_3b407ffb-e9a0-4b16-9039-5e1da0954220" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fc8c39b0-0c06-4ab6-bd69-0c277b32f267" xlink:to="loc_srt_AffiliatedEntityMember_3b407ffb-e9a0-4b16-9039-5e1da0954220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_55e54140-2728-4c1a-b0d0-7bfdeda491d2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0c40083e-dd64-4f70-9b81-280e2a313b97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_LongTermDebt_0c40083e-dd64-4f70-9b81-280e2a313b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d94e8b34-b8ec-4829-99ae-159d95b3f78c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d94e8b34-b8ec-4829-99ae-159d95b3f78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2636027b-d70b-4073-89a1-61b0ea2a7297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2636027b-d70b-4073-89a1-61b0ea2a7297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e18f8778-eda7-40f0-af26-a37978ab4a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_e18f8778-eda7-40f0-af26-a37978ab4a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b651a3f8-a538-4e5d-b539-9852bffbc874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b651a3f8-a538-4e5d-b539-9852bffbc874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_65afefcb-607c-4617-8b4a-e24c07fdfddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_65afefcb-607c-4617-8b4a-e24c07fdfddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_81861efb-7112-4227-b95f-79d0e8e44ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_81861efb-7112-4227-b95f-79d0e8e44ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92db80dd-4b3c-4341-ad3c-de659332b17a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92db80dd-4b3c-4341-ad3c-de659332b17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f5f36593-e75d-4fee-8d21-a800d98c3425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_LongTermDebtCurrent_f5f36593-e75d-4fee-8d21-a800d98c3425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_db511d3c-7395-4643-a8d6-ea91a1983e2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_64113d9d-126e-474e-98aa-89016d41071f" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_db511d3c-7395-4643-a8d6-ea91a1983e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#STRATEGICARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_35936176-b70f-4316-9f03-2da126f1ccc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_9ec58a08-3e6e-40d3-a285-3f5a23407473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_35936176-b70f-4316-9f03-2da126f1ccc2" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_9ec58a08-3e6e-40d3-a285-3f5a23407473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STRATEGICARRANGEMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_2d47458d-3423-4b49-92ab-b03a63cbd765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_2d47458d-3423-4b49-92ab-b03a63cbd765" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ba9edaeb-8f48-489b-b592-1f3e44784914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ba9edaeb-8f48-489b-b592-1f3e44784914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_65d073ed-0f16-4813-815b-fb23d8a4761e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ba9edaeb-8f48-489b-b592-1f3e44784914" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_65d073ed-0f16-4813-815b-fb23d8a4761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementTermsMember_192a94cd-a3a3-462a-9608-a1b122f69336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_65d073ed-0f16-4813-815b-fb23d8a4761e" xlink:to="loc_us-gaap_RoyaltyAgreementTermsMember_192a94cd-a3a3-462a-9608-a1b122f69336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_799fb955-f845-442a-9870-85496e9d1346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_799fb955-f845-442a-9870-85496e9d1346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_4819a3ff-506b-4e93-8529-eca59ac2f009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_799fb955-f845-442a-9870-85496e9d1346" xlink:to="loc_us-gaap_ProjectMember_4819a3ff-506b-4e93-8529-eca59ac2f009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_CaseWesternReserveUniversityMember_e2beb9ad-d309-490a-8c7a-3fbff63bce51" xlink:href="kids-20200630.xsd#kids_CaseWesternReserveUniversityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_4819a3ff-506b-4e93-8529-eca59ac2f009" xlink:to="loc_kids_CaseWesternReserveUniversityMember_e2beb9ad-d309-490a-8c7a-3fbff63bce51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_abb98980-d4b4-44ab-aa73-6058f4f7e8f5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm_aa43799d-921d-4aba-b3a5-c2e65d7fa7bb" xlink:href="kids-20200630.xsd#kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm_aa43799d-921d-4aba-b3a5-c2e65d7fa7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_a489115c-3e31-46dd-a893-d5aaa43ae0a9" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_a489115c-3e31-46dd-a893-d5aaa43ae0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_577277c8-db7e-4222-bf3a-2ac5cd27661b" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_577277c8-db7e-4222-bf3a-2ac5cd27661b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment_bb1ca4fc-fc61-4a1b-8363-ad3ea2554622" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment_bb1ca4fc-fc61-4a1b-8363-ad3ea2554622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment_32467c4b-1c5e-4660-85bf-91efa27fe943" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment_32467c4b-1c5e-4660-85bf-91efa27fe943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_9ff49a73-d338-4919-9491-5b6012fd9c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_us-gaap_RoyaltyExpense_9ff49a73-d338-4919-9491-5b6012fd9c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_a40b8885-bc8b-4396-a037-e5bb33d8451a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_fc1f8b84-bcea-4e6a-a325-13d3effa2214" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_a40b8885-bc8b-4396-a037-e5bb33d8451a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="kids-20200630.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1a746ff1-16e2-432b-a975-857906d9e830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ee056cc7-47ad-4299-b5b3-4639dfa36949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a746ff1-16e2-432b-a975-857906d9e830" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ee056cc7-47ad-4299-b5b3-4639dfa36949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c0cbb550-6a7d-46f7-bc85-669733b56832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c0cbb550-6a7d-46f7-bc85-669733b56832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_fa1d080d-e935-468a-a82a-cb500d45407e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_fa1d080d-e935-468a-a82a-cb500d45407e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_3ea8515c-7f2a-498f-8582-29b3d42d3cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_3ea8515c-7f2a-498f-8582-29b3d42d3cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation_fb56983b-fc3c-43c1-b709-eb9147b1b0ba" xlink:href="kids-20200630.xsd#kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:to="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation_fb56983b-fc3c-43c1-b709-eb9147b1b0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit_dca7eef8-c14c-416c-ac6d-9f17e43fd92d" xlink:href="kids-20200630.xsd#kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:to="loc_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit_dca7eef8-c14c-416c-ac6d-9f17e43fd92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease_1786971a-1737-4d80-af1b-7d2572ca62c3" xlink:href="kids-20200630.xsd#kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:to="loc_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease_1786971a-1737-4d80-af1b-7d2572ca62c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_dc45f44a-0cec-4d16-9d53-9acb38928521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c17daf3d-d0cf-49f3-8d8f-b894adffec3d" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_dc45f44a-0cec-4d16-9d53-9acb38928521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ca5883c0-d5d7-4321-9822-3e71584cccbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_dc45f44a-0cec-4d16-9d53-9acb38928521" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ca5883c0-d5d7-4321-9822-3e71584cccbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ca5883c0-d5d7-4321-9822-3e71584cccbd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b82c8c95-e2e0-4caf-9099-79343572c3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:to="loc_us-gaap_DomesticCountryMember_b82c8c95-e2e0-4caf-9099-79343572c3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_4e28011b-e006-49c0-8628-78de3af22906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_688bfef7-bc2f-48df-9623-a1967ab4d810" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_4e28011b-e006-49c0-8628-78de3af22906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_0f0214e1-951b-4918-8db0-620489b9e780" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_dc45f44a-0cec-4d16-9d53-9acb38928521" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_0f0214e1-951b-4918-8db0-620489b9e780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4d25993a-b76c-4ef8-b7c1-55cdea530d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_0f0214e1-951b-4918-8db0-620489b9e780" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4d25993a-b76c-4ef8-b7c1-55cdea530d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_885c48fa-4743-4534-b0df-2ebf9574d0e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_93de1e99-02aa-4332-be04-5c5d96229add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_885c48fa-4743-4534-b0df-2ebf9574d0e9" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_93de1e99-02aa-4332-be04-5c5d96229add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_825d9843-8b9e-49c8-bc0a-6d04d7a03a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5914d6f9-27de-4ea7-9c2e-f714020e2050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_825d9843-8b9e-49c8-bc0a-6d04d7a03a6f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5914d6f9-27de-4ea7-9c2e-f714020e2050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_eb88d04e-ff0b-4adb-b4ca-f018ef5f557a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_825d9843-8b9e-49c8-bc0a-6d04d7a03a6f" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_eb88d04e-ff0b-4adb-b4ca-f018ef5f557a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_ea647c44-10de-4b8e-9b31-3eec2d7e4eee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_825d9843-8b9e-49c8-bc0a-6d04d7a03a6f" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_ea647c44-10de-4b8e-9b31-3eec2d7e4eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a9dc456-61fd-48fa-9db9-18bcfa46d25f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bca2f932-04ac-4df1-bd21-45f2bd5c474e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4a9dc456-61fd-48fa-9db9-18bcfa46d25f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bca2f932-04ac-4df1-bd21-45f2bd5c474e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ea418345-2aab-4c25-950a-09a30e4a8503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bca2f932-04ac-4df1-bd21-45f2bd5c474e" xlink:to="loc_us-gaap_AwardTypeAxis_ea418345-2aab-4c25-950a-09a30e4a8503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213153a9-df0d-431d-b291-6340f121b8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ea418345-2aab-4c25-950a-09a30e4a8503" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213153a9-df0d-431d-b291-6340f121b8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3161b4f4-afc0-4970-935d-8960e734fa4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_213153a9-df0d-431d-b291-6340f121b8ac" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3161b4f4-afc0-4970-935d-8960e734fa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bca2f932-04ac-4df1-bd21-45f2bd5c474e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_815922ed-e279-4212-883b-a037835274f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_815922ed-e279-4212-883b-a037835274f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d80d269d-63ec-47ef-af8d-7f51c1b97f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d80d269d-63ec-47ef-af8d-7f51c1b97f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ee082bd-3f44-4b12-b7fb-fe3ef6487861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1ee082bd-3f44-4b12-b7fb-fe3ef6487861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f39a1b54-d87b-4aeb-9990-5bb2b1f675cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3ddc1fe8-4e2b-4fba-a1ed-1daaba6616f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f39a1b54-d87b-4aeb-9990-5bb2b1f675cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c358d29d-f592-4ee6-b69b-b5c8027ee84d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c358d29d-f592-4ee6-b69b-b5c8027ee84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18254792-9c2d-4820-84b8-c7da770d484d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18254792-9c2d-4820-84b8-c7da770d484d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_21b128ef-e269-452c-b324-0d9053f72b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_2f08193a-870f-4dbf-9e1c-f690fa24b420" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_21b128ef-e269-452c-b324-0d9053f72b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9a247e9-db92-46af-a926-94c7b14674ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b9a247e9-db92-46af-a926-94c7b14674ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87224850-b3b7-4c2a-a009-e15000b5fc48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87224850-b3b7-4c2a-a009-e15000b5fc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a09739f7-41fd-4260-83ab-78b48478bf1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a374f12e-87c7-4c98-8446-f45b68f50eef" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a09739f7-41fd-4260-83ab-78b48478bf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a13c5169-996e-46dc-88a1-7cba27ac07a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a13c5169-996e-46dc-88a1-7cba27ac07a6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6adcba14-77ae-4a98-ab7b-5971257fae42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:to="loc_us-gaap_AwardTypeAxis_6adcba14-77ae-4a98-ab7b-5971257fae42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04fce695-1b65-46dd-83fd-fa60f4922f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6adcba14-77ae-4a98-ab7b-5971257fae42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04fce695-1b65-46dd-83fd-fa60f4922f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a931bddf-ea23-4369-b45e-96549dcb3cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04fce695-1b65-46dd-83fd-fa60f4922f8e" xlink:to="loc_us-gaap_RestrictedStockMember_a931bddf-ea23-4369-b45e-96549dcb3cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_a294a803-5bbf-4e2a-80f7-6e958ce6a405" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:to="loc_srt_TitleOfIndividualAxis_a294a803-5bbf-4e2a-80f7-6e958ce6a405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9d687e36-72e2-403b-90e8-38083419dd21" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_a294a803-5bbf-4e2a-80f7-6e958ce6a405" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9d687e36-72e2-403b-90e8-38083419dd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_20acf146-8e0a-4e49-90f1-c3fa1eff1340" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9d687e36-72e2-403b-90e8-38083419dd21" xlink:to="loc_srt_ChiefExecutiveOfficerMember_20acf146-8e0a-4e49-90f1-c3fa1eff1340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd70d1d5-1df5-44ff-b4b5-4fef412aa5f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d0669aa3-fd73-40b3-8adf-6dc26f93cfca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d0669aa3-fd73-40b3-8adf-6dc26f93cfca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a40c4842-f442-43be-a225-3f12ad3dab97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a40c4842-f442-43be-a225-3f12ad3dab97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1f5118a8-596d-48e3-afec-3f5e96cc0055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1f5118a8-596d-48e3-afec-3f5e96cc0055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04fb44dc-c28e-4396-be64-f67f879012d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_04fb44dc-c28e-4396-be64-f67f879012d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b2e35ef-edb9-4db7-b1d5-3174c04bb631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b6171b-a83d-49ed-bb6e-9cff1d036dfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b2e35ef-edb9-4db7-b1d5-3174c04bb631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8f1c65bb-1949-4382-b711-453084929626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_8f1c65bb-1949-4382-b711-453084929626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_9b952b9d-4ae9-442d-b526-4b715200f8a2" xlink:href="kids-20200630.xsd#kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_9b952b9d-4ae9-442d-b526-4b715200f8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f023b6f1-ee09-4b1d-b434-e195511e2122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f023b6f1-ee09-4b1d-b434-e195511e2122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c4f52bc9-9b16-465b-9dd2-baeb1161bf82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_a9d4f0c5-cc8e-4d2a-a7dc-b3c0df5d4ca3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c4f52bc9-9b16-465b-9dd2-baeb1161bf82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_27a7e099-f4e3-4e67-8141-120f1067c8d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf23d05c-2ab8-4600-84f1-061ddd21d63a" xlink:to="loc_us-gaap_ShareBasedCompensation_27a7e099-f4e3-4e67-8141-120f1067c8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#STOCKHOLDERSEQUITYWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b411500-0820-42f4-ad56-9eb5f72de4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ClassOfWarrantOrRightOutstandingRollForward_338f84b0-127d-4583-a880-2b9bf53caa16" xlink:href="kids-20200630.xsd#kids_ClassOfWarrantOrRightOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b411500-0820-42f4-ad56-9eb5f72de4b0" xlink:to="loc_kids_ClassOfWarrantOrRightOutstandingRollForward_338f84b0-127d-4583-a880-2b9bf53caa16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_411cea29-bff9-470b-8409-e246403a9a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_ClassOfWarrantOrRightOutstandingRollForward_338f84b0-127d-4583-a880-2b9bf53caa16" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_411cea29-bff9-470b-8409-e246403a9a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_75a3c563-664f-485a-a234-469d3da98f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kids_ClassOfWarrantOrRightOutstandingRollForward_338f84b0-127d-4583-a880-2b9bf53caa16" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_75a3c563-664f-485a-a234-469d3da98f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_52cc25ca-f1f4-46e4-b48b-28e66339b2c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b411500-0820-42f4-ad56-9eb5f72de4b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_52cc25ca-f1f4-46e4-b48b-28e66339b2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b0b6d074-cf31-4626-be6f-c93a54173d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b411500-0820-42f4-ad56-9eb5f72de4b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b0b6d074-cf31-4626-be6f-c93a54173d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ClassOfWarrantOrRightTerm_72fbfdae-f8bf-4c79-b652-aac72622346b" xlink:href="kids-20200630.xsd#kids_ClassOfWarrantOrRightTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b411500-0820-42f4-ad56-9eb5f72de4b0" xlink:to="loc_kids_ClassOfWarrantOrRightTerm_72fbfdae-f8bf-4c79-b652-aac72622346b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ClassOfWarrantOrRightExercised_c16fd9fe-945e-406b-b92b-090f48bae224" xlink:href="kids-20200630.xsd#kids_ClassOfWarrantOrRightExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3b411500-0820-42f4-ad56-9eb5f72de4b0" xlink:to="loc_kids_ClassOfWarrantOrRightExercised_c16fd9fe-945e-406b-b92b-090f48bae224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARE" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5ea3643c-5413-41fb-a9db-e611e65e31af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_bfd2b6f2-5a7f-4b5a-b76f-1c91643688cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5ea3643c-5413-41fb-a9db-e611e65e31af" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_bfd2b6f2-5a7f-4b5a-b76f-1c91643688cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHARETables" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a9e37008-d84f-41ee-b6f2-a013f4a42fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5f0b6e35-72f7-462d-bf80-3d400d230873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a9e37008-d84f-41ee-b6f2-a013f4a42fa8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5f0b6e35-72f7-462d-bf80-3d400d230873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a77f2ed4-d7e4-4aca-8e56-235d4e4a4324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a9e37008-d84f-41ee-b6f2-a013f4a42fa8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a77f2ed4-d7e4-4aca-8e56-235d4e4a4324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_75555401-2157-43dc-8c91-1c7c836dfebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1aa9138a-5a52-4433-b2fb-805451309553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75555401-2157-43dc-8c91-1c7c836dfebb" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1aa9138a-5a52-4433-b2fb-805451309553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_93c02a21-ba47-44a5-b315-a28862bc3c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75555401-2157-43dc-8c91-1c7c836dfebb" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_93c02a21-ba47-44a5-b315-a28862bc3c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_4e3b3460-50bf-48d3-b4c9-d2edd3f5d1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_75555401-2157-43dc-8c91-1c7c836dfebb" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_4e3b3460-50bf-48d3-b4c9-d2edd3f5d1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#NETLOSSPERSHAREAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_23f6662b-70cf-41b7-a216-08b80e66c483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91ba4edf-f6cb-4578-b1cd-3d3e4db5350f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_23f6662b-70cf-41b7-a216-08b80e66c483" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91ba4edf-f6cb-4578-b1cd-3d3e4db5350f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3998fdfe-0b4c-456d-a75f-993b6589b918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91ba4edf-f6cb-4578-b1cd-3d3e4db5350f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3998fdfe-0b4c-456d-a75f-993b6589b918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3998fdfe-0b4c-456d-a75f-993b6589b918" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2072c7a6-21db-4be4-9e8e-ef880ac5df22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:to="loc_us-gaap_RestrictedStockMember_2072c7a6-21db-4be4-9e8e-ef880ac5df22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_780d2be7-baad-4d56-9975-0eff89adeeef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:to="loc_us-gaap_EmployeeStockOptionMember_780d2be7-baad-4d56-9975-0eff89adeeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_5e4f63ed-9706-446a-978d-c07ad315ba25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d36a4185-1bad-4d0e-a869-864d87355017" xlink:to="loc_us-gaap_WarrantMember_5e4f63ed-9706-446a-978d-c07ad315ba25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d320b8d5-cb9c-49d0-8363-035d488661c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91ba4edf-f6cb-4578-b1cd-3d3e4db5350f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d320b8d5-cb9c-49d0-8363-035d488661c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f14e5527-10fa-4832-8b03-8e300f0d6615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_d320b8d5-cb9c-49d0-8363-035d488661c5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f14e5527-10fa-4832-8b03-8e300f0d6615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENT" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENT"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b29e357d-a22f-46f0-a61c-224a8dbefcc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2e9736bb-1ebc-4e06-acda-5fcd54f0149a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b29e357d-a22f-46f0-a61c-224a8dbefcc7" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2e9736bb-1ebc-4e06-acda-5fcd54f0149a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTTables"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_892c99f7-5774-4dbe-ab81-effa9c53a1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_bd40b642-5b8b-4791-a2d6-9bc14e016fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_892c99f7-5774-4dbe-ab81-effa9c53a1a3" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_bd40b642-5b8b-4791-a2d6-9bc14e016fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1c79a6b1-0dfc-4d0e-8722-3a3edd333f98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_892c99f7-5774-4dbe-ab81-effa9c53a1a3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1c79a6b1-0dfc-4d0e-8722-3a3edd333f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bc505af0-7287-4998-a717-2bc64b07b876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_a53caf1b-686a-4e23-b8b1-8f43661efbc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bc505af0-7287-4998-a717-2bc64b07b876" xlink:to="loc_us-gaap_NumberOfOperatingSegments_a53caf1b-686a-4e23-b8b1-8f43661efbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_986a6ea1-da1b-4d66-8865-811178f061be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bc505af0-7287-4998-a717-2bc64b07b876" xlink:to="loc_us-gaap_NumberOfReportableSegments_986a6ea1-da1b-4d66-8865-811178f061be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bc480fc3-0cd4-4b07-8084-ba11c4f2a978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2839ab5e-b1f3-4418-9edd-9ae55ebec577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bc480fc3-0cd4-4b07-8084-ba11c4f2a978" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2839ab5e-b1f3-4418-9edd-9ae55ebec577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6ec37416-b7d2-4fc1-a3dc-982a86d16b30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2839ab5e-b1f3-4418-9edd-9ae55ebec577" xlink:to="loc_srt_StatementGeographicalAxis_6ec37416-b7d2-4fc1-a3dc-982a86d16b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6ec37416-b7d2-4fc1-a3dc-982a86d16b30" xlink:to="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_2de9eb6d-e05b-4107-bc02-9c279b07aad8" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:to="loc_country_US_2de9eb6d-e05b-4107-bc02-9c279b07aad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_056dccc3-a6d8-47db-8ffc-206ad6bcc9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f0239250-3784-41ea-9de5-b3522a125cf9" xlink:to="loc_us-gaap_NonUsMember_056dccc3-a6d8-47db-8ffc-206ad6bcc9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_34352d6e-8bff-420d-9511-c35c9394dcb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2839ab5e-b1f3-4418-9edd-9ae55ebec577" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_34352d6e-8bff-420d-9511-c35c9394dcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ff21c30-91f6-401d-9938-bf237531b5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_34352d6e-8bff-420d-9511-c35c9394dcb6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ff21c30-91f6-401d-9938-bf237531b5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f130e755-2b62-42f1-8c27-5bf433f95cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccdc4fd7-38fc-4db5-bbe6-4ef94a6a3d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f130e755-2b62-42f1-8c27-5bf433f95cd5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccdc4fd7-38fc-4db5-bbe6-4ef94a6a3d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_535de56e-e3a5-4b48-93b5-766106913ece" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccdc4fd7-38fc-4db5-bbe6-4ef94a6a3d2a" xlink:to="loc_srt_ProductOrServiceAxis_535de56e-e3a5-4b48-93b5-766106913ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_535de56e-e3a5-4b48-93b5-766106913ece" xlink:to="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TraumaAndDeformityMember_eae17183-f765-4b49-b2cd-647bb3d826a3" xlink:href="kids-20200630.xsd#kids_TraumaAndDeformityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:to="loc_kids_TraumaAndDeformityMember_eae17183-f765-4b49-b2cd-647bb3d826a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SpineMember_896ca8bd-795f-49c7-b260-4c714c93cbaa" xlink:href="kids-20200630.xsd#kids_SpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:to="loc_kids_SpineMember_896ca8bd-795f-49c7-b260-4c714c93cbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SportsMedicineandOtherMember_61b16568-ecf0-4137-a89c-7699a176546a" xlink:href="kids-20200630.xsd#kids_SportsMedicineandOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ecdd3cc-f12f-4075-98d6-7dfcd211b213" xlink:to="loc_kids_SportsMedicineandOtherMember_61b16568-ecf0-4137-a89c-7699a176546a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b0e2739f-24c2-4b9c-a6b5-1e95fa275fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ccdc4fd7-38fc-4db5-bbe6-4ef94a6a3d2a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b0e2739f-24c2-4b9c-a6b5-1e95fa275fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fb50359-5a1d-477f-a3fd-e18f0bd505b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e2739f-24c2-4b9c-a6b5-1e95fa275fba" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fb50359-5a1d-477f-a3fd-e18f0bd505b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="kids-20200630.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_874dd100-8c1d-4e16-b3a6-98446551bef7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b4115db1-64b5-4c19-bb08-32e3acdc549f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_874dd100-8c1d-4e16-b3a6-98446551bef7" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b4115db1-64b5-4c19-bb08-32e3acdc549f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_c2616345-1706-4d89-abd9-50f7c5652d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_c2616345-1706-4d89-abd9-50f7c5652d95" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_43c68be0-680a-4749-9de4-c634dbdcd44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_43c68be0-680a-4749-9de4-c634dbdcd44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5573aa5e-ac2e-4afc-94b3-299756f84134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_43c68be0-680a-4749-9de4-c634dbdcd44d" xlink:to="loc_us-gaap_RelatedPartyDomain_5573aa5e-ac2e-4afc-94b3-299756f84134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_836e4453-0ce1-4bd4-b88f-7405eeedc566" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_5573aa5e-ac2e-4afc-94b3-299756f84134" xlink:to="loc_srt_AffiliatedEntityMember_836e4453-0ce1-4bd4-b88f-7405eeedc566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3ce67a30-edac-493a-b1bf-6371e2fa0e34" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:to="loc_srt_CounterpartyNameAxis_3ce67a30-edac-493a-b1bf-6371e2fa0e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cd1139e-7f30-473f-9b5d-45a40dfc11b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_3ce67a30-edac-493a-b1bf-6371e2fa0e34" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cd1139e-7f30-473f-9b5d-45a40dfc11b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FMIHansaMedicalProductsMember_2a267c41-fd31-4b05-a396-7d0feb6c669b" xlink:href="kids-20200630.xsd#kids_FMIHansaMedicalProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5cd1139e-7f30-473f-9b5d-45a40dfc11b4" xlink:to="loc_kids_FMIHansaMedicalProductsMember_2a267c41-fd31-4b05-a396-7d0feb6c669b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_820cabdd-8e2d-4e17-afca-e22c8ab05ad8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_820cabdd-8e2d-4e17-afca-e22c8ab05ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_504859dc-13f5-4d05-865f-08da7279be6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_820cabdd-8e2d-4e17-afca-e22c8ab05ad8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_504859dc-13f5-4d05-865f-08da7279be6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6ba9db7e-6896-44b2-bc33-f1f769a6acd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_504859dc-13f5-4d05-865f-08da7279be6d" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_6ba9db7e-6896-44b2-bc33-f1f769a6acd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c66781a7-aa87-4c50-8888-d3aa3141923c" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_NumberOfRelatedPartyEntitiesSuppliers_4391d9bb-583a-473d-85f4-d1ccd11a7222" xlink:href="kids-20200630.xsd#kids_NumberOfRelatedPartyEntitiesSuppliers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_kids_NumberOfRelatedPartyEntitiesSuppliers_4391d9bb-583a-473d-85f4-d1ccd11a7222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_86a26d39-8d3f-4c84-aa7b-610be1da846e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_86a26d39-8d3f-4c84-aa7b-610be1da846e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_788a923c-403f-4a68-b3f6-a0abc387326d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_788a923c-403f-4a68-b3f6-a0abc387326d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0094b811-4683-4d30-96ed-dfe1f76869c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_bccb8f04-83b1-49ec-9733-f1eb9c149b59" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_0094b811-4683-4d30-96ed-dfe1f76869c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN" xlink:type="simple" xlink:href="kids-20200630.xsd#EMPLOYEEBENEFITPLAN"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2b9291c2-e0c5-4cb0-aa71-c77958584cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e12e9c8e-ce47-4347-babd-dc52ef688182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2b9291c2-e0c5-4cb0-aa71-c77958584cbd" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_e12e9c8e-ce47-4347-babd-dc52ef688182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#EMPLOYEEBENEFITPLANNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b87f26c1-327a-4202-97a9-1eb049493cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e69bcbea-ed67-4fff-93dd-357e379d5991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b87f26c1-327a-4202-97a9-1eb049493cc4" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e69bcbea-ed67-4fff-93dd-357e379d5991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="kids-20200630.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3431f36b-e4df-4259-a481-f4052820e1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9cd897f7-fe29-4fb0-a6e0-a5eaf0639be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3431f36b-e4df-4259-a481-f4052820e1e4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9cd897f7-fe29-4fb0-a6e0-a5eaf0639be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7e6c5a99-2392-446c-8ff5-3c80bb31b3b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_90c74214-b358-4ba1-bced-c6009550a05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7e6c5a99-2392-446c-8ff5-3c80bb31b3b6" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_90c74214-b358-4ba1-bced-c6009550a05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_90c74214-b358-4ba1-bced-c6009550a05a" xlink:to="loc_srt_RangeAxis_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a27c5c4d-3efb-40c6-8622-95e6fcb3c02f" xlink:to="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7cb060ae-40e7-4e3f-8b20-4990471edc97" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:to="loc_srt_MinimumMember_7cb060ae-40e7-4e3f-8b20-4990471edc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6110e94-ab07-42d0-bfd5-8639166c7638" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5be9c650-ef8d-47c9-919a-13d748231630" xlink:to="loc_srt_MaximumMember_a6110e94-ab07-42d0-bfd5-8639166c7638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_90c74214-b358-4ba1-bced-c6009550a05a" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_72542621-acdd-4834-ba31-32a3ea399e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_us-gaap_OperatingLeaseLiability_72542621-acdd-4834-ba31-32a3ea399e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_455d022a-9589-4250-88bc-8e3a44b0535a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_455d022a-9589-4250-88bc-8e3a44b0535a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_ad213de4-a22c-4ed7-ae53-4c3eb5de4e41" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent_ad213de4-a22c-4ed7-ae53-4c3eb5de4e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_ffbf45b3-0d38-48b9-8373-7803be445b45" xlink:href="kids-20200630.xsd#kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_1da5f3d3-efd5-4ada-ac1e-9e156ed54be9" xlink:to="loc_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment_ffbf45b3-0d38-48b9-8373-7803be445b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="kids-20200630.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_4438719b-b3bd-4948-9b3d-67ee7b77db08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_33acc1ea-a69b-4809-b453-75dafb1acce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_4438719b-b3bd-4948-9b3d-67ee7b77db08" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_33acc1ea-a69b-4809-b453-75dafb1acce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="kids-20200630.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_7d4a8c03-e5bc-4c03-876d-d5b4e361747f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_7d4a8c03-e5bc-4c03-876d-d5b4e361747f" xlink:to="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_96f4cb82-6c7e-404d-8ac7-3108e98bd518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_96f4cb82-6c7e-404d-8ac7-3108e98bd518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_35948416-fdc3-4513-b2f9-5271a15bde72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_96f4cb82-6c7e-404d-8ac7-3108e98bd518" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_35948416-fdc3-4513-b2f9-5271a15bde72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e4e2dc99-a548-48fb-8595-ad42b43581c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_35948416-fdc3-4513-b2f9-5271a15bde72" xlink:to="loc_us-gaap_SubsequentEventMember_e4e2dc99-a548-48fb-8595-ad42b43581c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03784e66-86a3-4fcf-be24-3e279800914d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03784e66-86a3-4fcf-be24-3e279800914d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_83942a9a-68e3-49b8-92ef-4d577e537950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03784e66-86a3-4fcf-be24-3e279800914d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_83942a9a-68e3-49b8-92ef-4d577e537950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_2c98bb24-128d-45d3-8e0c-c3b5f6a6c2ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_83942a9a-68e3-49b8-92ef-4d577e537950" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_2c98bb24-128d-45d3-8e0c-c3b5f6a6c2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9149c9f4-ff2f-431d-ad58-bb66011e4bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_DebtInstrumentAxis_9149c9f4-ff2f-431d-ad58-bb66011e4bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9149c9f4-ff2f-431d-ad58-bb66011e4bfc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_TermNoteAMember_858cbdf9-e8ec-4c68-842b-8f460cecb42e" xlink:href="kids-20200630.xsd#kids_TermNoteAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:to="loc_kids_TermNoteAMember_858cbdf9-e8ec-4c68-842b-8f460cecb42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SecondAmendedLoanAgreementMember_83419678-f5f3-4f99-bc09-324b2e035254" xlink:href="kids-20200630.xsd#kids_SecondAmendedLoanAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:to="loc_kids_SecondAmendedLoanAgreementMember_83419678-f5f3-4f99-bc09-324b2e035254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_FirstAmendedLoanAgreementMember_f43a707a-122e-4e64-96cd-ef9f9b0b8047" xlink:href="kids-20200630.xsd#kids_FirstAmendedLoanAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_271a7238-693f-4eb9-97db-bfc970272579" xlink:to="loc_kids_FirstAmendedLoanAgreementMember_f43a707a-122e-4e64-96cd-ef9f9b0b8047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_dffbae6c-a58b-4643-9449-5affe5abbcac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_srt_CounterpartyNameAxis_dffbae6c-a58b-4643-9449-5affe5abbcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c7b61c8-a263-4f8a-a2b3-1fa5d0711cbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_dffbae6c-a58b-4643-9449-5affe5abbcac" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c7b61c8-a263-4f8a-a2b3-1fa5d0711cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kids_SquadronMember_2a74864d-1915-4f3c-af99-d11dee473e9d" xlink:href="kids-20200630.xsd#kids_SquadronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0c7b61c8-a263-4f8a-a2b3-1fa5d0711cbb" xlink:to="loc_kids_SquadronMember_2a74864d-1915-4f3c-af99-d11dee473e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_0e3c77ac-f45e-4f5a-87ec-b299e813606a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_VariableRateAxis_0e3c77ac-f45e-4f5a-87ec-b299e813606a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_99357c2d-c629-4401-829a-ef6ecee4cb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_0e3c77ac-f45e-4f5a-87ec-b299e813606a" xlink:to="loc_us-gaap_VariableRateDomain_99357c2d-c629-4401-829a-ef6ecee4cb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da7cb665-f229-4ccc-953b-6d22d827f347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_99357c2d-c629-4401-829a-ef6ecee4cb9d" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_da7cb665-f229-4ccc-953b-6d22d827f347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_123086d1-4872-4985-9ca6-2478c8144798" xlink:to="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_68a08eda-740e-4d1b-a80f-9a218eb6eb9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_68a08eda-740e-4d1b-a80f-9a218eb6eb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4f921b27-b961-4a56-a513-27b71c1a5481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4f921b27-b961-4a56-a513-27b71c1a5481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_03ca3af7-06d3-4597-b970-57c46e6e15a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_03ca3af7-06d3-4597-b970-57c46e6e15a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_375611a4-b75b-4903-b501-2e62f9567d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_375611a4-b75b-4903-b501-2e62f9567d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_0b10cfaf-d128-453e-96b9-70289db0d7f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_496e3613-5aca-4d31-b833-13fee6a58f50" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_0b10cfaf-d128-453e-96b9-70289db0d7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>kids-20200630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:kids="http://www.orthopediatrics.com/20200630"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="kids-20200630.xsd" xlink:type="simple"/>
    <context id="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i64001efefd914b23a423885f1db0f016_I20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2020-08-04</instant>
        </period>
    </context>
    <context id="i4daa9a471c454c999687c99d7d5c379c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie4e2a354b98945b7ac75843c10a25a44_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if5b873289d394f8698109e34413ebc6c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if33c7e6e77b34aadafae7225d988f633_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3c138c5223b945249abec4b41802cfe9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ee305abb72e4348bdb25affaa6c5bb0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i581093052fd24f5683c783d8150a5768_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f552ff6bd064623b1279ee353b79be5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3c69752a2cd84ef3bf96562629d01f6d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i688ab3c7a7c14968861796de50cec944_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8efc4342789a4574a5010b2cd5a5e4d4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i003a46bd442946f49063fccbb2f71fd2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic378826a602e45ea8c6a8ded2624b481_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i96caa6529642403084788194234fac2d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i84610b8d7d3b44b680b451fe979cb9a8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i9fd36dae3b2b4256bc00944063093da2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i78c7b4f7e5904e5e9d5168eb8819cc11_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i582149af38174a49b5d43f5c23400d89_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie3d201608e0848fc80fcef2eecd22d46_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia54ab828e6394dc29714827ff395896a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4e8f67a7223747f88624ef41a564ed11_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ied22f6706c404fd681c4a5fc164e16db_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i956afb27a29242589884eb0e1ccf86c9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6f59b1fe6bf14e1d934932e9f19a662a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i21ce4cf60f7042b380ec1757dc4f8a08_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i557ae529b0534b7e83bdfd35a6d1216a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id101b89cfc2f41c28814b80debdc3cb8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i296365e2b77b4e8183cf0fe4076355f8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1d138a5d3c994ce39162445d9d354401_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i55478baf239442988af0a3137120ff79_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i22bef0eaffe04104b79fd06b8e9b6aa1_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i75a8b5cca80f46518592a4750ba5850a_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i77602246977e4ab48559ae10f9ef671c_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i368ef1c3bb964a91992f82e0a63d6ec9_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i264938c435d846aa93d88d47ad3d77af_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1922e3a342ea477b82afbb406801bb66_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ib89641723e5a4a5189fce4a3e9a9f517_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic2e6fb5fc5ad4a8883252831c70d9b8e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i514e1984bf624bcab1ca800517fe8409_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i0edebf080f80402f883427d33eb82646_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i17d824c1eb834a1196d7d2349e2b3500_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic5c58d0d3a06407fae45526ac0b7f3a6_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id2de6637c368451a83b9fbebce1b02cc_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i7da59944142842809e0da6afc8bff8e2_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5be348dea4b94b1290c68f97c0b18392_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i437c34bd707949e2b3624b784bd27f1b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i606ed33122784ef28a374862e04b8938_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if5b1d0fd10514bb7ae0a9c0147334def_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2a285bb683e44422bf5d4ef530eb8f9a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:BandLokMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7586dec2cc8146b0a84c69f0ed6a9b88_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:BandLokMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ieae79c794ca74ecaab7e1f4be1666580_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i1722f284f22149b0b62e23f146f1da73_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="iade7dd3801514191b80df2d859180efe_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:SecondAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="ia07305a71eeb47d99be5750a3a47cb18_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:ThirdAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i974a053f052c4233bccf37c504b97db0_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:FourthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i1832772ced4e4d7694796baf90a940a1_D20200610-20200610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:BandLokMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-10</startDate>
            <endDate>2020-06-10</endDate>
        </period>
    </context>
    <context id="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kids:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-22</startDate>
            <endDate>2020-06-22</endDate>
        </period>
    </context>
    <context id="iee7c30dda4914c6593234714105f5846_I20200622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kids:FollowOnOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-22</instant>
        </period>
    </context>
    <context id="i06a679238a7a43869b57724937813e35_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifa4a9026c5c340bca4066b1c0efd2063_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic55ec3187d414b9abaf5fb65b6c8a434_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6f6897b493df42eeb47e27f00c5abf4b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i96d7db72a7864d59befbe7a971698da9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i53ba86c7840345919cc20c4229f816e0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1287bce70e774c27965e7c70d082232c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i940588eb8f6a40e3a2e23b5b87a7a8b9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i47943924a14342328b889ec2d330cf79_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3fd8747608254c9ab234730b9575a4fb_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2ad4e18322904bda9fe3bf97682b7114_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">kids:SampleInventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7ce4805a31e8410d81b81251b9b1f57c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie6bbf783a9584fe0a1bd64259cbff166_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kids:A2007EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="iaa05c196b8e04e13accf63a52bae4361_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kids:New2017EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9e55361217974608a2b11df6efaf5506_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i292238a1b0524036b2e519416ce7ebbc_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6dd7fadd1c8141f4bce22e9933efeca0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i44bb1450f6e841a0b1500229ed099770_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i66ddcda9efb2401e914b895725e8449a_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="icad1fff330924b20990fd0c7cf170c10_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="ib40f513d923c4826b58162f6f5582202_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i5cf98eb1a09e4ccb8140a7acdb7780b3_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="ia313240909774cbe8dc30507a797ccc1_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i6ad06b13cdff4f36ab42c19c49f5ec90_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i938290d2cdad418ea88e9197cb42d54e_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="iea2114642e614c76862ec79220c8b6de_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i4871de21cf3c497a9d2222f88b61d7ab_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:SecondAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="iefda4158f9254c1eb3becf702fc558a8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:SecondAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i36be2612ceac48918982f7de2682e1c5_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:ThirdAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i3de47578e860485f8740cf50e09ee68f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:ThirdAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i136967d17bba4ed28cf1f18b639b6b83_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:FourthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i190a872146ee4e9187065e968ab399b3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="kids:BusinessAcquisitionAnniversaryAxis">kids:FourthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0891c5d60bc5463e814034e47be08954_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:ApiFixLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-09</instant>
        </period>
    </context>
    <context id="i80a8bd33230e4f23a9d792dc0bb5a7ee_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i8a9d0f0383c646788001508a2c5597bd_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i95b3a7b0f9324955af777d48822570a9_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:TelosPartnersLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-04</instant>
        </period>
    </context>
    <context id="i7c8ff79382af4dbeb5b7c523481aa645_I20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2019-06-04</instant>
        </period>
    </context>
    <context id="id9512287e4134097a7d49339bfdae2a8_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="if66e4ed42c0340ae95515133232879f3_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i697f880d24684012827b17b5de98d360_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i51c7929e645642919dea6b4923e42798_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i32b0fbb66fe2467f9e999a25aaa3b1cc_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i2036398d56b74a198f2a687eeb8fde44_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexAndOrthexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="i0ce021843bf7476ab44bfacfc23770c3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:VilexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i779524b02e4741949cdceb2816836fca_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">kids:OrthexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i43216f47eeee41f6bb129feaeb6cdc7e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaae923d4563d427bacf487bd51f6a91d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic6894ee1ed534a779143dc099648c47f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id145432eb8c441e5b1dbddc0c0a863d0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iee46e00cdee24529b067135f7e8c5115_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i217400e5358b4111bcda2d87a7c82ea6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2b0498ea6ef04efdafac30fa191f07f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i26700fd1a63342dd8c4212993b04610d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i44183e3bfe624d5d8cb321bdf8e45312_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ba47742d675456f97dcddba2466e3f9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i12a267c66f9e460cbcdd61aca29f6e43_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibb96a082b67d4e369fad244fcf9ecea7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i58298dbcea9a43738bf180f55aa6c005_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4212d5ada3e1486386101c68b4a3ff9b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i97ee1b03f3f34cb8a5a900dbd94f9e8a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i55c4e72e21c0402b9665b56e75791946_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i522cee87c6934a54b91779a2e4a36983_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i32ecfc1db0094cdf9b81fbbdb546dc71_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i91313831b49b4497a30f40930e592148_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia750dea5d4f84490a3ed6d2032d6b369_D20190604-20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-04</startDate>
            <endDate>2019-06-04</endDate>
        </period>
    </context>
    <context id="ifea33470bf02413c92995e85b05b1ad0_D20171231-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-31</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="iaabfc50f270c4500963cf0c8d1d79fe8_I20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-04</instant>
        </period>
    </context>
    <context id="i2a7811335a9947b3b93354b5f0367da1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i2d597c299e87430aaf3c619817196928_I20190604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-04</instant>
        </period>
    </context>
    <context id="i7eba4623b24a447fbe2ee28df0cdd245_D20191231-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:TermNoteBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-31</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if5755d80d80843eaa4f3d75bcc7bbba4_D20191231-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:RevolvingLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-31</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9e31cbfbaa6540549a2b910c978401be_D20200104-20200104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:RevolvingLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-04</startDate>
            <endDate>2020-01-04</endDate>
        </period>
    </context>
    <context id="i3be7e495a9b44feba44e00526454ab10_D20130801-20130831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-08-01</startDate>
            <endDate>2013-08-31</endDate>
        </period>
    </context>
    <context id="i901f004c0d1149749e65dd0a69e57ff2_I20130831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-08-31</instant>
        </period>
    </context>
    <context id="i0ce9195684154b7296d03f48c3f26321_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic2f23483cdc3453791280df0471e41a9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2007-12-01</startDate>
            <endDate>2007-12-01</endDate>
        </period>
    </context>
    <context id="i9e4452d90eff4a999d49f7af62efccde_D20170802-20170802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">us-gaap:RoyaltyAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-08-02</startDate>
            <endDate>2017-08-02</endDate>
        </period>
    </context>
    <context id="ib62efb33448d425f8bb4b13674e7e6c7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6e2ab5c81fda421daa443c34171cffb0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6b009d063c2e467993e163ef9a164f0e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i720e0f76ea12446a83bf8ab6c5736641_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">kids:CaseWesternReserveUniversityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8ae1c5b976b9426ea7c2afb46f2de085_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9cf3572a27664de18b2b944dc137f71d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i86c42bd634d6439e9ab4f9d4586e1807_I20140530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2014-05-30</instant>
        </period>
    </context>
    <context id="i5fc9092f14204444ba24d4c873eb6e82_I20181211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <instant>2018-12-11</instant>
        </period>
    </context>
    <context id="iaff3b8a415a248e1b649428771d5dd22_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6b8a3c8fd6994c91bfa372ef62e86e22_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i20d35bb680f64b0ba2acd454d8e86d83_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iad46059f454f4bbea038030b853e05e6_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4c7c78b58af646cd96f6b8bd5e1d1d13_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i432d3aa78750469da80bdc567e4824f6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie158e3539d5e4934824bb0f77b22ef76_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3bb3e606a2bd424d964faaf220d28e88_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idbb6455ee34645b9b482fe979192967c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7f161809f3474a4cabfb3f9e420c96d1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7204f2c032b942a68028138eeece4cee_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i46623ac889f4451080c334614620617b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ife2d42f413d047f09f78455b81ba82e0_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i00909a9da62143989aea8f861f283df1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1d4b7eb4460144da819f7cf668aa8bdd_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ice73e8c1b57f4796918a790a968b7015_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2622759db9c144acb87d793c9cf03743_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic9c269ea2edf4cf5aef8ed02d7e1f45c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3fb48cad575945baac6067e33a96cadc_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia756c05cec28403f884770d9344bdac2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i721aca0cd1734c8aaf8b8d90702bc1d1_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id10512dde3404dfcb6e3c0cce3a1f040_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i266ee2942a4a4657a71d21bdf2710068_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id78469ce723d4142ae3b8ab43ffa60a0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i225cd71c1ec1426d8041c44a2184d1ae_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8c889130704d4f80946a9c6286e05061_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6ed7c2942fcb4d46a5ca89a0294a7bf5_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:TraumaAndDeformityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0fff3612ea874d5180f15f4a42bc8604_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9200b24feefc4b159ffafee02cb55e00_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1e7ea47b72ee450b8582bd233a4fac65_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id56952e6da1c40bb95f3ecf288efc864_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i83e4b27552214a3a879d0adf2748bebb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1c76b6d6fbcd4e0e87b78db6dea4ab41_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iba3dd237ec5246bbba457e8a049a8981_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1ce3387f4cd14200af133e93202fc096_D20190101-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">kids:SportsMedicineandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie0deb0d220a848e5ab3218335eba7b86_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4fb8f7b19c8b43a0ab7aa696389aad13_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:FMIHansaMedicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i82095520751c4542b0194bd4a6b61005_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:FMIHansaMedicalProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icef3ad5351134de9bd2e9409f0f579f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibaad49ffb99f40309f22c27c5a29b41a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7249b3def0b34e65b3e605e288e1cc43_D20200101-20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-01</endDate>
        </period>
    </context>
    <context id="i70d54ac0693a4a3780155e252a95c82c_I20200803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:FirstAmendedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-03</instant>
        </period>
    </context>
    <context id="idfc293021e554021ac712a08de896501_I20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:FirstAmendedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-04</instant>
        </period>
    </context>
    <context id="ie9d46247c02e4dad89dcf4bf7fdb0780_D20200804-20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-04</startDate>
            <endDate>2020-08-04</endDate>
        </period>
    </context>
    <context id="icc09a7c192ec43ffbf6d23af854df8b2_D20200804-20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:SecondAmendedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-04</startDate>
            <endDate>2020-08-04</endDate>
        </period>
    </context>
    <context id="i5ab10817a561491dad2e85b5bebc393f_I20200804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">kids:SquadronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:SecondAmendedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-04</instant>
        </period>
    </context>
    <context id="ic1955253c07c4f0f85875d92dbf6bbb7_D20200715-20200715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001425450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kids:TermNoteAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-15</startDate>
            <endDate>2020-07-15</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="facility">
        <measure>kids:facility</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>kids:segment</measure>
    </unit>
    <unit id="supplier">
        <measure>kids:supplier</measure>
    </unit>
    <dei:DocumentFiscalYearFocus
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGFibGU6ZGRiYWUyOWYxZmZmNGU0NThjY2E1Y2E4NjlmNGE3YTYvdGFibGVyYW5nZTpkZGJhZTI5ZjFmZmY0ZTQ1OGNjYTVjYTg2OWY0YTdhNl8zLTEtMS0xLTA_680ccb9f-3d48-4b27-b135-bc092a4e36db">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGFibGU6ZGRiYWUyOWYxZmZmNGU0NThjY2E1Y2E4NjlmNGE3YTYvdGFibGVyYW5nZTpkZGJhZTI5ZjFmZmY0ZTQ1OGNjYTVjYTg2OWY0YTdhNl80LTEtMS0xLTA_409d467f-47da-494b-bb24-96936a0178f7">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGFibGU6ZGRiYWUyOWYxZmZmNGU0NThjY2E1Y2E4NjlmNGE3YTYvdGFibGVyYW5nZTpkZGJhZTI5ZjFmZmY0ZTQ1OGNjYTVjYTg2OWY0YTdhNl81LTEtMS0xLTA_247cf476-978a-4c5f-8459-2e8e0f499358">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGV4dHJlZ2lvbjozYmY3OTE3YjlhMTE0NjYzYTRhYWMxYTRmYWY5NGYwN182MQ_86f3fb8f-e51f-498c-8b4a-b9bb39ede328">0001425450</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80L2ZyYWc6M2JmNzkxN2I5YTExNDY2M2E0YWFjMWE0ZmFmOTRmMDcvdGV4dHJlZ2lvbjozYmY3OTE3YjlhMTE0NjYzYTRhYWMxYTRmYWY5NGYwN182Mw_fbc6db9f-ea86-4dde-9159-1fec82ad23db">--12-31</dei:CurrentFiscalYearEndDate>
    <kids:ResearchandDevelopmentArrangementContracttoPerformforOthersTerm
      contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfODQ_bf262227-ff5c-44d1-a84e-6eebb551fe29">P10Y</kids:ResearchandDevelopmentArrangementContracttoPerformforOthersTerm>
    <kids:ClassOfWarrantOrRightTerm
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTU5Ng_22c0bf25-8204-4c32-a466-8f4c334e3f8a">P10Y</kids:ClassOfWarrantOrRightTerm>
    <dei:DocumentType
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY184Mg_6a6bf04c-3b7c-4428-a8ad-dd0dcae2c50e">10-Q</dei:DocumentType>
    <dei:EntityExTransitionPeriod
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY185Nw_0b58b2e4-d628-4c4f-8083-00bbb9ac2a67">true</dei:EntityExTransitionPeriod>
    <dei:DocumentQuarterlyReport
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY185Nw_ddf27337-bdbe-4007-9c13-b73b61c0662a">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMjA_36e2a63b-e6ce-4965-8d15-19e27cebfa93">2020-06-30</dei:DocumentPeriodEndDate>
    <dei:EntityShellCompany
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMjk_649c0d45-39cf-4257-a0a5-63fd43fc7993">false</dei:EntityShellCompany>
    <dei:DocumentTransitionReport
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMjk_86330223-e2f0-4e2c-84fc-c55a3099a20f">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18zOTc_eeb6321e-d283-4a90-9298-54b925eabc53">001-38242</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY180MDA_3089d0ab-98a8-4dd7-9ae4-d64ff7484bc5">OrthoPediatrics Corp</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjUzYjYyZjg1OTA2NGZhOThkZDYxNTFmYTIyN2NiNzkvdGFibGVyYW5nZTpiNTNiNjJmODU5MDY0ZmE5OGRkNjE1MWZhMjI3Y2I3OV8wLTAtMS0xLTA_c9dd5444-23eb-413a-a0fb-9c89f0d57065">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjUzYjYyZjg1OTA2NGZhOThkZDYxNTFmYTIyN2NiNzkvdGFibGVyYW5nZTpiNTNiNjJmODU5MDY0ZmE5OGRkNjE1MWZhMjI3Y2I3OV8wLTEtMS0xLTA_f8041d4a-8c17-4f30-aa01-08292476928f">26-1761833</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV81_0ff520cb-9174-4a92-b44c-b9d82a207a81">2850 Frontier Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV84_4e7bfeb8-19e8-4401-8c77-ccd55ebdab3f">Warsaw</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV8xMg_138b97bd-0ab4-45fe-b38f-b09b83c6f6cd">IN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjpmZTk4ZGJkNDc3MjM0NjY5OTg0Njk4ODhjZTFjZmNlZV8xNQ_26bd43c5-3368-471b-bd8b-4b8621bcb51a">46582</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTEtMS0xLTAvdGV4dHJlZ2lvbjo5Y2RjNDQ1ZTk5Y2M0OGJlOGMzMGY3ZDQ2ZjUyNjk0Yl82_6afc3984-812a-40f5-95cb-d72ff7230835">574</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6NTE4OTUzOWJmOTUxNDVlZTkzMWM4Y2RkNDdjNzNiMzgvdGFibGVyYW5nZTo1MTg5NTM5YmY5NTE0NWVlOTMxYzhjZGQ0N2M3M2IzOF8wLTEtMS0xLTAvdGV4dHJlZ2lvbjo5Y2RjNDQ1ZTk5Y2M0OGJlOGMzMGY3ZDQ2ZjUyNjk0Yl8xMA_08d90c9a-d906-4a78-8a28-dd880ec48014">268-6379</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6ZjdiNWYzMjhkZTNjNGMzZGFlNDUxMTE0NTczZmE1ZTYvdGFibGVyYW5nZTpmN2I1ZjMyOGRlM2M0YzNkYWU0NTExMTQ1NzNmYTVlNl8xLTAtMS0xLTA_a1147f3e-ce27-4257-9047-0e660836664a">Common Stock, $0.00025 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6ZjdiNWYzMjhkZTNjNGMzZGFlNDUxMTE0NTczZmE1ZTYvdGFibGVyYW5nZTpmN2I1ZjMyOGRlM2M0YzNkYWU0NTExMTQ1NzNmYTVlNl8xLTItMS0xLTA_97d8db6f-8547-4aa0-b44e-653efad493ba">KIDS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6ZjdiNWYzMjhkZTNjNGMzZGFlNDUxMTE0NTczZmE1ZTYvdGFibGVyYW5nZTpmN2I1ZjMyOGRlM2M0YzNkYWU0NTExMTQ1NzNmYTVlNl8xLTQtMS0xLTA_87eb18a5-b3ee-4d5e-82c5-cc8574c97846">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY185MDU_f58f4f0d-0826-47c9-9683-9df7cd36bfdc">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xMjI3_e991f960-5b60-41d0-8972-2e4d98dcfde9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjY5Y2Q0ODZkNTI1NGU4NDlhZmIyZTJmZWViZDU2MTUvdGFibGVyYW5nZTpiNjljZDQ4NmQ1MjU0ZTg0OWFmYjJlMmZlZWJkNTYxNV8wLTItMS0xLTA_9d24c090-dc1f-43f1-8622-a9ffec475c68">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjY5Y2Q0ODZkNTI1NGU4NDlhZmIyZTJmZWViZDU2MTUvdGFibGVyYW5nZTpiNjljZDQ4NmQ1MjU0ZTg0OWFmYjJlMmZlZWJkNTYxNV8xLTMtMS0xLTA_7273b154-53ea-4e03-95cd-3549d5e3517d">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGFibGU6YjY5Y2Q0ODZkNTI1NGU4NDlhZmIyZTJmZWViZDU2MTUvdGFibGVyYW5nZTpiNjljZDQ4NmQ1MjU0ZTg0OWFmYjJlMmZlZWJkNTYxNV8yLTEtMS0xLTA_f8df9ea7-04ad-4119-863d-d7be09bb3804">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xODMy_0b58b2e4-d628-4c4f-8083-00bbb9ac2a67">true</dei:EntityExTransitionPeriod>
    <dei:DocumentQuarterlyReport
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xODMy_ddf27337-bdbe-4007-9c13-b73b61c0662a">true</dei:DocumentQuarterlyReport>
    <dei:EntityShellCompany
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xOTUz_649c0d45-39cf-4257-a0a5-63fd43fc7993">false</dei:EntityShellCompany>
    <dei:DocumentTransitionReport
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18xOTUz_86330223-e2f0-4e2c-84fc-c55a3099a20f">false</dei:DocumentTransitionReport>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i64001efefd914b23a423885f1db0f016_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xL2ZyYWc6OWMyYTRlNmUxZDQ4NGU1MGEyOGQzYmZkYTNkMzU4ZWMvdGV4dHJlZ2lvbjo5YzJhNGU2ZTFkNDg0ZTUwYTI4ZDNiZmRhM2QzNThlY18yMDAz_20462fbb-79f8-45ed-9f0c-b52d27aab8ae"
      unitRef="shares">19549201</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMy0xLTEtMS0w_c17fbafb-552e-4e24-b0bc-db04d54f1a56"
      unitRef="usd">113054000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMy0zLTEtMS0w_69f137a3-ea90-42b6-87b3-d48362c027e6"
      unitRef="usd">70777000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNC0xLTEtMS0w_53c1bfbc-5f9e-4c19-9e74-eac471fb4f6f"
      unitRef="usd">1361000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNC0zLTEtMS0w_31d1d38c-6b55-4253-a12d-4267b1a4f054"
      unitRef="usd">1250000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0wLTEtMS0wL3RleHRyZWdpb246MWFjOTg0MWJjODI0NGFkNzkyMWU1MzMxZWIzNTUyNjlfNzM_dd8995ea-09a7-4069-952f-98bfddabc3c7"
      unitRef="usd">185000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0wLTEtMS0wL3RleHRyZWdpb246MWFjOTg0MWJjODI0NGFkNzkyMWU1MzMxZWIzNTUyNjlfODA_550dfb2d-19a5-4516-8c66-d6d412aa55c4"
      unitRef="usd">506000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0xLTEtMS0w_e16a2631-8082-4057-9834-451d0fd27268"
      unitRef="usd">14897000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNS0zLTEtMS0w_03dffe8c-b5d9-4ccf-b88e-2031fa972d7d"
      unitRef="usd">16003000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNi0xLTEtMS0w_89b8633f-fbe2-4e84-abdb-e8690fe674ac"
      unitRef="usd">48875000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNi0zLTEtMS0w_4e24d857-452d-4264-a58c-e398a9550599"
      unitRef="usd">38000000</us-gaap:InventoryNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOC0xLTEtMS0w_827aa140-6634-4f84-8f4c-2fae22d6afd1"
      unitRef="usd">656000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOC0zLTEtMS0w_2c5d19e5-e6ca-4969-9052-dbffbfada6f8"
      unitRef="usd">564000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOS0xLTEtMS0w_ce3c753e-26a7-41bb-9cac-2e0746308425"
      unitRef="usd">1534000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfOS0zLTEtMS0w_4df20434-a314-4101-ab8c-b5773de89e2c"
      unitRef="usd">1464000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTEtMS0xLTEtMA_ebe5662d-1703-4bc1-b942-53941faf11a2"
      unitRef="usd">180377000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTEtMy0xLTEtMA_652e3cc1-2ad4-4423-a3a9-7bf7b7b806d3"
      unitRef="usd">128058000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTMtMS0xLTEtMA_3e0c90d8-4307-46cc-9b72-3d0cd3ad86dc"
      unitRef="usd">24131000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTMtMy0xLTEtMA_a093b2bd-fb01-4669-bba1-2aae3d865b42"
      unitRef="usd">21349000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTYtMS0xLTEtMA_05a6e098-d1b4-4152-954d-166733d5d620"
      unitRef="usd">42206000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTYtMy0xLTEtMA_d6845ba8-b85b-421e-a330-2776a1d60f88"
      unitRef="usd">14484000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTctMS0xLTEtMA_84dbf1ea-27fb-4617-890b-b371e6e97c22"
      unitRef="usd">68420000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTctMy0xLTEtMA_1ed81ec4-725d-4f4f-ba32-40938f754fa4"
      unitRef="usd">13773000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTktMS0xLTEtMA_db156739-795c-446e-88b7-e2fd2d290c42"
      unitRef="usd">13357000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMTktMy0xLTEtMA_40631726-4384-4fbc-a09b-9765a5dfb6a8"
      unitRef="usd">4490000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <kids:AssetsNoncurrentExcludingPropertyPlantAndEquipment
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjAtMS0xLTEtMA_0758ac44-2f7d-42e9-bcbe-edd536460888"
      unitRef="usd">123983000</kids:AssetsNoncurrentExcludingPropertyPlantAndEquipment>
    <kids:AssetsNoncurrentExcludingPropertyPlantAndEquipment
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjAtMy0xLTEtMA_de4f562f-146d-4912-86ff-48ac283afedf"
      unitRef="usd">32747000</kids:AssetsNoncurrentExcludingPropertyPlantAndEquipment>
    <us-gaap:Assets
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjItMS0xLTEtMA_2fb39804-b2c2-4dc8-a44d-9223fcfe1c4b"
      unitRef="usd">328491000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjItMy0xLTEtMA_0dfb3e71-ecd0-4887-a9ba-4ad1e4395de6"
      unitRef="usd">182154000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjYtMS0xLTEtMA_a79fa506-e5c5-4c67-8442-d37300c7a276"
      unitRef="usd">6003000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjYtMy0xLTEtMA_dd9066b4-3a82-4324-9704-70d75c44c03f"
      unitRef="usd">6467000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjctMS0xLTEtMA_956e11ef-0b32-41e6-944c-44cdc86f61e7"
      unitRef="usd">4501000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjctMy0xLTEtMA_c58f25a5-b08f-4a93-a493-82aebebdf68d"
      unitRef="usd">4349000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <kids:LongTermDebtCurrentMaturitiesRelatedParty
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjgtMS0xLTEtMA_dd7f2afa-6550-4afa-9d52-3bb447af56d8"
      unitRef="usd">128000</kids:LongTermDebtCurrentMaturitiesRelatedParty>
    <kids:LongTermDebtCurrentMaturitiesRelatedParty
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjgtMy0xLTEtMA_af4d0bda-03af-4916-a7ef-61b7b3966d43"
      unitRef="usd">124000</kids:LongTermDebtCurrentMaturitiesRelatedParty>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjktMS0xLTEtNTE2_a11cf308-0af9-485a-8ece-c776cd812134"
      unitRef="usd">11485000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMjktMy0xLTEtNTE2_d6ed23ce-121c-45d4-9a9f-51d3a4670da4"
      unitRef="usd">0</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzItMS0xLTEtMA_c9014898-5005-47ae-b2f3-fc958c80299d"
      unitRef="usd">2654000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzItMy0xLTEtMA_06d53f66-8d17-460c-9a53-f4351d5b6bd0"
      unitRef="usd">2723000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzMtMS0xLTEtMA_84ad94a1-f6c2-4473-89a1-e176a348e550"
      unitRef="usd">24771000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzMtMy0xLTEtMA_394cde90-c23d-41ee-860c-6e25a5976a38"
      unitRef="usd">13663000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesAndLoans
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzUtMS0xLTEtMA_97db733a-6025-4872-bb8a-c2b2db655f6a"
      unitRef="usd">21017000</us-gaap:LongTermNotesAndLoans>
    <us-gaap:LongTermNotesAndLoans
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzUtMy0xLTEtMA_cfee6033-803c-4835-88af-21d33699d760"
      unitRef="usd">26067000</us-gaap:LongTermNotesAndLoans>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMS0xLTEtMjUyNg_1bbe2216-537f-42ad-9e6d-47f0af01b9db"
      unitRef="usd">12021000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMy0xLTEtMjUyNg_79745a6b-a0f5-4ff9-ae3b-c5d736d84dc7"
      unitRef="usd">0</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzYtMS0xLTEtMA_c360ff53-01ed-45f3-b9bc-9d7470e8743f"
      unitRef="usd">28100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzYtMy0xLTEtMA_f015367f-f51c-4aff-8772-d7f18d141294"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMS0xLTEtMA_b0130cb2-5564-48d0-a59a-e86e947e1b82"
      unitRef="usd">120000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzctMy0xLTEtMA_710a3615-8abd-4e6f-8bea-d028c3052677"
      unitRef="usd">63000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzgtMS0xLTEtMA_e794e32b-4c43-4c49-9aa1-00cf86583ced"
      unitRef="usd">61258000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfMzgtMy0xLTEtMA_d8085234-18c3-49a1-9df3-b32a92922fb0"
      unitRef="usd">26130000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNDAtMS0xLTEtMA_c3d34772-c67a-4dd6-9631-ba6d05fb8df8"
      unitRef="usd">86029000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNDAtMy0xLTEtMA_046b81bc-5e3c-4d1e-97ef-4a80949f18d2"
      unitRef="usd">39793000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzE4_2d3c9c47-cabe-4d00-ba24-1c013c923d90"
      unitRef="usdPerShare">0.00025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzE4_fecce4a5-2c03-425f-9d7d-200a8fe562c9"
      unitRef="usdPerShare">0.00025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzMy_62446702-cbdd-4493-9e07-179302fa91ac"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzMy_89c00f66-6c86-4dac-94f8-4261ca3dc46f"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzU0_5317c855-0ce4-4b8b-b980-2cde6ff052d6"
      unitRef="shares">19544008</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzU0_5358b0da-33e6-4451-a049-1ea75675a227"
      unitRef="shares">19544008</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzY4_b9da3925-ef5f-4613-b885-015442aa190f"
      unitRef="shares">16723128</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMC0xLTEtMC90ZXh0cmVnaW9uOjkzODU4NzdjZDdmZDQ5OGNiM2VmOGIxYWQwMjY1NzY4XzY4_d0af5785-8be4-446f-b8cb-0b576fb099b3"
      unitRef="shares">16723128</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMS0xLTEtMA_e6ca2cb8-ed07-4613-8745-44beff94dfb6"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTAtMy0xLTEtMA_a471a48f-d7c7-45f8-b20b-554a8383fe0f"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTEtMS0xLTEtMA_f12c1aaa-22f5-4bb6-8a9b-74d54e115eb3"
      unitRef="usd">385510000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTEtMy0xLTEtMA_1c174389-7c52-489f-ae51-2c28ed7d6420"
      unitRef="usd">271182000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTMtMS0xLTEtMA_f7af988b-c5ca-434c-bfee-68976588f740"
      unitRef="usd">-143214000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTMtMy0xLTEtMA_b2e2bc8f-d080-43f6-b3c9-9b7f2662c5d2"
      unitRef="usd">-128822000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTQtMS0xLTEtMA_4ca11bc6-933f-49f5-b35e-fb6a0d650622"
      unitRef="usd">161000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTQtMy0xLTEtMA_dbd10c6f-5477-4639-9275-c123744d51ba"
      unitRef="usd">-3000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTUtMS0xLTEtMA_a52abb7a-03ca-4b9b-926b-c695e0393672"
      unitRef="usd">242462000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTUtMy0xLTEtMA_70a1d0a1-0440-45d5-8676-6ee6953ecf7b"
      unitRef="usd">142361000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTctMS0xLTEtMA_d4837e72-13ed-4741-9137-853a180fe74c"
      unitRef="usd">328491000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8xOS9mcmFnOjAwMWIxNjY2MzZlMTQxMjFiNWExNGQ4NmNjNzdkMzE4L3RhYmxlOjlhZjE1YzcyY2NhNTQyZDY5MGY2ZDdjODdjMWE1ZDJiL3RhYmxlcmFuZ2U6OWFmMTVjNzJjY2E1NDJkNjkwZjZkN2M4N2MxYTVkMmJfNTctMy0xLTEtMA_1014c4b0-67bb-4655-a1b7-3f92338a7ddf"
      unitRef="usd">182154000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi0xLTEtMS0w_25e93eb3-69c8-4218-a7a9-50086c6f8819"
      unitRef="usd">13593000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi0zLTEtMS0w_326db432-6c03-495b-9623-8e25ea644660"
      unitRef="usd">18200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi01LTEtMS0w_86e0eb15-ce9f-4640-83aa-89c24c1a24fe"
      unitRef="usd">29949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMi03LTEtMS0w_7bc49f2a-01ed-4667-9ba9-595adadd5f1d"
      unitRef="usd">32856000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy0xLTEtMS0w_27281beb-29f0-48e6-b4bb-a9fd6047a745"
      unitRef="usd">3532000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy0zLTEtMS0w_09e0af53-eb34-44cc-816a-9aa970733bdb"
      unitRef="usd">4581000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy01LTEtMS0w_2a75e144-6d0d-4546-8e64-9ae9b2151da9"
      unitRef="usd">7675000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMy03LTEtMS0w_65652d61-efe4-4ce3-983a-697d220538c9"
      unitRef="usd">8582000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC0xLTEtMS0w_50a37991-6d80-47f7-b2b9-c952660c11ee"
      unitRef="usd">10061000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC0zLTEtMS0w_222a131c-eaec-4300-9e3c-c7fc1fd9f544"
      unitRef="usd">13619000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC01LTEtMS0w_bfcb3287-05c2-447b-9bb5-71a17fd51af4"
      unitRef="usd">22274000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNC03LTEtMS0w_08727af2-d19a-49fe-ab5c-6614b0bb1efb"
      unitRef="usd">24274000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi0xLTEtMS0w_6fb4b26e-10d4-4197-bc8f-87d6cb14ef45"
      unitRef="usd">5620000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi0zLTEtMS0w_fde0bfa6-6be6-41fc-9bd7-060c5b242110"
      unitRef="usd">7606000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi01LTEtMS0w_269f9e5a-32b9-4cf9-b796-2148d244a248"
      unitRef="usd">13184000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNi03LTEtMS0w_e74cb87c-0ed9-4a49-a7a2-643a59fc588f"
      unitRef="usd">14153000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy0xLTEtMS0w_64325c4c-71cc-4ab7-a83a-68e229508651"
      unitRef="usd">10577000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy0zLTEtMS0w_8c7982b5-822a-4d02-b749-44753f50f714"
      unitRef="usd">6569000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy01LTEtMS0w_88d2055f-bde4-469c-8ac3-a0b0b8388371"
      unitRef="usd">18458000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfNy03LTEtMS0w_a01cdfe3-f54d-46ff-84e5-352d393925a0"
      unitRef="usd">12181000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC0xLTEtMS0w_98ef8ba7-332e-42c3-ae4c-8a99eba39558"
      unitRef="usd">881000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC0zLTEtMS0w_0342f6d5-acd2-42b9-9c80-312b8748515a"
      unitRef="usd">1234000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC01LTEtMS0w_85932ce1-6538-491b-be47-3bd2a22b252b"
      unitRef="usd">2146000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOC03LTEtMS0w_c4729a1e-e50f-478d-abc4-0a29a8ec8dae"
      unitRef="usd">2447000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS0xLTEtMS0w_6c4dd153-4f32-4f2f-ae73-959b09546fc3"
      unitRef="usd">17078000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS0zLTEtMS0w_5374f058-6d2f-433c-a0c7-7f77a195bc46"
      unitRef="usd">15409000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS01LTEtMS0w_7652adcb-de02-4b15-ab3a-611036c007bb"
      unitRef="usd">33788000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfOS03LTEtMS0w_65f05c45-9dcf-4b21-b8bf-4e2fb45f9ec9"
      unitRef="usd">28781000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtMS0xLTEtMA_c47e1efb-ab92-4108-a9df-08ecf547104d"
      unitRef="usd">-7017000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtMy0xLTEtMA_6e8bc409-225f-4357-8727-67f4c4dfac03"
      unitRef="usd">-1790000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtNS0xLTEtMA_e063e2e1-82cb-4a01-9487-99270c3dcbda"
      unitRef="usd">-11514000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTAtNy0xLTEtMA_33360542-8c89-4b24-8c22-918c537b48dd"
      unitRef="usd">-4507000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItMS0xLTEtMA_8fdcdc11-28a7-4490-bf1e-31c217ab3925"
      unitRef="usd">-1399000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItMy0xLTEtMA_ac9a40d7-50f5-4b07-b468-013bb7fd756e"
      unitRef="usd">-632000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItNS0xLTEtMA_a976e199-bcae-4c50-a9d3-d009f3f62ed5"
      unitRef="usd">-1778000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTItNy0xLTEtMA_26a3865e-5818-443b-8518-6367c190cad0"
      unitRef="usd">-935000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMS0xLTEtNTQw_0108e1d5-12e7-4fb1-b525-1abb593664fd"
      unitRef="usd">910000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMy0xLTEtNTUw_d5343433-d2e5-43b4-a855-74a0ebfac24e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNS0xLTEtNTQw_1c2a2e52-8071-4503-b29a-19bab49f44ca"
      unitRef="usd">910000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNy0xLTEtNTUw_3089ff6e-5c86-474d-81bf-f79cdeb3a4de"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMS0xLTEtMA_553e7294-59ab-4efd-bc17-96ff6cd6d00a"
      unitRef="usd">-121000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtMy0xLTEtMA_e75d5a3a-290e-4d78-88d0-09884cf6b376"
      unitRef="usd">-37000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNS0xLTEtMA_dc030c15-c176-4dc4-af07-2b5ffbbc1fbf"
      unitRef="usd">-190000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTMtNy0xLTEtMA_bad10fb7-4b9d-42c4-b109-ec1a2db471eb"
      unitRef="usd">-37000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtMS0xLTEtMA_c96e00e0-b5d8-427d-a4a4-20584d58c969"
      unitRef="usd">-2430000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtMy0xLTEtMA_4ba71f1a-c857-4e8a-a5c7-461c0cfc4aea"
      unitRef="usd">-669000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtNS0xLTEtMA_8a9f1216-0e3b-497b-9053-836afcbf5d2c"
      unitRef="usd">-2878000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTQtNy0xLTEtMA_51130a36-7db5-49b6-ab44-34503a0c6743"
      unitRef="usd">-972000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtMS0xLTEtMA_3e7b9623-fc7f-46de-b074-2e8c8f031603"
      unitRef="usd">-9447000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtMy0xLTEtMA_49e1d90d-d5b3-4c6e-a2b8-c5f5ad3cf051"
      unitRef="usd">-2459000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtNS0xLTEtMA_3c474fa6-542e-490d-b2b2-bd110be701a7"
      unitRef="usd">-14392000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTUtNy0xLTEtMA_c135aa54-f251-4d77-81d1-2ce6e2a6e1df"
      unitRef="usd">-5479000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtMS0xLTEtMA_0b5d6440-4fe2-488e-aa07-8cca0b24e4f0"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtMy0xLTEtMA_98b43ff9-2d0a-4b6a-9dfc-8eb3e511e812"
      unitRef="usd">-159000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtNS0xLTEtMA_5dbd8075-0ec1-47cc-9def-f927b6bb4f7e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTYtNy0xLTEtMA_39b69175-589c-425b-8876-fbe8f2573179"
      unitRef="usd">-159000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctMS0xLTEtMA_a5754da6-ec59-4fda-b504-6bd19879375e"
      unitRef="usd">-9447000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctMy0xLTEtMA_3b402a0f-6cc3-499a-82dc-87e1332764df"
      unitRef="usd">-2618000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctMy0xLTEtMA_d5a0baf5-9ffb-42ee-85b3-dffa3d94b999"
      unitRef="usd">-2618000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctNS0xLTEtMA_52ea228c-54cb-435d-9c0f-212c3ebc1c9b"
      unitRef="usd">-14392000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTctNy0xLTEtMA_64e0c2ed-8d6e-43b8-bc52-021358e3db26"
      unitRef="usd">-5638000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktMS0xLTEtMA_e3a584f5-98be-421b-aaaa-622b96733bed"
      unitRef="shares">17549118</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktMy0xLTEtMA_2ca6c1c7-5ca8-43cf-a629-6617bad985e8"
      unitRef="shares">14451979</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktNS0xLTEtMA_69e6483f-ed8e-4ef1-8b0a-ef961f10b121"
      unitRef="shares">16986485</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMTktNy0xLTEtMA_85be0bc7-7e5f-428d-a3ad-8b1d038d75f1"
      unitRef="shares">14409752</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtMS0xLTEtMA_1c01a9ec-7c5b-44d6-b3bb-8f81dff0bf32"
      unitRef="usdPerShare">-0.54</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtMy0xLTEtMA_4c596636-68ad-47fb-94dd-8031a9c85b64"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtNS0xLTEtMA_c529dda4-4bf7-4722-9f79-efa425697803"
      unitRef="usdPerShare">-0.85</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yNS9mcmFnOjI1NTQ5YjIxNmVkNzQ3MDE4ZGVhNThkZjYzNTYxODI2L3RhYmxlOjcxODJhODc5OTQwNzRlYzViOTBlYWE2MmE5YjE4NmNhL3RhYmxlcmFuZ2U6NzE4MmE4Nzk5NDA3NGVjNWI5MGVhYTYyYTliMTg2Y2FfMjAtNy0xLTEtMA_d219c374-9313-4cd8-9f66-29d2deb8f980"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi0xLTEtMS0w_fcccabc7-f9f9-448c-a2ff-8e14f8646602"
      unitRef="usd">-9447000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi0zLTEtMS0w_51094bd9-f83c-4b39-a73c-16c743783b14"
      unitRef="usd">-2618000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi01LTEtMS0w_0c7f76e7-78bc-40ec-8094-fcc0f015429b"
      unitRef="usd">-14392000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfMi03LTEtMS0w_3adfb7eb-c537-405d-87e0-b6b7c7f22a00"
      unitRef="usd">-5638000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC0xLTEtMS0w_7dc06b78-8c47-4929-8518-85392b9fa371"
      unitRef="usd">1522000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC0zLTEtMS0w_0af670a5-b92a-4076-bf99-a26589cc217b"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC01LTEtMS0w_03d0b2eb-699c-4ed1-a5f5-03756d1ace8d"
      unitRef="usd">164000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNC03LTEtMS0w_e4d580d0-da98-43a0-9379-65d7571c610e"
      unitRef="usd">168000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS0xLTEtMS0w_c6f4c85b-be8a-4813-b986-9f51e11d9828"
      unitRef="usd">1522000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS0zLTEtMS0w_c61bbdcc-a584-40b8-81bc-cb6090473697"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS01LTEtMS0w_e2cc41ad-8d39-4307-aa30-98312341777a"
      unitRef="usd">164000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNS03LTEtMS0w_43c54e23-32ed-40d1-841c-c44529c82945"
      unitRef="usd">168000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi0xLTEtMS0w_89c061e7-756b-4ec5-b98a-13dbea6a2108"
      unitRef="usd">-7925000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi0zLTEtMS0w_7c4865fe-5b71-44ad-8e8a-9c7a2b29418d"
      unitRef="usd">-2751000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi01LTEtMS0w_2a7b41a2-7d1a-4b70-9231-c7e3eb25781b"
      unitRef="usd">-14228000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8yOC9mcmFnOjBlYWQ5OThmY2ZmNzQ5N2ZiYzZmNjU3ZDZmOWExMTFlL3RhYmxlOmRiODA2MzliYzRhYjRmMjQ4YzNkNzlhMDI3ZDA3MTE3L3RhYmxlcmFuZ2U6ZGI4MDYzOWJjNGFiNGYyNDhjM2Q3OWEwMjdkMDcxMTdfNi03LTEtMS0w_9eb88dc6-06a4-4ef2-9831-5f823f9ad6b4"
      unitRef="usd">-5470000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if5b873289d394f8698109e34413ebc6c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xMC0xLTEtMA_f871e620-252d-4ba0-85be-1a6782a490e9"
      unitRef="shares">16723128</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if5b873289d394f8698109e34413ebc6c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xMi0xLTEtMA_586201a3-6f69-4243-8e2b-e9157cc7e519"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="if33c7e6e77b34aadafae7225d988f633_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xNC0xLTEtMA_7b9940b4-1dc4-48d0-82f8-fd78b0252328"
      unitRef="shares">0</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="if33c7e6e77b34aadafae7225d988f633_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xNi0xLTEtMA_48882db8-3bb2-4a7d-ba0b-1ce0780651e5"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i3c138c5223b945249abec4b41802cfe9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0xOC0xLTEtMA_3ebdef14-5831-4949-a06c-b0ac6fd678a3"
      unitRef="usd">271182000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ee305abb72e4348bdb25affaa6c5bb0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0yMC0xLTEtMA_3ecda4e3-1347-4a4a-a468-03fd447c2104"
      unitRef="usd">-128822000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i581093052fd24f5683c783d8150a5768_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0yMi0xLTEtMA_f25ca132-55d9-414a-a4f7-3d9f2a30a7c7"
      unitRef="usd">-3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNS0yNC0xLTEtMA_1074414c-4555-40de-bbf1-204cd342ec81"
      unitRef="usd">142361000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i1f552ff6bd064623b1279ee353b79be5_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNi0yMC0xLTEtMA_f650e203-c937-46a7-bc39-bb4b845e44bd"
      unitRef="usd">-4945000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNi0yNC0xLTEtMA_7eb0fe94-b03e-4471-8857-6da5b2c4ae93"
      unitRef="usd">-4945000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3c69752a2cd84ef3bf96562629d01f6d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNy0yMi0xLTEtMA_967e2a10-9761-41c1-829c-a6773795a7f5"
      unitRef="usd">-1358000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfNy0yNC0xLTEtMA_94513df0-ee3e-457f-b51c-6cfa0bc5077f"
      unitRef="usd">-1358000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOC0xMC0xLTEtMA_ded7559a-d68c-4675-9895-74b9d22785c9"
      unitRef="shares">22208</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i688ab3c7a7c14968861796de50cec944_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOC0xOC0xLTEtMA_376c4771-beaf-4919-a72a-ff75957c6203"
      unitRef="usd">688000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOC0yNC0xLTEtMA_cfd67353-fbb3-4501-885f-e9c37c552df4"
      unitRef="usd">688000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOS0xMC0xLTEtMA_4a3705df-9367-4174-94c7-ffe0f67f0372"
      unitRef="shares">105710</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i688ab3c7a7c14968861796de50cec944_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOS0xOC0xLTEtMA_0e0451d1-7b20-4cca-8d50-3fed3069e3a8"
      unitRef="usd">958000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfOS0yNC0xLTEtMA_d8240a75-9c53-4e5f-9bd9-86c6b60435de"
      unitRef="usd">958000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="idd71c9cae44d456f907c32c625ea459c_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTAtMTAtMS0xLTA_c109254a-8dad-4bbd-9a96-2bb7b38469c0"
      unitRef="shares">36628</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i688ab3c7a7c14968861796de50cec944_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTAtMTgtMS0xLTA_780b24e8-b17d-45cd-ab9d-b9da03d210f4"
      unitRef="usd">1750000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTAtMjQtMS0xLTA_5db4260d-896c-4184-baf0-203b9d765ea7"
      unitRef="usd">1750000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8efc4342789a4574a5010b2cd5a5e4d4_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTEtMTQtMS0xLTA_406767dc-072d-4ae0-9a98-9749e5c3c170"
      unitRef="shares">4014000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8efc4342789a4574a5010b2cd5a5e4d4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTEtMTYtMS0xLTA_9f32e138-d318-41ce-be34-4173aa1cec82"
      unitRef="usd">187000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id002a2a6876547638c69ff7d88eaf7c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTEtMjQtMS0xLTA_73b888df-6607-4831-a0f3-3e202a3f6d0d"
      unitRef="usd">187000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i003a46bd442946f49063fccbb2f71fd2_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTAtMS0xLTA_eaa7d75e-3843-4333-97fe-5cafdf20c44d"
      unitRef="shares">16887674</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i003a46bd442946f49063fccbb2f71fd2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTItMS0xLTA_a562c856-6d1d-49d1-980a-e49cf863bb35"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockShares
      contextRef="ic378826a602e45ea8c6a8ded2624b481_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTQtMS0xLTA_8679065a-0fad-4d8b-8a34-8d78804b5ca3"
      unitRef="shares">4014000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ic378826a602e45ea8c6a8ded2624b481_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTYtMS0xLTA_a02dca51-f2bb-4e4c-852e-e2ef3b3a1ea1"
      unitRef="usd">187000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i96caa6529642403084788194234fac2d_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMTgtMS0xLTA_016fa2f0-b564-428a-8404-c921cdab5219"
      unitRef="usd">274578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84610b8d7d3b44b680b451fe979cb9a8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMjAtMS0xLTA_8605d9c4-8a85-4781-8261-e78078fbeedb"
      unitRef="usd">-133767000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9fd36dae3b2b4256bc00944063093da2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMjItMS0xLTA_83951947-700f-43ec-a680-77b41f667946"
      unitRef="usd">-1361000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i78c7b4f7e5904e5e9d5168eb8819cc11_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTItMjQtMS0xLTA_df4a69c5-2acc-4b02-867c-3eb0d90f13d2"
      unitRef="usd">139267000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i582149af38174a49b5d43f5c23400d89_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTMtMjAtMS0xLTA_3bc0286a-6200-4144-bb17-be8b656b830a"
      unitRef="usd">-9447000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTMtMjQtMS0xLTA_ecb92bbf-21bc-48ed-9f76-3205d0fd09ee"
      unitRef="usd">-9447000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie3d201608e0848fc80fcef2eecd22d46_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTQtMjItMS0xLTA_134b33e7-fb77-4402-a4fe-9c310c4fb6eb"
      unitRef="usd">1522000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTQtMjQtMS0xLTA_56ccd95d-6704-49ab-9cad-48767a1c81f2"
      unitRef="usd">1522000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTYtMTAtMS0xLTA_ee4df976-d862-4f85-a1d0-8eda907dfe37"
      unitRef="shares">19162</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTYtMTgtMS0xLTA_ea5225a2-5a76-4d37-85fe-f531acdb1a73"
      unitRef="usd">593000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTYtMjQtMS0xLTA_c5d6348d-95bd-45c1-b83a-ad5bc1068169"
      unitRef="usd">593000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTctMTAtMS0xLTA_98e1a974-ccc6-4114-92fc-98bb6b47a728"
      unitRef="shares">52032</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTctMTgtMS0xLTA_a9e20ae9-d7b2-4538-8ac4-293fbd8872c9"
      unitRef="usd">2495000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTctMjQtMS0xLTA_70151236-1dd4-4246-bd67-17a92bd2862c"
      unitRef="usd">2495000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTAtMS0xLTU2OQ_0249fdcf-c8c2-40f8-b777-c48ebd8deb76"
      unitRef="shares">989154</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTgtMS0xLTU2OQ_f409d08d-318a-4010-b9b9-8ed7e15892d9"
      unitRef="usd">37638000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjQtMS0xLTU2OQ_46364969-86f2-429f-892a-c71811eca5b1"
      unitRef="usd">37638000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTAtMS0xLTU3OA_332cb720-5082-4474-b14d-7439a091267d"
      unitRef="shares">1595986</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ibea87b3d6a5c423e9cdba67282c39f93_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTItMS0xLTU3OA_4e4222f8-6d27-45b4-a229-72283be49d08"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4e8f67a7223747f88624ef41a564ed11_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTQtMS0xLTU3OA_c249e90a-362e-493f-825e-4d7363dbe079"
      unitRef="shares">4014000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4e8f67a7223747f88624ef41a564ed11_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTYtMS0xLTU3OA_c0bc29a6-cbb2-4e0f-982e-5a9ff38d0549"
      unitRef="usd">187000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia54ab828e6394dc29714827ff395896a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMTgtMS0xLTU3OA_94296496-eae8-4750-b368-7636d47d0acd"
      unitRef="usd">70206000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTktMjQtMS0xLTU3OA_d28d07e8-7c6f-4d02-9d93-0d0525bc8066"
      unitRef="usd">70394000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ied22f6706c404fd681c4a5fc164e16db_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTAtMS0xLTA_d61b881f-5d68-4437-822b-d361482101b8"
      unitRef="shares">19544008</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ied22f6706c404fd681c4a5fc164e16db_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTItMS0xLTA_88b3bd26-2bab-4085-8c77-81cff2a40123"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i956afb27a29242589884eb0e1ccf86c9_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMTgtMS0xLTA_f0127c84-b0db-4cc8-9649-31e8171167ab"
      unitRef="usd">385510000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f59b1fe6bf14e1d934932e9f19a662a_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjAtMS0xLTA_63f0c7c8-cf24-4df7-b08e-a5527379ee27"
      unitRef="usd">-143214000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i21ce4cf60f7042b380ec1757dc4f8a08_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjItMS0xLTA_b65a3a37-5c50-45a1-a00c-50143f2a7792"
      unitRef="usd">161000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmY4NmZjZmNiYzlkODQ0YTdhNzY1NGUzZTE2Y2JiOTM0L3RhYmxlcmFuZ2U6Zjg2ZmNmY2JjOWQ4NDRhN2E3NjU0ZTNlMTZjYmI5MzRfMTgtMjQtMS0xLTA_feae6997-ad55-426c-b9a9-7c518ef22f7f"
      unitRef="usd">242462000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i557ae529b0534b7e83bdfd35a6d1216a_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS01LTEtMS0w_a5cabab0-ac60-4d30-a269-8143ae3bf620"
      unitRef="shares">14538202000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i557ae529b0534b7e83bdfd35a6d1216a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS03LTEtMS0w_179527d9-a6c7-43c6-b5e6-e7f33ab04006"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id101b89cfc2f41c28814b80debdc3cb8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS05LTEtMS0w_c5248f35-a837-4bfc-b326-fcad544c812e"
      unitRef="usd">197442000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i296365e2b77b4e8183cf0fe4076355f8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS0xMS0xLTEtMA_490acb1d-9d49-456d-bbdd-b91bb768dd84"
      unitRef="usd">-115091000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1d138a5d3c994ce39162445d9d354401_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS0xMy0xLTEtMA_2e0fd352-3af0-4665-96f8-4a686248bdb7"
      unitRef="usd">-623000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55478baf239442988af0a3137120ff79_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNS0xNS0xLTEtMA_057d456d-b844-476c-a083-ae75934c6b83"
      unitRef="usd">81732000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i22bef0eaffe04104b79fd06b8e9b6aa1_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNi0xMS0xLTEtMA_b020f552-31ca-4309-981b-75c432d04282"
      unitRef="usd">-3020000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNi0xNS0xLTEtMA_3b5be776-ef74-46a2-be2a-6e68fb0f9258"
      unitRef="usd">-3020000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i75a8b5cca80f46518592a4750ba5850a_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNy0xMy0xLTEtMA_aec6baa2-c6e6-4479-a93f-53800038e9d6"
      unitRef="usd">301000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfNy0xNS0xLTEtMA_071ab351-a4fe-4ff4-b876-5c6e0fb23a0f"
      unitRef="usd">301000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i77602246977e4ab48559ae10f9ef671c_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOC01LTEtMS0w_90e77767-5cd6-4335-b2e8-83ae16aa3b35"
      unitRef="shares">18427000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i368ef1c3bb964a91992f82e0a63d6ec9_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOC05LTEtMS0w_4929d3ee-8ecb-4748-8f59-10ec2bff4586"
      unitRef="usd">565000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOC0xNS0xLTEtMA_4102a42b-822c-48a6-8f17-93b7607b0383"
      unitRef="usd">565000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i77602246977e4ab48559ae10f9ef671c_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOS01LTEtMS0w_67b82f1c-2c6e-4cd4-8c06-3d8d10afb643"
      unitRef="shares">125769000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i368ef1c3bb964a91992f82e0a63d6ec9_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOS05LTEtMS0w_7cec00eb-142f-4890-a0e4-01890e94dc20"
      unitRef="usd">471000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib1c29901565d40a2a8f94d1e1065b61a_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfOS0xNS0xLTEtMA_b7172c06-ea43-423b-995b-b68df06146be"
      unitRef="usd">471000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i264938c435d846aa93d88d47ad3d77af_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtNS0xLTEtMA_6446d337-fe9f-4296-8793-26f47fb9a5dc"
      unitRef="shares">14682398000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i264938c435d846aa93d88d47ad3d77af_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtNy0xLTEtMA_fbbd12ff-02ef-4282-adfd-6906cc1bd485"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1922e3a342ea477b82afbb406801bb66_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtOS0xLTEtMA_3da01e57-5230-461e-9bcd-3c14fb751afb"
      unitRef="usd">198478000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib89641723e5a4a5189fce4a3e9a9f517_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtMTEtMS0xLTA_7e918970-5b58-40be-9789-37f87cdbec3f"
      unitRef="usd">-118111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2e6fb5fc5ad4a8883252831c70d9b8e_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtMTMtMS0xLTA_0424a3f6-cba9-45cd-9b76-ddf21b171e87"
      unitRef="usd">-322000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i514e1984bf624bcab1ca800517fe8409_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTAtMTUtMS0xLTA_05c525ad-23df-480d-9f1c-c4858aac328c"
      unitRef="usd">80049000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0edebf080f80402f883427d33eb82646_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTEtMTEtMS0xLTA_2a02ec58-4fbb-49fa-bc7d-886655285115"
      unitRef="usd">-2618000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTEtMTUtMS0xLTA_1d186c11-b426-481d-a757-cf121b30e285"
      unitRef="usd">-2618000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i17d824c1eb834a1196d7d2349e2b3500_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTItMTMtMS0xLTA_2c57f049-214e-46ee-aa29-41dbb8add3d6"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTItMTUtMS0xLTA_e9179ad2-bceb-41fa-95b5-492625db1b4a"
      unitRef="usd">-133000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtNS0xLTEtNjY3_e07fae5a-e364-4f42-ae1c-0d006fbd2bba"
      unitRef="shares">245352000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtOS0xLTEtNjcx_3423f0c3-e2d4-414b-b6f4-0aa3fa18d586"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtMTUtMS0xLTY3MQ_478ab99b-e965-402a-888f-719d4f064f20"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtNS0xLTEtNjc1_3bb34d9c-44e5-4f6a-a008-cc6733022ff4"
      unitRef="shares">2983000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtOS0xLTEtNjc5_4669166e-e586-4aff-8506-7c40fdeb1cf9"
      unitRef="usd">92000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTUtMS0xLTY3OQ_7f1b432b-47bd-448a-8a84-65250679b4a6"
      unitRef="usd">92000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ie90e4ed2370e499b84f3e12b44191d66_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtNS0xLTEtMA_821fdfc8-3cc6-41d9-be97-2c6f924a6817"
      unitRef="shares">8729000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i38646b1b5b5f4b0099904db56145601d_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtOS0xLTEtMA_9539da38-412b-4428-a021-8efd9228dd94"
      unitRef="usd">692000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTMtMTUtMS0xLTA_9fcc3040-0f00-482f-bd30-e7ee8bc743e8"
      unitRef="usd">692000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic5c58d0d3a06407fae45526ac0b7f3a6_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtNS0xLTEtMA_19918c8b-ce02-4f9c-bf76-698f2396ecfd"
      unitRef="shares">14939462000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic5c58d0d3a06407fae45526ac0b7f3a6_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtNy0xLTEtMA_270f97d7-6f06-4e0e-898a-91861b44c3e1"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2de6637c368451a83b9fbebce1b02cc_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtOS0xLTEtMA_d8e4ca13-3684-4173-a8f9-90de63ff9c90"
      unitRef="usd">209262000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7da59944142842809e0da6afc8bff8e2_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTEtMS0xLTA_842ced0b-4a0e-4444-a968-12057b6cdc67"
      unitRef="usd">-120729000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5be348dea4b94b1290c68f97c0b18392_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTMtMS0xLTA_8fc6950c-9331-4f43-987b-e8182a6d4289"
      unitRef="usd">-455000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zMS9mcmFnOjg2YjVkNGNhODJhZjQzMmNiY2M3NTRiYzFiOTQxN2I4L3RhYmxlOmI3OGViZGNkNTMzNDRhNDFiNTQ2ODhiYzAwOTMxNDYwL3RhYmxlcmFuZ2U6Yjc4ZWJkY2Q1MzM0NGE0MWI1NDY4OGJjMDA5MzE0NjBfMTQtMTUtMS0xLTA_fc6a4d04-ff15-4719-afee-8546142bd60f"
      unitRef="usd">88082000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMy0xLTEtMS0w_add1eadd-4caf-4bbf-90ec-32608156264c"
      unitRef="usd">-14392000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMy0zLTEtMS0w_0a08ce54-1a30-4dc1-b006-508cf496becf"
      unitRef="usd">-5638000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNi0xLTEtMS0w_e3b49542-a399-452b-b453-53fb983c76cb"
      unitRef="usd">3285000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNi0zLTEtMS0w_9ccf1dc7-9a83-4ab0-a5fd-7427fbbf384c"
      unitRef="usd">1912000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNy0xLTEtMS0w_48ee25fd-7270-4682-b04c-21eff46ae760"
      unitRef="usd">3453000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNy0zLTEtMS0w_7c336d2d-85da-4592-81f2-78f0d56e34e3"
      unitRef="usd">1163000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOC0xLTEtMS0zODI3_655baed8-f6ef-4aaa-b4bc-1bc0d0ada0e9"
      unitRef="usd">910000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOC0zLTEtMS0zODI3_f1c5582d-cd85-4afa-9eef-8619ce6935f2"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <kids:BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOS0xLTEtMS0zODI3_834f39b2-ada1-4ad6-9976-3ced4fe317d8"
      unitRef="usd">886000</kids:BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfOS0zLTEtMS0zODI3_7dd02586-13c3-4efd-95d7-9242cfad115d"
      unitRef="usd">0</kids:BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTAtMS0xLTEtMA_b9e474d1-4081-4ed6-8a0f-230bcdc2b6db"
      unitRef="usd">-1609000</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTAtMy0xLTEtMA_e33ee84f-f7ea-40e7-8ef6-d2bde89bf849"
      unitRef="usd">5499000</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTEtMS0xLTEtMA_8c6b787a-b45c-47f8-b562-3eafbfc61859"
      unitRef="usd">9599000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTEtMy0xLTEtMA_716ed9c0-b6f0-4986-a6ff-56a0a2f29f1c"
      unitRef="usd">5139000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTMtMS0xLTEtMA_a1945601-926d-4ea8-9f6e-68262843abd6"
      unitRef="usd">-66000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTMtMy0xLTEtMA_2990a406-5db6-43a6-9dbb-59eb82eb7b88"
      unitRef="usd">14000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTQtMS0xLTEtMA_1893d29a-4417-499a-a097-233a4be51aff"
      unitRef="usd">-746000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTQtMy0xLTEtMA_bbcd0215-4fe2-48d9-87b0-604b9ba18e84"
      unitRef="usd">1934000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTUtMS0xLTEtMA_9172dff9-14c2-4c38-bfb3-24dffc8ef4d4"
      unitRef="usd">-129000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTUtMy0xLTEtMA_3a320345-c64a-4a46-a015-03b80f2de8cb"
      unitRef="usd">357000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTctMS0xLTEtMA_d4669f84-86f1-4aaf-98e0-4e8086af167e"
      unitRef="usd">50000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTctMy0xLTEtMA_0d9f8271-56c0-458f-9e44-4150a500add1"
      unitRef="usd">-139000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTgtMS0xLTEtMA_482c82fa-9378-42a1-9180-d3ced1d478f6"
      unitRef="usd">-14707000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTgtMy0xLTEtMA_d2d34fb1-2536-4527-b579-388702336aa5"
      unitRef="usd">-10785000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTktMS0xLTEtMA_98608106-cec9-4fbc-a675-6420849ca1c1"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMTktMy0xLTEtMA_7c5a6d75-b131-43a9-801d-a01ade7c09bc"
      unitRef="usd">371000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjAtMS0xLTEtMA_4b42ddae-62c5-4908-a883-295579473347"
      unitRef="usd">-14707000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjAtMy0xLTEtMA_19ab3adf-df4b-4755-9c3b-f5fa94941747"
      unitRef="usd">-10414000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjMtMS0xLTEtMA_de76ba97-6c21-4c77-be70-a6c2e7961e67"
      unitRef="usd">1670000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i606ed33122784ef28a374862e04b8938_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjMtMy0xLTEtMA_6fb64ed8-3ee7-4e29-b41c-42bfe1395095"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMS0xLTEtNzIy_04891040-7d9d-419f-9104-8af12181c88d"
      unitRef="usd">1723000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if5b1d0fd10514bb7ae0a9c0147334def_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMy0xLTEtNzIy_0c5641da-d1cf-4980-a6c8-cb0595fc9cca"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2a285bb683e44422bf5d4ef530eb8f9a_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjUtMS0xLTEtNzIy_2f9391e3-8387-4e85-a2dd-6d56ce6b73a4"
      unitRef="usd">796000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7586dec2cc8146b0a84c69f0ed6a9b88_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjUtMy0xLTEtNzIy_2549425b-c7e0-4bc9-ba91-f2a198d9be97"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ieae79c794ca74ecaab7e1f4be1666580_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjYtMS0xLTEtNzIy_e9cce4d0-450b-4092-9907-3bd83bc70049"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjYtMy0xLTEtNzIy_a891ff71-6e50-4ae7-9daf-0a519e992227"
      unitRef="usd">49926000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMS0xLTEtMA_eaac19bb-7581-4fc6-a843-d305246429be"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjQtMy0xLTEtMA_893d038c-8d4f-41df-aee8-759125aacd7e"
      unitRef="usd">170000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjctMS0xLTEtMA_7103a408-b327-4664-a623-55a1d44f7c16"
      unitRef="usd">5160000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjctMy0xLTEtMA_de15c76b-0433-4148-8753-f7f58297b240"
      unitRef="usd">8514000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMS0xLTEtNzMx_a3837c02-1b17-442f-a4f2-a02b0e71a61d"
      unitRef="usd">-9349000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMy0xLTEtNzMx_6978a849-6fcc-49fc-b259-0f91153be019"
      unitRef="usd">-58610000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMS0xLTEtNzMx_f2f833d3-9f4d-4f6a-b3ac-244ddab1c909"
      unitRef="usd">0</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMy0xLTEtNzMx_fe451c6b-a46e-4da5-884a-4af7a60f4dc6"
      unitRef="usd">-47000</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjgtMS0xLTEtMA_a3e14e51-e4b1-4535-b7da-d71fda644896"
      unitRef="usd">-9349000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMjgtMy0xLTEtMA_2502c8aa-2092-4870-9f00-189f8b88ed6b"
      unitRef="usd">-58657000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMS0xLTEtMA_ff67c3a5-a606-42da-969c-637b4b75566e"
      unitRef="usd">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzEtMy0xLTEtMA_d88daccd-b0c5-46c0-994d-361245df87ea"
      unitRef="usd">30000000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMS0xLTEtMA_ccd9b482-a38f-4c32-9111-47921f7d77ea"
      unitRef="usd">5000000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzItMy0xLTEtMA_7e451278-272c-4f8f-b83f-26f9f0f2262a"
      unitRef="usd">0</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzMtMS0xLTEtMA_f84feff9-793f-491f-9ad6-85961d756814"
      unitRef="usd">70207000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzMtMy0xLTEtMA_a7e3edd6-e5ab-4101-82a7-d3fcf5923067"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzQtMS0xLTEtMA_78ed134a-3cfd-4a7d-ac3e-c827a34e2175"
      unitRef="usd">1281000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzQtMy0xLTEtMA_3c9adbf2-4580-46f6-b52e-cc61ea2884f7"
      unitRef="usd">657000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzYtMS0xLTEtMA_3fb14db9-4e52-447e-b636-109caaf6b4fc"
      unitRef="usd">61000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzYtMy0xLTEtMA_606077ad-44d7-4740-8362-1ab20429826c"
      unitRef="usd">59000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzgtMS0xLTEtMA_96d062c3-3811-4bd3-9c8c-32bf53791056"
      unitRef="usd">66427000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfMzgtMy0xLTEtMA_a9dff8ae-79bc-418f-855b-6b5b9c3796a9"
      unitRef="usd">30598000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDAtMS0xLTEtMA_6ccd527e-514f-4fbd-9c8f-77aeebfdf447"
      unitRef="usd">17000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDAtMy0xLTEtMA_0cda2d29-b3fc-49dd-852b-f5dff1de7b81"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDItMS0xLTEtMA_61fb9312-c5b8-4ee9-99b9-46f7a8edc38b"
      unitRef="usd">42388000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDItMy0xLTEtMA_a90ef318-e7b9-406d-ab71-e1ef26098b5a"
      unitRef="usd">-38473000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDQtMS0xLTEtMA_4aceceb2-9636-476b-b566-b6bf04c3341a"
      unitRef="usd">72027000</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="i55478baf239442988af0a3137120ff79_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDQtMy0xLTEtMA_d2429a1a-dc18-4a8e-9391-86dd8348d2b6"
      unitRef="usd">60691000</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDUtMS0xLTEtMA_c6c9259f-7d13-4081-968e-fcf1733a9e55"
      unitRef="usd">114415000</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
      contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDUtMy0xLTEtMA_920d53d5-4157-4b0f-9e21-5574cb2a75ed"
      unitRef="usd">22218000</us-gaap:CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDYtMS0xLTEtMA_f8ab9947-8609-4a5f-bf07-e9349ec3995e"
      unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
      contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDYtMy0xLTEtMA_cf52adaf-a513-43e8-bb06-dcb5f579e4fa"
      unitRef="usd">360000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDctMS0xLTEtMA_258dac73-9dca-43ba-a660-73ee26450327"
      unitRef="usd">114415000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i437c34bd707949e2b3624b784bd27f1b_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNDctMy0xLTEtMA_7371eecc-dd55-4fba-9576-72aa89ab1d63"
      unitRef="usd">21858000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTAtMS0xLTEtMA_e8e360d3-99a2-4546-994b-13a8aa4edcd5"
      unitRef="usd">513000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTAtMy0xLTEtMA_872cb3aa-0722-41ee-baad-1edc95a4f00e"
      unitRef="usd">935000</us-gaap:InterestPaidNet>
    <kids:TransferOfPropertyAndEquipmentToInventory
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTItMS0xLTEtMA_d8ab182c-d0cf-4a43-b041-c3c64ff221a3"
      unitRef="usd">229000</kids:TransferOfPropertyAndEquipmentToInventory>
    <kids:TransferOfPropertyAndEquipmentToInventory
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTItMy0xLTEtMA_e5f86578-505e-4e89-af6c-f694d91ea4d4"
      unitRef="usd">267000</kids:TransferOfPropertyAndEquipmentToInventory>
    <us-gaap:StockIssued1
      contextRef="ieae79c794ca74ecaab7e1f4be1666580_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTgtMS0xLTEtNzY0_de7a78ce-2858-476a-8d69-185572ff8fbe"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTgtMy0xLTEtNzY0_028fc031-3e10-4c29-bfd7-f9352489f688"
      unitRef="usd">10000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTMtMS0xLTEtMA_72a4f414-fefa-478e-94f4-f0f415d51602"
      unitRef="usd">1568000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i606ed33122784ef28a374862e04b8938_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTMtMy0xLTEtMA_b0bca902-4443-42b8-b423-37efcadc38e3"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMS0xLTEtMzg1_c57a1cf1-d12c-43f0-8f3a-80a41b0c0979"
      unitRef="usd">35176000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="if5b1d0fd10514bb7ae0a9c0147334def_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMy0xLTEtMzg1_826ee932-686f-481d-82b0-c5df15167b6b"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i2a285bb683e44422bf5d4ef530eb8f9a_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMS0xLTEtMA_2fc3c6b4-7dcd-4fa4-9cfd-7cfba378a39f"
      unitRef="usd">2644000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i7586dec2cc8146b0a84c69f0ed6a9b88_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF8zNC9mcmFnOmUyYjZmMzk5N2E3MDQ2ZGRhN2ExZjI1ZGVmOTI2N2ZmL3RhYmxlOmRhZjJjNTUxZmQyMjQ2NGI5N2M2OTFlM2RjNzgxMzcyL3RhYmxlcmFuZ2U6ZGFmMmM1NTFmZDIyNDY0Yjk3YzY5MWUzZGM3ODEzNzJfNTQtMy0xLTEtMA_52dc13e4-e0b0-4833-8443-4b98039817ff"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:NatureOfOperations
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMjgxMg_772ae6c9-791a-43d4-8fa0-4a3f624f29c0">BUSINESS&lt;div style="padding-right:8pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"&gt;OrthoPediatrics Corp., a Delaware corporation, is a medical device company committed to designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers the ability to treat children with technologies specifically designed to meet their needs. We sell our specialized products, including PediLoc&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"&gt;, PediPlates&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"&gt;, Cannulated Screws, PediFlex&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:400;line-height:121%;vertical-align:top;"&gt;TM&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"&gt;nail, PediNail&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:400;line-height:121%;vertical-align:top;"&gt;TM&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"&gt;, PediLoc&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"&gt; Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, Bandloc, Pediguard, Pediatric Nailing Platform | Femur, Orthex, QuickPack&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;"&gt;TM &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"&gt;and ApiFix to various hospitals and medical facilities throughout the United States and various international markets.  We currently use a contract manufacturing model for the manufacturing of implants and related surgical instrumentation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In 2017, we expanded operations and established legal entities in the United Kingdom, Australia and New Zealand, permitting us to sell under an agency model direct to local hospitals in these countries. In September 2018, we further expanded operations in Canada selling direct to local hospitals, and in January 2019 we expanded to Belgium and the Netherlands. Additionally, in March 2019 we established a holding company and an operating company in the Netherlands and began selling direct to Italy in March 2020 enhancing our operations in Europe. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On June 4, 2019, we purchased all the issued and outstanding shares of stock of Vilex in Tennessee, Inc. ("Vilex") and all the issued and outstanding units of membership interests in Orthex, LLC ("Orthex") for $60,000 in total consideration. Vilex and Orthex (the "Vilex Companies") are primarily manufacturers of foot and ankle surgical implants, including cannulated screws, fusion devices, surgical staples and bone plates, as well as Orthex Hexapod technology which is used to treat pediatrics congenital deformities and limb length discrepancies.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On December 31, 2019, we divested substantially all of the assets relating to Vilex's adult product offerings to a wholly-owned subsidiary of Squadron Capital LLC ("Squadron") in exchange for a $25,000 reduction in a Term Note owed to Squadron in connection with the initial acquisition.  As part of the sale, we also executed an exclusive license arrangement with Squadron providing for perpetual access to certain intellectual property and a mutual distribution agreement.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On March 9, 2020, we purchased all the issued and outstanding membership interest of Telos Partners, LLC ("Telos") for $3,300 in total consideration. Telos is a boutique regulatory consulting firm formed in Colorado. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On April 1, 2020, we purchased all the issued and outstanding membership interest of ApiFix, Ltd. ("ApiFix") for (a) $2,000 in cash, and (b) 934,783 shares of the Company's common stock, $0.00025 par value per share, representing approximately $35,000 (based on a closing share price of $37.63 on April 1, 2020. ApiFix, a corporation organized under the laws of Israel, has developed a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis ("ApiFix System"). In addition, we have also agreed to pay as part of the purchase price the following anniversary payments: (i) $13,000 on the second anniversary of the closing date, provided that such payment will be paid earlier if 150 clinical procedures using the ApiFix System are completed in the United States before such anniversary date, (ii) $8,000 on the third anniversary of the closing date; and (iii) $9,000 on the fourth anniversary of the closing date. In addition, to the extent that the product of our revenues from the ApiFix System for the twelve months ended June 30, 2024 multiplied by 2.25 exceeds the anniversary payments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;actually made for the third and fourth years, we have agreed to pay the selling shareholders a system sales payment in the amount of such excess. The anniversary payments and system sales payment may each be made in cash or cash and common stock. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On June 10, 2020, we purchased certain intellectual property assets from Band-Lok, LLC, a North Carolina limited liability company ("Band-Lok"), related to its Tether Clamp and Implantation System ("Tether Clamp System") for approximately $3,400 in total consideration. We use the Tether Clamp System in connection with our Bandloc 5.5/6.0 System. We were previously the sole licensee of the purchased assets under a license agreement with Band-Lok. &lt;/span&gt;&lt;/div&gt;Our largest investor is Squadron, a private investment firm based in Granby, Connecticut.</us-gaap:NatureOfOperations>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTY5Mw_c21da05d-9fd7-4be6-8a0a-a0df592d3c2c"
      unitRef="usd">60000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMjIyNQ_ce1a7afd-74fb-4ed5-b0eb-6e64cf0315f3"
      unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTgyNg_9e4d3d61-916e-421a-a5bc-b102e694526b"
      unitRef="usd">3300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTgzNw_9ebf1f89-c37d-43b1-9c1f-ebb8a3127604"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg0OA_e28d075a-b0b4-42df-8ca1-b906d1511add"
      unitRef="shares">934783</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg3Nw_8c038528-068e-4c85-b96c-2612a597276a"
      unitRef="usdPerShare">0.00025</us-gaap:CommonStockParOrStatedValuePerShare>
    <kids:BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg1Nw_13bb0413-13f6-4ff3-8f52-7479b7a32df1"
      unitRef="usd">35000000</kids:BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg2OQ_6d71aef0-a40c-4327-973e-a48dc84b27b6"
      unitRef="usdPerShare">37.63</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="iade7dd3801514191b80df2d859180efe_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkxNQ_a17e3a07-1290-41f5-8e7e-edde17e816e4"
      unitRef="usd">13000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <kids:BusinessCombinationContingentConsiderationNumberOfClinicalProcedures
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkzOA_688541d3-9161-4cab-85e8-d1138c9fa993"
      unitRef="facility">150</kids:BusinessCombinationContingentConsiderationNumberOfClinicalProcedures>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="ia07305a71eeb47d99be5750a3a47cb18_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkwNA_9a4f2d8f-3428-47ee-a80e-3f0f519a3284"
      unitRef="usd">8000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="i974a053f052c4233bccf37c504b97db0_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg4Nw_ff9d3dba-6b9e-4183-ab86-44a71e092917"
      unitRef="usd">9000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <kids:BusinessCombinationContingentConsiderationRevenueMultiplier
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTg5OA_e1ffc5a5-41ea-4fe9-bd15-9eda8873429c"
      unitRef="number">2.25</kids:BusinessCombinationContingentConsiderationRevenueMultiplier>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1832772ced4e4d7694796baf90a940a1_D20200610-20200610"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80MC9mcmFnOjdmNzQ2MWI0YjMzYjQ1MTVhM2IxZWJkYWJmMTI2ZjllL3RleHRyZWdpb246N2Y3NDYxYjRiMzNiNDUxNWEzYjFlYmRhYmYxMjZmOWVfMTA5OTUxMTYzNTkyNw_e29be7f5-597e-4397-8814-0afc966345c5"
      unitRef="usd">3400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTc_40bf1b35-d490-4394-8339-f87d8df18b19">SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The accompanying condensed consolidated financial statements include the accounts of OrthoPediatrics Corp. and its wholly-owned subsidiaries, OrthoPediatrics US Distribution Corp., OrthoPediatrics EU Limited, OrthoPediatrics AUS PTY LTD, OrthoPediatrics NZ Limited, OP EU B.V., OP Netherlands B.V., Vilex in Tennessee, Inc., Orthex, LLC, Telos Partners, LLC, ApiFix Ltd. and ApiFix Inc. (collectively, the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our&#x201d; or &#x201c;us&#x201d;).  All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Unaudited Interim Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have prepared the accompanying condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The accompanying condensed consolidated balance sheets as of June&#160;30, 2020 and December 31, 2019, the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of comprehensive loss for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of stockholders&#x2019; equity for the three and six months ended June&#160;30, 2020 and 2019 and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2020 and 2019 are unaudited and should be read in conjunction with the annual consolidated financial statements as of and for the year ended December&#160;31, 2019 and related notes thereto contained in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 5, 2020. The financial data and other financial information disclosed in the notes to the accompanying condensed consolidated financial statements are also unaudited. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to applicable rules and regulations thereunder. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended December 31, 2019 and, in management&#x2019;s opinion, include all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the financial statements for the interim periods. The results of operations for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results to be expected for the full fiscal year or for any other period. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:1pt;padding-right:1pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The accompanying condensed consolidated financial statements have been prepared assuming our Company will continue as a going concern.  We have experienced recurring losses from operations since our inception and had an accumulated deficit of $143,214 and $128,822 as of June&#160;30, 2020 and December 31, 2019, respectively. Management continues to monitor cash flows and liquidity on a regular basis. We believe that our cash balance at June&#160;30, 2020 and expected cash flows from operations for the next twelve months subsequent to the issuance of the accompanying condensed consolidated &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;financial statements, are sufficient to enable us to maintain current and essential planned operations for more than the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:1pt;padding-right:1pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On June 22, 2020, we completed a follow-on offering of our common stock, in which we issued and sold 1.6&#160;million shares of common stock at a public offering price of $47.00 per share for aggregate gross proceeds of $75,200. We received $70,207 in net proceeds after deducting $4,512 of underwriting discounts and commissions and paying $481 in offering costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:1pt;padding-right:1pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Preparation of the condensed consolidated financial statements requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as of the date of the condensed consolidated financial statements.  By their nature, these judgments are subject to an inherent degree of uncertainty. The impact of the coronavirus disease ("COVID-19") has significantly increased economic and demand uncertainty.  We use historical experience and other assumptions as the basis for our judgments and estimates.  Because future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.  Any changes in these estimates will be reflected in the condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Foreign Currency Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We currently bill our international distributors in United States ("U.S.") dollars, resulting in minimal foreign exchange transaction expense. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in the second quarter of 2017, we began selling direct within the United Kingdom, Ireland, Australia and New Zealand and billing using the local currency for each country. In September 2018, we began selling direct in Canada, in January 2019 in Belgium and the Netherlands, in March 2020 in Italy and in April 2020 in Israel. The financial statements of our foreign subsidiaries are accounted for and have been translated into U.S. dollars using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. Foreign currency translation adjustments have been recorded as a separate component of the condensed consolidated statements of comprehensive loss.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In accordance with ASC 606, "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Revenue From Contracts With Customers &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(ASC 606)", revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services, and excludes any sales incentives or taxes collected from a customer which are subsequently remitted to government authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Revenue Recognition &#x2013; United States&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Revenue in the United States is generated primarily from the sale of our implants and, to a much lesser extent, from the sale of our instruments.  Sales in the United States are primarily to hospital accounts through independent sales agencies.  We recognize revenue when our performance obligations under the terms of a contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customers, generally upon implantation or when title passes upon shipment. The products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Revenue Recognition &#x2013; International&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Outside of the United States, we primarily sell our products through independent stocking distributors. Generally, the distributors are allowed to return products, and some are thinly capitalized. Based on our history of collections and returns from international customers, prior to 2019, we concluded that collectability was not reasonably assured at the time of delivery for certain customers who had not evidenced a consistent pattern of timely payment. Accordingly, in the past we did not recognize international revenue and associated cost of revenue at the time title transfers for these customers for whom collectability had not been deemed probable based on the customer&#x2019;s history and ability to pay, but rather when cash had been received. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Following a review of our collection history, we deemed collectability was probable for all international stocking distributors effective January 1, 2019. Based on a history of reliable collections, we have concluded that a contract exists and revenue should be recognized when our performance obligations under the terms of the contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customer, generally upon implantation or when title passes upon shipment.  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#226600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In the countries where we sell under an agency model direct to local hospitals, the products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.     &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We maintain cash in bank deposit accounts which, at times, may exceed federally insured limits.  To date, we have not experienced any loss in such accounts.  We consider all highly liquid investments with original maturity of three months or less at inception to be cash equivalents.  The carrying amounts reported in the balance sheet for cash are valued at cost, which approximates fair value.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Accounts receivable are uncollateralized customer obligations due under normal trade terms, generally requiring payment within 30 days from the invoice date. Account balances with invoices over 30 days past due are considered delinquent.  No interest is charged on past due accounts. Payments of accounts receivable are applied to the specific invoices identified on the customer's remittance advice or, if unspecified, to the customer's account as an unapplied credit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected, determined principally on the basis of historical experience, management's assessment of the collectability of specific customer accounts and the aging of the accounts receivable. All accounts or portions thereof deemed to be uncollectible or to require an excessive collection cost are written off to the allowance for doubtful accounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Inventories, net &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Inventories are stated at the lower of cost or net realizable value, with cost determined using the first-in-first-out method. Inventories, which consist of implants and instruments held in our warehouse or with third-party independent sales agencies or distributors, are considered finished goods and are purchased from third parties. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We evaluate the carrying value of our inventories in relation to the estimated forecast of product demand, which takes into consideration the life cycle of the product.  A significant decrease in demand could result &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;in an increase in the amount of excess inventory on hand, which could lead to additional charges for excess and obsolete inventory.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The need to maintain substantial levels of inventory impacts our estimates for excess and obsolete inventory.  Each of our implant systems are designed to include implantable products that come in different sizes and shapes to accommodate the surgeon&#x2019;s needs.  Typically, a small number of the set components are used in each surgical procedure.  Certain components within each set may become obsolete before other components based on the usage patterns.  We adjust inventory values, as needed, to reflect these usage patterns and life cycle.     &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition, we continue to introduce new products, which may require us to take additional charges for excess and obsolete inventory in the future.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Property and Equipment, net &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful life of the assets. When assets are retired or otherwise disposed of, costs and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in operations for the period. Maintenance and repairs that prolong or extend the useful life are capitalized, whereas standard maintenance, replacements, and repair costs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Instruments are hand-held devices, specifically designed for use with our implants and are used by surgeons during surgery. Instruments deployed within the United States, United Kingdom, Australia, New Zealand, Canada, Belgium, the Netherlands and Italy are carried at cost less accumulated depreciation and are recorded in property and equipment, net on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Sample inventory consists of our implants and instruments, and is maintained to market and promote our products. Sample inventory is carried at cost less accumulated depreciation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Depreciable lives are generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;25 to 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Business software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Office and other equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sample inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Amortizable Intangible Assets, net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amortizable intangible assets&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;include fees necessary to secure various patents and licenses, including Band-Lok, the value of internally developed software, customer relationships, and non-competition agreements related to the acquisition of Orthex, and customer relationships and non-competition agreements related to the acquisitions of Telos and ApiFix. Amortization is calculated on a straight-line basis over the estimated useful life of the asset.  Amortization for patents and licenses commences at the time of patent approval and market launch, respectively. Amortization for assets acquired commences upon acquisition. Intangible assets are amortized over a 3 to 20 year period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amortizable intangible assets are assessed for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets. No impairment charges were recorded in any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our goodwill represents the excess of the cost over the fair value of net assets acquired. The determination of the value of goodwill and intangible assets arising from acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of net tangible and intangible assets acquired. Goodwill is not amortized and is assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstances warrant such a review. The goodwill is considered to be impaired if we determine that the carrying value of the reporting unit exceeds its respective fair value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have indefinite lived tradename assets that are reviewed for impairment by performing a quantitative analysis, which occurs annually in the fourth quarter or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.  No impairment charges were recorded in any of the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Cost of revenue consists primarily of products purchased from third-party suppliers, excess and obsolete inventory adjustments, inbound freight, and royalties.  Our implants and instruments are manufactured to our specifications by third-party suppliers who meet our manufacturer qualifications standards.  Our third-party manufacturers are required to meet the standards of the Food and Drug Administration (the &#x201c;FDA&#x201d;), and the International Organization for Standardization, as well as other country-specific quality standards.  The majority of our implants and instruments are produced in the United States.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Sales and Marketing Expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Sales and marketing expenses primarily consist of commissions to our domestic and select international independent sales agencies and consignment distributors, as well as compensation, commissions, benefits and other related costs for personnel we employ. Commissions and bonuses are generally based on a percentage of sales.  Our international independent stocking distributors purchase instrument sets and replenishment stock for resale, and we do not pay commissions or any other sales related costs for international sales to distributors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Advertising Costs &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Advertising costs consist primarily of print advertising, trade shows, and other related expenses. Advertising costs are expensed as incurred and are recorded as a component of sales and marketing expense. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Research and development costs are expensed as incurred. Our research and development expenses primarily consist of costs associated with engineering, product development, consulting services, outside prototyping services, outside research activities, materials, development and protection of our intellectual property portfolio, as well as other costs associated with development of our products. Research and development costs also include related personnel and consultants&#x2019; compensation expense.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Prior to our Initial Public Offering ("IPO") in October 2017, we maintained an Amended and Restated 2007 Equity Incentive Plan (the &#x201c;2007 Plan&#x201d;) that provided for grants of options and restricted stock to employees, directors and associated third-party representatives of the Company as determined by the Board of Directors. The 2007 Plan had authorized 1,585,000 shares for award. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Immediately prior to our IPO, we adopted our 2017 Incentive Award Plan (the "2017 Plan") which replaced the 2007 Plan. The 2017 Plan provides for grants of options and restricted stock to officers, employees, consultants or directors of our Company. The 2017 Plan has authorized 1,789,647 shares for award. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Options holders, upon vesting, may purchase common stock at the exercise price, which is the estimated fair value of our common stock on the date of grant. Option grants generally vest immediately or over three years. No stock options were granted in any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Restricted stock may not be transferred prior to the expiration of the restricted period, which is typically three years. The restricted stock that had been granted under the 2007 Plan had restriction periods that generally lasted until the earlier of six years from the date of grant, or an IPO or change in control, as defined in the 2007 Plan. All restricted stock granted prior to May 2014 vested upon our IPO and the remaining grants under the 2007 Plan vested six months after the IPO. We recognize the reversal of stock compensation expense when a restricted stock forfeiture occurs as opposed to estimating future forfeitures.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We record the fair value of restricted stock at the grant date.  Stock-based compensation is recognized ratably over the requisite service period, which is generally the restriction period for restricted stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income (loss) includes foreign currency translation adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements. Under this method, we determine deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We record uncertain tax positions on the bases of a two-step process in which (i) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the positions and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;&#x201c;Emerging Growth Company&#x201d; Reporting Requirements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We qualify as an &#x201c;emerging growth company&#x201d; as defined in the JOBS Act. For as long as a company is deemed to be an emerging growth company, it may take advantage of specified reduced reporting and other regulatory requirements that are generally unavailable to other public companies. Among other things, we are not required to provide an auditor attestation report on the assessment of the internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act of 2002. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Section 107 of the JOBS Act also provides that an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2017, the SEC adopted new rules that included an inflation-adjusted threshold in the definition of an emerging growth company. Under the new inflation-adjusted threshold, we would cease to be an emerging growth company on the last day of the fiscal year in which our annual gross revenues exceed $1.07 billion. This is an increase of $70 million from the previous $1 billion threshold.    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2016, the FASB issued ASU No. 2016-13 "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments"&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financials assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Based on ASU 2019-10 and our status as a Smaller Reporting Company, the Company will adopt ASU 2016-13 effective January 1, 2023. The adoption of this guidance is not expected to have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2017, the FASB issued ASU 2017-04, "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment"&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. This pronouncement eliminates Step 2 from the goodwill impairment test and requires an entity to perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. Under this guidance, an entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. It is effective for reporting periods beginning after December 15, 2020, although earlier adoption is permitted. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, the FASB issued ASU No. 2019-12 "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Income Taxes: Simplifying the Accounting for Income Taxes"&lt;/span&gt; intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside cost basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTU_0efd3d4c-4113-4e34-a5c3-76b94cfc7809">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The accompanying condensed consolidated financial statements include the accounts of OrthoPediatrics Corp. and its wholly-owned subsidiaries, OrthoPediatrics US Distribution Corp., OrthoPediatrics EU Limited, OrthoPediatrics AUS PTY LTD, OrthoPediatrics NZ Limited, OP EU B.V., OP Netherlands B.V., Vilex in Tennessee, Inc., Orthex, LLC, Telos Partners, LLC, ApiFix Ltd. and ApiFix Inc. (collectively, the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our&#x201d; or &#x201c;us&#x201d;).  All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Unaudited Interim Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We have prepared the accompanying condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The accompanying condensed consolidated balance sheets as of June&#160;30, 2020 and December 31, 2019, the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of comprehensive loss for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of stockholders&#x2019; equity for the three and six months ended June&#160;30, 2020 and 2019 and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2020 and 2019 are unaudited and should be read in conjunction with the annual consolidated financial statements as of and for the year ended December&#160;31, 2019 and related notes thereto contained in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 5, 2020. The financial data and other financial information disclosed in the notes to the accompanying condensed consolidated financial statements are also unaudited. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to applicable rules and regulations thereunder. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended December 31, 2019 and, in management&#x2019;s opinion, include all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the financial statements for the interim periods. The results of operations for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results to be expected for the full fiscal year or for any other period. &lt;/span&gt;&lt;/div&gt;The accompanying condensed consolidated financial statements have been prepared assuming our Company will continue as a going concern.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjcwNg_f7af988b-c5ca-434c-bfee-68976588f740"
      unitRef="usd">-143214000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjcxMw_440b0555-67ce-4b5f-b11d-9793b26e05b5"
      unitRef="usd">-128822000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzY3MQ_bc41ed9e-db7b-4b5b-a32c-161ed47f0328"
      unitRef="shares">1600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="iee7c30dda4914c6593234714105f5846_I20200622"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzcwOA_aeee88ae-bf49-4b9e-8181-0582900906e8"
      unitRef="usdPerShare">47.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzY4NA_7964aa6f-ba5b-47b9-8165-b5df76bb1279"
      unitRef="usd">75200000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzY5Mw_4f56dc19-6844-4c17-b026-cb554a5d8967"
      unitRef="usd">70207000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfNTQ5NzU1ODE2NDg2NQ_1e559a1a-f923-4397-8498-b01dd16102da"
      unitRef="usd">4512000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ib0bd40ea533f45f9baa2567763faf3ad_D20200622-20200622"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTA5OTUxMTY1MzcwMg_5d49046e-94b4-4a94-9392-93325630f3d8"
      unitRef="usd">481000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:UseOfEstimates
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTQ_d805542e-8c53-4dbb-a52d-0085f30a01af">Use of EstimatesPreparation of the condensed consolidated financial statements requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as of the date of the condensed consolidated financial statements.  By their nature, these judgments are subject to an inherent degree of uncertainty. The impact of the coronavirus disease ("COVID-19") has significantly increased economic and demand uncertainty.  We use historical experience and other assumptions as the basis for our judgments and estimates.  Because future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.  Any changes in these estimates will be reflected in the condensed consolidated financial statements.</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDM_6cfb1793-5d14-4ee9-8422-2041f9b23365">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Foreign Currency Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We currently bill our international distributors in United States ("U.S.") dollars, resulting in minimal foreign exchange transaction expense. &lt;/span&gt;&lt;/div&gt;Beginning in the second quarter of 2017, we began selling direct within the United Kingdom, Ireland, Australia and New Zealand and billing using the local currency for each country. In September 2018, we began selling direct in Canada, in January 2019 in Belgium and the Netherlands, in March 2020 in Italy and in April 2020 in Israel. The financial statements of our foreign subsidiaries are accounted for and have been translated into U.S. dollars using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. Foreign currency translation adjustments have been recorded as a separate component of the condensed consolidated statements of comprehensive loss.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTk_0deafc92-e2c5-4ed1-856c-88097f2ff7f6">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In accordance with ASC 606, "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Revenue From Contracts With Customers &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;(ASC 606)", revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services, and excludes any sales incentives or taxes collected from a customer which are subsequently remitted to government authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Revenue Recognition &#x2013; United States&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Revenue in the United States is generated primarily from the sale of our implants and, to a much lesser extent, from the sale of our instruments.  Sales in the United States are primarily to hospital accounts through independent sales agencies.  We recognize revenue when our performance obligations under the terms of a contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customers, generally upon implantation or when title passes upon shipment. The products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Revenue Recognition &#x2013; International&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Outside of the United States, we primarily sell our products through independent stocking distributors. Generally, the distributors are allowed to return products, and some are thinly capitalized. Based on our history of collections and returns from international customers, prior to 2019, we concluded that collectability was not reasonably assured at the time of delivery for certain customers who had not evidenced a consistent pattern of timely payment. Accordingly, in the past we did not recognize international revenue and associated cost of revenue at the time title transfers for these customers for whom collectability had not been deemed probable based on the customer&#x2019;s history and ability to pay, but rather when cash had been received. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Following a review of our collection history, we deemed collectability was probable for all international stocking distributors effective January 1, 2019. Based on a history of reliable collections, we have concluded that a contract exists and revenue should be recognized when our performance obligations under the terms of the contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customer, generally upon implantation or when title passes upon shipment.  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#226600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    &lt;/span&gt;&lt;/div&gt;In the countries where we sell under an agency model direct to local hospitals, the products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDQ_87c35ded-e010-48e6-93f0-db5c534d63dd">Cash and Cash EquivalentsWe maintain cash in bank deposit accounts which, at times, may exceed federally insured limits.  To date, we have not experienced any loss in such accounts.  We consider all highly liquid investments with original maturity of three months or less at inception to be cash equivalents.  The carrying amounts reported in the balance sheet for cash are valued at cost, which approximates fair value.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDA_41506e55-6abe-41d8-905f-47aa2ee4d259">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Accounts receivable are uncollateralized customer obligations due under normal trade terms, generally requiring payment within 30 days from the invoice date. Account balances with invoices over 30 days past due are considered delinquent.  No interest is charged on past due accounts. Payments of accounts receivable are applied to the specific invoices identified on the customer's remittance advice or, if unspecified, to the customer's account as an unapplied credit.&lt;/span&gt;&lt;/div&gt;The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected, determined principally on the basis of historical experience, management's assessment of the collectability of specific customer accounts and the aging of the accounts receivable. All accounts or portions thereof deemed to be uncollectible or to require an excessive collection cost are written off to the allowance for doubtful accounts.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4ODk_70f9948e-7e94-47bd-99c7-221400d38377">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Inventories, net &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Inventories are stated at the lower of cost or net realizable value, with cost determined using the first-in-first-out method. Inventories, which consist of implants and instruments held in our warehouse or with third-party independent sales agencies or distributors, are considered finished goods and are purchased from third parties. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We evaluate the carrying value of our inventories in relation to the estimated forecast of product demand, which takes into consideration the life cycle of the product.  A significant decrease in demand could result &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;in an increase in the amount of excess inventory on hand, which could lead to additional charges for excess and obsolete inventory.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The need to maintain substantial levels of inventory impacts our estimates for excess and obsolete inventory.  Each of our implant systems are designed to include implantable products that come in different sizes and shapes to accommodate the surgeon&#x2019;s needs.  Typically, a small number of the set components are used in each surgical procedure.  Certain components within each set may become obsolete before other components based on the usage patterns.  We adjust inventory values, as needed, to reflect these usage patterns and life cycle.     &lt;/span&gt;&lt;/div&gt;In addition, we continue to introduce new products, which may require us to take additional charges for excess and obsolete inventory in the future.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTE_92559c84-34b4-47d2-8860-8099e7eac7fb">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Property and Equipment, net &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful life of the assets. When assets are retired or otherwise disposed of, costs and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in operations for the period. Maintenance and repairs that prolong or extend the useful life are capitalized, whereas standard maintenance, replacements, and repair costs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Instruments are hand-held devices, specifically designed for use with our implants and are used by surgeons during surgery. Instruments deployed within the United States, United Kingdom, Australia, New Zealand, Canada, Belgium, the Netherlands and Italy are carried at cost less accumulated depreciation and are recorded in property and equipment, net on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Sample inventory consists of our implants and instruments, and is maintained to market and promote our products. Sample inventory is carried at cost less accumulated depreciation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Depreciable lives are generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;25 to 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Business software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Office and other equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sample inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTA_ee8c9493-f08b-4c90-8ee2-d7a418f8bb3a">Sample inventory is carried at cost less accumulated depreciation. &lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Depreciable lives are generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.000%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;25 to 30 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3 to 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Business software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Office and other equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sample inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i06a679238a7a43869b57724937813e35_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMC0xLTEtMS0wL3RleHRyZWdpb246Njg3N2Y2YzhkZDhlNGRhNWI3OGU3ZjAxYmNlNjAyNGVfNA_a56cd397-6c73-4731-80ad-1d55044d41ef">P25Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ifa4a9026c5c340bca4066b1c0efd2063_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMC0xLTEtMS0wL3RleHRyZWdpb246Njg3N2Y2YzhkZDhlNGRhNWI3OGU3ZjAxYmNlNjAyNGVfMTA_7eeebe39-66c4-47d8-8968-7341faeb4e08">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic55ec3187d414b9abaf5fb65b6c8a434_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMS0xLTEtMS0wL3RleHRyZWdpb246OWU4NGYyNzAzYWUzNDI1MWI1NDAyNTc3ZjNhNTRhYmZfNA_58aed653-cd1c-4d8a-96ca-ae87d614bc6c">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6f6897b493df42eeb47e27f00c5abf4b_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMS0xLTEtMS0wL3RleHRyZWdpb246OWU4NGYyNzAzYWUzNDI1MWI1NDAyNTc3ZjNhNTRhYmZfMTA_97cab574-a798-4696-964a-c69c8ae16800">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i96d7db72a7864d59befbe7a971698da9_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMi0xLTEtMS0wL3RleHRyZWdpb246ODY3MzJiMDI1MTU2NGM1MmExNWNjZGVmOTc4MzQ3NTZfNA_49670fa8-5abf-463d-b562-66a6ccb325ee">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i53ba86c7840345919cc20c4229f816e0_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMi0xLTEtMS0wL3RleHRyZWdpb246ODY3MzJiMDI1MTU2NGM1MmExNWNjZGVmOTc4MzQ3NTZfMTA_279e673d-addf-4e7f-800d-e93007bb046a">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1287bce70e774c27965e7c70d082232c_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfMy0xLTEtMS0wL3RleHRyZWdpb246OWM5ZDM3NzYzODZmNDAyNzgyMGVkYzA0NTYxY2YwOTFfNA_cd4ba9d7-a451-4228-b2cf-d706f1ff3d47">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i940588eb8f6a40e3a2e23b5b87a7a8b9_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNC0xLTEtMS0wL3RleHRyZWdpb246ZTBjMTJiYzkwNzJlNDgzMzg3ZGM3MDUxNGRiYTQ5MDZfNA_2907580b-e4da-4d4b-89a2-83e0fbd4ae90">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i47943924a14342328b889ec2d330cf79_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNC0xLTEtMS0wL3RleHRyZWdpb246ZTBjMTJiYzkwNzJlNDgzMzg3ZGM3MDUxNGRiYTQ5MDZfMTA_0d5770ff-4a51-43eb-98a7-0366700003aa">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3fd8747608254c9ab234730b9575a4fb_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNS0xLTEtMS0wL3RleHRyZWdpb246ZWIzZmQ4NDU2ZTc4NGM5ZDhlNDMyNjJlYTk5YTM5MDNfNA_51f08fab-f9ad-458f-a867-52d5dec74704">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2ad4e18322904bda9fe3bf97682b7114_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RhYmxlOjc5MzRjMDA0MGU2YTRlYjE5N2NmNGQ3NjEyNjQ0MWE4L3RhYmxlcmFuZ2U6NzkzNGMwMDQwZTZhNGViMTk3Y2Y0ZDc2MTI2NDQxYThfNi0xLTEtMS0wL3RleHRyZWdpb246ZDJlZWJlYWY4ZTU0NDliNThmYTllZTk5ZmU4ODI3MjBfNA_c3347463-dae2-432c-a97d-8635c3485840">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4ODU_8a05127d-48d4-46ba-95e4-7886dab71a67">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Amortizable Intangible Assets, net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amortizable intangible assets&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;include fees necessary to secure various patents and licenses, including Band-Lok, the value of internally developed software, customer relationships, and non-competition agreements related to the acquisition of Orthex, and customer relationships and non-competition agreements related to the acquisitions of Telos and ApiFix. Amortization is calculated on a straight-line basis over the estimated useful life of the asset.  Amortization for patents and licenses commences at the time of patent approval and market launch, respectively. Amortization for assets acquired commences upon acquisition. Intangible assets are amortized over a 3 to 20 year period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amortizable intangible assets are assessed for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is &lt;/span&gt;&lt;/div&gt;measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTMwMDA_d17b778d-afd1-4638-ac62-6fcabe8ea3b5">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7ce4805a31e8410d81b81251b9b1f57c_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTMwMDY_8566c0d5-1c63-49f7-822b-3faa03458da9">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_4f4f859b-cbdc-495d-8221-b494e9067572"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_9b62658a-3f91-459a-bfc6-5f98cf22f8c1"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_ae42fa20-5e6b-4dc9-86a1-ef14b08be36c"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTM1Mzk_c9f2111d-6be9-4e24-a1cd-3fc5c0e2bf70"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4Nzk_0d936fd3-09c3-4087-bf06-44aab478d0bb">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our goodwill represents the excess of the cost over the fair value of net assets acquired. The determination of the value of goodwill and intangible assets arising from acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of net tangible and intangible assets acquired. Goodwill is not amortized and is assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstances warrant such a review. The goodwill is considered to be impaired if we determine that the carrying value of the reporting unit exceeds its respective fair value. &lt;/span&gt;&lt;/div&gt;We have indefinite lived tradename assets that are reviewed for impairment by performing a quantitative analysis, which occurs annually in the fourth quarter or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_05c512af-f6ac-4d15-84ca-45148d6aa291"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_904541cb-e062-4eee-ab29-cb78b5395ff4"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_a21d772a-5a0e-4ee6-a811-5b1949e2f06f"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTQ5MjA_ca6ec78e-441d-442e-b2c4-0f9034d5659c"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <kids:CostOfGoodsAndServicesSoldPolicyPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4OTE_535b8486-bdc1-4d2f-bf40-92e6e1c9a586">Cost of RevenueCost of revenue consists primarily of products purchased from third-party suppliers, excess and obsolete inventory adjustments, inbound freight, and royalties.  Our implants and instruments are manufactured to our specifications by third-party suppliers who meet our manufacturer qualifications standards.  Our third-party manufacturers are required to meet the standards of the Food and Drug Administration (the &#x201c;FDA&#x201d;), and the International Organization for Standardization, as well as other country-specific quality standards.  The majority of our implants and instruments are produced in the United States.</kids:CostOfGoodsAndServicesSoldPolicyPolicyTextBlock>
    <kids:SalesAndMarketingExpensePolicyPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4NzM_3b034b09-a519-4e23-9291-654d7489c81e">Sales and Marketing ExpensesSales and marketing expenses primarily consist of commissions to our domestic and select international independent sales agencies and consignment distributors, as well as compensation, commissions, benefits and other related costs for personnel we employ. Commissions and bonuses are generally based on a percentage of sales.  Our international independent stocking distributors purchase instrument sets and replenishment stock for resale, and we do not pay commissions or any other sales related costs for international sales to distributors.</kids:SalesAndMarketingExpensePolicyPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDY_e8d2ba6e-3e22-40f0-905c-e9801a07b1cd">Advertising Costs Advertising costs consist primarily of print advertising, trade shows, and other related expenses. Advertising costs are expensed as incurred and are recorded as a component of sales and marketing expense.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDc_430d94af-a777-4240-87a9-8d16c6bdc137">Research and Development CostsResearch and development costs are expensed as incurred. Our research and development expenses primarily consist of costs associated with engineering, product development, consulting services, outside prototyping services, outside research activities, materials, development and protection of our intellectual property portfolio, as well as other costs associated with development of our products. Research and development costs also include related personnel and consultants&#x2019; compensation expense.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTI_e977ed9b-aa6f-4697-b6ee-424afe16f538">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Prior to our Initial Public Offering ("IPO") in October 2017, we maintained an Amended and Restated 2007 Equity Incentive Plan (the &#x201c;2007 Plan&#x201d;) that provided for grants of options and restricted stock to employees, directors and associated third-party representatives of the Company as determined by the Board of Directors. The 2007 Plan had authorized 1,585,000 shares for award. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Immediately prior to our IPO, we adopted our 2017 Incentive Award Plan (the "2017 Plan") which replaced the 2007 Plan. The 2017 Plan provides for grants of options and restricted stock to officers, employees, consultants or directors of our Company. The 2017 Plan has authorized 1,789,647 shares for award. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Options holders, upon vesting, may purchase common stock at the exercise price, which is the estimated fair value of our common stock on the date of grant. Option grants generally vest immediately or over three years. No stock options were granted in any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Restricted stock may not be transferred prior to the expiration of the restricted period, which is typically three years. The restricted stock that had been granted under the 2007 Plan had restriction periods that generally lasted until the earlier of six years from the date of grant, or an IPO or change in control, as defined in the 2007 Plan. All restricted stock granted prior to May 2014 vested upon our IPO and the remaining grants under the 2007 Plan vested six months after the IPO. We recognize the reversal of stock compensation expense when a restricted stock forfeiture occurs as opposed to estimating future forfeitures.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We record the fair value of restricted stock at the grant date.  Stock-based compensation is recognized ratably over the requisite service period, which is generally the restriction period for restricted stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ie6bbf783a9584fe0a1bd64259cbff166_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTczNDE_0302f09c-5213-4384-960e-4c8d149ea12d"
      unitRef="shares">1585000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iaa05c196b8e04e13accf63a52bae4361_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc2NDM_bf1970e4-dee5-4f61-9a39-e09cb75c633e"
      unitRef="shares">1789647</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9e55361217974608a2b11df6efaf5506_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzE_d2bc94c5-59c1-4e7e-bd1c-92195d1d9aea">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_51dbc7ad-3b7a-4389-8a79-a97b55bcf91f"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_6511da61-6ad5-43bd-b9ee-d7427979dc3e"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_ef30983d-30d2-4dfa-84ae-bb51afc1e5f9"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTc4NzU_f3284a52-772c-4e62-b1b7-df029c58dadc"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i292238a1b0524036b2e519416ce7ebbc_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTgxOTE_b6aa7160-672a-4a97-888e-fa5ff26345d1">P6Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6dd7fadd1c8141f4bce22e9933efeca0_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMTgzOTg_f8ec7369-5564-4aea-a682-cb8f3809a3a6">P6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTM_196c33ad-af44-4a4f-8122-2b4168268280">Comprehensive Income (Loss)Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income (loss) includes foreign currency translation adjustments.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ4ODM_7c5c6be4-134e-447e-996d-634afabbe284">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements. Under this method, we determine deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance. &lt;/span&gt;&lt;/div&gt;We record uncertain tax positions on the bases of a two-step process in which (i) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the positions and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.</us-gaap:IncomeTaxPolicyTextBlock>
    <kids:EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MTQ_b0c772f0-5858-4983-9a26-5c08f40e7217">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;&#x201c;Emerging Growth Company&#x201d; Reporting Requirements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We qualify as an &#x201c;emerging growth company&#x201d; as defined in the JOBS Act. For as long as a company is deemed to be an emerging growth company, it may take advantage of specified reduced reporting and other regulatory requirements that are generally unavailable to other public companies. Among other things, we are not required to provide an auditor attestation report on the assessment of the internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act of 2002. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Section 107 of the JOBS Act also provides that an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. &lt;/span&gt;&lt;/div&gt;In April 2017, the SEC adopted new rules that included an inflation-adjusted threshold in the definition of an emerging growth company. Under the new inflation-adjusted threshold, we would cease to be an emerging growth company on the last day of the fiscal year in which our annual gross revenues exceed $1.07 billion. This is an increase of $70 million from the previous $1 billion threshold.</kids:EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80My9mcmFnOmJlNDY0YzQ4ZDMzNjQ5MWFhMTJmOTE0NWUzOTY4ZTEzL3RleHRyZWdpb246YmU0NjRjNDhkMzM2NDkxYWExMmY5MTQ1ZTM5NjhlMTNfMjQ5MDI_5b39a649-5069-4570-836c-b3aa94a9c3a2">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2016, the FASB issued ASU No. 2016-13 "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments"&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financials assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Based on ASU 2019-10 and our status as a Smaller Reporting Company, the Company will adopt ASU 2016-13 effective January 1, 2023. The adoption of this guidance is not expected to have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2017, the FASB issued ASU 2017-04, "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment"&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. This pronouncement eliminates Step 2 from the goodwill impairment test and requires an entity to perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. Under this guidance, an entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. It is effective for reporting periods beginning after December 15, 2020, although earlier adoption is permitted. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, the FASB issued ASU No. 2019-12 "&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Income Taxes: Simplifying the Accounting for Income Taxes"&lt;/span&gt; intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside cost basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfNDcxNQ_58f28862-3c37-41ad-b40e-d9a3d209cc22">BUSINESS COMBINATION&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;ApiFix&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;On April 1, 2020, the Company purchased all the issued and outstanding membership interest of ApiFix for $2,000 in cash, including $343 of cash acquired, 934,783 shares of the Company's common stock, $0.00025 par value per share, representing approximately $35,176 (based on a closing share price of $37.63 on April 1, 2020), $30,000 in anniversary payments, and approximately $41,741 in a system sales payment. The total consideration transferred of $87,379 is preliminary and subject to certain limitations and adjustments. ApiFix, a corporation organized under the laws of Israel, has developed a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis ("ApiFix System").  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Company incurred $310 of acquisition-related costs that are included in general and administrative expenses on the consolidated statements of operations. The purchase price allocation set forth herein is preliminary. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The following table summarizes the total consideration paid for ApiFix and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.677%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.574%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.549%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Preliminary fair value of estimated total acquisition consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts receivable-trade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Company is obligated to make anniversary payments of: (i) $13,000 on the second anniversary of the closing date, provided that such payment will be paid earlier if 150 clinical procedures using the ApiFix System are completed in the United States before such anniversary date, (ii) $8,000 on the third anniversary of the closing date; and (iii) $9,000 on the fourth anniversary of the closing date, subject to adjustments. The Company anticipates making the second anniversary payment of $13,000 during the first half of 2021. In addition, to the extent that the product of our revenues from the ApiFix System for the twelve months ended June 30, 2024 multiplied by 2.25 exceeds the anniversary payments actually made for the third and fourth years, we have agreed to pay the selling shareholders a system sales payment in the amount of such excess. The anniversary payments and system sales payment may each be made in cash or cash and common stock, subject to certain limitations; provided that the Company makes the determination with respect to anniversary payments and a representative of the former ApiFix shareholders may make the determination with respect to the system sales payment, if any. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of the contingent consideration payments is considered a Level 3 investment and were determined by an independent valuation specialist at the original issuance date using an option pricing model and a Monte Carlo simulation based on forecast annual revenue, expected volatility and an implied probability of achieving revenue forecasts. The fair value of the payments will continue to be adjusted as additional information becomes available regarding the progress toward achievement of the revenue forecast. The adjustment in the fair value of the contingent consideration payments of $910 was recognized as an expense for the six month period ended June 30, 2020 in other expenses on the condensed consolidated statements of operations. An additional $886 was recognized as interest expense for the six month period ended June 30, 2020 on the condensed consolidated statements of operations for the adjustment in the fair value of the acquisition installment payable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Presented below is a summary of the present value of the anniversary payments and system sales payment related to the ApiFix acquisition: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:56.974%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.873%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;April 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Anniversary Payments: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Second Year Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Third Year Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fourth Year Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total acquisition installment payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: current portion of acquisition installment payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Acquisition installment payable, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;System sales payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;ApiFix future consideration, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Pre-acquisition revenues and earnings for ApiFix were not material to the condensed consolidated operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;Telos&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;On March 9, 2020, the Company purchased the issued and outstanding membership interest of Telos for $1,750 in cash, including $81 of cash acquired, and 36,628 shares of common stock, $0.00025 par value per share, of the Company. The shares of common stock were valued at $42.81 per share, the Company's closing share price on March 9, 2020. The Company incurred $25 of acquisition-related costs, that are included in general and administrative expenses on the consolidated statements of operations.  The purchase price allocation set forth herein is preliminary.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The following table summarizes the total consideration paid for Telos and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.677%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.574%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.549%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Preliminary fair value of estimated total acquisition consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts receivable-trade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Vilex and Orthex&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On June 4, 2019, the Company purchased all the issued and outstanding shares of stock of Vilex and units of membership interests in Orthex for $50,000 in cash, adjusted for working capital, and 245,352 shares of common stock, $0.00025 par value per share, of the Company. The shares of common stock were valued at $40.76 per share, the volume weighted average trading price during the thirty day trading period ending on May 30, 2019. In addition, $3,000 was placed in an escrow account for a period of up to twenty months to cover certain indemnification obligations and to secure certain closing adjustments. The Company incurred $737 of acquisition-related costs, that are included in general and administrative expenses on the consolidated statements of operations.  The purchase price allocation set forth herein is final as to working capital amounts, intangible values and tax accounting matters. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The following table summarizes the total consideration paid for Vilex and Orthex and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.677%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.574%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.549%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value of estimated total acquisition consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts receivable-trade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Internally Developed Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Company recorded a measurement period adjustment during fiscal 2020 to increase inventory and decrease goodwill related to working capital adjustments to allocate inventory between Orthex and Vilex. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Since the Vilex products include adult offerings that are not core to the Company's pediatric business, the Company received Board approval to take the steps necessary to divest the non-core Vilex assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;On December 31, 2019, the Company divested substantially all of the assets relating to Vilex's adult product offering to a wholly-owned subsidiary of Squadron Capital, LLC in exchange for a $25,000 reduction in a term note owed to Squadron in connection with the initial acquisition along with certain ongoing intellectual property rights. Of the $25,000 purchase price, $12,410 was attributable to the license of the Orthex intellectual property and the remaining $12,590 was applied to the Vilex assets and liabilities divested.&lt;/span&gt;&lt;/div&gt;After the issuance of our December 31, 2019 annual consolidated financial statements, and in connection with the preparation of our condensed consolidated financial statements for the three months ended March 31, 2020, we identified and corrected an immaterial error related to the deferred revenue liability recognized from license of Orthex intellectual property as of December 31, 2019.  The immaterial correction of the error resulted in a reduction of the deferred revenue liability and goodwill on the consolidated balance sheet as of December 31, 2019 of $12,410, based on the conclusion that the consideration transferred was allocable to a portion of certain Orthex patent assets sold concurrently with the sale of Vilex. We have evaluated the adjustment and, based on an analysis of quantitative and qualitative factors, determined that the related impact was not material to our consolidated financial statements for any prior annual or interim period presented. In order to accurately present the historical period, we have revised our December 31, 2019 balance sheet and related footnotes to reflect the immaterial correction of this error.Pro forma net revenue and net loss from continuing operations for the six months ended June 30, 2019 assuming the Orthex and Vilex acquisition occurred on January 1, 2019 would have been $34,792 and ($4,948), respectively.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ4MQ_9ebf1f89-c37d-43b1-9c1f-ebb8a3127604"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU0NQ_3e8d6d32-511a-4d09-9738-11899fea7f97"
      unitRef="usd">343000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ5MA_e28d075a-b0b4-42df-8ca1-b906d1511add"
      unitRef="shares">934783</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUwMA_8c038528-068e-4c85-b96c-2612a597276a"
      unitRef="usdPerShare">0.00025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU2Ng_5a3d314e-5f03-4d47-a8d9-c81777681121"
      unitRef="usd">35176000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUwNw_6d71aef0-a40c-4327-973e-a48dc84b27b6"
      unitRef="usdPerShare">37.63</us-gaap:BusinessAcquisitionSharePrice>
    <kids:BusinessCombinationContingentConsiderationAnniversaryPayments
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU1NA_1554941b-ae67-4ba8-b47d-747b54765902"
      unitRef="usd">30000000</kids:BusinessCombinationContingentConsiderationAnniversaryPayments>
    <kids:BusinessCombinationContingentConsiderationSystemSalesPayment
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU3OA_53626521-df28-4f17-8f0c-c91012dc8d73"
      unitRef="usd">41741000</kids:BusinessCombinationContingentConsiderationSystemSalesPayment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i44bb1450f6e841a0b1500229ed099770_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NTI3MA_a70902c7-5030-4897-9041-f653fcd97d6e"
      unitRef="usd">87379000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU5MA_69192033-8bbf-403c-a6e5-8153012b8b7a"
      unitRef="usd">310000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyMw_28974099-8aeb-4c19-9170-6f99a6b7ad78">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The following table summarizes the total consideration paid for ApiFix and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.677%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.574%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.549%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Preliminary fair value of estimated total acquisition consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts receivable-trade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The following table summarizes the total consideration paid for Telos and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.677%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.574%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.549%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Preliminary fair value of estimated total acquisition consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts receivable-trade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The following table summarizes the total consideration paid for Vilex and Orthex and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:62.677%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.574%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.549%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair value of estimated total acquisition consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts receivable-trade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: total net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMS0yLTEtMS0zMzc3_236efd67-5f83-4cf7-8282-f8a8a8931cdc"
      unitRef="usd">87379000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMy0yLTEtMS0zMzc3_eba6009e-dd48-45d6-86af-2fa0d7f0ee4d"
      unitRef="usd">344000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNC0yLTEtMS0zMzc3_aa78f1fe-24ce-4e2c-9fa5-7319303ceec5"
      unitRef="usd">245000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNS0yLTEtMS0zMzc3_cd26d313-6420-4e0f-865a-d814e202c881"
      unitRef="usd">685000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNi0yLTEtMS0zMzc3_e456661a-2644-42f5-8079-8b2deef6b840"
      unitRef="usd">77000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfNy0yLTEtMS0zMzc3_7e8529a9-c4fb-4ecd-a14f-d41c0047643a"
      unitRef="usd">153000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfOC0yLTEtMS0zMzc3_1761d490-12a2-486f-bdd4-172a3d7c63fb"
      unitRef="usd">24330000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfOS0yLTEtMS0zMzc3_b6e75cdb-38a7-46b2-b9eb-47c0fe9b223a"
      unitRef="usd">8620000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTAtMi0xLTEtMzM3Nw_1a609785-478d-4edf-a4d2-2eed56f07ec6"
      unitRef="usd">104000</kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTEtMi0xLTEtMzM3Nw_bf943b1c-b638-4400-8993-7ebd15592ad2"
      unitRef="usd">34558000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTMtMi0xLTEtMzM3Nw_13d47dca-2611-4935-b99e-28a4cc04daa9"
      unitRef="usd">226000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTQtMi0xLTEtMzM3Nw_e8d2c13a-fc40-4324-ac65-35d5abbb5e0c"
      unitRef="usd">106000</kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTYtMi0xLTEtMzM3Nw_fa737e07-2582-4c6b-bc47-92440628f033"
      unitRef="usd">270000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTctMi0xLTEtMzM3Nw_9b4b39bc-5696-4cf4-8140-bebf7e82d667"
      unitRef="usd">602000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTgtMi0xLTEtMzM3Nw_d322ce15-e7de-4ff9-96cd-b771c10688ee"
      unitRef="usd">33956000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmRhMmJkNGM5YzU2NDQyNGZiYzE5ZWNmYjYxYmFlZWM2L3RhYmxlcmFuZ2U6ZGEyYmQ0YzljNTY0NDI0ZmJjMTllY2ZiNjFiYWVlYzZfMTktMi0xLTEtMzM3Nw_f31b1755-6f8c-4912-9424-0e7446600207"
      unitRef="usd">53423000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyNA_1cbfa600-aac9-4372-8f63-9a20340b3051">The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Internally Developed Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyNA_f0a7be16-50e1-4738-a6f6-c1c8b46da087">The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.737%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.883%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:38.226%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining Economic Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks / Names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Internally Developed Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-competition Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i66ddcda9efb2401e914b895725e8449a_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMS0yLTEtMS0zMjQ1_ef2c16c3-7a51-44a7-b490-4b5a639a8e65"
      unitRef="usd">8620000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="icad1fff330924b20990fd0c7cf170c10_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMi0yLTEtMS0zMjQ1_31464e1f-dce9-4332-90c8-a1a0725bd9eb"
      unitRef="usd">23790000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib40f513d923c4826b58162f6f5582202_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMi00LTEtMS0zMjQ3_28a04012-4652-481a-a8e9-622de6d7c82c">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i5cf98eb1a09e4ccb8140a7acdb7780b3_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMy0yLTEtMS0zMjQ1_a28e884f-62a0-4919-925a-9a03d9765b44"
      unitRef="usd">340000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia313240909774cbe8dc30507a797ccc1_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfMy00LTEtMS0zMjQ3_b1008aac-e35a-4179-af3a-5ee539c35145">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i6ad06b13cdff4f36ab42c19c49f5ec90_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfNC0yLTEtMS0zMjQ1_002eb94d-8715-429e-94d7-38f99f057c8e"
      unitRef="usd">200000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i938290d2cdad418ea88e9197cb42d54e_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfNC00LTEtMS0zMjQ3_6cb417d0-33fb-4b70-bba7-13385f63e0f7">P4Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <kids:IntangibleAssetsAcquired
      contextRef="iea2114642e614c76862ec79220c8b6de_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjI2NjBiN2E2MGI0NzQ0ZTJhMDcwM2M0MDQ5NGI2YTYyL3RhYmxlcmFuZ2U6MjY2MGI3YTYwYjQ3NDRlMmEwNzAzYzQwNDk0YjZhNjJfNS0yLTEtMS0zMjQ1_43863b9f-038d-4b4a-91e1-368053dc2ba0"
      unitRef="usd">32950000</kids:IntangibleAssetsAcquired>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="iade7dd3801514191b80df2d859180efe_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUxNg_a17e3a07-1290-41f5-8e7e-edde17e816e4"
      unitRef="usd">13000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <kids:BusinessCombinationContingentConsiderationNumberOfClinicalProcedures
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUyMQ_688541d3-9161-4cab-85e8-d1138c9fa993"
      unitRef="facility">150</kids:BusinessCombinationContingentConsiderationNumberOfClinicalProcedures>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="ia07305a71eeb47d99be5750a3a47cb18_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUyOQ_9a4f2d8f-3428-47ee-a80e-3f0f519a3284"
      unitRef="usd">8000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="i974a053f052c4233bccf37c504b97db0_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDUzNw_ff9d3dba-6b9e-4183-ab86-44a71e092917"
      unitRef="usd">9000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="iade7dd3801514191b80df2d859180efe_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYwMQ_5f37d783-17aa-41a3-ab1d-1b340a400ef9"
      unitRef="usd">13000000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <kids:BusinessCombinationContingentConsiderationRevenueMultiplier
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDU0Mw_e1ffc5a5-41ea-4fe9-bd15-9eda8873429c"
      unitRef="number">2.25</kids:BusinessCombinationContingentConsiderationRevenueMultiplier>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NTI4Mg_87d929a8-c757-4fc3-9d27-f9ac89c00980"
      unitRef="usd">910000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:InterestExpense
      contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NTI4OA_e5429f0c-d828-43ff-9ce3-c32abc3e444b"
      unitRef="usd">886000</us-gaap:InterestExpense>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDYyNQ_3724080d-0fcf-4400-8e76-98c8ca9606ac">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Presented below is a summary of the present value of the anniversary payments and system sales payment related to the ApiFix acquisition: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:56.974%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.871%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.873%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;April 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Anniversary Payments: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Second Year Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Third Year Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fourth Year Payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total acquisition installment payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: current portion of acquisition installment payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Acquisition installment payable, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;System sales payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;ApiFix future consideration, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Pre-acquisition revenues and earnings for ApiFix were not material to the condensed consolidated operations.</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="i4871de21cf3c497a9d2222f88b61d7ab_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMi0yLTEtMS0zMjQx_d38a6be4-5421-4376-93a9-51ac5694d60e"
      unitRef="usd">10980000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="iefda4158f9254c1eb3becf702fc558a8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMi00LTEtMS0zMjQz_703bed0c-b100-4607-bfed-c78e53763ace"
      unitRef="usd">11485000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="i36be2612ceac48918982f7de2682e1c5_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMy0yLTEtMS0zMjQx_fab43373-5900-4d92-ad31-8963b95c16fe"
      unitRef="usd">5780000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="i3de47578e860485f8740cf50e09ee68f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfMy00LTEtMS0zMjQz_838a3602-b75a-4564-b049-dffd85114cd9"
      unitRef="usd">5965000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="i136967d17bba4ed28cf1f18b639b6b83_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNC0yLTEtMS0zMjQx_730e94e0-df8b-4193-a3ed-bcc090ddbba4"
      unitRef="usd">5860000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="i190a872146ee4e9187065e968ab399b3_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNC00LTEtMS0zMjQz_42dc5d97-263f-4ac9-8750-fdecdf631799"
      unitRef="usd">6056000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNS0yLTEtMS0zMjQx_7b52d626-b454-47bb-b0c3-cd601f2e42bd"
      unitRef="usd">22620000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable
      contextRef="i0891c5d60bc5463e814034e47be08954_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNS00LTEtMS0zMjQz_99a1474a-02c3-4f39-9d22-1c3f5e9aa25a"
      unitRef="usd">23506000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNi0yLTEtMS0zMjQx_95d83f35-9c14-41dd-b643-d6084117b92e"
      unitRef="usd">10980000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent
      contextRef="i0891c5d60bc5463e814034e47be08954_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNi00LTEtMS0zMjQz_92521fd0-ef17-4136-b854-f65c419217f9"
      unitRef="usd">11485000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNy0yLTEtMS0zMjQx_7436086b-4867-4173-bca2-d6aa2fe9b0ad"
      unitRef="usd">11640000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent>
    <kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent
      contextRef="i0891c5d60bc5463e814034e47be08954_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfNy00LTEtMS0zMjQz_5c78c21c-17f4-4d30-ad85-43c5542617b7"
      unitRef="usd">12021000</kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent>
    <kids:BusinessCombinationContingentConsiderationRevenuePayment
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOC0yLTEtMS0zMjQx_3cd806d9-08b7-4d3f-924a-f879fad154b0"
      unitRef="usd">27190000</kids:BusinessCombinationContingentConsiderationRevenuePayment>
    <kids:BusinessCombinationContingentConsiderationRevenuePayment
      contextRef="i0891c5d60bc5463e814034e47be08954_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOC00LTEtMS0zMjQz_6a93f723-143b-4beb-b1c7-87548b275d15"
      unitRef="usd">28100000</kids:BusinessCombinationContingentConsiderationRevenuePayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i1722f284f22149b0b62e23f146f1da73_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOS0yLTEtMS0zMjQx_4264f87a-71d7-407c-8238-48d7b7b4b465"
      unitRef="usd">38830000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i0891c5d60bc5463e814034e47be08954_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjM2ZjU0NTYyMDZmMTQwMDFiMTgyNjc1N2NkODFjZWNiL3RhYmxlcmFuZ2U6MzZmNTQ1NjIwNmYxNDAwMWIxODI2NzU3Y2Q4MWNlY2JfOS00LTEtMS0zMjQz_f6f3e0e6-5eef-450a-83c4-3b22b6db8fe3"
      unitRef="usd">40121000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTQy_e47db6c9-dbe4-4d24-8536-cbbce35444a3"
      unitRef="usd">1750000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTY0_e790941d-4d08-4667-814c-76ec88a3fa70"
      unitRef="usd">81000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTg5_d303ca3a-b47b-49bd-8445-b811c34a5332"
      unitRef="shares">36628</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMjE2_2a2d2a38-7d5f-41f8-b2fd-66e0472ecf79"
      unitRef="usdPerShare">0.00025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ1OA_16387f4c-97a6-4018-96eb-6113c41cfd16"
      unitRef="usdPerShare">42.81</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ2Nw_a8c9de6a-1dac-4901-a807-faa701eb3e67"
      unitRef="usd">25000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMS0yLTEtMS0w_2b9a35e3-db6e-4fa5-8216-2a313501e8e5"
      unitRef="usd">3318000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMy0yLTEtMS0w_2bd6b049-5eb2-42f5-a45e-7591e71da866"
      unitRef="usd">81000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfNC0yLTEtMS0w_b4275d32-74ce-454c-aee7-4b94efb3cdbb"
      unitRef="usd">215000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfNy0yLTEtMS0w_20fb1498-313f-4e28-bdf1-6baa1bbacfc2"
      unitRef="usd">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfOC0yLTEtMS0w_2990850d-8f01-4ac7-9e73-72292d82d132"
      unitRef="usd">950000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfOS0yLTEtMS0zMzcz_991695e3-8b24-4123-b602-11d07648da44"
      unitRef="usd">210000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTEtMi0xLTEtMA_c088393f-2659-4291-bc0b-9d5b5a249071"
      unitRef="usd">1466000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTMtMi0xLTEtMA_5cf56e0b-6b8b-4815-accc-205475cfae33"
      unitRef="usd">60000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTctMi0xLTEtMA_55a98997-a15d-455f-a61f-e271effd24c5"
      unitRef="usd">60000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTgtMi0xLTEtMA_5b368dca-45bb-4ef1-ae66-6cf9b6247d5f"
      unitRef="usd">1406000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i9933c5128ccd40729a7bc27dbc6eb1e1_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjkxYjYxYjgwOGMyNzQ3YWI5NWZhNTM4YjEyZmJiZTZjL3RhYmxlcmFuZ2U6OTFiNjFiODA4YzI3NDdhYjk1ZmE1MzhiMTJmYmJlNmNfMTktMi0xLTEtMA_d0494b01-6d52-4ad2-b742-2663ae6280b8"
      unitRef="usd">1912000</us-gaap:Goodwill>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="i80a8bd33230e4f23a9d792dc0bb5a7ee_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMS0yLTEtMS0w_b4666fb5-3dcd-458f-b879-de20107b8d75"
      unitRef="usd">210000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i8a9d0f0383c646788001508a2c5597bd_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMi0yLTEtMS0w_2c668cdb-ffd0-444a-b3b4-ef5b01546475"
      unitRef="usd">910000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8a9d0f0383c646788001508a2c5597bd_D20200309-20200309"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMi00LTEtMS0w_19d15078-ebf6-4f58-be75-3426c5ae5044">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i95b3a7b0f9324955af777d48822570a9_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMy0yLTEtMS0w_6dfb5fc9-04b1-4ccd-80f5-7047a0c60285"
      unitRef="usd">40000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i95b3a7b0f9324955af777d48822570a9_D20200309-20200309"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfMy00LTEtMS0w_f7ed75ce-4d44-4d74-ae0d-ab39437bac60">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <kids:IntangibleAssetsAcquired
      contextRef="icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjUzMjc3MTA5MzFmZDQ1YTNhNjIwNzNlMWMzM2IyMWU4L3RhYmxlcmFuZ2U6NTMyNzcxMDkzMWZkNDVhM2E2MjA3M2UxYzMzYjIxZThfNC0yLTEtMS0w_f8d107a1-53c3-42be-b609-bb4921a9fd0d"
      unitRef="usd">1160000</kids:IntangibleAssetsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTE0MQ_a0fc8613-cb8a-41d3-a0bf-ba8303df22bf"
      unitRef="usd">50000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTE4Nw_c0463524-273e-4ac5-bdc2-411160a7e8ca"
      unitRef="shares">245352</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTIxNA_1c074bf9-ea8c-4293-a941-5d608d8a3cd1"
      unitRef="usdPerShare">0.00025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i7c8ff79382af4dbeb5b7c523481aa645_I20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTI5Ng_c2578d60-e793-404e-b82a-88595a0345db"
      unitRef="usdPerShare">40.76</us-gaap:BusinessAcquisitionSharePrice>
    <kids:BusinessCombinationEscrowDeposit
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTQyNg_ca083ff7-298d-4afd-b9fa-06e9846a78ed"
      unitRef="usd">3000000</kids:BusinessCombinationEscrowDeposit>
    <kids:BusinessCombinationEscrowDepositMaximumTerm
      contextRef="id9512287e4134097a7d49339bfdae2a8_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTQ4Mw_5f562251-cb6b-4071-ab8f-2e444d61a520">P20M</kids:BusinessCombinationEscrowDepositMaximumTerm>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTU5NQ_7ce74f78-108a-4c9f-a5e7-2f26a1d19e6f"
      unitRef="usd">737000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMS0yLTEtMS0w_81b35dba-6aaa-424f-ba8c-b018c0309631"
      unitRef="usd">60184000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMy0yLTEtMS0w_c5321d95-1064-4069-a057-f754ec2e44e7"
      unitRef="usd">348000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNC0yLTEtMS0w_91ec5a01-e14e-4d73-9e00-e7fee2baa416"
      unitRef="usd">2088000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNS0yLTEtMS0w_efbba9d8-70c1-4176-9583-685f658be462"
      unitRef="usd">3652000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNi0yLTEtMS0w_c36f0931-a419-4937-9928-0881a66284b8"
      unitRef="usd">12000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfNy0yLTEtMS0w_9554b652-2aed-4ac5-a53d-18369f5ea3f3"
      unitRef="usd">7540000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfOC0yLTEtMS0w_2af0a061-d428-4232-954c-d3285299082b"
      unitRef="usd">31180000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTAtMi0xLTEtMA_93eba735-d358-4f9f-8fe2-b01518e8ff27"
      unitRef="usd">323000</kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTEtMi0xLTEtMA_48d98cf6-5400-49fc-b0c3-21e65a6fbbe6"
      unitRef="usd">45143000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTMtMi0xLTEtMA_da55c98c-73bd-4e3e-809f-076ddec3b525"
      unitRef="usd">563000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTQtMi0xLTEtMA_0066ade4-76d3-4f26-807a-c3d59d949968"
      unitRef="usd">323000</kids:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTUtMi0xLTEtMA_7f18ef79-34e8-4c0b-8ef0-0b9b1ebb41bf"
      unitRef="usd">1175000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTYtMi0xLTEtMA_d431a756-0c83-4832-a7fb-f3cc5f338349"
      unitRef="usd">68000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTctMi0xLTEtMA_fd8c84df-6538-4fd8-8905-3c308bb45b89"
      unitRef="usd">2129000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTgtMi0xLTEtMA_e78907a9-891e-40cd-888e-28009b61a4d2"
      unitRef="usd">43014000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i0e15739a1dfc4f73b185ac8552a5c39e_I20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOjc1MjIwYjkzN2U4MDRiY2FhM2FhNmQxZjcyMmQ5MzkwL3RhYmxlcmFuZ2U6NzUyMjBiOTM3ZTgwNGJjYWEzYWE2ZDFmNzIyZDkzOTBfMTktMi0xLTEtMA_339415fe-8154-44fc-8424-bbcb8ea4da37"
      unitRef="usd">17170000</us-gaap:Goodwill>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="if66e4ed42c0340ae95515133232879f3_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMS0yLTEtMS0w_390e4749-38aa-4119-b39a-c1ecd84b2024"
      unitRef="usd">4610000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i697f880d24684012827b17b5de98d360_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMi0yLTEtMS0w_b4248c69-fe91-499d-a8bd-65189c3f5ce4"
      unitRef="usd">22390000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i697f880d24684012827b17b5de98d360_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMi00LTEtMS0w_2c207d16-dd3c-4e82-aba8-0fa22dcac311">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i51c7929e645642919dea6b4923e42798_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMy0yLTEtMS0w_916b5959-788f-4145-8073-3c688c67e1c3"
      unitRef="usd">1550000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i51c7929e645642919dea6b4923e42798_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfMy00LTEtMS0w_b20195bb-1f65-46b3-bb7c-1c339b5c6648">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i32b0fbb66fe2467f9e999a25aaa3b1cc_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNC0yLTEtMS0w_ccbd830e-c646-41a4-babe-50424ea39605"
      unitRef="usd">2570000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i32b0fbb66fe2467f9e999a25aaa3b1cc_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNC00LTEtMS0w_abd405f3-943e-4a95-8a89-ab7b45538172">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i2036398d56b74a198f2a687eeb8fde44_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNS0yLTEtMS0w_b769ba13-306a-41cf-ba50-02697ecc6da0"
      unitRef="usd">60000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2036398d56b74a198f2a687eeb8fde44_D20190604-20190604"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNS00LTEtMS0w_4be2ad79-2257-43b3-93c8-740c8def2e71">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <kids:IntangibleAssetsAcquired
      contextRef="if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RhYmxlOmQ1MjlkYjhiYjg1MDRkMjk4NGRiNWRiNTY2ZjUzYjZlL3RhYmxlcmFuZ2U6ZDUyOWRiOGJiODUwNGQyOTg0ZGI1ZGI1NjZmNTNiNmVfNi0yLTEtMS0w_e41678bf-ead4-4889-900a-9b631e147a8d"
      unitRef="usd">31180000</kids:IntangibleAssetsAcquired>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMjkzMQ_9257f965-c33e-4ed6-8834-20fa9cec80ea"
      unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzA4Mw_b6ad940b-c046-4e85-8efe-07afc56afa4b"
      unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <kids:DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue
      contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzEwMg_a7635751-4520-4c36-85a3-3ee88c293722"
      unitRef="usd">12410000</kids:DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue>
    <kids:DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities
      contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzE5MQ_76df2bcc-a93a-49f6-894b-2f8a9d43ad66"
      unitRef="usd">12590000</kids:DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities>
    <kids:DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue
      contextRef="i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMzgxNA_2c95e232-3f16-4e5d-97a7-1439dc659b59"
      unitRef="usd">12410000</kids:DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQzMw_3beb9169-515f-42b1-a66d-3b2c3d1e13fc"
      unitRef="usd">34792000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="id755d1f9e93544b2b485f95f5cf26c80_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80Ni9mcmFnOjY0N2VlMTc5OWJmZjQ1MGU4YzRmMjdmOWUwYmFmNzU3L3RleHRyZWdpb246NjQ3ZWUxNzk5YmZmNDUwZThjNGYyN2Y5ZTBiYWY3NTdfMTA5OTUxMTY0NDQ0NQ_46220301-2319-45b0-b4e8-ac6529c9a8b7"
      unitRef="usd">-4948000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90ZXh0cmVnaW9uOjQxNjJjZWQxMGE4NjRiYTdiYzU4NWI2YzQ4MzNhMmU5XzEwOTk1MTE2MzE1ODY_99d240a7-d0d3-44ec-a141-7a651df4779f">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Changes in the carrying amount of goodwill for the six months ended June 30, 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:77.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.872%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vilex Companies acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Divestiture of Vilex in Tennessee, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Telos acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Orthex measurement period adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(688)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;ApiFix acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of June 30, 2020, the balances of amortizable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.504%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intellectual Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;License Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total amortizable assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December 31, 2019, the balances of amortizable intangible assets were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.504%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intellectual Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;License Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total amortizable assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On June 10, 2020, we purchased certain intellectual property assets from Band-Lok, LLC, a North Carolina limited liability company ("Band-Lok"), related to its Tether Clamp and Implantation System ("Tether Clamp System") for $3,394 in total consideration. We use the Tether Clamp System in connection with our Bandloc 5.5/6.0 System. We were previously the sole licensee of the purchased assets under a license agreement with Band-Lok.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Licenses are tied to product launches and do not begin amortizing until the product is launched to the market. &lt;/span&gt;&lt;/div&gt;Trademarks are non-amortizing intangible assets which were $13,357 and $4,490 as of June 30, 2020 and December 31, 2019, respectively. Concurrently with our acquisition of each company, we acquired the trademark of Orthex on June 4, 2019 valued at $4,230, the trademark of Telos on March 9, 2020 valued at $210 and the trademark of ApiFix on April 1, 2020 valued at $8,620. Trademarks are recorded in Other Intangible assets on the Condensed Consolidated Balance Sheets.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90ZXh0cmVnaW9uOjQxNjJjZWQxMGE4NjRiYTdiYzU4NWI2YzQ4MzNhMmU5XzEwOTk1MTE2MzE1ODc_4076d66f-bdc2-43b9-860b-55427a8499c7">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Changes in the carrying amount of goodwill for the six months ended June 30, 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:77.487%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.872%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vilex Companies acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Divestiture of Vilex in Tennessee, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Telos acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Orthex measurement period adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(688)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;ApiFix acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;53,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i55478baf239442988af0a3137120ff79_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzEtMi0xLTEtMzQyMA_3d7ede13-2470-4265-b9c7-fa2c7c512622"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0ce021843bf7476ab44bfacfc23770c3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzItMi0xLTEtMzQxOA_5ba86953-5778-4015-8067-2e4c09189c69"
      unitRef="usd">17170000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i0ce021843bf7476ab44bfacfc23770c3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzMtMi0xLTEtMzQxOA_9acb0121-dd89-44ad-9ca1-4497d0953b75"
      unitRef="usd">3397000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:Goodwill
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzQtMi0xLTEtMzQxOA_7237dfa9-71bc-413f-a381-103367ca7353"
      unitRef="usd">13773000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i50914e6fa4a14b89be845b37b109e7e5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzUtMi0xLTEtMzQxOA_17f0a2ee-32fe-4e64-a5b4-699120b30c8d"
      unitRef="usd">1912000</us-gaap:GoodwillAcquiredDuringPeriod>
    <kids:GoodwillMeasurementPeriodAdjustment
      contextRef="i779524b02e4741949cdceb2816836fca_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzYtMi0xLTEtMzQxOA_0c0c6c0c-f9c8-444b-96c0-bfc61c869a87"
      unitRef="usd">-688000</kids:GoodwillMeasurementPeriodAdjustment>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib3d074f252d44765bb40d10297e541b2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzctMi0xLTEtMzQxOA_c46c279e-26e4-49bf-9fc2-fad6e5e008c8"
      unitRef="usd">53423000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo2MTg3ZjM3M2RmZWQ0M2RiOTJlODdjNWZmNWJiNDIzYS90YWJsZXJhbmdlOjYxODdmMzczZGZlZDQzZGI5MmU4N2M1ZmY1YmI0MjNhXzgtMi0xLTEtMzQxOA_87a6cf57-5c0f-4d11-890d-46735a6223c2"
      unitRef="usd">68420000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90ZXh0cmVnaW9uOjQxNjJjZWQxMGE4NjRiYTdiYzU4NWI2YzQ4MzNhMmU5XzEwOTk1MTE2MzE1ODk_8f3fb81e-95f0-4628-86cb-f8b64eec51dc">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of June 30, 2020, the balances of amortizable intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.504%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intellectual Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;License Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total amortizable assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of December 31, 2019, the balances of amortizable intangible assets were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.428%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.504%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intellectual Property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;License Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total amortizable assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i43216f47eeee41f6bb129feaeb6cdc7e_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtMi0xLTEtMzQzMA_db24b931-715a-42dc-bda3-6d3bf2347f32">P15Y3M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaae923d4563d427bacf487bd51f6a91d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtNC0xLTEtMjkzNQ_228e1e70-8464-4ba9-a138-b5c6695ba46f"
      unitRef="usd">33182000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaae923d4563d427bacf487bd51f6a91d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtNi0xLTEtMjkzNQ_f440ab2d-1019-4b19-8067-9e5cbf0d2c8b"
      unitRef="usd">1019000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaae923d4563d427bacf487bd51f6a91d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzEtOC0xLTEtMjkzNQ_d7b50e27-a363-46dd-bdd1-760f54e5da87"
      unitRef="usd">32163000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic6894ee1ed534a779143dc099648c47f_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItMi0xLTEtMzQzMA_644a6118-6895-41b4-a583-2097a44d8cce">P10Y9M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItNC0xLTEtMjkzNQ_0c30e7cf-f539-4e01-b9cf-4421490b2f91"
      unitRef="usd">8950000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItNi0xLTEtMjkzNQ_4b166035-82d6-42b5-8e81-3b5ca4073594"
      unitRef="usd">473000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6b805b39d0304b6f9ddad2f3afb3cbaf_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzItOC0xLTEtMjkzNQ_bc4ff914-fc87-45b0-8e9c-0e6f1a4721c2"
      unitRef="usd">8477000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id145432eb8c441e5b1dbddc0c0a863d0_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtMi0xLTEtMzQzMA_1942f5fa-78ba-4b26-b56c-fe5c566d25bd">P3Y1M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iee46e00cdee24529b067135f7e8c5115_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtNC0xLTEtMjkzNQ_aeb713d0-acfa-4f21-9d53-e03d4040c528"
      unitRef="usd">2765000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iee46e00cdee24529b067135f7e8c5115_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtNi0xLTEtMjkzNQ_4c54d5d9-01df-46c9-91fd-c0dd60d6e454"
      unitRef="usd">1199000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iee46e00cdee24529b067135f7e8c5115_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzMtOC0xLTEtMjkzNQ_ebcdcd78-bdde-4017-a5f4-5611d6cd8f23"
      unitRef="usd">1566000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzQtNC0xLTEtMjkzNQ_ab30bbc2-c66f-401c-978d-233c2f9457d0"
      unitRef="usd">44897000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzQtNi0xLTEtMjkzNQ_9066418f-41a8-4a39-b079-5ededab7c223"
      unitRef="usd">2691000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTplYWNhNDI1YmY5ZWI0M2M1OWMzZDZjOTdhNTlmN2JhMy90YWJsZXJhbmdlOmVhY2E0MjViZjllYjQzYzU5YzNkNmM5N2E1OWY3YmEzXzQtOC0xLTEtMjkzNQ_5b4c6d77-a8da-4d4d-8f6f-d4677641d5f5"
      unitRef="usd">42206000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i217400e5358b4111bcda2d87a7c82ea6_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtMi0xLTEtMzQzNw_c15b5f3a-02f5-40b0-9333-0c242b1c4cdb">P17Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2b0498ea6ef04efdafac30fa191f07f5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtNC0xLTEtMjg5OA_51958cb8-c06b-4c42-8e27-d23a0675efc0"
      unitRef="usd">9287000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2b0498ea6ef04efdafac30fa191f07f5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtNi0xLTEtMjg5OA_22608902-981d-429e-bd31-21afadad2ee4"
      unitRef="usd">363000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2b0498ea6ef04efdafac30fa191f07f5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzEtOC0xLTEtMjg5OA_31413f46-c501-43f0-aa6b-c434b91c3183"
      unitRef="usd">8924000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i26700fd1a63342dd8c4212993b04610d_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItMi0xLTEtMzQzNw_ac668a28-715e-4432-8ec9-0939b4f04f83">P10Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i44183e3bfe624d5d8cb321bdf8e45312_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItNC0xLTEtMjg5OA_7e142fee-8b45-4010-af2c-119293c05e43"
      unitRef="usd">4020000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i44183e3bfe624d5d8cb321bdf8e45312_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItNi0xLTEtMjg5OA_63377c76-29ef-43ea-b528-e3eab2d7fedf"
      unitRef="usd">213000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i44183e3bfe624d5d8cb321bdf8e45312_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzItOC0xLTEtMjg5OA_e85ac772-ef17-4fe5-a7a8-4cf24d7af3d9"
      unitRef="usd">3807000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6ba47742d675456f97dcddba2466e3f9_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtMi0xLTEtMzQzNw_ebda0699-305d-451d-9f7e-7b7a9534b729">P3Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i12a267c66f9e460cbcdd61aca29f6e43_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtNC0xLTEtMjg5OA_f883f11d-16eb-4011-b246-844bdb21f18c"
      unitRef="usd">2765000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i12a267c66f9e460cbcdd61aca29f6e43_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtNi0xLTEtMjg5OA_8ebbe9ad-a31f-452e-85d0-9a87c6b48d65"
      unitRef="usd">1012000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i12a267c66f9e460cbcdd61aca29f6e43_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzMtOC0xLTEtMjg5OA_3c001233-b6ed-43e2-b930-f41b8fd936ea"
      unitRef="usd">1753000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzQtNC0xLTEtMjkwMw_5aeab268-b545-4d9a-bbe3-22ba8bd44af8"
      unitRef="usd">16072000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzQtNi0xLTEtMjkwMw_7941d5df-5703-4ace-960e-fbe71c8ac7db"
      unitRef="usd">1588000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NTgvZnJhZzo0MTYyY2VkMTBhODY0YmE3YmM1ODViNmM0ODMzYTJlOS90YWJsZTo5YTM0Y2RkY2E1NDY0YzM2OTA4ZTg0Mzg3NTljY2NjOS90YWJsZXJhbmdlOjlhMzRjZGRjYTU0NjRjMzY5MDhlODQzODc1OWNjY2M5XzQtOC0xLTEtMjkwMw_c8d6790c-2629-4e9a-9eee-e183c3ab0e67"
      unitRef="usd">14484000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90ZXh0cmVnaW9uOmU4YjVmY2I0MjkyMTQyMTBiMDZlODAyMzZkOGIyOWI5XzEwOTk1MTE2MjkxMDY_bc984318-660c-4d5d-a141-ff4672b08a4e">DISCONTINUED OPERATIONS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On June 4, 2019, the Company acquired Vilex, a manufacturer of foot and ankle surgical implants. Since the Vilex products included adult offerings that were not core to the Company's pediatric business, the Company received Board approval to take the steps necessary to divest the non-core Vilex assets and those Vilex assets were sold on December 31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following summarized financial information has been segregated from continuing operations and reported as discontinued operations for the three and six months ended June 30, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:75.403%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.597%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three and Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90ZXh0cmVnaW9uOmU4YjVmY2I0MjkyMTQyMTBiMDZlODAyMzZkOGIyOWI5XzEwOTk1MTE2MjkxMDc_131cabad-b0b6-4f73-953d-f4c2b4a2aacd">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following summarized financial information has been segregated from continuing operations and reported as discontinued operations for the three and six months ended June 30, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:75.403%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.597%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three and Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzItMS0xLTEtMzQ0Mw_a9e86ba5-5d21-4b99-b307-a6fd72903260"
      unitRef="usd">414000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzItMS0xLTEtMzQ0Mw_feefc105-7ab2-4582-9a65-e658e3cb927a"
      unitRef="usd">414000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzMtMS0xLTEtMzQ0Mw_0e9710e4-4d85-48d2-b8b0-bff0d6f89bc9"
      unitRef="usd">507000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzMtMS0xLTEtMzQ0Mw_a4f127cc-4516-400d-b236-2a487dbe12ad"
      unitRef="usd">507000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzQtMS0xLTEtMzQ0Mw_256b1a9d-b0aa-4121-a15a-702669592771"
      unitRef="usd">66000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzQtMS0xLTEtMzQ0Mw_d0abebed-aeab-4e92-a74b-664514e1895d"
      unitRef="usd">66000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzUtMS0xLTEtMzQ0Mw_0f4dd68f-6dbc-42fe-bd46-f08be29a579e"
      unitRef="usd">-159000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzUtMS0xLTEtMzQ0Mw_d924158d-11da-4986-a2da-dbbddaa6ce65"
      unitRef="usd">-159000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzctMS0xLTEtMzQ0Mw_2f8c4c70-2ff8-421f-8156-da2471a95bf9"
      unitRef="usd">-159000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ic9c7589d608c48a49adf5d55b43929f4_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NDkvZnJhZzplOGI1ZmNiNDI5MjE0MjEwYjA2ZTgwMjM2ZDhiMjliOS90YWJsZTo3NzhkNDNiMDAyYWQ0OWE5YmZmMjliYjg5MWQ3ODkzMC90YWJsZXJhbmdlOjc3OGQ0M2IwMDJhZDQ5YTliZmYyOWJiODkxZDc4OTMwXzctMS0xLTEtMzQ0Mw_588c3888-38ff-49c1-bd1d-613140d453af"
      unitRef="usd">-159000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzY3MA_da987bad-2915-4894-95c7-5d6b1c21dfa4">DEBT AND CREDIT ARRANGEMENTS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Long-term debt consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:57.069%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.064%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.065%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Note payable to Squadron&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revolving credit facility with Squadron&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mortgage payable to affiliate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term debt with affiliate, net of current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On December 31, 2017, we entered into a Fourth Amended and Restated Loan and Security Agreement, or the Loan Agreement, with Squadron Capital LLC, or Squadron. Pursuant to the Loan Agreement, a majority of the term loan amounts under the previous agreement with Squadron were consolidated into a $20,000 term note, or the Term Note A, and a $15,000 revolving credit facility was established. Both facilities include interest only payments and provide for an interest rate equal to the greater of (a) three month LIBOR plus 8.61% and (b) 10%. The Loan Agreement also extended the maturity date to January 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In order to finance a portion of the cash consideration for the acquisition of the Vilex Companies, the Company entered into a First Amendment, or the First Amendment, to the Loan Agreement (as so amended, the "First Amended Loan Agreement"), with Squadron. The First Amended Loan Agreement provided for a new $30,000 term loan facility, represented by a Term Note B,  in addition to the existing $20,000 Term Note A and $15,000 revolving credit facility. Similar to the other facilities under the First Amended Loan Agreement, the Term Note B was subject to interest only payments at an interest rate equal to the greater of (a) three month LIBOR plus 8.61%, and (b) 10.00%. The Term Note B, which would have matured no later than May 31, 2020, was paid in full on December 31, 2019 using $25,000 received in exchange for the divestiture of the adult product offerings of Vilex and the related Orthex license agreement, and $5,000 from the available Squadron revolving credit facility. On January 4, 2020, the Company paid $5,000 on the revolving loan agreement with Squadron. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:7pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:123%;"&gt;Borrowings under the First Amended Loan Agreement are secured by substantially all of the Company's assets and are unconditionally guaranteed by each of its subsidiaries with the exception of Vilex. There are no traditional financial covenants associated with the First Amended Loan Agreement. However, there are negative covenants that prohibit us from, among other things, transferring any of our material assets, merging with or acquiring another entity, entering into a transaction that would result in a change of control, incurring additional indebtedness, creating any lien on our property, making investments in third parties and redeeming stock or paying dividends.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of our notes payable to Squadron were estimated based on prices for the same or similar issues and the current interest rates offered for the debt of the same remaining maturities, which are considered level 2 inputs in accordance with ASC Topic 820, &#x201c;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&#x201d; At June&#160;30, 2020, the fair value approximated the carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In connection with the purchase of our office and warehouse space in Warsaw, Indiana in August 2013, we entered into a mortgage note payable to Tawani Enterprises Inc., an affiliate of Squadron. Pursuant to the terms of the mortgage note, we pay Tawani Enterprises Inc. monthly principal and interest installments of $16 with interest compounded at 5% until maturity in 2028, at which time a final payment of remaining principal and interest is due. The mortgage is secured by the related real estate and building.  At December 31, 2019, the mortgage balance was $1,300 of which current principal due of $124 was included in current portion of long-term debt.  At June 30, 2020 the mortgage balance was  $1,238 of which current principal of $128 was included in current portion of long-term debt.  &lt;/span&gt;&lt;/div&gt;Interest expense relating to notes payable to Squadron and Tawani was $513 and $632 for the three months ended June&#160;30, 2020 and 2019, respectively, and $892 and $935 for the six months ended June&#160;30, 2020 and 2019, respectively.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzY3Mg_11cf1b66-a197-4313-8d82-f7439c29eeb7">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Long-term debt consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:57.069%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.064%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.602%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.065%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Note payable to Squadron&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Revolving credit facility with Squadron&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Mortgage payable to affiliate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Long-term debt with affiliate, net of current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:NotesPayable
      contextRef="ibb96a082b67d4e369fad244fcf9ecea7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMS0xLTEtMS0w_cf81f3d4-8bb4-4009-8a65-d29f7d7a6827"
      unitRef="usd">19907000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="i58298dbcea9a43738bf180f55aa6c005_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMS0zLTEtMS0w_52cc6ffe-8e17-41a0-8231-6d14b3e83f3f"
      unitRef="usd">19891000</us-gaap:NotesPayable>
    <us-gaap:LongTermDebt
      contextRef="i4212d5ada3e1486386101c68b4a3ff9b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMi0xLTEtMS0w_51386c07-99a6-4574-b356-aaf9d8a9d8ae"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i97ee1b03f3f34cb8a5a900dbd94f9e8a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfMi0zLTEtMS0w_14b5f50b-eae5-4c8d-a74f-8055cc0d072b"
      unitRef="usd">5000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i55c4e72e21c0402b9665b56e75791946_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNC0xLTEtMS0w_0a8e42e9-4f26-4e2d-85b8-22bc858c3859"
      unitRef="usd">1238000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i522cee87c6934a54b91779a2e4a36983_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNC0zLTEtMS0w_f4e4d633-e1a7-4260-8e4d-0dcb8bf590ab"
      unitRef="usd">1300000</us-gaap:LongTermDebt>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNS0xLTEtMS0w_adb65dc7-77d7-43f5-a90c-55b2d463de17"
      unitRef="usd">21145000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNS0zLTEtMS0w_277de826-481c-4ba6-a1af-a87d42283175"
      unitRef="usd">26191000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNi0xLTEtMS0w_28a475b6-fa96-4a7e-833e-b5f21c8eb0e5"
      unitRef="usd">128000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNi0zLTEtMS0w_dd611b7b-8dde-457a-9f93-56785017e4af"
      unitRef="usd">124000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNy0xLTEtMS0w_1ea815b8-48f4-416e-a93d-150dc48150fe"
      unitRef="usd">21017000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RhYmxlOjgxZTcxMmZlMzIwMzRkODhiNzY2ZmQxODQwM2RmMTlmL3RhYmxlcmFuZ2U6ODFlNzEyZmUzMjAzNGQ4OGI3NjZmZDE4NDAzZGYxOWZfNy0zLTEtMS0w_f2a81a49-5626-4869-a9a6-b162c8553c3b"
      unitRef="usd">26067000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i32ecfc1db0094cdf9b81fbbdb546dc71_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzg3_d86f5052-aef8-4da3-bec9-943e628ca59b"
      unitRef="usd">20000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i91313831b49b4497a30f40930e592148_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNDI3_e9fce331-0912-444a-b012-e616ea6f753e"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia750dea5d4f84490a3ed6d2032d6b369_D20190604-20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjA0_3902f82c-8902-4f44-be28-384c6780f8e7"
      unitRef="number">0.0861</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifea33470bf02413c92995e85b05b1ad0_D20171231-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjA0_551fb194-4d98-4ce8-a13a-a12a52e3b032"
      unitRef="number">0.0861</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iaabfc50f270c4500963cf0c8d1d79fe8_I20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjE1_89c53362-42f0-4fdf-b2fb-5a0d0af71b70"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i2a7811335a9947b3b93354b5f0367da1_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfNjE1_b08fd373-0c4a-480a-9141-b500876920b6"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2d597c299e87430aaf3c619817196928_I20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfOTg1_33b5cd1c-b415-44c4-a1c0-2428dd9e5153"
      unitRef="usd">30000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt
      contextRef="i32ecfc1db0094cdf9b81fbbdb546dc71_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTA2Nw_d86f5052-aef8-4da3-bec9-943e628ca59b"
      unitRef="usd">20000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i91313831b49b4497a30f40930e592148_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTA4Ng_e9fce331-0912-444a-b012-e616ea6f753e"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia750dea5d4f84490a3ed6d2032d6b369_D20190604-20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMwNw_3902f82c-8902-4f44-be28-384c6780f8e7"
      unitRef="number">0.0861</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifea33470bf02413c92995e85b05b1ad0_D20171231-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMwNw_551fb194-4d98-4ce8-a13a-a12a52e3b032"
      unitRef="number">0.0861</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="iaabfc50f270c4500963cf0c8d1d79fe8_I20190604"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMxOQ_89c53362-42f0-4fdf-b2fb-5a0d0af71b70"
      unitRef="number">0.1000</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i2a7811335a9947b3b93354b5f0367da1_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTMxOQ_b08fd373-0c4a-480a-9141-b500876920b6"
      unitRef="number">0.1000</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="i7eba4623b24a447fbe2ee28df0cdd245_D20191231-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTQzNw_6b6e193c-5126-4028-bc40-851ca935a1a9"
      unitRef="usd">25000000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="if5755d80d80843eaa4f3d75bcc7bbba4_D20191231-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTU2Nw_4143b4ee-ae66-4202-aa7b-4c008b8a0239"
      unitRef="usd">5000000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="i9e31cbfbaa6540549a2b910c978401be_D20200104-20200104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMTY2Mg_b96430e9-f75c-48b6-a33f-638ad76024f8"
      unitRef="usd">5000000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="i3be7e495a9b44feba44e00526454ab10_D20130801-20130831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzA2MQ_d6e94a63-4fe1-4662-bb28-71805cdf9d51"
      unitRef="usd">16000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i901f004c0d1149749e65dd0a69e57ff2_I20130831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzA5Mg_80d3b0ab-e0f9-44be-b7ae-824d5a49884e"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i522cee87c6934a54b91779a2e4a36983_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzMwNw_ede04ab3-accf-47da-b98f-638b4241dbe2"
      unitRef="usd">1300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i522cee87c6934a54b91779a2e4a36983_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzM0NQ_2feba72b-6a3a-4b22-9a01-f28f5c1cb781"
      unitRef="usd">124000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebt
      contextRef="i55c4e72e21c0402b9665b56e75791946_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzQ0NQ_2f57f47f-b1ec-48a6-b62e-d9452d4508c4"
      unitRef="usd">1238000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i55c4e72e21c0402b9665b56e75791946_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzQ4MA_3397a05d-8921-445c-ae6c-989394f30105"
      unitRef="usd">128000</us-gaap:LongTermDebtCurrent>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0ce9195684154b7296d03f48c3f26321_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzYwOA_606729de-a536-4bc4-8b3c-62d2090efbdd"
      unitRef="usd">-513000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic2f23483cdc3453791280df0471e41a9_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF80OS9mcmFnOjg0MTMwOGM3NzhiNzQzZjBiZDU5YTIxYjJjNGRlZGUyL3RleHRyZWdpb246ODQxMzA4Yzc3OGI3NDNmMGJkNTlhMjFiMmM0ZGVkZTJfMzYxNQ_b7095ce6-c8a2-4af4-a8ca-3910dd0d509d"
      unitRef="usd">-632000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTU2MQ_4169419b-d338-4852-927f-29a539aa4257">STRATEGIC ARRANGEMENTS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Effective December 1, 2007, we entered into a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfODQ_bf262227-ff5c-44d1-a84e-6eebb551fe29"&gt;ten&lt;/span&gt;-year agreement with Case Western Reserve University (&#x201c;CASE&#x201d;) to assist in certain aspects of our research and development. Effective August 2, 2017, we entered into an Amended and Restated License Agreement to account for additional licensed product and extend the agreement for another ten years. The main focus of this research and development involves leveraging our exclusive rights to the Hamann-Todd Collection of the Cleveland National History Museum, the world's largest pediatric osteological collection, to assist in the design of implants which match pediatric bone curvature and structure.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In exchange for services, CASE receives certain royalties and up-front fees. The royalties and certain fees are contingent upon our obtaining FDA approval and the launch of our products into the marketplace. CASE receives a minimum annual royalty of $10 or a royalty of 3% of net sales on products, whichever is greater. Additionally, for each new product developed, CASE will receive milestone payments of $5 for FDA approval to sell our products within the United States and $10 for general product launch. Additionally, CASE receives a royalty of 3% of net sales on products fully developed and being sold in the marketplace.&lt;/span&gt;&lt;/div&gt;The royalty expense recognized related to the CASE agreement is recorded as a component of cost of revenue and was $24 and $37 for the three months ended June&#160;30, 2020 and 2019, respectively, and $55 and $74 for the six months ended June&#160;30, 2020 and 2019, respectively. At June&#160;30, 2020 and December 31, 2019, $24 and $39, respectively, was due to CASE.</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <kids:ResearchandDevelopmentArrangementContracttoPerformforOthersTerm
      contextRef="i9e4452d90eff4a999d49f7af62efccde_D20170802-20170802"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMzc0_3f07be00-5474-48a1-bdcc-7c87e7957d67">P10Y</kids:ResearchandDevelopmentArrangementContracttoPerformforOthersTerm>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment
      contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfOTMz_64b66a0a-51ca-41a0-adf5-f2bbdb9f5a39"
      unitRef="usd">10000</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent
      contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfOTUy_2c012d31-2cb8-42a5-b830-69d7116cd153"
      unitRef="number">0.03</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment
      contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTA4OQ_d63ecf04-9a0d-4a83-9701-0507a22dca8d"
      unitRef="usd">5000</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment
      contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTE1OQ_5ec90c39-6d8b-4d3c-b588-33f78aab8538"
      unitRef="usd">10000</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent
      contextRef="id02075ffbd724ac9804ef8be24dc2e25_D20071201-20071201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTIzMQ_c3dc8411-ffd2-487c-82a3-9d30ca66357c"
      unitRef="number">0.03</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent>
    <us-gaap:RoyaltyExpense
      contextRef="ib62efb33448d425f8bb4b13674e7e6c7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTQyNg_e8450ffa-6316-456b-b740-4e07be44cc7d"
      unitRef="usd">24000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="i6e2ab5c81fda421daa443c34171cffb0_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTQzMw_67e0e00d-3f3a-4846-a734-c02ff2dd25dc"
      unitRef="usd">37000</us-gaap:RoyaltyExpense>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i6b009d063c2e467993e163ef9a164f0e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTUxNw_6969ab88-cf1b-47f2-a6b2-c1f5d87383df"
      unitRef="usd">24000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i720e0f76ea12446a83bf8ab6c5736641_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfMTUyNA_18405ff3-fcc0-49e2-974b-82f611a9e91d"
      unitRef="usd">39000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMzMyMw_e53a4b0f-2d94-4b58-bd5b-a90371c933ba">INCOME TAXES &lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 ("2017 Tax Act"). Corporate taxpayers may carryback net operating losses ("NOLs") originating during 2018 through 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for tax years beginning January 1, 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In addition, the CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally eligible for 15-year cost-recovery and 100% bonus depreciation. The enactment of the CARES Act did not result in any material adjustments to our income tax provision for the three or six months ended June 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For the three and six months ended June&#160;30, 2020 and 2019, we calculated the provision of income taxes by applying an estimate of the annual effective tax rate for the full fiscal year to the ordinary loss for the reporting period resulting in a zero tax provision consistent with prior periods.  &lt;/span&gt;&lt;/div&gt;The deferred tax assets were fully offset by a valuation allowance at June&#160;30, 2020 and December 31, 2019, and no income tax benefit has been recognized in our condensed consolidated statements of operations for any of the periods presented.  At December 31, 2019, we had available federal and state tax loss carryforwards of $86,807, state loss carryforwards of $64,026 and tax credits for federal and state tax purposes of $260. Federal net operating losses generated after January 1, 2018 will have an indefinite carryforward period. An ownership change under Section 382 of the Internal Revenue Code was deemed to occur on May 30, 2014.  Given the limitation calculation, we anticipate approximately $16,200 in losses generated prior to the ownership change date will be subject to potential limitation. The estimated annual limitation is $1,062. A second ownership change under Section 382 was deemed to occur on December 11, 2018. The estimated annual limitation is $9,736, which is increased by $22,430 annually over the first five years as a result of an unrealized built in gain. NOLs sustained prior to May 30, 2014 will still be constrained by the lower limitation. Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred over the three-year period ended  June&#160;30, 2020. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_4cb09a7c-07a8-4c8c-bf50-3c8031b7b395"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_64cc34ab-8088-462a-836a-15436ba9a825"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_95978b75-23bc-40c3-a3f0-ad8dab986b19"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTY5MQ_f9472ef0-ec96-4857-8ab0-ee48d744365c"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTg0MA_39b7c3d6-25da-44e2-ad84-dcebc6108fbd"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMTg0MA_5c81297d-196f-4c59-9696-a5594593dbca"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8ae1c5b976b9426ea7c2afb46f2de085_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjA1Mw_2813e677-aa4c-4749-ba35-a55b2efd7d7e"
      unitRef="usd">86807000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i9cf3572a27664de18b2b944dc137f71d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjA4NQ_15514056-2061-4e1c-a7df-7af228944345"
      unitRef="usd">64026000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjE0Mg_daecb844-580f-4887-86d9-9a7a848e85df"
      unitRef="usd">260000</us-gaap:TaxCreditCarryforwardAmount>
    <kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation
      contextRef="i86c42bd634d6439e9ab4f9d4586e1807_I20140530"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjQxOQ_6447a114-349b-42a8-b9b0-ed55b8db1ab9"
      unitRef="usd">16200000</kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation>
    <kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit
      contextRef="i86c42bd634d6439e9ab4f9d4586e1807_I20140530"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjU1Mw_970bde24-214a-4736-b7dd-6520c01bf773"
      unitRef="usd">1062000</kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit>
    <kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit
      contextRef="i5fc9092f14204444ba24d4c873eb6e82_I20181211"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjY3OA_1ade6bba-db0d-45f9-b1fb-fc848dc37b03"
      unitRef="usd">9736000</kids:OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit>
    <kids:OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease
      contextRef="i5fc9092f14204444ba24d4c873eb6e82_I20181211"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81NS9mcmFnOmZmNGFiMmMxNzQzYjQ3MGM5N2M5NmZkN2YwNmY2NjgyL3RleHRyZWdpb246ZmY0YWIyYzE3NDNiNDcwYzk3Yzk2ZmQ3ZjA2ZjY2ODJfMjcwNA_76a2cd77-d3d6-41dc-b670-f656e91a7848"
      unitRef="usd">22430000</kids:OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg1Nw_49ea64ca-0cd2-472d-8dd9-2872db9a9e08">STOCKHOLDERS&#x2019; EQUITY&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value for options granted at the time of issuance were estimated at the date of grant using a Black-Scholes options pricing model. Significant assumptions included in the option value model include the fair value of our common stock at the grant date, weighted average volatility, risk-free interest rate, dividend yield and the forfeiture rate. There were no stock options granted in any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our stock option activity and related information are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.070%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.788%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.788%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contractual Terms&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(41,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Options generally include a time-based vesting schedule permitting the options to vest ratably over three years. At June&#160;30, 2020 and December 31, 2019, all options were fully vested. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;There was no stock-based compensation expense on stock options for the three and six months ended June&#160;30, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our restricted stock activity and related information are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:56.333%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.032%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.033%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contractual Terms&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;318,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;158,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(38,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;437,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted stock exercisable at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;At June&#160;30, 2020, there was $9,865 of unrecognized compensation expense remaining related to our service-based restricted stock awards. The unrecognized compensation cost was expected to be recognized over a weighted-average period of 1.6 years or earlier upon an elimination of the restriction period as a result of a change in control event. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Stock-based compensation expense on restricted stock amounted to $2,495 and $692 for the three months ended June&#160;30, 2020 and 2019, respectively, and $3,453 and $1,163 for the six months ended June&#160;30, 2020 and 2019, respectively. The increase in the stock compensation expense for the three months ended June 30, 2020 was due to a one-time stock grant to the Company's Chief Executive Officer that vested immediately resulting in an additional $1,322 of expense.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our warrant activity and related information are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:54.058%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.607%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.163%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.607%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.165%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For all periods presented, the warrants were issued at an exercise prices of $30.97 per share. The warrants have a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTU5Ng_22c0bf25-8204-4c32-a466-8f4c334e3f8a"&gt;ten&lt;/span&gt;-year term. At June&#160;30, 2020, no warrants had been exercised.  At inception, no fair value was assigned to the warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNDE3_071249f6-43a6-48a8-9283-1088bf581eca"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNDE3_bb3ccead-a930-4e03-a229-72b77b7c48fc"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg1OQ_ede436df-88aa-4a49-b858-2cc926944e46">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our stock option activity and related information are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.070%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.788%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.788%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.951%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contractual Terms&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(41,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMi0yLTEtMS0w_4dc08e6f-7413-4cc9-8fe5-36f0a9f831cd"
      unitRef="shares">70628</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMi00LTEtMS0w_3fcafe0f-d71e-4888-8c8c-fe04c5b37b85"
      unitRef="usdPerShare">30.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iaff3b8a415a248e1b649428771d5dd22_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMi02LTEtMS0w_f294d825-84f2-4a21-b995-84c9bac65a80">P1Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMy0yLTEtMS0w_0dfedc81-296a-430c-9242-1b81e4d2e28d"
      unitRef="shares">41370</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfMy00LTEtMS0w_e8aa0eee-a7f2-4bdc-be71-57788e7cdcc7"
      unitRef="usdPerShare">30.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfNS0yLTEtMS0w_6a7ec493-2b22-4526-9482-f0dfd9552e8f"
      unitRef="shares">29258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfNS00LTEtMS0w_a1097fbb-2ad6-4877-a1b3-69d50b10b757"
      unitRef="usdPerShare">30.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQ0ZTNlYjI3MDFmYzRlMmU4MjE2OGYyMDdhYzFhZWEzL3RhYmxlcmFuZ2U6NDRlM2ViMjcwMWZjNGUyZTgyMTY4ZjIwN2FjMWFlYTNfNS02LTEtMS0w_9d04ed77-873a-465a-97ef-14cc8eb02ad4">P1Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6b8a3c8fd6994c91bfa372ef62e86e22_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNjU3_e38cc4df-4f3f-4f57-9ba6-aac9b76af4d6">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i20d35bb680f64b0ba2acd454d8e86d83_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_12d9ebfc-1611-470d-aaf5-986d095d93ed"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iad46059f454f4bbea038030b853e05e6_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_8459f26f-1e50-486d-b004-21d6e4600478"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6b8a3c8fd6994c91bfa372ef62e86e22_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_9a51c7c4-a9a8-4edf-a8c7-4e4a11985039"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4c7c78b58af646cd96f6b8bd5e1d1d13_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfNzMx_9dbf093b-54c3-4fcf-927c-16dfddc0b76b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg2NA_d68f2a0f-e428-484b-a6bb-fda83e423d84">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our restricted stock activity and related information are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:56.333%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.032%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.033%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Contractual Terms&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;318,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;158,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(568)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(38,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;437,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted stock exercisable at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i432d3aa78750469da80bdc567e4824f6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNC0yLTEtMS0w_090845d1-0ce4-493b-8150-fa53dbcb294e"
      unitRef="shares">318002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ie158e3539d5e4934824bb0f77b22ef76_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNC00LTEtMS0w_22cf397e-e2d8-4483-b94c-6aa87fee5688">P1Y8M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNS0yLTEtMS0w_e9044876-5115-40fb-bf86-0552501ac9a1"
      unitRef="shares">158310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNi0yLTEtMS0w_17669840-62fa-442b-8f35-de40b35292f8"
      unitRef="shares">568</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfNy0yLTEtMS0w_1a8bcc56-4d1c-4c2d-af20-d32f857fa45b"
      unitRef="shares">38397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3bb3e606a2bd424d964faaf220d28e88_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfOC0yLTEtMS0w_8800d1b9-caed-47cf-bc3a-6dc2c1cd5798"
      unitRef="shares">437347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfOC00LTEtMS0w_a28c8966-68e9-4cc5-a55c-96052a59312b">P1Y7M6D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <kids:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber
      contextRef="i3bb3e606a2bd424d964faaf220d28e88_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOjQwMGNjYWY5YTJkNjQ0NmZhMjE5MjljMTJkM2M0NTg4L3RhYmxlcmFuZ2U6NDAwY2NhZjlhMmQ2NDQ2ZmEyMTkyOWMxMmQzYzQ1ODhfOS0yLTEtMS0w_bf1554f2-ed5f-4b05-904b-0190706e20db"
      unitRef="shares">0</kids:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i3bb3e606a2bd424d964faaf220d28e88_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfOTU3_a5dee106-2074-4fb3-801c-52a217ee1f2b"
      unitRef="usd">9865000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i063b52e563b84f4b8d2d06e63e4a151e_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTE2MA_2d55f263-c086-48a5-981f-006097cc5a46">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensation
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMzg0ODI5MDY5OTI4Mw_4288501d-5d8c-4198-9b71-f304eeb4830f"
      unitRef="usd">2495000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMzg0ODI5MDY5OTI4OQ_5b2b3254-4983-4fab-9441-a0095c4d9fac"
      unitRef="usd">692000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTMzNQ_48ee25fd-7270-4682-b04c-21eff46ae760"
      unitRef="usd">3453000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMzg0ODI5MDY5OTI2MQ_f1911a56-b290-44c2-9807-799ebe74d9e7"
      unitRef="usd">1163000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idbb6455ee34645b9b482fe979192967c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTA5OTUxMTYzMDQ1NA_9a870fc8-7526-4f59-96f4-bf73fda86b76"
      unitRef="usd">1322000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTg2MQ_337c5597-4529-498a-90a4-866f78e596d8">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our warrant activity and related information are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:54.058%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.607%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.163%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.607%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.165%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted-Average&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Outstanding at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfMi0yLTEtMS0w_bcf99818-a615-4738-9ea6-62b3703241cb"
      unitRef="shares">404</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ie4e2a354b98945b7ac75843c10a25a44_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfMi00LTEtMS0w_5f3e8781-8a8f-4722-a20f-14900637e4d3"
      unitRef="usdPerShare">30.97</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfNC0yLTEtMS0w_f71a519e-6592-4f15-a965-be34b17250d3"
      unitRef="shares">404</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RhYmxlOmNiMjg2ZWU4MzIxODRlZTc5YTdhZWI5ZjA3MjYyMWI1L3RhYmxlcmFuZ2U6Y2IyODZlZTgzMjE4NGVlNzlhN2FlYjlmMDcyNjIxYjVfNC00LTEtMS0w_13b3b5eb-552a-4c3a-b90b-685719d76013"
      unitRef="usdPerShare">30.97</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTU2Mg_ab74e385-98e0-4176-b86a-e5a2d9ca702d"
      unitRef="usdPerShare">30.97</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <kids:ClassOfWarrantOrRightExercised
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTYxNw_30b0a5fe-aec9-4c01-90a3-ceccebb917ec"
      unitRef="shares">0</kids:ClassOfWarrantOrRightExercised>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RleHRyZWdpb246MTllYmQyYjBhMTQyNDYxN2JiNjA1YmE1YmZkNzE4NzhfOTQ3_b0b5d5b3-a157-4fc7-acf9-464f8b1fab9f">NET LOSS PER SHARE&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following is a reconciliation of basic and diluted net loss per share:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:49.762%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.538%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.538%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.538%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.541%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average number of shares - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,549,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,451,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,986,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,409,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.54)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Our basic and diluted net loss per share is computed using the two-class method.&#160; The two-class method is an earnings allocation that determines net income per share for each class of common stock and participating securities according to their participation rights in dividends and undistributed earnings or losses.&#160; Non-vested restricted stock that includes non-forfeitable rights to dividends are considered participating securities.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Because we have incurred a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share. The following contingently issuable and convertible equity shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for all periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.160%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.520%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.600%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.520%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;437,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;307,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;467,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;403,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RleHRyZWdpb246MTllYmQyYjBhMTQyNDYxN2JiNjA1YmE1YmZkNzE4NzhfOTQ4_38b06b8e-ad5b-495e-b5a4-8163a2369915">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following is a reconciliation of basic and diluted net loss per share:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:49.762%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.538%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.538%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.538%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.541%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Weighted average number of shares - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,549,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,451,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,986,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,409,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.54)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS0xLTEtMS0w_84be1d29-a645-4ba8-ab8e-f43bd854fb81"
      unitRef="usd">-9447000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS0zLTEtMS0w_14075e3b-032d-454b-9814-6e419bd2b558"
      unitRef="usd">-2618000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS01LTEtMS0w_feccc401-16e0-41ae-9ad8-6ee170a935d9"
      unitRef="usd">-14392000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNS03LTEtMS0w_879eb903-509d-44af-ab28-ddd8afa2e1b8"
      unitRef="usd">-5638000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy0xLTEtMS0w_f26c6a55-96a4-48fc-a882-236f5ec94dfa"
      unitRef="shares">17549118</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy0zLTEtMS0w_d9c49ce6-43bd-472d-8c02-3e3b678d7661"
      unitRef="shares">14451979</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy01LTEtMS0w_7a8ab222-7efd-4a55-99df-bb71b3b5e5fb"
      unitRef="shares">16986485</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfNy03LTEtMS0w_232c42cb-fe8e-4d4d-9b49-3ead5057524c"
      unitRef="shares">14409752</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC0xLTEtMS0w_5a9a0616-141a-4caf-af7e-1d4ef50a3508"
      unitRef="usdPerShare">-0.54</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC0zLTEtMS0w_21d40350-c507-48b4-9ea5-1b0ef8bf8f72"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC01LTEtMS0w_00e554c0-c9b8-4c15-94f5-0974c56fbfaf"
      unitRef="usdPerShare">-0.85</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOmYxMmU0OThmYTQ2MjQ2YzdhYWJmYjZlNWI4YWQ4OWU3L3RhYmxlcmFuZ2U6ZjEyZTQ5OGZhNDYyNDZjN2FhYmZiNmU1YjhhZDg5ZTdfOC03LTEtMS0w_c613b5a4-9e3d-4d9d-b9b8-10fa9db21baf"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RleHRyZWdpb246MTllYmQyYjBhMTQyNDYxN2JiNjA1YmE1YmZkNzE4NzhfOTUx_75dd4045-e3b5-40db-a7fe-f44b19e81c51">The following contingently issuable and convertible equity shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for all periods presented:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.160%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.520%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.600%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.520%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;437,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;307,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;90,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;467,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;403,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7f161809f3474a4cabfb3f9e420c96d1_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNC0xLTEtMS0w_ba6aa2ea-83fd-4c4d-85d6-b8522bdbcd5a"
      unitRef="shares">437347</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7204f2c032b942a68028138eeece4cee_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNC0zLTEtMS0w_fef23cef-cf27-4b07-aba0-2261bcdff087"
      unitRef="shares">307347</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i46623ac889f4451080c334614620617b_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNS0xLTEtMS0w_0f13a88a-4c95-4e7c-b5ec-7114136143c6"
      unitRef="shares">29258</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ife2d42f413d047f09f78455b81ba82e0_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNS0zLTEtMS0w_b287d5b9-0a75-4c06-a9e5-377430f87858"
      unitRef="shares">90685</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i00909a9da62143989aea8f861f283df1_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNi0xLTEtMS0w_afe463a4-1d64-4278-8b30-47f6d69d3387"
      unitRef="shares">404</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1d4b7eb4460144da819f7cf668aa8bdd_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNi0zLTEtMS0w_9a57f7d0-b01d-41eb-a061-0e8862b8c769"
      unitRef="shares">4979</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNy0xLTEtMS0w_bd8c5f96-72d6-4408-8c73-49d1f2bba3ab"
      unitRef="shares">467009</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82MS9mcmFnOjE5ZWJkMmIwYTE0MjQ2MTdiYjYwNWJhNWJmZDcxODc4L3RhYmxlOjA4Njk2YzY0MTg3ZjQ4Nzk5OTU3MmU2MWM2YjdmYWZjL3RhYmxlcmFuZ2U6MDg2OTZjNjQxODdmNDg3OTk5NTcyZTYxYzZiN2ZhZmNfNy0zLTEtMS0w_8c25d6c4-1ccb-43e7-8898-ab1487ef6ceb"
      unitRef="shares">403011</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMTg3MQ_cbf3e21f-c59a-439f-9432-01709b56f5b4">BUSINESS SEGMENT  &lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. We have one operating and reporting segment, OrthoPediatrics Corp., which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. Our chief operating decision-maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance, accompanied by disaggregated revenue information by product category. We determined that disaggregating revenue into these categories achieves the disclosure objective of illustrating the differences in the nature, timing and uncertainty of our revenue streams. We do not assess the performance of our individual product categories on measures of profit or loss, or other asset-based metrics. Therefore, the information below is presented only for revenue by category and geography. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Product sales attributed to a country or region includes product sales to hospitals, physicians and distributors and is based on the final destination where the products are sold. No customers accounted for more than 10% of total product sales for the three and six months ended June&#160;30, 2020 or 2019. No customer accounted for more than 10% of consolidated accounts receivable as of June&#160;30, 2020 and December 31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Product sales by source were as follows: &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.423%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.425%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Product sales by geographic location:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.423%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Product sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trauma and deformity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Scoliosis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sports medicine/other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;No individual country with sales originating outside of the United States accounted for more than 10% of consolidated revenue for the three and six months ended June&#160;30, 2020 and 2019.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMzE5_2450d501-5972-4a75-b1e5-5802773d560e"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMzE5_c1661e31-e0e6-451d-a7f7-61a06d17a0a4"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMTg3Mw_7c9e869b-e64a-468c-af11-c98ae7fd3927">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Product sales by source were as follows: &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-bottom:6pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.423%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.425%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Product sales by geographic location:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice73e8c1b57f4796918a790a968b7015_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi0xLTEtMS0w_ba8d9d3c-118e-4dd1-ab12-6c312b42a185"
      unitRef="usd">12146000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2622759db9c144acb87d793c9cf03743_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi0zLTEtMS0w_606915a1-aae1-490e-81ab-cae7e39604d1"
      unitRef="usd">13848000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9c269ea2edf4cf5aef8ed02d7e1f45c_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi01LTEtMS0w_3c5f3cf2-6a3a-4f49-80c4-6c67aec09829"
      unitRef="usd">25530000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fb48cad575945baac6067e33a96cadc_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMi03LTEtMS0w_e33b0025-a1ae-43fc-b75f-481465c2757c"
      unitRef="usd">24115000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia756c05cec28403f884770d9344bdac2_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy0xLTEtMS0w_75a15d30-e44f-417d-8875-2efadbd08ecf"
      unitRef="usd">1447000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i721aca0cd1734c8aaf8b8d90702bc1d1_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy0zLTEtMS0w_67232c60-f74c-4439-b37e-63b7dae95911"
      unitRef="usd">4352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id10512dde3404dfcb6e3c0cce3a1f040_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy01LTEtMS0w_bbbd0f70-3d0c-49e5-8b9e-ac845c399cf2"
      unitRef="usd">4419000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i266ee2942a4a4657a71d21bdf2710068_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfMy03LTEtMS0w_d36ad5ac-958e-4c64-ba0a-b28f6573dbba"
      unitRef="usd">8741000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC0xLTEtMS0w_3a772023-5042-4fd3-a71f-8d7e2f01300d"
      unitRef="usd">13593000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC0zLTEtMS0w_c6bf7ba2-fa4c-4e90-ae6f-348aba7126b1"
      unitRef="usd">18200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC01LTEtMS0w_ae72df90-d7fe-49af-b1ec-085b8a2d8d57"
      unitRef="usd">29949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOjg0MmYxMjUzOGQ4NTQ4N2ZhNzE0YTg2MjJmY2RiMzhhL3RhYmxlcmFuZ2U6ODQyZjEyNTM4ZDg1NDg3ZmE3MTRhODYyMmZjZGIzOGFfNC03LTEtMS0w_1b594549-ed27-4e6c-b369-d24d592ad80c"
      unitRef="usd">32856000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RleHRyZWdpb246MDRmNDI3YjQ3NGUyNDUxNzgyMWZhMGY4MDU5YTRlNDdfMTg3MA_baaab50c-eda0-4f46-b9ff-8300045689d4">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:37.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.423%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.601%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.583%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.441%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.585%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Product sales by category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trauma and deformity&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Scoliosis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sports medicine/other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id78469ce723d4142ae3b8ab43ffa60a0_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi0xLTEtMS0w_68c53832-5995-42d1-becd-c251e93ff99c"
      unitRef="usd">9220000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i225cd71c1ec1426d8041c44a2184d1ae_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi0zLTEtMS0w_241cb43a-7c62-4c21-afb0-3d4e8ca08dc4"
      unitRef="usd">11887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c889130704d4f80946a9c6286e05061_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi01LTEtMS0w_e87fc33f-6266-4559-8db8-8612bbf2857c"
      unitRef="usd">21430000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ed7c2942fcb4d46a5ca89a0294a7bf5_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMi03LTEtMS0w_0a298dfe-b792-4ed9-a38f-46c046c8d652"
      unitRef="usd">21904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0fff3612ea874d5180f15f4a42bc8604_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy0xLTEtMS0w_23b20b09-c81e-4e57-9073-acadb01ac394"
      unitRef="usd">3836000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9200b24feefc4b159ffafee02cb55e00_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy0zLTEtMS0w_7ca79d2c-0dd0-40c0-beed-eded9d6e8af3"
      unitRef="usd">5866000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e7ea47b72ee450b8582bd233a4fac65_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy01LTEtMS0w_0a1512df-d2f5-46f3-b680-3582acfab64b"
      unitRef="usd">7547000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id56952e6da1c40bb95f3ecf288efc864_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfMy03LTEtMS0w_8b47acb2-808c-415c-a210-60a892fff912"
      unitRef="usd">10124000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83e4b27552214a3a879d0adf2748bebb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC0xLTEtMS0w_759c86a1-6036-407a-bc40-cacd707ec910"
      unitRef="usd">537000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c76b6d6fbcd4e0e87b78db6dea4ab41_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC0zLTEtMS0w_da2e20db-fe0e-4532-af52-91fa92b76569"
      unitRef="usd">447000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba3dd237ec5246bbba457e8a049a8981_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC01LTEtMS0w_4c138db4-2a8a-46a9-9d31-623bc8dca48e"
      unitRef="usd">972000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ce3387f4cd14200af133e93202fc096_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNC03LTEtMS0w_00066db4-430b-4eb0-88a5-c90d6f575f02"
      unitRef="usd">828000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS0xLTEtMS0w_834faec7-5c35-4369-997d-79ff3ef04cf3"
      unitRef="usd">13593000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58140275d34e4a39acc5ddb9312155b8_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS0zLTEtMS0w_8fb8d27d-0ec1-49dc-834d-2db43cc26de5"
      unitRef="usd">18200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS01LTEtMS0w_2998ae45-b652-4b98-af84-df54460586fe"
      unitRef="usd">29949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38cd6eb152154a98bb4064a5f50cff2c_D20190101-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82NC9mcmFnOjA0ZjQyN2I0NzRlMjQ1MTc4MjFmYTBmODA1OWE0ZTQ3L3RhYmxlOmY0YWI3YWFjZjAyMTRjZmI4YTM2YjA1NzcwYmI5MzgxL3RhYmxlcmFuZ2U6ZjRhYjdhYWNmMDIxNGNmYjhhMzZiMDU3NzBiYjkzODFfNS03LTEtMS0w_a0f51277-6eeb-4e7d-94c9-5a487931d3f7"
      unitRef="usd">32856000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMTA2Mg_d63d3659-3fdd-422c-bb1b-0aa4a421d9e0">RELATED PARTY TRANSACTIONSIn addition to the debt and credit agreements and mortgage with Squadron and its affiliate (see Note 6), we currently use Structure Medical, LLC (&#x201c;Structure Medical&#x201d;) as one of our suppliers. Structure Medical is affiliated with Squadron and we do not have a long-term contract with them. We made aggregate payments to Structure Medical of $934 and $1,729 for the three months ended June&#160;30, 2020 and 2019, respectively, and $2,135 and $2,493 for the six months ended June&#160;30, 2020 and 2019 . On December 31, 2019, the Company divested Vilex for $25,000 to an affiliate of Squadron. In conjunction with the divestiture, the Company also entered into an exclusive perpetual license agreement to permit the purchasers of Vilex the ability to access intellectual property and sell products using the external fixation technology of Orthex, LLC to non-pediatric accounts. The Orthex license agreement was determined to have a value of $12,410 and is determined to be a sale of functional intellectual property, resulting in the derecognition or sale of certain patent intangibles acquired in the Vilex and Orthex acquisition.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <kids:NumberOfRelatedPartyEntitiesSuppliers
      contextRef="ie0deb0d220a848e5ab3218335eba7b86_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMjEy_371f2132-f994-4a5c-b863-2c28c2199eee"
      unitRef="supplier">1</kids:NumberOfRelatedPartyEntitiesSuppliers>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i4fb8f7b19c8b43a0ab7aa696389aad13_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMzgx_75ffd39e-8cc4-4a09-86f7-d32e5cc141a8"
      unitRef="usd">934000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i82095520751c4542b0194bd4a6b61005_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfMzg4_28d5dd19-4a92-447c-8cfe-805174c2f883"
      unitRef="usd">1729000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="icef3ad5351134de9bd2e9409f0f579f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfNDk3_24079efa-9d36-4a26-8e16-dfbeda893f49"
      unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ibaad49ffb99f40309f22c27c5a29b41a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF82Ny9mcmFnOjJhYTkzZGFlZGMxMjRiYWM4MjA5M2ZmYmZjZDJhYTRjL3RleHRyZWdpb246MmFhOTNkYWVkYzEyNGJhYzgyMDkzZmZiZmNkMmFhNGNfODc3_441176a9-6a10-4e5e-88d4-1efadf80444c"
      unitRef="usd">12410000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83MC9mcmFnOmFlMWU3MWE1NWFiZjRjOTlhMDZiYzY1OGZjNWUwZGFkL3RleHRyZWdpb246YWUxZTcxYTU1YWJmNGM5OWEwNmJjNjU4ZmM1ZTBkYWRfNzgz_4e963da0-6120-4c08-b8db-23f87b5b6d36">EMPLOYEE BENEFIT PLANWe have a defined-contribution plan, OrthoPediatrics 401(k) Retirement Plan (the &#x201c;401(k) Plan&#x201d;), which includes a cash or deferral (Section 401(k)) arrangement.  The 401(k) Plan covers those employees who meet certain eligibility requirements and elect to participate. Employee contributions are limited to the annual amounts permitted under the Internal Revenue Code. The 401(k) Plan allows us to make a discretionary matching contribution. Discretionary matching contributions are determined annually by management. Effective January 1, 2020, we have elected to match our employees' 401(k) contributions up to 4% of employees' salary. Prior to January 1, 2020, we matched our employees' 401(k) contributions up to 3% of employees' salary.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i7249b3def0b34e65b3e605e288e1cc43_D20200101-20200101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83MC9mcmFnOmFlMWU3MWE1NWFiZjRjOTlhMDZiYzY1OGZjNWUwZGFkL3RleHRyZWdpb246YWUxZTcxYTU1YWJmNGM5OWEwNmJjNjU4ZmM1ZTBkYWRfNjUy_7b3dceb3-d123-4ab9-a60a-1ff29acdb73e"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="iaff3b8a415a248e1b649428771d5dd22_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83MC9mcmFnOmFlMWU3MWE1NWFiZjRjOTlhMDZiYzY1OGZjNWUwZGFkL3RleHRyZWdpb246YWUxZTcxYTU1YWJmNGM5OWEwNmJjNjU4ZmM1ZTBkYWRfNzU2_9dbdbd3b-dccc-4039-bfbd-3d1490d9a237"
      unitRef="number">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzk2OQ_fcf5927c-8bf1-43dc-ab69-20217760dbf7">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company calculates the associated lease liability and corresponding right-of-use asset upon lease commencement using a discount rate based on a borrowing rate commensurate with the term of the lease. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Company records lease liabilities within current liabilities or long-term liabilities based upon the length of time associated with the lease payments. The Company records its operating lease right-of-use assets as long-term assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;As of June 30, 2020, the Company has recorded a lease liability of $120 and corresponding right-of-use-asset of $123 on its condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;From time to time, we are involved in various legal proceedings arising in the ordinary course of our business. On January 20, 2017, K2M, Inc. filed suit against us in the United States District Court for the District of Delaware (K2M, Inc. v. OrthoPediatrics Corp. et al., Case No. 1:17-cv-0061) seeking unspecified damages for alleged infringement of U.S. Patent No. 9,532,816. The complaint was amended on August 21, 2017 to add, among other things, a claim of patent infringement regarding U.S. Patent No. 9,655,664. These patents relate to certain instruments used in our RESPONSE&#x2122; spine systems, which represent a portion of our total scoliosis portfolio. We have denied these claims and responded with counterclaims seeking declaratory relief that the patents in question are both invalid and not infringed. The parties attended a court-ordered mediation on October 24, 2017, which did not resolve the dispute, but as we move forward with this matter we welcome constructive discussions on a negotiated settlement. Nevertheless, we view our case as particularly strong and will continue to vigorously defend this matter. On June 28, 2018, the United States Patent and Trademark Office's Patent Trial and Appeal Board ("PTAB") instituted limited review concerning whether certain third parties had described the invention of certain of K2M's patent claims before allegedly invented by K2M. On July 10, 2018, the Court stayed the litigation pending the outcome of PTAB's review. On June 4, 2019, PTAB completed its review, finding, among other things, insufficient evidence of such description by the third parties. In early October 2019, the Court orally lifted the stay in federal district court. Thereafter, on November 19, 2019, K2M amended its complaint to add two (2) additional issued patents, to add claims of patent infringement regarding U.S. Patent Nos. 10,285,735 and 10,292,736 (both issued in May 2019). Like before, these newly issued patents relate to certain instruments used in our RESPONSE&#x2122; spine systems. Additionally, we have denied these most recent claims and responded with counterclaims seeking declaratory relief that the subject patents are both invalid and not infringed. Moreover, on November 20, 2019, the Court issued a Scheduling Order, which in part, set a trial date for April 12, 2021. Subsequently, the parties attended a second court-ordered mediation on February 25, 2020, which did not resolve the dispute, but we continue to welcome constructive discussions on a negotiated settlement. Although we believe that the K2M lawsuit is without merit and will vigorously defend the claims asserted against us, intellectual property litigation can involve complex factual and legal questions, and an adverse resolution of this proceeding could have a material adverse effect on our business, operating results and financial condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;We are not presently a party to any other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate materially affect our financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;Royalties&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of June&#160;30, 2020, we are contracted to pay royalties to individuals and entities that provide research and development services, which range from 0.5% to 20% of sales.  Additionally, we had minimum royalty commitments of $500 annually through 2026 which ceased upon the purchase of the Band-Lok assets in June 2020.  &lt;/span&gt;&lt;/div&gt;We have products in development that have milestone payments and royalty commitments.  In any development project, there are significant variables that will affect the amount and timing of these payments and as of June&#160;30, 2020, we have not been able to determine the amount and timing of payments.  We do not anticipate these future payments will have a material impact on our financial results.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfODkw_5f78eac7-8c91-4c4c-8c5f-6b0909b115de"
      unitRef="usd">120000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4daa9a471c454c999687c99d7d5c379c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfOTMz_932c5b3e-30b5-4a38-9b38-76685f3b719b"
      unitRef="usd">123000</us-gaap:OperatingLeaseRightOfUseAsset>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent
      contextRef="i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzQ3Ng_1590763b-584b-4a0b-8711-fada6af56fee"
      unitRef="number">0.005</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent
      contextRef="i7ce4805a31e8410d81b81251b9b1f57c_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzQ4Mg_46455420-f32f-46b7-8693-bf8672dd249b"
      unitRef="number">0.20</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent>
    <kids:ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83My9mcmFnOjgyYzA5MmEyNWY2ODQzZWJiMzhhNGJhYjRiYjNlZDc1L3RleHRyZWdpb246ODJjMDkyYTI1ZjY4NDNlYmIzOGE0YmFiNGJiM2VkNzVfMzU0OQ_342162ae-a321-4e5f-8db9-b030390645da"
      unitRef="usd">500000</kids:ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NDcxOA_43e455ea-9fad-40a8-a57c-2b0d8c0c43a1">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On August 4, 2020, the Company entered into a Second Amendment (the &#x201c;Second Amendment&#x201d;) to its First Amended Loan Agreement with Squadron (as so further amended, the &#x201c;Second Amended Loan Agreement&#x201d;).  Pursuant to the Second Amendment, the First Amended Loan Agreement&#x2019;s revolving credit commitment was increased from the previously established $15,000 to $25,000. The Company has agreed to pay Squadron an unused commitment fee in an amount equal to the per annum rate of 0.50% (computed on the basis of a year of 360 days and the actual number of days elapsed) times the daily unused portion of the revolving credit commitment.  The unused commitment fee is payable quarterly in arrears.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Borrowings under the revolving credit facility will be made under a First Amended and Restated Revolving Note, dated August 4, 2020 (the &#x201c;Amended Revolving Note&#x201d;), payable, jointly and severally, by the Company and each of its subsidiaries party thereto. The Amended Revolving Note will mature at the earlier of: (i) the date on which any person or persons acquire (x) capital stock of the Company possessing the voting power to elect a majority of the Company&#x2019;s Board of Directors (whether by merger, consolidation, reorganization, combination, sale or transfer), or (y) all or substantially all of the Company&#x2019;s assets, determined on a consolidated basis; and (ii) January 1, 2024.  Prior to the Second Amendment, the revolving credit facility was to have matured on January 31, 2023. The Second Amended Loan Agreement continues to provide for interest only payments, which are payable monthly, with interest rates equal to the greater of (a) three month LIBOR plus 8.61%, and (b) 10.00%&lt;/span&gt;&lt;/div&gt;On July 15, 2020, the Company repaid the $20,000 principal amount outstanding under the Loan Agreement&#x2019;s Term Note A, together with all unpaid interest and other related amounts payable. Following such repayment, there are no outstanding term loan obligations under the Second Amended Loan Agreement.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i70d54ac0693a4a3780155e252a95c82c_I20200803"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQzNw_4b9715df-b256-4758-94dc-c055c7c41b41"
      unitRef="usd">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idfc293021e554021ac712a08de896501_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQ0Ng_a07fe8ee-fe1c-43b8-868b-331a895f3a1c"
      unitRef="usd">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ie9d46247c02e4dad89dcf4bf7fdb0780_D20200804-20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQ1NQ_355681ce-a1b3-44ff-aaa9-a61988658c95"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icc09a7c192ec43ffbf6d23af854df8b2_D20200804-20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQyMg_07532a0d-154a-41c5-9c86-37bfee1b5fbb"
      unitRef="number">0.0861</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5ab10817a561491dad2e85b5bebc393f_I20200804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NjQyOQ_e238b900-5862-4546-adb9-5d77e4b96808"
      unitRef="number">0.1000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ic1955253c07c4f0f85875d92dbf6bbb7_D20200715-20200715"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF83Ni9mcmFnOjVmZDkzYjQzOTZlMDRjZWU4N2EwMzY2Y2Y5YzI5NzEyL3RleHRyZWdpb246NWZkOTNiNDM5NmUwNGNlZTg3YTAzNjZjZjljMjk3MTJfMTA5OTUxMTY0NDcyMA_cd08c48d-7136-4072-b77d-73cdebfe6646"
      unitRef="usd">20000000</us-gaap:RepaymentsOfNotesPayable>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933600968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Aug. 04, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">OrthoPediatrics Corp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001425450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,549,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1761833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2850 Frontier Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Warsaw<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">46582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">268-6379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.00025 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KIDS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933947992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 113,054<span></span>
</td>
<td class="nump">$ 70,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted Cash</a></td>
<td class="nump">1,361<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable - trade, less allowance for doubtful accounts of $185 and $506, respectively</a></td>
<td class="nump">14,897<span></span>
</td>
<td class="nump">16,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">48,875<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Notes receivable</a></td>
<td class="nump">656<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,534<span></span>
</td>
<td class="nump">1,464<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">180,377<span></span>
</td>
<td class="nump">128,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">24,131<span></span>
</td>
<td class="nump">21,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">42,206<span></span>
</td>
<td class="nump">14,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">68,420<span></span>
</td>
<td class="nump">13,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">13,357<span></span>
</td>
<td class="nump">4,490<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment', window );">Total other assets</a></td>
<td class="nump">123,983<span></span>
</td>
<td class="nump">32,747<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">328,491<span></span>
</td>
<td class="nump">182,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">6,003<span></span>
</td>
<td class="nump">6,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">4,501<span></span>
</td>
<td class="nump">4,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_LongTermDebtCurrentMaturitiesRelatedParty', window );">Current portion of long-term debt with affiliate</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent', window );">Current portion of acquisition installment payable</a></td>
<td class="nump">11,485<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">2,654<span></span>
</td>
<td class="nump">2,723<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">24,771<span></span>
</td>
<td class="nump">13,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesAndLoans', window );">Long-term debt with affiliate, net of current portion</a></td>
<td class="nump">21,017<span></span>
</td>
<td class="nump">26,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent', window );">Acquisition installment payable, net of current portion</a></td>
<td class="nump">12,021<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">28,100<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">61,258<span></span>
</td>
<td class="nump">26,130<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">86,029<span></span>
</td>
<td class="nump">39,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00025 par value; 50,000,000 shares authorized; 19,544,008 shares and 16,723,128 shares issued as of June 30, 2020 (unaudited) and December 31, 2019, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">385,510<span></span>
</td>
<td class="nump">271,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(143,214)<span></span>
</td>
<td class="num">(128,822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">161<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">242,462<span></span>
</td>
<td class="nump">142,361<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 328,491<span></span>
</td>
<td class="nump">$ 182,154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets, Noncurrent, Excluding Property, Plant and Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Acquisition Installment Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Acquisition Installment Payable, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_LongTermDebtCurrentMaturitiesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Current Maturities, Related Party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_LongTermDebtCurrentMaturitiesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesAndLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesAndLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927712088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">19,544,008<span></span>
</td>
<td class="nump">16,723,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">19,544,008<span></span>
</td>
<td class="nump">16,723,128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627934019288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 13,593<span></span>
</td>
<td class="nump">$ 18,200<span></span>
</td>
<td class="nump">$ 29,949<span></span>
</td>
<td class="nump">$ 32,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">3,532<span></span>
</td>
<td class="nump">4,581<span></span>
</td>
<td class="nump">7,675<span></span>
</td>
<td class="nump">8,582<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">10,061<span></span>
</td>
<td class="nump">13,619<span></span>
</td>
<td class="nump">22,274<span></span>
</td>
<td class="nump">24,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">5,620<span></span>
</td>
<td class="nump">7,606<span></span>
</td>
<td class="nump">13,184<span></span>
</td>
<td class="nump">14,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">10,577<span></span>
</td>
<td class="nump">6,569<span></span>
</td>
<td class="nump">18,458<span></span>
</td>
<td class="nump">12,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">1,234<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
<td class="nump">2,447<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">17,078<span></span>
</td>
<td class="nump">15,409<span></span>
</td>
<td class="nump">33,788<span></span>
</td>
<td class="nump">28,781<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(7,017)<span></span>
</td>
<td class="num">(1,790)<span></span>
</td>
<td class="num">(11,514)<span></span>
</td>
<td class="num">(4,507)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustment of contingent consideration</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="nump">2,430<span></span>
</td>
<td class="nump">669<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Net loss from continuing operations</a></td>
<td class="num">(9,447)<span></span>
</td>
<td class="num">(2,459)<span></span>
</td>
<td class="num">(14,392)<span></span>
</td>
<td class="num">(5,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (9,447)<span></span>
</td>
<td class="num">$ (2,618)<span></span>
</td>
<td class="num">$ (14,392)<span></span>
</td>
<td class="num">$ (5,638)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common stock - basic and diluted (in shares)</a></td>
<td class="nump">17,549,118<span></span>
</td>
<td class="nump">14,451,979<span></span>
</td>
<td class="nump">16,986,485<span></span>
</td>
<td class="nump">14,409,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="num">$ (0.85)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627934195928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,447)<span></span>
</td>
<td class="num">$ (2,618)<span></span>
</td>
<td class="num">$ (14,392)<span></span>
</td>
<td class="num">$ (5,638)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">1,522<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="nump">1,522<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (7,925)<span></span>
</td>
<td class="num">$ (2,751)<span></span>
</td>
<td class="num">$ (14,228)<span></span>
</td>
<td class="num">$ (5,470)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627934811016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,538,202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 81,732<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,442<span></span>
</td>
<td class="num">$ (115,091)<span></span>
</td>
<td class="num">$ (623)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="nump">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercise (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,427,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercise</a></td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,769,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted stock</a></td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,682,398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2019</a></td>
<td class="nump">80,049<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,478<span></span>
</td>
<td class="num">(118,111)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,538,202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">81,732<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,442<span></span>
</td>
<td class="num">(115,091)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(5,638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,939,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2019</a></td>
<td class="nump">88,082<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,262<span></span>
</td>
<td class="num">(120,729)<span></span>
</td>
<td class="num">(455)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,682,398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2019</a></td>
<td class="nump">80,049<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,478<span></span>
</td>
<td class="num">(118,111)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(2,618)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,618)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(133)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Consideration for acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Consideration for acquisition</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercise (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercise</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted stock</a></td>
<td class="nump">692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,939,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2019</a></td>
<td class="nump">$ 88,082<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,262<span></span>
</td>
<td class="num">(120,729)<span></span>
</td>
<td class="num">(455)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">16,723,128<span></span>
</td>
<td class="nump">16,723,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 142,361<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,182<span></span>
</td>
<td class="num">(128,822)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(4,945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="num">(1,358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,358)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Consideration for acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Consideration for acquisition</a></td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,014,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercise (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercise</a></td>
<td class="nump">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted stock</a></td>
<td class="nump">958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,887,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="nump">$ 139,267<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,578<span></span>
</td>
<td class="num">(133,767)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">16,723,128<span></span>
</td>
<td class="nump">16,723,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 142,361<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,182<span></span>
</td>
<td class="num">(128,822)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(14,392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="nump">$ 164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercise (in shares)</a></td>
<td class="nump">41,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2020</a></td>
<td class="nump">19,544,008<span></span>
</td>
<td class="nump">19,544,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="nump">$ 242,462<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,510<span></span>
</td>
<td class="num">(143,214)<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,014,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,887,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="nump">139,267<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,578<span></span>
</td>
<td class="num">(133,767)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(9,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="nump">1,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Consideration for acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Consideration for acquisition</a></td>
<td class="nump">37,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance cost (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,595,986<span></span>
</td>
<td class="nump">4,014,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance cost</a></td>
<td class="nump">70,394<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">70,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercise (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercise</a></td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted stock</a></td>
<td class="nump">$ 2,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2020</a></td>
<td class="nump">19,544,008<span></span>
</td>
<td class="nump">19,544,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2020</a></td>
<td class="nump">$ 242,462<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 385,510<span></span>
</td>
<td class="num">$ (143,214)<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627934768376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,392)<span></span>
</td>
<td class="num">$ (5,638)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,285<span></span>
</td>
<td class="nump">1,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,453<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustment of contingent consideration</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable', window );">Acquisition installment payable</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in certain current assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable', window );">Accounts receivable - trade</a></td>
<td class="nump">1,609<span></span>
</td>
<td class="num">(5,499)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(9,599)<span></span>
</td>
<td class="num">(5,139)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">66<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable - trade</a></td>
<td class="num">(746)<span></span>
</td>
<td class="nump">1,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(129)<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(50)<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities - continuing operations</a></td>
<td class="num">(14,707)<span></span>
</td>
<td class="num">(10,785)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by operating activities - discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(14,707)<span></span>
</td>
<td class="num">(10,414)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchases of licenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(5,160)<span></span>
</td>
<td class="num">(8,514)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities - continuing operations</a></td>
<td class="num">(9,349)<span></span>
</td>
<td class="num">(58,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash used in investing activities - discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(9,349)<span></span>
</td>
<td class="num">(58,657)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from issuance of debt with affiliate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on note with affiliate</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs</a></td>
<td class="nump">70,207<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,281<span></span>
</td>
<td class="nump">657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Payments on mortgage notes</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">66,427<span></span>
</td>
<td class="nump">30,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH</a></td>
<td class="nump">42,388<span></span>
</td>
<td class="num">(38,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations', window );">Cash and restricted cash, beginning of year</a></td>
<td class="nump">72,027<span></span>
</td>
<td class="nump">60,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations', window );">Cash and restricted cash, end of period</a></td>
<td class="nump">114,415<span></span>
</td>
<td class="nump">22,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations', window );">Less cash of discontinued operations, end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash of continuing operations, end of period</a></td>
<td class="nump">114,415<span></span>
</td>
<td class="nump">21,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_TransferOfPropertyAndEquipmentToInventory', window );">Transfer of instruments from property and equipment to inventory</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember', window );">Telos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of Telos, net of cash acquired</a></td>
<td class="num">(1,670)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common shares to acquire business</a></td>
<td class="nump">1,568<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustment of contingent consideration</a></td>
<td class="nump">910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of Telos, net of cash acquired</a></td>
<td class="num">(1,723)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common shares to acquire business</a></td>
<td class="nump">35,176<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_BandLokMember', window );">Band-Lok</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of Telos, net of cash acquired</a></td>
<td class="num">(796)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common shares to acquire business</a></td>
<td class="nump">2,644<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of Telos, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(49,926)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common shares to acquire business</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Change in Fair Value, Acquisition Installment Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_TransferOfPropertyAndEquipmentToInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_TransferOfPropertyAndEquipmentToInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_BandLokMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_BandLokMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929946136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">BUSINESS</a></td>
<td class="text">BUSINESS<div style="padding-right:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">OrthoPediatrics Corp., a Delaware corporation, is a medical device company committed to designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers the ability to treat children with technologies specifically designed to meet their needs. We sell our specialized products, including PediLoc</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">, PediPlates</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">, Cannulated Screws, PediFlex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:400;line-height:121%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">nail, PediNail</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:4.22pt;font-weight:400;line-height:121%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">, PediLoc</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;"> Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, Bandloc, Pediguard, Pediatric Nailing Platform | Femur, Orthex, QuickPack</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:121%;vertical-align:top;">TM </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:121%;">and ApiFix to various hospitals and medical facilities throughout the United States and various international markets.  We currently use a contract manufacturing model for the manufacturing of implants and related surgical instrumentation. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In 2017, we expanded operations and established legal entities in the United Kingdom, Australia and New Zealand, permitting us to sell under an agency model direct to local hospitals in these countries. In September 2018, we further expanded operations in Canada selling direct to local hospitals, and in January 2019 we expanded to Belgium and the Netherlands. Additionally, in March 2019 we established a holding company and an operating company in the Netherlands and began selling direct to Italy in March 2020 enhancing our operations in Europe. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 4, 2019, we purchased all the issued and outstanding shares of stock of Vilex in Tennessee, Inc. ("Vilex") and all the issued and outstanding units of membership interests in Orthex, LLC ("Orthex") for $60,000 in total consideration. Vilex and Orthex (the "Vilex Companies") are primarily manufacturers of foot and ankle surgical implants, including cannulated screws, fusion devices, surgical staples and bone plates, as well as Orthex Hexapod technology which is used to treat pediatrics congenital deformities and limb length discrepancies.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 31, 2019, we divested substantially all of the assets relating to Vilex's adult product offerings to a wholly-owned subsidiary of Squadron Capital LLC ("Squadron") in exchange for a $25,000 reduction in a Term Note owed to Squadron in connection with the initial acquisition.  As part of the sale, we also executed an exclusive license arrangement with Squadron providing for perpetual access to certain intellectual property and a mutual distribution agreement.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On March 9, 2020, we purchased all the issued and outstanding membership interest of Telos Partners, LLC ("Telos") for $3,300 in total consideration. Telos is a boutique regulatory consulting firm formed in Colorado. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2020, we purchased all the issued and outstanding membership interest of ApiFix, Ltd. ("ApiFix") for (a) $2,000 in cash, and (b) 934,783 shares of the Company's common stock, $0.00025 par value per share, representing approximately $35,000 (based on a closing share price of $37.63 on April 1, 2020. ApiFix, a corporation organized under the laws of Israel, has developed a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis ("ApiFix System"). In addition, we have also agreed to pay as part of the purchase price the following anniversary payments: (i) $13,000 on the second anniversary of the closing date, provided that such payment will be paid earlier if 150 clinical procedures using the ApiFix System are completed in the United States before such anniversary date, (ii) $8,000 on the third anniversary of the closing date; and (iii) $9,000 on the fourth anniversary of the closing date. In addition, to the extent that the product of our revenues from the ApiFix System for the twelve months ended June 30, 2024 multiplied by 2.25 exceeds the anniversary payments </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">actually made for the third and fourth years, we have agreed to pay the selling shareholders a system sales payment in the amount of such excess. The anniversary payments and system sales payment may each be made in cash or cash and common stock. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 10, 2020, we purchased certain intellectual property assets from Band-Lok, LLC, a North Carolina limited liability company ("Band-Lok"), related to its Tether Clamp and Implantation System ("Tether Clamp System") for approximately $3,400 in total consideration. We use the Tether Clamp System in connection with our Bandloc 5.5/6.0 System. We were previously the sole licensee of the purchased assets under a license agreement with Band-Lok. </span></div>Our largest investor is Squadron, a private investment firm based in Granby, Connecticut.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927936104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying condensed consolidated financial statements include the accounts of OrthoPediatrics Corp. and its wholly-owned subsidiaries, OrthoPediatrics US Distribution Corp., OrthoPediatrics EU Limited, OrthoPediatrics AUS PTY LTD, OrthoPediatrics NZ Limited, OP EU B.V., OP Netherlands B.V., Vilex in Tennessee, Inc., Orthex, LLC, Telos Partners, LLC, ApiFix Ltd. and ApiFix Inc. (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;).  All intercompany balances and transactions have been eliminated.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Unaudited Interim Condensed Consolidated Financial Statements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have prepared the accompanying condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The accompanying condensed consolidated balance sheets as of June&#160;30, 2020 and December 31, 2019, the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of comprehensive loss for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of stockholders&#8217; equity for the three and six months ended June&#160;30, 2020 and 2019 and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2020 and 2019 are unaudited and should be read in conjunction with the annual consolidated financial statements as of and for the year ended December&#160;31, 2019 and related notes thereto contained in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 5, 2020. The financial data and other financial information disclosed in the notes to the accompanying condensed consolidated financial statements are also unaudited. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to applicable rules and regulations thereunder. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended December 31, 2019 and, in management&#8217;s opinion, include all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the financial statements for the interim periods. The results of operations for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results to be expected for the full fiscal year or for any other period. </span></div><div style="padding-left:1pt;padding-right:1pt;"><span><br/></span></div><div style="padding-left:1pt;padding-right:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying condensed consolidated financial statements have been prepared assuming our Company will continue as a going concern.  We have experienced recurring losses from operations since our inception and had an accumulated deficit of $143,214 and $128,822 as of June&#160;30, 2020 and December 31, 2019, respectively. Management continues to monitor cash flows and liquidity on a regular basis. We believe that our cash balance at June&#160;30, 2020 and expected cash flows from operations for the next twelve months subsequent to the issuance of the accompanying condensed consolidated </span></div><div style="padding-left:1pt;padding-right:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">financial statements, are sufficient to enable us to maintain current and essential planned operations for more than the next twelve months. </span></div><div style="padding-left:1pt;padding-right:1pt;"><span><br/></span></div><div style="padding-left:1pt;padding-right:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 22, 2020, we completed a follow-on offering of our common stock, in which we issued and sold 1.6&#160;million shares of common stock at a public offering price of $47.00 per share for aggregate gross proceeds of $75,200. We received $70,207 in net proceeds after deducting $4,512 of underwriting discounts and commissions and paying $481 in offering costs. </span></div><div style="padding-left:1pt;padding-right:1pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Preparation of the condensed consolidated financial statements requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as of the date of the condensed consolidated financial statements.  By their nature, these judgments are subject to an inherent degree of uncertainty. The impact of the coronavirus disease ("COVID-19") has significantly increased economic and demand uncertainty.  We use historical experience and other assumptions as the basis for our judgments and estimates.  Because future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.  Any changes in these estimates will be reflected in the condensed consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Foreign Currency Transactions</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently bill our international distributors in United States ("U.S.") dollars, resulting in minimal foreign exchange transaction expense. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in the second quarter of 2017, we began selling direct within the United Kingdom, Ireland, Australia and New Zealand and billing using the local currency for each country. In September 2018, we began selling direct in Canada, in January 2019 in Belgium and the Netherlands, in March 2020 in Italy and in April 2020 in Israel. The financial statements of our foreign subsidiaries are accounted for and have been translated into U.S. dollars using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. Foreign currency translation adjustments have been recorded as a separate component of the condensed consolidated statements of comprehensive loss.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue from Contracts with Customers</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In accordance with ASC 606, "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue From Contracts With Customers </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ASC 606)", revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services, and excludes any sales incentives or taxes collected from a customer which are subsequently remitted to government authorities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue Recognition &#8211; United States</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue in the United States is generated primarily from the sale of our implants and, to a much lesser extent, from the sale of our instruments.  Sales in the United States are primarily to hospital accounts through independent sales agencies.  We recognize revenue when our performance obligations under the terms of a contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customers, generally upon implantation or when title passes upon shipment. The products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.   </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue Recognition &#8211; International</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Outside of the United States, we primarily sell our products through independent stocking distributors. Generally, the distributors are allowed to return products, and some are thinly capitalized. Based on our history of collections and returns from international customers, prior to 2019, we concluded that collectability was not reasonably assured at the time of delivery for certain customers who had not evidenced a consistent pattern of timely payment. Accordingly, in the past we did not recognize international revenue and associated cost of revenue at the time title transfers for these customers for whom collectability had not been deemed probable based on the customer&#8217;s history and ability to pay, but rather when cash had been received. </span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a review of our collection history, we deemed collectability was probable for all international stocking distributors effective January 1, 2019. Based on a history of reliable collections, we have concluded that a contract exists and revenue should be recognized when our performance obligations under the terms of the contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customer, generally upon implantation or when title passes upon shipment.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#226600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the countries where we sell under an agency model direct to local hospitals, the products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.     </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We maintain cash in bank deposit accounts which, at times, may exceed federally insured limits.  To date, we have not experienced any loss in such accounts.  We consider all highly liquid investments with original maturity of three months or less at inception to be cash equivalents.  The carrying amounts reported in the balance sheet for cash are valued at cost, which approximates fair value.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accounts receivable are uncollateralized customer obligations due under normal trade terms, generally requiring payment within 30 days from the invoice date. Account balances with invoices over 30 days past due are considered delinquent.  No interest is charged on past due accounts. Payments of accounts receivable are applied to the specific invoices identified on the customer's remittance advice or, if unspecified, to the customer's account as an unapplied credit.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected, determined principally on the basis of historical experience, management's assessment of the collectability of specific customer accounts and the aging of the accounts receivable. All accounts or portions thereof deemed to be uncollectible or to require an excessive collection cost are written off to the allowance for doubtful accounts. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Inventories, net </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories are stated at the lower of cost or net realizable value, with cost determined using the first-in-first-out method. Inventories, which consist of implants and instruments held in our warehouse or with third-party independent sales agencies or distributors, are considered finished goods and are purchased from third parties. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate the carrying value of our inventories in relation to the estimated forecast of product demand, which takes into consideration the life cycle of the product.  A significant decrease in demand could result </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in an increase in the amount of excess inventory on hand, which could lead to additional charges for excess and obsolete inventory.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The need to maintain substantial levels of inventory impacts our estimates for excess and obsolete inventory.  Each of our implant systems are designed to include implantable products that come in different sizes and shapes to accommodate the surgeon&#8217;s needs.  Typically, a small number of the set components are used in each surgical procedure.  Certain components within each set may become obsolete before other components based on the usage patterns.  We adjust inventory values, as needed, to reflect these usage patterns and life cycle.     </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, we continue to introduce new products, which may require us to take additional charges for excess and obsolete inventory in the future.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Property and Equipment, net </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful life of the assets. When assets are retired or otherwise disposed of, costs and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in operations for the period. Maintenance and repairs that prolong or extend the useful life are capitalized, whereas standard maintenance, replacements, and repair costs are expensed as incurred. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Instruments are hand-held devices, specifically designed for use with our implants and are used by surgeons during surgery. Instruments deployed within the United States, United Kingdom, Australia, New Zealand, Canada, Belgium, the Netherlands and Italy are carried at cost less accumulated depreciation and are recorded in property and equipment, net on the condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sample inventory consists of our implants and instruments, and is maintained to market and promote our products. Sample inventory is carried at cost less accumulated depreciation. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciable lives are generally as follows:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:48.000%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Building and building improvements</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">25 to 30 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and fixtures</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Business software</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office and other equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instruments</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sample inventory</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2 years</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Amortizable Intangible Assets, net</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amortizable intangible assets</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">include fees necessary to secure various patents and licenses, including Band-Lok, the value of internally developed software, customer relationships, and non-competition agreements related to the acquisition of Orthex, and customer relationships and non-competition agreements related to the acquisitions of Telos and ApiFix. Amortization is calculated on a straight-line basis over the estimated useful life of the asset.  Amortization for patents and licenses commences at the time of patent approval and market launch, respectively. Amortization for assets acquired commences upon acquisition. Intangible assets are amortized over a 3 to 20 year period. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amortizable intangible assets are assessed for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets. No impairment charges were recorded in any of the periods presented.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Goodwill and Other Intangible Assets</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our goodwill represents the excess of the cost over the fair value of net assets acquired. The determination of the value of goodwill and intangible assets arising from acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of net tangible and intangible assets acquired. Goodwill is not amortized and is assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstances warrant such a review. The goodwill is considered to be impaired if we determine that the carrying value of the reporting unit exceeds its respective fair value. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have indefinite lived tradename assets that are reviewed for impairment by performing a quantitative analysis, which occurs annually in the fourth quarter or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.  No impairment charges were recorded in any of the periods presented. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Cost of Revenue</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cost of revenue consists primarily of products purchased from third-party suppliers, excess and obsolete inventory adjustments, inbound freight, and royalties.  Our implants and instruments are manufactured to our specifications by third-party suppliers who meet our manufacturer qualifications standards.  Our third-party manufacturers are required to meet the standards of the Food and Drug Administration (the &#8220;FDA&#8221;), and the International Organization for Standardization, as well as other country-specific quality standards.  The majority of our implants and instruments are produced in the United States.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Sales and Marketing Expenses</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales and marketing expenses primarily consist of commissions to our domestic and select international independent sales agencies and consignment distributors, as well as compensation, commissions, benefits and other related costs for personnel we employ. Commissions and bonuses are generally based on a percentage of sales.  Our international independent stocking distributors purchase instrument sets and replenishment stock for resale, and we do not pay commissions or any other sales related costs for international sales to distributors. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Advertising Costs </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Advertising costs consist primarily of print advertising, trade shows, and other related expenses. Advertising costs are expensed as incurred and are recorded as a component of sales and marketing expense. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Research and Development Costs</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Research and development costs are expensed as incurred. Our research and development expenses primarily consist of costs associated with engineering, product development, consulting services, outside prototyping services, outside research activities, materials, development and protection of our intellectual property portfolio, as well as other costs associated with development of our products. Research and development costs also include related personnel and consultants&#8217; compensation expense.  </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to our Initial Public Offering ("IPO") in October 2017, we maintained an Amended and Restated 2007 Equity Incentive Plan (the &#8220;2007 Plan&#8221;) that provided for grants of options and restricted stock to employees, directors and associated third-party representatives of the Company as determined by the Board of Directors. The 2007 Plan had authorized 1,585,000 shares for award. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Immediately prior to our IPO, we adopted our 2017 Incentive Award Plan (the "2017 Plan") which replaced the 2007 Plan. The 2017 Plan provides for grants of options and restricted stock to officers, employees, consultants or directors of our Company. The 2017 Plan has authorized 1,789,647 shares for award. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Options holders, upon vesting, may purchase common stock at the exercise price, which is the estimated fair value of our common stock on the date of grant. Option grants generally vest immediately or over three years. No stock options were granted in any of the periods presented.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Restricted stock may not be transferred prior to the expiration of the restricted period, which is typically three years. The restricted stock that had been granted under the 2007 Plan had restriction periods that generally lasted until the earlier of six years from the date of grant, or an IPO or change in control, as defined in the 2007 Plan. All restricted stock granted prior to May 2014 vested upon our IPO and the remaining grants under the 2007 Plan vested six months after the IPO. We recognize the reversal of stock compensation expense when a restricted stock forfeiture occurs as opposed to estimating future forfeitures.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We record the fair value of restricted stock at the grant date.  Stock-based compensation is recognized ratably over the requisite service period, which is generally the restriction period for restricted stock.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Comprehensive Income (Loss)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income (loss) includes foreign currency translation adjustments. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Income Taxes</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements. Under this method, we determine deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We record uncertain tax positions on the bases of a two-step process in which (i) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the positions and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">&#8220;Emerging Growth Company&#8221; Reporting Requirements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We qualify as an &#8220;emerging growth company&#8221; as defined in the JOBS Act. For as long as a company is deemed to be an emerging growth company, it may take advantage of specified reduced reporting and other regulatory requirements that are generally unavailable to other public companies. Among other things, we are not required to provide an auditor attestation report on the assessment of the internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act of 2002. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Section 107 of the JOBS Act also provides that an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2017, the SEC adopted new rules that included an inflation-adjusted threshold in the definition of an emerging growth company. Under the new inflation-adjusted threshold, we would cease to be an emerging growth company on the last day of the fiscal year in which our annual gross revenues exceed $1.07 billion. This is an increase of $70 million from the previous $1 billion threshold.    </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU No. 2016-13 "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments"</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financials assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Based on ASU 2019-10 and our status as a Smaller Reporting Company, the Company will adopt ASU 2016-13 effective January 1, 2023. The adoption of this guidance is not expected to have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2017, the FASB issued ASU 2017-04, "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment"</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. This pronouncement eliminates Step 2 from the goodwill impairment test and requires an entity to perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. Under this guidance, an entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. It is effective for reporting periods beginning after December 15, 2020, although earlier adoption is permitted. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU No. 2019-12 "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes: Simplifying the Accounting for Income Taxes"</span> intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside cost basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929350440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">ApiFix</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On April 1, 2020, the Company purchased all the issued and outstanding membership interest of ApiFix for $2,000 in cash, including $343 of cash acquired, 934,783 shares of the Company's common stock, $0.00025 par value per share, representing approximately $35,176 (based on a closing share price of $37.63 on April 1, 2020), $30,000 in anniversary payments, and approximately $41,741 in a system sales payment. The total consideration transferred of $87,379 is preliminary and subject to certain limitations and adjustments. ApiFix, a corporation organized under the laws of Israel, has developed a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis ("ApiFix System").  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company incurred $310 of acquisition-related costs that are included in general and administrative expenses on the consolidated statements of operations. The purchase price allocation set forth herein is preliminary. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for ApiFix and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands):  </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"/><td style="width:62.677%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.574%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:31.549%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preliminary fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87,379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">602&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,956&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,423&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">340&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company is obligated to make anniversary payments of: (i) $13,000 on the second anniversary of the closing date, provided that such payment will be paid earlier if 150 clinical procedures using the ApiFix System are completed in the United States before such anniversary date, (ii) $8,000 on the third anniversary of the closing date; and (iii) $9,000 on the fourth anniversary of the closing date, subject to adjustments. The Company anticipates making the second anniversary payment of $13,000 during the first half of 2021. In addition, to the extent that the product of our revenues from the ApiFix System for the twelve months ended June 30, 2024 multiplied by 2.25 exceeds the anniversary payments actually made for the third and fourth years, we have agreed to pay the selling shareholders a system sales payment in the amount of such excess. The anniversary payments and system sales payment may each be made in cash or cash and common stock, subject to certain limitations; provided that the Company makes the determination with respect to anniversary payments and a representative of the former ApiFix shareholders may make the determination with respect to the system sales payment, if any. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of the contingent consideration payments is considered a Level 3 investment and were determined by an independent valuation specialist at the original issuance date using an option pricing model and a Monte Carlo simulation based on forecast annual revenue, expected volatility and an implied probability of achieving revenue forecasts. The fair value of the payments will continue to be adjusted as additional information becomes available regarding the progress toward achievement of the revenue forecast. The adjustment in the fair value of the contingent consideration payments of $910 was recognized as an expense for the six month period ended June 30, 2020 in other expenses on the condensed consolidated statements of operations. An additional $886 was recognized as interest expense for the six month period ended June 30, 2020 on the condensed consolidated statements of operations for the adjustment in the fair value of the acquisition installment payable. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Presented below is a summary of the present value of the anniversary payments and system sales payment related to the ApiFix acquisition: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:56.974%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.873%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">April 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anniversary Payments: </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Second Year Payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Third Year Payment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,780&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,965&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fourth Year Payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,860&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,056&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total acquisition installment payable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,506&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current portion of acquisition installment payable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition installment payable, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,640&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,021&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">System sales payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ApiFix future consideration, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,830&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,121&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Pre-acquisition revenues and earnings for ApiFix were not material to the condensed consolidated operations. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Telos</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On March 9, 2020, the Company purchased the issued and outstanding membership interest of Telos for $1,750 in cash, including $81 of cash acquired, and 36,628 shares of common stock, $0.00025 par value per share, of the Company. The shares of common stock were valued at $42.81 per share, the Company's closing share price on March 9, 2020. The Company incurred $25 of acquisition-related costs, that are included in general and administrative expenses on the consolidated statements of operations.  The purchase price allocation set forth herein is preliminary.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for Telos and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"/><td style="width:62.677%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.574%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:31.549%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preliminary fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,318&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,466&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,912&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">910&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Vilex and Orthex</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 4, 2019, the Company purchased all the issued and outstanding shares of stock of Vilex and units of membership interests in Orthex for $50,000 in cash, adjusted for working capital, and 245,352 shares of common stock, $0.00025 par value per share, of the Company. The shares of common stock were valued at $40.76 per share, the volume weighted average trading price during the thirty day trading period ending on May 30, 2019. In addition, $3,000 was placed in an escrow account for a period of up to twenty months to cover certain indemnification obligations and to secure certain closing adjustments. The Company incurred $737 of acquisition-related costs, that are included in general and administrative expenses on the consolidated statements of operations.  The purchase price allocation set forth herein is final as to working capital amounts, intangible values and tax accounting matters. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for Vilex and Orthex and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"/><td style="width:62.677%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.574%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:31.549%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,088&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,652&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,540&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,143&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Deferred tax liability</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43,014&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,610&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Internally Developed Software</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,550&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company recorded a measurement period adjustment during fiscal 2020 to increase inventory and decrease goodwill related to working capital adjustments to allocate inventory between Orthex and Vilex. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Since the Vilex products include adult offerings that are not core to the Company's pediatric business, the Company received Board approval to take the steps necessary to divest the non-core Vilex assets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On December 31, 2019, the Company divested substantially all of the assets relating to Vilex's adult product offering to a wholly-owned subsidiary of Squadron Capital, LLC in exchange for a $25,000 reduction in a term note owed to Squadron in connection with the initial acquisition along with certain ongoing intellectual property rights. Of the $25,000 purchase price, $12,410 was attributable to the license of the Orthex intellectual property and the remaining $12,590 was applied to the Vilex assets and liabilities divested.</span></div>After the issuance of our December 31, 2019 annual consolidated financial statements, and in connection with the preparation of our condensed consolidated financial statements for the three months ended March 31, 2020, we identified and corrected an immaterial error related to the deferred revenue liability recognized from license of Orthex intellectual property as of December 31, 2019.  The immaterial correction of the error resulted in a reduction of the deferred revenue liability and goodwill on the consolidated balance sheet as of December 31, 2019 of $12,410, based on the conclusion that the consideration transferred was allocable to a portion of certain Orthex patent assets sold concurrently with the sale of Vilex. We have evaluated the adjustment and, based on an analysis of quantitative and qualitative factors, determined that the related impact was not material to our consolidated financial statements for any prior annual or interim period presented. In order to accurately present the historical period, we have revised our December 31, 2019 balance sheet and related footnotes to reflect the immaterial correction of this error.Pro forma net revenue and net loss from continuing operations for the six months ended June 30, 2019 assuming the Orthex and Vilex acquisition occurred on January 1, 2019 would have been $34,792 and ($4,948), respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628018325528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Goodwill</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Changes in the carrying amount of goodwill for the six months ended June 30, 2020 were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:77.487%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.872%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vilex Companies acquisition</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Divestiture of Vilex in Tennessee, Inc. </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3,397)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at January 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,773&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Telos acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,912&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthex measurement period adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(688)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ApiFix acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,423&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68,420&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Intangible Assets</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the balances of amortizable intangible assets were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.504%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Intangible Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Intangible Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.3 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,182&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,019)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intellectual Property</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8 years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(473)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">License Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,199)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amortizable assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,897&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,691)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, the balances of amortizable intangible assets were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.504%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Intangible Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Intangible Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.4 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,287&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(363)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,924&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intellectual Property</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7 years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,020&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(213)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,807&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">License Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,012)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,753&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amortizable assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,072&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,588)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,484&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 10, 2020, we purchased certain intellectual property assets from Band-Lok, LLC, a North Carolina limited liability company ("Band-Lok"), related to its Tether Clamp and Implantation System ("Tether Clamp System") for $3,394 in total consideration. We use the Tether Clamp System in connection with our Bandloc 5.5/6.0 System. We were previously the sole licensee of the purchased assets under a license agreement with Band-Lok.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Licenses are tied to product launches and do not begin amortizing until the product is launched to the market. </span></div>Trademarks are non-amortizing intangible assets which were $13,357 and $4,490 as of June 30, 2020 and December 31, 2019, respectively. Concurrently with our acquisition of each company, we acquired the trademark of Orthex on June 4, 2019 valued at $4,230, the trademark of Telos on March 9, 2020 valued at $210 and the trademark of ApiFix on April 1, 2020 valued at $8,620. Trademarks are recorded in Other Intangible assets on the Condensed Consolidated Balance Sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628026921016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISCONTINUED OPERATIONS</a></td>
<td class="text">DISCONTINUED OPERATIONS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On June 4, 2019, the Company acquired Vilex, a manufacturer of foot and ankle surgical implants. Since the Vilex products included adult offerings that were not core to the Company's pediatric business, the Company received Board approval to take the steps necessary to divest the non-core Vilex assets and those Vilex assets were sold on December 31, 2019. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following summarized financial information has been segregated from continuing operations and reported as discontinued operations for the three and six months ended June 30, 2019:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:75.403%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:20.597%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three and Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">414&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">507&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(159)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss from discontinued operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(159)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627928064712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND CREDIT ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT AND CREDIT ARRANGEMENTS</a></td>
<td class="text">DEBT AND CREDIT ARRANGEMENTS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Long-term debt consisted of the following: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:57.069%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:18.064%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.065%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Note payable to Squadron</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,907&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revolving credit facility with Squadron</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mortgage payable to affiliate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current maturities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt with affiliate, net of current maturities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On December 31, 2017, we entered into a Fourth Amended and Restated Loan and Security Agreement, or the Loan Agreement, with Squadron Capital LLC, or Squadron. Pursuant to the Loan Agreement, a majority of the term loan amounts under the previous agreement with Squadron were consolidated into a $20,000 term note, or the Term Note A, and a $15,000 revolving credit facility was established. Both facilities include interest only payments and provide for an interest rate equal to the greater of (a) three month LIBOR plus 8.61% and (b) 10%. The Loan Agreement also extended the maturity date to January 31, 2023. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In order to finance a portion of the cash consideration for the acquisition of the Vilex Companies, the Company entered into a First Amendment, or the First Amendment, to the Loan Agreement (as so amended, the "First Amended Loan Agreement"), with Squadron. The First Amended Loan Agreement provided for a new $30,000 term loan facility, represented by a Term Note B,  in addition to the existing $20,000 Term Note A and $15,000 revolving credit facility. Similar to the other facilities under the First Amended Loan Agreement, the Term Note B was subject to interest only payments at an interest rate equal to the greater of (a) three month LIBOR plus 8.61%, and (b) 10.00%. The Term Note B, which would have matured no later than May 31, 2020, was paid in full on December 31, 2019 using $25,000 received in exchange for the divestiture of the adult product offerings of Vilex and the related Orthex license agreement, and $5,000 from the available Squadron revolving credit facility. On January 4, 2020, the Company paid $5,000 on the revolving loan agreement with Squadron. </span></div><div><span><br/></span></div><div style="padding-right:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:123%;">Borrowings under the First Amended Loan Agreement are secured by substantially all of the Company's assets and are unconditionally guaranteed by each of its subsidiaries with the exception of Vilex. There are no traditional financial covenants associated with the First Amended Loan Agreement. However, there are negative covenants that prohibit us from, among other things, transferring any of our material assets, merging with or acquiring another entity, entering into a transaction that would result in a change of control, incurring additional indebtedness, creating any lien on our property, making investments in third parties and redeeming stock or paying dividends.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of our notes payable to Squadron were estimated based on prices for the same or similar issues and the current interest rates offered for the debt of the same remaining maturities, which are considered level 2 inputs in accordance with ASC Topic 820, &#8220;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurements and Disclosures</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#8221; At June&#160;30, 2020, the fair value approximated the carrying value. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In connection with the purchase of our office and warehouse space in Warsaw, Indiana in August 2013, we entered into a mortgage note payable to Tawani Enterprises Inc., an affiliate of Squadron. Pursuant to the terms of the mortgage note, we pay Tawani Enterprises Inc. monthly principal and interest installments of $16 with interest compounded at 5% until maturity in 2028, at which time a final payment of remaining principal and interest is due. The mortgage is secured by the related real estate and building.  At December 31, 2019, the mortgage balance was $1,300 of which current principal due of $124 was included in current portion of long-term debt.  At June 30, 2020 the mortgage balance was  $1,238 of which current principal of $128 was included in current portion of long-term debt.  </span></div>Interest expense relating to notes payable to Squadron and Tawani was $513 and $632 for the three months ended June&#160;30, 2020 and 2019, respectively, and $892 and $935 for the six months ended June&#160;30, 2020 and 2019, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628026921016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STRATEGIC ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">STRATEGIC ARRANGEMENTS</a></td>
<td class="text">STRATEGIC ARRANGEMENTS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Effective December 1, 2007, we entered into a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81Mi9mcmFnOmM3NDQxNzViMTliODRhMmM5ZDgxMjU0YTE0NzFjNjAyL3RleHRyZWdpb246Yzc0NDE3NWIxOWI4NGEyYzlkODEyNTRhMTQ3MWM2MDJfODQ_bf262227-ff5c-44d1-a84e-6eebb551fe29">ten</span>-year agreement with Case Western Reserve University (&#8220;CASE&#8221;) to assist in certain aspects of our research and development. Effective August 2, 2017, we entered into an Amended and Restated License Agreement to account for additional licensed product and extend the agreement for another ten years. The main focus of this research and development involves leveraging our exclusive rights to the Hamann-Todd Collection of the Cleveland National History Museum, the world's largest pediatric osteological collection, to assist in the design of implants which match pediatric bone curvature and structure.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In exchange for services, CASE receives certain royalties and up-front fees. The royalties and certain fees are contingent upon our obtaining FDA approval and the launch of our products into the marketplace. CASE receives a minimum annual royalty of $10 or a royalty of 3% of net sales on products, whichever is greater. Additionally, for each new product developed, CASE will receive milestone payments of $5 for FDA approval to sell our products within the United States and $10 for general product launch. Additionally, CASE receives a royalty of 3% of net sales on products fully developed and being sold in the marketplace.</span></div>The royalty expense recognized related to the CASE agreement is recorded as a component of cost of revenue and was $24 and $37 for the three months ended June&#160;30, 2020 and 2019, respectively, and $55 and $74 for the six months ended June&#160;30, 2020 and 2019, respectively. At June&#160;30, 2020 and December 31, 2019, $24 and $39, respectively, was due to CASE.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627931108104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 ("2017 Tax Act"). Corporate taxpayers may carryback net operating losses ("NOLs") originating during 2018 through 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for tax years beginning January 1, 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally eligible for 15-year cost-recovery and 100% bonus depreciation. The enactment of the CARES Act did not result in any material adjustments to our income tax provision for the three or six months ended June 30, 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the three and six months ended June&#160;30, 2020 and 2019, we calculated the provision of income taxes by applying an estimate of the annual effective tax rate for the full fiscal year to the ordinary loss for the reporting period resulting in a zero tax provision consistent with prior periods.  </span></div>The deferred tax assets were fully offset by a valuation allowance at June&#160;30, 2020 and December 31, 2019, and no income tax benefit has been recognized in our condensed consolidated statements of operations for any of the periods presented.  At December 31, 2019, we had available federal and state tax loss carryforwards of $86,807, state loss carryforwards of $64,026 and tax credits for federal and state tax purposes of $260. Federal net operating losses generated after January 1, 2018 will have an indefinite carryforward period. An ownership change under Section 382 of the Internal Revenue Code was deemed to occur on May 30, 2014.  Given the limitation calculation, we anticipate approximately $16,200 in losses generated prior to the ownership change date will be subject to potential limitation. The estimated annual limitation is $1,062. A second ownership change under Section 382 was deemed to occur on December 11, 2018. The estimated annual limitation is $9,736, which is increased by $22,430 annually over the first five years as a result of an unrealized built in gain. NOLs sustained prior to May 30, 2014 will still be constrained by the lower limitation. Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative loss incurred over the three-year period ended  June&#160;30, 2020. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628026921016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock Options</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value for options granted at the time of issuance were estimated at the date of grant using a Black-Scholes options pricing model. Significant assumptions included in the option value model include the fair value of our common stock at the grant date, weighted average volatility, risk-free interest rate, dividend yield and the forfeiture rate. There were no stock options granted in any of the periods presented.</span></div><div style="padding-left:36pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our stock option activity and related information are summarized as follows: </span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.070%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.788%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.788%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.951%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contractual Terms</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in Years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70,628&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(41,370)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Options generally include a time-based vesting schedule permitting the options to vest ratably over three years. At June&#160;30, 2020 and December 31, 2019, all options were fully vested. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There was no stock-based compensation expense on stock options for the three and six months ended June&#160;30, 2020 and 2019, respectively.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Restricted Stock</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our restricted stock activity and related information are summarized as follows: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:56.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.032%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.033%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contractual Terms</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in Years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">318,002&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">158,310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(568)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38,397)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">437,347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock exercisable at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At June&#160;30, 2020, there was $9,865 of unrecognized compensation expense remaining related to our service-based restricted stock awards. The unrecognized compensation cost was expected to be recognized over a weighted-average period of 1.6 years or earlier upon an elimination of the restriction period as a result of a change in control event. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Stock-based compensation expense on restricted stock amounted to $2,495 and $692 for the three months ended June&#160;30, 2020 and 2019, respectively, and $3,453 and $1,163 for the six months ended June&#160;30, 2020 and 2019, respectively. The increase in the stock compensation expense for the three months ended June 30, 2020 was due to a one-time stock grant to the Company's Chief Executive Officer that vested immediately resulting in an additional $1,322 of expense.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Warrants</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our warrant activity and related information are summarized as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%;"><tr><td style="width:1.0%;"/><td style="width:54.058%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.607%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.163%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.607%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.165%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For all periods presented, the warrants were issued at an exercise prices of $30.97 per share. The warrants have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjM4YzRkMjg4ZjI2MDQ2ODVhOGM4MWQ0NjQyMTY3YmJkL3NlYzozOGM0ZDI4OGYyNjA0Njg1YThjODFkNDY0MjE2N2JiZF81OC9mcmFnOmVhOTRlNWE3NjY4MzQzMDM4NDc5NGYxZTUzNGMxYzk2L3RleHRyZWdpb246ZWE5NGU1YTc2NjgzNDMwMzg0Nzk0ZjFlNTM0YzFjOTZfMTU5Ng_22c0bf25-8204-4c32-a466-8f4c334e3f8a">ten</span>-year term. At June&#160;30, 2020, no warrants had been exercised.  At inception, no fair value was assigned to the warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627930897496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET LOSS PER SHARE</a></td>
<td class="text">NET LOSS PER SHARE<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic and diluted net loss per share:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:49.762%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.538%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.538%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.538%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.541%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,447)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,618)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,392)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,638)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of shares - basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,549,118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,451,979&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,986,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,409,752&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share - basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.54)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.18)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.85)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.39)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our basic and diluted net loss per share is computed using the two-class method.&#160; The two-class method is an earnings allocation that determines net income per share for each class of common stock and participating securities according to their participation rights in dividends and undistributed earnings or losses.&#160; Non-vested restricted stock that includes non-forfeitable rights to dividends are considered participating securities.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because we have incurred a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share. The following contingently issuable and convertible equity shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for all periods presented:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.160%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:25.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.600%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.520%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">437,347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">307,347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90,685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,979&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total shares</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">467,009&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">403,011&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927900760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT</a></td>
<td class="text">BUSINESS SEGMENT  <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. We have one operating and reporting segment, OrthoPediatrics Corp., which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. Our chief operating decision-maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance, accompanied by disaggregated revenue information by product category. We determined that disaggregating revenue into these categories achieves the disclosure objective of illustrating the differences in the nature, timing and uncertainty of our revenue streams. We do not assess the performance of our individual product categories on measures of profit or loss, or other asset-based metrics. Therefore, the information below is presented only for revenue by category and geography. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Product sales attributed to a country or region includes product sales to hospitals, physicians and distributors and is based on the final destination where the products are sold. No customers accounted for more than 10% of total product sales for the three and six months ended June&#160;30, 2020 or 2019. No customer accounted for more than 10% of consolidated accounts receivable as of June&#160;30, 2020 and December 31, 2019. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Product sales by source were as follows: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.423%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.425%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by geographic location:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S.</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,848&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,530&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,115&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.423%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by category:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trauma and deformity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,887&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,904&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Scoliosis</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,836&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,866&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,547&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sports medicine/other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">537&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table>No individual country with sales originating outside of the United States accounted for more than 10% of consolidated revenue for the three and six months ended June&#160;30, 2020 and 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929326376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text">RELATED PARTY TRANSACTIONSIn addition to the debt and credit agreements and mortgage with Squadron and its affiliate (see Note 6), we currently use Structure Medical, LLC (&#8220;Structure Medical&#8221;) as one of our suppliers. Structure Medical is affiliated with Squadron and we do not have a long-term contract with them. We made aggregate payments to Structure Medical of $934 and $1,729 for the three months ended June&#160;30, 2020 and 2019, respectively, and $2,135 and $2,493 for the six months ended June&#160;30, 2020 and 2019 . On December 31, 2019, the Company divested Vilex for $25,000 to an affiliate of Squadron. In conjunction with the divestiture, the Company also entered into an exclusive perpetual license agreement to permit the purchasers of Vilex the ability to access intellectual property and sell products using the external fixation technology of Orthex, LLC to non-pediatric accounts. The Orthex license agreement was determined to have a value of $12,410 and is determined to be a sale of functional intellectual property, resulting in the derecognition or sale of certain patent intangibles acquired in the Vilex and Orthex acquisition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927840776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLAN<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLAN</a></td>
<td class="text">EMPLOYEE BENEFIT PLANWe have a defined-contribution plan, OrthoPediatrics 401(k) Retirement Plan (the &#8220;401(k) Plan&#8221;), which includes a cash or deferral (Section 401(k)) arrangement.  The 401(k) Plan covers those employees who meet certain eligibility requirements and elect to participate. Employee contributions are limited to the annual amounts permitted under the Internal Revenue Code. The 401(k) Plan allows us to make a discretionary matching contribution. Discretionary matching contributions are determined annually by management. Effective January 1, 2020, we have elected to match our employees' 401(k) contributions up to 4% of employees' salary. Prior to January 1, 2020, we matched our employees' 401(k) contributions up to 3% of employees' salary.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929348760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Leases</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company calculates the associated lease liability and corresponding right-of-use asset upon lease commencement using a discount rate based on a borrowing rate commensurate with the term of the lease. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company records lease liabilities within current liabilities or long-term liabilities based upon the length of time associated with the lease payments. The Company records its operating lease right-of-use assets as long-term assets. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">As of June 30, 2020, the Company has recorded a lease liability of $120 and corresponding right-of-use-asset of $123 on its condensed consolidated balance sheet. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">From time to time, we are involved in various legal proceedings arising in the ordinary course of our business. On January 20, 2017, K2M, Inc. filed suit against us in the United States District Court for the District of Delaware (K2M, Inc. v. OrthoPediatrics Corp. et al., Case No. 1:17-cv-0061) seeking unspecified damages for alleged infringement of U.S. Patent No. 9,532,816. The complaint was amended on August 21, 2017 to add, among other things, a claim of patent infringement regarding U.S. Patent No. 9,655,664. These patents relate to certain instruments used in our RESPONSE&#8482; spine systems, which represent a portion of our total scoliosis portfolio. We have denied these claims and responded with counterclaims seeking declaratory relief that the patents in question are both invalid and not infringed. The parties attended a court-ordered mediation on October 24, 2017, which did not resolve the dispute, but as we move forward with this matter we welcome constructive discussions on a negotiated settlement. Nevertheless, we view our case as particularly strong and will continue to vigorously defend this matter. On June 28, 2018, the United States Patent and Trademark Office's Patent Trial and Appeal Board ("PTAB") instituted limited review concerning whether certain third parties had described the invention of certain of K2M's patent claims before allegedly invented by K2M. On July 10, 2018, the Court stayed the litigation pending the outcome of PTAB's review. On June 4, 2019, PTAB completed its review, finding, among other things, insufficient evidence of such description by the third parties. In early October 2019, the Court orally lifted the stay in federal district court. Thereafter, on November 19, 2019, K2M amended its complaint to add two (2) additional issued patents, to add claims of patent infringement regarding U.S. Patent Nos. 10,285,735 and 10,292,736 (both issued in May 2019). Like before, these newly issued patents relate to certain instruments used in our RESPONSE&#8482; spine systems. Additionally, we have denied these most recent claims and responded with counterclaims seeking declaratory relief that the subject patents are both invalid and not infringed. Moreover, on November 20, 2019, the Court issued a Scheduling Order, which in part, set a trial date for April 12, 2021. Subsequently, the parties attended a second court-ordered mediation on February 25, 2020, which did not resolve the dispute, but we continue to welcome constructive discussions on a negotiated settlement. Although we believe that the K2M lawsuit is without merit and will vigorously defend the claims asserted against us, intellectual property litigation can involve complex factual and legal questions, and an adverse resolution of this proceeding could have a material adverse effect on our business, operating results and financial condition. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">We are not presently a party to any other legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate materially affect our financial position, results of operations or cash flows.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Royalties</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;30, 2020, we are contracted to pay royalties to individuals and entities that provide research and development services, which range from 0.5% to 20% of sales.  Additionally, we had minimum royalty commitments of $500 annually through 2026 which ceased upon the purchase of the Band-Lok assets in June 2020.  </span></div>We have products in development that have milestone payments and royalty commitments.  In any development project, there are significant variables that will affect the amount and timing of these payments and as of June&#160;30, 2020, we have not been able to determine the amount and timing of payments.  We do not anticipate these future payments will have a material impact on our financial results.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628014773896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On August 4, 2020, the Company entered into a Second Amendment (the &#8220;Second Amendment&#8221;) to its First Amended Loan Agreement with Squadron (as so further amended, the &#8220;Second Amended Loan Agreement&#8221;).  Pursuant to the Second Amendment, the First Amended Loan Agreement&#8217;s revolving credit commitment was increased from the previously established $15,000 to $25,000. The Company has agreed to pay Squadron an unused commitment fee in an amount equal to the per annum rate of 0.50% (computed on the basis of a year of 360 days and the actual number of days elapsed) times the daily unused portion of the revolving credit commitment.  The unused commitment fee is payable quarterly in arrears.  </span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Borrowings under the revolving credit facility will be made under a First Amended and Restated Revolving Note, dated August 4, 2020 (the &#8220;Amended Revolving Note&#8221;), payable, jointly and severally, by the Company and each of its subsidiaries party thereto. The Amended Revolving Note will mature at the earlier of: (i) the date on which any person or persons acquire (x) capital stock of the Company possessing the voting power to elect a majority of the Company&#8217;s Board of Directors (whether by merger, consolidation, reorganization, combination, sale or transfer), or (y) all or substantially all of the Company&#8217;s assets, determined on a consolidated basis; and (ii) January 1, 2024.  Prior to the Second Amendment, the revolving credit facility was to have matured on January 31, 2023. The Second Amended Loan Agreement continues to provide for interest only payments, which are payable monthly, with interest rates equal to the greater of (a) three month LIBOR plus 8.61%, and (b) 10.00%</span></div>On July 15, 2020, the Company repaid the $20,000 principal amount outstanding under the Loan Agreement&#8217;s Term Note A, together with all unpaid interest and other related amounts payable. Following such repayment, there are no outstanding term loan obligations under the Second Amended Loan Agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933011192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Unaudited Interim Consolidated Financial Statements</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying condensed consolidated financial statements include the accounts of OrthoPediatrics Corp. and its wholly-owned subsidiaries, OrthoPediatrics US Distribution Corp., OrthoPediatrics EU Limited, OrthoPediatrics AUS PTY LTD, OrthoPediatrics NZ Limited, OP EU B.V., OP Netherlands B.V., Vilex in Tennessee, Inc., Orthex, LLC, Telos Partners, LLC, ApiFix Ltd. and ApiFix Inc. (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;).  All intercompany balances and transactions have been eliminated.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Unaudited Interim Condensed Consolidated Financial Statements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We have prepared the accompanying condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The accompanying condensed consolidated balance sheets as of June&#160;30, 2020 and December 31, 2019, the condensed consolidated statements of operations for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of comprehensive loss for the three and six months ended June&#160;30, 2020 and 2019, the condensed consolidated statements of stockholders&#8217; equity for the three and six months ended June&#160;30, 2020 and 2019 and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2020 and 2019 are unaudited and should be read in conjunction with the annual consolidated financial statements as of and for the year ended December&#160;31, 2019 and related notes thereto contained in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 5, 2020. The financial data and other financial information disclosed in the notes to the accompanying condensed consolidated financial statements are also unaudited. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to applicable rules and regulations thereunder. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended December 31, 2019 and, in management&#8217;s opinion, include all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the financial statements for the interim periods. The results of operations for the three and six months ended June&#160;30, 2020 are not necessarily indicative of the results to be expected for the full fiscal year or for any other period. </span></div>The accompanying condensed consolidated financial statements have been prepared assuming our Company will continue as a going concern.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesPreparation of the condensed consolidated financial statements requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as of the date of the condensed consolidated financial statements.  By their nature, these judgments are subject to an inherent degree of uncertainty. The impact of the coronavirus disease ("COVID-19") has significantly increased economic and demand uncertainty.  We use historical experience and other assumptions as the basis for our judgments and estimates.  Because future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.  Any changes in these estimates will be reflected in the condensed consolidated financial statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Foreign Currency Transactions</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We currently bill our international distributors in United States ("U.S.") dollars, resulting in minimal foreign exchange transaction expense. </span></div>Beginning in the second quarter of 2017, we began selling direct within the United Kingdom, Ireland, Australia and New Zealand and billing using the local currency for each country. In September 2018, we began selling direct in Canada, in January 2019 in Belgium and the Netherlands, in March 2020 in Italy and in April 2020 in Israel. The financial statements of our foreign subsidiaries are accounted for and have been translated into U.S. dollars using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. Foreign currency translation adjustments have been recorded as a separate component of the condensed consolidated statements of comprehensive loss.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition - United States and International</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue from Contracts with Customers</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In accordance with ASC 606, "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenue From Contracts With Customers </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(ASC 606)", revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services, and excludes any sales incentives or taxes collected from a customer which are subsequently remitted to government authorities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue Recognition &#8211; United States</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Revenue in the United States is generated primarily from the sale of our implants and, to a much lesser extent, from the sale of our instruments.  Sales in the United States are primarily to hospital accounts through independent sales agencies.  We recognize revenue when our performance obligations under the terms of a contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customers, generally upon implantation or when title passes upon shipment. The products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.   </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Revenue Recognition &#8211; International</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Outside of the United States, we primarily sell our products through independent stocking distributors. Generally, the distributors are allowed to return products, and some are thinly capitalized. Based on our history of collections and returns from international customers, prior to 2019, we concluded that collectability was not reasonably assured at the time of delivery for certain customers who had not evidenced a consistent pattern of timely payment. Accordingly, in the past we did not recognize international revenue and associated cost of revenue at the time title transfers for these customers for whom collectability had not been deemed probable based on the customer&#8217;s history and ability to pay, but rather when cash had been received. </span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a review of our collection history, we deemed collectability was probable for all international stocking distributors effective January 1, 2019. Based on a history of reliable collections, we have concluded that a contract exists and revenue should be recognized when our performance obligations under the terms of the contract with our customer are satisfied. This typically occurs when we transfer control of our products to the customer, generally upon implantation or when title passes upon shipment.  </span><span style="background-color:rgb(255,255,255, 0.0);color:#226600;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div>In the countries where we sell under an agency model direct to local hospitals, the products are generally consigned to our independent sales agencies, and revenue is recognized when the products are used by or shipped to the hospital for surgeries on a case by case basis.  On rare occasions, hospitals purchase products for their own inventory, and revenue is recognized when the products are shipped and the title and risk of loss passes to the customer. Pricing for each customer is dictated by a unique pricing agreement, which does not generally include rebates or discounts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and Cash EquivalentsWe maintain cash in bank deposit accounts which, at times, may exceed federally insured limits.  To date, we have not experienced any loss in such accounts.  We consider all highly liquid investments with original maturity of three months or less at inception to be cash equivalents.  The carrying amounts reported in the balance sheet for cash are valued at cost, which approximates fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accounts receivable are uncollateralized customer obligations due under normal trade terms, generally requiring payment within 30 days from the invoice date. Account balances with invoices over 30 days past due are considered delinquent.  No interest is charged on past due accounts. Payments of accounts receivable are applied to the specific invoices identified on the customer's remittance advice or, if unspecified, to the customer's account as an unapplied credit.</span></div>The carrying amount of accounts receivable is reduced by an allowance that reflects management's best estimate of the amounts that will not be collected, determined principally on the basis of historical experience, management's assessment of the collectability of specific customer accounts and the aging of the accounts receivable. All accounts or portions thereof deemed to be uncollectible or to require an excessive collection cost are written off to the allowance for doubtful accounts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories, net</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Inventories, net </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inventories are stated at the lower of cost or net realizable value, with cost determined using the first-in-first-out method. Inventories, which consist of implants and instruments held in our warehouse or with third-party independent sales agencies or distributors, are considered finished goods and are purchased from third parties. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We evaluate the carrying value of our inventories in relation to the estimated forecast of product demand, which takes into consideration the life cycle of the product.  A significant decrease in demand could result </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in an increase in the amount of excess inventory on hand, which could lead to additional charges for excess and obsolete inventory.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The need to maintain substantial levels of inventory impacts our estimates for excess and obsolete inventory.  Each of our implant systems are designed to include implantable products that come in different sizes and shapes to accommodate the surgeon&#8217;s needs.  Typically, a small number of the set components are used in each surgical procedure.  Certain components within each set may become obsolete before other components based on the usage patterns.  We adjust inventory values, as needed, to reflect these usage patterns and life cycle.     </span></div>In addition, we continue to introduce new products, which may require us to take additional charges for excess and obsolete inventory in the future.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, net</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Property and Equipment, net </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful life of the assets. When assets are retired or otherwise disposed of, costs and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in operations for the period. Maintenance and repairs that prolong or extend the useful life are capitalized, whereas standard maintenance, replacements, and repair costs are expensed as incurred. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Instruments are hand-held devices, specifically designed for use with our implants and are used by surgeons during surgery. Instruments deployed within the United States, United Kingdom, Australia, New Zealand, Canada, Belgium, the Netherlands and Italy are carried at cost less accumulated depreciation and are recorded in property and equipment, net on the condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sample inventory consists of our implants and instruments, and is maintained to market and promote our products. Sample inventory is carried at cost less accumulated depreciation. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciable lives are generally as follows:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:48.000%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Building and building improvements</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">25 to 30 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and fixtures</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Business software</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office and other equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instruments</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sample inventory</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Amortizable Intangible Assets, net</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Amortizable Intangible Assets, net</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amortizable intangible assets</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">include fees necessary to secure various patents and licenses, including Band-Lok, the value of internally developed software, customer relationships, and non-competition agreements related to the acquisition of Orthex, and customer relationships and non-competition agreements related to the acquisitions of Telos and ApiFix. Amortization is calculated on a straight-line basis over the estimated useful life of the asset.  Amortization for patents and licenses commences at the time of patent approval and market launch, respectively. Amortization for assets acquired commences upon acquisition. Intangible assets are amortized over a 3 to 20 year period. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amortizable intangible assets are assessed for impairment annually or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is </span></div>measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Goodwill and Other Intangible Assets</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our goodwill represents the excess of the cost over the fair value of net assets acquired. The determination of the value of goodwill and intangible assets arising from acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of net tangible and intangible assets acquired. Goodwill is not amortized and is assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstances warrant such a review. The goodwill is considered to be impaired if we determine that the carrying value of the reporting unit exceeds its respective fair value. </span></div>We have indefinite lived tradename assets that are reviewed for impairment by performing a quantitative analysis, which occurs annually in the fourth quarter or whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability is measured by a comparison of the carrying amount to future net undiscounted cash flows expected to be generated by the associated asset. If such assets are determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount exceeds the fair market value of the assets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text">Cost of RevenueCost of revenue consists primarily of products purchased from third-party suppliers, excess and obsolete inventory adjustments, inbound freight, and royalties.  Our implants and instruments are manufactured to our specifications by third-party suppliers who meet our manufacturer qualifications standards.  Our third-party manufacturers are required to meet the standards of the Food and Drug Administration (the &#8220;FDA&#8221;), and the International Organization for Standardization, as well as other country-specific quality standards.  The majority of our implants and instruments are produced in the United States.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_SalesAndMarketingExpensePolicyPolicyTextBlock', window );">Sales and Marketing Expenses</a></td>
<td class="text">Sales and Marketing ExpensesSales and marketing expenses primarily consist of commissions to our domestic and select international independent sales agencies and consignment distributors, as well as compensation, commissions, benefits and other related costs for personnel we employ. Commissions and bonuses are generally based on a percentage of sales.  Our international independent stocking distributors purchase instrument sets and replenishment stock for resale, and we do not pay commissions or any other sales related costs for international sales to distributors.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising Costs Advertising costs consist primarily of print advertising, trade shows, and other related expenses. Advertising costs are expensed as incurred and are recorded as a component of sales and marketing expense.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">Research and Development CostsResearch and development costs are expensed as incurred. Our research and development expenses primarily consist of costs associated with engineering, product development, consulting services, outside prototyping services, outside research activities, materials, development and protection of our intellectual property portfolio, as well as other costs associated with development of our products. Research and development costs also include related personnel and consultants&#8217; compensation expense.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Prior to our Initial Public Offering ("IPO") in October 2017, we maintained an Amended and Restated 2007 Equity Incentive Plan (the &#8220;2007 Plan&#8221;) that provided for grants of options and restricted stock to employees, directors and associated third-party representatives of the Company as determined by the Board of Directors. The 2007 Plan had authorized 1,585,000 shares for award. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Immediately prior to our IPO, we adopted our 2017 Incentive Award Plan (the "2017 Plan") which replaced the 2007 Plan. The 2017 Plan provides for grants of options and restricted stock to officers, employees, consultants or directors of our Company. The 2017 Plan has authorized 1,789,647 shares for award. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Options holders, upon vesting, may purchase common stock at the exercise price, which is the estimated fair value of our common stock on the date of grant. Option grants generally vest immediately or over three years. No stock options were granted in any of the periods presented.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Restricted stock may not be transferred prior to the expiration of the restricted period, which is typically three years. The restricted stock that had been granted under the 2007 Plan had restriction periods that generally lasted until the earlier of six years from the date of grant, or an IPO or change in control, as defined in the 2007 Plan. All restricted stock granted prior to May 2014 vested upon our IPO and the remaining grants under the 2007 Plan vested six months after the IPO. We recognize the reversal of stock compensation expense when a restricted stock forfeiture occurs as opposed to estimating future forfeitures.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We record the fair value of restricted stock at the grant date.  Stock-based compensation is recognized ratably over the requisite service period, which is generally the restriction period for restricted stock.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text">Comprehensive Income (Loss)Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income (loss) includes foreign currency translation adjustments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Income Taxes</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the condensed consolidated financial statements. Under this method, we determine deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the valuation allowance. </span></div>We record uncertain tax positions on the bases of a two-step process in which (i) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the positions and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock', window );">"Emerging Growth Company" Reporting Requirements</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">&#8220;Emerging Growth Company&#8221; Reporting Requirements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We qualify as an &#8220;emerging growth company&#8221; as defined in the JOBS Act. For as long as a company is deemed to be an emerging growth company, it may take advantage of specified reduced reporting and other regulatory requirements that are generally unavailable to other public companies. Among other things, we are not required to provide an auditor attestation report on the assessment of the internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act of 2002. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Section 107 of the JOBS Act also provides that an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. </span></div>In April 2017, the SEC adopted new rules that included an inflation-adjusted threshold in the definition of an emerging growth company. Under the new inflation-adjusted threshold, we would cease to be an emerging growth company on the last day of the fiscal year in which our annual gross revenues exceed $1.07 billion. This is an increase of $70 million from the previous $1 billion threshold.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the FASB issued ASU No. 2016-13 "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments"</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. The ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The ASU requires the measurement of all expected credit losses for financials assets including trade receivables held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will now use forward-looking information to better inform their credit loss estimates. Based on ASU 2019-10 and our status as a Smaller Reporting Company, the Company will adopt ASU 2016-13 effective January 1, 2023. The adoption of this guidance is not expected to have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2017, the FASB issued ASU 2017-04, "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment"</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. This pronouncement eliminates Step 2 from the goodwill impairment test and requires an entity to perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. Under this guidance, an entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. It is effective for reporting periods beginning after December 15, 2020, although earlier adoption is permitted. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures. </span></div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued ASU No. 2019-12 "</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Income Taxes: Simplifying the Accounting for Income Taxes"</span> intended to simplify the accounting for income taxes by eliminating certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside cost basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard is effective for annual periods beginning after December 15, 2020 and interim periods within, with early adoption permitted. Adoption of the standard requires certain changes to be made prospectively, with some changes to be made retrospectively. The Company adopted this standard on January 1, 2020 and it did not have a significant impact on the Company's consolidated financial statements and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of Goods and Services Sold, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company Reporting Requirements, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_SalesAndMarketingExpensePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_SalesAndMarketingExpensePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929432440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and equipment, depreciable lives</a></td>
<td class="text">Sample inventory is carried at cost less accumulated depreciation. <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Depreciable lives are generally as follows:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:48.000%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Building and building improvements</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">25 to 30 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Furniture and fixtures</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Computer equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3 to 5 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Business software</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Office and other equipment</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instruments</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5 years</span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sample inventory</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2 years</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929396264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for ApiFix and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands):  </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"/><td style="width:62.677%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.574%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:31.549%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preliminary fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87,379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">77&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">602&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,956&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,423&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for Telos and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"/><td style="width:62.677%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.574%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:31.549%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Preliminary fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,318&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other intangible assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,466&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,912&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The following table summarizes the total consideration paid for Vilex and Orthex and allocation of purchase price to the estimated fair value of the assets acquired and liabilities assumed at the acquisition date (in thousands): </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%;"><tr><td style="width:1.0%;"/><td style="width:62.677%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.574%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:31.549%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of estimated total acquisition consideration</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable-trade</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,088&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,652&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,540&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45,143&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Deferred tax liability</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: total net assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43,014&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text">The estimated fair value and useful life of identifiable intangible assets are as follows: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">340&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">910&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,610&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Internally Developed Software</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,550&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text">The estimated fair value and useful life of identifiable intangible assets are as follows: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">340&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">910&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The fair value of identifiable intangible assets were based on valuations using a combination of the income and cost approach. The estimated fair value and useful life of identifiable intangible assets are as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:33.737%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.883%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:38.226%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Economic Useful Life</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks / Names</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,610&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Indefinite</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Internally Developed Software</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,550&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer Relationships</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,570&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12 years</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-competition Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5 years</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Presented below is a summary of the present value of the anniversary payments and system sales payment related to the ApiFix acquisition: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:56.974%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.871%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.873%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">April 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anniversary Payments: </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Second Year Payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Third Year Payment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,780&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,965&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fourth Year Payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,860&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,056&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total acquisition installment payable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,506&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current portion of acquisition installment payable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition installment payable, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,640&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,021&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">System sales payment</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27,190&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ApiFix future consideration, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,830&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,121&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div>Pre-acquisition revenues and earnings for ApiFix were not material to the condensed consolidated operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of characteristics and cost, by total and major class, of indefinite-lived intangible assets acquired as part of a business combination. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. The future benefit is not expected to diminish over a stated period of time. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4922-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927895992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Changes in the carrying amount of goodwill for the six months ended June 30, 2020 were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:77.487%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.872%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at January 1, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vilex Companies acquisition</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Divestiture of Vilex in Tennessee, Inc. </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3,397)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at January 1, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,773&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Telos acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,912&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthex measurement period adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(688)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ApiFix acquisition</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">53,423&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68,420&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June 30, 2020, the balances of amortizable intangible assets were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.504%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Intangible Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Intangible Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.3 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,182&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,019)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intellectual Property</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8 years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(473)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">License Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,199)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amortizable assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44,897&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,691)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42,206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of December 31, 2019, the balances of amortizable intangible assets were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.428%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.504%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Amortization Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Intangible Assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Intangible Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.4 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,287&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(363)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,924&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intellectual Property</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7 years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,020&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(213)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,807&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">License Agreements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4 years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,012)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,753&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amortizable assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,072&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,588)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,484&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627928014376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following summarized financial information has been segregated from continuing operations and reported as discontinued operations for the three and six months ended June 30, 2019:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:75.403%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:20.597%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three and Six Months Ended</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenue</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">414&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating expenses</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">507&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(159)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss from discontinued operations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(159)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927910216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND CREDIT ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of long-term debt instruments</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Long-term debt consisted of the following: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%;"><tr><td style="width:1.0%;"/><td style="width:57.069%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:18.064%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.602%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.065%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Note payable to Squadron</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,907&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revolving credit facility with Squadron</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Mortgage payable to affiliate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,300&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: current maturities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt with affiliate, net of current maturities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,017&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628017283992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our stock option activity and related information are summarized as follows: </span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.070%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.788%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.788%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.951%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contractual Terms</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in Years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70,628&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(41,370)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of restricted stock activity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our restricted stock activity and related information are summarized as follows: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:56.333%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.032%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.033%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contractual Terms</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(in Years)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">318,002&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">158,310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(568)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38,397)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">437,347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock exercisable at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrants</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Our warrant activity and related information are summarized as follows: </span></div><div style="margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%;"><tr><td style="width:1.0%;"/><td style="width:54.058%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.607%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.163%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.607%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.165%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercise Price</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Outstanding at June 30, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627928053480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of basic and diluted net loss per share attributable to common stockholders</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic and diluted net loss per share:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:49.762%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.538%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.538%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.538%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.541%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,447)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2,618)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,392)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5,638)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average number of shares - basic and diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,549,118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,451,979&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,986,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,409,752&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net loss per share - basic and diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.54)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.18)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.85)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.39)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of antidilutive securities excluded from computation of net loss per share</a></td>
<td class="text">The following contingently issuable and convertible equity shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for all periods presented:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.160%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:25.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.600%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.520%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restricted stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">437,347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">307,347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock options</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90,685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Warrants</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">404&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,979&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total shares</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">467,009&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">403,011&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929122104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of product sales by geographic location</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Product sales by source were as follows: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.423%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.425%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by geographic location:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S.</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,848&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,530&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24,115&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of product sales by category</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.743%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.423%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.601%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.583%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.441%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.585%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Six Months Ended June 30,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Product sales by category:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trauma and deformity</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,887&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,904&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Scoliosis</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,836&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,866&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,547&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sports medicine/other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">537&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">972&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:top;border-top:1pt solid #000000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Arial',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627930575112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 10, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($) </div>
<div>facility </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 04, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Divestiture purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of shares and membership interests in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase of shares and membership interests in common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember', window );">Telos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of shares and membership interests in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase of shares and membership interests in common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of shares and membership interests in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase of shares and membership interests in common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">934,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned', window );">Common stock approximate value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures', window );">Number of clinical procedures | facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationRevenueMultiplier', window );">Revenue multiplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Second Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Subsequent payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Third Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Subsequent payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Fourth Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Subsequent payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_BandLokMember', window );">Band-Lok</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Approximate Value Assigned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Number of Clinical Procedures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationRevenueMultiplier">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Revenue Multiplier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationRevenueMultiplier</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_SecondAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_SecondAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_ThirdAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_ThirdAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_FourthAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_FourthAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_BandLokMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_BandLokMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628095414200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 22, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,214,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,822,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment charges, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment charges, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=kids_FollowOnOfferingMember', window );">Follow-on Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock issued and sold</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price (in dollars per share)</a></td>
<td class="nump">$ 47.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Aggregate gross proceeds</a></td>
<td class="nump">$ 75,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="nump">70,207,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Discounts and commissions</a></td>
<td class="nump">4,512,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">$ 481,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=kids_FollowOnOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=kids_FollowOnOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933199016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Assets Useful Lives (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and building improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and building improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Business software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office and other equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office and other equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember', window );">Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kids_SampleInventoryMember', window );">Sample inventory</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Depreciable lives</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=kids_SampleInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=kids_SampleInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627932998216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Amortization Intangible Assets, net (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933928280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Stock-Based Compensation (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock | Vesting period one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock | Vesting period two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kids_A2007EquityIncentivePlanMember', window );">2007 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares available for award (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,585,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kids_New2017EquityIncentivePlanMember', window );">2017 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares available for award (in shares)</a></td>
<td class="nump">1,789,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,789,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kids_A2007EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kids_A2007EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kids_New2017EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kids_New2017EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627924688088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - ApiFix (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($) </div>
<div>facility </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 04, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Fair value of estimated total acquisition consideration</a></td>
<td class="nump">$ 87,379,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 737,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,773,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">910,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">910,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">ApiFix future consideration, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of shares and membership interests in cash</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="nump">$ 343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase of shares and membership interests in common stock (in shares) | shares</a></td>
<td class="nump">934,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Common stock value</a></td>
<td class="nump">$ 35,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 37.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAnniversaryPayments', window );">Anniversary payments</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationSystemSalesPayment', window );">System sales payment</a></td>
<td class="nump">41,741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Fair value of estimated total acquisition consideration</a></td>
<td class="nump">87,379,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="nump">310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable-trade</a></td>
<td class="nump">245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">77,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">24,330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Other intangible assets</a></td>
<td class="nump">8,620,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">104,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">34,558,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">226,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">602,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Less: Net assets</a></td>
<td class="nump">33,956,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 53,423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_IntangibleAssetsAcquired', window );">Fair value of identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationRevenueMultiplier', window );">Revenue multiplier</a></td>
<td class="nump">2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustment of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">ApiFix future consideration, net of current portion</a></td>
<td class="nump">$ 38,830,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,121,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,121,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationRevenuePayment', window );">System sales payment</a></td>
<td class="nump">$ 27,190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 886,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures', window );">Number of clinical procedures | facility</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Second Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Subsequent payments</a></td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Third Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Subsequent payments</a></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Fourth Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Subsequent payments</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Trademarks and Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,620,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Noncompete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationAnniversaryPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Anniversary Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationAnniversaryPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Number of Clinical Procedures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationRevenueMultiplier">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Revenue Multiplier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationRevenueMultiplier</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationRevenuePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Revenue Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationRevenuePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationSystemSalesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, System Sales Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationSystemSalesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_IntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_IntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_SecondAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_SecondAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_ThirdAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_ThirdAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_FourthAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_FourthAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628012177896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Summary of the Present Value of Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent', window );">Less: current portion of acquisition installment payable</a></td>
<td class="nump">$ 11,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent', window );">Acquisition installment payable, net of current portion</a></td>
<td class="nump">12,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">ApiFix future consideration, net of current portion</a></td>
<td class="nump">28,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable', window );">Anniversary payments</a></td>
<td class="nump">23,506<span></span>
</td>
<td class="nump">$ 22,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent', window );">Less: current portion of acquisition installment payable</a></td>
<td class="nump">11,485<span></span>
</td>
<td class="nump">10,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent', window );">Acquisition installment payable, net of current portion</a></td>
<td class="nump">12,021<span></span>
</td>
<td class="nump">11,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationRevenuePayment', window );">System sales payment</a></td>
<td class="nump">28,100<span></span>
</td>
<td class="nump">27,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">ApiFix future consideration, net of current portion</a></td>
<td class="nump">40,121<span></span>
</td>
<td class="nump">38,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Second Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable', window );">Anniversary payments</a></td>
<td class="nump">11,485<span></span>
</td>
<td class="nump">10,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Third Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable', window );">Anniversary payments</a></td>
<td class="nump">5,965<span></span>
</td>
<td class="nump">5,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd | Fourth Anniversary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable', window );">Anniversary payments</a></td>
<td class="nump">$ 6,056<span></span>
</td>
<td class="nump">$ 5,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Acquisition Installment Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Acquisition Installment Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Acquisition Installment Payable, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationContingentConsiderationRevenuePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Revenue Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationContingentConsiderationRevenuePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_SecondAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_SecondAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_ThirdAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_ThirdAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessAcquisitionAnniversaryAxis=kids_FourthAnniversaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessAcquisitionAnniversaryAxis=kids_FourthAnniversaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627930214056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Telos (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 04, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Fair value of estimated total acquisition consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember', window );">Telos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of shares and membership interests in cash</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase of shares and membership interests in common stock (in shares)</a></td>
<td class="nump">36,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share)</a></td>
<td class="nump">$ 42.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Fair value of estimated total acquisition consideration</a></td>
<td class="nump">3,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable-trade</a></td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Other intangible assets</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Less: total net assets</a></td>
<td class="nump">1,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_IntangibleAssetsAcquired', window );">Fair value of identifiable intangible assets</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember', window );">Telos | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember', window );">Telos | Noncompete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember', window );">Telos | Trademarks and Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired</a></td>
<td class="nump">$ 210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_IntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_IntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627926514984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Vilex and Orthex (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 04, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock (in dollars per share)</a></td>
<td class="nump">$ 40.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationEscrowDepositMaximumTerm', window );">Escrow deposit period</a></td>
<td class="text">20 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Fair value of estimated total acquisition consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Divestiture purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue', window );">Attributable to deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities', window );">Allocated purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of shares and membership interests in cash</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Purchase of shares and membership interests in common stock (in shares)</a></td>
<td class="nump">245,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationEscrowDeposit', window );">Escrow deposit</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Fair value of estimated total acquisition consideration</a></td>
<td class="nump">60,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable-trade</a></td>
<td class="nump">2,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">3,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">7,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">31,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">45,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">1,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="nump">2,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Less: total net assets</a></td>
<td class="nump">43,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">17,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_IntangibleAssetsAcquired', window );">Fair value of identifiable intangible assets</a></td>
<td class="nump">31,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,948)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex | Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 22,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex | Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 1,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 2,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex | Noncompete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Remaining Economic Useful Life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember', window );">Vilex and Orthex | Trademarks and Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired</a></td>
<td class="nump">$ 4,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationEscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Deposit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationEscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationEscrowDepositMaximumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Deposit, Maximum Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationEscrowDepositMaximumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Assets And Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_IntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_IntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_VilexAndOrthexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933081048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Changes in Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 13,773<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">68,420<span></span>
</td>
<td class="nump">13,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_VilexMember', window );">Vilex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, acquired during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill, divestiture of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,397)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember', window );">Telos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, acquired during period</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_OrthexMember', window );">Orthex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_GoodwillMeasurementPeriodAdjustment', window );">Goodwill, measurement period adjustment</a></td>
<td class="num">(688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember', window );">ApiFix Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, acquired during period</a></td>
<td class="nump">$ 53,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_GoodwillMeasurementPeriodAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Measurement Period Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_GoodwillMeasurementPeriodAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_VilexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_VilexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_TelosPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_OrthexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_OrthexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=kids_ApiFixLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627932892808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Amortizable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible Assets</a></td>
<td class="nump">$ 44,897<span></span>
</td>
<td class="nump">$ 16,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,691)<span></span>
</td>
<td class="num">(1,588)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 42,206<span></span>
</td>
<td class="nump">$ 14,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">17 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible Assets</a></td>
<td class="nump">$ 33,182<span></span>
</td>
<td class="nump">$ 9,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,019)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 32,163<span></span>
</td>
<td class="nump">$ 8,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">10 years 9 months 18 days<span></span>
</td>
<td class="text">10 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible Assets</a></td>
<td class="nump">$ 8,950<span></span>
</td>
<td class="nump">$ 4,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(473)<span></span>
</td>
<td class="num">(213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 8,477<span></span>
</td>
<td class="nump">$ 3,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible Assets</a></td>
<td class="nump">$ 2,765<span></span>
</td>
<td class="nump">$ 2,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,199)<span></span>
</td>
<td class="num">(1,012)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortizable intangible assets, net</a></td>
<td class="nump">$ 1,566<span></span>
</td>
<td class="nump">$ 1,753<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628016928104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (159)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (159)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Net loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (159)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933337432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT AND CREDIT ARRANGEMENTS - Schedule of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total debt</a></td>
<td class="nump">$ 21,145<span></span>
</td>
<td class="nump">$ 26,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current maturities</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net of current maturities</a></td>
<td class="nump">21,017<span></span>
</td>
<td class="nump">26,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note payable to Squadron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable to Squadron</a></td>
<td class="nump">19,907<span></span>
</td>
<td class="nump">19,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Term loan facility with Squadron | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Mortgage payable to affiliate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember', window );">Mortgage payable to affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Mortgage payable to affiliate</a></td>
<td class="nump">1,238<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current maturities</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627934919944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT AND CREDIT ARRANGEMENTS - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 04, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Aug. 31, 2013</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on note with affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt with affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,399,000)<span></span>
</td>
<td class="num">$ (632,000)<span></span>
</td>
<td class="num">(1,778,000)<span></span>
</td>
<td class="num">$ (935,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=kids_TermNoteBMember', window );">Term Note B | Squadron | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on note with affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=kids_RevolvingLoanMember', window );">Revolving Loan | Squadron | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on note with affiliate</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Term loan facility with Squadron | Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Term loan facility with Squadron | Revolving Loan | Squadron | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on note with affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note payable to Squadron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(513,000)<span></span>
</td>
<td class="num">$ (632,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note payable to Squadron | Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Mortgage balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember', window );">Mortgage payable to affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Mortgage balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,238,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,238,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly interest and principal installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt with affiliate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">Three month LIBOR | Note payable to Squadron | Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">Three month LIBOR | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kids_TermNoteBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kids_TermNoteBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=kids_SquadronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=kids_SquadronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kids_RevolvingLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kids_RevolvingLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kids_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kids_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933977096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STRATEGIC ARRANGEMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2017</div></th>
<th class="th"><div>Dec. 01, 2007</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment', window );">Minimum annual royalty payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=kids_CaseWesternReserveUniversityMember', window );">CASE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalty payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember', window );">Royalty Agreement Terms | CASE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm', window );">Royalty agreement period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment', window );">Minimum annual royalty payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent', window );">Royalty agreement percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment', window );">Milestone payments for FDA approval to sell our products within the United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment', window );">Milestone payment for general product launch</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement Contract to Perform for Others Minimum Annual Royalty Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=kids_CaseWesternReserveUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=kids_CaseWesternReserveUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_RoyaltyAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628008784600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 11, 2018</div></th>
<th class="th"><div>May 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax provision</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation', window );">Estimated limitation on losses generated prior to ownership change date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit', window );">Estimated annual limitation of losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,736,000<span></span>
</td>
<td class="nump">$ 1,062,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease', window );">Increase of estimated annual limitation of first five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,430,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal and state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,026,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,026,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards Limitations on Use Estimated Amount Subject to Limitation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140628006963656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Stock Options (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at period start (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41,370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at period end (in shares)</a></td>
<td class="nump">29,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at period start, Weighted-Average Exercise Price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted-Average Exercise Price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at period end, Weighted-Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 30.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Contractual Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627931427688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Restricted Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract', window );"><strong>Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 2,495<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 3,453<span></span>
</td>
<td class="nump">$ 1,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract', window );"><strong>Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 1,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at period start (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(568)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,397)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at period end (in shares)</a></td>
<td class="nump">437,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">437,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber', window );">Restricted stock exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract', window );"><strong>Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 9,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627930747592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Warrants (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ClassOfWarrantOrRightOutstandingRollForward', window );"><strong>Class of Warrant or Right Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding at January 1, 2020</a></td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding at June 30, 2020</a></td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Beginning weighted-average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 30.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Ending weighted-average exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 30.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ClassOfWarrantOrRightTerm', window );">Term of warrants</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ClassOfWarrantOrRightExercised', window );">Number of warrants exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ClassOfWarrantOrRightOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ClassOfWarrantOrRightOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ClassOfWarrantOrRightTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ClassOfWarrantOrRightTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927782248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Reconciliation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (9,447)<span></span>
</td>
<td class="num">$ (2,618)<span></span>
</td>
<td class="num">$ (14,392)<span></span>
</td>
<td class="num">$ (5,638)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares - basic and diluted (in shares)</a></td>
<td class="nump">17,549,118<span></span>
</td>
<td class="nump">14,451,979<span></span>
</td>
<td class="nump">16,986,485<span></span>
</td>
<td class="nump">14,409,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="num">$ (0.85)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627934167368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET LOSS PER SHARE - Antidilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total shares</a></td>
<td class="nump">467,009<span></span>
</td>
<td class="nump">403,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total shares</a></td>
<td class="nump">437,347<span></span>
</td>
<td class="nump">307,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total shares</a></td>
<td class="nump">29,258<span></span>
</td>
<td class="nump">90,685<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total shares</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">4,979<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929139992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT - Narrative (Details) - segment<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933887096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT - Schedule of Revenue by Geographical Location (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 13,593<span></span>
</td>
<td class="nump">$ 18,200<span></span>
</td>
<td class="nump">$ 29,949<span></span>
</td>
<td class="nump">$ 32,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">12,146<span></span>
</td>
<td class="nump">13,848<span></span>
</td>
<td class="nump">25,530<span></span>
</td>
<td class="nump">24,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 1,447<span></span>
</td>
<td class="nump">$ 4,352<span></span>
</td>
<td class="nump">$ 4,419<span></span>
</td>
<td class="nump">$ 8,741<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627934361768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT - Schedule of Revenue by Category (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 13,593<span></span>
</td>
<td class="nump">$ 18,200<span></span>
</td>
<td class="nump">$ 29,949<span></span>
</td>
<td class="nump">$ 32,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=kids_TraumaAndDeformityMember', window );">Trauma and deformity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">9,220<span></span>
</td>
<td class="nump">11,887<span></span>
</td>
<td class="nump">21,430<span></span>
</td>
<td class="nump">21,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=kids_SpineMember', window );">Scoliosis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">3,836<span></span>
</td>
<td class="nump">5,866<span></span>
</td>
<td class="nump">7,547<span></span>
</td>
<td class="nump">10,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=kids_SportsMedicineandOtherMember', window );">Sports medicine/other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 537<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 972<span></span>
</td>
<td class="nump">$ 828<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=kids_TraumaAndDeformityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=kids_TraumaAndDeformityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=kids_SpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=kids_SpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=kids_SportsMedicineandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=kids_SportsMedicineandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627933375240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>supplier</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Divestiture purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_NumberOfRelatedPartyEntitiesSuppliers', window );">Number of related party suppliers | supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Divestiture purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | FMI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Payments to related party</a></td>
<td class="nump">$ 934<span></span>
</td>
<td class="nump">$ 1,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_NumberOfRelatedPartyEntitiesSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Related Party Entities Suppliers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_NumberOfRelatedPartyEntitiesSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=kids_FMIHansaMedicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=kids_FMIHansaMedicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627928033112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLAN - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer contribution as a percentage of employees' salary</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627927710504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">$ 120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">123,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment', window );">Minimum annual royalty commitments through 2026</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent', window );">Royalty agreement percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent', window );">Royalty agreement percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement Contract to Perform for Others Minimum Annual Royalty Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kids_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140627929599336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 04, 2020</div></th>
<th class="th"><div>Jul. 15, 2020</div></th>
<th class="th"><div>Aug. 03, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Squadron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Unused commitment fee</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Second Amended Loan Agreement | Squadron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Second Amended Loan Agreement | Squadron | Three month LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">8.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">First Amended Loan Agreement | Squadron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Note payable to Squadron | Term Note A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=kids_SquadronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=kids_SquadronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kids_SecondAmendedLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kids_SecondAmendedLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kids_FirstAmendedLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kids_FirstAmendedLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kids_TermNoteAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kids_TermNoteAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M4E!8-F53L/;T+H=*,A/67I2:_=$A#BG!Q@FC39"D*7$A'?B1OGF4UR/='LQ
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M+4V4QZ@ ZOV:,?EV4PW0'5W/_@502P,$%     @ <&T&48U@)'(P P  \0D
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MA>47C+PCZ"H[05^I@/,X:T9P)\-, N#[@E*QZ\@$Y2VO]P=02P,$%     @
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M7T]GKV]G4T^^NKU^>35]?B??W-[)7Z]FK^^\ZQ?RS?7DW[]=OYS.;FY__4>
MD?B7-_OC[=7=7]Z)]_9VZCWZY;'WBY>NO+M%OBFCU;P\'5?27'V)<=P:N=@:
MP18C=WD594"SB;O9)%\NY8J^K?+X ]!ZVG-1&;WEIOAB;3]SMW\^GZ=U1$69
M]R9*YR=R"";1.H7OY$5/7W&\66ZRJ$KFWC2Y3^.T CJY'-[)=;5("D\.D-RC
M%O7F\2GQKE9QODR\1R_SLGS<[7XL5\YN^>#=\L'-]:CE>A=1%JUBV:&\\W(1
M%4GYV(LJZ3]^ZA'TQ,,^"J!)W?;*FE[KW?+3.:*,!-B76ZA_.OX$6"([2V20
MI0$V+K8]\3T; 1($[PQLS9HJVE7,3 4*!:5:1R],V0E"S ]15W<)Z#@F\+#0
MW;#0IA6Q#(N<^7JQRZF2H]*\>EQ';+/P%WDV3XKRG][LXR:MOGC_O<FSS)-;
M_4-4S/_G6"9L=W'FG)/7DJF97'+0'#!C*9P0N0RTH>M3=6SQG2WNM+6-D+@3
M(8]JG_70U($"^>6&$^+K$^C6=+R*G5?A]-I,E)>O&X GGY,B3LM.W$%A)LPP
M"R@6UA@+=F:"P\U @Q48!AAG6O"X-1U_X<Y?Z/1WDY15D<;U+E@V5GO&*33'
M"3/!0^M (5_QU3_("DA&W[@^%=J:FO6(NO;V\(^.V<!?1<5NYPQ!*B-@!^<!
M)F%@'S1%%30,*P.<7""3)=("#;5-O)6Y=G&@)Q0&5 3:7@3HY#X>(*1O Y"0
M8&P9'04X-(QPAT*W[?8@ZB+%%T2_&W?;KCIS!H"WE3GGS.P)1"^@@]D+":WP
M10J B/UX_"(%.N0FG0O R*35">,DL-RR A9R$^LHNB( 6=QF1>$*N7EEB9C?
M-RNY3GW'+F>R"=&0A)0[(D9!"KDIM1<Q?4XND(FH(/ #(V+"_H@Q>\)^B+D1
M,:;N!&%?X%"/&$!(F87@6($3N\%Y+)FPR<E>,F'%2SR,ET/(A$U&0F1J9:XY
M WH"R03H8#)!0BN9\%XUB'_\+H<5&+$;C*Y=#IOP.\$<&2/8)^M:4W3$;CH>
MM1EB"%J$Z'/9H^HZ5L3"[IIMDDN7<L:B)LF_SPLOBN7,E<V!1U]"C<UZ#<M4
M@]FW3:Q8AMTL<QH#A]$$'/+WC;1!UB?K^E4<Q']#Y89-#N(P('8[BH7X.]5N
MV(1?B/4Q<VJZ#A47\?>MWC# 1HDI^TF28A#Y]N*-F+SAQCCUB+KV%(S(4<5;
M;UI#H.*M)ZTA"@)D</'6F]80LRJ#TAI 9AS!F;46F-8 .CBM@836M(;LG4Z2
M'X](HCA$W!S:G7@WZ_E)NVR@DW-B8L6V-!13B)LIW:N#5V7&3-NNJH!!W, 8
M4"_#BQ,  A>8(!SHZW. LFM>T8.XZ6$IJV'#PCR'IIAPI-LU=48X ?P1,I4T
MPLG4R7 * HSU< *$EAR%*):1X"<$DP(5<8/*E6\2J"H**=/'KT_6/>Q7Y*)N
M<AV5;U*34C*39-IJO^R5=3TKG%$WSKXIXZ0FTPCGMOBCBF;43;.#LTT*G"(*
MIB>;?:JN6T47ZJZ ;I+UIH@7=4CD]_7TUQ^.#DFBIA0H?*B/J#4AH'N?/+F9
M8S<%CA]4S@2B.WY3:AX-=E1=JPI0U VHHW)U"A0[&/NVI:>X1=W<&IRI4Q,_
M/ CT%><6=3TJ/%$WG@[-U2EPON<S@6R+3*& NLN:(:DZ!:H5?7>;]8BZ]A0J
MZ+"S/OMI5OUA)C!>P$=3<MH$%Q2VQ!0BV+ #M@$V+MJN.ID%D=FU%I830*=G
M%LRD!Q:4&6=9@*X^UA#Z-2]A(;=\-,84CMA1U55O%L: Z@I.&X<HN^85MMC@
M(JS?L%E=@6DCH#,F%ZC"H+01T,%I(R2TI(U,49+]A!J,*1XR-P^=3T- ]*/$
M=E; ]I[ <)/MJ(20F=48XK:-1W&-'<&U'G!<,!-?%!%AX093 &/#ZBO[&8IE
M1P1 %C(J\R4CR@<HN^85]-BPS[4&&0Z,N<044_V 9 +H]"<VF(E($C"&C(=V
M3%V]F#&B>I0#G[-9-W#%7!;^^##GBJ_<S=?A1RT<()@S]^8*8MP-L?X3%VY^
M_&3/I+D"$#_JR<#>A(<#A9$SX>%JV^>#GPSL37@X\*P$E/#P_H<#@:[ A ?0
MP0D/++3%"U=<XC_A$4&N",6/?TB0 \__A90*?0C[9%UK>\\)_AT/"@*'@LQ(
M</I47<<*:]R-M6\Z2^$FL<(@1,P6@8I7W,VK@P]3.$ :L?]L2AMB?;*N7T40
M[J[:KLIRTVP9VKG%$V\E%ZO\8_I5$.=EU3NL0"W'0A8&7#O< (1.' C%).%F
MTF$W!,V(,%DE?!)JF]Y$  6C=I>01#_GF8&7PSZW#(3BHG!S\;C'::'',!"W
M!*M0K!1N5@X^Z!$F'%E(]"%SB[H>%3Q%W\GB80<]PH04PSZQC96"E.@[3.P_
MYQ'FX2"FH9[%"K/4ZJBZ!A7&A!MCQQ84PF27I: 8HNR:5Z 3PSXJ&V28#RLH
M )TQ%:8$+"@ '5Q0 $*SH!CO?6VJ_MZ=3 K?IZO2RY)[V<I_6H]SL?TJV_9-
ME:^;;U*]RZLJ7S8O%TDD>58+Y/_O\[SZ^J;^<M;N"X7G_P=02P,$%     @
M<&T&49&R1+:F"    RD  !@   !X;"]W;W)K<VAE971S+W-H965T-RYX;6S-
M6MMNV[@6_17"F(<9H*DE4A>K2 (XCG/&@]0Q8K?SS$ATS%-9](AT+N?K#RFK
MIB->[$XSP/2AEI1-:NW-O=?B1>?/K/[&5X0(\+(N*W[16PFQ^=3O\WQ%UIA_
M9!M2R;\L6;W&0M[6CWV^J0DNFD;KL@^#(.FO,:UZE^?-LUE]><ZVHJ05F=6
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MA(?!9]O$$ ZK!Q((T< (.7"T(A5-SQ4.W61ONI02S^ NTK-8%L9E>\E5X8H
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M[-YGQT[##3]%^SGL/IM4Y$8Z@5;G_&K^C0P69&/'=%D$&>GAD=9[_9(<Q^C
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M2@#J@.YA290$E1OL8U*.PR6/7(GB@7V13?*3"W<2LX!(!S0RI,[.U9'11<?
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M"N!7T0"\7Q=PK/N#%N@^VGSV/U!+ P04    " !P;091Z>Q@[P4%  !Z"P
M&0   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6S55MU3XS80_U=V7*8#,[[$
M7XD3"LR$<$>YR0%ST..ATP?%WB0JLN239 +]Z[N2G4!Z0%_ZTI=$DG=_^_%;
MK?9HK?2]62%:>*R$-,?!RMKZL-\WQ0HK9GJJ1DE?%DI7S-)6+_NFULA*KU2)
M?A)%PW[%N Q.COS9M3XY4HT57.*U!M-4%=-/IRC4^CB(@\W!5[Y<67?0/SFJ
MV1)OT/Y67VO:];<H):]0&JXD:%P<!Y/X\#1S\E[@&\>U>;$&%\E<J7NWN2B/
M@\@YA (+ZQ 8_3W@%(5P0.3&]PXSV)ITBB_7&_1//G:*9<X,3I6XXZ5='0>C
M $I<L$;8KVK]*W;Q#!Q>H83QO[!N90=I $5CK*HZ9?*@XK+]9X]='EXHC*(W
M%)).(?%^MX:\EV?,LI,CK=:@G32AN84/U6N3<UPZ4FZLIJ^<].S)^=75V=W%
M; :3RS.XN+R=7)Y?G,X^PN3FYN/MS5'?D@TGV2\ZO-,6+WD#;PA?E+0K Q]E
MB>6N?I]\VSJ8;!P\3=X%_-S('J11"$F41._@I=N 4X^7OA6P4N6:"P%,EG A
M+9-+/A<($V/0&CCCIA#*-!KA]\G<6$UE\\<[9K.MV<R;S?ZS/+^+Y^[JH:E9
M@<<!74:#^@&#?S$"V]"G*XH:#7 )=H50,*V?N%P"JU0C+:@%+#>B=.V]C.&/
M4+7,HF,6B!?<\@)KI(0Q0^*"KKDYA%MEF7BVR"Q\9K*A:P^Q4XG'L <__S1*
MXN07^,8%/L)45363G-QBQ?>&&^YO;9R'<1X1+0]H++>.%W*OU2#W;U%*).8P
M)"Z+'NRG83K.#]XV3+[N09R&>9Z2,C&]:RT<QPE<:8J8PD7FZH ZD(4:-5<E
ML/)/NI+^9'\X&AW I.:?*#,O,09IF"7IK@<[N=J#X8A$HE>J;V)<=#OBH4__
MG DF"_2?B25M^5_,Z?%G"-9"_,#$G6],6'Z8/*"F/@N33M][>]T&=JZ5,:\Y
M5!1-U0A&^KMZE_1>_"A^38*2_N-!+X4G9-I0M&D:QJ.$%OMQ2,0?N*,DC(>I
M Z!V3/VYH5JYUO32:$L\1;U1ISP*QX,(]K,\/:!UEN<PXP6]"&1PJ=%38R#M
MQ9UX$N;#@3,3C\E,' Z&PZX07^:L2]0>9%DX&N?.L20<CF/G6):$233L>#C#
M JLY:DB[FOU_<I'WLBT7XS 9^8C38>KBI00GV=L\Y)UB%KK"W4]B4DK#4?0&
M#]D_>8CBQ/&0#]+W>(B'891W!3)PMXJ.LC ;97 EV\L0;R_#&J%N=+&BA[B$
M@ORDN<-E_MG_>N-_A[_0JH)3ZO8?9NH^A-EL&@*#2_)C!5.F%756!H)7W.55
M<#;G@I-VX=O1$^P'&]W@(*0QI,V_5< )^Q:I(#1,!:OJ]D&I:BH.V_)R\V0L
M5H2P(]:>!@>^M>ZY?I7Y1NSS4R@:=TJJ#0?0HWJ!AI+LJNX5#*=&"K(;<-:<
M(E*-]L$*5<"@-^@/>U$G[=%\1=*#\<!58\13V]H5D2%:/GUW=8?/2>[2V%#7
MU\ V@L VQ+=V-TGJ;2J#&BN9LKQ-%I%2-H4%P1I)<Z7QR2H52&5ACDL*I*L,
M]PS1&\1%ZT6GQLU&TZ.Y3S1"WJ/MP6MO<__%/%2A7OJISU"N"+D=C;:GV\%R
MTLY3S^+M5/J%:?*.S.."5.E&# +0[:37;JRJ_70U5Y9F-;]<T7",V@G0]X52
M=K-Q!K;C]LG?4$L#!!0    ( '!M!E'4?M%^<P,  %X'   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;*55;6_;-A#^*P>AP%H@B^2WM EL W&2K1G6
M.(C3]L.P#[1TLHA0I,JC8K>_?D=2]I1ASI=^L?AR]]QSY[N'TZVQ3U0A.MC5
M2M,LJ9QK+M*4\@IK0:>F0<TWI;&U<+RUFY0:BZ((3K5*AUEVEM9"ZF0^#6?W
M=CXUK5-2X[T%:NM:V.\+5&8[2P;)_N!!;BKG#]+YM!$;7*'[W-Q;WJ4'E$+6
MJ$D:#1;+67(YN%B,O7TP^")Q2[TU^$S6QCSYS6TQ2S)/"!7FSB,(_CSC%2KE
M@9C&MPXS.83TCOWU'OVWD#OGLA:$5T9]E86K9LF'! HL1:O<@]E^Q"Z?B<?+
MC:+P"]MH.YDDD+?D3-TY,X-:ZO@5NZX./8</V1&'8><P#+QCH,#R6C@QGUJS
M!>NM&<TO0JK!F\E)[?^4E;-\*]G/S:]O5U?+N\?;N\\WU["\OWFX?+Q=WJVF
MJ6-P;Y+F'= B @V/ )W!)Z-=17"C"RQ>^J=,ZL!LN&>V&+X*^$>K3V&4G< P
M&V:OX(T.F8X"WNA8II)R9BAUBP4L&[3"MP6!T 7P76-(*/C=FK8A^.MR3<YR
MQ_S]2N#Q(? X!![_?(E?!?+S>4&-R'&6\  2VF=,CJ'#4@-7$&'L"S@X/P%7
M(5R9NA'Z.\_"MU9:KL,7J7!W H);2K<E)]Q:M&!**(UQH31"/RGDF;4;F7.!
M9-THH5D'8"5UC@$U@$!C3='FCH#/5<L] *+@T6"P$JW4&V);X6"+%D$S>&YX
MX4R?UR\$#192."MS6+?$^1.]9&XQ1Q[C A9&6 [1<-AGYN6!Q%/D0P[Y/]1L
M2<1"X^\*]B$7;K71OX;8D;8@0A>[P%6&_G,<V))1!;""7#-BO>;ZC :QJ*?P
MR("E42QMG&&G;/('TRNE%CJ7OF(Z2J?7H$H0K!$U$&XL;H3SEM;4T'6F!S$O
M6]-B8ZRW8]>BW\(].PX04G.510Q>)'=0QWE$/X^Q%^(T#<XOF/?><L66_<E]
M:0D/^(P<#M[ >##>CPVSQ!T_"X0$D^P]%X;[D9.-.NN;IF;.\D<\.#OK^2E#
M!&\'D_-W\*=?ANR/Y?6FL_R_(4Q[FE>CW01E)RYDJUV4O\/IX?&XC)KYKWE\
M>3X);FX.I[!DU^ST/6NUC6H>-\XT04'7QK$>AV7%#R!:;\#W?ECV&Q_@\*3.
M_P%02P,$%     @ <&T&48!"Z(0="   O1,  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&ULK5AK<]NX%?TK=U2GW<RP>OD1.[$](S_2]8Z=9&PW^Z'3
M#Q )2=B   . DOWO>RY 4O)+[73VBRV"P'V>>^X%CU?6_? +*0,]E-KXD]XB
MA.KC8.#SA2R%[]M*&KR965>*@$<W'_C*25'$0Z4>C(?#@T$IE.F='L>U;^[T
MV-9!*R._.?)U60KW>":U79WT1KUVX5;-%X$7!J?'E9C+.QG^67US>!IT4@I5
M2N.5->3D[*0W&7T\V^/]<<-W)5=^XS>Q)U-K?_##57'2&[)!4LL\L 2!?TMY
M+K5F03#C9R.SUZGD@YN_6^F?H^_P92J\/+?Z=U6$Q4GOL$>%G(E:AUN[^E4V
M_NRSO-QJ'__2*NT='_4HKWVP97,8%I3*I/_BH8G#QH'#X1L'QLV!<;0[*8I6
M7H@@3H^=79'CW9#&/Z*K\32,4X:3<A<<WBJ<"Z<7EV?W-/ER0>>WEQ=7^'E[
M._GRC\N;RR_W=\>#  V\;Y WTLZ2M/$;T@[HQIJP\'1I"ED\/3^ 99UYX]:\
ML_%6@;_5ID^[PXS&P_%PB[S=SMW=*&_W+7?E--"%\KFVOG:2_C69^N  C7]O
M$;[7"=^+PO?^I%ANE<;5^-%7(I<G/92;EVXI>UM5T+4U\[\'Z4K $F[F%J7C
M@RS(SB@L),VL1@TJ,_](B*OLXDH7,I?E5#K:'?'*Z(B^V""I$H]BJB4%2W<_
M:U$X5-$.C8ZRH^&']./P:$2W<FGU$E(I=[)0@68B5UJ%1R Y+-8G__J7P_%H
M_(GVL^%P")RX,$?5;RH1LQD."F@>9>/=0_S=Q<Y[&X1.'HU'V6AOG\8'V0B*
MKZ7W'U$CSDD34!.A=BHHZ6DTQMGQWO-X1',Z'1D94!XB\XJ '=8T'+&3T#4\
M^$!?S8L@?<AH)0DG)=PF9=@!^FQK!RT3T!8*@(0I$!\?!&?AV@H35^YDSIH>
M:3)W4F)KR,BZF**X9V/Y:0C/1:4X&-?7Y_%$^Z)/WVKG:P$O8,5K<@3<^\-&
MI0T88EQT-*FTM0F>:IB<K #>ELK6GD0KX9DA*_@<\66U*J)SC?\[XV%,;Y1N
M+(>Y\>R>5R*L)EF, C:/$A;<VP@2GCA\4ZU <46?SBS,:%YSII3)=5U(5@^3
M/!)J]"-CBHWV44_E[%(5C'Z'Y_5.QT"3\$BW08.S6',<H5_$>RS!>2J9T.CZ
MZNSK+54:,3GL'XS>1<F_3-_3:/BN3_<O(DY">TOR(20<L/0&7X_$ 6.5OPE3
MHP\V>!KO]NG*(%HQ"99FR@B32X2I0JEP VL2EPN_2+6-G2*^F34Q%OG/6GFU
MN?N[TO*!SFU9"8. 97$Q/3Z^ *]RB$O$[A-0OEA_%62(F2<X+1+VDZ;>QMFV
M!+H3O??/ )XBN>U(F\TBI1,UO**=W0W,142W^,D K<B=AB$Z?<2!-0S/,OA-
MHBA2O!J?Y ,HDZ'8(GD#MS'I_Q6T?;I3I=+"M2(!6:1T [3K0MOF:O:L;,YB
M-?AZ^@<&&I;]%N;#GP?S; /G_6$+]2<Q7"U4OL#H5>N"%F+9X!S>&$LZZ@D+
MV',C.J"CZ[ GE5",/)K56L.%5YI0[5,BVH#G$@-</",?<@B=RP[Y!=X@;ZRY
M1;XH,)@Q7HHZ9Z*?20=QGE^GHF#7>*.3.E+85S WEK7*,7/*-?>E(.PD*V;.
MEDG\4B#)W+DZ5MP""?2/MMSWVB!L5F(,1J."P1C-:J4EEGZ=BID2G8M=_7\%
M%@D$R7,/2D4!2(%B35!" T>"LS';-.YOP)3WLJ%3/EP;\$^JFWAF#L<@0"9Y
M4@ 0$*%"A"MX2@G'N(^&IR++9=6R5$Q&!!8DLW0 !R-9*[XA0A@'TEM*_ [1
M'INKF+5.Z#:7^_2K7<FE=#'JK1XY%WPEV) +J$;(+-04Z4,5<+HS[I!(0ZKC
ML.!09VRB\< 4@XHXA7 %S9_A#Z#!VA2SC$KIYKPG&LJDQ23=G$HB86 DJTC'
M_*+AXZA"I-M+M"Q5&<J:D<WD14T9\!B# G96,ZGQ1!/E%UT0E>$12!8&,U/&
M\!2AM5LK:1AS;#Q<KZ1C6TKQ(UG"=96(1;$5RJ&C"A=YC.$ #"'$O!57E?P'
M.P@FXF>4)(C:%#Z1QDPH1TNA:]E&BL<#_^J0&<<+KN<RIIAO706;6#G4IN^*
MWJ/5L$+?\*WROF[,BHVR&>R>4*%/3- TD$@=/!LVB(\2G>3+++NP'@E;GA/-
MW,.]%S(T,*5I#!55G2(D\APM/';NF/#)W3DFV$KE=,@UST/P>/B)/G,TOL=H
MW$C!5Y'UP+*^GGCJQP.C3S0)3V?V1!\;0145DO?01"S-"<[%1,3W<;B Y::Y
M#7=E4]4.(/)=5A >Q6,'#%G!VP7&0,2%[R'LWN_">;'*( Q%;00O3>HYKJG,
MV+NO3<1E.^B;9U>*>['"2(*;(K8CL1[>7IF\SVR[<1. 56]/N=SQ?9N[)XJB
M)5#VEI;4[[AMHE)R57&]FF(-%65 B5JGI$#!SN@@A:S;D8,<;9VF_$#[[T"*
M0>GUE(?(($^'&;]-V &<>9QC/M-MNV;9:[R]98RG@C-XO^DE%C<X?+./H;@U
MI4M'E#.ME2X@OL\@>M%ELZ?!FPJ=P(L.O9,N8# Q.= 6U-K,(E7S#M^V^$0S
MCL<>W>U>CZ_ZR86L_P+46TWA&^$64Y(9A_^/&:]=_0<;GU28P>.'(X^L(\WI
MZTJWVGV;FJ1/,NOMZ</6C> &X$$6,QP=]C_L]\BECT7I(=@J?J"9VA!L&7\N
MI ##\ :\GUD@NGE@!=T7N]/_ %!+ P04    " !P;091-SV:R"X#   -!P
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M]*=[%.^TJ KM(C1B/G:FT=1UJ^WLMM>G78M[#N]^%#?"+J1VH+!@:-([/HS
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M(*FI8?"=!+O-X+0+(PGG:P[81AVU.$&JC=#;1&WT+R; ;3D!EH7R1=KBRC*
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M-=V)?\[@ISU^ZO'3_Y7$LQBN^:Y,S7)<!-1=!O4+!D> X;%$V"A!S401 3?
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M=!RT5[1;6%7[.;M6EJ:V%TOZ3$+M%.A\HY3M%LY!_^&U_!=02P,$%     @
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MUZ$$CY#8_!,4:@9%B/KNU157#,=T@P67)S3SVK@.G6)6?U"X ]A55=<=SX"
M%P77:T*^.'^H-]Y"SJ&7"*^:?55U.+<>=YW?,0IG9T\&:"0YK<S?"&U\'["
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M0]Q_PV?)#QY:#^#YPAA:#[S Y@F=_ !02P,$%     @ <&T&44H6$21#"0
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M5!BT'&W >F%MZ!](P?;[[?E_ %!+ P04    " !P;091A,O&\>T$   2"P
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MO[;;)V_'1W'ZXVBOL%QH],L1?&VZT2&/O2#&ZPO;<+/D!S']$MUJP(#0KI6
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M(XY2]=)CM7I34K\&6'_HDH\UT$[?/H@RHK0UZ0A?%=.TJ&H=5DWS16X+B=>
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M,)W/[Y\6C]'B%I;W/Z)Y=+V"+X]L+=!\'?F6HCF,'S?,LYHY/,!\!G=*VLS
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MIBQJYT#V5"G;;ER ;FY/_@)02P,$%     @ <&T&48"7-B"U!@  -1H  !D
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M-TRH3:.R -K?2FF.$RM0-_[1/U!+ P04    " !P;091 @;1_]P"  #6!0
M&0   'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q]5&UOVD ,_BM65DV;Q)H7
M: L,D*"PK5-;5<"V#],^'(E#3KODZ)T#[;^?+Z$IG5J^)/?BYWELG^W!3IN_
M-D,D>,A588=>1K3I^[Z-,\R%/=4;+/@FU287Q%NS]NW&H$@J4*[\* C._5S(
MPAL-JK,[,QKHDI0L\,Z +?-<F,<)*KT;>J'W=#"7ZXS<@3\:;,0:%T@_-G>&
M=W[#DL@<"RMU 0;3H3<.^Y..LZ\,?DK<V8,UN$A66O]UFZMDZ 7.(508DV,0
M_-OB)2KEB-B-^SVGUT@ZX.'ZB?U+%3O'LA(6+[7Z)1/*AE[7@P1342J:Z]TW
MW,=SYOABK6SUA5UMV^YY$)>6=+X'LP>Y+.J_>-CGX0#0#=X 1'M 5/E="U5>
M3@6)T<#H'1AGS6QN485:H=DY6;A'69#A6\DX&DUGDR6,;Z=P.9]-KW@YGX]O
MO\YN9K?+!7Q8BI5"^W'@$TLY@!_O:2<U;?0&[3G<Z((R"[,BP>0EWF<7&S^C
M)S\GT5'"[V5Q"NV@!5$0!4?XVDW<[8JO_5;<N"*82ALK;4N#\'N\LF2X1OX<
M(>\TY)V*O/,&^8);)RD5@DY!Z6+]B=#D7"LL*0N6*;FJR;Z6U:.\KD'[=B-B
M''K<@1;-%KW1]4N!6'/#6,+$B5.&D&K%G2>+=1\XB=@D$:888[Y" ^W0G80]
MN-6$L!&/[M6!-"SN2Y$8[IT3"'NM7G!1+[J]$.:XU6K+K! ;3"1!*F*I)#UR
M_5+VC'S_KAN%T6<X:P5!P$5A:,V]?B@BTI2!@I7#5M3N\K?-EDM-0M4116$K
M[)Q!=-X*6?@:K>US9QC#.>1.H-)(DF@AC!@;=>"_?%3N-!HM*'C0<69>(3AQ
M2D'H@F2MX/P"7BL%_Z#7<C3K:J)83GM94-UVS6DSM,9UKSZ;UQ/O1I@UUP,H
M3!D:G%Z<>6#J*5)O2&^JSEUIXCE0+3,>O&B< =^GFA]LOW$"S2@?_0-02P,$
M%     @ <&T&41" )Z53 P  VP@  !D   !X;"]W;W)K<VAE971S+W-H965T
M,CDN>&ULK5;;;MLX$/V5@7;130#7DB7YDM0VX*39[64+NW;:H%CL RV-;2(2
MZ26I.-FO[Y!2%*>)U3STQ>9EYLSES' TW$EUK3>(!F[S3.B1MS%F>^K[.ME@
MSG1;;E'0S4JJG!G:JK6OMPI9ZI3RS ^#H.?GC MO/'1G,S4>RL)D7.!,@2[R
MG*F[,\SD;N1UO/N#.5]OC#WPQ\,M6^,"S9?M3-'.KU%2GJ/07 I0N!IYD\[I
M6<_*.X&O''=Z;PTVDJ64UW;S/AUY@74(,TR,16#T=X/GF&46B-SXK\+T:I-6
M<7]]C_ZGBYUB63*-YS*[XJG9C+R!!RFN6)&9N=R]PRJ>KL5+9*;=+^Q*V3CR
M("FTD7FE3![D7)3_[+;*PY["(#B@$%8*H?.[-.2\?,L,&P^5W(&RTH1F%RY4
MITW.<6%)61A%MYSTS'AQ.3W_^&[Z]]N+^>(/N/C\Y?WE-SBZ9,L,]?'0-V3"
M"OI)!7=6PH4'X'KP20JST7 A4DP?Z_OD6NU?>._?6=@(^*$0;8B"%H1!&#3@
M176\D<.+#L6[80I?6QY3F+$[*B\#$Z686*-;_S-9:J.H5OYM,!;7QF)G+#YD
MC%HH+3($N0)B,KD&N7VH16[NGDMP,^2T4,]# 1,I=4G&#$7&1=FN3D!AU7+\
M?[IB&E8RHU[4IW#E:A;3UY,;5-2"<$[DV> +EL$EJES#U%DA/F]1)5PCS!1/
M$(ZX@&_(E#Z&:6&T(>-<K($9^,!$0=T-G9(RZ >M7CB WXG$]DD?.NVPQDKA
M*.ZTHGYP7%W^"%4(K+F'\*05=A\!-3#4K1GJOI@AA<0\3VS^R@PWL=0(:U_2
M4[UE"8X\>BHUJAOT''4';?P2^N9HGV&;O?F#G:><+ISEEU,8=0:M( @IY7WX
MBUK%HG:Z@U;4"8">QA5R>W+4[0V.X2L9MIN(KD_Z3Z$?41I'_5846RY[^QZ7
MF<&R2NQ+]%3SU6^#L!.^@882Z-4ET'MQ">R8?0J,?H[Q1I3#C%>0OY;HJ\K/
M']OR)T3&05SW3S,Q>X+/I=C?&S@YJK4;JQH260A3SI[ZM)[<DW)@/8B78_\3
M4VM.#TR&*U(-VGWJ+%6.TG)CY-:-KZ4T- S=<D-?'ZBL -VOI#3W&VN@_IX9
M?P=02P,$%     @ <&T&40T%-/>I P  6P@  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S N>&ULG59MC^(V$/XKHZ@?;J4<>2$!@@!I]TIUK7I7!%SW0]4/
M)AF(M8[-V<ZR^^\[-I#=U;'HU"]D_#*/GYEY[&%R4/K!U(@6GAHAS32HK=V/
MH\B4-3;,]-0>):ULE6Z8I:'>16:OD57>J1%1&L>#J&%<!K.)GUOHV42U5G")
M"PVF;1JFG^]0J,,T2(+SQ)+O:NLFHMEDSW:X0OMMO] TBCJ4BC<H#5<2-&ZG
MP6TROLO=?K_A;XX'\\H&%\E&J0<W^+V:!K$CA )+ZQ 8?1[Q$PKA@(C&]Q-F
MT!WI'%_;9_3??.P4RX89_*3$/:]L/0U& 52X9:VP2W7XC*=X/,%2">-_X7#:
M&P=0ML:JYN1,#!HNCU_V=,K#SSBD)X?4\SX>Y%G^RBR;3;0Z@':["<T9/E3O
M3>2X=$5964VKG/SL[.M\#7_^M5K!8KZ$U>?;Y1P^K-E&H+F91)8.<-NB\@1V
M=P1+WP$;P!<E;6U@+BNLWOI'1*QCEY[9W:57 ?]H90_Z<0AIG,97\/I=M'V/
MUW\';\ZTY')G8($:5C73"/_<;HS5)(Y_K^!G'7[F\;-W\)=8*EERP9F7G-HZ
MQ? 2F*R@XJ*U6(&DFR:4,; G#L9S8-9JOFFMRSM8!:5J&G*GXI</M1(5:G.I
M&%>YN-L\-GM6XC2@ZVI0/V(P6]<(6R7H*E(:@!M@=+/^#^<QK&N-^*;@L.)/
M;R>H?NCKUQFND/23%*^LKV?T7^!#$6;9\,99:3A(1MY*LK!?I-[,PT&?)N_]
M9:,#V"-J>CM MLV&J!%YS\[ QPM1),,PSXHP249 D%F>A,6P@&00%J-!F(UR
M/QL7X3!/7SB]5.D2)%&*>WEV<S1.?./>*#\9_>(&KN@J[W257]75BM[BJB5Q
M4(!,6NZ/I]<,#):MYI93Q/A4BM8E?:M5XR2T)T&=2_IC 2\)ZBJ)GQ$4*<G2
M%Z45SZ0NTWI%NX31"I7*<C?&[RVWS^=*'9!R^Y:\)="2B;(570!7;L\&2]8:
M=%Y< VZW].!3+VA%!37I@]91^JQ][-)&S0R8$ Z$JXK 7#R2\,=7-/PBV"72
MD\%+Q\??4<CZP["?#6G;\;ORLVKOV!M(BS#-1U#$X8!$=L^T)C8&LCB#S$MP
MK2P3YWQD@V$8QP4M]\,X22[*)WKUX#>H=[ZM&4IR*^WQ[>]FN\YY>VP8+]N/
M;?<+TSM.) 5NR37N#4D$^MC*C@.K]KY];)2E9N3-FKH_:K>!UK=*V?/ '=#]
MGYC]!U!+ P04    " !P;091:#]RQA4#  !,!P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6RM54V/VS80_2L#H8<$$*QO6S9L ^MDVVZ!#18K;WLH
M<J"EL41$$E62BG?_?8>4K3J-[4.;"S4D9QYGYHF/RX.07U2%J.&UJ5NU<BJM
MNX7GJ;S"AJF)Z+"EG;V0#=,TE:6G.HFLL$%-[86^/_4:QEMGO;1K3W*]%+VN
M>8M/$E3?-$R^;; 6AY43.*>%9UY6VBQXZV7'2LQ0OW1/DF;>B%+P!EO%10L2
M]ROG+EAL$N-O'7[G>%!G-IA*=D)\,9.'8N7X)B&L,=<&@='G*W[ NC9 E,9?
M1TQG/-($GMLG])]M[53+CBG\(.H_>*&KE9,Z4.">];5^%H=?\5B/33 7M;(C
M' ;?>.Y WBLMFF,P9=#P=OBRUV,?S@)2_TI > P(;=[#03;+CTRS]5** TCC
M36C&L*7::$J.MX:43$O:Y12GUYN7[.'3?99!=O_+X_VG+;S;LEV-ZOW2TP1O
MG+S\"+49H,(K4%-X%*VN%-RW!1;?QGN4UIA;>,IM$]X$_*UO)Q#Y+H1^Z-_
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M4'\R(\KDH-W#1(O.ZN5.:%)?:U;TW*$T#K2_%T*?)N: \0%=_PU02P,$%
M  @ <&T&4>SD7V1"!0  L!D  !D   !X;"]W;W)K<VAE971S+W-H965T,S(N
M>&ULO5E;;^(X%/XK%IJ'CM0EL9UP&5&D%MK9KCJS56EG'U;[X 93K"9Q:CM
MI?GQZUR*0TD\V164!\CM?.<[Q^=\ML-HS<6S7%*JP"8*8WG662J5?'$<&2QI
M1&27)S36=Q9<1$3I4_'DR$10,L^-HM!!KMMS(L+BSGB47[L5XQ%/5<AB>BN
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MNI70K#:=F''=?W#;ZS;.+9%KRA7*(3.FT5G?!"7KSD@]T:*PW8BET%HP.]P
M24%6&\S]3 B]GU0.FO[4Z!]02P,$%     @ <&T&485YK=-: @  .P8  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULO97?;]HP$,?_%2M/F]22-)0?
MJ@ )Z(]EHA25=GN8]F#(A5CU#V9?!MU?/]L)&=-*]C+MA?CLN\]][YP<@YW2
M+R8'0+(77)IAD"-NK\+0K',0U+34%J0]R906%*VI-Z'9:J"I#Q(\C*.H&PK*
M9# :^+V%'@U4@9Q)6&AB"B&H?IT 5[MA<!$<-A[9)D>W$8X&6[J!)>#S=J&M
M%=:4E F0ABE)-&3#8'QQ->D[?^_PB<'.'*V)JV2EU(LSDG081$X0<%BC(U#[
M^ Y3X-R!K(QO%3.H4[K X_6!?NMKM[6LJ(&IXI]9BODPZ <DA8P6'!_5[@-4
M]70<;ZVX\;]D5_E& 5D7!I6H@JT"P63YI/NJ#T<!EO-V0%P%Q%YWF<BKO*9(
M1P.M=D0[;TMS"U^JC[;BF'27LD1M3YF-P]$RN9LGM\ET/'\BX^GTX7G^E,SO
MR.)AEDR3FR4Y)V.A-+(?U#<QD4CEAJTXD+$Q@.:,2/OFO+L&I(R;]X,0K2B'
M#M>5@$DI(#XAH$ONE<3<D!N90OI[?&B+J2N*#Q5-XD;@QT*V2#LZ(W$41PV\
M=MVAMN==GN#=,\E$(1I(ES7ITI/:)TBWEH1P/K.O8?IG)\F7F?4G"8(P7QNR
M=>ILG4;=1PFH2W!&"@-9P0EG&;QU3\VX-GD%JDV#L&XMK-O<4+K_2T-[-:GW
M'QK:K[/U_VU#FW%Q=+JCX=$'+4!O_-@R9*T*B>6W7>_6DW%<#H1?[N58O:=Z
MPZ0A'#(;&K5Z]IIU.:I* ]76CX>50CML_#*WTQVT<[#GF5)X,%R"^O]B]!-0
M2P,$%     @ <&T&4:4XL;&N P  1Q   !D   !X;"]W;W)K<VAE971S+W-H
M965T,S8N>&ULS5A=;]HZ&/XK5JXVZ;2)'1*@ B0(L#&M+2K[N#@Z%R8Q8#6)
MF6U**^W'SW;2A'9@D-"1N('8>9_G_>2U7SI;QA_%BA )GK,T%UUG)>7ZQG5%
MO"(9%M=L37+U9L%XAJ5:\J4KUIS@Q("RU$6>%[H9IKG3ZYB]*>]UV$:F-"=3
M#L0FRS!_&9"4;;L.=%XW'NAR)?6&V^NL\9+,B/R^GG*U<BN6A&8D%Y3E@)-%
MU^G#FS%"&F D?E"R%3O/0+LR9^Q1+R9)U_&T120EL=046'T]D8BDJ692=OPJ
M29U*IP;N/K^RCXWSRIDY%B1BZ4^:R%77:3D@(0N\2>4#VWXFI4.!YHM9*LPG
MV!:RS;8#XHV0+"O!RH*,YL4W?BX#L0-0//L!J 2@]X#& 8!? OQ3-31*0.-4
M#4$)"$X%A"4@-+$O@F4B/<02]SJ<;0'7THI-/YAT&;0*,,UU9<TD5V^IPLG>
M;/+I;C*>1/V[;Z ?1???[[Y-[CZ!Z?W72309S< 5F$D6/UX-5/82$+%,E;3
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ML,!9+&=L?0M%0"W-%[!8F%^T+FP="P69D"PIP$I!0FC^CU^*1&P!%$\UP"L
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MA;=$D&8"CB^$T/N&<5#=.\?_ E!+ P04    " !P;091TE$W/NP#  "+#P
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M+E:P_G"_6L -K'#!64$H0?8P^0:F2)("$"MA3NA>X1(^ZQK^R*6$)1:PKI#
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MDQ++$[XE3)^LN2BQTDNQ<>56$)Q94EFXT/-&;HDI<V83NW<I9A->J8(R<BF
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M@MHYV/M"*=H;KE.[ARG[ U!+ P04    " !P;091M&T$\,L"   O"   &0
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ <&T&44&40?_4!   ,"<
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !P;0911-9-.>\    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !P
M;091F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( '!M!E%HQ.)Z0 4  .X5   8
M  " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !P
M;0914WK6]*D&  #7&@  &               @(&$#0  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ <&T&4:(69OW2 @  D <  !@
M         ("!8Q0  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( '!M!E&Q2WSXH04  ,86   8              " @6L7  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !P;091C6 D<C #  #Q"0
M&               @(%"'0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ <&T&40J!S$I("0  7#@  !@              ("!J"   'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( '!M!E&1LD2VI@@
M  ,I   8              " @28J  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " !P;091Y5R1P,()  !&%@  &               @($"
M,P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ <&T&4>+4
MG T4(0  *F4  !@              ("!^CP  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( '!M!E'V$["?60T  , I   9
M  " @41>  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M<&T&4>GL8.\%!0  >@L  !D              ("!U&L  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " !P;091U'[1?G,#  !>!P  &0
M            @($0<0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( '!M!E& 0NB$'0@  +T3   9              " @;IT  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ <&T&43<]FL@N P
M#0<  !D              ("!#GT  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " !P;091!64671@%   G"P  &0              @(%S
M@   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( '!M!E%K
M"X4^M@4  $(.   9              " @<*%  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ <&T&42_G QHT!   A D  !D
M     ("!KXL  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '!M!E&$R\;Q[00  !(+   9              "
M@3ZG  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ <&T&
M40&*20"J'0  QUP  !D              ("!8JP  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " !P;091,%$1 ;H"  ##!0  &0
M        @(%#R@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( '!M!E& ES8@M08  #4:   9              " @33-  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ <&T&46-3*5PE!   T D
M !D              ("!(-0  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " !P;091?=LD%L "   $!@  &0              @(%\V
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( '!M!E$"!M'_
MW (  -8%   9              " @7/;  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ <&T&41" )Z53 P  VP@  !D
M ("!AMX  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !P
M;091#04T]ZD#  !;"   &0              @($0X@  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( '!M!E%H/W+&%0,  $P'   9
M          " @?#E  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#
M%     @ <&T&4>SD7V1"!0  L!D  !D              ("!/.D  'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !P;091NZX*1H$#   -
M#   &0              @(&U[@  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM
M;%!+ 0(4 Q0    ( '!M!E$K\^,(L@,  *L2   9              " @6WR
M  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ <&T&485Y
MK=-: @  .P8  !D              ("!5O8  'AL+W=O<FMS:&5E=',O<VAE
M970S-2YX;6Q02P$"% ,4    " !P;091I3BQL:X#  !'$   &0
M    @('G^   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M '!M!E'RJ0*-T @  .HL   9              " @<S\  !X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ <&T&405LY@7% P  1P\  !D
M             ("!TP4! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " !P;091$60-9+P%   4&0  &0              @('/"0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( '!M!E&VTZ!:Q <
M &LD   9              " @<(/ 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ <&T&4=OYMSM4 P  3PL  !D              ("!
MO1<! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !P;091
M6LO2MU<$  !#$@  &0              @(%(&P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( '!M!E$*:/@H/@,  .P*   9
M      " @=8? 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ <&T&4?LGMQM% P  YPH  !D              ("!2R,! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !P;091514$:%\%   .&P
M&0              @('')@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( '!M!E%WN5-G?0,  + ,   9              " @5TL 0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ <&T&4677&(/#
M P  @PX  !D              ("!$3 ! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " !P;091TE$W/NP#  "+#P  &0
M@($+- $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( '!M
M!E'6V#\O700  +<0   9              " @2XX 0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ <&T&4<"WAU/( @  A <  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( '!M!E&X4WP85 ,  *H+   9
M  " @0U, 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M<&T&48)_PNA/ P  2@L  !D              ("!F$\! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " !P;091K&%U41D"  "D!   &0
M            @($>4P$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( '!M!E&T;03PRP(  "\(   9              " @6Y5 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ <&T&47V5%)$J P
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M2P$"% ,4    " !P;091678!^/4!   X(P  &@              @ $>9 $
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !P;091%\C,
M&]L!  #1(@  $P              @ %+9@$ 6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     0P!# $P2  !7: $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>216</ContextCount>
  <ElementCount>363</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>68</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESS</Role>
      <ShortName>BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - BUSINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSCOMBINATION</Role>
      <ShortName>BUSINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2116104 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2121105 - Disclosure - DISCONTINUED OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS</Role>
      <ShortName>DISCONTINUED OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - DEBT AND CREDIT ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS</Role>
      <ShortName>DEBT AND CREDIT ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2128107 - Disclosure - STRATEGIC ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS</Role>
      <ShortName>STRATEGIC ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2137110 - Disclosure - NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/NETLOSSPERSHARE</Role>
      <ShortName>NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2141111 - Disclosure - BUSINESS SEGMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSSEGMENT</Role>
      <ShortName>BUSINESS SEGMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2146112 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2148113 - Disclosure - EMPLOYEE BENEFIT PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN</Role>
      <ShortName>EMPLOYEE BENEFIT PLAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2150114 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2152115 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - BUSINESS COMBINATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables</Role>
      <ShortName>BUSINESS COMBINATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/BUSINESSCOMBINATION</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - DISCONTINUED OPERATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables</Role>
      <ShortName>DISCONTINUED OPERATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - DEBT AND CREDIT ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables</Role>
      <ShortName>DEBT AND CREDIT ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - NET LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/NETLOSSPERSHARETables</Role>
      <ShortName>NET LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/NETLOSSPERSHARE</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2342308 - Disclosure - BUSINESS SEGMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables</Role>
      <ShortName>BUSINESS SEGMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/BUSINESSSEGMENT</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSDetails</Role>
      <ShortName>BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Assets Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Assets Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Amortization Intangible Assets, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Amortization Intangible Assets, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - BUSINESS COMBINATION - ApiFix (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails</Role>
      <ShortName>BUSINESS COMBINATION - ApiFix (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - BUSINESS COMBINATION - Summary of the Present Value of Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails</Role>
      <ShortName>BUSINESS COMBINATION - Summary of the Present Value of Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - BUSINESS COMBINATION - Telos (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails</Role>
      <ShortName>BUSINESS COMBINATION - Telos (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - BUSINESS COMBINATION - Vilex and Orthex (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails</Role>
      <ShortName>BUSINESS COMBINATION - Vilex and Orthex (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Changes in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Changes in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Amortizable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Amortizable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - DISCONTINUED OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails</Role>
      <ShortName>DISCONTINUED OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - DEBT AND CREDIT ARRANGEMENTS - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails</Role>
      <ShortName>DEBT AND CREDIT ARRANGEMENTS - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - DEBT AND CREDIT ARRANGEMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails</Role>
      <ShortName>DEBT AND CREDIT ARRANGEMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - STRATEGIC ARRANGEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails</Role>
      <ShortName>STRATEGIC ARRANGEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/INCOMETAXES</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - STOCKHOLDERS' EQUITY - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - STOCKHOLDERS' EQUITY - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - NET LOSS PER SHARE - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>NET LOSS PER SHARE - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - NET LOSS PER SHARE - Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails</Role>
      <ShortName>NET LOSS PER SHARE - Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2443423 - Disclosure - BUSINESS SEGMENT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails</Role>
      <ShortName>BUSINESS SEGMENT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - BUSINESS SEGMENT - Schedule of Revenue by Geographical Location (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails</Role>
      <ShortName>BUSINESS SEGMENT - Schedule of Revenue by Geographical Location (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - BUSINESS SEGMENT - Schedule of Revenue by Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails</Role>
      <ShortName>BUSINESS SEGMENT - Schedule of Revenue by Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2447426 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - EMPLOYEE BENEFIT PLAN - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLAN - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="kids-20200630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2453429 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>59</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="kids-20200630.htm">kids-20200630.htm</File>
    <File>exhibit311-ceocertific.htm</File>
    <File>exhibit312-cfocertific.htm</File>
    <File>exhibit321-ceocertific.htm</File>
    <File>exhibit322-cfocertific.htm</File>
    <File>kids-20200630.xsd</File>
    <File>kids-20200630_cal.xml</File>
    <File>kids-20200630_def.xml</File>
    <File>kids-20200630_lab.xml</File>
    <File>kids-20200630_pre.xml</File>
    <File>kids10-qex103xsecondam.htm</File>
    <File>kids10-qex104xfirstame.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "kids-20200630.htm": {
   "axisCustom": 1,
   "axisStandard": 26,
   "contextCount": 216,
   "dts": {
    "calculationLink": {
     "local": [
      "kids-20200630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "kids-20200630_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "kids-20200630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "kids-20200630_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kids-20200630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "kids-20200630.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 496,
   "entityCount": 1,
   "hidden": {
    "http://www.orthopediatrics.com/20200630": 2,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 7
   },
   "keyCustom": 36,
   "keyStandard": 327,
   "memberCustom": 25,
   "memberStandard": 40,
   "nsprefix": "kids",
   "nsuri": "http://www.orthopediatrics.com/20200630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.orthopediatrics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - BUSINESS COMBINATION",
     "role": "http://www.orthopediatrics.com/role/BUSINESSCOMBINATION",
     "shortName": "BUSINESS COMBINATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116104 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121105 - Disclosure - DISCONTINUED OPERATIONS",
     "role": "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS",
     "shortName": "DISCONTINUED OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - DEBT AND CREDIT ARRANGEMENTS",
     "role": "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS",
     "shortName": "DEBT AND CREDIT ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128107 - Disclosure - STRATEGIC ARRANGEMENTS",
     "role": "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS",
     "shortName": "STRATEGIC ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - INCOME TAXES",
     "role": "http://www.orthopediatrics.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137110 - Disclosure - NET LOSS PER SHARE",
     "role": "http://www.orthopediatrics.com/role/NETLOSSPERSHARE",
     "shortName": "NET LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141111 - Disclosure - BUSINESS SEGMENT",
     "role": "http://www.orthopediatrics.com/role/BUSINESSSEGMENT",
     "shortName": "BUSINESS SEGMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146112 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148113 - Disclosure - EMPLOYEE BENEFIT PLAN",
     "role": "http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN",
     "shortName": "EMPLOYEE BENEFIT PLAN",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150114 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152115 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - BUSINESS COMBINATION (Tables)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables",
     "shortName": "BUSINESS COMBINATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - DISCONTINUED OPERATIONS (Tables)",
     "role": "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables",
     "shortName": "DISCONTINUED OPERATIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - DEBT AND CREDIT ARRANGEMENTS (Tables)",
     "role": "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables",
     "shortName": "DEBT AND CREDIT ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - NET LOSS PER SHARE (Tables)",
     "role": "http://www.orthopediatrics.com/role/NETLOSSPERSHARETables",
     "shortName": "NET LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342308 - Disclosure - BUSINESS SEGMENT (Tables)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables",
     "shortName": "BUSINESS SEGMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - BUSINESS (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSDetails",
     "shortName": "BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "if165c6b0a0c54a44934985e5b43808c7_D20190604-20190604",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "role": "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
       "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i06a679238a7a43869b57724937813e35_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Assets Useful Lives (Details)",
     "role": "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Assets Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i06a679238a7a43869b57724937813e35_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Amortization Intangible Assets, net (Details)",
     "role": "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Amortization Intangible Assets, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i2489a995cb5647f2b66c0e03b90c4ae7_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "span",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Stock-Based Compensation (Details)",
     "role": "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i9e55361217974608a2b11df6efaf5506_D20200101-20200630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - BUSINESS COMBINATION - ApiFix (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
     "shortName": "BUSINESS COMBINATION - ApiFix (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i92dbc1f53eb841a9b8cf360c70741128_D20200401-20200401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAcquiredFromAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - BUSINESS COMBINATION - Summary of the Present Value of Payments (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
     "shortName": "BUSINESS COMBINATION - Summary of the Present Value of Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i0891c5d60bc5463e814034e47be08954_I20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "kids:BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - BUSINESS COMBINATION - Telos (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
     "shortName": "BUSINESS COMBINATION - Telos (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "icc2d3cdb9e9a4e96b2a2aa190e714f3a_D20200309-20200309",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAcquiredFromAcquisition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - BUSINESS COMBINATION - Vilex and Orthex (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
     "shortName": "BUSINESS COMBINATION - Vilex and Orthex (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "id9512287e4134097a7d49339bfdae2a8_D20190604-20190604",
      "decimals": null,
      "lang": "en-US",
      "name": "kids:BusinessCombinationEscrowDepositMaximumTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ie4e2a354b98945b7ac75843c10a25a44_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Changes in Goodwill (Details)",
     "role": "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Changes in Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i0ce021843bf7476ab44bfacfc23770c3_D20190101-20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Amortizable Intangible Assets (Details)",
     "role": "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Amortizable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - DISCONTINUED OPERATIONS (Details)",
     "role": "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails",
     "shortName": "DISCONTINUED OPERATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i403840bd39d049079fe8e6879ec4c0e9_D20190401-20190630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - DEBT AND CREDIT ARRANGEMENTS - Schedule of Long-term Debt (Details)",
     "role": "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails",
     "shortName": "DEBT AND CREDIT ARRANGEMENTS - Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfRelatedPartyDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - DEBT AND CREDIT ARRANGEMENTS - Narrative (Details)",
     "role": "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
     "shortName": "DEBT AND CREDIT ARRANGEMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i7eba4623b24a447fbe2ee28df0cdd245_D20191231-20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfRelatedPartyDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "kids:ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - STRATEGIC ARRANGEMENTS (Details)",
     "role": "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails",
     "shortName": "STRATEGIC ARRANGEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ib62efb33448d425f8bb4b13674e7e6c7_D20200401-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.orthopediatrics.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "span",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - STOCKHOLDERS' EQUITY - Stock Options (Details)",
     "role": "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock (Details)",
     "role": "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "idbb6455ee34645b9b482fe979192967c_D20200401-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "role": "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ie4e2a354b98945b7ac75843c10a25a44_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - STOCKHOLDERS' EQUITY - Warrants (Details)",
     "role": "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ie4e2a354b98945b7ac75843c10a25a44_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - NET LOSS PER SHARE - Reconciliation of Basic and Diluted Net Loss Per Share (Details)",
     "role": "http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails",
     "shortName": "NET LOSS PER SHARE - Reconciliation of Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - NET LOSS PER SHARE - Antidilutive Securities (Details)",
     "role": "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails",
     "shortName": "NET LOSS PER SHARE - Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443423 - Disclosure - BUSINESS SEGMENT - Narrative (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails",
     "shortName": "BUSINESS SEGMENT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfReportableSegments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - BUSINESS SEGMENT - Schedule of Revenue by Geographical Location (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails",
     "shortName": "BUSINESS SEGMENT - Schedule of Revenue by Geographical Location (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ice73e8c1b57f4796918a790a968b7015_D20200401-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4c0ae8075c97496d98156163a0dbb173_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - BUSINESS SEGMENT - Schedule of Revenue by Category (Details)",
     "role": "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails",
     "shortName": "BUSINESS SEGMENT - Schedule of Revenue by Category (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "id78469ce723d4142ae3b8ab43ffa60a0_D20200401-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i2598dfdadeaa4dfaaf591eb9e05e7ab9_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447426 - Disclosure - RELATED PARTY TRANSACTIONS (Details)",
     "role": "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails",
     "shortName": "RELATED PARTY TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ie0deb0d220a848e5ab3218335eba7b86_D20200101-20200630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "kids:NumberOfRelatedPartyEntitiesSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "supplier",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i7249b3def0b34e65b3e605e288e1cc43_D20200101-20200101",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - EMPLOYEE BENEFIT PLAN - Narrative (Details)",
     "role": "http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails",
     "shortName": "EMPLOYEE BENEFIT PLAN - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i7249b3def0b34e65b3e605e288e1cc43_D20200101-20200101",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i4daa9a471c454c999687c99d7d5c379c_I20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ie9d46247c02e4dad89dcf4bf7fdb0780_D20200804-20200804",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453429 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ie9d46247c02e4dad89dcf4bf7fdb0780_D20200804-20200804",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i557ae529b0534b7e83bdfd35a6d1216a_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY",
     "role": "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "i22bef0eaffe04104b79fd06b8e9b6aa1_D20190101-20190331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BUSINESS",
     "role": "http://www.orthopediatrics.com/role/BUSINESS",
     "shortName": "BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kids-20200630.htm",
      "contextRef": "ia00d2b62af61475eb1f390c6d706fbe2_D20200101-20200630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 68,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "kids_A2007EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "2007 Equity Incentive Plan [Member]",
        "terseLabel": "2007 Plan"
       }
      }
     },
     "localname": "A2007EquityIncentivePlanMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_ApiFixLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ApiFix Ltd.",
        "label": "ApiFix Ltd. [Member]",
        "terseLabel": "ApiFix Ltd"
       }
      }
     },
     "localname": "ApiFixLtdMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assets, Noncurrent, Excluding Property, Plant and Equipment",
        "label": "Assets, Noncurrent, Excluding Property, Plant and Equipment",
        "totalLabel": "Total other assets"
       }
      }
     },
     "localname": "AssetsNoncurrentExcludingPropertyPlantAndEquipment",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BandLokMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Band-Lok",
        "label": "Band-Lok [Member]",
        "terseLabel": "Band-Lok"
       }
      }
     },
     "localname": "BandLokMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_BusinessAcquisitionAnniversaryAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition Anniversary",
        "label": "Business Acquisition Anniversary [Axis]",
        "terseLabel": "Business Acquisition Anniversary [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAnniversaryAxis",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kids_BusinessAcquisitionAnniversaryDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition Anniversary",
        "label": "Business Acquisition Anniversary [Domain]",
        "terseLabel": "Business Acquisition Anniversary [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAnniversaryDomain",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Approximate Value Assigned",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Approximate Value Assigned",
        "terseLabel": "Common stock approximate value"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableApproximateValueAssigned",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Acquisition Installment Payable",
        "label": "Business Combination, Contingent Consideration, Acquisition Installment Payable",
        "totalLabel": "Anniversary payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails": {
       "order": 1.0,
       "parentTag": "kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayable",
       "weight": 1.0
      },
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Acquisition Installment Payable, Current",
        "label": "Business Combination, Contingent Consideration, Acquisition Installment Payable, Current",
        "terseLabel": "Less: current portion of acquisition installment payable",
        "verboseLabel": "Current portion of acquisition installment payable"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableCurrent",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent",
       "weight": 1.0
      },
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Acquisition Installment Payable, Noncurrent",
        "label": "Business Combination, Contingent Consideration, Acquisition Installment Payable, Noncurrent",
        "terseLabel": "Acquisition installment payable, net of current portion",
        "verboseLabel": "Acquisition installment payable, net of current portion"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionInstallmentPayableNoncurrent",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationContingentConsiderationAnniversaryPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Anniversary Payments",
        "label": "Business Combination, Contingent Consideration, Anniversary Payments",
        "terseLabel": "Anniversary payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAnniversaryPayments",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Change in Fair Value, Acquisition Installment Payable",
        "label": "Business Combination, Contingent Consideration, Change in Fair Value, Acquisition Installment Payable",
        "terseLabel": "Acquisition installment payable"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationChangeInFairValueAcquisitionInstallmentPayable",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationContingentConsiderationNumberOfClinicalProcedures": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Number of Clinical Procedures",
        "label": "Business Combination, Contingent Consideration, Number of Clinical Procedures",
        "terseLabel": "Number of clinical procedures"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationNumberOfClinicalProcedures",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kids_BusinessCombinationContingentConsiderationRevenueMultiplier": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Revenue Multiplier",
        "label": "Business Combination, Contingent Consideration, Revenue Multiplier",
        "terseLabel": "Revenue multiplier"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationRevenueMultiplier",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "kids_BusinessCombinationContingentConsiderationRevenuePayment": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Revenue Payment",
        "label": "Business Combination, Contingent Consideration, Revenue Payment",
        "terseLabel": "System sales payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationRevenuePayment",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationContingentConsiderationSystemSalesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, System Sales Payment",
        "label": "Business Combination, Contingent Consideration, System Sales Payment",
        "terseLabel": "System sales payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationSystemSalesPayment",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationEscrowDeposit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Escrow Deposit",
        "label": "Business Combination, Escrow Deposit",
        "terseLabel": "Escrow deposit"
       }
      }
     },
     "localname": "BusinessCombinationEscrowDeposit",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationEscrowDepositMaximumTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Escrow Deposit, Maximum Term",
        "label": "Business Combination, Escrow Deposit, Maximum Term",
        "terseLabel": "Escrow deposit period"
       }
      }
     },
     "localname": "BusinessCombinationEscrowDepositMaximumTerm",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiability",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Asset",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_CaseWesternReserveUniversityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Case Western Reserve University [Member]",
        "terseLabel": "CASE"
       }
      }
     },
     "localname": "CaseWesternReserveUniversityMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_ClassOfWarrantOrRightExercised": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of Warrant or Right Exercised",
        "label": "Class of Warrant or Right Exercised",
        "terseLabel": "Number of warrants exercised (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercised",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "kids_ClassOfWarrantOrRightOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of Warrant or Right Outstanding",
        "label": "Class of Warrant or Right Outstanding [Roll Forward]",
        "terseLabel": "Class of Warrant or Right Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstandingRollForward",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kids_ClassOfWarrantOrRightTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of Warrant or Right Term",
        "label": "Class of Warrant or Right Term",
        "terseLabel": "Term of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTerm",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kids_CostOfGoodsAndServicesSoldPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost of Goods and Services Sold, Policy",
        "label": "Cost of Goods and Services Sold, Policy [Policy Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldPolicyPolicyTextBlock",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kids_DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Assets And Liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Assets And Liabilities",
        "terseLabel": "Allocated purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationAssetsAndLiabilities",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Deferred Revenue",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Deferred Revenue",
        "terseLabel": "Attributable to deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationDeferredRevenue",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Emerging Growth Company Reporting Requirements, Policy",
        "label": "Emerging Growth Company Reporting Requirements, Policy [Policy Text Block]",
        "terseLabel": "\"Emerging Growth Company\" Reporting Requirements"
       }
      }
     },
     "localname": "EmergingGrowthCompanyReportingRequirementsPolicyPolicyTextBlock",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kids_FMIHansaMedicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "FMI Hansa Medical Products",
        "label": "FMI Hansa Medical Products [Member]",
        "terseLabel": "FMI"
       }
      }
     },
     "localname": "FMIHansaMedicalProductsMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_FirstAmendedLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First Amended Loan Agreement",
        "label": "First Amended Loan Agreement [Member]",
        "terseLabel": "First Amended Loan Agreement"
       }
      }
     },
     "localname": "FirstAmendedLoanAgreementMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_FollowOnOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Follow-on Offering",
        "label": "Follow-on Offering [Member]",
        "terseLabel": "Follow-on Offering"
       }
      }
     },
     "localname": "FollowOnOfferingMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_FourthAnniversaryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fourth Anniversary",
        "label": "Fourth Anniversary [Member]",
        "terseLabel": "Fourth Anniversary"
       }
      }
     },
     "localname": "FourthAnniversaryMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_GoodwillMeasurementPeriodAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Goodwill, Measurement Period Adjustment",
        "label": "Goodwill, Measurement Period Adjustment",
        "terseLabel": "Goodwill, measurement period adjustment"
       }
      }
     },
     "localname": "GoodwillMeasurementPeriodAdjustment",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_IntangibleAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible Assets Acquired",
        "label": "Intangible Assets Acquired",
        "totalLabel": "Fair value of identifiable intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsAcquired",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_LoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loan Agreement",
        "label": "Loan Agreement [Member]",
        "terseLabel": "Loan Agreement"
       }
      }
     },
     "localname": "LoanAgreementMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_LongTermDebtCurrentMaturitiesRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term Debt, Current Maturities, Related Party",
        "label": "Long-term Debt, Current Maturities, Related Party",
        "terseLabel": "Current portion of long-term debt with affiliate"
       }
      }
     },
     "localname": "LongTermDebtCurrentMaturitiesRelatedParty",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_New2017EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "New 2017 Equity Incentive Plan [Member]",
        "terseLabel": "2017 Plan"
       }
      }
     },
     "localname": "New2017EquityIncentivePlanMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_NumberOfRelatedPartyEntitiesSuppliers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number Of Related Party Entities Suppliers",
        "label": "Number Of Related Party Entities Suppliers",
        "terseLabel": "Number of related party suppliers"
       }
      }
     },
     "localname": "NumberOfRelatedPartyEntitiesSuppliers",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Loss Carryforwards Limitations on Use Estimated Amount Subject to Limitation",
        "label": "Operating Loss Carryforwards Limitations on Use Estimated Amount Subject to Limitation",
        "terseLabel": "Estimated limitation on losses generated prior to ownership change date"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitation",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Loss Carryforwards Limitations on Use Estimated Amount Subject to Limitation Annual Limit",
        "terseLabel": "Estimated annual limitation of losses"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUseEstimatedAmountSubjectToLimitationAnnualLimit",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Loss Carryforwards Limitationson Use Estimated Amount Subject to Limitation Annual Limit Increase",
        "terseLabel": "Increase of estimated annual limitation of first five years"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsonUseEstimatedAmountSubjectToLimitationAnnualLimitIncrease",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_OrthexMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Orthex",
        "label": "Orthex [Member]",
        "terseLabel": "Orthex"
       }
      }
     },
     "localname": "OrthexMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research and Development Arrangement Contract to Perform for Others Minimum Annual Royalty Payment",
        "label": "Research and Development Arrangement Contract to Perform for Others Minimum Annual Royalty Payment",
        "terseLabel": "Minimum annual royalty payment",
        "verboseLabel": "Minimum annual royalty commitments through 2026"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersMinimumAnnualRoyaltyPayment",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Research and Development Arrangement Contract to Perform for Others Royalty Agreement Ability to Sell Milestone Payment",
        "terseLabel": "Milestone payments for FDA approval to sell our products within the United States"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementAbilityToSellMilestonePayment",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Research and Development Arrangement Contract to Perform for Others Royalty Agreement Percent",
        "terseLabel": "Royalty agreement percentage"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementPercent",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "kids_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Research and Development Arrangement Contract to Perform for Others Royalty Agreement Product Launch Milestone Payment",
        "terseLabel": "Milestone payment for general product launch"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyAgreementProductLaunchMilestonePayment",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_ResearchandDevelopmentArrangementContracttoPerformforOthersTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ResearchandDevelopmentArrangementContracttoPerformforOthersTerm",
        "terseLabel": "Royalty agreement period"
       }
      }
     },
     "localname": "ResearchandDevelopmentArrangementContracttoPerformforOthersTerm",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kids_RevolvingLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revolving Loan",
        "label": "Revolving Loan [Member]",
        "terseLabel": "Revolving Loan"
       }
      }
     },
     "localname": "RevolvingLoanMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_SalesAndMarketingExpensePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Sales And Marketing Expense Policy [Policy Text Block]",
        "terseLabel": "Sales and Marketing Expenses"
       }
      }
     },
     "localname": "SalesAndMarketingExpensePolicyPolicyTextBlock",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kids_SampleInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SampleInventoryMember",
        "terseLabel": "Sample inventory"
       }
      }
     },
     "localname": "SampleInventoryMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_SecondAmendedLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Second Amended Loan Agreement",
        "label": "Second Amended Loan Agreement [Member]",
        "terseLabel": "Second Amended Loan Agreement"
       }
      }
     },
     "localname": "SecondAmendedLoanAgreementMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_SecondAnniversaryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Second Anniversary",
        "label": "Second Anniversary [Member]",
        "terseLabel": "Second Anniversary"
       }
      }
     },
     "localname": "SecondAnniversaryMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award Equity Instruments Other than Options Exercisable Number",
        "terseLabel": "Restricted stock exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "kids_SpineMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SpineMember",
        "terseLabel": "Scoliosis"
       }
      }
     },
     "localname": "SpineMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_SportsMedicineandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SportsMedicineandOtherMember",
        "terseLabel": "Sports medicine/other"
       }
      }
     },
     "localname": "SportsMedicineandOtherMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_SquadronMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Squadron",
        "label": "Squadron [Member]",
        "terseLabel": "Squadron"
       }
      }
     },
     "localname": "SquadronMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_TelosPartnersLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Telos Partners LLC",
        "label": "Telos Partners LLC [Member]",
        "terseLabel": "Telos"
       }
      }
     },
     "localname": "TelosPartnersLLCMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_TermNoteAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Note A",
        "label": "Term Note A [Member]",
        "terseLabel": "Term Note A"
       }
      }
     },
     "localname": "TermNoteAMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_TermNoteBMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Note B",
        "label": "Term Note B [Member]",
        "terseLabel": "Term Note B"
       }
      }
     },
     "localname": "TermNoteBMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_ThirdAnniversaryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Third Anniversary",
        "label": "Third Anniversary [Member]",
        "terseLabel": "Third Anniversary"
       }
      }
     },
     "localname": "ThirdAnniversaryMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_TransferOfPropertyAndEquipmentToInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Transfer Of Property And Equipment To Inventory",
        "terseLabel": "Transfer of instruments from property and equipment to inventory"
       }
      }
     },
     "localname": "TransferOfPropertyAndEquipmentToInventory",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kids_TraumaAndDeformityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trauma and Deformity [Member]",
        "terseLabel": "Trauma and deformity"
       }
      }
     },
     "localname": "TraumaAndDeformityMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_VilexAndOrthexMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vilex and Orthex",
        "label": "Vilex and Orthex [Member]",
        "terseLabel": "Vilex and Orthex"
       }
      }
     },
     "localname": "VilexAndOrthexMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "kids_VilexMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vilex",
        "label": "Vilex [Member]",
        "terseLabel": "Vilex"
       }
      }
     },
     "localname": "VilexMember",
     "nsuri": "http://www.orthopediatrics.com/20200630",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r273",
      "r396",
      "r397",
      "r400",
      "r481"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r77",
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r284",
      "r286",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r458",
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r284",
      "r286",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r458",
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r190",
      "r264",
      "r266",
      "r416",
      "r457",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Products and Services [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r190",
      "r264",
      "r266",
      "r416",
      "r457",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Products and Services [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r269",
      "r284",
      "r286",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r458",
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r269",
      "r284",
      "r286",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r458",
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r264",
      "r267",
      "r460",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r264",
      "r267",
      "r460",
      "r468",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r196",
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable - trade"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r28",
      "r49",
      "r197",
      "r198"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable - trade, less allowance for doubtful accounts of $185 and $506, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r33",
      "r34",
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalty payable"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r52",
      "r79",
      "r80",
      "r81",
      "r450",
      "r466",
      "r467"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r78",
      "r81",
      "r82",
      "r132",
      "r133",
      "r134",
      "r373",
      "r462",
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "netLabel": "Weighted-Average Amortization Period",
        "terseLabel": "Remaining Economic Useful Life (in years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r50",
      "r315"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r289",
      "r308",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r56",
      "r203",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r126",
      "r174",
      "r179",
      "r186",
      "r207",
      "r370",
      "r374",
      "r377",
      "r436",
      "r448"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r30",
      "r31",
      "r76",
      "r126",
      "r207",
      "r370",
      "r374",
      "r377"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r290",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Unaudited Interim Consolidated Financial Statements"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and building improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r283",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r283",
      "r285",
      "r346",
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Common stock value"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Purchase of shares and membership interests in common stock (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Common stock (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r344",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Pro forma net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r344",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Pro forma net revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r359",
      "r360",
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r114",
      "r365"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      },
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Fair value adjustment of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r358",
      "r361"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "ApiFix future consideration, net of current portion",
        "totalLabel": "ApiFix future consideration, net of current portion",
        "verboseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable-trade"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r348",
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r348",
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r348",
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Less: total net assets",
        "totalLabel": "Less: Net assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r348",
      "r349"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Fair value of estimated total acquisition consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "auth_ref": [
      "r419",
      "r420",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by project.",
        "label": "Project [Axis]",
        "terseLabel": "Project [Axis]"
       }
      }
     },
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r26",
      "r59",
      "r117"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents.",
        "label": "Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations",
        "periodEndLabel": "Cash and restricted cash, end of period",
        "periodStartLabel": "Cash and restricted cash, beginning of year"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r118",
      "r124"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r111",
      "r117",
      "r123"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Cash of continuing operations, end of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": {
     "auth_ref": [
      "r111",
      "r117",
      "r123"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations",
        "terseLabel": "Less cash of discontinued operations, end of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r111",
      "r378"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE (DECREASE) IN CASH"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r17",
      "r111"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations",
        "terseLabel": "Net cash used in investing activities - discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r17",
      "r111"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Net cash provided by operating activities - discontinued operations"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "periodEndLabel": "Ending weighted-average exercise price (in dollars per share)",
        "periodStartLabel": "Beginning weighted-average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "periodEndLabel": "Outstanding at June 30, 2020",
        "periodStartLabel": "Outstanding at January 1, 2020"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r132",
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r47",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.00025 par value; 50,000,000 shares authorized; 19,544,008 shares and 16,723,128 shares issued as of June 30, 2020 (unaudited) and December 31, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r85",
      "r87",
      "r88",
      "r93",
      "r442",
      "r455"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r253",
      "r254",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r97",
      "r416"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT AND CREDIT ARRANGEMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r437",
      "r438",
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r389",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r69",
      "r242",
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt instrument, interest rate, effective percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r70",
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Monthly interest and principal installments"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r70",
      "r130",
      "r245",
      "r246",
      "r247",
      "r248",
      "r388",
      "r389",
      "r391",
      "r446"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employer contribution as a percentage of employees' salary"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLANNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r115",
      "r172"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology Rights [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r1",
      "r3",
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Divestiture purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r16",
      "r23"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r24",
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "DISCONTINUED OPERATIONS"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal and state"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share - basic and diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized [Abstract]",
        "terseLabel": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized [Abstract]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation expense, weighted average period of recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock option",
        "verboseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r141",
      "r143",
      "r155",
      "r208",
      "r244",
      "r249",
      "r312",
      "r313",
      "r314",
      "r334",
      "r335",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r219",
      "r223",
      "r226",
      "r228",
      "r417",
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r226",
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Intangible Assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r219",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r226",
      "r417"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Amortizable intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 1.0,
       "parentTag": "kids_IntangibleAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r124",
      "r386"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r213",
      "r214",
      "r435"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, acquired during period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r124",
      "r217",
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Goodwill, divestiture of business"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r95",
      "r126",
      "r174",
      "r178",
      "r182",
      "r185",
      "r188",
      "r207",
      "r377"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r115",
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Impairment charges, indefinite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r115",
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment charges, finite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r96",
      "r116",
      "r137",
      "r138",
      "r139",
      "r140",
      "r146",
      "r149",
      "r367"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Net loss from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r15",
      "r20",
      "r368"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      },
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Net loss from discontinued operations",
        "totalLabel": "Net loss from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r18",
      "r21",
      "r22",
      "r23",
      "r233",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r325",
      "r328",
      "r331",
      "r336",
      "r338",
      "r340",
      "r341",
      "r342"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r127",
      "r142",
      "r143",
      "r173",
      "r324",
      "r337",
      "r339",
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r124",
      "r322",
      "r323",
      "r328",
      "r329",
      "r330",
      "r333",
      "r469"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.",
        "label": "Increase (Decrease) in Accounts and Notes Receivable",
        "negatedTerseLabel": "Accounts receivable - trade"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable - trade"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in certain current assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r222",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "kids_AssetsNoncurrentExcludingPropertyPlantAndEquipment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r222",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails": {
       "order": 2.0,
       "parentTag": "kids_IntangibleAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.",
        "label": "Indefinite-lived Intangible Assets Acquired",
        "terseLabel": "Indefinite-lived intangible assets acquired"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r124",
      "r225",
      "r413",
      "r414",
      "r415",
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Amortizable Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Intellectual Property"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r90",
      "r171",
      "r387",
      "r390",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r443"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTerseLabel": "Interest expense, net",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r110",
      "r112",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r27",
      "r74"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r35",
      "r75",
      "r124",
      "r154",
      "r210",
      "r211",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r66",
      "r126",
      "r180",
      "r207",
      "r371",
      "r374",
      "r375",
      "r377"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r55",
      "r126",
      "r207",
      "r377",
      "r439",
      "r452"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r68",
      "r126",
      "r207",
      "r371",
      "r374",
      "r375",
      "r377"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r44",
      "r45",
      "r126",
      "r207",
      "r371",
      "r374",
      "r375",
      "r377"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-term liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Unused commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Term loan facility with Squadron"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "Three month LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r44",
      "r241",
      "r438",
      "r449"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "netLabel": "Mortgage payable to affiliate",
        "verboseLabel": "Mortgage balance"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt with affiliate",
        "verboseLabel": "Less: current maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Total long-term debt, net of current maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesAndLoans": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes and Loans, Noncurrent",
        "terseLabel": "Long-term debt with affiliate, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesAndLoans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Long-term Purchase Commitment [Line Items]",
        "terseLabel": "Long-term Purchase Commitment [Line Items]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-term Purchase Commitment [Table]",
        "terseLabel": "Long-term Purchase Commitment [Table]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r70",
      "r240"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MortgagesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.",
        "label": "Mortgages [Member]",
        "terseLabel": "Mortgage payable to affiliate"
       }
      }
     },
     "localname": "MortgagesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r156",
      "r164"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations",
        "totalLabel": "Net cash used in investing activities - continuing operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r111",
      "r113",
      "r116"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "auth_ref": [
      "r111",
      "r113",
      "r116"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "totalLabel": "Net cash used in operating activities - continuing operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r23",
      "r83",
      "r86",
      "r92",
      "r116",
      "r126",
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r142",
      "r143",
      "r146",
      "r174",
      "r178",
      "r182",
      "r185",
      "r188",
      "r207",
      "r377",
      "r441",
      "r454"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      },
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140",
      "r144",
      "r145",
      "r147",
      "r149",
      "r174",
      "r178",
      "r182",
      "r185",
      "r188"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other expenses"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Schedule of restricted stock activity"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r48",
      "r197",
      "r198",
      "r440"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Notes receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r44",
      "r438",
      "r449"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Note payable to Squadron"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Note payable to Squadron"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office and other equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r174",
      "r178",
      "r182",
      "r185",
      "r188"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r25",
      "r131",
      "r164",
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other assets:"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r368",
      "r369",
      "r372"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r84",
      "r87",
      "r368",
      "r369",
      "r372"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive (loss) income",
        "totalLabel": "Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r32",
      "r33",
      "r67"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expenses:"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.",
        "label": "Payment for Contingent Consideration Liability, Investing Activities",
        "terseLabel": "Subsequent payments"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "terseLabel": "Discounts and commissions"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "verboseLabel": "Offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r103",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Purchase of shares and membership interests in cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of Telos, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchases of licenses"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r287"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLAN"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/EMPLOYEEBENEFITPLAN"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r290",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r30",
      "r57",
      "r58"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Aggregate gross proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds from issuance of debt with affiliate"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r106",
      "r311"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProjectMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Planned program of work.",
        "label": "Project [Domain]",
        "terseLabel": "Project [Domain]"
       }
      }
     },
     "localname": "ProjectMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r61",
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r40",
      "r41",
      "r232",
      "r453"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r124",
      "r232",
      "r470",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r40",
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and equipment, depreciable lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r40",
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Depreciable lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r273",
      "r396",
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Payments to related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r273",
      "r396",
      "r400",
      "r422",
      "r423",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r394",
      "r395",
      "r397",
      "r401",
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayment of principal amount outstanding"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Payments on note with affiliate",
        "terseLabel": "Payments on note with affiliate"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedTerseLabel": "Payments on mortgage notes"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r320",
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r320",
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r319",
      "r482"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r124",
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "terseLabel": "STRATEGIC ARRANGEMENTS"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r26",
      "r39",
      "r123"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r51",
      "r249",
      "r315",
      "r451",
      "r465",
      "r467"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedTerseLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r141",
      "r143",
      "r208",
      "r312",
      "r313",
      "r314",
      "r334",
      "r335",
      "r462",
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r177",
      "r183",
      "r184",
      "r190",
      "r191",
      "r194",
      "r263",
      "r264",
      "r416"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails",
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition - United States and International"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyAgreementTermsMember": {
     "auth_ref": [
      "r320",
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Terms of the royalty agreement under research and development arrangements.",
        "label": "Royalty Agreement Terms [Member]",
        "terseLabel": "Royalty Agreement Terms"
       }
      }
     },
     "localname": "RoyaltyAgreementTermsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty expense"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Common stock issued and sold"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Public offering price (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSAmortizableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of antidilutive securities excluded from computation of net loss per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r346",
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONSummaryofthePresentValueofPaymentsDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails",
      "http://www.orthopediatrics.com/role/BUSINESSDetails",
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r70",
      "r130",
      "r245",
      "r246",
      "r247",
      "r248",
      "r388",
      "r389",
      "r391",
      "r446"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of long-term debt instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r0",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r18",
      "r21",
      "r22",
      "r23",
      "r233",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DISCONTINUEDOPERATIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of basic and diluted net loss per share attributable to common stockholders"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r219",
      "r225",
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAmortizationIntangibleAssetsnetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r219",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r222",
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of characteristics and cost, by total and major class, of indefinite-lived intangible assets acquired as part of a business combination. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. The future benefit is not expected to diminish over a stated period of time. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.",
        "label": "Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r61",
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r128",
      "r398",
      "r400"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "auth_ref": [
      "r320",
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.",
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STRATEGICARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r94",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of product sales by geographic location"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r91",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyGeographicalLocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r174",
      "r175",
      "r181",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r174",
      "r175",
      "r181",
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of product sales by category"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r290",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r296",
      "r304",
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r252",
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of warrants"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r167",
      "r168",
      "r174",
      "r176",
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r193",
      "r194",
      "r195"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSSEGMENTScheduleofRevenuebyCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at period end (in shares)",
        "periodStartLabel": "Outstanding at period start (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted-Average Remaining Contractual Terms"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares available for award (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r298",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at period end (in shares)",
        "periodStartLabel": "Outstanding at period start (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at period end, Weighted-Average Exercise Price (in dollars per share)",
        "periodStartLabel": "Outstanding at period start, Weighted-Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r288",
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYRestrictedStockDetails",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised, Weighted-Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Vesting period one"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Vesting period two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r124",
      "r290",
      "r294"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Contractual Terms"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Business software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r73",
      "r132",
      "r133",
      "r134",
      "r136",
      "r141",
      "r143",
      "r155",
      "r208",
      "r244",
      "r249",
      "r312",
      "r313",
      "r314",
      "r334",
      "r335",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r155",
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r120",
      "r121",
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of common shares to acquire business"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r46",
      "r47",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Consideration for acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r46",
      "r47",
      "r244",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, net of issuance cost (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r46",
      "r47",
      "r244",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r46",
      "r47",
      "r244",
      "r249",
      "r299"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Stock option exercise (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY",
      "http://www.orthopediatrics.com/role/STOCKHOLDERSEQUITYStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r73",
      "r244",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Consideration for acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r46",
      "r47",
      "r244",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock, net of issuance cost"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r244",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r73",
      "r244",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option exercise"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r47",
      "r53",
      "r54",
      "r126",
      "r205",
      "r207",
      "r377"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r385",
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r385",
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r385",
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r385",
      "r404"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r403",
      "r405"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURES"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment used in the creation, maintenance and utilization of information systems which include computers and peripherals.",
        "label": "Technology Equipment [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "TechnologyEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESAssetsUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and Trade Names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONApiFixDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONTelosDetails",
      "http://www.orthopediatrics.com/role/BUSINESSCOMBINATIONVilexandOrthexDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r72",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r72",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedLabel": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r47",
      "r244",
      "r249"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r72",
      "r250",
      "r251"
     ],
     "calculation": {
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r244",
      "r249",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/DEBTANDCREDITARRANGEMENTSNarrativeDetails",
      "http://www.orthopediatrics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/SIGNIFICANTACCOUNTINGPOLICIESStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average common stock - basic and diluted (in shares)",
        "verboseLabel": "Weighted average common shares - basic and diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.orthopediatrics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.orthopediatrics.com/role/NETLOSSPERSHAREReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4922-128472"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5558-128473"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(a)(32))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6806780-109447"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r484": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r485": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r486": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r487": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r488": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r489": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001425450-20-000107-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001425450-20-000107-xbrl.zip
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M<<0O#3@SB%1-$";%!&@HY:6GEC$K%+(LY>%HJ9W51BT-3-.,5$V2C:*GPIM
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M2^QP  ^0"*\0PPY<08(5\]B$!5&(<X3C;+2B2FM"F((APU(M=*29,-H)HD1
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MCVG^JK]%/_78M*LO9?#YL+G3LC@>M=P[&K_Y4]YNK]5@6M<^C7XJ$@F%6A>
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M! ][LF)IA/']*3ONG>51YS"_Z[P8G/G^2AH"#WG(@FCC[K3QX0IM&&=0>1W
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M,E9E+R3AA0A"B:920)<CY=(3WFTXWBVW/R#AW<+P;NH;C6B$\SQ#5JP &IO
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M;GQH*JLU+FKIEI&AO$EG!S? T;)NJ+?(F!Q!V\- V]1OXJ/SR)(!Q8H"#,Q
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M,P@BVV@+DQ50&V[J(K:J$TTK@8FR*M88^QZE>2MAW^*Q;\:SZS)/CB5(*DC
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MCX/=6.^7RD'O,I/@)7OWNL08?7.0M[CB -%&\*(4L)ECL1JU9F*5>C6M?L;
MAJ6K$5EL%ED\?@\>(HOYR.+C9[)0G#D,R4&Q,@(&Z<";^HKK:% :*P/'F_KK
M$%D065 CA*7E5*XZ33Q^1QVBB?EH@G^F"19-,3H;,#94FF Y@JW$ =768(5Q
MA8*ZY1!)$$FT3*Q7CR0>OUL.D<1\)"$_DX3TJ023 T0E324)E9J^K@R"#J;R
MAQ!5 Z!..'1.9=&AH(>/:3_VFA^-3_*PZ7_R=IA/<G_4^S-W_M)$BO[:Z4V
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MMO/.#],DZ^^GP;#DWOA\,GA*19B#7^.55 1G,_=5,X(8HP;D',&)$L'9$'1
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MC"XPP8IJ/+(\>D#)'#C+ Q@548K$4%BQM2V[];(']<D2(!(@MA@020\@L=]
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MD07&BSA\')D6-KBXMLG7!54MJM\6JC\9I6A9[ )WM^=;_L-X.,JA$2F28A
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M:%G<3[*XCW/Q1DH4"A<"N> T F;GD!&2(\%(H9AV!CN\O'VWOG\.EPK_6I_
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M^YP@Q\$G_8K(USOE$+XZ@\M!$P&E]5/IT@5G,*V+[$(H1TF2!!G3AR&@+RS
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M_[DZ[Q/*@N]A)WJANKJR(2=>"T23@BQR@'T5"P$ZPM:P<VX&HX;B85M#/AQ
M%GV@P^#&H\R@$TUV ;D^!0 +EZ(X "8'B4AS$YC\E,D(X%A\*C/^)0(&8C@/
MHW%^-"!>%0H".IPI>YFK=[LPU/3U7(,9TSD;YT\!CP"_[#C/QIP,0GXB#/U1
M0%,E<>KU+'0N)GY=(QRE;<Q%RCHO85-[\&TC(^5/?T)$<BZQ6P\ H@T+6EAB
MB#$@"P6)6:1-W#PM-&I>M"+2W8I(6_SP^/47&//7@^.3BX.3]SHP3[W 2&,1
M$",8)"5N';*X($%HQDE*1*/K=!%IJ2*C['>S0'7E?\<!,.@D"3/]P46^&CA@
M/N,E0%':Y)!5P>UT9HSO/Q+U: LDP6X'W^(!K4Q!<#!'/NE%U=OZ:/YF?E_H
M>((P;!V.G :K&$YQOBY243A92(8Q4?7Q9$U( ;SXZ>/YTESDV+SC_E:5H]6<
MUS $46 X;(]D=22_'GR&(VDCCDHC1Z5'C%HXG+!/*%BK#,5$)E5RD]RHP#@S
M/*V,*[_9WSLW$D2E@=\N3>P=//L)S-Z:2A6I;\KHHND<.JQBQ0\'.>O/=L/!
M.)V*PY@#B^IOER60_*%)ISC<>A^(\H7D!H1#RP#-?43*&8RL+H3''&/C?>H3
MRM:ENMKC><8HDY"I4FLO_F<X2;1,EIKU;V/,RS#(FW.)KK D)!+%4L,NIF%T
M@@1"(V8B@KHN:5(M;B"G>9K9SD/)B00@IAP.LDG;_V.ZXS!]=$L0B2 H8(ER
M!56<*%0(!>S=*= ;M'"("$P,UQ+ Q*QM CLL"G*U>6P2[SN?TMHF0;PBCW7@
MY.= )<E@G>)A4@A,\C"!+'ZQ$/OY.9+X(:Z3^S)]%UTN@\O6="J9GK:&58A,
MRYLJ>L) 3YC:U'Z/(DRC0"Q&BE3D!-12J:TT%! 'Y[H\US*GWVP6?9(NUG$@
M(DX,P<ED5N5TWQ^XD!]@1_EI+]/86E"IB( <_OU>>(E-B 4RK$C%F8A$6M(
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MP"4O##5,.HMO5X%M0>\6R/'SP=9[;5CB3!%11E*[L0#"!/ H1&,1.=8@5RH
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M8&E=8%Y(7"AZI7WX96)*7',QIGO;+<:_.X6E/9F-^)'4[&Y.YIZ/>37#NM7
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MO[)Y@P*_8H(B;P(!X8TX9+3T2 F:8L045PPT +(8I/TKQPW?G+>Z4.6KNRX
M-#*]DU0):2OG9STK4T++BU3*_:F6& 3R>/U>F8)C H3 E&>("6N0YH$AJ93P
M!G# B"N5@%*U ^F<=L$4S,1H%/R?5SC@M 4%6=UTRJVS5%&K*H(SI9C.5MV8
MOA=&JY\E-#O'<CK'*FUQ*=L=WK!92UPAOBFO$$.JD!U2IGEJ<##JI\;'XUS
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M/(3#'#FYJ3ZP%@M/C'0Z APBS'J?)+.".ALYDR3K@ZMS$5M]<&?Z #[?WG>
M5A6.'(48!>( 1I&QS* (.L(IX25C,>L#I<VZY.IIZ(/=>L\=#GNA;*W22>EK
M/JG*[GI.CI\>P>3#D^&@WH]U8GW\%D>^VY2U-%G]W?%25ZG%.I>\+Q=N-JS.
MV4/.V<\5.UDE/.M48VL4Q.R@*8^NTYU39+ @I63HTA;^40C8FN X&\4EUI8Z
M0D*2,=DD!)8_VO[G@@S"&V_7\J__5O/]IF2KD:>W/_G.]U?[X"-ZP[U @*M(
M)E$"WSFS51I*C @D&!OMVL;D<!1CTVES,=CW[)IJ_&[SBV\L(?46_:ML@ZU!
M)21_C8;C\5-6Z2 R'_8%"<XK&Q!SRF:(9Y"VRN1NK4X(YY,AEZ4=GV_<[[3B
MH)6*VY<**4"S6S#OT@8P],P%Y$R,*"A.0?N;X+.AOYY4W&T^>BL5MR\5,3%L
M- -= ?L;\9 LTMR"C7&"V.1)%,E<5RKNMC*ME8K;EXK$*$B!H$@IZ@%T2(H<
M<0J%A*GQN3MAN+WBA1KLUI"[U"T4<'N[_2U6U--XM^S1SQ7>3F 6QBF6'(=I
M5*)R+XZZHX6R_KG 0#5+\S['Z5&F).CEH. 4)5:>_]EX0@YIYJB@BW$P70:8
MH[KUP&+HL+D\#Z19G'*'F5?2L^/J#I-NKQJ['>4$[3SP2[O,&DJ9ML1A03EF
MTM$HB.%$>D# SOUP7]+6,;E]'7'P+==V.&FM(A(CF2O<P%-02&L=87<(<!,D
MX^"=K&V,N]_.=TN:*H,E_W:]2D#,@;=9,7NI90?I& U[ZU6H.Y4X=YV(/A=1
MVRR=-):$NA'CZ1[:ACT&>(07GSE+9_;NZW#?- M_%//903Y?J%WM\W9!?8/+
M)%F&H)(-X+,!6"*).Q\IC<8P%E/T]H<YCUM)_@62#/<YV$\Z>L6D04)(#I(<
M+;)24^2=3DQC8YF5E23W86$/SXIR.<:N2C?>[#[K_#/72: 6I:]Q-+:]DHE6
M1/*\)(72S*%T!%F27Q"&%+NE94+3&&(,]O)H.*[J4.J 4NE?4G56F%V1,XP?
MOI7\ITGN.Z<]S)GIJF-P9=<6Y0)34)V05KG8"W/?'<]W?0"C:ET.G36M=DJY
MSSCW_:B3;,Z:UYFMFS?$,Y/8Y%XO#/+90^RQLF(9AUG?C>)AU8-H:P#+VA;*
M3%,>MO>)D9XQFQO&\ZS5>$*:4(JH Q2E*?Q_+GQ92CL,/&F7NY+*R)G/)86&
M:6]2D+G/?SQ;>SFW!)UJ#3J__0TNU+^?3,[A55.V-$G=>I)Z>9*R_FC C*U.
M!V:()U8I"6#ZJXY!C3HIN"F[!I4#-5^Y4G<!.MMTJER4>36&)X-<UP%@QV?;
M<.G8JLR[<K0#$P$0+.="#OQI]?2*M6.^Y/,G,ZE_-7M3?K<]^^W):P>^^W)[
M7WGAI8L<$<9SCP(5D3$R(,#M-ED'<ZKYLG:06BJ>B(\A81X$,R%) XK%&)NH
M,P\X@:K67" =\1'T%?PG-JWXZF*M\G*3_')S3DS5YZLBJ6G:>?7CY' &;J:=
M_BI@4U!2$W0 K54%)N"VTY9;<_?JUD?"=;BBZN55H]-\24Y0*-WR?)7,5&NN
M.OX NJ@$(&H5-/7TX*I0)6?GZV$CA^H<M3L -9=3PTI*5Z6,.A_J5RVMO.KW
MFN^;]R.O4!_!UGW^JEA+Z.;$LVKD+DY.\D ++#T[BLJ9A-MGY%EN<,%SW&G=
M@# .;-7V#"X:E0:*V1+  _UD.I^% P3^/&M#-C^D)H>]Z9Y6.1^Q"OC4=\H#
MF;,TLX?!^_[(M"RBYNZ@D;%ZF6I+519S:D6*).2WJTHU"RY_%'MMYNN=-W73
MD%VA>2I3<I*EN]>%=9FVXALO<)Z4;I*][I=8G IXY1P0;%K4@4[[GBL2M@:=
MOBVEH74GR85^GT76FQZ2N>=FQWZUW5XA6JG2TK]6S30'\:#J01AS\A%(4.FD
M=[;!)/SE9'C<RY'!3KE+$:TRF*J0]YQW;]H65ML^"_)\5U-PXG('P%G55FFA
MMSY[$KQ>+!T)IQ"CF<WL_-7PH]<;GM@R[(?H4MT$<5YIAN?<Y6.8F5'.?RW+
MTM0CS.NU6BUU)B=#,)OQ**>AE46:*IC?NO]>E(>3PUC09G=2VB2>*ZQ-B\G%
MQY;FIB! 8UC/*BGW/ 5;=5OUH$CSVDVF?Y_=)PON;UT85Z42A^/E!Y7G3_MS
MY"&B:H@H#Q'E(<X;M!P8'^=DGR)]B\&;7NFG-&DZ/.:Q9(5>E8W7.JZ>A?+Z
M O_/=#H6MFP59LP5/3G[)]=K3WJ5E2B5,I61K>GM\AZJ<M0FIU?#ZG-K5RZ5
M]K:PY7J%+7*%"EO.;P=T52W*<N]PG;"3X*UJQ[EES!BMM=2"&N4(SBG O[+1
MR2NXYT'N%C<:GDP.ZV34=TVCXG<5[BPPKHWH-!&=M_L.>Z5HPDAHH1$WFB%C
MJ43"8YTXCHJ2LT2[SH!M\#0%ICCC5&.>A/:*!.&<-.GA^FQU648C2IU*EIK,
MYKI(HS,5JLZ\5#T*W%GUL2JU'S"Z>CIB,QT'U73XQ>DX>WCVG]T_WW<V_>19
MYW7A$NWTACG:U%30Y^/W$J2"&S==E.%I%SQF/6."?((]*= M?+6S=B=5+ZH<
M9(]5&ZE98_+Y/@ 'F9TU]Q(;S:W7K+WV+-I^/)@AVIP&7ZX_JDJ#JN&4+F.;
M_?P^U:?@"PX.QE5"?^X_75# K)]7G8!?(.=QZ$[R?$PFI4PHZ]EJO UBJ?K(
M-W6MI9UTS:C;'%56IP@SKW"^$7L&Y>_KBEM0V+^Y?S=W>6]'S@[B&.U^Z\73
MO#+Y$]"A]#&X2\T[$ZR:%VX$L"KWG19!5"M^H:1UO,VN:L_6O;E#E3]2ZJUK
MQ#M'1S!KT-8D(F3(./MKY6\4(3G):=OVZ*B";T>C[M<,UN8$:MH3'KR=KT-?
MSHM*WZ(8&C^M"&;VBL:Q-RW6ZN:FYK%?#;.*Q\:33CD;^MHM]>;GC1?^6YJ5
MCV*.PE;.T11$N\_9F:]]HG'N1O]#MQQ?L%EFNRR_Q_D37Z;@J7A:5QK/#7#"
M-T%&>G7!8=G KUY,RX7R<HR.>\W43L-9-D=,4A5!1Y5[6ZJ#:B^DT<UUB]U:
MKB_>#+-85R4!E]U[SK_V,=<O7*73&X67,WDZP4ZSL5(W)\DM!:-R)*#FQCC(
MF71-\\EQW1F_\R_R#+:^ Q$N?-1[>5MTQ]6$^%$9$-S_7PIW^M5W9GDB1UFJ
M,^/YOTAS@]EKG5OA?ZVC[U][_+ 33S:GF_'-:#@89M>\A;@+O5*V]H5CQDIN
MD,#2("X41II)CQRS%K:B\<S298@;&"7>&24(3YDIR08MK6 $&Z8LH>3A0MQW
M,7O*G9G@=!8EY^'C ="?_SD>E!)$6:G/UYOO_P2-,(;5[6R^_]#9&3XKGR+"
M.FO-.ZW4XEWP:J^GP&]KKI$JZKP M DH.1^2@UK\;6]X!.J&4?GOYYWM.<HA
MT(*+WP1M=^XM[W52+I^"ZLPAKV+6\J!02_$]&)QN/^.\>"XX=@WTS[],NOU8
MTD6K>&;^4T9XU<3TIA/3&]J%<_#9?>>;V![&7JF-7_RT.SE>/D8?SK7<'<]>
M8N$\K+^X5CG"/CUU61Q?CE%.'SF>Q<;KCOEU2S1XP0A8TV6P4 9:!U!G$U/R
M)*?M),%P@H-2HJ3YN:-NCMVOUV?TDW)25L5"Z[[+,-SAP#846KE/,MRV_)Z!
MI0?C#F_Z^EHS4R'1P?"D$(#!;7)&(>H-A^54 D!(26(L9CICC$E.DJO^6H?_
MY^9IQACVK/-G\XYYTG/=""*X&D/N_PS>V/&X<E#?]V':X:8S)_]%XX?.-T>H
M:,XR)&ON6+1)=1:6CS[^8P$S@,M)UN%#RJH5GW<I"GH_..Z&?-+04(O-'[(5
MC\!V<B?2TEIZ,"D]^?W47:S'\K_CJT\NZ_6J(L&9'0GFI\KD>QSZOI[L&6)>
M5OGY$X3Y^L/2]S.&C#$ZA[^P4?0"@Z)_GQMM=U-ACLHSL)</&+*>F%XXX]Y8
M<?W>S?48<Z $?.%N.80$/?8^GR?1&8*?\=O-,6^5LY4B\;5VS:Y(ID:K'/"*
M,ZW0U5UXN3MM>,?J^5S,$+7+''CEO"7?<8F^:R%GH-GNZW,# E<C.TZS Z+L
MMRQS;TS/Z:]+&+8XRKJ?V7B!FF^K'#;--%>56]I<UM1@N A^7$E=KS*37X)M
MR>T/.D04#8?AG7H3>)>#PVD]QE3=Y07-!WV324,D.6TR4WNU97J:>$)6<(OZ
ML]+5W=R.N8J(W(=R/)-]>.TCLHM( Z\Z.%GR3KPCDDL3,=:"VQ@-5P:3$"SC
M+D9F+HH]7.W5+#XG$Q!'G3Q5.' )WI*@(5+MHV0J8N]7\EP-S,%4-K.AO]0%
M !A 'YI)F*65G57Z<VY=WL;S7YZ^Y5FQ/?N7U5O6\R7ZICOA:LE>\"W&]317
M*GAQCA=2X=SIU%:5)L-UV#AKY*.&ZK8^CJ\BK/8(+)T%15ZW0!_9)M$I']=7
MM+8E]:;R#W+*&<SSP6GY/@!UGX\V*F@\-XQ2XU@='G3[3>K4K CIXJR[Y52[
MIOEG(0NN$BKF\L(J59ZC@U,<6P+N]725=OJ%#7::;K$T=VD$%QUVQ\VX\Q";
M;+4YSM$R,GM2V@Z-I@S O@?&.75KWVGIS@O)S"50"@K]N#<I4]/)22GH^*B)
MB=;9=%6V2(,(JI>;FJ0S)K(.2?ZP?6QHAN>69%Q00S<G5I7VK6 V3V=&<\YB
M;B[X#7.CF@*<1M*:6:LBL'U;M75M*'E[I_6CQEE6SOGN*$[FO_V ;/6/J+4;
M.3MMMLNM9+NHB[-=\BM66EE['JC6B4K, ?]8[34!_<PIR8WCPSZ7:_??^_6>
M)O:">.[.[MZK#BM']83\<6G5Z"T<.?R9,XKC> P[UM59H2^GFW!5#AIVNO5!
MP^>/>(?^M[>]Y\7N/__I?_K\EFS_]2$_N[_].?1W__EP\K'_NK_S_0-;/FB
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M+Y9/-SMY\<9M=.WZ.^O%\1@&&T>==^6P=S@8'W:/5B["UM:(WP8P%#X9'1T
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MA=XOXW(G:)!4(L<%1QQ\,.2P9\@'B4FBD5,7UC8H;7FIV_!XJT9OHD:Q-@2
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M7'&#F,[DR808Y)BQR)/H@^;@/E*^ML'7)5F]UK$/_\!@!0S'K[/ZER*I&Y_
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MX10,,[\)+@N9M8<?/[JT<?)CCO:',18]F.W^J(C][+QH6= LZM%2O%P<QRE
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M/77<4FM]N,RY%I5A;,'9J+H]9W5R-.Z!T@/WAR*!#=CWG7SX^Y7;*;-'L']
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MZ-4>3PW_>OD^V\75+"^6^I<IN]/T@>6B'W,3]SMHGL^TR+<:0;="/UWKH%B
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M=^UQMCU;9=@SGZTJO#6]I>AVTM%Y7 PV8%S)NVZGUSDJ-POLW&%GKU.A0W3
MLAJ=5XS!>2S>C^OZZS\&;E0^$ZRM'":'H97_Y(O*T:WDZ1T.2F#+(WMR:$_C
M< 0V\6E5U9SWJNJ<>U@"6)=0(*-<&?O/I?;FGR.87CV2\KLP+H$1X!4ZJXV#
M\5XUPU+K&Q]66-G?8Q4CGL)NP?KT!T?3WD452,;@&*9T#K@Q.^K+ZU4AD.?5
MZ9?^QWR]QJ5C *94YOUV2E9U805=_9H2%F>Z!B561(XQYJ&6_H/Q4:<+A%7
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M4\:&+YTO&12^S&[9LQV0M3E!#R3R**<1SHKQ636RDMRPU97\SMZ:HV%U?9T
ME3/QAA=D^,, V[T$7_R/?>LMV[=[==NOK#9-,JC.'5)5Y.=[E3TS[8D5R^9-
MOLP]G6:Z'._'$A=I-,Z-53HE7-*X!(>YE&$U4;?.=;2L<,5AF>0WFJ;,Q)/.
MJ,K+O.K]+\5H9Z_?@3?E-BF''1")I5>N/.=YC%<'&ZO80*S*]:H>2KUQ%0>K
M_"M5=ZS<C6E"PF7J4)7052?:5'E#UP045HK/XXS',AW!],4E^=4K6Y7\E^F#
M=:.ENG58K7S.WK@,'V9PH=&D=/V@T@UJ!T"UN$!]QT?["U)[H%]![8%Y_-J#
M\Y*#S91A&F-_5.Y9W0;R_6!T-/J\;X?QMRR%ZY+]T:*4)VR^GT@G>.;6IV[[
M*TB8@VW> @G56FMQD#2B_6'[9&?KRUG[0^LD2YPKTNGK.ESS!=[AL_0Z:Z^U
MCEMG>[A]]@WO'/S>;6^U\/;9[P>;6SLY'$!R@U$3K>3>(NQSC;6B >D0#*(:
M?G3&FHCUY?"BH"HHCK72AO! F.%*!D$B*"HN!B>OPC9NOO___K/YY]KZI\\9
MRHZH7XOUCU\VMK8?NE;AQR.[.)- I/$N)). DW/KM*<&,RL)M4;&*)^S5N'&
MGFLW'+//93/ S;+)X^CE2]]+_?\R;QY4<P/FG#M?EHV62FF2^^WDS-%1[NZ5
M&U=<; 587Q;JQ-'R[KH'MRU^Z\)LT6>_/RBA NHWY*:!93._08A=$$$S0A%$
MY;A77S8+L%\Z0JH.F]6(RWLGEUQN&%?CBX'D[@WZ=1_'>IS5^/)HL[,N+TF>
M0PEX%XOO@RQ9NV7ORF%G] VEG(1[H5OA\K0-9'':B=TPA3:#)4RQ:C"=KYOT
M_RQ7ZT9S9)09YNA9 [GG/'N6J\\@:_QV>H6MKV;[I3X+'_*"CC;Z5>>S#T/0
M2:8V"7YC7#\7=>YF,!-N$A@CP.HR<*-&AFJ&"-;:):%)S"'@^4CB:3,V&I)X
M8))PCGD?;4#6L!+1@2%+J4&*.J6<\EPG?\>L@+HI[25>7==7W!C,_V%+Z&Y,
M1[\P>=X2^@:EX!$53) 2,8R[H%Y>3W^E!*XI;#4;'1F&+-MH;UG'W/R8>YAQ
M)D-"6EN+N,VA>BTTHMX;*@WGD5_1&1=5+=D<#R]0>&'KC:Y;,U=5+9U^Q<O*
M"X9ET1[89Z5#QF8[LRR.^^6>3=*OYH#"L_<Z?52GC]9GI*K0FBQ>QMT9YH7K
MVL-1_&7RPZ^A,SKLVM-?.OURLN5-OX*R<911;>NW' T.SQ,L5W"=9'DTA#]A
M\H+Z^Y7JNW\?A:M?<KJ"U2W?WWHS7B&W?2GQK5_?\N6M;R5B16G=#/G1AVS$
M76_^=TEW%>T!%><S4KJ6Y^,2,V<H"Y;+%%^=I%\OR!X"QVKRP;!B"=5!FXRY
M&<T+'LWD>N!UO]##D^G]-4_-'\T_X)H]_\R09R7@N;32UPBK'XBZBW+QCG-9
M>O>UMD#1:F6!3J52L[$O>V,G<)0YI)T[&(PN[&S#91N">V""N^R9;/;S9>_G
M^DD<^LXH%G^!K=W(A=>RK?_L](OMG%?PKWD$PGU6\_]X'V-*#[KAS[UZF^.C
MT9'MAS*X<'0Q:9CB^QR2QUBE*^^G#[V1Y>MN&&/MB\AO@/$492E0,5GI'TR@
M,@2?>Y?G<XW?KPK@LD?\]AJ1GW6(S]!MNP9+?]GN\/WMWDEW\^ CWMF"=QYL
ML-;:[ST89[?5^\+S\_.[6VMA?_OL]_V=K^MGDWO@7>,=^D6VU^!:^G<G9W&U
MONX<M#]\.=W9VLMSR?,\;M/?#UI??^]N;[53JX-/_]Q:/VI]QL>[/'BLHTQ(
M<<(0]]X@G:) 3"9L3=*,^+#T3N%E>4W?[BKYY3*?6+"SN5 <]_H5>V[.^F1B
M<3YFN@#[]8\70=P++F?&H_!7')8<_4&$#7U$>3+Q(-4.I(G94%H-C9293\K@
MJ91AR=L4<4)!D9CKWC32&=\*/N->.*:<%DOO&%XQ5ZM?&R'S.H3,X]EAM]JQ
M/Z._+\A^WIHHD!)SVG(B+.4Z$B>YX50K18((@=)+R4T5*[VFRVQ.;[Z6K;H?
MLU4W-UO]%'M56\L9OVYVZSYWZZ 7PECIE+$F:GC05"#-$T7<4H*<,?E7;X"^
MI+ :+[TC*_3&W-5'<I<\OK?LN4_E1#4(+\29^'->DQ\.^#81^B+<)/]\UA3"
M'SA,<@[/QF@TCF&M1"BO4@%+[CN:3>2:$F6CJ\[#4D]G/"(XI!B\AFTSTB+.
ML$>&<HJ(TR3R0"/-32<Y66;J:@7<OQY03WV0([=0+//^BFG#+Q>.7][#W/])
MGCF_W3_Z@>$_89?3Y.K&_'\XEGIN_D=M+8XQ(IL[9G&7BXJC(D@HI754/GBO
MGLS\;]CJ@L2TGVLT/[!V)CG&0(3Q!S-X2Y<V(?5[A=1GVVDLK$=N<0+J]9?U
MZQA\'P;C7!GPBB/N/%AK+%?$<\&],49J!?\$%81GROCK>W8V$?>7HPRU/\_8
ME]*JZ+EAB#H*RI"@$AFN*4I@> 8C!(TZ8P :H*@7%G&_\^%=*(Z]F-&2YQ.K
M"[ ESQAU?U'BY&9+^WXRI0FLOPQA<FY96X*-2LXA:C-<E\X(T\0Q)$T0V!'L
ME'@ZR_JGCMJ"L)[%E ;/%#M_&2;7@]?1-^'QE\T>S\/C)F >,YJA5LPB+H5%
M1L6$"/=>1X>!:_([AL?_71:;S[9?FKW\UH+W6R @%A4W8(*',>UO.D$&LB6
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M]_8.MBW7M?[G7Q%QW=?W7ODKCX=R!.\;YP66DFYE)1_DY;0]I;R]=S4CVW2
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MN,A*7:!\UL]X'YX>,W@1_"D;L1&'A5G92.L0"JKPVE.6#52YL.ZD4%KRE T
MZJK9PO%TP(K!N96<Z[+J?B93*Y\M#G6/$E\T9-]ET<'.#<T_X2T(RW%']7Z
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MC,'RD"*VF1>E-@VX _]$(O")$AY@5AKA\<R+9$S"SFU2P>!REI=9V:J9*C>
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MR_5C6#>NF7K=/+)VC+A=/;SU^J&OO=S*1K"G3$S9 & ^!2YX;IT!$ZS&<^6
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M_XH(<5Y?N*S^[KY^:;'2NE0=+Z?C\2"3Q9).+AW8%#  XK"(1M)GB4?<R/,
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MHW78W-5;F?L5%^MH9A9I'8/2B55CD)U%O7O\PQR;JK2UJL93,SA 651A$%%
M*P&^B[<(X'^#?*P$.BS[%'3,N<VBHU1H']\N=X;0*&9Q[//$#VB8DB0(N",=
M+XD=3ID,;U+:VBA?_5PM>',DMN;+W9S'!NN<^ .P:0O,I'^?%RJUMM3(<;Y9
MY_NW+Z'FP?,!_O9ZQ]\P1AX&7F+[$4VPQ#"QH]!U 9L%"UCJ!RF6NSI=?T52
MS>U3]+BDD>,SSY41Q:".FT0N\=TD3MS4#[E!A\=$![I[_(T&U/<I<>S4(ZE-
M@R2THR#V["2-@I (@3F6&V]6^,!5BI5J:M*U5NG3H )FHVPX'5:,ZER%@ZML
MG=OZQG^S.^,=XM&NWM2FRH^MD.J3CI@]6]_Z[L\OSM[?WSQ,8R-,VLPC+I;>
MI'8DDMA.',^!TP)$$VSCC;^JQ&V6;CSI%TI%AU,,*EG$Y6(@LZX[JW,(WH(P
MLS_FW^O(8U;[60 1NLOY?;?/+6BCMK Z:'Y]$+QV*LXJ[@!6335 *0OJ#E@K
M&!SYJ-%>0%F_%TD90(Q=.U1FSOQ-\ 6T<CM5H@UJ,&5V/,K2#.R=B?*I,U7H
MI#ZI;*M*R55*L,J65U^<9$/5*RFMS/*%Y;"KM":U#]3J$REA@=@U#.373#&_
M_$/S #AZ8:OF#+#J*ON_6D@Z57T69NM1>U@VM++AF,T-K+GN7FGL*Q-2K5_-
M2379+S<B'L^Y//OE%IFZP<:CI<P\-E>Z,OG7?ZCDW[EO:AN]RV5;\GQ[62U]
M_QD>;7W_>7CR]\^]@Z/![M;GDZ.O7VB/;)_M_CPD\'__\.>.W_NY?;XL?7M?
MC[[O'?2RWM:NWQM^.>M] "E]<.P='FS^[)T<P?\')[LGW[W=@[^PW96_=_#E
M!ZS9Z6WQ'WN;WZ@G0:N3S(Y!J[>IPR*;@;9MDP14< Z6F,<N-&?BT@]]+_3<
M5+H4_I]$B<.\-(P=D@H27LCYW?_R=G_[[R_;O0-K^Q_,_+WK/-_K%[2X ; R
M08(P&;#0HTGH,!KX/I@Z#@=S@W'9QAPP33A[LX@G7952M%BL;^UK=^LF.OJ5
MK&U6UBU?G+6I0A\!2*GW60&?V:R"!!]S ,7FO")^H3G1"Y"N90YRKE#.KRJP
MH)>VXFL77E=_&L3HIVE13IF.0^#CRZO4+[UJ;8JGA*]5]"8?G"K7INX'-E=%
M5!0Y&\'?E<*HO!=*8<2(CW;:@DX#BD!68OG0;>R/T!$^9=P!RXA1YH61XP)]
M$9^PV.<1J7-S(L>[JE'7-:TU9#+9F84SW@/&;BKMI#5FQ:,R-OA6[^P;3>+0
M]45J)\0/;! <D1U3P6WN^#X/.3 )ZFZ\<2]OI'&;0Q<I)['G$%>"A0S_83QT
M"7,B(:,X\!UW=NC4'/I]';K3._[&G#"5D90V" )N4R^)["B($MOSP,2)_12$
M&;^T>\IB%BMF9ZH.(#,O:J,7&^#"5&=VS3A**C'RK<(MVE( A0/4]XJ-C9$M
M@N4ZU.GN8#K<SCLF8] H"06CC4@JF(ABP5.:I&$J$@=X3*4$ 8+9EV+:(CI]
M!.&RE[Y3G!&0225YSHNDWDM9N;U 3VV/Y^N14<SM_?W-\_T@<KFTF9MX-J5I
M:C/&L(C5C:,H\",>^\HINLH/]@+#=BK=HO)0) R3>51)R[ED!?[D!8XEP!30
MIB9:GCK"I_$"[U!7P7 ; PJ^5-EH.KPD6(8M*C5J-O*'5 W*Y<*PJH>_!*4Q
M8^-<F<2 SP6H%RI) XMN8+WE!:_)+U1%GH ZDZ6M,P%UR.]M7:=2-LKP+P S
MK0A(F_9)U7A1/\"6M!4\UL^H72 :?)Z]"?N-=BR=([JHXBUH;?5;%A^<MT:H
M#JMCG>29#D^JWDFGLM .URH'9=;B"0- C*MD?U3Z2K"4,I&Q @-"55P3W3*3
M7'/'U9_7VP8QAFZ.*DJ..2V9PM=7UHOL986@R/M&E;<.OP]\L=2=;O1/LW8V
MUHL?+RTP(C*5]C8!6ZW&Y'KIXWQ6JH5_/LU5%'J<GTE5#JZ[,:"#Y20OJGSZ
MQN,S+5%G1&$6)'R53_*BM%[4&4_8T4 6QY@2,<_AK>*H>7',1MG/ZG>@FD0U
MZ\9?=-,>6 7V+TQE <<"O[TX?XEY3JJK#T!Y@FXB';(=#"Y;G/93=IHQ8I6V
ML)11##SDM3K*%QE >K$0GJ)27=?(7ZY17X'2K)QUO-)'K!91?T6WIR.>QH\K
MU?R9%:9>6$<:4Q711KNE1/<7 *1VE-4A1J:=9XH)J6:"*G*0J428ZKE"Y<0M
MB%SX*OK6$+0OV,MFET/KX\[;O<_6>#"]HB'O2C',N1.SD+LQD6 9IVF2!H)X
M+(U\*M(H(;<7PXM:W5L\RGVP0IC8&_U3>3X_PS9<(X,K&7R^>_S- 6L?U&MA
MXZ 2F[K<MV,>!;87)B"SW,1/DV3C3=0-W(LR6&?%O$A>WO+H?9:X3N2&S ]<
M&KN@@Q$9^8F?R(1[L9=>H>)?=>([%0;C(:O,3F'TKHMGOO?W-TF\*(D=Q_:C
M@-C4IX'-,&3DBS"48.P%D1.!/0<ZP0K%Z_E$=JYW;<T2:OU5'J1"CEFF]<Y;
M]1-UL4.P[W$'3.O4 888A;Z(B0 .F21)G<P!%KE=__ ;+8)K ;&7HO91?M*R
MP1C"VJU[OKOYC0LGXC02=NAB&U$G)'82XNAQCPL)3#((:("Q^M7>CW&1C3""
M53>C4O-'0&$1NK*C5H,O\;L=8!VG4@LW,4GX6.M22EZCJC,=*0R;B6YDQSII
M3N?LBGD'+'VN7>M]C@VM\.,JI[JH$: 9,QSE"ZO4-:ZXP#P95 F4317^2D7E
M#KJ_W$F+EWB]6[SL'&SO6J2K Z[ZW[N;O<T/V]C^HT*7?6MK9__=E_W]G;V>
M:@@"-WP\W-_9M_;>6^]W>IN]=SN;'[%-R-;.07W/Y^W]+Q\/U"U[G[8_;U9C
M-&YM:O[>\41DX]%%Q&WS( \PZ7=WUJ7M/ZH^K$J)UG4B(S8XKWP2[V=!Z'=U
M%F]MO=9)I'OS)-*RKY)5$[0EF,JN7]EM^)*RR'G 6UG&C3R"BBF,\JIG!1JC
M=>L.B5WW2GFF6W2,=$[SW$\!C"+'!'95'81Y V55H*)EC99IR!$V%+OZ/*M5
M>*]KB.R/>:ZR]/=G:^IN/#R>^>O-!O9.,654GJU_ZFV5_ZU2N=%0'5:3,X3$
ME%B5DX\Z5)ISY4J;M<K&M.U19?#JOBAX:R'[V.-UGF0#!)7*0DFOVFM<-ZK.
ML183?^46%GKI'C&J@$*%ZX;X;ED50IU*19J\GPU$(2O2:[Q@EI)?JMI!(3'=
MIE/GY%0%Z\,AF"$ ,0 /?&J4GZHTD>9K,JP8JJFT65PSJ9IFJA(6+ )5;P$*
MEE+H.J'9MLII<2R5UT?[.K,"BUVRVOC/F_47R@&A$G0&#)X"F([D<=5 LO)J
M-5<W$D"#V"#P:W-^#V8OUQ,/ZL8R^#;00SB0^'&N'%\U)]&@5J_ FHJA3NFI
MJR*;#M;9S566TL5OSFH[L=W0'UZ76$DV&*@7C/%5J%R?6\>#/-&.NJSNF*_[
M_?SA=NGLB56%OFN1MG\M>:DN[U=AEBJWK#J:ZXKBJ6[<M))69OB%!(7^H-5T
MH(1512[JM&O?%'YMMAJX264-JA-6+9G*B7;=ZQQX=*'J>RW<=KU\U:2VDCOS
MK8PD]KM'!YINE8\2J2KZ*HX54U'%(V):2%4B>.&\.TN@F)R/\3&,7/_ \1Q5
M]U=%->D4H*K6/E_C1>@"8I7P 73@*I=P/R^U^Q6KJZK<MEE&I=I/_2;0UC/5
MU>I<\<>ZNDY!'TEPDW-5\7Y<I?P.T;NM^]*"!![;:9&KND&<0S#4)815(2B6
MQ54S#(%)X6LO6WU528J4!R\]EB.I(FVS@8<8XF>-"MWY]JK12D,L?V1JV3/O
MK#5 IJC!-EO/\I?91+FRCX$_CG0O+I.4=Y])>6Z+6E*UEY/.Y4\EF#Q_SENJ
MZE;-RFXF$ZN^4M>H)56LIV#3(:M*AY"S93CM0 4GYAT,JG@%_@WE7ZFU*=C+
MG\H;H/AP4:E.S$J*G*$*,3G+BRH4U*Q"5QVD1U-5#5EI:*ABY:.ZA "999W+
M7,<5SM2-JC)8<4Q<T1C.#U!'?;W6/)04F.M LY1H^&&(=D.E?HDY?!D'\#.N
MQ7A1M<=3 D..^+E>CRH%K$NP^KHGC!97>&]:U9%CJ!5$DU2AF3Z<L:5<'*S0
MJA1G#?F@\XP5AZUD ,;!?HR5AV6^_[F:.3]37.#LK!<-)E7E7>!PED8M> ,Q
M*I2Y BF>@&J"L:UF)!'!68L6S!11>FDM=,1*!0VQ3FH)I;2<)D;.BAE8$\6]
M$-58B?T,5.6=&@O,JJZU5<]B/,;&R-^ 5K?-U$V%LZ55=6/1&D)MH*AF"75_
ME[JWR>I/5N7G0-G*ZD[.57VJ;CP ^H%<W([*N"\T#8*-PW3C KU%]4Y;MYQ3
MR095/;:B/JT(*6)(<DQ(J&P4K7U<#C<,(,^[[JO2]?YY";^RD9V?X8IG2\V+
MLI^-2Q63_;2W]404YXK)SR8E+4 ITV,#ZK(K! _UJIG3BM['!1@W1=:HJEG
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MH!>T-B[./UW=&!,/^!$,+_//]+;]P8%APFK\^;E:=L:5RI[*XWE/Y6;LQ3F
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M;]!5A\HPV[#7[MCA.(TMT $DQSH#99:L)&S9+?6]+YPCJHHI25>88 BT"9_
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M]ARZ##(0)6%E@^ECJ8Y(>Y/0"Z5Y0?"Q&$PK>"M")Q5"A)21D$E]Y7!V]&I
M>Z?Q6Z%$6[YON '4,H6-NJ?(]Z<H[>>(+KD0)2&^7C:8@6?N@'3@!0Z_;Z$
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M@=[[YR_GG\YOUU4&=0L(#EUQPP"KDZ$OW'FD]HF1+"DA/8&R"""=U%/14>H
M$83P"V<B.Z'C4@9!Z%"9:NM),GZ^>'OQDJ_KP;)"T6JV<.-5;.'&R6O8PJWF
MJU<H6HU8.%/M4&ZU]*W$E-JF=HMR9'&GJ*7X!_7#1SQ@[(GI!]>GU:6'/F(5
M"*S<+\<2!Y-L6AA3H*G%(?QKJP_(ZU6^=A3;\Q>/JYVZN?CRTF=KU25/UJHM
MEC@O>';I5QO5=FO)BS=PQ!VXVCA>\>$CVD+>1B ()*Z_[#7V9CUVL/T?ZI/'
MM ZT)#/\TXI"0*-K=/_-TA>_<*:8MU;=FT_CFG/"[HW]=9VGL $S2H\5WRHJ
M8H-G<9E@'M2,_)(45D [;T 8Y6A>-)JU<+DDY.\9LLX!RZGU"5+/\\6*<]G[
MZ^>LK$U*]2L(3<4U6#O@53=::G#<)E@A@UHS&3BK[R>!M8VY'-DNC>Q5*'!3
M,,?8M6U NIN .8;#U;7UR5-F$6IK&J.-M?C)^?6!G:5X&PY6;,=(<S:H=!Y\
MW#-&H3,$&H_CR8>CHX>'ARK<5KT+[H^ZH37"(MQ'CGTGPB-;Q.+(;-9;S5;M
M"(9NFF#ZM4[JM5K3/*G5CN)QO0:7CYNV^2_GL7YH5D?Q>.^O]:KY7_]S)&8-
MM6U1YN5H?C#0>0USII0?NR,_^I2=J#*6C.Y=Z,C>#]Q'<R9U><#)NUQTL; :
M;267.KPO#[SPW^11EX-*FJDIRZI[:?+Q*/#P;'26@IR5H(DPIY//RYC''[/*
MK'PFPA=C/J9+SM?]<]TCJ[MB,<XB+5P#A*<Z;(?E'OSXIRB-T,FZ0\%,]O:!
ML8\5B,XPI(=U:&&A#QN=>K-^L$ *E_BAY/^WX?]FLPZ\?UQKU=NMYE%\WSP^
MKIDM8/Z&8OY&U2RQPTZ.IL0.I>Q8K^SHRE+%J)UO'&H=;1NG2!R4TD"Y]ID2
MEF7;BNO7KZ:L&RLI:U6QV6QSN?)27Y?Z>OMYKJ[T=;W4USLYFE)?E[)CO;*C
M4%]_FF+5]._7S/52,Y>:>6-&^MK<U3HV:\T3X*Y:I]:N'<7P$UQL W<U%1IN
MEI;TCHZFU,RE[%BO[.AC5S;0SO*\OZ79T+)W45H./2V>D*L0L)J6;A;8SP0*
MQJJG6@-O)\7=/S3G%7>]6&\W&H QS'KMN%TJ[HTDZ??+?!(6M\U:IW5B'MTW
M 2*W:L1[=:6W2XMZ-T=3ZNU2=*Q5=-Q(14J^[1L<9*2'SV6D?.#$#]A-A]KF
MI*J7+O7_2(0=8@LH#K4+TNS86*_!O>&:*VOV!?9W3HUSB28VOMNE$B^5^'9Q
M8H%ORZQE:KQ1JO&='$VIQDOAL6;A<4:]KC)3&#3KJ^OV6>?WBIK=K)6N]5*Y
M;]!(?RA_IK[U9JG<=W(TI7(OA<>:A4<?/>0JJ?R-5'B9MU:J\,T9Z6MS(?]H
M=NBX<N=H&&!C*UE,&O@HE+DF7L ,B?Q0JO.='$VISDM!\N,$R1E=-PKSVBX"
MV.YY;<_'UO*Z7K8!2P:1:[LB;7E:[)R?;:_TRB#@;\)/L#]&AU[>*3% B0&V
M@W4E$C^IU4\Z9@V0>*O>J+7;.3>;62.J+5=HX0J5N0@[.IH2&)72=<VRHR"(
M@3CG.2!)!SJ4+-!4+217.?4_AZ+R!_)U3&6<B@D62L;>2Z\;"*%AMWC8)7HJ
MT=,;\/<WUXZ +?] YFP\1MC)UQ;CU/>QS7D*:^& XLI[S^*!XLI[1;N\GLI[
M_YVKM_=N=[($))LZTA<+K#[]]GJPHIO<)0!3FL\I)_1"8*'+V1]7G':EG9KK
M\%?"C[?GD1WDYN;C$*T"8)<4?FQS)D4)/TKX4<*/]R2P-*?&+,JX<>X#[QX/
M1EX&L9-6*YS!%]0W>2*FV"2B8OP>N'[LR?;C#I"*\+PI@9#BZ@=XGR.LD>I6
MG4,A$X$]I0F%Q$'I4=A$NML1#I&_-TSST'("=3Q85@0RMSJ;HE3II4HO5?I[
M$EA9A4!9$O!TY#I#H_?H6 G5\;T:PE4G-"9)&"6"70Z]1VLD_#O'Z%JQ<9-X
MH'[-AC@TF_OB@+2TV;+YMPHZ&H0=3! -Z*_H.Q9]L5&C. (Z,?HB' C?B0ZO
M'CUG2N^&*_5:;5$8ME3G)7>\(G?4#ZWAO#K?YAR 4IV7ZKQ4Y^])8"U0YV>N
M+WP+QENJ\U*=OP_NJ!=9Y_72.M]%=5[J\U*?;_1(7RRQ7F2>FQWC:[5?/:VF
M:MELM&I/ZNZ36KO4W:7NW@1.*#+%ZZ4I7NKNG=W*4G=OZDA?++%>9(N_$]V]
MMO[>/TYRF36S>G[9+\77CNQGJ8A>9\!OO8_G/HIMXY^?;BZ,<S^*!1Y=^AQ8
M"25,[]^"B'35GVWU9SO 1.8@-L1DXH@0[B!9>HY4#7(?+:W/(A9\>FG@6"*)
M',I!HL_$X@[$<^@8>!C=QMRH!S<>I>_(QJ.^5SW($5LI@5\L@?NGOY1\NR/[
M64K@W9/ M^(Q\(/QU.@]QHX?(5;M6R-G+%*17$K"UY&$I]V+DG]V9#]+2?@N
M).&I\*S$8__ A>M_&XC(*>7B*\O%S[VSDIMV9#]+N?@NY.)G9^CZ;BD6URD6
M+[J?2F;:D?TLQ>*[$(L78N!XI41<ET2\ONF5?+0C^UE*Q'<A$:]#)P)B+2WH
M-0K&YM:Q4CF:4LP\C\I/ QB]<2WN%H5\]X=!.!:QK)RE2R4\'^/ZEI=@V-?U
MM0J99D&0]RC&TA<J_:8X ?7W)(K=X52MRU__9Q >S>3M+'\PE[$4)>.Q"*>S
MJ[S>LEMF[:FDJV83ZV[]UX^O"&;65QN:@?^\P?!67#E,8XBLD6/3<2U9!JZ/
M_>B-ZR2T1J@'TZ)OQDC<8]J"XQO!V(UGD\C.8V=LM&OF_N!@OWZ V6(WSIWR
M2_</?ZT:^+738 RK,#4$OI4^.4Q"WXU&A@!!,YGB<WA=C2K]U# ,QC2\@H&I
M@?=.C60"7PN=/Q(GBJMSY+X2+TR"B+Q&'T('1W_O?'QP[7C$*7YR_5K-N>3O
M]#$QB (OB9V/4AK6].>?2AC?!JZKTSR:S9DL0.V_HS#3%'?.X2!TQ+=#,80)
M?A#>@YA&>T>Y=1B[_J&^LG,+MGCC9O9VL];HOTGNVP;6$\)DGF=2Y$9.">;$
M'*O/RRA9;9VLUEK,:CA%U_[+GMOH6$V[WND,Z^U:L]UIB8[5,>UFNUDWV\>#
M@?TOLUG?>TL&S>V$Z]NP"Q_JJ$>W8FN.9[?FF#1H__SGR^[MUYM>?SFV4O-M
MYN<[@](VA>QX;M>:=N?V.G\D;D@J-TKSQ!TK"8$909?G#H##9?.DT>24<R[U
M5IGMQP=:W  =/S4H$1*+O[H17)\$(7UR -@$UHAKP&.6Y, 9"6^(E=WP191;
M+V^@@FV)#P_1^T02CX(0IFK/"]S%\@"([ [(7(J2-DL=0MKIM@0A?!.WQ!.3
MR/F@?OAHN]'$$],/+D'Z0WIHUI0!6TFRS<E)M=,RB7.D*T&^7W)5E;E*V5^Y
MB\U6M7VRY/K2AY=>K%>;QVMY,0RYTUSUX2<<+)) &VC4;99)7(YLV<B>V-9-
M6+#VAGLWUH ';]TQR.U+Y\&X"<;"?[&Z8!CPG_]AMFL?-PO$SFEM'NK5S>TO
M5]>]S^?=VYOST[YQ>G5S/:,JEC"4DO9^P$?0-NKL\BMXS HW?#TN,UG:M<VE
M75?P$6_F.FX\;WZ:?EB9O#=SB=^<5(^B(^.+"+\9I^C)"@-;C+SGQ(8V0<=M
MZFA^-,E)((^?@\$94>"YMJ$HXLU8_OML-F;TA12Z$>IXP: 7E"-9=,IX+ORQ
M@A-MX<5U&'@PK6I-^D9>8N$=MX_78^&US<::++QV?4<MO/;&CJP$I"4@W=AU
MU %GN7@O@)J?Q3U@DG[5^"1<SYF62'/'D.:VT.(L'2*,PH0YUR[,C7M5;/:\
MQ)4?[<;?6)37;#?7A/*.VR<ERBM1WM8KV!U!>:7;<?=)%;'@68@=6*O&+V[L
ME$!PQX#@UKL<"ZES\]V-\Q44,0F;KUU-'"SAB.V+7],56::]/2_MK;TX[>UH
M$-A3^-\H'GM__7]02P,$%     @ <&T&490,3FCP$   RK4  !$   !K:61S
M+3(P,C P-C,P+GAS9.U=;9/B.)+^/K]"QT7<[44L#087]7)3O4&!JYI8W@ZH
MZ9E/$\(6H&UC,9+=5>RO/TFV"X.QL TTS$!'1W>543XIY9-*I5ZP?O['^]P&
MWQ%EF#B/!>U3N0"08Q(+.]/'PNOHN7A7^,?GGW[Z^3^*Q5^?!FW0)*8W1XX+
M&A1!%UG@#;LS\-5"[!N84#('7PG]AK_#8O&S%&J0Q9+BZ<P%E7*EO/DI?:B9
MT*J-R]6BKMV;17URHQ?O$)H4J]5)6:M5:S7]'OY]^G WOKL;UVYK10N.>3'M
M%A;'^OVD"*TJO(6U\7WM]E:"OK,'9L[0' +>,(<]O+/'PLQU%P^ETMO;VZ>W
MZB="IZ5*N:R5?NVTA[)H(2AK8^?;6NGW,;7#\M62^'@,&0J+?\/6.CBA[HPL
MD(6A2[')/IED7A*M+M>JY5!(0&*%$NPP%SKFAQ+'FV\O;;FTY"X7J,1+(*[N
M0X X*62(4]R0$X4L]T,N6JN;DO]A 4"7MVSLN>B9T'D33:!G<Q'/^<.#-IY@
M9''OL9'PC[4"D8]=2*?([<(Y8@MHHO3V^_P3 ()=/%_P<L")(4P@&\L:,^I*
ML6)9*U:U O#]H4U,Z$HGC[8P)E1"MLO$;\45Q*=W9A5*Z2O@L>(4PD7V2D0%
M_8H$3[)7)N+LVOW]?>E=>&]B->)^*,L7Q8]%K9)-;9)#I]?-?RN&<H>HPZKG
M9JM#*+=G';9WNS15B4IV?4%1EWM1%ZVV7UWRU2-O);;'DY1TA )"[4T6A0R9
MGZ;D>\DDGN/2Y<X>R52"X2_9.^,:I(4PA]/N,]4C%!(_%%?2Z_JAXQ!7HH@G
MP;/% CL3XC_@CX1+/X1^/4"3,/K'QKXMP4/^]P"I28F](]*4%I1'<NIBQ*+C
MI@28431Y+(C1LQA&]]]-:'_B-0F+Q!2L=T[Q<8F+F)XMF]M>M2=$$-[Z6&"<
M$AOY%CKGYEMHDK7Y7 0[^"_1>AN.L[:>BR#[3]_P!459&\Y%&$^O\KB]D!_Q
MSP&V'@L-PI/^ A#/7@>MG6F8U.W+A* A[,H1/Y=Y6LW_@N)JFE $4NKGTF;9
M#12/(:OG?)8_;[8Q$ Z** 0W0D)JN?6^M%4L>!C:4&797K=I=(=&D_\P[+5;
MS?K(:#[5V_5NPQA^,8S1,*O9=P,J.-$D)Q5.Q)!;%(6DA)@@"@H"5.##7DF+
MV+@/*6_>#+F85_C@#*ZCJ^D4P2 /G>!O:UK^Y]+I'8[XOQVC.QKVGGM]8U ?
MM?BGAZ V 5E-:[5<UM/1NH('O6>P4G E=&7V1J_3'QA?>)G6+T:[-SPXKW$%
M:GIU/G7)0^^:'B 476D.[--['HYZC7]^Z;6;QF!H_-]K:_3;06G>JD!-\PW/
M[#+2+%B.ZOFO_[RK:+?_"WQ]5[8C?:X^_/+<[GT]?&?^ %:S6RN7;W-U8HX/
MI((+HO/I==CJ&IDC[X>8@HJ*5M8T?Z*!F6D3YE'$?PE%+]#(3>1";+.<M@ZE
M52;7R_QOHLG!WP*,2THKAZV7;NNYU:AW1_5&H_?:';6Z+WT> QHM(ZO;J['4
M?:&JR0G>&C$1/+ "!"'BE27?#GUB8Q.CK!TG'::*M4I9K\2[TP[6^!0NP+YV
ML\ D(SBV#TM?@*@BKUJ^J>8@ST>^4A<8I LIY?7[CO(-7MFPU4-;3<\<07F)
M#R77T6_3_G7&D,M>&9IX=IM;B!V!XT0=:JYO=;E^EI%K7QGPM0&I[LIZC)$Y
M9Q+_6U:QQ9OH3#&/>+[I'.0>PP?2:51[Q)TNE]ZR>D1$-5CI#CSE[X"KOWK(
M)E]#EYC?GB"';I#Y CE,5O8(CJ%6I/:'>UVNU67T!ZFQ*%6"J,Z+=()P7MCH
M=9Y:7;D^G7-N&D503H.TLA8/[!_STPC,9=.0*V%.QE&FR9I6C>=5VRBYQ-QX
MBTWK"_R,W_=;RTF$4\8\323!J9CB Y^$O88UWR!#;SZ'=$DF[@SU_<;] FT/
MD4D?+L4B<<[4=R]5:JZKNES&3L-UH!*0">!*0: 52+7B8:CXZ@U!5$3<H@<C
M? U-S:G.T]B4G$K4*V&^/7[!-GJ'CM7CM*##A=[ML&H*;WCFF9)""0\X/O 5
M7"2;+[U>\VNKW:YWFRT^!>B^M)[:1GTXS'[$2H6DSCEK6GSJ&*(!#@=6>, '
MO!(DK) K"]V-I\Y&;ZOQ"8*:K$O,2Q56SA<>4P"J ^.=KI6S\G:-AU$[-V;0
MF2*&G1="K#=LVP=G,E&#FMI[78OMH^R@M@@"70 [(-1V)7R=CG!QD@>OS671
M@U.?0I?2"2IE/OW,[ 01K?'5UXMTAV:+9Z!B6?+5:.8^T)H HLR"Q-I;;,$T
M"G29AU2WFS)7YJ.$4B8]E4HUGJ$F<'.)V<YVR^:+D6HL=0RLZEHL-TVDZ1*#
MF_'$QX!F8V T6Z/Z8,#' _]\95:.$G'4(8ZGH+'U48$EQR<?#43AKM3DG.3M
M0E-'NYOJEI%(0=-%AKPD"XO785B>C<BD39RIB\0K',8Y=^US*E$'R9JNQ<<R
M%;M%$*H3B]5"85%H!$+E-8RFIN5W[8>PS]5<^3\1_WL>QDN/JV;X5M>RQ>^+
M/X4WXEFA\=)J[)$3;<=0YT-W6GP/\0/G4C.AK8;,>;A)!:7N0_>Z%DM5MU-S
MD3VFU6WT.L:H_FOF[VA$)96]HUK6XKNQOC20XI=I[GP]80N TO^KFJ[%0E/4
M^!?I]7M_53;;5V%Y'ZAH\>WL*,A_7]XW7.,VS/?UE208Y=R8_XDO86PCY!+G
MQ'&3RN.\O87 S_OEA528ZEBFZUIL(-G*67#^& 3HUQ@GS3) 3)#B(DM:YU \
M)L"JJ;S1M53QD#]>X0>L7MD4EODJ9GJY#U3NQE/S5],KL5,("?R%P!?)6]<8
MB=>4]+E)OM0'1D:6-J75.<:M%C\9PA'D>U( QP 2Y'*-GRN]V(ZASBWNJO'E
M@#@1EYA9;%AS@$SBF-C&LEID\@09-J%C-;'M\7C?16Z;,-9'=#B#-.=BW$%4
MJH/AO5Z)G=O9PK<8RJ+*Q2JL5"_/K@85 +P&0%0!\#H 68EKX!P8=<?%EK 0
M_HZ&R/0H%B^6/(A'J*&5S.MEO1([K+.5^:@2L-)RD=2&Q[B'QHM8>,MYOCR4
M5HZ)NJ;%C]1]'",/("[7]'M]_6T=0SDBZI6JX@L9 = ECH<;MMQSWVD7FCJ6
M"99V<G3I.TP;)E[MX [0=^1X:+Q\061*X6(F7BL:OLC\('1FU*4F6]<KL<WC
M+61'-XP#K6"\!%&](%1\]8>M'#6@BZ:$+H_E YOX:MYO]$IL2SD][Z&NBZ1Z
M8+3%VPS[]<'HM]&@WAW6&WG.%"?"J!.9FA8_%AY  8D%HF!76G+NK^U"4_>N
M6[T2VU1()NDB>Y'1Z;=[OQG&D]$UGENC?KN>]5T8VQ#4?>=.BQ\G#E%   ,$
MSF7SL&?VF091W7WN]4ILW6PK3Q>?AC9ZG4YK)#,"<=!,GHM_,;HY7K6I0E+V
MJINR%C]_&$'S#ZE%\:[\""ODZUPI )5]ZT;3*[$9N)*MB^Q7P]<GL1W&+6+\
MDN?LX*:XN@=5M/CYSA4$\#$NV/HYMS834-3]HZI7XAO2FUS\U?O$SZ7U6]+\
MW]=N4A/WJ 776DK.Q"5.OS]Y##N(L0:9C[$CRS:(XV)GRHOQGQBV$)6/N]Y\
MC&AOTN#:Q>I!GQ*3SS2I6(6$8^92:+J/A0FTQ651XO(X/L4^"+B#;5LL+SX6
M7.J)BZC$W:,/"T0QL4;RHBC_DD5Q$9_'*X)=3T"^4.(M'@M^:>RB>0'XUTH%
M3QP^(4:TQ3\0(*OKYV(F&G 7@-2<U1VKR2?4-EF(S^MB:WPJBXHVB=:/2!_1
M":'S9T)[[@Q1UN&MF7OSNN-XT!Z0);3=9?"JH42C'4O=;C-R>TLRPL_&T!97
M5SX63,H[:S;SSHG#^QM=IK!O>B^IFW]XF,G>T1*4V[9 XBT4[3J %^[ S^"(
M/]2 >WA,X"3U*46R)/_</))S)JK*XIBI#.AX<R$NT'^P]2BQ/--M0\\Q9QUL
M(^9R%H_8X3-6X*\0 AP'BWN^.6[XSK9#=/QMJ.?:W1LV9*PW"0YG]>A W$O>
M\UQ1%W'A^8#8-O>0-TBMJ&G\1OB6R01Q\/[I/Q%' YWI09TC6._>U>'R YZK
M2_AO3^L@D40E<;Y>YO!!5U[8_F"1.<1.BBK+\S&Q%QM'HM[3<E4D(* N'-+@
M8[2[%.,SE7=S,AD*1S/H!&>&C7<>^S$3K?/3RD1'^*%U.$X:RT3]6!H764B?
M=J;BA%*#=_SEQ._@K(WGV)\E,.*\,F1PW7/H(JL^%S=%#[WQOY 8?%;E_ 13
M_MYRN&?+^V$3;'QTO?G[I(7&Q^N20\A'7SZD=R#]AD3[C7?A84C>?++T_QVA
M=_?))N:W9 _-AG*L7NV&*O*%:W%X;NK@?R.K9?&R>(+AQZN59,[-@R-O9)L_
MQK8\7<4_XQW+6CF/X-H?I2;<5:1HEOA^K!J<J?,9<T2GO-(<\<V=B> &G>4
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M1$J3-W@@,HNY%DC(3)>E!&DF!2*<1(@XC8ZT2G&!E][@E729?#3,8$>1XE9
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MTN[(^(ZPF@U",#_5VZ!>%(:G$@U$@P64LQE\IN4O!:X9AL*M;72Y<A5&ARO
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MHL&85 )RX7C)+<@P'\X^L* #03=(*#A(Z?3X=%#K$RV*/;W8L7ATTDL)&(4
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M4$<-0O?G#&0V ]Z3WXX]&['"\E $TZ""C1"]2\"Y8%YQ9L+-&XEF>^!/5'O
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MG8^R?4XRZTK#<[SCC7V$B^RW7D$>@K<%G(@(2I%DG. 12B$<KM3@W"85PBX
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M3$5@7EA016IPG!M@UF!AY,<9T>1 < 6,3\+,:*6S!OEO=T#]"?1=.+Z85LO
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M%\BR#,P4LOM(G9%&' 0X%B1X[GC2)AC%FA2O7@QIOUG2D2H6+B9;JCK_C_X
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M+T ]4GP[K)J6X1I<AS$-.]#<-BZT$'L?N\("'DW2Z! 2 ::S"XL9J+/Y0Z#
MD[5&Y&^C2LNP7MFPQ3SLCPR[2+N&A["B3XE%KDMRO50JVR4TGU,N6DE,<,YD
MPX0*5B5I]264_FV!3K34H!7,#B*N8/H]/_3FU$[&2":,**.7@$@9D%B5C1^;
M':!,[.2@CM)?0GDKED!+(5?/53^#;P_L;H*KZA"J-< .-'NJI>(V\J"EU*L7
M5C[!IQU2J=&2[+/DG2I&0[QU>0M4ACIIG*2FBAW0+QNVS93JB0R["+M#$I2^
M#8-RWI5@Q;N'.PQN,?N[+/NHI2N2#)"7BB+K25(MG,,HZ7/%OVS_L.K!A\X;
MWE?<XXYDU>%)/L?R:0RCDR\3G">7+O"H5 87E>M-SDK4@I4[3I0$C$?@/"@3
M62/=K7CX6]!?6YEU_>T]WB868 _6H6:)J1@SB6RV.FQ,Q'JG2%0&;0HQ@0^-
M=+CBX6]!AVUEUF$VSG0R&[POI:DXN2DEB65Y\T."RRB\HIIP-8\>\NPP.,-(
M--EC@.2E$DTJR?/SGQR<^7?+A^8Z *_=BNY$L!U6]A4\%WAS.PE?88J/.\@R
MQ 6UFX#<P:!NQ(+&Z/JUJKM1Y+@O+72XO^\&-I61\R"1),#2X<!I M%Z MXH
M9P-'NKSIOUJJK#&Y#\B4783?M05P^>];B)/QPT%F ECG8PDJ:E>JSQ)QBN>#
M3#MP5AL>K&IT^#]_;G_G?D7)C[L16X6(VM.V!%<3&$TAS >]OKM[^C=S-GN,
M6EO(+@*/V7VT#(F/%DD(3DOG67"R2ME&<XBOW7:HK)0*)=_/NEHLA@XW0%0S
M)O<2TF&B<;64N($K+310)<OW!;(4;!#.9[6%?"I*R.Z3SQM=_BTWQ@N>N*[4
MQ[4?3FR)R1V.$KL(OF-+\B2EX?6P #H=S7[D&PN?W>24/$$'E$C/=)E-[H@J
MQRIU2G).NS(;5T/H/Z+05C'C3J7::\O>RZN+DZO3WS^^;SN)??6#NFO%VP#H
M4MM=Y#9%Q;VU,LDRS@T=]T88$(8EKN)@*^3N)-JB[_'&YU66;Y/NQM%3T"D
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M%TEI!T%C"HPURC1^#539D)9S(*;L(ORNLP5^^^/CW\K^.;_LANN'R_2'+F+
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M@*0DRI(H@ )IUDST9-DR29SS0'QP !P\YW_^KQ^/2_!=%&66K_[Y)_^OWD]
MK%C.L]7]/__T^]U'B'_Z7__RW_[;__R_(/P_[[Y^ A]R]OPH5A5X7PA2"0[^
MR*H'\'<NRG\ 6>2/X.]Y\8_L.X'P7^J;WN=/+T5V_U"!P N\UW\M_BEFA,?4
M"R'R4P:1C!#$0D@8AM+SXS".44HN[O\)4XQIG,20$ZHN\Q,"*4HE)#PD"8EI
M&B=)_=!EMOK'/^E_*"D%4,ZMROK7?_[IH:J>_NF77_[XXX^__J#%\J]Y<?]+
MX'GA+^NK?VHO_[%W_1]A?;6?INDO]5\WEY;9H0O58_U?_L]OGV[9@W@D,%N5
M%5DQW4"9_5-9?_@I9Z2J,3]I%SAZA?X-KB^#^B/H!S#T__JCY#_]RW\#H(&C
MR)?BJY! __?WK]='FTQ_T5?\LA+WNF>_B"++^6U%BNH3H6*IK*^?5KT\B7_^
MJ<P>GY9B_=E#(>3AQRZ+8N>IVLI46^G'VLK_?JRQ7\XPWY&]U;ZM#HRKW?WL
MRL8^3#\[,_=.\8,8W^!.,V>;W'RAKE9\JN_NIJFS31_?8E=?B[PBRPF^%MMF
M.B8O]0>?U$]M,_I!/61:M]-2=\=4\:,2*RX:MMQY-,CX/_^D?EH\E_">D*?%
M[0,IQ#M%M/Q]_O@D5F7-WY=%05;W0@^)[UZVEWPA+_JCRS](P:_^XSFK7J[5
M(%#40V=Y4SV(XNZ!K&Z>]"/*7]4CJO)ZU7R1%CA-4,PYAQY./(A"F<*4I!2F
M(O%C24(LL5A4FW=E(5;P]]NU6[7M;V/X3Q8]41UAE$*4^7/!MF/QX_+0 *O&
M5CT:XU]6Y%&43Z2]07FOPY8&D'^IK5,1RL_9"I3:P?(O__.7+4@SZO'EG[8?
ME^-V8>T/U-$-!UVG0<=K0%] ][K6<U"[?@$:YT''>U"[#RKE/V@!N  -!$!]
M51H0CGY3<K;C[5+'<7GQNMMR]F;=ML.W=9=)4M(:\]:D7W0H_HM85N7Z$Z@_
M@9[?QH[_?7+;?]E[&R^+-="D8">^BNT5O[!<1=E/%=SY5NI9R=OV2)6_[8O<
M?%,52#^!O."B4/.\ X#OT5_]\,_Y*G\2A;)P=7^M)H:/XNJ'-EDLL$22"9]#
M-5;Y:N8F(XCC)(1>DJJ/8S4AX\%B+[([R7+]K1IQDUGPZI*G&D81C8UV@\P)
ME,V&!@>@34/H#5!=2T%C*OBY-?;X&&W-O&:HN.3+$RU.RG)FWK_F)L.[AC&*
MHKO'K*J9ZW*ER&^E&Q KEHGR0U:R95X^%^).Q>3OE"/_6'".* YI# 5!&"(<
M,(@9QY#'-!2($\ZI;Q,(VS4_MW#V_<UOOUW?_7;U^>X67'[^ -[??+Z[_OSK
MU>?WUU>W=IQCV0]F'#0>NB-S4L=P0%8ZT.R8#K:V@V_:>E";__^Y8ZEAN+ED
M+4L+)F6Q8>B\9K6!3QG&<H/#NX-!W*]%7I8+@9/ $SR$(J(4(A9BF&*J@BT_
MBD(>,2]*V>*[*&@^^JK <2MMWNFNK2.&&XVMX/[-E@)Z^C2,<2APFD".A>I3
M&G*((^K!4/IAD'H1%K'5\/;&/?I?>TFGIQ]'7KUQTSOS7Z@YNA2C/U'>SF!%
MYG17S&+QI<?,/\<ZRVF<G2VI&#0U+ KX*I;UYA IJI<[]?22L+JE=R_=OUS^
MR,H%DC@(L(^A)[F * P3B(6/8$Q9FDK!)$T#FX' O.FY\7MK'Z@-!-^TB<<C
M[7-A-^/M<< <F8ZM<+3F3WM(7-*B1>N3LIT]*J]);, 3AG'372&(FO&\W%9J
MMO.;>*2B6/@R#CA-.&0RYA %(H!I2GV(O3A-?.J'+) V)'2@C;FQS=I$4-MH
MQS.'(#0CE#.!&9DY=C$!WQH#'9)'C_LN6>)0,Y/208^?K]_[ODN'O>#OGLML
M)<I2!4,T6]6QT%?!\OM5]I^"7W,5_&0R(W0I+LM25.4E^X_GK!#\<L4_J8^S
M959EHE1_>WX4_(.0HE!_O",_.G]<("_U(Y^E,&91J/B"!) FL80DC&4@:4!2
M@FWX8GR3YT8_:RM!17Z 96OGBQT-3=#19JPVK^X;F237SH*.MQ=@ZR_H.@P:
MC\':Y7J-N>,7:+V^ )LOA'*\>X4[\IVNEUQR^0163SHT3-<+KT>:"5L>-G!]
M45-W/7%?\7HC\DM>5H6HE WU'%ZLA,RJ@WM40OK"2V(!(QE'$'G84\,1BV":
MX(1C+TQY8I4T-]20N0TR5[]]^73S;U=7X-W5YZN/UW?@RZ?+SW9CS. ^,1LY
MID!Z].GVVEZP-GBDS<)SP7))RX-MF91LST7L-86>_3P[8OQ'QLM#M+W9PZS4
M3V7&ZVP-S>;?Q>I9M"N<"Q33D 0>AQ%*D6)%AB%)/ G#B 1^* 1G@INPXEE6
MS(T2;U_*2CR"DBQ5\/74V&C&B.=U1C\=3@;QF\3&6R_ CALZ:JX=6>\&3=$1
MO#W#5O_M[3MDQYP_7\<8CV%. &T&,/VH>ECRXM"K!Z7S'C[)B.3$__5PY.9A
M Q-<V(/@STMQ(^L5JX=\J>XMF^3DSWDE_DZ*>COMIOBJ3WZ6G2@]C!/N1SZD
MGN]#Y,<AQ!&.(>*4>#(6:12$5BD/0RV9W9C4.@)R"?YHC;;,;!C<*8;Y"U-
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MH)'OK\,\LYN&\<IG4;TGY<.7(O^>*>)Z]_*["A6O5]>K[^I-TAN%K,J^UTN
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M]@^%RFJ:<!J),R8*/0^?;*IPVL'N9,'@ZK/3N]L)R4+$@1K(?0\*'B@""*2
M1)<HC2D*TLA+8^%9#?+[3<QMC*\K[@'6SGV7!DI4IEB:C?;G(33RZ]XQ[@*T
MYHV2;OW*]9$2J]>MO%4*]2LO>Y*E7U]YQGK 6KWEDK'\>5657P43V7=]Q/=+
MOLS8R\(+F/32E,!0!!PB#PF] 2.A+Z*0>#2D"-FO"YQJ=6XQP-I.L#5TP,+
M2:PM%@A<(C@R31P #WQKK!SG&+D50,X7#4XV//WB@2D6!Q<1C&\>DN'WE*W6
MIQ-EPDF<DA BD<:Z"+JG-QY2& GLA0S%.$B,B.;U@^?&);=,P9:7F6$(L8=3
M/TF<X_W(/-"QRE5>V+Z?_2E@G>LGS/;:MW(WL>O WP=J1A;BB62\+5&W>7%K
M!<MUW.DQ''@BP3 *8Z+>-1E RD0  QK1-(U#%(>IE3SDZ3;G]@:V)J^K5#;K
MUWE=CW$=Z9/:?DMU2 /TS49XQYB._%ZOX6S-K=%LJELV%H\P-[  R*G.HT&S
MTTHZFN.PI]YH<>LP-OH;*6H%W:^D$LU)_07R<8Q1D,#8XQ*B5 J8QM*#?N#'
M(2-IC*EG0S[[3<R-:]86 FVBI7Y##Y!F/'(>/"/3AB4RUAQQW'F7E'"@E4D9
MX+B7KU_XGBN=9G9NMB-.9 3R.$722S@4/J<015Q *L(8^D)G'J4H"N+806:G
MH3ES6WC<R^S<EHF>*+/3M!_-J&BZWAF9MDYD=FXW0-\^L],2W DR.TTMFD-F
MIR5ZAIF=MD\]/_2J*[R%G. T3B-(D? A0HIQ<8(8I-3GS&/$]Y)D:. UQ_)Y
MKX*+ >7S]B"T#[EF5@K/"I.SPJVQ"M[MM?%FH59?\;JCUYVK,;P6.:Z+D919
M6Q&O\ULMS;I Q&<^1@C*!.DT#>9!' 8$)I+X8<1\&G*K'1M; ^;&!5VMVXWT
M=]>%"SV$=SYH-6YME2EL^\F,4,9$?^P%7^? GZ$H;(?>.$+"AC:\D7ZP'4+'
M98,MGS.0%;58V'59/@O^X;E0L5-S:O%O9/DLOHJR*C)6B492K!:D4.'8C?R8
M%U)DU;/ZDB^D3&5,P@!&0B00\2B&*6$8,A4I^6DH(\^NU/"Y!LV--;<V@]*^
M*.C9W6-(CA."/C99UE5&&U] X\RFZGOMCZY#L>F2YNJV7KR>DBJ*[?CED$ =
M(>R44,^U:5J"=83@'N&Z>JY3I37=DJ[8K$:#NS_R]=8^]0(6A2E$OIY]8D6S
MU/,2*#!G(L24I&'L0%+M4-MSH]6_M>=^G^K. M4?N1/]LX.P&W+H.&".39>'
ME,JVNE07H+4=*.-'.(\T +0)%,H.-C\'*;(^7 PUQWH?,8S"VM*>:XUD'"0,
M<\$AD0ITA&D*4ZG^B=5T6DVIXSAF5L*/NX^?&Q%=WMY>W=W:D<\KP,SX93@,
M(U-(6XUX#*GHPSZ[9(!7+4SZDA_V[O5[?.2J<Q?!OA1ZGZMZ^:+ZLKI<<:T4
M_:0IOUE48:&/ HH%#+U80J1B#4A\GT,I/.Y1E@HJK82J3!N>V^N]MO8"U/9N
MM-&?&IF[\Q:X3O2![<*6.V1'9HSS0#UC\<H,H7$6K4ZT_4:+56:('%^D,KQ_
MX-&I?'6O]=9UN2Q]_EJK]96+$(>ZN%\($4V9/C[)(68*>1X%(9,4R<2S*OEW
ML)6Y\9 V$E9:>YYK ;A:<IY(F2TSH@O,K9JEBW7:Y5->Z&#/\G#50;3-2.AL
M#,?.-M!VU3Q36W8!/JL7Q?E)JSX0G!ZV.MC0M.>M^GS=.W+5>_$P;M!) ?5:
M>"'X1V5>9UU\X0=<II)CJ(\\*)H0$:18KY-0CX<T##&)D U#]+0U-YZH4VI(
M:ZO=^]^'J!D+.,)I9"ZH(5J;"?17N[MWYHX.#-!P20I]S4U*#09^OR8(DULF
M+F11_].N,C8KPOY""A&G2>1IU4P?(B)T1@!',$D)B1+L"^);\8I+X^9&1+L+
MM!,5ISC4:6>MWH[>%1,N[PXJ6''1UJU8=^>7_NZ<KG)%#^ZSJ&%QR+XY+"&?
MA:RSNA9];0Q<A&Z.U>KGZ>.TNA2:Y?KJT0?,Z'W>&@G65HZS\'H2#*>+L,=;
MFW9!]J37>XNSI^\8]G7^^%RLZOUE-5WZF/VH=YK7-??BR$,A8=#S_$0O@GB0
M:'E9%LA$$DJ$"D5LHI#C3<TMIMA86L_D96NK76S1 ZP93[B!:V2>V$5J;>8(
M&[BGT7!)%#VM34H4I[U^310&=PS5F+M]$,NE'G_)ZF6!4!1X@DLHTX1!%(H0
M$I%0J!5F>)HFA)B=##W\^+D10BN45IL(6AMMA>1VX.NG@/-!&?FUM\)C@%K<
M(;?/5HG;>>C$ZG"''-I7A3MXU<3K$4TEWVUUD;(^9W[W0%8W3W5JL(ZF]<FH
M)IQ>1#AD.$$<2B\4$/%$$0%-,&0TDD3X7ACR:+$2]T3==#?!DH6E_48O5=J\
M5'M>C+NJH:;(/V<K4&HW>R19W[;[1U[U&*,W_S0K(FUM]([WK4Y'I?P'+0 7
MH/VNJ*_*;!9-!G;;+!94;&W_<RRV#.P19PLQ0]L?4"DE_RX*PS69O>MG1""U
M74X778YZ>TZECIWG35>>XY ;.S4Y#EYPUI)?J;[/.MEDK0V5)"C"$5+D[1,/
MJI\Q)$A@!5 <>:%,9$2-*N_T-S.WJ=!&'?*I,1- 4&G90<O,U,.06JV@G@'4
M-*NG)6@M'$%1JQ^#$19-7[?T%@NF1[P]LEAZ[.H!NI?K(Y)JT*/9JA[S&A6(
M>_5@]5.9\58)XG*URA3SE*1X:8>_<A$BYH<QX3!.&88HIA*F,B408^D'4OW.
M8Z,<U_--F1V9;$W4?&)1DM5!M_23S;1@CTQ(F]/<'4?6*C?:%;#CRP7H]LN7
MJ?O%HO[V9/TS47'N4?O)3JO5";2]ZJ[GM3"='JP3)'849-T\T7YJ]*']%M^I
M6Q=!BD/AQ0F4'M9)1AZ%) A#Z.,T8 &)) ^%Z0I^]\%S&V/6M@%MG/FB_0Y6
MIV>10Q$8F?C-G+>:01[R](P)Y,[C)IL_'G*B.WT\^/<!@>/'K"BK2_4D+NIL
MY,O[0M3K).U6<.JKB:*OWKHT#-4<,O0B]9.DD"%?846EB(0T#@U/-#:W%[,V
M%[3VUOGR8&.Q1;!Q"F*#,,\A<&/OM_=@=GK7W1X\BUC,(8@315N#OH!V490A
M*+UQTJEG3!<)&7JS$^N8WC-L:>ZKJ(@*I?@5*58J?"K5U/_Y\7FIM^D^")FQ
MK%HP'%,2Q0'D'A,0"8(A)5@%.VF:1#+T,0FLI!1/-SDWHNU8"'ACHMUJG0'*
M"#./2H] (=3PA2A5 QGR&8Q)X,6(AA'Q\8!M8$=@3[^!.P7F9JNE;K^O(X]O
M:V/!VEKP<Q?)UF"']4G-T7&YIFK0ZJ3KJ^8HO%YKM;CSS.+%GP0IQ=?L_J&Z
MD;^7HI8K6"#*5?RL)A6^%+&BG81 XLE8XRX13S@B@95246]K<^/U3D%C;2TH
MM+DPE_!95_70%@\L<GP0:C.V<0;@R$2SQ:XV] )\78.GC&T*H8Q0!+D/E%'*
M(1]L\&T*(_?Y?K1$<N]-0W=SV_-_V2JKQ*?LN\XZJ-1W(Z/+IH'R[T*W*/CE
M=V7&O5 -R^?EITR*A8QY$# 6P9C3 "(4<TAEF$*>)AX. QY[R$JNY!QCYD9'
M7X4N4J%?J2OUW<@?,P8:8X&VMLYE>Q&DL$UE.ZN_(I)&H4PY#.-4]9>/8X@C
MFJA_I)_Z(F(T35186LVDMS9Q:C5R7ZW-A*V=:A:LI1S^LTE1.Y%'YKZ;S,:6
MJ5Z6D8>>S9'PQ@^XU(Z K2>;,EQK9\"ZDSJOD\M,@O-1=9MO<(8]$V<EG(_<
M?NZ"@V<.K2^L!MOGXJ66(*VS^,JU-0LN$$51[$&*M48]3RDDU--[1XRAB'D^
M0\EZ>F_&I3VM#9C2CSZT/:E'/>@@6ZO?Y(^/BB5KF>7A*=I]<)OQX;D03D-W
M:RL;#>2+)N%9L=OE*?&0 76$3^+AMGKP\>8FKAE\TN_]2L&G;YGXX$F;!WSS
M7)6*[[B*(S\_UWL0+(I5",<X]+F:Z*,XD#!-5?3-0QR%+"(R#?Q%(_]P6Y'"
M,)9S;J?-*_?:VA'GN5LS :G6,L:E;OD-3I<<[6,4>L(C?@ 3$B40X<"'*55=
MGD@J8Q*C@+*P[>.KE>$(,X,>7MLZ=?^*U5N<'3K:NV;#V9OVU\B#H(/30)OS
M/AT_+T#CZ0R._)SJA%F<[3EJY)_C$,\IC)V=UCG9T+#8X$#>VU?!\OM5]I]J
MFL-5ZYFL2W&U6L1M1**5_-3'V;(NOZ?^]ORHS#TF"+J@(F4J)(BAGK% Y"&F
MX@4N((]$'*<D9JF=>M8D5L]M,6]M:*WK(-96V@TDTW2WV> RNTX<>< YG$F\
M=1ET?6Y7G+9BA;6 Z=9OT#I^ 5XI*E_L2BJ[&X8F[2Z70],TAD\Z7$W:%Z^'
ML&D;'YJ$5.]W?U%SJA==\J+4%9_SU9=VR:C42I/=:Q;(QTE >0 #'NG4ZUC-
M:!G":MZ3!%'B"S]*K7:1; V8W6#3IK:#*@=%8R=XTH;:ILQ8]H-I LUXZ(Z>
M3M. 6=L%.L8K_EZ;WRC3[ESI,KUF&'9NDVTL;9@X]6880ON). .?,XSS%)<R
M(?C>8S\(6BV\%*4$2:8Z0_V#(C^%:1QBF"9)Y/N"I.IO-OS6U]CLN*RUM7FM
M,C7R$/4]T-L&!P3U[?BM%W,S+G.%Y,B\M0OB+HMI4]T1E D@+LFHM[U)B<?$
M\]<D8W3/P-U'\N.]"MRRZCTIBA>9%[5\ZZ,^R+T0GO3C()&0>S*$2 0<TIA$
M4.](1DSPF",K/NEI:VYTHDP%K+85L(ZQEEN-/=@:;C6Z06SLK48%5F,FZ-IY
M 1I+'>XTGH;#Z4YC3W/3[C2>]GMOI]'@EF&,<;UB^:-0SZ\E<5_NQ(_JG3+V
M'PL1Q%2*0$*6<#6]DLR'*4E\&"<DC25'*OZP.O%QK*&Y<45C)U"&VHK5'H72
MC!U< #0R-6RQN6@4K5_ M_:_VEQ0V^M0K_84)"[IX6A;DW+#*8]?$\/)Z\\\
M+W#U0^]XB'*1)-QC"0DA\4.]'T!]B-,PA2R*&64>B06.%E5>D:49'>RU8,4#
MFW9&' 9U&R#?9+B+ULZ!IP$V0)J1P5GPC,P"VZS_JU.8#$_R?^WW*(G]FT;>
M)IG_M8]'$_CW+ARN6O&OSVJJ(8KERU>AZ\XM4)K& >$>3*@^^\,# E/$T[I>
M#L6!%$@8U>?K:6-N(_Q&SF%C)V@,M=>U>(UF_\OM"*.17V][> 8I7QP!P($(
MQNLG3ZZ'<<2U0](8QRX=6&:OSJFMTQ&_D.*FN*WTXL+?R/)9?!%%G:6PP#@F
MF*($)CS $(6QBNLC$D%"B8]3*C$VTYRW:'-N!/"^DWI\H?=(P'=M;IWLQ?/E
MDA2ES@%K$K\L\[Y,NL L!' ,[,BLT6+:IB<K@]47%S0F@]IF?1ZFR<QR6+3/
M'"*GQ?L,FIVVB)\Y#GO%_"QN';@F*=C#*E_F]R^;K>)6%\63)*CK?08!XA"E
M<0)3$4DHXX"+(/9\% =6*Y+'6IH; 744G"W7((]B:;@"Z0*AL=<?-S9VRXP[
MKX5S$@JG:X]'&YMVY?&4SWOKCB=O&+CQV>8JW,B/V8JLF)KCO,]++5O)D8A]
MGVLI@@BBV/=@RGP!/>%[B$>I[TG?:M/S2$-S8X0/6=FJ'>M<,'TV*BM+G3UJ
MN;EY#%?#C4T':(V]J;G.<LDEV!@):BL=[F>>P,'I7N:QMJ;=QSSA\=X>YJGK
M!ZX[ZGH&G9RS;>'W18*#,$D5%6 6$(@\+&$:D@3&*&0J:DAD$%JE>QUO:F[<
MT)0K6>:K>ZB:>P3+K=&6BY''T35<E72"V=C+DS5<'2LOP-9.ARN5)[%PNF1Y
MO+5IURY/>KVWB'GZCM$D2#YE*W%=B<=RD3)!L!>'T L5N"A&&&(UX8"1'R0B
M"AAAR$BG=TCC<^.3U]()GPY+)X!OV@-0NV"HACFH:\RH9RS 1R8CIUB/H4JQ
M!]K$*A3;]N>F.K&'S "5B?UG#)$_5M_&ZJ$C8MY.^<,T9@&*=43D)1!Q$D(J
MHA"&3,9^* +D,:/ED[Y&YL9=C9E=R7X;G=XC0/8SD"MX1F::?60&21D?@<A&
MPOA\J*:2+C;_,ED*%O=#T"]4?.3>"06*^ZW?%28^<>VPT.Y*2L&J&WGU@SWH
M4[9?225N5N])^:#_7R]%?2=+/?W\*LJJR%@EN/[#Y8KO?M"Y<A&K62+A(8:A
M\".(0JEX4X0)3$(O2B(_B22Q.M Z@HUS(]O&1;W2(EHG0:&\!,W/)<A7@"D/
M[&+#,?K6+(1\XQX;F?^WG;7V#V@'=2=IHR_J?T''=GV0=>U6\T>]]/CZL\X-
M[N+2$7O"9?@ZAIF31KDCXOPZ&!ZSJ:&9S=_54_+BY;.H%HQX*$%> ),$"YW-
MS"$F+(0I2R-*?8'CQ*A$R*&'SXVVU[;52U\K6_WB'=C,B'4H&",SXL:L"_#9
MI1#Q(7?=9B)WGC]Q]O&^9_L9QP>N&:ARQAX$?UZ*&WEZ*OWNY3?R[WGQ?DG*
M\DX?55\PY,=!78TBYEJU7.<FIUS]P^*$)2A%.+;:*CS+FKEQP-H9'0^8K4%I
MX:3:*5![!;[5?EDN_)W7HV9L,UD_C4Q/XW>1O6Z5"VB=:E2=9="T>E0NL-O3
MGG+RT*&"'(KHGX4^I:KK*NH2X'_/JH?WSV65/XI"!7K+9RUJI1M7_^-WY,<"
MQY3& 55AEJ\GV8G@D. D@2%B"'D^C3Q)[30YK&V8&Q.K81(4C1NV0ASV^)LQ
MZ,BHCLR;K?7-J?:U_8TDP-J#"[#Q :R=T*?67$IR#(;0K2J'O1D3"W,,QFE?
MFV/XH^S/RURMJJQZ^9@M12N_23GB(O08I )CB+A/(1$A@IS)$+.$1\1+30_*
MO'[XW#BKL0]H T]I8YX&KI^3SH5C[%4U<R2L3L$<<_F,XR][CYSLW,LQ9[H'
M7HY><YX(9AT6E5FMR/DC*Q<T)*G 7@)]2IC.$@L@]I@'*?/"$ D/X]3H+3W1
MSMQ>V(U08<=.\$U;:CF!.X:K66#A *V1W^<A0 W673P"PQA*B:^;>A-MPR/^
M'E,C/':Y'2.41;6X%?=ZN_A7D=\7Y.DA8V3Y(==UE!9$,,F91R$2@D D/01Q
MHJA3>!S'*8\"RHVR1GM;F1L;="T$WQH;#7F@'\U^%G"&T<@<8 >/\=MOY'[/
MNZ_N[[SWZK?7[WQ_ Y.\\48^KM]WLXL')$3=B>+Q<UZ)=VURBO $"C%/81+H
M-SUD&!*/1# )$XSBU)."8.-$J%</G]N[K<T#VC[PSB*MYS5B_2_RN3B,_/YV
M(!B2XO0:"XO4IC,PF2BER>3K89?+=,3GWARFU_=,E[MTQ-J=G*5CUPS<Q-('
M9G7/?MID-$LOE!X/(B@8]74]70Q3*AD,11H1HF(07UAM-N\W,3=6VEAX1M+X
M 2 --X3.@F?L71X[9.RW;(XZ[W0?9K^5:3=7CGJYMV-R_,JA[W?._G%=EL^"
M?W@NLM5]4]>S4^ZKF<*4"QKX(@T2IMYX@2#R52Q"(D] F:0DPC$+A&]UQL2X
MY;FQP7ME4\9K[2(UNY9Y 4AGMCV\I))Q3YCRQ@CXCDXGNEQB8S1HK&X+S;ZJ
M"=B:[I)H+-%RRS^FC4],2Y:8[+.5[0/.SK1951G/EL]5]EW<"J8:U8?RFLT3
MP9O-E<>GYR9.O9%7I-#%J,NU%LA6U))%7BI0$D$2QQY$GJ_EA*F$(B0\2$@4
M$&DEWN'>Q+G18C?A@W1\!.7&29UH77O9[&ZRK9_ZII6HP#(O.^)$@[-S7'T+
M#)GV3?MV;$KNYO%TNW7K'[C:Z=;WN]VZ=G*KD-1F]HPCJCI>9XR4^>/*RK=*
M!W*,<D^.D.N6!JO0J49$\5JBB#&"F4P32$D:040\IN)C0F <$$003Q'QK4:,
M(^W,C?;79@XM '<,3C/J=0#2R/RYP6=,M:<3,#A6ASO8U-2*<'W^'E"!Z[W\
M[2M5OF\T(YHKOQ3BB62\E<55U]<B$\W?%C+$0G(/0R;C "+&&,0>UXF($O,X
M34*&^%M5KC3V8FXDUMJZ4<&NSXKEM=)*J^8!2&WXVQ6W-/^&F#'G[/M]9%X>
MJ?AE"T5[@RZ&V7RS6CCJ&QL)G\O^+]2;EL.T[M"YEL<T=^1/6R[3NJ_&+)]I
M;\QPK?>/6<G(LEE2^J@^*Q<^HC$7H81IHFO*L41 $OHJ(D<D1BRB-$J-=J9Z
M6YG;V+41-&\L;==+06VKO>3[/JC]PXDSJ$:F^T$H#5)^/XJ" ^WW_6=/KOY^
MU+U#^N_'+W86<G>6D=MJ<XTD:$2)YT<J3D[3@$)$6:JS9!&,%+P(!UX24J/*
M#_9-SXT@NKF@Z\JYK%=1]%SL!T>@#A!]D["Q"_&Z$J5CT59[M$:.R8ZU_M:!
MU E4#**?4T]PQEWZH$^VNE=$N;.GO ZK7KKZL)QC+%,)J6011,*/(4Z(@(S+
MD"<4I0*%B^^BH/D9A&9NC\T;V;5JU%WYUG9%;AWCSR8YBT[B/(XE]2CT6!3H
M2NUZ^Y Q&& <Q3Z6?F*G^#]9%TTR##UE'[,?0#Y7SX78[:-:QT/O%:T76W2Q
MF(G[3B:Q2'&JH@1?>!!Q02'%$5?_4"'"5 9UEJUY!;CI^FZ":G$S[[O!\<8X
M/?(F(4B'_][O]L_&FW&4HIW .G*L8F'06X<O]M@91#0#'GIFNG C>1)ZL<>C
M*(8)2=6 J!@6$I^HT"4.(D_Z)$74ZKSB[N/G-L)UDF$'J<OL8F>8>S(8D;'S
M1HS!&)X4/)XPRVX+;Y,,W"^=<O@J^\.%7[6<77T(5OK<ET@&,.1"0.3S!%*A
M1>0]&H=I''F1-'I9=YXZQW<T*ZOZ<-QO@I0JGFF^I!:GB7=AZW]/!X,QP>LY
M  >KXX)[?I][/'#[P,F. ^[YT#W^M__'@2E%A>!9]9&P>C"NOU4)#:,D""1,
M8I1 )'$(4S]*H20X#%(6R#BUJV.YU\3<WLS&0K V<=#Y_@- F@VCY\$S\KMJ
MB8Q]]M!1YYTF#NVW,FW.T%$O]]*%CE_Y]IE"W4]H6>L$+1#V S5F,RC5& T1
M3PFDV/-@Y,=)Q(*(!SQ^JYR@ _;.C7DZ)KY=?L^A?AV\KO%6O?4F*Q]GY^QT
M/_RV=GL$P921.VBN.3B'3'[K598Q\!\SKZ:OV:'ZEZ50-VF)\@_BNUCF=6+L
M95'HF/:Q62FJV[G+OXA"YL7CQ[RH$WC*=R]WJLTZNO)C]?" $!@&D2YH&D>0
M!!&%OI2I)Y"7I('567 G5LUM?%D[53-0QRW0\>MBJ_58Y:#UK3Y<VGAW ;1W
M@X)B-SUM-A9-WG\CCSC3==T C4Z'4+M5[71AV,0ZG@ZQW%?V=/GPR=E>6] *
M9$6!'Z#4ES".60*11Q"D,?-@$">,QEX<I3*9B.VW5OU79GLK<3.W?3TZWP_K
MP3\1WSN37AL%[)DP?L>P/POC[V/ID/$//'S@FK(6RK^1?R>ZU>JF^)K=/U17
M/T3!LE)\*3(F-G\LV[^6_D)0]7\ZS2RF^A!KHK-F$R9@A&/$91 $:<H63XV*
M0T6*RG#Q>8@M-JSPVJ(1ER#$?;;2YXK!'T+;J4L ?!<%N1= M Z!)^U1+03#
M\^62%!U% TM-F&&=F'I!REC*8>AQ+1@8,YBFB*E1FR0R3%A,HG4G7JG)YIRZ
M<&W/>!VH6IAW[QEN6(S='V/O:=0E7G()6B,5MX':2EW<H.V)VHW.->7F(H=Y
MU6<!Z71_9) ATVZAG(/5WB[+60]SMA'C8+7]S[)4/MGJ]M1+T_-95QZR*.QJ
M1?>UX,D[4F9,AZ!:,T7P!2$QECX/H AT\0"$0XB)EZHH(111P!#SN%4RWHGV
MYC8O_[PG+P4@H-KF>K+'&ZN=#/RG>L*,:1SB.S+9[$L\78!W&V1;>QW6US4#
MQFFMW!--3EOWULS_O1JVAK<-D"PW3SGNG*VZ7I4562[U?/@+>:ES7D7$?*9F
MF3!*(@01CWR8<A%#/Q$!#AGR_8"8',)P:905CTUQ%F-;C1X\D1=MJ6':@M.N
MZN>PM^J -TE .'[THGLNM.,8:#U[@VZSD(-_@^Z;2$9^JFZTDZ)WC'>OA+VK
MMJ:3OG>,SHYDONMG#ZWHS@I!2O%!-/^]7M7ZN0_Y4CVCU-IEU<M7%9E^S(L_
M2,$7.,!>C&(.D\13@V48QI!&S(,A1QX+X@1[U++HNU7[<XOOU^:#G]<._ 6H
M6+[KP_\ C1?@F_8#M(Y8;J_9=I-9L#\B^"./B2/@/J!F_2#TW):UMS-ATAG#
M0'Q>SR"&/F;@64*B55_K%IJBBNJ76CF\412_7MT59%425D<RF(<)]:F S$<Q
M1%0*2/TH@=C3"0LA%X$?69TTM&A\;DRHAK%'%:F4M9A^UHCIZXEXJ?K)\DBB
M31>8$=U8P([,<MILO151&W[1%DNM/ZB-7]<L4,37L=_AD<<!J#D]$&G3_K3'
M)0<@LW>8<L@S!B9BY2]D6;U<WA>B.;XIBL>RE3Q.N!<F48(ABR(,42H8)"Q2
M1"8(3SA)0T]8'>/H:6MNE-6:"C:V@MI8R\2G'FS-R,D18B-ST1&P1M"5-L##
M:1Y13W/39@>=]GLOY\?@EF&4\4'0ZD-6LF6N3^ENBU.0*$5)&$8P85$*44(9
M3*/4@X$DB>0T26F$;.CB2#MSHXH/5^_NP.7G#^#]UZL/U^K'KU\O/_]Z]=O5
MY[M;.[XX!JP95SB :V2>T!:"K8G@VR@%-T[@X)(?CC4U*3><\/<U+YRZ?" G
M9.537I+EKT7^_*2F9<MGG=6DVZG7K530<O/4+EE]%=^%^F"12"1TX2*(8RX5
M780,TI3Z,/&$%P8!"CS?2CC>WH2Y,4EKEB5IV"-OR">CXCDVU;3&@]KZ"["Q
M'W0= !L/]*G-?O#M>6@P?DXIRMZ*:=EK,$I[Q#;\2<,X[TN1,R%XJ2O]Z(D9
M6>D4L6:QHYZ[+:*81Z$0/B081Q!Q?3Z%RP2F,O*XQ)A&S*A2MG&+<V.TM<%-
M(:ZL-;E6Y^NL"6TD^S87#) #/MT;9K3G%..166X7WNL.O.V26VVP.THSQL8E
M@YUN=%+",L;@-3^9WSB,CG[-<_Y'MEQV]WI(ZL584%V   <0A7X*,><(8H8\
M'/IZ <=*M>= &W.CG+6)9^VI'<+2C#[.1&ADPK %QYHA>MQWR0F'FIF4!7K\
M?/W>]UUZ;GG9$RETM1;?=AT!$1JF'M9B/&&BPI&$0((0AY+%4>PG-%4AR; :
MLE9VS(TQM C&2FLK;4J$[F?A[M>"!:2JBHP^5[6V2Y7O1#3M#N30>K%VW6JX
MSS5^9XV]Y=6I_&J4X3M17==!>(Y3O-7.E#>JT#H(K^-E6(<];D!2\=U#5O!.
MMFN[DZ,F>$FJSRTP(BE$@9[?!5$ 24Q\W_,D]YE189>>-N;&F+65H&.F1>+H
M$13[2<P1-B,3U!XLIW? C/&QR),]'Z>)TE[-OT9VB:O] /3FH1ZY=;JTTG[;
M=[)$3UPZ++;\F*VR2GQ2S^37Z@NPNL\V@F"_D7_/B_J4Y&?5J:TL!R%QP@-/
M0BYXJ@6W,"0!B6 2AA[#21PDQ$J"Q;+]N3%C8SZL[0=;!S;E-VL?0'/86'LQ
M4%+%MI?,0L01L1^9>=W#;AT/#@3/91QH:\*D\=] ?%['?4,?<][Y[$Z:?9-5
MJMH6Z@M<-0E9-T6]H*<L^1M9/FMSLON5X(N(("%Y*B#&PH>(1;HL=AA!WV.Q
ME(&(L#>HYM\P<^;&E3MIH=^UI</4;@=VCADG3@?YR!2Y.6/4\>1BG0>_=F:=
M-JK(<NW/!:@] FN7W!_4/P_:,8[R#[3H30[[GX?>,3F ,Y\Z<%VSG;[K^H:/
MND9S<\1I*U/U[F5[R9?FJ.FE7D_=39*]?*X>\D*+VBXHX7'*U+0<8QI#1%($
MB1?ZD,HD\E(2BS@A5BN>KBV<&R>WV>/D.\F6]=J9EI$CVH-:B*!>^2PMU0?<
M=ZOABN=;=M;8:Z':-$BUY:#K75<7$- 7T+VN=1'4/AXX,K!UU.$JZ5A]X'3]
MU+F1TZZLCH7QWIKK: VY%)&]^J%-$U_R9<9>%JK+64@%@DC$*40XU=DW?@KC
M-(THYB1*0JND9(,VY\;I1S5$^RM"#X;<C)T= SDRWQ[%L#7X C0F@V_M?T?9
M<[+ ;'PYU=UF9R"6>A ',RG4P[>>NSN_7UU!<(/:"J^V=R-&F!]$!$9<,(@"
MRB%.9 @Y9TC]@7FQ%,-V[9W8-S>VZ^X2'ZC$HGXTK,,R=//>3:_;;NI/WI<3
M;O:?U8T3)0$XQ7^<Y  W)KY1TH!3?(\G$[AMQFX X2);7*K1B.L1Z>.2W"]P
M$"2>)WP5LB84(@^ED,A00HZ]E/O,"SW?*&%K[\ES(^V-<4!;9\:\^W#U<^99
M((S,=H;^&_/345^WS%*NJ:44[*_W^?=?U#W*83_5/T#]0X=,]I\W"0T<=6/]
M A^_8$!^S^53]C'[\:GB;<I%*GR?)3B&OD<]]?9A#U(941@QC\320P1[1E/'
M0P^?W0M8FP>4?1:I*J\!ZW__SH5A[%=P@\!?AZ3MO,;"(E_G#$PF2M3I8.,H
M1>>(S[VY.:_OF2XIYXBU.]DXQZYY^PJMUZOOZOJ\>%%T&4CL8SV+C#E$,0Y@
M&DH$L1">)R56<TNKJ>0H5LZ-&M>&O6DUUFT?VFU;OUG/3+6;[;;RZL;5>19;
MW>N)N998W1KZU@+X[K >LYSJ?F-#=T36"LQZ*KLDE=Z'*:H7+?JPB"7R@B@(
M($L] A$/(DA3@6%$. _2,$B](%BLQ+V^RW0SY'AS1F21-F31;70\SFAWI$J0
MK\ JKP3X(ZL> )&R/OICF7S4BW3 " GC2 VQJ8(;85WPB' $/35I2(5$<4RM
MQ/_.QGG*(]^3H6RZS^0&N]$WF)XVP.D5S]I04%L*M*DN-Y%. ^)V]ZBGO8FW
MC4Y[OK]?9'#/,++^+*KWI'SX4N3?,R[XNY??2ST2M"H5J_M+5F7?ZU%B$26>
M2)B0T/=C12@^#2%&D81(D("@* DC7YK4(;!OVHI>)J@VH*NF,&4Z>"X;><M\
M;3,@&Z/M2,:B'\PH9QQT1R8@#:RV&JS-UNE#/__>H/P7L#$>7)Z&V9J3[!%S
MR5 6K4_*5_:HO&:O 4\8&GAVJ+$Y<Y+@D(2(IC#&7J!S+SU(*)<P$%Q]C ,>
M"BM]K_TFYA;Z[([:0XLE[P%I&N>< \_HT8T5,@-BFF/.NXUD]EJ9.'XYYN5^
MU'+TRO/?[X[X\"<U [ZNQ&.YX!$*41R$D$@/0R29@%BF'&*N)IM)Y'LQ&ORV
M'VIPWN]^QV+P3=L,:J//X(*#H-LSP[E03LH3UBB>Q1M]T(S%(@?;?#-.Z4.@
MCV%Z[W-^#/G=R_:@W^6/K%R04'HDI$3'&"K0D()"$G@$1E)]WP+L"1Y8U9VQ
M:'MN+-1_#E9']-V3L-^T"^Y.'N]UC!D]C03WR$SE%&F7AXV/83;10>.]YN=R
MR/@8+A8'C(\^XMQ$X9XV7Z6%ILCCB'F>FE0E/D2<1Q!'40B#*$Y%D'JA;Z>Q
M/L"&N7%>-U.T_ZT<FM%KWCUFC#<RZ",SGSG>$Z7>6H,X3GJMN1EOE$)KC=/Q
M-%G[1]E19%E4B]M*!9AZY?U7D=\7Y.DA8V19QQ6>'_!$D A&./(@2M0TDT@4
MJRY*&4Y0'#/?2%:AMY6YT5S7/JO(K1_+?L9RAM#(G&0#CC'3&#G?PR7J_@Z/
MJ-]><TA_ Y.PA)&/:QXPNWA@,/1,2_$?S_HLEDZ%*#OGGSCB6)?.0\(/(6(I
MA51P ;T8!ZDD/,'<2L/X:$MS>^-O?W]W>_6OOU]]O@-7?[.O)G,<4<,HQ05.
M8\<B&QM!8^1(-65.8N$TI#C:V+2!PRF?]\*#DS?8GX?YI+IF^>4A7XGF#/F"
M8!1P)#CD3(_](0]@ZM$("D8P]BF/$$I-C\2\?OC<"*"V#]0&MFH-YB=C]H#K
M?^G/A6/D]]P"":LS,L=</N.8S-XC)SLI<\R9[F&9H]>X5&#H*$+HLN4%8=5=
M_D44,B\>/^;%3?6@7I[M+H80GNI_CT#I<1\BZ2&(PT3 R*,L]BBFH3!ZI5T:
M-3<J.*H_T''K JP=TW+DK6NU@$_CW%D[40[ZV72W:MK>&WU':ZJ.<Z0F,0SI
M\>4F+.V:@1[%,"3-!"L&/GO J<CWI!1_%Z4BN94VI?@N?F\4A[-JK4TM/2:2
M($!0<%WF*M$:P)X*S,($HR@-/>9Y1BIKANW-C9O?7]Y>69P4- "TGRE'@&ED
M$M3&@M9:T)H+MO8Z+!1LB4WO>4.#QTQW!-'<IYU3B1:W#5RW6:\'W4B=:?AQ
MF?]17M*R9B33A8:>1\SH2[PQLZZOIC-E:TO!M[6M+M<;#"!QNN30U]ZTJPX&
MGN\M/)C<XTP NOQ2Y&J(?22?176]8OFC^)27Y<+WI22I+V 24KU,&<201I&
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MO='O?K^]_GQU>PMNKW[][>KSG>7BN '(A@OD;J$;>Y&\L;8SG&_M'>MDNCE
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M#,(Y))(&,$ED)%(_I+XP.B%GW.+<7O]-_=>GQC[797;70 ^=>IT!W]M,OS:
MMA9/44/W%3C3%,Y=-SJ3:KFO,# OD?OZQH'I# =3,3NIQN]>MI>TF<AU?J8^
M_EN]7*_*JJ@9L+RI'D1Q]T!6-T_U=N$FG?-KOEQ^S M]TX*H65N<1C[T>1A
MY*E )8T\JD(6GZ*4^F%*[-(F)S5_;B2H0M"JR)C>CJ^7_"P3(J;M>C,FG6^'
MCDS+W8S_KNO=M'^=?W'P9$!S!*"! '0P #4(H%(H@!:&SM$!]>.F)$_]V!)\
MT^" %AV7:1UOTJU.\T&F]6#:1)(WZ9V]#)2WL<)5B%XW>O-4BSVN[M^3IZPB
M2UWN/*8XBN(T@7'D:VUH]?5*8X+5KR+P/8\((CTG^R/'+)CI9DEM[KGQ^E'4
MAP;N9X'XIA%\P_4;T]=R0Z]4AAS7H[<'<-PH_VCK;QSNGT+E=-Q_\@D#2A=N
M'J>WD=^3HGB1#3N6G[+'K*FV5MZL?B_%55EECYH9+A_U[./VF?Z[8-5=OKWN
M<K5Z)LOZ]P7C<9#$OH !(JD*[@,!4TPB]4_  A)A0I'1B> QC9Q;,+\Q7KVQ
MVDBPW%BM S2='6.ZJSQJW_83ZUQZ;&0*WK*L=A'L^ @Z3FH5;^4FV'9NXRAH
M/=5I.=O+0>-L\XFC"H,C]T5O3<*QVIZNBN'(Z.W4/1R[K:$*X[3:AM:UIIA6
MB_%YC&'BXQ B&A"(:2@@\X.()PSA$%N51-AO8F[<K"WLS*NMI-EZ@#2+4<^#
M9^QM)CMD!@B 'W/>K=SW7BL3BWL?\W)?ROOHE</>[TO.L^:TY1>2\>M5&UBV
MYRAUS4',60Q3EB00!2JDPXC$D(<2(<KB($ZL]IEZ6YO;6[\U%FAKH9ICM?;:
MO?G]$)N1@#/@1N:#XYB-<*#5"!27/-'?X*248>3[:_8PN^F\DFA-7G);JDFO
MQ'@DC"(F"$P\I@ND,0Y3&@D8^8QR$H5J+A@/6O\ZW-Y,5[M>ETP;5D'Y,,*4
M2LJPB"$+0P\BX@60(LDAC>-(1 F2@M$AU><&0?NG*T.W!Z?ITN'Y((V^4-CB
MLSX4TEKY%^>+@/U0C%&O;J^M-RE<=\SC8Q7LCEX_,'A;51G/EG4IVEO!GHMZ
MB?>S^DJTQ5 CPC@)$@RC,-'2?!&!Q(LD#*4N)!TH:I96I9].-3@WANC:"[8&
MJ^^_NFE@N=F3H!M&= ZA'#NH.P]%^[C.$!JGH=VI-J>-[@P1V OP3.]SF)A8
M/(MNE8 %\D.J(@\&N8<E1(P)2*D^%!9*BD/N4R3DV;F)KQJ='>\T%JX#DV87
M+J\WZ ;+@QN!/W3;\SQ(WV;#<PWR*'KC-A"-GKCXNMVWSUT\@H11^N*Q>X=Q
M4IL)\C$O-K(*U4[=S753+]=U%HBZXI(I?FS>%Q%1Q%$801%[$42QFJ&F/.$P
M( R%?I B'QO5J7-BS=Q8[/:9EN(_GO6Z[E/CER5EG=<W9EPV&>(CD]PZF4\+
M]6X]>54=>./+!=AX [;NN*,_)ZBZY,7S#)J4,)U@]YI)W3QT&,7>:>Y^+E[J
M).._D>6S6!>(TIJ\OXGJ(><+2AGQ$Y) *40,4:@"0(SB"'*>$$0$DYP'ZV4^
M,RXU:7; :M_(I/E5/*E'/>AP)9=:P%UK;I3VZ=E&H)M1I#,@IV'"M;GK NFU
MQ1>;NGFMUGECMCO&LP'));$9M3LI?]D@\9JFK.X]5X'S>L6%S%99)3[IPNK7
MJTI]C;+]*G:E5JR[D0>*X&W/L@<)3HCG(QCX2!=)YQ12CZ=0ADG@!SR(96IW
M,F4,*V<7('9T([=NPJ7V$VP=W:]\6=;ZD?JV0R4TAPI[NOP^F#'KF_?RR%0\
M4@>WNJ%@%'6$4?MD'(E1EX:^D03I"%@?ER@=H[&AZ3/__EPVPHYWN2Y"L6+9
M4NS(<]WE6B+^2Y%_5[$Z?_?R>ZDMWF3[;:/TC=(I2X+(1PF'F/  HC0.(68"
M089QZN$H"D)JM8(ZAI%S&XHZ/NJDVF+MI=YFKY.G]:?Z9Z8++3SKXW/9"N2;
M/%ZR\?"?;+-[1O@&&&XAO7&_CKWMM-NE&P?!OLZA5C?4_;IV5)^4_/GWII/_
MTCT3L_%W%!W=,3O$;1[3"'9.G/XT'M+[65,CMC5<.;O5>6Q.[MX\5Z4:!+EJ
M;,$X%Y3X#%*68(@"X<,T]3WH1U'("??\((YLAH^^QN8V#+SOK+=<@+(YU9QO
M[04_*]9O/OZ+'<_W0D[BE*41]V#"B0<1#1E,L420)B@4A*>,!VS15.F[K51,
M,BWPKQL>#_YW1/W*Q$@HAS'E3"AL211'.ILE57%1Q"%+>4+\0,8,1RW*5RO#
M14:W&*^;_;,B;!9WN,)LY/BAJW=\T2H<7(".K6X%]$\AXEHO_VA[D\OCG_+\
MD!K^R7L&9ZBH(?F._!A<0*+G"3/Z;K?AKS)S[-H0!G@XSG\XVMS4:0^G_#Z0
M[7#REJ'2N=_SY7=][KL0/*L^$E9O]:U/Z21(("1]Z,4HAHC% 4Q#'$$O%(AS
M+$*"K [D];8VMXAO8RQHK 5K<VU5</L0-J,.9[B-3!Y'(1OAC(X1)F[U:/L:
MG%ASUL#W?5U9DYL&'N;-RJ>\),M?B_SYZ7->:9ZJLPF>!6\GJ_FJ83$U6ZAJ
MU9TMEVV7IU+D>8GT.?0H0XVD#2$LA1%A29 (2OW42H_;D5USHZ:U6Z#V2Z?L
ML.5S/0OM.@@V'EZL5[4V3G8&=Z,5JU%[W8P$WZ O1Z;+Z;O1_IBT6]"=GJUV
M9-JT![+=XKEWBMOQX\^KQW"YXAT1\_9PT@(G0M!48(A\HH]^,P)QA+38,/6T
MK+A$H=71H=[6YL;<:V/KO'V^-7=8987# )O&E(Y@&SVF["#6L11<G3B;.;CZ
M02\B8U0X.-S@FU0QZ/7]6*6"_IL&)F-M4L2O=)F8=KI$ DP2KI?#44JTN"^"
MJ20QQ 'V:!P@AGVK@N4'6YD;9W2RY6LK+;.8#@)IQA%GPS,R-[Q&9H1I9B\$
M3I-V#C8T;=)-GZ][23.]%T\L&M[JL7:6>_\NLOL'K63U744]]^+JARA85HHO
M1<;$(HD580B)H1<E0H4@6$"28!^2( R9U')COF>_JS:1]?/<H.L8#T@%FH9!
MJ5N^ &MW8.L/6#L$:H_J/2>>+Y>D*/6=S?Z3Y?;35-\=Z1,6DX#!) @I1"Q,
M((FC"!)!PR#%4HC L]TKG.TW9_QMQ\/?&['B_[6^-8;C[?R^!V./X.>KTV_T
MYSO>;[\\X/"79P8*],/Z;!;2\Y:F_SDTYX?UAS.Q^8'-.UBOWRP['EPMVN2:
MK9<7:,A$B()$:W,RG9(4P)1)-1'#7%=T5W%5;"7==X8M<YNI;?-!U_H,9RRH
M6W;+@$7T\<">W<+YMF><+QLY@'2T97%+<]YN*7P8;KW+WP,?.3AO]JD0#^I)
MV7?1++!_R9<9>VG^W1[_\F-/((_&$*4T@4AX'DS3 ,,$84JX'Z:(6!W!,&UX
M;E2Y8_=NTKUUVJ$9\F8$.0:>([/A(2@O0&,O^-;^=Y03<;9@.<Y4-&M[ZJQ%
M*T0.9##:W3\P_E//+:N,O=<R[\4Z&2GFW!=4)WE1O;K.@PAB7[$4$[[P4THI
MBHA59'>HE;D1T4>AA2Z6]?92J?=$+4.V@T@:!F/GXC-VF-7:5V>#7CY7#WDQ
M3BY7+Q!.@Z.##4T;]O3YNA?0]%X\H##/X2V[SO14B\#H%("[_(LH9%X\?LR+
MND)0^5NVRAZ?'YL*$%_S%[*L7MH)["+ A-.(<BB(5%&-Y!@2QE/( A7M8.Q+
MC#WCNCSCV#@WWFE-71?E*1ICUWI8%O5X1NI23),X]6,!$Q'K=6XB(4FX#RD+
MD&14T@@%B^^BH/F?I%.[MD[>K5JN)UL?.7U0TY/[!Z X*G[[?NX?JF;2=V^5
M8])=A5X[J<\$MV[6FFJ-HV#=\6VII=;7]6+UV_<S;RO*U[/?N??WCK'_)?O=
MKMC6N#W26VMKI*:G*[4U+G8[E;9&;NHL'=/R+F_E2]:J):+\+*H;J0^8KX5-
M%D$41"@2%*9<UY0EDD+*HP2F3. D35&,4F(GMF?3O!%%3"JZ5UM69NMBB7>J
M3\NZPD:MP:>5(4AK^R !4[-.,9M-.@=Z4GG26HFC-0]L+:\+2FBL:Q6.RU-8
M#Y4CM0)M!/51L_;?0FS4"IDCVJ)VSW D7-&N5_RG>G]"EE+BA2%DGJ>F,GZ"
M(/6)!R/I<3^(0B',9J<&;<UMEGE0MH)LS'5XVK^#M_%*NPL4QU]<WSOK#[:6
MCGC2?Q^.40_Z=YI[VW/^^WZ?/.9_X);A14D_Y:M[]6JJ4(S?JJ=6^N=&X&U=
M%W7A\RC"BDR@AT@$$95<YX^&,"$DDGZ4>@$-%E5>D:7A0KE1LU;<LFE\O%?C
M3K<!N++=OF"I <B&:^C.H1M[45T9? &TR5#;64\]:ZOK7R_ VO"VH+/;BJ?F
M2+FN@FK0\N254<W1.%0MU>+N@1.W(F="\/*C,KXFNS9%;)T(QA>2R(3':J+F
M,Y9"A+0P5,I"O60;QR(,T]@35D4F3K4XM_!F;3#0'0S$.L53S1?JB ?DC?V6
M<[.3N!M.R%RB.?8L; ?(VMIU8NTF<];EM,L4&J=SK9.-3CO!,L5@;U9E?..Y
M.NBWXE[/W[Z*)\5OV>K^>J77K.I%V7<O[1^W"38$<QG$.%#XTU"Q4<(A#7@(
M98R(2$+&!/>'*9U;V3$WCNI*73\5.7]F%2C)4DTCZ M0+XJXSPM+39FA/63&
M6Q/@/C*;=2%OS00;)T#'BXOZ;$%[Q33:X8,P'4<=W,Z4-]+_'H37<87O88\;
MD&EQ]2B*>]7 KT7^1_6@\[K(ZF73[%=1KWK5JV.'TQ513'$:AA(&(6$0\4@J
M-@U#2+%63_"1CYB1]I8+8^9&J3^M_0&-0Z#UZ*?.6]YURF+W]=QN,]A.G[ S
M1N;9(]UPI!<&Y:2Z[R&+C? )>VJB'>]A/>9H%]L1G+W;U>>V,=V^M",T=C:@
M73W3;KSC(EM\:+^_7];GAC^HR'8A4Q1Z,1(P12R!B/ (8AH)+?BC9@L1#:@P
M*GYTM(6YC4QK(T%C);C2B27&2<7'@>P?5IS ,_:ZIRTRQMQRTOMM]%RNP^=2
ML+_>Y]]_4?<J"/Q4_P#U#YV ^?AS)R&)DVZMW_S3%]J_SE>K*JL4<]QG6A%L
M5>E*WXN01SX*6 "QC#E$24 AI8C ( EB+R$218G1!/]8 W-[F?]_[MZMN7%<
M2Q/]*WR8B*Z*,+H)$@3!GB?GK<8S66F?3-?N,U$/"ER=ZI8E;U'.2O>O/P!)
M2=2- BB 8IV.WEG.-,FUU@?RPP*P+K6.T5;)JB^]_:=\%,3S7_*ET(1V^MQ0
M<?J,NTR_X"L^^MC!/N(NH]K?<.=UEU0MWY3ZZU6Q_.#N$;V+!_4PPQ4J/PF#
M_R+EAZ*N4*#\I+W'BY.?OKQG_S.N)[37F0GQJP(DCR3&-;E6$J,T2T0"I/GP
M$4Z%J4?  )&,9BAE4*7"J:F9K>2Q35<MQ>O@Y,A;DJW]:-@Q2Q", W/-[?W[
MN^AVM5I.V>NJVBDV >%T*8/4G7-&R&L;+VOAP_;F<L7DH.&6\P-Z3[NF7;'\
M(.O_WLT?EO*%3L4'J>1R*453=.!V7NM1=Y><")8+B%$!!)3('.=G0+,7 ;3
MB,=Y(B1/U\'7C_:$UD\;JR]O-Q;[<9 3_TKU38&5*GYF4;$=?UU6'R.M]'<C
MN)XC9NU'A1J P=RL2O'HE[4)OYHFE^NQ:-2OAJ*>>&Z[AZ"/"W8!@IX]M#Z:
M#.W 78#6$?_NDJ?U8] CG75-@\2GN0GRO!/Z,Y^J*3ULS#L7G_4_F\86IB=B
M6;X^M[OXEI,\EWFA(#%Q4J:CC8* (D0!1['"$L84,J<8A4!ZCLVU;'7D[L.N
MH4;3CGY',$:!^?E8*_2;:&MDU+;RL*>ZINV6I5%CZDWTJ6[*_GFO*;M'7@\\
M-#Z)/Y2J@\X,@?'>GSI"B^N]M;!\E:).LM0"WM=^XT1E::9D2@!/TA@@B M0
MQ#P&$A&J$BQ@@9S:VYZ0,S9N_[JM/&&&PGECX"B6UML ER(4>M%?:QAM5+R)
M&B6]+O6[4/"\L#\J:NAE?)>]1Q;MG9</$N1JOHP)EUR[O(D @E&HU^>F) K"
M!.!4QDROSG-&G"J?]M!A;.1Q2:2E8[>Q/B-F1T.!QR$P1849@M 1KFT0KQC=
M6JDQYLC6-DX71K7N/*IGEC4MOS\L%S^F0HIW;W^4QBW;5%*]Y:OIC\IE.UIQ
MM9Q@2FE&"PI4G%" &,T!(Q"#E"F402GR-';J_'61-F-C4E/GH"HH\=)89+[6
MQ:9L,=V8$X%(M*L<+S8F.69P7S26=LPZV @%YMBJ^L1#:V!^,;9$T_FOK<K2
M6WMN3M2A]KAR]H*LUX3RBQ0:-N7<!W8'2>E>'NHES.,=U2\OE]^^2[G2:^E;
M(:H"-G36:O7X[FVG6';972V[K-VI#&64(ZQ GA$$4,(P*&!6 !$GI) Q3"!+
M70A\(+W'1O6[Y>O+\_7KRWX>\U"O1:]HHC$,=N!9(\ X7QJ\%!KU@,%0P52_
M9G!5Z/$X$ZP57'R_^>S+8OY#EBLIONH_EU.N?VI7>ZDGT[=*4JNS DT0+5((
M\K3( (HA B2#IK."DA+!@LG<*M?@$B7&-M.T]P:6&S.:X@C-DL(Q][C7V-C-
M$*$1#TSW&_6CK?Y-*85UW:C&A*"IQI>@Z).^>^DQ*!=?@M0^L5[TK'XLJ=<8
M]^ICN9H^:S8O)R)F/"M,)TI8",U_) 8DD5C[ZCQCF529C)TZR^P^?FS,]D==
MYF6CGQN)[4%G1T_] 0E,//M8#-/\Y3@</AED3\*@W'#<NOVO_L15/<^EJT/P
MYGAKDZJ1)B3'12X 3#@T=?@+4##!0:(XD1C"7%"GB*6C4L;V=;_?">7\=\<S
MZ:,X6IY(7XI.Z//H2K_-(720?)=.#+R>1A\5-.Q9=)>M!R?1G1=?>@Y=1UM5
MP5;;6)>]P)CR@2Y7]^I(7,W6UXX5+:B("Y!P1  J4@&T8T U^!A2(4A2H)ZG
MU)XT'!O9M!=))T+>#F/F2I/Z456F/A9\U_=DV]<[X'KN?861'?!4W-.@#E0@
MRO-8A#E<]Z7DE8[>/6-\^F#>MZ!+SH<>Z<]-$[</BV<ZG4\PPUF!) %IIO1<
MP04&-&4YD&FAX@2*F'*GCG^G!(V-\IM4R+V^=K6NO0Y9CF#K<BIR&6*!J;0?
M6#U/*DXCX?]HX8BL*YP%G+;X^.9]Q_4]7="%6OU%ER:!9_UCJWO-^T6Y*M>I
MUKEV(%,J ,ZE BB+$U! 2(!*28I)DC NG.C"6O+8^&/C'I2-VHX.GS7BEHY<
M"!Q#.VB-HG4!]/5?VDVX*KT#I%8[H^75A;(6/JQKY(K)@<OC_ !OC=:K5C*:
M%2>)*B3D) -ZA1OKE2\NS%ZX_JOI9YSR6*D,N;1EZ)#E1$@#]&+8K?0P6Y2N
MP8 =L-IQD">P K-.1T6,3:LIK?'-B4(/05NG[\,5N%OZ1MRU&Z3OVVW1$_W@
MEKZM\5:F%F(SUQ9IF@FNL8L3+C1]B!P0G#/MW:0Y03E-!'/R;G:>/C8/IE'.
MM6M=&R\[7NB-0F F:/0*X%\<M=AOT[BV@(&[PAVQ[;#MV[&+>M307KO9K2Z,
MM_.Y9H%E29=OMS^GY22.$[TBR0G 3$& )(]!P9"&3(I8,%Q(*KEUF>SS\L;V
M&6\6(NU&E2V=HS^-UB[EE2TP[_[P R 9F JN J)#&6J_8 Y4:?H<J)YJ2MMC
MTUDVVN(QPU6&MK=II_BSPVUN7%PN5Y.O\D6_&=]I*6^?EK)I9OPZUQSW0I>K
M-U.KLMGWE#(O"H4$P 7- 4*9 "SF%$"I8B8AY518Q2$Y21T;+[>UK.JC.NXN
MNT'>3<C!@ R^5G/&T)H[>F'2X</IY[7\-_VW?=_-3> @7-,+@S7C]+O94P?S
MAZ5)>ER]/>CWQ<2M?]3_6NTS34RU>2$Y!Y+!W-3P(("(G((T1AGBF<A(JGJ4
MT+/7P.K[N4+9O&:@RJ8+5:5\M?4JUYI?V,#\])C8KA.]0GR]YN5KO6^B2O.;
M"N6/9U&^O'7Y6<""-BX_+?VZ;<O/HG*V:?GY)_18VGZ1?R4QS,VS5F]WVK3Y
M2GMJ1D2SNR)PFL2<)R#+])H6(0(!4UR!@F8Q3Q%F*;5*9[&2-C;WR2A;?3X.
M:ZZSB%HL6WWB%)AZM*I1!5.M;+31ML+-X[:6$S"=BZRS#QENB65KS\X"R_HF
M7U$ZU49!*B7F6'$@TA0!)&@&"EXD %(!8YE"B3.K':YN,6-C@.-!)P[[,&=0
MM7-*+L<J, OT@<E#9,[AODJHN)SAME[LK#T?DW/!1LNV"XA^X+H^(J\VZKZ\
M5G,8RC09I D!'%9'W(("PA(.6*[=!8Z3.(VM*C"<E30V/JB5K5[T776C6E_7
MKCRG .[F!:^P!::&WHCUZ-AS!HV+6_><>O[ /7S.F'G8S.?<#?T<A=\6"_'7
M=#;3:Y']H.)MWOXV&4 5+$8TS@%F!0>(YP*0F&, <Q'#A"<4"N+B0+B)'QN1
M_'9__^$_[CY_CFZ_?(CNOCS>?OGM[MWGC]'MMV\?'[^Y^1:. V'G<X2#-S#A
MK!6O-CP.TRRVRD=_!DFAZ ><3_?%48-!W9I^Z.R[.SV?XNX&/2ZIJ3'R[>V9
M+6:3E,L"096#K(CU&BC+): PCP'#J<0Y*I(,6X7F'#QY;.S4*!?5VMD[-;MP
MG7=B>H,0F$,L[7=R48[:>H%+LON\P5R0HV:T78[C%UR__T:3,-OZQ012B;#@
M#*1(% "1F.@5C/ZR)21)DJM<<N;DDH15=VPD<<NY.68KUR7;JPF7-I7*9UN]
MK]>DX\B0VSD_XQG(P$07J&7'NB[ 9XNWX*K=.DX/SEB;=AS1^&_;N^,T^B%;
M>'1([7&"]H_I3/XT3:>6J^_R9W/&$T.N?4&> )%!"A#E&: F$H"G&4$9X:9(
MG/6IV3$)8YL+*AWKSFN5E@X'9D<!M#@DNQ26P,RZC\CYHS!+:!PB-B^%:* 8
M3>N7Q^VPL,OZS@/"HS<.=RC8I??.06#GA7U+7JYD^5#[<U4;O>;G=;)%PA.L
M[8E!DB<F4U^OA2G+(" D$WJ)@EDBG*JZG)$W-IHSZF[<W=4B^O;/5RJ6KH56
MSH%LYZ-ZA"XP%5::1HUZ-TUOSK6V 3)?+)'Q6V6R6^3 !26M[#^L'6EW6S]F
M^;R8/^E/]/F#9*M'_8@F9EAE,2:$90#F3.@E.#.1DGH=GD/,\R1)LD0YE8L\
M+F9L/&*T!$;-R.AY$QE->Q;^.(&K'8=<CE9@ZN@'E#-C=./@DRA.2!J4'[JM
MW:>%,U?W+/9AZM&^HZ5>C2V>3=_>VIO%4C"2%QE("Z79 '((BJQ ((]5$A=)
M@7B:.%7V."IF;&Q05>@%S*@9\9:>CM4\CD-J1P27 Q68""H%&XR:T-CH=KG4
MEU0!_S?1%_WNF_8X31MHCW4Z.J'Q6I3CN*1A*W!T6GM0;J/[Z@OC"II-G ^O
MR^G\Z4$NIPLQ$7&>PSQ.@50P 2B-<\ @R8"@&49I(F3,1:\H@B/"QL83:UUO
M(KK>@165NM%+I6_/J(%C,-NQAB_P G/'%K?-SG6M:?30C5O_L_\.0(*<]!^3
M=YUS_0[+3Y[B=]W3CT,^2#6=&U::U_53-"N9 .F/SR^SQ9M<_DY7_+N6M?-[
MN32AU!-%&4E%(D":DE0S3,%!(5.F:4:A7"0P)X53_^7^JHR-?]8J1[REJRE7
M2@T!&8WI4U7I5-87RO)?HI+.NK*L?0^>'6\-,R2!6:TQ(FIK625=W$2;@5I;
MLG/13=084U7KWP[5;\M%66W3^./#RX'VR987:#,HEUZ.VC[3>GCB!7536H=V
M[ZM.34]5BNZ\G(JF7=.WMW(EG[_16;4!5:5KH@(6G NJUWY) 5">(T!H&@.6
M)T@BF:1Q8A5B?K$F8V/A6D-#K+(*O;!/FKU\4"R.Y8:".C"['@^,V%H2[9AR
M$S6C4EFS7J .-2H]:KB$'IVAJ[N$&*5^%6 N0=:J-DPO <-7C;D$AZ/U9"YZ
M8,^*#Z=2KO\HI7J=?9XJ.4D*2/,",H +H0"B&00TCA'@C&(%D4J8D$[E^L[+
M'-N,]$&^+"6O0\1FTQ^N$7\V*-OY]9ZQ"SS%[%5HV"W0<!/5.D=&:8_5&NP1
M\EJFP4+LL/49['$X*,S@<*M[@:M;I::SJ:G'4J=N-2$!E$&9QRD#$LL,($D8
MH##3?V0I) 7A&4]CVVI6QT6,C52V6D:UFO85JTY@V,TA?I )3!D'H'B,GC@/
MP*6%ITX\?; J4]W6M4M*G;FR?P3$8W.0.H$9%U 4*<BQ@ !AD0$F,0(BBQ.4
M)3B7/)O,Y<K.:6@_VNIUW91^6@7^C']?+%=/9ENP%35%U^BZ1SIL\,MP4<!$
MXU?P!&O\LA10F7' N"9(+%+]6S;Y(9=LX1(YXH1A\\FWA0R (ZM[95\ G9TO
MU1>.P RX&Q#B-P)DWUS?<1^;YP\>[;%OV;$8CX-K>NSXW6H%.TH?$92K#,?:
M;3&M0Q$K"D#S%(,T3O($I9F4.+?>T^N6-39WQBCK6DKJ#)H6FW'^, K\65?P
M#%)"R@Z2SIV8,X\8;J_%SI:=W13+6]PSI=^;FC-+2=\OA)P(BF*NM&.#84KU
MAPYC4.2:%XM,4A['$L6*V29*MQ\\MJ_:Z!89Y2*CG7V>] Y8W=_Q)1 $_F@M
MK7?*DCYFZ@5)TCN/&RQ'^I@1[13IH[_OV8CHM5PMGN7RJYQ5>Z#E]^G+.H\
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M4]B^1?NSR\'O@X:JM_I@F(PV.IN9>>F!OIDY:)V_E"!$24(H$)AJ4L0B!TQ
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MU4(!XGI!PV0<@T01*0A*TCAV.GP[)6ALLTG5%T[IWYE*7:^N10].PFGG*?L
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MQ+)$X" FR_8^;\4WUP&E>A$B]5JK+C=SOZP68)L84KTJVZDJE3""BQ3I]9+
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MX1KP7E?P2]DW.3ON7!B#?9JH'$/HF9C:4V,)7J>J?"-!HRQ8:^L..(,,)G<
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M38OM096>Q+__^[_ZG\@_5![;?__7_P)02P,$%     @ <&T&46Q$)0A_H0
MC74' !4   !K:61S+3(P,C P-C,P7W!R92YX;6SDO6EW6TF2'OQ]?D6]Y:]O
M=.6^])D9'XJ2:GBL$F51U6W["TZN$EP@0 .@),ZO=R1 4EQ \A*XB9N4J[M8
M) 7=&\N3F1&1L?SK?_U^.OGE:YHOQK/IO_U*_T9^_25-PRR.IY__[=<_/[T%
M\^M__?=_^9=__?\ _L>KC^]^>3T+YZ=INOSE<)[<,L5?OHV77W[Y9TR+OW[)
M\]GI+_^<S?\:?W4 _[[Z2X>SLXOY^/.7Y2^,,'+W3^=_5\%%Y0D'06T D:4
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M? .$7BKDO]Q[Z5I(VU%_M0X_X6='3)G@):>0B68@+*-@O;3 A0\)%XQ*AO=
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M@1;-)!?10U!HS0F)=ITQ@H,2G!)"A G>[R?0LATW/RS5M_@;!),RU#%*0?%
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M"3?LWX%X=(^2!REE:=8=!/@0,U@C'54^2"ZJ1%0?H&?8O*E*IV@?LF_ .-O
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M/8M@J9?@D_7))<L9K;+C[)BHLX^SJQZ4>M)' \?8C0F)Z\8BZ'$P+J2%*'(
M(67 C9FA0XW&'I$H&9*JQ#+N$C)TGZE^%'RWM\LNTFX +0<QKGQ:-_G@QO%H
M>NC.QKC'C6R(GJ6HP4INT2.P$JQ($0+Q091R "JJU%H\0,_0J8)5L-.'[!N
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M3=/S]!;79TEL+(_\YWCYY?!\L<37S:_[_93&+OC_6,++C(04I4?NC<?%(V(
M9_!+"");':F6L=)(BF?3.JR?V0>&[M]$U558$R?I D^%TK)L%3],\Z_CD!8G
MLTD<!:),$D2!9J4WT6KXH0X<$N&:"<KPUY7.T8=(&M:=K(&PGL3? )!^G\\6
MBP_S61XO1U8R+EE&GY<SE$A$KP0EDB#SZ$-,S%B2:R#G!@W#.H8UH+*M@!NX
M0#H^6R7N3S]?MKC_T?\,;1\5N-. -*-%2#0#ZRB!Z'A*,1,K2950\H,4#>O_
MU<!-/\)O8(<Y29-).6RG\0\W_RO=8&G$DF>&4PZ4RI*K;Q.@VYHA""E16'@
MZRIU/ ^3-'!SYGYT?O<FNQ\%- "EW],4!31!3@[BZ7@Z+L(I<^.OV"$2SU@9
M)!"C'$J)X%*C+ ,E-%K-J!:Z2@'.$W0-W,*Y"JCZ5$4#R/J(.D$"RL3$U^@]
M3&:K1JU7S 2J&9IU!K*SN$R("."ML&"5%,@CR317R4M]E*J!^S57055_:F@
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M!A#SP'R=2V8RR2(+2B$:40I<20)7?G261Y4XD3K7Z3S]&%7#!J7Z1U%_*F@
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M@*A0T-D33X.N@<[GD3ELED,E2%;45 ,XW#PFYBY3CGLB"T*4EQ3E5XHQO>9
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MRZR&YAJ X,>T*)',98HK5J[K/8GDW :@S#H\?KP 1UD"M$A49CH)22J-)]E
MS<!G>FO0VUUC+>3'K,N%F$V^M%[SY99?N)(=HC6N&A(DR6CMTM2EI5.%I*D]
MY+T/82)N+_X6,'.57L"#DIP*L+24"(6L<:_E#"2A*5"GN?==KC)?8D[5LS3V
M4$[5,\375%8-RSD)K]#13E2"H )9(#F"I,':C%XY[]3ALU)63?V<JN?H[<&L
MFN<(L0'SY!]XV)4V8 7\D<;,B J@,D7()\' (C.@9 HV!6>TJ5)*=8.&@>>]
M-!%>V%8E[:#IT@AC5B"5R#KAGH)0L0RD5 )X")X;:GP652[4;E$QK%^UM2XW
M8V(+P3: B@<6TVJUX(+"17<\O=J$J5'6)A: X3%<8K^X":<0(2F;.1=2<%IG
M FAW&IM U#9(Z!8@VEDM+P)QG[[-+ED3+BE<C.@JEH&\@A())B8+FA"KDDM>
M5:I7ZD[CL [Z/A&WG5K:1=P/@^$A>^'==0IDXH19ZI%%'E/A.((-9;R-BRAF
M;2S+53)(=R=]X&EI35AM>P; 2X;\[3&M!^?++[/Y^#]3'!&22WVXPK/%H._$
M\*@QJE0D^$Q2))H&/\PUTG,Y:3R8WS,4^UH)O>#B)2^,U9?+X_9#FH]GD8YX
MRLX'9%O9H$ X@TK(V4 T*?-D1!:\K36Q@8G&+Q@:70Z[HN$EKX3UC=_B=_Q@
MF7JU9O_W^6RQ&#F:1;:$@4-E@)".@T<]E%& R8<<A>=U4LC[YV7@FY(7NBYZ
MPD:/$R+KE/F\^O/DZ/V;DY/#XS]>';T_^'1T_'Z;^IU-C^FS,.=),GNJN'EU
MOD#<+1:(%C^>KNB]T3E#YJC8J@%W2>P+7("-!B&0A55AM3%6Z;CR&%&[SU"Y
M]^S7XT68S!;G\_0)I?H*/_W7R//(?0G(1,%7;6(-6*4)E,B,R8(R(ZH8"-W(
M&]82[@TS]\>G]*Z;QHL.-RSSE=.\54WAPP^KO#-M(GD?^Y/F1$EM,Q N$7"2
M"O1E5(9D!?$F*(?_O+3]Z4?<Y6,*L\_3XJH=Q9)SG<<IK@M\#\+_.1\CD ^F
M:#4X/YZ,EZ5H;;$X/TWKH,N-Q4+0M.5&0?#9@N"6@>?4X!?FK:>!2E,G]-\O
M'PWO>,]!X<,U@OO7=@N>3)?V"=?\+SZX^?(X;U#&#P$(X8K0!90Q6B@ [\$9
M(B 3SQ31D41=N12V)TZ&]>[W /@A--X4Y'^,G=Y="#G[TF8Z033HG8FD/!A2
MN@]E)C37D8HZL^ZK<#.L [\'Z ^E^:;@?\75BMO%>"7G5Q<W?CJ<K6KR4YD,
M-5V,4>MW6(^XP%.,'))C)7G8$?!&*4C94<&)C#Q4!OW./ R;F;4'J.]7RR_/
MVSLX&[\=?]^AD<R3SZSL^SW"P#Y<P*!"\#))8%JX$F1 6]?B%R7P'\F3-[Q*
M6YC]N(!/KI[+&W:/:T%Q 5I)/ .,8KA4,P,ME-7X!X[1*N/!GDMHPT[<<W"T
MPV[W?'TU<&9OX&J=UJ\2(V78!8L9+6]O)%CF& 07$I>:,I.KE$X_0$\K75YJ
M@."!0.DN&FD46&O;]ZKB3%JFE MX^/M8& JE:8&Q(&,P*80RC;:*B?<D96UL
M93OIOP.FME?&T$U UF;)NV6\3'PDDL4@B +<RP4(*\N= 8]@K0S&NB CXT^9
M6IL>W!X.=M#9K"<!-K"U/!)=>G7QA_O?L_GAQ*'@5BV_(V&9" _$,HUG/Y=@
M*%5 M$J9$.,5VW=[V[LTMM(@9 ]G6RW-M0W*'XS=J+<6SN*Z<A9XDAZ$2QR<
M- 2XY9Y9;W)*59R;9]+9;"/<W?#2'9<[*Z\!;'YPRY+*?;G;!Q.9MRY"T D%
M95A&=PBEY;+,UMEH?*IRLWJ+BF9QM;N^[S;AVUKX#2#G\'RQG)VF^<<T63O5
M7\9GUZQ(QZDM#"16[B.# L>U@F")%$EJ%U.5V^=':!KV*-TGJOI23 ,8>S^;
MAI+/N$P'G]&X/;VQ6I(VFELE(3/+H$SR!6,M;O'>>.*D5\94J8=]F*1A[Z_V
MB;">U-( P)ZXDKMG25#BK0BD=*JQN$<[Y\'ARD%+0FIF;1945 E,/)/.5KK&
M[,%OJ*G!]@&Z<6EG)8VSG$-4 C=YS5"<I76&=UQ$S8-(NDK^[A:T#FOK5<7.
M\W"ZLR(;P.JG.9H/IV[^U^)@&E<_%%ZN3@:&)D>VDH(R$1<YX0:\0)],.4>#
MT":%.AU7'Z6J:?SMCHE9+04-'>?=% &=3E&(\X6;7ZR[HRM.I0X&G C(CB^+
MU00--@JIO!=6L3L&X@.AWZ??U4JCG8K';0VIMPVBR_5FHY*TE ;BVW'/]S&
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M!EA1M"PC$)QAM3C "TQ:<6.;9*&L2%^WB-L$%0\Q-[B(.D!>^RWEYC(&.<J
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M*/?G<1+ZP<XF0IT-RN$.[,Q39;Q&<2ZSS\"%05"6=GWO0@#G&3=9<6;Y#IJ
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M+<LQ;__.B3,4_&3IP66*IE1RBI301C"<1>0Y.&6:%/>O2^BX1V5-4+@3F76
MR3M.R+OI9:;;H\[#6]H@)OGRAQ/K7*BF'Q2KZPS&093%0&"!7 =GI=A!0+$&
MP>-&N$TQNA,9=H#5QY(SWT]"G)Q.SGY]F$W3^;S*XH0QKZ+CQ$;C)+G-M7[<
M8(9<L/JSSOC4Q/M;D;YQG<"F2&PAH<ZST [__/3^X[\?'KXY_'#X^[OC3^\/
M/FR2>?;88X;,-GN1S($RS.K0("10+>$\S9_Q;#)?GAK?)"/>3-N.7GB>!"!+
M-1<QLKI5<DC6>NVTHW]ILH6L0>.V)NL3O>?B+<L"FT\S>NSUZ][@%,OD[-$\
M3>0"?7(("15%75+5H8R1-"1I@<4XQUV3N:J;$CQN(-(*=??MVT[$N7\&;XC.
M]ZL\MK%!W$D'_'6@&ITMPB124F%#;;<C:"L.OLX_8LHK+U-JDFBU0P/Y&ZG,
M%//2<9C$\V5L=1JFES-JYW^&,U+]Z9<[G^,\52<"C8\I8@#,AG2JE )>Y@Q2
M6Y369^U]DW9/FY.\/T9R'>0]"$=V(]+.S>3;CW_^^>YXV0?IX,-O;S]^.'[W
MX8_##V_?'6Y46/7<XX8TBRN3/9PY_#8Y6W;4)TR^70:L7W":)KAX!)9225ZD
MB8 JU_YCVD-0CD-13 LG&')L91!7IW+[,'>%E]VX%CYEYVVQ4%!XTIGJSQBD
M+QI#(?SXB$TNVM8C<W33UPAE#R/@9L+;7X.WA5NXPE-W9/X:.X5KX-.B23IX
M#[7';9V\GFI36@TR.1:CY%&V:=:Z4RM8>U >X_S;U4G[S<LO)W^S9)7@JK;T
M=:!BX! 39DB&,:\U"TPW:>CP EW[9.?6P=%].S>D>,9.'@[$HV6V3Q VZ:3(
MW\020;%DP!E!KJ]&4U*4B8E5RIA72PZ^>NNXB!E4CK-MF=H#$BY38G1$GXQF
M@,75!@_)@^<^ )?9*B<D-\--]+CUWA$S?3>3V'V9;\"^D:7^YV0Z^7;^[9)P
MFR(S+""M&RD$15G 19*8\IXIRS$GOTH[AY7D?N?-(TM^$[G-AF#BV-(//V\1
M'@SG#+V"4$<@*9$9Q))KVIWTW)ADC5PEF%I-^K??/%Z3N4&DOS$3.[A6?GH+
M?']]*<IST$5F28RAA:B0 X3$$3QR;3!K18S;K;?YOH_N82W\AU:"Z0!KUP-)
MWR,MZ/IJ_,0*K801G(C/I'A.UM%KLAZ_!HE!>H\LML#7$_3TZI-N*/?9\$+H
M#DN?)U^^GGTL?RUP.;3A1&F=F1"!O#;GZR%63=N-%.&A#*J64<DV\?&S5/5J
MJUK@:AN!C)WJ_)D$0V__NNP,_ -/9]\KEP[F\^HK7-0 7B3Z',\^X;RVX_M]
M-E]>B2\^SWZ%T[-?U]6"5U<[(0OR(I"< B$2N8390D M026)4=,'J.[=UCV1
M%ST\;>.F!K9"90^"W&,<7P8T!]/I>3B]Y,6G\*O^T4DIL2@=); LR:EQT8.3
M5H)U3,;:="$JW1K+S] W;H)AKW@>2J ;8_H'SN-L!Q<Q1W^].3K\/W\=?C@^
M_%N]R-CDVN7!,X:\9'F>P*'& )W'!?[G.1%Z^&-Y'GYUZJV4=);[2!%))"_/
MU\$)468P%M%&:W-D;<9H/T'0UJWM[CWWYG)1RI!2'7T8#"U7.>8AUH8P5N=0
M(J</V]P,/TG1R%W!AD#$@]9T@W"_\ZO=^PJ[Q7WN4X]J:5^:3AM["E0VJ^ 2
MHRU.DY.OZG?.F@R9]A*4AEMEF[3$W9&9N3C=X4*R.FR9X&T%:8[3X%,P()1U
MR7&EK-^%A>G@YG40'+Q@7-;G>0>G%/?70'^VO&3RIJ@4G0"3;+TG4!G<_^WN
M6EH;.8+P/?^EH-^/2\"[P6 P4; A5U/571U,L+2QM(?\^W3+6OFQMC4>S42]
M>S$"PTSU5U]W/::Z"I.OFA:!8Z!LY?]"G9T\7;%GA*(/,&<,ZGV29]<:0=MJ
MIMOX]Y)3C3VMU$"J1+#*2Y26,OM9[D>\*5%?!!JE[\,<&@%^?RSZ-N+*L,HI
M1D!K6LQ7"(*-%C ;14;;(-,L??M?E:8[]HS1]/O\&0%[!]QIV8SZM+O?F!YW
ME6A3Y=FUL@BLJ)14@%@9T*SJF2Q$E//T7WY-F!.WJ9S:<!V-=X><V>VEH*-1
M&!%<X+J*2#7,5%S 9.L]6^VC'5)1=#1K>K!7QZOY &]&8-X!<WY?;7C]!_[;
MMM'##<.'W_MFB*G:;*J02-7J,VRNP02+!$F3+0Y=4CS+P7- KKZX-$;UJ_GT
MT &M&C(7RQJ0?MUFR[>.H30QQ6*@E#8Y4,M<+; -0.2<D)(-E5E&6WPORHE;
M3TYMP([$NCNV/.GPVGP^KW0 %UN[$*8(T6>"*G[T0GEE_2Q%4&\)=.+V?4<J
M^EW>C$3]U-];VW>_=G:>?>M!;T.B7.,%#MR27RY J&X^A&*<2)S(J(,9X]<>
MW)/FQZIJ-1%NI];Y-:?5,I_=;;/IERM<[BL&]H,(C(S.!RBV-+>NQGZ41 2M
M#"D6VBIK!I'@T)M.&PI-SXI)D3TU3<YO[]>;=]92C$8O/%:7JDV_8&<@NI2!
M2RR1! 5A_""6''C1:=V-Z4DR):X]C@')I1"R2X V$!AG-$1CVMS54M@B4<(A
MCNJ\8T#F:]DZE7LZ";ZGOIXU>!:!2)Z<3 %0N78P!JR_2(,L:+/P4B8:4D[]
M4T_Y^)#B1TWY^(@63FV>KO_YBOE^M=Q/G? F.)-!1FFKZ+K"U,QKEC(S&Z\Y
MYF$^R[/G_@AS/#ZDM=4T$'80]?Z)][?M=+W"S2X;R3IYCPF*L=5P%HL0?/7&
M2<7(06HGW"P%]"\%&<09V[T!F@3GSGBRVS$Q:NN3:I>:6A,/4W4:5,3J8CE.
ME>J)7AX6TS.EAXS(<:I]AR<C<.Z *9<U>%LM+]H92[C\>U'-:A6BK>?RXM/B
M:G=,9O2)G+-05%M42@FBU00N*Y6#\D6_C'LF^RIT6+I^^#2& M]_(II8'QV0
M[,7Y?+DOL3?1M?(R7?VYA*W%K@0*6K=1(LRN^GQEGJ^-;PDTB$KNAS%CD^#>
M 7^>)R3.,?'97?,+;UQ $3ACFQ=:S^XL"3"( A&5#$R.*<Y2O_J60%U5R(Q4
M][LI_Y'8=\"AAL:B?*XOOFVKV%ZF?;SU<\Z\NSJ&?_&-*5%)4AXHNKKQT+H:
M?U;XE"<ODVQ%0;,T[?R C%U5U$S#M+DTU 'YGF^B3[B^75]763 OED_]!WDC
M=$*-Q8-PN96RQ;9"+Z#Z$\:Q8VEQEMZ10P7LZCOX' ?<1+KICG-;CY+7F[:4
MZ\UVN,+C;M+>.BG1 'E+U<<0&LA6DBAVJD3K?!:S].H;+F)7">XY>#>9?CI@
MWA5_>;BRNEZ4IT5*-X*D2 4+9*E"W4&:(3J*X(4*,9/(OLQ2#_^60%UEK:9A
MU238SW_3;_>/]H=PS;_^\A]02P,$%     @ <&T&4=TRI,1@)P  A+@! !H
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M&<0OI@76&3JOV,IC''5]%OG(0TU95V RY'\O20R02)>Q#E"VX+ 9S(503-G
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M1/'1QB4X%$K.S4_VMA:%W]**>),/# \APV3YP]00S7'7D_[N&;_]43R*IVV
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M>?J](??[0#^&88\U;X>4<!HCD0Z:WU"3RE$@SN(?SAT9C%P^.9,>@9I>.G_
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M2^6/*O 5<*_+Q]P7++X0'*\_WQ!DS6PZ_[O)8FT68WA'BPS@YVY$./H9,0A
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M0"TA>V!"Z200_H2'#'R;!'2&;Y@??8&9$A)D[Z^(.@*[KS3@DKH)$)H'YRU
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M4LP-?&<&;V,Y<2_^#U!+ 0(4 Q0    ( '!M!E%(:IDI: @  ,TI   :
M          "  0    !E>&AI8FET,S$Q+6-E;V-E<G1I9FEC+FAT;5!+ 0(4
M Q0    ( '!M!E$#"ZO59P@  -TI   :              "  : (  !E>&AI
M8FET,S$R+6-F;V-E<G1I9FEC+FAT;5!+ 0(4 Q0    ( '!M!E'(<8T,.04
M %@5   :              "  3\1  !E>&AI8FET,S(Q+6-E;V-E<G1I9FEC
M+FAT;5!+ 0(4 Q0    ( '!M!E$;W4%T004  )\5   :              "
M ; 6  !E>&AI8FET,S(R+6-F;V-E<G1I9FEC+FAT;5!+ 0(4 Q0    ( '!M
M!E&J;<B[(A@" .67&@ 1              "  2D<  !K:61S+3(P,C P-C,P
M+FAT;5!+ 0(4 Q0    ( '!M!E&4#$YH\!   ,JU   1              "
M 7HT @!K:61S+3(P,C P-C,P+GAS9%!+ 0(4 Q0    ( '!M!E'2E)<.RR$
M #%O 0 5              "  9E% @!K:61S+3(P,C P-C,P7V-A;"YX;6Q0
M2P$"% ,4    " !P;091> ZPSQ)]  !CD 4 %0              @ &79P(
M:VED<RTR,#(P,#8S,%]D968N>&UL4$L! A0#%     @ <&T&4<12Z<-LX
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MC@0 :VED<S$P+7%E>#$P-'AF:7)S=&%M92YH=&U02P4&      P #  Z P
&/YP$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
